Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,vascular transport (GO:0010232),-0.5194522566524767,-2.1054721269656493,0.0,0.056827818570233425,0.052,27/81,10.11%,SLC24A3;SLC1A3;SLC6A13;LEPR;SLC13A3;SLC16A12;INSR;ABCC4;SLC2A1;SLCO2B1;SLCO1C1;SLC1A5;SLC6A9;SLC1A2;SLC7A5;SLCO3A1;ABCC9;SLC12A2;SLC6A6;SLC2A13;SLC1A1;TFRC;ATP8A1;SLC16A1;SLC6A1;SLC29A1;SLC16A7
prerank,transport across blood-brain barrier (GO:0150104),-0.515115396960172,-2.0925338514445553,0.0,0.036024777843630125,0.065,27/83,10.11%,SLC24A3;SLC1A3;SLC6A13;LEPR;SLC13A3;SLC16A12;INSR;ABCC4;SLC2A1;SLCO2B1;SLCO1C1;SLC1A5;SLC6A9;SLC1A2;SLC7A5;SLCO3A1;ABCC9;SLC12A2;SLC6A6;SLC2A13;SLC1A1;TFRC;ATP8A1;SLC16A1;SLC6A1;SLC29A1;SLC16A7
prerank,amino acid import across plasma membrane (GO:0089718),-0.6820509253830069,-2.0778436601976553,0.0,0.030105213409230804,0.081,9/24,5.61%,SLC1A3;SLC6A13;SLC47A1;SLC1A5;SLC6A9;SLC1A2;SLC7A5;SLC6A6;SLC1A1
prerank,negative regulation of endothelial cell migration (GO:0010596),-0.6105295717068019,-2.05537720822312,0.0,0.03171195232713919,0.109,15/36,9.23%,PTPRM;DCN;SP100;NR2F2;ADAMTS9;ACVRL1;NOTCH1;FGF2;DAB2IP;THBS1;RGCC;SLIT2;TGFB1;MECP2;PPARG
prerank,positive regulation of nuclear division (GO:0051785),-0.6685552361983883,-2.0546637693212744,0.0,0.025775474851498732,0.11,11/25,17.58%,IGF1;PDGFRB;TGFA;INSR;RGCC;IGF2;LRP5;EDN1;SIRT2;EDN3;EGF
prerank,regulation of dendritic cell apoptotic process (GO:2000668),-0.851116674696414,-2.051892311963494,0.0,0.021648692788660353,0.111,6/10,4.50%,RAPGEF2;LYN;CXCL12;GAS6;AXL;LGALS9
prerank,negative regulation of epithelial cell migration (GO:0010633),-0.6113658355409254,-2.029479852881663,0.0,0.026819251110952003,0.154,11/33,7.20%,PTPRM;PTPRG;DCN;MCC;SP100;NR2F2;ADAMTS9;ACVRL1;DAB2IP;THBS1;SLIT2
prerank,vitamin D metabolic process (GO:0042359),0.9205645815323454,2.0028483589563253,0.0,0.380808655238365,0.254,1/13,0.03%,CUBN
prerank,cell-substrate junction assembly (GO:0007044),0.7786349773750484,1.9887399499546614,0.0014005602240896359,0.2739237193685889,0.327,5/33,1.11%,FN1;ITGB4;SORBS1;ACTN2;LAMC2
prerank,aorta development (GO:0035904),-0.7415778120235277,-1.9552519984735648,0.0,0.06938575169178055,0.392,9/14,13.45%,PDGFRB;JAG1;ADAMTS9;ROBO1;PKD2;ROBO2;TBX2;PDE2A;TBX1
prerank,cobalamin metabolic process (GO:0009235),0.8400727803028787,1.9317557040504274,0.0015408320493066256,0.5992184931862174,0.686,2/17,2.69%,CUBN;AMN
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.760815939797673,1.9293438843142858,0.0,0.4675594520256949,0.698,4/27,1.72%,AGTR1;GPR4;LPAR1;LPAR4
prerank,tetrapyrrole metabolic process (GO:0033013),0.8253559763925034,1.9168887641220047,0.0030721966205837174,0.4700948621323733,0.768,2/18,2.69%,CUBN;AMN
prerank,aorta morphogenesis (GO:0035909),-0.6776613477383737,-1.9146551870948807,0.0,0.10655215981918768,0.565,6/17,3.01%,PDGFRB;JAG1;ENG;ADAMTS9;MYLK;ACVRL1
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.6555479962034048,1.9117719773743345,0.0,0.43118543121419745,0.791,7/76,1.72%,ADRA1B;AGTR1;GPR4;LPAR1;CHRM1;ACTN2;LPAR4
prerank,hematopoietic stem cell proliferation (GO:0071425),-0.7767325135574226,-1.8930325742979477,0.002583979328165375,0.12684780930855674,0.661,5/11,4.58%,MECOM;ETV6;WNT5A;CD34;RUNX1
prerank,steroid metabolic process (GO:0008202),0.6573915388327898,1.8766952996602617,0.0,0.6590645879544997,0.927,12/72,8.74%,CUBN;SULT1A1;FDFT1;STARD3;SULT2B1;HSD17B14;DHRS4;NPC1;CYP39A1;CYP51A1;MSMO1;FDX1
prerank,regulation of acrosome reaction (GO:0060046),-0.7897515089980457,-1.875071845065817,0.0,0.14520614680121335,0.751,2/10,7.24%,PLCB1;GLRA1
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.7312492920607603,1.8651099060225,0.0013089005235602095,0.6838150199482651,0.948,6/30,2.55%,GPR4;LPAR1;RTN4R;PRAG1;LPAR4;AKAP13
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),-0.7509260021965878,-1.8589329066559015,0.005333333333333333,0.16101215261566137,0.803,6/12,7.45%,ADAMTS12;DCN;SEMA6A;XDH;DAB2IP;PIK3CB
prerank,heterotypic cell-cell adhesion (GO:0034113),0.7487047605699109,1.8527323382972798,0.002890173410404624,0.7244975808103271,0.965,6/25,2.84%,CXADR;DSG2;PARVA;CD200;NINJ1;ITGB7
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),-0.7730911974002761,-1.8518384576936335,0.0024937655860349127,0.16072593191773438,0.833,5/10,9.87%,BMP6;NEXMIF;NOTCH1;RGCC;NOTCH4
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),0.891428811345692,1.8442118877381646,0.001658374792703151,0.7384506220510018,0.972,3/10,1.66%,DPP4;CCL5;PODXL
prerank,cell-matrix adhesion (GO:0007160),0.6152510373900668,1.8420071941617615,0.0,0.691837039448005,0.977,12/95,2.84%,FN1;ITGB4;SORBS1;ITGA10;MSLN;CD44;ITGB8;LYPD5;ACTN2;ITGBL1;EMP2;ITGB7
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),-0.7746803279267075,-1.8349774542127868,0.0024875621890547263,0.18048631153046077,0.877,5/10,7.45%,DCN;SEMA6A;XDH;DAB2IP;PIK3CB
prerank,endothelial cell differentiation (GO:0045446),-0.7192397961719564,-1.8249168620949177,0.005263157894736842,0.19138797468475044,0.912,8/12,17.15%,JAG1;ACVRL1;TIE1;KDR;KDM6B;SCUBE1;BMPR2;SOX18
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),-0.6570154404891647,-1.8234956843577563,0.0,0.18247057369035888,0.915,8/16,9.62%,IGF1;ZFPM2;NOTCH1;FGF2;GLI1;ERBB4;FGFR2;TBX2
prerank,ganglioside biosynthetic process (GO:0001574),-0.6930733119818225,-1.8192081614806501,0.0,0.17931803254724918,0.923,8/15,17.07%,ST6GALNAC3;ST3GAL1;ST3GAL5;ST8SIA4;ST6GALNAC5;ST8SIA6;B4GALT5;ST8SIA2
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.7918133151343869,1.8147257438350968,0.0029806259314456036,0.8885535288895182,0.991,3/17,2.55%,ADRA1B;ADCY9;AKAP13
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),-0.7704878317666093,-1.8126486295167314,0.002506265664160401,0.18294272942500742,0.942,7/10,13.69%,GHR;LYN;STAT5B;JAK2;STAT5A;STAT3;STAT6
prerank,positive regulation of nervous system development (GO:0051962),-0.5152412416650707,-1.804080071239133,0.0,0.18933704589424577,0.954,20/42,20.54%,IL1RAPL1;NRXN1;GRID2;TGM2;EPHB2;CLSTN2;SERPINF1;NLGN1;LRRC4B;DLG5;NLGN3;SYNDIG1;BDNF;MME;SRPX2;SOX11;EPHB3;NUMB;OPRM1;CX3CR1
prerank,regulation of complement activation (GO:0030449),0.6791572858378312,1.8030933067716233,0.005249343832020997,0.9369927365585881,0.995,7/40,6.32%,CD55;CLU;CFHR1;C8A;CFH;CD81;CFP
prerank,fat-soluble vitamin metabolic process (GO:0006775),0.7575774883944602,1.8024955393736506,0.005979073243647235,0.8765274940231073,0.995,2/22,4.82%,CUBN;UBIAD1
prerank,low-density lipoprotein particle remodeling (GO:0034374),0.8644209334918463,1.7994252840231315,0.00641025641025641,0.8446727056053063,0.997,1/11,0.18%,AGTR1
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),-0.5755140438217919,-1.7974881236952396,0.0,0.19499045246911345,0.96,20/27,29.11%,FLT1;PDGFRB;PRKD1;TEK;PTK2;PDGFRA;FGF2;TGFB1;KIT;EPHA8;P2RY12;FLT3;CCL19;NOD2;FGFR3;AGAP2;FGR;AMBRA1;IRS1;ATG14
prerank,positive regulation of vasoconstriction (GO:0045907),0.8190985163994979,1.7967380689763899,0.007886435331230283,0.8167997657397307,0.997,2/13,2.65%,ADRA1B;CAV1
prerank,regulation of immune effector process (GO:0002697),0.6724107165065819,1.7939782763483962,0.0038809831824062097,0.7927323779912148,0.997,7/41,6.32%,CD55;CLU;CFHR1;C8A;CFH;CD81;CFP
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.6314891877096095,1.7934629529248942,0.0036101083032490976,0.752668804217865,0.997,21/67,16.81%,FN1;CDH13;UTRN;DOCK5;EMP2;CDK6;LIMS2;S100A10;PTK2B;DMTN;ILK;CDC42;NPNT;DOCK1;RREB1;SFRP1;GSK3B;FLNA;TESK1;CRK;ABL1
prerank,cell-cell junction organization (GO:0045216),0.615836409205688,1.7820614757445778,0.0070921985815602835,0.8047375979463484,0.999,17/79,8.30%,CDH1;CXADR;SDK1;DSG2;CDH13;NECTIN3;TJP2;TJP1;OCLN;PKP4;LIMS2;CTNNA1;CSK;PVR;TGFB2;ANG;PARD6B
prerank,positive regulation of cell junction assembly (GO:1901890),-0.48331173822787815,-1.7820172584126386,0.0,0.2170668035862998,0.974,21/56,13.96%,PTPRJ;IL1RAPL1;CNTNAP2;TEK;NRXN1;CLDN5;GRID2;KDR;TSC1;EPHB2;CLSTN2;NLGN1;ROCK1;LRRC4B;MAP4K4;DLG5;MYOC;NLGN3;SYNDIG1;BDNF;SRPX2
prerank,negative regulation of amyloid fibril formation (GO:1905907),0.8156272416968989,1.780619404255862,0.0030816640986132513,0.7752886394833292,1.0,4/12,5.33%,CLU;LDLR;PFDN1;CRYAB
prerank,acidic amino acid transport (GO:0015800),-0.6372358655597747,-1.7763228915220386,0.0031545741324921135,0.22062293524466434,0.981,6/17,8.63%,SLC1A3;SLC6A13;SLC1A2;SLC6A6;SLC1A1;SLC6A1
prerank,regulation of vasoconstriction (GO:0019229),0.7150078407113586,1.7748899862659324,0.007122507122507123,0.7838702096389868,1.0,3/27,2.65%,ADRA1B;AGTR1;CAV1
prerank,regulation of humoral immune response (GO:0002920),0.6610238010932687,1.7738565130295871,0.005082592121982211,0.7556064451614317,1.0,6/44,3.22%,CD55;CLU;CFHR1;C8A;CFH;CD81
prerank,myofibril assembly (GO:0030239),0.6738308916585203,1.7696180744905172,0.006265664160401002,0.7554787216421464,1.0,8/42,5.09%,PGM5;MYOM2;KRT19;ACTN2;TMOD3;TMOD2;CSRP3;LMOD3
prerank,integrin-mediated signaling pathway (GO:0007229),0.6114058707908582,1.766231200248421,0.002380952380952381,0.7496031122588094,1.0,20/73,12.97%,FN1;ITGB4;ITGA10;ITGB8;ITGBL1;ADAM10;ITGB7;LAMA5;PTK2B;FYB2;FBLN1;PTPRA;ILK;CDC42;ADAMTS1;TXK;ADAM15;BCAR1;PTN;DOCK1
prerank,heart morphogenesis (GO:0003007),-0.4795197400536132,-1.762435751388359,0.0,0.2438125197353338,0.985,17/50,14.11%,FLRT2;ENG;INSR;NOS3;PTK2;ACVRL1;TBX3;NOTCH1;EPHB4;CHD7;SOX17;HEYL;TBX2;MEGF8;TBX1;NIPBL;RYR2
prerank,vitamin transport (GO:0051180),0.7005221807501325,1.7623531939594161,0.013333333333333334,0.747419013879331,1.0,2/29,2.69%,CUBN;AMN
prerank,epithelial structure maintenance (GO:0010669),0.8427508470896692,1.7607575315687294,0.017107309486780714,0.7302210556112251,1.0,2/11,1.01%,CXADR;VSIG1
prerank,regulation of cell-cell adhesion (GO:0022407),0.668007991303151,1.759760277531368,0.006570302233902759,0.7100621303845037,1.0,8/39,6.10%,DPP4;CDH1;WNT1;B4GALNT2;PODXL;SPINT2;FLOT2;EFNA5
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),-0.7145407713713071,-1.759308126843774,0.007407407407407408,0.2419410549545206,0.988,5/11,9.69%,RAPGEF2;LYN;LGALS9;PIK3CB;PIK3CD
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),-0.7071517785485721,-1.7562075227105043,0.008108108108108109,0.23924511618068275,0.99,4/11,2.88%,MERTK;CXCL12;GAS6;AXL
prerank,regulation of cardiac muscle cell action potential (GO:0098901),0.7162698368510465,1.7560267610683906,0.012622720897615708,0.7112997177433503,1.0,5/25,2.65%,CXADR;FGF13;DSG2;ANK2;CAV1
prerank,sarcomere organization (GO:0045214),0.7200790827906591,1.7553239555044513,0.005390835579514825,0.6916749627062911,1.0,4/27,3.66%,MYOM2;KRT19;ACTN2;CSRP3
prerank,regulation of amyloid fibril formation (GO:1905906),0.7711335637416836,1.7547126534172586,0.010416666666666666,0.673159668977061,1.0,4/15,5.33%,CLU;LDLR;PFDN1;CRYAB
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),0.8025331760036014,1.749961598680719,0.010703363914373088,0.6831976050899026,1.0,3/14,1.37%,ANK2;ACTN2;GAL
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),-0.5949018458300441,-1.7485883521492556,0.012861736334405145,0.24807528491236513,0.993,10/19,13.02%,HS6ST2;NDST3;HS6ST3;XYLT1;CSGALNACT1;EXTL3;XYLT2;EXT2;HS3ST3B1;B3GAT3
prerank,cGMP-mediated signaling (GO:0019934),-0.6743057549867753,-1.7473221559204366,0.008152173913043478,0.2418940742844063,0.995,5/13,9.95%,IRAG1;PDE3A;GUCY1B1;PDE9A;PDE2A
prerank,positive regulation of osteoblast differentiation (GO:0045669),-0.5014690886355432,-1.7462883426520692,0.0,0.23586444085145356,0.995,18/43,16.84%,BMP6;IGF1;PRKD1;WNT4;ZHX3;BMPR1B;RUNX2;FBN2;IL6R;ACVR2A;LRP5;CCN4;IL6ST;CCN1;BMPR2;CTNNBIP1;SOX11;SUCO
prerank,phosphate ion homeostasis (GO:0055062),-0.7321350381400724,-1.74541147019789,0.0024691358024691358,0.22951580172546865,0.995,4/10,12.69%,ENPP1;XPR1;SFRP4;FGFR4
prerank,regulation of intracellular pH (GO:0051453),0.6804893792981676,1.7437755353667315,0.01478494623655914,0.7017431036682827,1.0,14/34,16.86%,SLC9A2;CFTR;SLC9A4;SLC4A2;TMEM165;CHP1;SLC9A6;SLC9A7;GPR89B;GPR89A;SLC9A8;ATP5F1B;SLC4A4;SLC9A1
prerank,positive regulation of synapse assembly (GO:0051965),-0.5573573355971488,-1.7413682867847071,0.00980392156862745,0.23126892593136067,0.998,12/27,13.96%,IL1RAPL1;NRXN1;GRID2;EPHB2;CLSTN2;NLGN1;LRRC4B;DLG5;NLGN3;SYNDIG1;BDNF;SRPX2
prerank,autonomic nervous system development (GO:0048483),0.7549363614536179,1.7381565285071123,0.006220839813374806,0.7169049088331084,1.0,2/17,3.81%,FN1;GDNF
prerank,sulfation (GO:0051923),0.8553873452391416,1.737182532742537,0.0032679738562091504,0.7019021151152846,1.0,3/11,3.24%,UST;SULT1A1;SULT2B1
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.8036572144318105,1.7361997825093798,0.017488076311605722,0.6883247830231692,1.0,1/12,0.05%,FZR1
prerank,actomyosin structure organization (GO:0031032),0.6069857890376671,1.7345490468031612,0.002317497103128621,0.678954102968141,1.0,12/75,5.09%,SORBS1;PGM5;MYOM2;PHACTR1;KRT19;ACTN2;TJP1;TMOD3;TMOD2;CSRP3;EPB41L1;LMOD3
prerank,positive regulation of mitotic nuclear division (GO:0045840),-0.5359122280665652,-1.7324025363126268,0.0038314176245210726,0.24416975732452254,0.999,12/34,17.58%,IGF1;PDGFRB;TGFA;INSR;ANAPC11;RGCC;IGF2;LRP5;ANAPC7;EDN1;EDN3;EGF
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),-0.7314077361513328,-1.728755995353453,0.005141388174807198,0.24545051101205734,0.999,4/11,1.02%,PLCB1;IGF1;GHR;PIK3R1
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.6953841187235874,1.728629918254791,0.011461318051575931,0.6977147642797903,1.0,7/27,5.41%,FN1;WNT1;PDGFC;CDKN1A;S100A6;CDK6;CDK4
prerank,adrenergic receptor signaling pathway (GO:0071875),0.7273977455773162,1.7244424599498687,0.018651362984218076,0.7055452376324387,1.0,3/20,2.55%,ADRA1B;ADCY9;AKAP13
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),-0.6316322198913543,-1.7179198523081296,0.016483516483516484,0.26335142761660124,1.0,8/16,15.00%,IGF1;TRPC3;CAMK2D;ROCK1;PDE9A;IL6ST;MTPN;EDN1
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),-0.5629559719838874,-1.7157536952377064,0.01056338028169014,0.2603215512445252,1.0,9/24,13.19%,SULF1;CCBE1;HIF1A;CYP1B1;PTGS2;RORA;TGFB1;IL6ST;FLT4
prerank,entry into host (GO:0044409),0.7924900338167207,1.7156391648974159,0.012698412698412698,0.7431084342831802,1.0,3/13,7.09%,CDH1;CXCR4;CBLL1
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),-0.571015988601409,-1.7140346000417077,0.009345794392523364,0.2570878914603366,1.0,10/22,15.00%,IGF1;CAMK2D;NOTCH1;LMCD1;ROCK1;PDE9A;GLRX3;IL6ST;MTPN;EDN1
prerank,striated muscle cell development (GO:0055002),0.7793093029193525,1.7136404885094534,0.025487256371814093,0.7372077739594927,1.0,4/14,5.09%,PGM5;TMOD3;TMOD2;LMOD3
prerank,peptide cross-linking (GO:0018149),0.6995285195452025,1.713100340419506,0.017045454545454544,0.7226221937714322,1.0,1/25,0.04%,FN1
prerank,negative regulation of response to wounding (GO:1903035),0.7353735987676298,1.7122234058521826,0.01579778830963665,0.7101515628397658,1.0,6/19,11.50%,CD109;RTN4R;EPHA4;ALOX5;CASK;CERS2
prerank,regulation of actin filament depolymerization (GO:0030834),-0.6922053054456111,-1.7120399559730892,0.0113314447592068,0.2546258358853763,1.0,3/12,3.32%,PLEKHH2;SEMA5A;LIMA1
prerank,positive regulation of leukocyte proliferation (GO:0070665),-0.6854142735886164,-1.7104078910973017,0.013020833333333334,0.2511723757076244,1.0,3/12,2.51%,IL34;LYN;PTK2
prerank,negative regulation of transforming growth factor beta production (GO:0071635),0.8360708437070874,1.708986260530853,0.017770597738287562,0.7149787132567542,1.0,1/10,0.04%,FN1
prerank,positive regulation of ion transport (GO:0043270),0.6297263322745437,1.7049427642665533,0.01272264631043257,0.7242866732554043,1.0,10/48,8.01%,ANK2;CHRM1;ACTN2;STIM2;CCL5;FHL1;GDNF;AHCYL1;ANK3;RAB3B
prerank,lipid modification (GO:0030258),0.6457840114486935,1.698100753065827,0.013280212483399735,0.7496417786438786,1.0,2/37,1.64%,PLPPR2;MBOAT2
prerank,bone morphogenesis (GO:0060349),-0.6466637649658724,-1.6966914698902162,0.016,0.2796793909238979,1.0,7/14,14.37%,CYP26B1;BMPR1B;LRP6;LRP5;FGFR2;SFRP4;BMPR2
prerank,phospholipid catabolic process (GO:0009395),-0.5516715652063234,-1.6948988461166905,0.006600660066006601,0.2769835754029922,1.0,9/24,20.90%,PLA2G4A;GPCPD1;ENPP2;ENPP6;GDPD1;ABHD12;PNPLA6;PLA2G4C;GDPD3
prerank,phospholipid dephosphorylation (GO:0046839),0.6460511960881313,1.6925806230926803,0.01195219123505976,0.7669993830816996,1.0,1/37,0.01%,PLPPR2
prerank,dendrite self-avoidance (GO:0070593),-0.6210866331891453,-1.691007200538187,0.01015228426395939,0.28005459339143157,1.0,7/16,10.61%,PALLD;EMB;NEXN;DSCAML1;CNTN6;BSG;ROBO4
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),-0.5928531060110384,-1.6892709620456574,0.00911854103343465,0.27720887107430936,1.0,9/19,13.01%,ZFPM2;NOTCH1;RUNX1;FGF2;GLI1;ERBB4;FGFR2;TBX2;RBP4
prerank,phospholipid metabolic process (GO:0006644),0.5882927583295942,1.6890367480159763,0.007050528789659225,0.7739294396555938,1.0,3/71,1.69%,PLPPR2;PLB1;FDFT1
prerank,protein localization to cell-cell junction (GO:0150105),0.7449231125084862,1.688761143189981,0.02531645569620253,0.7594423263165891,1.0,7/15,11.60%,TJP2;TJP1;ARHGEF18;LSR;ACTB;ACTG1;JAK1
prerank,negative regulation of extracellular matrix organization (GO:1903054),0.8067475612173385,1.687552238405671,0.022764227642276424,0.7515121945653587,1.0,2/10,1.00%,DPP4;ADTRP
prerank,growth hormone receptor signaling pathway (GO:0060396),-0.6513064341691288,-1.6831638071106663,0.013736263736263736,0.28454983813845197,1.0,9/14,13.69%,GHR;PIK3R1;LYN;STAT5B;PTK2;JAK2;STAT5A;STAT3;STAT6
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),0.7464082979352172,1.6817373417798784,0.015723270440251572,0.7718384931813003,1.0,3/15,7.50%,CD55;GLI3;NKAP
prerank,angiogenesis involved in wound healing (GO:0060055),-0.6678602556617843,-1.6790200968533897,0.015665796344647518,0.287631832530733,1.0,9/11,27.43%,ADIPOR2;CD34;NDNF;KDR;GATA2;PRCP;SRF;MCAM;HPSE
prerank,regulation of lamellipodium organization (GO:1902743),0.7647446180419294,1.6786360764474513,0.014469453376205787,0.7758686352593668,1.0,6/14,12.80%,CD44;CAPZB;TWF1;DMTN;CDC42;PDPN
prerank,response to iron ion (GO:0010039),-0.6525021127308008,-1.6783106779335368,0.013123359580052493,0.28266304561557665,1.0,5/12,13.00%,BMP6;HIF1A;BCL2;B2M;FXN
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.5467292006886117,1.67797947803313,0.0011025358324145535,0.7652502510519101,1.0,16/140,4.60%,ADRA1B;CD55;AGTR1;GPR4;LPAR1;CCR4;LPAR4;CACNA1A;CAV1;CXCR4;CACNB3;PTGFR;ACKR4;ACKR2;CCR10;ACKR3
prerank,cellular response to arsenic-containing substance (GO:0071243),0.7562459336722681,1.6760301575285212,0.030844155844155844,0.7625553090363595,1.0,5/15,6.86%,DAXX;CPEB2;ZC3H12A;MKNK2;GSTO1
prerank,neuron cell-cell adhesion (GO:0007158),-0.6375967568363522,-1.6669737400670606,0.005509641873278237,0.30560737986658865,1.0,8/14,18.29%,NRXN3;NRXN1;NCAM2;NLGN1;ASTN2;NLGN3;RET;ASTN1
prerank,regulation of extracellular matrix organization (GO:1903053),-0.6109201207333799,-1.6666869822466546,0.016901408450704224,0.299802039739702,1.0,6/15,5.11%,AEBP1;FAP;TIE1;NOTCH1;RUNX1;RIC1
prerank,negative regulation of developmental growth (GO:0048640),0.6571855040223185,1.6664809511165084,0.0223463687150838,0.8064150794640108,1.0,6/30,4.06%,FGF13;RTN4R;OSTN;CDKN1A;GDF15;DUSP10
prerank,glycerolipid catabolic process (GO:0046503),-0.5799109335263967,-1.6664074322743538,0.021021021021021023,0.2943732820617639,1.0,10/19,20.90%,PLA2G4A;GPCPD1;MGLL;ENPP6;GDPD1;ABHD12;PNPLA6;ABHD2;PLA2G4C;GDPD3
prerank,response to amino acid starvation (GO:1990928),0.5747112421815653,1.6621674261882897,0.013285024154589372,0.8197735622641413,1.0,6/72,3.80%,DAPL1;RNF152;ATP6V1B1;MAP3K5;CDKN1A;SESN2
prerank,cellular response to amino acid starvation (GO:0034198),0.5765400699499269,1.6608920305504173,0.012062726176115802,0.8129469366560527,1.0,6/71,3.80%,DAPL1;RNF152;ATP6V1B1;MAP3K5;CDKN1A;SESN2
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),-0.6716547895059352,-1.656429253606131,0.019230769230769232,0.3143711540697065,1.0,4/10,7.16%,PRKG1;RDX;SERPINE2;SH2B3
prerank,smooth muscle contraction (GO:0006939),-0.62751566269825,-1.6561555681302043,0.011461318051575931,0.3086388411633341,1.0,6/14,12.24%,SLC8A1;MYLK;SMTN;ROCK1;MYH11;ACTA2
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),0.6844218250997902,1.6558861303570152,0.020202020202020204,0.8317575515428041,1.0,5/22,6.85%,CD44;KLF4;GCNT2;FLOT2;MAPK7
prerank,regulation of neutrophil chemotaxis (GO:0090022),0.6928191522882351,1.6512159116163292,0.03268945022288262,0.8489595315282952,1.0,4/23,5.38%,DPP4;MCU;RIPOR2;MOSPD2
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),0.7284168997300534,1.6462100592693527,0.02526002971768202,0.8671456460567911,1.0,5/15,8.17%,SMO;GDNF;SOX9;BMP4;SIX1
prerank,regulation of cAMP-mediated signaling (GO:0043949),-0.5407479558089835,-1.6437674740135693,0.007462686567164179,0.33560885995620715,1.0,13/24,24.28%,PDE3A;RAPGEF2;PDE4D;PDE3B;GNAI1;PRKAR2B;PDE2A;PDE11A;PEX5L;PRKAR1B;CGAS;APLNR;RNF157
prerank,neural crest cell migration (GO:0001755),0.6252873794495228,1.6430309854022183,0.014397905759162303,0.8746004876488436,1.0,4/36,3.81%,FN1;SEMA3D;SEMA3B;GDNF
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),0.7195096139042452,1.6418419305343037,0.027777777777777776,0.8681518039338183,1.0,1/16,0.19%,CLDN11
prerank,nucleoside catabolic process (GO:0009164),0.7778856231410858,1.6360350347971793,0.030448717948717948,0.8930705466844652,1.0,5/11,9.45%,NT5E;NT5C1A;NT5C3A;UPP2;DERA
prerank,regulation of cellular pH (GO:0030641),0.6413771492623925,1.6329474592865418,0.02912621359223301,0.899159165937062,1.0,6/29,10.07%,SLC9A2;SLC9A4;SLC4A2;CHP1;SLC9A6;SLC9A7
prerank,sodium ion import across plasma membrane (GO:0098719),0.7188961045148032,1.631708817338455,0.025039123630672927,0.8933281369743988,1.0,2/17,0.16%,SLC9A2;SLC9A4
prerank,central nervous system neuron development (GO:0021954),-0.5974170222204743,-1.6315764994953945,0.03064066852367688,0.3642870106385972,1.0,8/15,19.68%,RAPGEF2;MAP2;NTRK2;LHX6;GBA2;B4GALT5;ARHGAP35;HSP90AB1
prerank,negative regulation of cell adhesion (GO:0007162),0.5638063730237852,1.6294400788502539,0.015457788347205707,0.8946823633756469,1.0,17/72,7.30%,CDH1;CDH13;ANGPT1;WNT1;B4GALNT2;PLXNB1;PODXL;ADAM10;PLXNA2;SPINT2;GCNT2;RIPOR2;DUSP1;FBLN1;DMTN;CBLL1;ERBB3
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),-0.645309024788999,-1.6290809252742264,0.0234375,0.36458011900037807,1.0,2/12,0.92%,PTPRJ;CBLB
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),-0.632121265413596,-1.6284065639172922,0.008823529411764706,0.35963507958379193,1.0,7/13,9.62%,ZFPM2;NOTCH1;FGF2;GLI1;ERBB4;FGFR2;TBX2
prerank,positive regulation of lipid kinase activity (GO:0090218),-0.5000473460980392,-1.6247076853791946,0.01444043321299639,0.3630854109112037,1.0,9/29,10.12%,FLT1;PDGFRB;PRKD1;TEK;PTK2;PDGFRA;FGF2;TGFB1;KIT
prerank,hemidesmosome assembly (GO:0031581),0.7592250336961162,1.6243278009258806,0.050793650793650794,0.9155647607449812,1.0,4/11,10.70%,ITGB4;LAMC2;LAMC1;PLEC
prerank,positive regulation of Ras protein signal transduction (GO:0046579),0.5793901980617505,1.6242084379676942,0.016766467065868262,0.9028493736037912,1.0,11/62,4.46%,GPR4;MAPRE2;STK19;LPAR1;NOTCH2;RTN4R;PRAG1;LPAR4;AKAP13;NGF;EPO
prerank,nuclear membrane disassembly (GO:0051081),0.7251188026651171,1.6233921435169267,0.027950310559006212,0.894733651948473,1.0,1/14,0.09%,PRKCB
prerank,"synaptic transmission, GABAergic (GO:0051932)",-0.6859090744685523,-1.621869666923716,0.014184397163120567,0.36401169888705687,1.0,7/10,19.24%,GABRG3;GABRG2;GABRG1;GABRA3;GABRB2;GABRA1;GABRE
prerank,camera-type eye morphogenesis (GO:0048593),-0.691040020138775,-1.6217777560222113,0.03763440860215054,0.3577108222501301,1.0,6/10,20.94%,IFT122;LRP6;TBX2;NF1;KDM2B;TENM3
prerank,positive regulation of muscle hypertrophy (GO:0014742),-0.6040614225491376,-1.6210047383852166,0.029490616621983913,0.3532867267254738,1.0,7/15,15.00%,IGF1;CAMK2D;ROCK1;PDE9A;IL6ST;MTPN;EDN1
prerank,dopamine metabolic process (GO:0042417),-0.5789611861989314,-1.6188884353898667,0.019886363636363636,0.3530393236176632,1.0,6/18,12.83%,MOXD1;SNCAIP;MAOB;MAOA;GCH1;DRD2
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),-0.5220564574751596,-1.618335266038934,0.01524390243902439,0.3486895780491351,1.0,12/23,28.20%,PRKAG2;CEMIP;TGFB1;IRGM;S1PR2;EGF;SPHK1;BMP7;STOX1;TRIM6;RIPK2;CALM3
prerank,stress fiber assembly (GO:0043149),0.7207044858911112,1.6182961712866613,0.021505376344086023,0.9016401274606838,1.0,2/15,0.50%,SORBS1;PHACTR1
prerank,contractile actin filament bundle assembly (GO:0030038),0.7207044858911112,1.6182961712866613,0.021505376344086023,0.9016401274606838,1.0,2/15,0.50%,SORBS1;PHACTR1
prerank,mucosal immune response (GO:0002385),0.7324049473618475,1.6175007863747388,0.020569620253164556,0.8941504297786049,1.0,3/15,9.98%,RAB17;OTUD7B;RNASE3
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),0.6776181736392161,1.6169429858923152,0.030882352941176472,0.8852530767354,1.0,1/21,0.05%,FZR1
prerank,sterol transport (GO:0015918),0.6823252606587769,1.6140297902185923,0.03298350824587706,0.8921810562872011,1.0,4/19,6.45%,LDLR;CAV1;STARD3;NPC1
prerank,negative regulation of platelet activation (GO:0010544),-0.5806308524226259,-1.6139078560948104,0.030726256983240222,0.35495399652782406,1.0,5/16,7.16%,PRKG1;NOS3;PDGFRA;SERPINE2;SH2B3
prerank,positive regulation of cyclase activity (GO:0031281),-0.6053290737612232,-1.613039339838576,0.03418803418803419,0.3513476370618647,1.0,3/14,2.50%,CACNA1C;STIM1;NOS3
prerank,regulation of fibroblast proliferation (GO:0048145),0.6007714897544307,1.6120900073057696,0.022670025188916875,0.893412952959022,1.0,7/45,5.41%,FN1;WNT1;PDGFC;CDKN1A;S100A6;CDK6;CDK4
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.5545379406422224,1.6056744874278488,0.013237063778580024,0.9240293848135519,1.0,18/70,9.94%,FN1;POF1B;SRGAP2;PARVA;ITGB7;MEGF9;LAMA5;TMEFF2;UNK;ANTXR1;PXN;ILK;SRCIN1;LAMC1;GRHL2;OPHN1;DACT2;LAMB2
prerank,cellular component maintenance (GO:0043954),-0.623269564131699,-1.6052309893006695,0.030927835051546393,0.36669655738695556,1.0,4/12,13.17%,INSR;IGF1R;MTMR2;CLDN1
prerank,regulation of feeding behavior (GO:0060259),-0.6565622723448632,-1.6045536274792036,0.023746701846965697,0.36268003484336053,1.0,5/11,10.70%,LEPR;AGRP;SGIP1;CFAP20;STAT3
prerank,regulation of vascular endothelial growth factor production (GO:0010574),-0.5155991870100662,-1.6043448920602734,0.013986013986013986,0.35752055053616727,1.0,9/26,13.19%,SULF1;CCBE1;HIF1A;CYP1B1;PTGS2;RORA;TGFB1;IL6ST;FLT4
prerank,selective autophagy (GO:0061912),0.5777715627883914,1.6032599436380433,0.02696078431372549,0.9289831592627821,1.0,19/56,18.46%,CFTR;DYNC1I1;VIM;DDRGK1;TEX264;WDFY3;LGALS8;RAB7A;ULK1;MAP1LC3B;RB1CC1;UBE2N;DYNC1LI2;UFM1;RPS27A;UBC;DYNC1H1;HDAC6;PARK7
prerank,endothelial cell migration (GO:0043542),0.6036544730511852,1.6017938370711067,0.028645833333333332,0.9265642353695743,1.0,3/37,2.06%,DPP4;CDH13;EMP2
prerank,epithelial cell migration (GO:0010631),0.6197356155318009,1.5995129382261286,0.02894736842105263,0.9298543270073567,1.0,5/37,3.59%,DPP4;CDH13;KANK1;FAT2;KANK2
prerank,T cell activation (GO:0042110),0.56166855153739,1.5982392967868395,0.01555023923444976,0.9264409925668787,1.0,3/69,0.58%,DPP4;CXADR;CD44
prerank,positive regulation of lyase activity (GO:0051349),-0.5858637798789648,-1.598220215290758,0.02452316076294278,0.36891245956445495,1.0,6/14,18.10%,CACNA1C;STIM1;NOS3;NF1;FXN;ISCU
prerank,stabilization of membrane potential (GO:0030322),-0.575009847929405,-1.5941458864052787,0.03216374269005848,0.37462386349127097,1.0,9/16,32.17%,KCNK2;KCNK5;KCNK13;KCNK3;KCNK12;KCNK1;KCNN4;KCNK6;KCNK4
prerank,keratinocyte differentiation (GO:0030216),0.6356907570690881,1.5939511462150158,0.024079320113314446,0.9432471305698588,1.0,2/29,0.45%,WNT16;SCEL
prerank,regulation of establishment of cell polarity (GO:2000114),0.7082368466443263,1.5936909676487225,0.04420731707317073,0.9333206102696013,1.0,12/16,18.79%,KANK1;GSN;RAP1B;PTK2B;RIPOR2;KRIT1;BCAS3;ARFGEF1;CDH5;SHTN1;KIF20B;ROCK2
prerank,icosanoid secretion (GO:0032309),-0.6254964106224283,-1.5912426129818456,0.034482758620689655,0.3768780942119186,1.0,4/12,12.83%,ABCC4;PNPLA8;ACE;DRD2
prerank,pyrimidine nucleoside metabolic process (GO:0006213),0.7199547802952855,1.5909217791792765,0.040061633281972264,0.9404904328761556,1.0,5/14,11.39%,NT5E;NT5C1A;NT5C3A;UPP2;UMPS
prerank,regulation of transferase activity (GO:0051338),0.6978440652945613,1.589058285117261,0.03823529411764706,0.9419291126299234,1.0,8/17,15.62%,SPTSSB;EMP2;NABP2;FEM1A;JMJD8;FEM1B;PINX1;HMBOX1
prerank,embryonic heart tube development (GO:0035050),-0.6018645723771223,-1.5881434078785868,0.043596730245231606,0.3793197196476347,1.0,6/14,17.15%,IFT122;SOX17;TBX2;MEGF8;RYR2;SOX18
prerank,aggrephagy (GO:0035973),0.643277608028563,1.5879053208278358,0.04283604135893648,0.9381964326589359,1.0,11/27,18.46%,CFTR;DYNC1I1;VIM;WDFY3;UBE2N;DYNC1LI2;RPS27A;UBC;DYNC1H1;HDAC6;PARK7
prerank,negative regulation of cell-cell adhesion (GO:0022408),0.5999049370297498,1.5859192182105124,0.03474903474903475,0.9405289486850172,1.0,9/39,6.85%,CDH1;ADTRP;WNT1;KLF4;B4GALNT2;PODXL;SPINT2;AKNA;MAPK7
prerank,secondary alcohol biosynthetic process (GO:1902653),0.6210666503403165,1.5836754819016128,0.03292181069958848,0.9450501274058666,1.0,13/30,18.18%,FDFT1;DHCR7;FDPS;HMGCR;INSIG1;PMVK;CYP51A1;MSMO1;ACAT2;SQLE;PLPP6;TM7SF2;HMGCS1
prerank,glycerophospholipid catabolic process (GO:0046475),-0.5083368454716943,-1.5833631571529267,0.015444015444015444,0.3875439563002643,1.0,16/27,34.89%,PLA2G4A;GPCPD1;ENPP2;PNPLA8;ENPP6;GDPD1;ABHD12;PNPLA6;PLA2G4C;GDPD3;PLA2G15;PLA2G4F;PLA2G4E;LIPC;PLA2G4B;PLA2G5
prerank,diterpenoid metabolic process (GO:0016101),0.5715993093802204,1.5829849451479163,0.031630170316301706,0.938976018818142,1.0,12/55,10.36%,PLB1;GPC6;NAPEPLD;OPN1SW;GPC1;ADH7;STRA6;GPC4;SDC4;GPC3;PECR;AKR1B10
prerank,water transport (GO:0006833),0.7379479758351946,1.5810969774668195,0.045075125208681135,0.9406891232251529,1.0,1/12,0.12%,CFTR
prerank,oligosaccharide biosynthetic process (GO:0009312),0.6648570207103417,1.579319180952314,0.03714710252600297,0.942307872562725,1.0,4/20,5.86%,B3GALT1;ST3GAL4;B4GALNT2;FUT8
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),-0.542248954372909,-1.578637574399537,0.023054755043227664,0.39548972408534133,1.0,9/19,9.77%,DCN;SEMA6A;CCBE1;ROBO1;XDH;DAB2IP;PIK3CB;TSPAN12;ADAMTS3
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.5778502014344805,1.5781026577631343,0.03201024327784891,0.9394274441019544,1.0,18/47,16.81%,DOCK5;KANK1;LIMS2;S100A10;FBLN1;EFNA5;DMTN;ILK;CDC42;PDPN;DOCK1;RREB1;ITGB1BP1;ACTN4;FLNA;TESK1;CRK;ABL1
prerank,cholesterol biosynthetic process (GO:0006695),0.6186698665667549,1.5771837600821739,0.03708791208791209,0.9348184352820139,1.0,13/31,18.18%,FDFT1;DHCR7;FDPS;HMGCR;INSIG1;PMVK;CYP51A1;MSMO1;ACAT2;SQLE;PLPP6;TM7SF2;HMGCS1
prerank,negative regulation of potassium ion transport (GO:0043267),0.724872049802735,1.5765797630571188,0.030959752321981424,0.9281373399895216,1.0,4/13,6.34%,ACTN2;CAV1;PTK2B;STK39
prerank,regulation of postsynaptic membrane potential (GO:0060078),-0.476350814506688,-1.576321165108679,0.015625,0.3966513131189935,1.0,18/34,25.51%,GRID2;GABRG3;GRIN2A;GRIN2B;LRRK2;GLRA1;GABRG2;GABRG1;GABRA3;NLGN3;DRD2;MPP2;GABRA1;GABRE;RAB3GAP1;INSYN2A;ARRB2;CHRNA4
prerank,positive regulation of bone mineralization (GO:0030501),-0.47215667900722813,-1.576150364281938,0.026515151515151516,0.3916073757375833,1.0,10/35,8.35%,BMP6;ADGRV1;WNT4;SLC8A1;KL;BMPR1B;FBN2;TGFB1;PKDCC;ACVR2A
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),0.7070025253550482,1.5751056875306884,0.04451510333863275,0.9277366536669857,1.0,3/14,5.81%,CD55;CD81;RASAL3
prerank,pyrimidine nucleoside catabolic process (GO:0046135),0.7740949550819597,1.5748380175070198,0.041390728476821195,0.9196652779944137,1.0,4/10,9.07%,NT5E;NT5C1A;NT5C3A;UPP2
prerank,positive regulation of calcium-mediated signaling (GO:0050850),0.7461730371862495,1.5729280348839194,0.03814262023217247,0.9217170768414754,1.0,1/11,0.37%,CDH13
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.6093439546440956,1.572657443558597,0.049315068493150684,0.913679774472859,1.0,3/32,1.93%,FZR1;FOXN3;CDKN1A
prerank,mitotic nuclear membrane disassembly (GO:0007077),0.7270574521103407,1.571019943728908,0.037337662337662336,0.9149924526890972,1.0,1/12,0.09%,PRKCB
prerank,positive regulation of cell-cell adhesion (GO:0022409),0.5877010984939258,1.5691333630242876,0.03389830508474576,0.9175465538922581,1.0,9/41,11.60%,CD44;TJP1;CCL5;PODXL;GCNT2;PTPRU;ANK3;DENND6A;JAK1
prerank,regulation of cell communication (GO:0010646),0.6147894968047724,1.5691297925747048,0.0324254215304799,0.9082984933170476,1.0,4/35,1.92%,CXADR;ANK2;GRK5;VEPH1
prerank,regulation of axon regeneration (GO:0048679),0.7251960419934442,1.5677222168230003,0.04141104294478527,0.9083429847679194,1.0,7/12,22.98%,RTN4R;EPHA4;CERS2;PTN;STK24;RTN4RL1;SCARF1
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),-0.5704402032067736,-1.5676972056931835,0.027190332326283987,0.41058376939589397,1.0,5/17,4.54%,CACNA1C;SLC8A1;GJC1;GJD3;ATP1B1
prerank,cellular response to alcohol (GO:0097306),0.5821008137151916,1.5636143520197636,0.036989795918367346,0.9241572299928131,1.0,9/42,11.13%,CDH1;CFTR;SMO;PTGFR;CTNNA1;GOLPH3;ADCY6;ADAM15;OSBPL7
prerank,lamellipodium assembly (GO:0030032),0.6324219759623625,1.5630831433066878,0.034383954154727794,0.9185768396491087,1.0,6/26,7.17%,CDH13;SRGAP2;ABLIM2;ABLIM1;DMTN;GOLPH3
prerank,homotypic cell-cell adhesion (GO:0034109),0.5794350290271626,1.5599931219399714,0.04365079365079365,0.9289553428364109,1.0,9/39,10.72%,FN1;TJP2;HSPB1;DSC2;ILK;STXBP1;CLIC1;ACTB;ACTG1
prerank,muscle tissue development (GO:0060537),0.7311588242243812,1.5593017407015812,0.041990668740279936,0.9245164537938244,1.0,5/13,6.81%,PGM5;SMO;STRA6;CSRP3;BMP4
prerank,regulation of transforming growth factor beta production (GO:0071634),0.6783131220222571,1.5586313184793117,0.05167173252279635,0.9196981183978855,1.0,3/18,2.15%,FN1;ITGB8;CD200
prerank,positive regulation of keratinocyte migration (GO:0051549),0.7382415731608852,1.5584486066081007,0.03889789303079417,0.9120441394845052,1.0,2/10,1.44%,MAPRE2;MMP9
prerank,protein localization to plasma membrane (GO:0072659),0.5144141550955293,1.5569059303423902,0.01406926406926407,0.9132215468353821,1.0,27/129,10.08%,CDH1;FGF13;NECTIN3;ANK2;TSPAN5;ACTN2;SLMAP;TTC7A;ANK1;EMP2;RAP1A;CD81;S100A10;CACNB3;EHD1;FYB2;RAMP1;FLOT2;ANK3;ZFYVE27;PACS1;RAB3B;STXBP1;TNFRSF1A;MYO5A;EZR;KCNB1
prerank,epithelial cell development (GO:0002064),0.6451297262348152,1.5560865240390744,0.044733044733044736,0.9099305160634734,1.0,6/20,9.77%,POF1B;ROS1;WNT5B;GRHL2;PDZD7;DACT2
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.5750311854699794,1.554592062980178,0.029023746701846966,0.9108229342037987,1.0,13/46,9.94%,FN1;SRGAP2;PARVA;ITGB7;MEGF9;LAMA5;TMEFF2;ANTXR1;PXN;ILK;SRCIN1;LAMC1;LAMB2
prerank,mesoderm formation (GO:0001707),0.684196761518351,1.5542528342153317,0.037821482602118005,0.9044228159149195,1.0,2/17,3.12%,ITGB4;CRB2
prerank,regulation of Rho protein signal transduction (GO:0035023),0.5386941607872029,1.5518338986252562,0.026900584795321637,0.9115742106565683,1.0,16/72,10.78%,GPR4;LPAR1;RTN4R;KANK1;PRAG1;LPAR4;AKAP13;EPS8L2;KANK2;RIPOR2;ARHGEF18;CCDC125;BCR;OPHN1;RAF1;DLC1
prerank,pyrimidine-containing compound catabolic process (GO:0072529),0.7089978462145415,1.5516255478477439,0.038922155688622756,0.9047046357548904,1.0,4/16,9.07%,NT5E;NT5C1A;NT5C3A;UPP2
prerank,embryo development ending in birth or egg hatching (GO:0009792),0.6904422827837324,1.5509896266790733,0.06289308176100629,0.9006931117821576,1.0,5/15,8.46%,SCEL;FGFR1;CELF1;TGFB2;RAI2
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.6371848174988597,1.5503174176089,0.045845272206303724,0.8969612872068143,1.0,7/26,7.89%,FGFR1;EYA2;GDNF;BCL2L1;MAPK7;EYA1;UNC5B
prerank,positive regulation of heart rate (GO:0010460),0.6693490482362824,1.5485560908206377,0.05538922155688623,0.8997442051546303,1.0,1/17,0.06%,ADRA1B
prerank,camera-type eye development (GO:0043010),-0.4987758719148725,-1.5472558360064943,0.03180212014134275,0.4703791034694925,1.0,8/25,10.36%,CACNA1C;LAMA1;FBN1;CYP1B1;IFT122;FBN2;NES;NF1
prerank,platelet aggregation (GO:0070527),0.5924228832677055,1.5460741080838238,0.05128205128205128,0.906756253466539,1.0,7/33,10.72%,FN1;HSPB1;ILK;STXBP1;CLIC1;ACTB;ACTG1
prerank,branching involved in blood vessel morphogenesis (GO:0001569),-0.608531426458303,-1.5437398411995178,0.04603580562659847,0.47556765883489627,1.0,5/13,9.87%,ENG;KDR;COL4A1;SEMA3E;NOTCH4
prerank,regulation of gastrulation (GO:0010470),0.710397651013833,1.5430179891310274,0.04038772213247173,0.9175660648513084,1.0,3/14,3.12%,PHLDB2;DAG1;CRB2
prerank,embryonic axis specification (GO:0000578),0.6942658923355065,1.5427115885176461,0.036308623298033284,0.9116101164221682,1.0,5/15,8.70%,WNT1;COBL;SMAD6;FZD5;CXXC4
prerank,non-motile cilium assembly (GO:1905515),-0.4757030020919023,-1.5424784194989296,0.03237410071942446,0.47387671077480836,1.0,18/30,31.80%,CEP250;IFT122;TTC8;GORAB;C2CD3;BBS1;CSNK1D;BBS4;ARL13B;FUZ;RPGRIP1L;TMEM17;TMEM107;IFT88;PIBF1;CCDC13;IFT57;DISC1
prerank,high-density lipoprotein particle assembly (GO:0034380),-0.630824326043723,-1.5421998548194698,0.04488778054862843,0.46873725025220137,1.0,1/10,0.28%,ABCA1
prerank,regulation of protein-containing complex disassembly (GO:0043244),-0.5671694460305189,-1.5416448200409498,0.03550295857988166,0.4644321124817291,1.0,8/16,20.58%,INSR;IRAK3;GSPT1;OGFOD1;IGF1R;CLN3;SHFL;UPF1
prerank,positive regulation of activated T cell proliferation (GO:0042104),-0.5585315511969415,-1.539416397504943,0.03333333333333333,0.46519426978322864,1.0,4/18,7.03%,IGF1;IGFBP2;IL18;IGF2
prerank,regulation of cholesterol esterification (GO:0010872),0.74741875158524,1.5390720109861442,0.04700162074554295,0.9261996412770309,1.0,3/10,11.53%,AGTR1;ABCA2;STARD4
prerank,protein localization to cell surface (GO:0034394),0.6355605837783963,1.5385186756737237,0.046703296703296704,0.9220938560523751,1.0,9/26,12.40%,ANGPT1;ANK2;EMP2;PIGU;WNT11;PTPRU;UNC50;GGA1;MESD
prerank,negative regulation of neuron projection development (GO:0010977),0.5575542178750188,1.5385031780224292,0.02247191011235955,0.9145800689788157,1.0,8/56,2.88%,LPAR1;RTN4R;KANK1;PRAG1;NGEF;EPHA4;EFNB2;ITM2C
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),0.6269827993932443,1.5381870363893486,0.04264099037138927,0.9089498206295178,1.0,5/26,6.34%,ANK2;ACTN2;FHL1;WWP2;STK39
prerank,skin development (GO:0043588),0.5329644997613139,1.5380720556761929,0.03272727272727273,0.9023602576068999,1.0,5/65,2.33%,WNT16;ITGB4;SCEL;WNT10A;COL5A2
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),0.5849833012620255,1.5374048440003467,0.040502793296089384,0.8989720705254369,1.0,14/35,16.81%,BAIAP2L1;NOTCH2;NTRK3;TJP1;PTK2B;DAPK3;HAX1;CDC42;BCAS3;RAPGEF3;TRPM2;HRAS;ARHGDIB;ABL1
prerank,regulation of keratinocyte migration (GO:0051547),0.7073465922468647,1.5369274179177195,0.05422647527910686,0.8947631293808552,1.0,2/12,1.44%,MAPRE2;MMP9
prerank,apoptotic cell clearance (GO:0043277),-0.4763111432451909,-1.5367271332257533,0.025089605734767026,0.46791619897740416,1.0,13/30,21.75%,RHOBTB1;TGM2;GAS6;MEGF10;THBS1;NR1H3;XKR6;ITGAV;HMGB1;TXNDC5;RHOBTB2;LRP1;TYROBP
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.7159436349373746,1.5325448159135684,0.050335570469798654,0.9069150599590353,1.0,9/12,21.74%,KANK1;FBLN1;EFNA5;DMTN;ITGB1BP1;ACTN4;RCC2;MELTF;AP1AR
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.7159436349373746,1.5325448159135684,0.050335570469798654,0.9069150599590353,1.0,9/12,21.74%,KANK1;FBLN1;EFNA5;DMTN;ITGB1BP1;ACTN4;RCC2;MELTF;AP1AR
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.606170719473241,1.5316855617212617,0.048,0.9054303702654679,1.0,10/32,16.66%,FHIT;DDX5;EP300;PMAIP1;PHLDA3;PPP1R13B;PML;PDK2;USP28;POU4F1
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.49704259330228767,1.5305535812184352,0.011891891891891892,0.9050862988509872,1.0,16/142,5.94%,ADRA1B;CD55;AGTR1;LPAR1;CCR4;CACNA1A;CAV1;ATP1A2;CXCR4;PTGFR;ACKR4;ACKR2;CCR10;ACKR3;CAV2;CCRL2
prerank,vasoconstriction (GO:0042310),-0.6215408857912138,-1.5295205268347376,0.04533333333333334,0.48571748808817244,1.0,7/11,29.63%,SLC8A1;ACTA2;EDNRB;EDN1;EDN3;HTR2B;PIK3C2A
prerank,carbohydrate biosynthetic process (GO:0016051),0.6359492852265103,1.5291683845358015,0.05752212389380531,0.9061165658175299,1.0,4/21,5.86%,B3GALT1;ST3GAL4;B4GALNT2;FUT8
prerank,base conversion or substitution editing (GO:0016553),-0.6212194316645206,-1.529166570623186,0.03968253968253968,0.4809945175020171,1.0,5/11,23.18%,ADAR;ADARB1;ADARB2;APOBEC1;NUDT16
prerank,phosphatidylcholine catabolic process (GO:0034638),-0.6322013606445341,-1.5281742924141835,0.046875,0.47840269209007397,1.0,3/10,6.77%,PLA2G4A;ENPP2;PNPLA8
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),-0.4431452534337835,-1.5265987613032406,0.03076923076923077,0.4780712721683349,1.0,10/34,7.31%,FLT1;PDGFRB;PRKD1;PIK3R1;TEK;PTK2;PDGFRA;FGF2;DAB2IP;TGFB1
prerank,myelin maintenance (GO:0043217),0.7293813659431524,1.5236781350689685,0.048414023372287146,0.9324814096281874,1.0,3/10,2.99%,CLU;ABCD1;CXCR4
prerank,sphingoid metabolic process (GO:0046519),-0.605710302788542,-1.523465264305614,0.05343511450381679,0.48301258061229074,1.0,7/12,33.30%,DEGS2;SGPP1;SPHK1;PLPP3;ASAH2;PLPP2;SPTLC3
prerank,mitochondrion localization (GO:0051646),-0.5207359972048399,-1.5233578904990908,0.04716981132075472,0.47767935036548786,1.0,9/19,16.83%,MARK1;LRRK2;MTM1;BRAT1;MFN1;ZBED3;TRAK2;ATCAY;MSTO1
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.6856142989012449,1.522418707331337,0.07097791798107256,0.9336500835796064,1.0,5/13,5.40%,CDH13;LDLR;SREBF2;CD81;CD9
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.5836206082709778,1.521876275840472,0.05366492146596859,0.9297774606746486,1.0,6/37,7.30%,CXADR;ALCAM;NECTIN3;CRB2;PTPRD;PVR
prerank,modulation by host of symbiont process (GO:0051851),0.5889631081476839,1.5216477608701227,0.04435483870967742,0.9243747605498669,1.0,10/31,12.28%,NAPEPLD;CCL5;HPN;EP300;SMARCB1;POU2F3;JUN;SMARCA4;AQP1;SP1
prerank,nitric oxide mediated signal transduction (GO:0007263),-0.550015430923115,-1.521348679723364,0.049132947976878616,0.47882569378625867,1.0,4/16,6.61%,GUCY1B1;NOS3;NDNF;GUCY1A1
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.6853240741018447,1.5211499250336054,0.06471494607087827,0.920635580958338,1.0,1/15,0.04%,DPP4
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.5866654797434778,1.5203450728067611,0.057692307692307696,0.9188229723103685,1.0,12/34,16.81%,DOCK5;LIMS2;S100A10;DMTN;ILK;CDC42;DOCK1;RREB1;FLNA;TESK1;CRK;ABL1
prerank,maturation of 5.8S rRNA (GO:0000460),0.6599729639272689,1.5195298971338904,0.050746268656716415,0.9167247522970562,1.0,7/17,14.56%,NSA2;PES1;EIF6;MAK16;MPHOSPH6;MTREX;RPF1
prerank,striated muscle tissue development (GO:0014706),0.6140114424081993,1.519450465978265,0.04845222072678331,0.9105861634624726,1.0,6/29,4.13%,PGM5;SGCG;SGCD;CAV1;CSRP3;BMP5
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.6625866033515055,1.5187620160226691,0.07538461538461538,0.9081052878350799,1.0,2/16,1.57%,AGTR1;JCAD
prerank,positive regulation of protein depolymerization (GO:1901881),-0.6242410112620617,-1.5183461631690454,0.06896551724137931,0.4829672681328159,1.0,3/11,9.30%,SEMA5A;STMN2;NES
prerank,negative regulation of smooth muscle cell migration (GO:0014912),-0.5725228475344091,-1.5183162950734055,0.049315068493150684,0.47765469011721884,1.0,3/14,7.20%,PRKG1;IGFBP5;SLIT2
prerank,actin cytoskeleton reorganization (GO:0031532),0.5392083266412637,1.517620051102547,0.027878787878787878,0.908131345492908,1.0,10/63,6.38%,CXADR;PHACTR1;PARVA;GSN;PTK7;SIPA1L1;GAB1;MCU;ANTXR1;DMTN
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.5228402506254579,1.516858987768922,0.038869257950530034,0.9063659219627199,1.0,22/78,15.23%,FZR1;CLU;TRIB2;CAV1;NFE2L2;ZYG11B;SH3RF2;NUB1;ELOB;DDRGK1;PLK3;RBX1;SUMO2;BCAP31;COP1;HSPBP1;CSNK1E;PIAS1;DDA1;GSK3A;GSK3B;MDM2
prerank,positive regulation of macrophage differentiation (GO:0045651),-0.6201844214904203,-1.516273365819558,0.04336734693877551,0.4786841685675972,1.0,6/11,18.79%,IL34;TGFB1;ID2;HSF1;RIPK1;CSF1
prerank,regulation of histone H3-K9 acetylation (GO:2000615),0.7307655883492296,1.5162455441036036,0.06217616580310881,0.9035260556632844,1.0,5/10,11.19%,HDAC5;SMARCB1;PIH1D1;KMT2A;RAPGEF3
prerank,regulation of neuron death (GO:1901214),0.5195390808086902,1.5154966668659848,0.027491408934707903,0.9015324553463024,1.0,23/82,15.65%,EGLN3;CLU;DAXX;PPARGC1A;CCL5;MAP3K5;EFNB2;CD200;FOS;CTSZ;GPR75;EGLN2;CHMP4A;CHMP4B;CHP1;CD200R1;MEF2C;GSK3B;EIF4G1;NENF;SNCB;IKBKG;ITGB2
prerank,protein localization to cell periphery (GO:1990778),0.5011343910636518,1.5149132675974506,0.01520086862106406,0.8988070256444678,1.0,28/133,10.08%,CDH1;FGF13;ANK2;TSPAN5;ACTN2;SLMAP;TTC7A;ANK1;EMP2;CAV1;RAP1A;CD81;S100A10;CACNB3;EHD1;ARL3;FYB2;RAMP1;FLOT2;ANK3;ZFYVE27;PACS1;RAB3B;STXBP1;TNFRSF1A;MYO5A;EZR;KCNB1
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),-0.5923012321830218,-1.5146658946356788,0.06233062330623306,0.4781855745899096,1.0,2/12,5.93%,IL1R1;IL18
prerank,cellular response to UV-A (GO:0071492),0.7157644827473114,1.511916160340997,0.06313993174061433,0.9095728043828829,1.0,3/11,4.45%,OPN1SW;MMP9;TIMP1
prerank,positive regulation of sprouting angiogenesis (GO:1903672),0.678137028702179,1.5115412902983252,0.06542056074766354,0.9057127776999597,1.0,6/15,11.60%,KLF4;TJP1;PKM;JMJD8;S100A1;JAK1
prerank,negative regulation by host of viral transcription (GO:0043922),0.6833281928172187,1.5110413521026016,0.06528662420382166,0.9023178601342576,1.0,3/12,8.32%,CCL5;POU2F3;JUN
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),-0.6464189496372288,-1.5102006444417366,0.06201550387596899,0.4870514667677071,1.0,4/10,4.52%,ACER2;NEXMIF;PDE3B;CYP1B1
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),0.5946973179799294,1.5094458102687915,0.055782312925170066,0.9054786565933475,1.0,8/30,10.33%,CLU;CD44;YJU2;ACKR3;BCL2L1;FBXO5;DDX39B;TWIST1
prerank,regulation of cell killing (GO:0031341),0.6706812020654849,1.5091047033446512,0.07142857142857142,0.9013968485859355,1.0,3/16,7.38%,CD55;CFH;TGFB2
prerank,limb development (GO:0060173),-0.47460154606430105,-1.5084718607857328,0.03691275167785235,0.48708467610534756,1.0,8/28,9.95%,PCSK5;SMOC1;ZNRF3;IFT122;BMPR1B;SALL1;CHD7;MEGF8
prerank,positive regulation of interleukin-2 production (GO:0032743),-0.49183129614546883,-1.5079997256394024,0.029411764705882353,0.4832523690117646,1.0,7/25,11.72%,PDE4D;GLMN;RUNX1;SPTBN1;PDE4B;TRAF6;PNP
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.7117992465980304,1.5075682915422435,0.05271317829457364,0.9047072398175583,1.0,4/12,8.17%,SMO;GDNF;SOX9;SIX1
prerank,second-messenger-mediated signaling (GO:0019932),0.5107942215452568,1.5070572978712435,0.0333716915995397,0.9018566675785006,1.0,13/82,6.75%,AGTR1;NUDT4;CCR4;CXCR4;MCU;PPP2CA;RCAN1;ACKR4;ACKR2;CCR10;ACKR3;CCRL2;DDAH2
prerank,membrane protein ectodomain proteolysis (GO:0006509),0.6269765910363737,1.5069824300970145,0.054285714285714284,0.8963093370675843,1.0,11/21,20.74%,DAG1;ADAM10;SPPL2B;HM13;BACE1;PRTN3;SPPL3;PRKCQ;SPPL2A;ADAM17;APH1A
prerank,positive regulation of inflammatory response (GO:0050729),0.5091797449681001,1.5056126197308686,0.029180695847362513,0.8982038787765295,1.0,14/86,9.74%,AGTR1;GPR4;NAPEPLD;IL17RA;NUPR1;NINJ1;IL15;IL16;CD81;NFKBIA;FEM1A;LBP;TNFRSF1A;NMI
prerank,lymphocyte mediated immunity (GO:0002449),0.7124043011303702,1.5049571105545019,0.06289308176100629,0.8957738844687612,1.0,1/12,0.15%,CD55
prerank,hemopoiesis (GO:0030097),-0.3719653119494588,-1.5041638322094946,0.016260162601626018,0.49004379788120844,1.0,26/87,15.34%,FLT1;MECOM;JAG1;TEK;KIRREL3;KITLG;SNRK;MFAP5;ETV6;WNT5A;CD34;KDR;RUNX1;RUNX2;SH2B3;TGFB1;FGFR2;NOTCH4;KIT;TP53;MEIS1;TIRAP;FLT4;KAT6A;TOX;FLT3LG
prerank,negative regulation of wound healing (GO:0061045),0.6049409130486194,1.5030631976017235,0.05491329479768786,0.9010343965198635,1.0,5/28,6.08%,CD109;PHLDB2;ADTRP;ALOX5;THBD
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),0.6884712035431928,1.5030381144327507,0.06645056726094004,0.8953987537627527,1.0,2/12,4.26%,CD44;GCNT2
prerank,negative regulation of cation transmembrane transport (GO:1904063),0.6428457335047123,1.501546109827224,0.07204610951008646,0.8983590989702986,1.0,5/18,6.34%,MMP9;CAV1;ATP1A2;EPO;STK39
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),-0.6035538409611559,-1.5010168836314157,0.0777479892761394,0.4948227334619042,1.0,7/10,24.28%,PDE3A;PDE4D;PDE3B;PDE2A;PDE11A;APLNR;RNF157
prerank,glutamate receptor signaling pathway (GO:0007215),-0.44833017114708407,-1.5005711302748934,0.026785714285714284,0.49092456079285235,1.0,12/37,6.85%,PLCB1;GRIK2;GRID2;GRM3;GRM7;GRIN2A;GRIA3;GRIA2;GRM8;GRIN2B;GRM5;GRIK3
prerank,regulation of lipoprotein lipase activity (GO:0051004),-0.5413805125690865,-1.5004892707019304,0.044444444444444446,0.4862464840417312,1.0,6/17,18.35%,PCSK5;NR1H3;SORT1;NR1H2;LPL;PCSK6
prerank,regulation of lamellipodium morphogenesis (GO:2000392),0.6978443954508649,1.4997927026861881,0.07504078303425775,0.9029181259032801,1.0,2/11,1.09%,CD44;KANK1
prerank,neutrophil activation (GO:0042119),0.7175352045621829,1.4992167593040902,0.0633116883116883,0.9002910175323481,1.0,3/12,11.65%,CCL5;IL15;FCER1G
prerank,regulation of cardiac muscle cell contraction (GO:0086004),0.6047603353607809,1.4989397541574703,0.061898211829436035,0.8962239730276148,1.0,4/27,2.65%,FGF13;DSG2;ANK2;CAV1
prerank,defense response to tumor cell (GO:0002357),0.716569110398317,1.4985081194649654,0.06976744186046512,0.8928497176547014,1.0,3/10,6.96%,KLF4;DAPK1;RBMS3
prerank,regulation of oligodendrocyte differentiation (GO:0048713),-0.5281386823396228,-1.4984127660781221,0.05278592375366569,0.48766960611425425,1.0,9/18,13.25%,IL34;DAAM2;NOTCH1;TNFRSF21;PTPRZ1;TENM4;NF1;SLC45A3;TNFRSF1B
prerank,retinoid metabolic process (GO:0001523),0.5238352098824286,1.4980565618437178,0.04152249134948097,0.8900633591636478,1.0,13/71,10.36%,PLB1;GPC6;NAPEPLD;OPN1SW;GPC1;ADH7;STRA6;GPC4;DHRS13;SDC4;GPC3;ALDH8A1;AKR1B10
prerank,negative regulation of signaling receptor activity (GO:2000272),-0.47209927369098903,-1.497530891453382,0.05190311418685121,0.48555311838366594,1.0,7/25,9.23%,ERRFI1;CBLB;SLC6A9;EPHB2;ZFYVE28;SOCS5;PPARG
prerank,branching morphogenesis of an epithelial tube (GO:0048754),-0.4294369300458924,-1.496325338052078,0.032388663967611336,0.4845536078830706,1.0,13/39,9.87%,ENG;GLI2;TIE1;KDR;COL4A1;PKD2;FGF2;SEMA3E;SALL1;SLIT2;LRP6;LRP5;NOTCH4
prerank,purine nucleotide catabolic process (GO:0006195),0.6987003359309112,1.495792765021715,0.07244094488188976,0.8975894665887676,1.0,3/13,6.84%,NT5E;NT5C1A;NT5C2
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.5124232391460171,1.4957542415197547,0.04738760631834751,0.8923164283145424,1.0,16/72,8.31%,FN1;WNT16;FGFR1;NTRK3;CCL5;PLXNB1;PDGFC;GAB1;EPO;SOX9;HAX1;MYDGF;ERBB3;TGFB2;UNC5B;MAZ
prerank,extracellular structure organization (GO:0043062),0.4777374432745401,1.4942623962111914,0.01564129301355579,0.895700282036329,1.0,22/204,3.20%,FN1;CDH1;ADAM12;ITGB4;THSD4;ITGA10;ADAMTS14;COL23A1;CD44;ITGB8;LAMA4;LAMC2;MMP9;COL4A3;SH3PXD2A;COL4A4;DAG1;ADAMTS7;ADAMTSL5;COL5A2;ITGB7;LAMA5
prerank,purine-containing compound catabolic process (GO:0072523),0.6942853694323811,1.4933881111335032,0.07668231611893583,0.8950303147671974,1.0,3/13,6.84%,NT5E;NT5C1A;NT5C2
prerank,positive regulation of protein import (GO:1904591),0.5935951570539638,1.4926087838848654,0.057455540355677154,0.894076636655857,1.0,10/30,15.66%,CDH1;ZC3H12A;MAVS;ARHGEF5;BAG3;ZIC1;HDAC3;UBR5;ZPR1;FLNA
prerank,external encapsulating structure organization (GO:0045229),0.4769732926887649,1.4915584400613944,0.013555787278415016,0.8943712416226296,1.0,22/205,3.20%,FN1;CDH1;ADAM12;ITGB4;THSD4;ITGA10;ADAMTS14;COL23A1;CD44;ITGB8;LAMA4;LAMC2;MMP9;COL4A3;SH3PXD2A;COL4A4;DAG1;ADAMTS7;ADAMTSL5;COL5A2;ITGB7;LAMA5
prerank,maintenance of gastrointestinal epithelium (GO:0030277),0.6980180506914435,1.4915270487571268,0.0654490106544901,0.8892909030629422,1.0,4/12,11.15%,VSIG1;SOX9;MUC6;TLR4
prerank,dicarboxylic acid transport (GO:0006835),-0.47722150077842007,-1.491090003774631,0.025830258302583026,0.49546256873532823,1.0,5/28,5.61%,SLC1A3;SLC13A3;SLC26A7;SLC1A2;SLC1A1
prerank,negative regulation of cell projection organization (GO:0031345),0.5493643353954113,1.4910509282098419,0.05044136191677175,0.886691693709297,1.0,9/48,7.66%,LPAR1;RTN4R;KANK1;PRAG1;EPHA4;EFNB2;ITM2C;PTPN9;ADCY6
prerank,regulation of hemopoiesis (GO:1903706),0.7118571558186201,1.4910000075114924,0.060034305317324184,0.8817447564209472,1.0,4/10,12.72%,PRKCB;LGALS3;PTN;MYSM1
prerank,endoderm formation (GO:0001706),0.5677404005075684,1.4909007069934703,0.05398110661268556,0.8771732795430807,1.0,4/35,5.44%,FN1;MMP9;COL6A1;DUSP1
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.528866113288839,1.4907873880152902,0.05660377358490566,0.8726718939321236,1.0,6/59,2.48%,CDH1;SDK1;DSG2;CDH13;NECTIN3;FAT2
prerank,regulation of developmental growth (GO:0048638),-0.46382140871406247,-1.4895039248077622,0.027210884353741496,0.4957163126493229,1.0,5/29,2.23%,PLCB1;IGF1;GHR;INSR;STAT5B
prerank,regulation of cell junction assembly (GO:1901888),0.5987191502523925,1.4894471699582927,0.07174231332357248,0.8751364837453198,1.0,6/27,3.22%,RAB17;PDLIM5;TJP1;OCLN;RAP1B;RAP1A
prerank,response to interferon-alpha (GO:0035455),-0.5372279563819617,-1.4884317356228383,0.06504065040650407,0.4942185801137231,1.0,6/16,12.52%,GAS6;AXL;ADAR;IFNAR2;IFITM3;KLHL20
prerank,positive regulation of defense response (GO:0031349),0.5023977856380472,1.4879571782768868,0.033936651583710405,0.8781581107191669,1.0,20/89,15.83%,AGTR1;GPR4;NAPEPLD;CCL5;IL17RA;NINJ1;IL15;IL16;NFKBIA;FEM1A;POLR3B;TNFRSF1A;NMI;TLR4;POLR3C;MEF2C;TNIP1;TLR3;DHX9;POLR3G
prerank,mitotic G2/M transition checkpoint (GO:0044818),0.5505098339499462,1.4879403878085278,0.060723514211886306,0.8732420170227608,1.0,15/43,21.18%,FZR1;FOXN3;CDKN1A;NABP2;MRE11;HUS1B;TOPBP1;ABRAXAS1;DONSON;NBN;INTS3;CDK5RAP3;TAOK3;NABP1;CHFR
prerank,positive regulation of actin filament polymerization (GO:0030838),0.5572097006781518,1.486987262791002,0.05222929936305733,0.8733135430261783,1.0,8/44,5.14%,BAIAP2L1;GSN;CDC42EP4;PTK2B;FCHSD2;CDC42EP5;LMOD3;FCHSD1
prerank,establishment of melanosome localization (GO:0032401),0.6200330252375084,1.4867340611991942,0.09009009009009009,0.8696640998432875,1.0,5/19,13.35%,RAB17;BLOC1S6;MLPH;MYO5A;MKKS
prerank,negative regulation of transmembrane transport (GO:0034763),0.7212191262127239,1.4859271312353548,0.08493589743589744,0.8689993855831095,1.0,1/10,0.09%,PRKCB
prerank,positive regulation of lipid storage (GO:0010884),0.6430183733387351,1.4848887662285644,0.06160458452722063,0.8697506182073106,1.0,4/21,3.69%,SREBF2;ZC3H12A;IKBKE;EHD1
prerank,negative regulation of autophagy (GO:0010507),0.5304402887469255,1.4845338632405025,0.034739454094292806,0.8668680041046323,1.0,12/54,14.88%,DAPL1;NRBP2;NUPR1;SNRNP70;TAB3;RUBCN;SMCR8;EIF4G2;WDR6;FOXK1;EIF4G1;WASHC1
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.48020070875482096,1.4840663779294507,0.009656652360515022,0.8643667034661882,1.0,17/159,7.38%,CDH1;CXADR;CLDN11;ALCAM;SDK1;DSG2;CDH13;NECTIN3;GPC6;FAT2;CRB2;GPC4;PTPRD;MYOT;PTPRF;PVR;TGFB2
prerank,proteoglycan biosynthetic process (GO:0030166),-0.45739172933332256,-1.484065213987278,0.04961832061068702,0.5029551881315506,1.0,16/31,16.87%,IGF1;NDST3;XYLT1;BMPR1B;CSGALNACT1;CHST8;EXTL3;XYLT2;EXT2;PXYLP1;HS3ST3B1;CANT1;B3GAT3;BMPR2;CHST10;B4GALT7
prerank,cellular response to cadmium ion (GO:0071276),0.6025312817502305,1.4817800049634053,0.06906474820143885,0.8721017517481442,1.0,5/24,8.53%,DAXX;MMP9;FOS;JUN;MAPK9
prerank,endodermal cell differentiation (GO:0035987),0.5802048991739933,1.4807926246349021,0.061196105702364396,0.8726144524231946,1.0,3/31,3.90%,FN1;MMP9;COL6A1
prerank,pigment granule transport (GO:0051904),0.6226134744209024,1.4804018762946716,0.08643815201192251,0.8652574773506094,1.0,5/18,13.35%,RAB17;BLOC1S6;MLPH;MYO5A;MKKS
prerank,melanosome transport (GO:0032402),0.6226134744209024,1.4804018762946716,0.08643815201192251,0.8652574773506094,1.0,5/18,13.35%,RAB17;BLOC1S6;MLPH;MYO5A;MKKS
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.6679756688903588,1.4803130544072105,0.07269789983844911,0.8611355467495617,1.0,5/14,8.46%,CCL5;ADAM10;PTK2B;STK39;OXSR1
prerank,cardiac muscle cell differentiation (GO:0055007),0.6282086317308817,1.47730006175722,0.0755813953488372,0.8718182708289577,1.0,2/21,2.55%,CXADR;AKAP13
prerank,regulation of protein modification process (GO:0031399),0.5402165177232036,1.4767684596536768,0.061957868649318466,0.8700673143135914,1.0,13/50,14.84%,FN1;SESN2;PPP2CA;KDM4D;HSPB1;SPRED3;PML;PPP1R16A;ABCA2;RABL3;PLXNB2;CCDC88A;FLCN
prerank,negative regulation of B cell proliferation (GO:0030889),-0.5942251912009651,-1.4767496089423704,0.08378378378378379,0.5215407513593626,1.0,6/11,27.64%,LYN;TNFRSF21;CD300A;RC3H1;TYROBP;FCGR2B
prerank,regulation of T cell cytokine production (GO:0002724),0.6513152089816098,1.4767255184215395,0.08978328173374613,0.8657339657553133,1.0,4/15,11.35%,CD55;FZD5;FOXP3;TRPM4
prerank,B cell receptor signaling pathway (GO:0050853),0.55893628792565,1.4764807137041307,0.07065217391304347,0.8625547952698607,1.0,2/32,0.33%,PRKCB;NFATC2
prerank,regulation of MAP kinase activity (GO:0043405),-0.35574495568735015,-1.4760558738082439,0.0,0.5187530073689299,1.0,32/92,19.60%,FLT1;PDGFRB;KSR1;PDGFD;PTPRJ;IL34;LYN;ROBO1;FGF2;DAB2IP;CDK12;IRAK3;LRRK2;SH2B3;TGFB1;PIK3CB;EZH2;TPD52L1;PIK3R6;KIT;NF1;CD300A;EDN1;SORL1;PIK3R5;EDN3;EGF;CD40;SPRY4;SPRY1;PAQR3;MST1R
prerank,positive regulation of lipid biosynthetic process (GO:0046889),0.5842032159231156,1.4757735952107154,0.07297297297297298,0.8619565797312252,1.0,5/29,8.66%,SORBS1;LDLR;CREBL2;CREB1;CHP1
prerank,focal adhesion assembly (GO:0048041),0.618343665653175,1.4746138935984519,0.0729483282674772,0.8636261604662437,1.0,2/21,1.06%,SORBS1;ACTN2
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",0.7198907973804082,1.4736648761510083,0.08333333333333333,0.8641663721798395,1.0,3/10,6.56%,CD55;CD81;ZBTB7B
prerank,regulation of autophagy of mitochondrion (GO:1903146),0.6239873532049927,1.4734673130289884,0.09687034277198212,0.860647446408169,1.0,10/19,21.53%,SREBF2;HAX1;FZD5;VDAC1;GSK3A;DNM1L;HDAC6;PARK7;SREBF1;FBXW7
prerank,detection of visible light (GO:0009584),0.6396083263594589,1.4734289289552924,0.09105180533751962,0.8564187191874265,1.0,8/16,20.93%,RP1;CACNA2D4;GNAQ;CNGB1;PDE6B;GNA11;ABCA4;TULP1
prerank,activin receptor signaling pathway (GO:0032924),-0.5416288124648455,-1.4729915862079614,0.08201892744479496,0.5239942060526137,1.0,9/15,39.02%,ACVR1B;ACVR2A;SMAD3;ACVR1C;ACVR1;SMAD2;ACVR2B;AMHR2;INHBB
prerank,aminoglycan metabolic process (GO:0006022),-0.6125945124276828,-1.4726595856458131,0.06005221932114883,0.5203506611283563,1.0,8/10,34.98%,XYLT1;XYLT2;B3GAT3;B4GALT7;CLN6;B3GAT1;CHST9;B3GALT6
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),-0.57117210113702,-1.4719280102073085,0.06842105263157895,0.5178988484925867,1.0,5/13,8.18%,BMP6;RBPMS;DAB2;TGFB1;JAK2
prerank,negative regulation of nervous system development (GO:0051961),-0.5097868566772011,-1.4718804087017903,0.07142857142857142,0.5133976524209457,1.0,6/17,15.38%,NOTCH1;APPL2;ROBO2;B2M;SLIT1;SORL1
prerank,heterochromatin organization (GO:0070828),-0.5576968424654518,-1.471714962057823,0.05785123966942149,0.5093573782785097,1.0,6/14,17.33%,MECOM;PRDM16;SMCHD1;HMGA2;HP1BP3;SETDB2
prerank,atrial septum development (GO:0003283),0.6686218786725128,1.470580979161511,0.0695266272189349,0.8668543685723834,1.0,4/13,12.26%,ANK2;NOTCH2;TGFB2;DAND5
prerank,Golgi localization (GO:0051645),0.6934662419412604,1.4693245483203143,0.07653061224489796,0.8688939318056483,1.0,8/11,19.80%,ARHGAP21;CDC42;YWHAZ;RIPOR1;TBCCD1;COPG1;HOOK3;UVRAG
prerank,nucleoside phosphate catabolic process (GO:1901292),-0.5577152801072379,-1.4687409469887294,0.06779661016949153,0.5142432640308592,1.0,7/13,20.98%,ENPP1;ENTPD1;ITPA;ENPP3;ENTPD3;ENTPD5;ENTPD6
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),0.6811193622087004,1.4669592908104596,0.07585139318885449,0.8764789578162313,1.0,2/13,2.17%,B3GALT1;B4GAT1
prerank,negative regulation of cholesterol transport (GO:0032375),0.6996155212199691,1.4650323392906943,0.1111111111111111,0.8822928887698903,1.0,2/10,11.07%,SREBF2;ABCA2
prerank,neurotransmitter biosynthetic process (GO:0042136),-0.5603534084139176,-1.4643240122849581,0.07669616519174041,0.5237167728322547,1.0,5/14,28.34%,MOXD1;ALDH9A1;SLC5A7;SLC22A2;CHAT
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),0.5224029214635165,1.4642628387027172,0.046798029556650245,0.8821476053929842,1.0,18/57,19.02%,FZR1;FOXN3;CDKN1A;MRE11;FBXO31;SDE2;CCND1;HUS1B;MDC1;TOPBP1;ABRAXAS1;CDK2;DONSON;NBN;CHEK2;ATF2;CDK5RAP3;TAOK3
prerank,response to laminar fluid shear stress (GO:0034616),0.698856586563964,1.4636067078472828,0.09359605911330049,0.8811719136239088,1.0,5/10,6.85%,KLF4;SREBF2;SMAD6;NFE2L2;MAPK7
prerank,amino acid import (GO:0043090),-0.4898025045214546,-1.4635657427755873,0.05396825396825397,0.521633488658506,1.0,7/21,8.63%,SLC1A3;SLC6A13;SLC47A1;SLC7A5;SLC6A6;SLC1A1;SLC6A1
prerank,tRNA aminoacylation for protein translation (GO:0006418),0.5456118045500086,1.462982842145749,0.06753246753246753,0.8801715491170291,1.0,22/42,21.36%,QARS1;EPRS1;VARS1;VARS2;FARS2;HARS1;CARS2;NARS2;LARS2;AARS1;EEF1E1;HARS2;TARS1;SARS2;SARS1;YARS1;TARS3;FARSA;DARS2;FARSB;NARS1;YARS2
prerank,neutrophil chemotaxis (GO:0030593),0.5241430660580756,1.4622740252511661,0.05947955390334572,0.879517292177135,1.0,4/53,8.27%,CXADR;CCL5;TGFB2;LGALS3
prerank,aortic valve morphogenesis (GO:0003180),-0.45337855945818367,-1.4613413513927325,0.03007518796992481,0.5240214224408178,1.0,12/30,8.93%,ELN;JAG1;NOS3;ROBO1;TIE1;NOTCH1;NFATC1;ROBO2;SLIT2;TGFB1;ROCK1;HEYL
prerank,regulation of calcium ion transmembrane transport (GO:1903169),0.6045260883898568,1.460083369981644,0.07142857142857142,0.8860427736555495,1.0,4/23,3.61%,ANK2;ATP1A2;DIAPH1;PTK2B
prerank,negative regulation of protein transport (GO:0051224),0.5967448093196891,1.459928868081345,0.06484149855907781,0.8825814225909014,1.0,8/25,13.93%,ADTRP;WWP2;HMGCR;CSK;CYP51A1;SNX12;SERGEF;RHBDF2
prerank,positive regulation of lipid metabolic process (GO:0045834),0.620938765817426,1.4595817937796336,0.0746054519368723,0.8803255142779051,1.0,3/22,6.06%,SORBS1;CREBL2;CREB1
prerank,regulation of peptide hormone secretion (GO:0090276),0.5151720422418572,1.4593665258077257,0.0485207100591716,0.8773981705707302,1.0,7/67,6.35%,DPP4;ITPR2;CCL5;CACNA1A;RAP1A;ALOX5;ABCC8
prerank,negative regulation of ERBB signaling pathway (GO:1901185),-0.4136899005898963,-1.4581233019143032,0.028925619834710745,0.5300460391428732,1.0,11/39,14.19%,ERRFI1;PTPRJ;TGFA;ITGA1;DAB2IP;SH3KBP1;ZFYVE28;PTPN12;PTPN3;GRB2;EPS15
prerank,AMP metabolic process (GO:0046033),0.6625275907028527,1.4574122048007032,0.08293460925039872,0.8830382170397342,1.0,4/13,10.00%,NT5E;NT5C1A;NUDT2;AK3
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.5439636124200269,1.457199277455367,0.07161125319693094,0.8798985715132193,1.0,7/42,3.61%,CDH13;UTRN;EMP2;GFUS;CDK6;S100A10;PTK2B
prerank,purine ribonucleotide catabolic process (GO:0009154),0.6331676990348434,1.4571341443254127,0.08187134502923976,0.8760441548600992,1.0,3/21,1.83%,NT5E;NUDT4;NT5C1A
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.6800099887296434,1.4561323908266788,0.0889967637540453,0.8771224531095008,1.0,1/12,0.12%,CFTR
prerank,adherens junction organization (GO:0034332),0.5378765216978778,1.455802830838154,0.06145966709346991,0.8746523021608278,1.0,9/48,9.26%,CDH1;CDH13;NECTIN3;TJP1;CTNNA1;CSK;PVR;ANG;ACTB
prerank,dermatan sulfate metabolic process (GO:0030205),0.6710247332820996,1.4541390587117566,0.08150470219435736,0.8793138632023619,1.0,3/13,4.40%,UST;CHST12;DSE
prerank,cell-cell junction maintenance (GO:0045217),0.6801598296419015,1.454049230807946,0.09190031152647975,0.8757003600374225,1.0,4/11,17.28%,TJP1;NLGN2;PRTN3;F2R
prerank,regulation of gluconeogenesis (GO:0006111),0.5846385817112831,1.453456365552232,0.06285714285714286,0.8745783925716611,1.0,9/27,16.37%,PPARGC1A;OGT;EP300;ZNF692;NNMT;PDK2;PTPN2;PGP;DDB1
prerank,energy reserve metabolic process (GO:0006112),-0.5145359281265186,-1.4532229766179672,0.06845238095238096,0.5415584471584911,1.0,4/19,6.03%,PID1;PRKAG2;LEPR;PHKA1
prerank,response to cadmium ion (GO:0046686),0.5803537342278016,1.4531098675776895,0.07898448519040903,0.872458741561319,1.0,5/26,8.53%,DAXX;MMP9;FOS;JUN;MAPK9
prerank,positive regulation of protein import into nucleus (GO:0042307),0.587973808729178,1.451948606924955,0.0737134909596662,0.8745363308421626,1.0,9/28,15.66%,CDH1;ZC3H12A;MAVS;BAG3;ZIC1;HDAC3;UBR5;ZPR1;FLNA
prerank,regulation of protein import into nucleus (GO:0042306),0.556939049712112,1.4516582862810372,0.07275132275132275,0.8718641788095651,1.0,12/36,16.23%,CDH1;ZC3H12A;MAVS;BMP4;CHP1;BAG3;ZIC1;HDAC3;UBR5;ZPR1;FLNA;UFM1
prerank,cellular response to fluid shear stress (GO:0071498),0.6799838335671767,1.4515499467085036,0.09870550161812297,0.8684163768420017,1.0,8/12,19.45%,KLF4;SREBF2;NFE2L2;MAPK7;HDAC3;MEF2C;ASS1;KLF2
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),0.6993657650950469,1.4491771540073266,0.09134615384615384,0.8768186434402778,1.0,3/11,6.34%,ACTN2;CAV1;STK39
prerank,potassium ion export across plasma membrane (GO:0097623),-0.5650606906903219,-1.44899003096916,0.06976744186046512,0.5511889077289328,1.0,2/13,2.37%,KCNT2;KCNK5
prerank,dermatan sulfate biosynthetic process (GO:0030208),0.6769202976870249,1.448952508650039,0.0926517571884984,0.8739707779491458,1.0,3/12,4.40%,UST;CHST12;DSE
prerank,dendritic cell differentiation (GO:0097028),-0.48289107456888125,-1.4477465989281897,0.05934718100890208,0.5506125141259626,1.0,5/22,4.50%,LYN;GAS6;AXL;CAMK4;LGALS9
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.5394080999811964,1.446857751095963,0.07170294494238157,0.8808593888958056,1.0,16/48,16.81%,DOCK5;FBXW8;LIMS2;S100A10;PTPRD;DMTN;ILK;CDC42;DOCK1;RREB1;CAPRIN2;SS18L2;FLNA;TESK1;CRK;ABL1
prerank,epidermis development (GO:0008544),0.5208329417918974,1.4463844372929544,0.056303549571603426,0.8793239022290025,1.0,10/56,8.89%,SCEL;LAMC2;EDA2R;WNT10A;CCN2;FLOT2;POU2F3;OVOL2;TGM5;GRHL2
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),-0.5644170055827886,-1.4461265947661261,0.07672634271099744,0.5464936340578024,1.0,4/12,10.90%,IGF1;STIMATE;LMCD1;CHERP
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),-0.5644170055827886,-1.4461265947661261,0.07672634271099744,0.5464936340578024,1.0,4/12,10.90%,IGF1;STIMATE;LMCD1;CHERP
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),0.6840400626950727,1.4459699847942469,0.10031847133757962,0.8775148283291999,1.0,2/12,2.17%,B3GALT1;B4GAT1
prerank,epidermal cell differentiation (GO:0009913),0.5414130076310748,1.4455526948934838,0.05394736842105263,0.8757525601688314,1.0,2/41,0.45%,WNT16;SCEL
prerank,positive regulation of neuron death (GO:1901216),0.5388100896657229,1.4451893846051838,0.07106598984771574,0.8740802799836398,1.0,11/46,11.15%,CLU;DAXX;MAP3K5;EFNB2;NUPR1;FOXO3;FOS;TGFB2;TLR6;SRPK2;TLR4
prerank,amino acid transport (GO:0006865),0.5379952998000737,1.444453514875719,0.062266500622665005,0.8741757388624822,1.0,11/49,12.80%,SLC7A14;SLC36A3;SH3BP4;SLC36A4;SLC3A1;SLC25A47;SLC7A6;SLC1A4;SLC25A45;SLC25A44;PDPN
prerank,regulation of interleukin-13 production (GO:0032656),-0.5708301913565005,-1.4443607956713902,0.06353591160220995,0.5479165341008047,1.0,4/13,7.64%,LEF1;LGALS9;IL18;TNFRSF21
prerank,dendritic spine organization (GO:0097061),-0.46101885498449946,-1.4435521566284975,0.04406779661016949,0.5461002783974189,1.0,7/26,12.24%,INSR;SHANK3;DOCK10;PAK3;EPHB2;IGF1R;MTMR2
prerank,calcium import into the mitochondrion (GO:0036444),0.7096519106150703,1.4430670824498457,0.0991869918699187,0.877292275905493,1.0,5/10,10.90%,MCU;MCUB;MICU1;AFG3L2;MCUR1
prerank,myoblast fusion (GO:0007520),0.6731521981459095,1.4429100678459286,0.08723747980613894,0.8742128631426223,1.0,3/12,5.40%,ADAM12;CD81;CD9
prerank,granulocyte chemotaxis (GO:0071621),0.5168886192843616,1.4428432819545738,0.065,0.8707339926164538,1.0,4/55,8.27%,CXADR;CCL5;TGFB2;LGALS3
prerank,inhibitory synapse assembly (GO:1904862),0.6920748548227927,1.4423007242059755,0.0893760539629005,0.8696336666780866,1.0,2/11,1.61%,FGF13;PLXNB1
prerank,T cell mediated immunity (GO:0002456),0.6723936001305582,1.4415234916263142,0.09451219512195122,0.8694901238853364,1.0,2/13,2.06%,CD55;EMP2
prerank,negative regulation of angiogenesis (GO:0016525),-0.3617359989174699,-1.4414335036962493,0.007518796992481203,0.5485345778790761,1.0,33/84,17.33%,PTPRM;DCN;SULF1;SEMA6A;TEK;ADAMTS9;CLDN5;EPN2;PDE3B;SLC12A2;DAB2IP;THBS1;COL4A2;SEMA3E;RGCC;THBS2;GTF2I;SERPINF1;PIK3CB;ROCK1;MECP2;PPARG;ISM1;NPR1;SPARC;AMOT;AGO1;HSPG2;NAXE;STAB1;HHEX;MINAR1;SPRED1
prerank,regulation of cell morphogenesis (GO:0022604),0.5681758342077786,1.44140417198692,0.09190672153635117,0.8663479763212237,1.0,12/30,18.39%,CD44;FMNL2;ZMYM6;CAPZB;EFNA5;MOV10;STRIP1;ZMYM4;PDPN;CAMSAP1;NTNG2;WTIP
prerank,regulation of protein processing (GO:0070613),-0.48398052954153004,-1.4407490059843413,0.0625,0.5461945861389018,1.0,9/21,25.77%,CCBE1;RUNX1;SERPINE2;LRRK2;NKD2;CLN3;GAS1;BAG2;ADAM8
prerank,negative regulation of cell development (GO:0010721),-0.4703822617084831,-1.4403485840252437,0.06923076923076923,0.5432362307811994,1.0,7/25,15.38%,IGF1;FBN1;NOTCH1;APPL2;B2M;PTHLH;SORL1
prerank,membrane raft organization (GO:0031579),0.6305428346484674,1.4372667585001877,0.08566978193146417,0.8829742868469541,1.0,5/15,6.89%,EMP2;S100A10;FLOT2;NPC1;ANXA2
prerank,transition metal ion transport (GO:0000041),-0.4393737377690207,-1.4372605350482095,0.04,0.5491083105205786,1.0,10/35,12.48%,SLC30A10;TRPC3;TRPC4;SLC39A8;TFRC;ATOX1;TRPC6;TRPC5;TTYH1;SLC30A1
prerank,cation transmembrane transport (GO:0098655),0.5219260688082811,1.4364493280857051,0.0694980694980695,0.8831973451369586,1.0,13/44,15.33%,TRPM3;ATP1A2;TRPM8;ABCC8;SFXN3;SLC36A4;SFXN1;TRPM6;SLC25A38;TRPM4;PKD2L1;TRPM2;SLC7A3
prerank,positive regulation of calcium ion import (GO:0090280),-0.5482470947436033,-1.4350772612674207,0.07714285714285714,0.5514595428309114,1.0,2/12,2.67%,PDGFRB;CXCL12
prerank,Rho protein signal transduction (GO:0007266),0.5200283666068849,1.434269106701395,0.08108108108108109,0.8903239319093219,1.0,15/53,16.31%,AGTR1;CDH13;CELSR1;EPS8L2;CDC42EP4;CDC42EP5;ARHGAP29;CDC42;GNA13;RHOA;PDPN;RHOU;ARHGDIB;RIPOR1;ARHGEF1
prerank,regulation of activated T cell proliferation (GO:0046006),-0.45258480471595,-1.4341553117475514,0.06153846153846154,0.5501369974664521,1.0,5/30,7.03%,IGF1;IGFBP2;LGALS9;IL18;IGF2
prerank,negative regulation of complement activation (GO:0045916),0.6977682913200751,1.433660101636218,0.10132890365448505,0.8896995949727811,1.0,1/10,0.15%,CD55
prerank,cellular response to organonitrogen compound (GO:0071417),0.4825721817569215,1.4336530448575615,0.0425531914893617,0.8860102838130022,1.0,22/99,14.09%,CDH1;CFTR;RAP1B;RAP1A;DIAPH1;CTNNA1;SESN2;SH3BP4;SOX9;DMTN;AANAT;GOLPH3;CAPN2;ACTB;EZR;HTR1B;AQP1;RAPGEF3;CPEB3;TRPM2;MEF2C;SFRP1
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.5685461764438551,1.4334880591855501,0.07240437158469945,0.883200996442086,1.0,4/31,11.39%,FZR1;ARRDC3;DCUN1D5;DCUN1D1
prerank,negative regulation of protein metabolic process (GO:0051248),0.52137913691563,1.433150633931708,0.06700379266750948,0.8811617629234204,1.0,11/48,12.17%,CLU;LDLR;PFDN1;HMGCR;FLOT2;CRYAB;AZIN1;CYP51A1;BANP;SF3B3;SNX12
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),0.6516137660630297,1.4330548718533938,0.1119751166407465,0.8779889777292972,1.0,2/13,6.56%,SORBS1;ZBTB7B
prerank,basement membrane organization (GO:0071711),-0.5420641664753311,-1.4323918446228965,0.07027027027027027,0.5516233588312872,1.0,8/14,9.67%,FLRT2;NID1;NID2;COL4A1;LAMB1;NTN4;NTNG1;RAMP2
prerank,positive regulation of exocytosis (GO:0045921),0.5544989687435791,1.4317224669933963,0.08412483039348712,0.881098486180944,1.0,15/35,20.29%,CFTR;SYTL4;UNC13D;SDC4;RAB7A;VPS4B;VPS4A;CHMP2A;PDCD6IP;STAM;TSG101;RAB2B;RAB27A;RAB9A;ATP6AP1
prerank,aminoglycan catabolic process (GO:0006026),0.5823958006029762,1.4313635530783877,0.09724238026124818,0.8792274141394626,1.0,8/28,10.09%,GPC6;GPC1;GPC4;NAGLU;SDC4;GLB1;GPC3;GUSB
prerank,leukocyte cell-cell adhesion (GO:0007159),0.5803114658693261,1.4305059790612151,0.10632183908045977,0.8798187586833971,1.0,5/24,9.58%,NT5E;CCL5;GFUS;MSN;EZR
prerank,artery development (GO:0060840),-0.4713204800085104,-1.4301514242740094,0.06389776357827476,0.5541327330279255,1.0,9/23,14.37%,ENG;ROBO1;ACVRL1;PKD2;ROBO2;PDE2A;NF1;TBX1;BMPR2
prerank,regulation of mitochondrial depolarization (GO:0051900),-0.5889237981330484,-1.4297403507391264,0.08673469387755102,0.5511794825047117,1.0,6/10,12.35%,DCN;KDR;BCL2;LRRK2;MYOC;RACK1
prerank,regulation of wound healing (GO:0061041),0.5351746193165008,1.4293279563453056,0.09090909090909091,0.8818158776096954,1.0,12/42,17.28%,CD109;KANK1;OCLN;CAV1;ALOX5;DMTN;CASK;ACTG1;ARFGEF1;HRAS;CRK;F2R
prerank,regulation of glucose transmembrane transport (GO:0010827),0.6245261434383945,1.4293034942490588,0.09451219512195122,0.8784027641799196,1.0,2/18,2.01%,PRKCB;OCLN
prerank,response to organonitrogen compound (GO:0010243),-0.4175505198473152,-1.4281954499069098,0.03418803418803419,0.5518144760046148,1.0,16/38,21.67%,IRAK3;KAT7;RCN3;GLRA1;DNAJB12;SEL1L;DRD2;SYVN1;GLRA3;DHFR;ERLEC1;GLRA2;GLRB;BRSK2;NR1H4;UBXN6
prerank,UV protection (GO:0009650),0.6987858785751393,1.4280080386464298,0.09803921568627451,0.881415838936024,1.0,2/10,2.72%,SCARA3;FEN1
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),0.6599195989222664,1.4277451182215697,0.09800664451827243,0.8793893959738133,1.0,6/13,12.85%,CLU;NUPR1;ALOX5;USP19;EIF2AK3;LPCAT3
prerank,response to UV-A (GO:0070141),0.6489623791752014,1.4275313138316543,0.11639344262295082,0.8769019108881606,1.0,4/14,9.74%,OPN1SW;MMP9;TIMP1;CCND1
prerank,GPI anchor biosynthetic process (GO:0006506),0.576114975537663,1.4273057597880654,0.08513513513513514,0.8745332781212392,1.0,12/30,19.29%,PIGU;GPAA1;PIGZ;PGAP2;PIGT;PIGA;PIGX;DPM2;PIGS;PIGN;PIGP;PIGQ
prerank,proteoglycan metabolic process (GO:0006029),-0.4468088068050457,-1.426404066984253,0.04946996466431095,0.5531992698224548,1.0,11/26,16.87%,IGF1;ADAMTS12;SULF1;XYLT1;BMPR1B;CSGALNACT1;CHST8;CANT1;BMPR2;CHST10;B4GALT7
prerank,positive regulation of ossification (GO:0045778),-0.41658055610703715,-1.4263166075581906,0.05531914893617021,0.5494375552020927,1.0,11/39,8.35%,BMP6;ADGRV1;WNT4;SLC8A1;WNT5A;KL;BMPR1B;FBN2;TGFB1;PKDCC;ACVR2A
prerank,positive regulation of focal adhesion assembly (GO:0051894),-0.5007851642875519,-1.4258527579818077,0.08099688473520249,0.5466788740559837,1.0,7/19,11.38%,PTPRJ;TEK;KDR;TSC1;ROCK1;MAP4K4;MYOC
prerank,sensory perception of pain (GO:0019233),-0.481635430215083,-1.4257485674793267,0.06287425149700598,0.5430262797796918,1.0,16/21,38.45%,RETREG1;PTGES;MME;OPRM1;OPRK1;NIPSNAP1;TRPA1;CHRNA4;CCR2;KCNA2;CCL2;KCNK4;OPRL1;CHRNB2;ALOXE3;PROK2
prerank,regulation of neuron apoptotic process (GO:0043523),0.4799726979757678,1.4255081763788362,0.052571428571428575,0.8799048843924142,1.0,18/96,10.71%,EGLN3;CRLF1;PPARGC1A;NRBP2;NUPR1;NGF;PTK2B;FOXO3;GDNF;CLCF1;EGLN2;ERBB3;TGFB2;UNC5B;SIX1;KCNB1;SRPK2;SOD2
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.686270912083647,1.4252971051410552,0.10631229235880399,0.8774173479926347,1.0,1/10,0.09%,PRKCB
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.5937742690578072,1.424733276916564,0.08656716417910448,0.8766521982410629,1.0,1/22,0.15%,CD55
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.5686099569047142,1.4245556213038535,0.0856353591160221,0.8740760544933677,1.0,10/27,16.82%,CD44;DDX5;PMAIP1;YJU2;SPRED3;TWIST1;EEF1E1;MDM2;ATR;KDM1A
prerank,purine nucleotide metabolic process (GO:0006163),0.5964957482849319,1.4243003869619884,0.09784172661870504,0.8717802581878611,1.0,4/24,6.84%,NT5E;NT5C1A;FHIT;NT5C2
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),0.6191477734069853,1.4241952378139504,0.11338582677165354,0.8688717155846044,1.0,7/17,16.81%,BAIAP2L1;NTRK3;HAX1;CDC42;BCAS3;HRAS;ABL1
prerank,vasculature development (GO:0001944),-0.5259405810723093,-1.4238997208292383,0.08595988538681948,0.5448067781094128,1.0,8/16,17.15%,ERRFI1;PDGFRB;ACVRL1;PDGFRA;NOTCH4;FLT4;BMPR2;SOX18
prerank,replicative senescence (GO:0090399),0.6669501323533101,1.42256893513769,0.11333333333333333,0.8732154346129108,1.0,1/12,0.08%,WNT16
prerank,positive regulation of neuron migration (GO:2001224),-0.577947616947458,-1.4225047659522119,0.07785888077858881,0.5450831577144839,1.0,5/11,13.56%,SEMA6A;RAPGEF2;DAB2IP;ARHGEF2;NIPBL
prerank,antibacterial humoral response (GO:0019731),0.638017321123959,1.4219676489438235,0.10975609756097561,0.8730110496931542,1.0,6/16,19.33%,SLPI;ANG;RNASE3;PLA2G6;RNASE7;JCHAIN
prerank,nucleotide catabolic process (GO:0009166),0.6383229948409622,1.418837566981549,0.11338582677165354,0.8850646312213539,1.0,4/16,9.45%,NT5E;NT5C1A;NT5C2;DERA
prerank,muscle contraction (GO:0006936),0.4734250911090223,1.4187184455290553,0.04357298474945534,0.8822183369318799,1.0,15/126,7.04%,SORBS1;MYOM2;UTRN;ACTN2;CALD1;VIM;TMOD3;SGCA;TMOD2;LMOD3;MYOT;CRYAB;GAMT;PXN;SNTB1
prerank,regulation of stress fiber assembly (GO:0051492),0.49264877001017565,1.418208921619644,0.06580493537015276,0.8814430463222184,1.0,27/74,16.86%,PHLDB2;LPAR1;TJP1;ARAP1;CCN2;WNT11;S100A10;TMEFF2;ARHGEF18;PXN;CDC42;ARHGEF5;RHPN2;ACTG1;DLC1;RAPGEF3;RHOA;ASAP3;ARHGEF10L;SFRP1;CCDC88A;ITGB1BP1;TESK1;PPFIA1;PFN2;ABL1;SLC9A1
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),0.5976466929744064,1.4177891175222568,0.10802919708029197,0.8768330947659545,1.0,6/21,7.89%,EYA2;GDNF;BCL2L1;MAPK7;EYA1;UNC5B
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.5976466929744064,1.4177891175222568,0.10802919708029197,0.8768330947659545,1.0,6/21,7.89%,EYA2;GDNF;BCL2L1;MAPK7;EYA1;UNC5B
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.5224802480759202,1.41743380278415,0.09319899244332494,0.8753665198058744,1.0,14/46,15.66%,CDH1;ZC3H12A;MAVS;TCF7L2;BAG3;ZIC1;HDAC3;RAPGEF3;UBR5;GSK3B;NEDD4;ZPR1;DHX9;FLNA
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.4696062151140687,1.4171684751883724,0.05714285714285714,0.8733502883756404,1.0,18/100,8.31%,FN1;WNT16;FGFR1;NTRK3;PIK3IP1;CCL5;PLXNB1;PDGFC;GAB1;EPO;TSC2;SOX9;HAX1;MYDGF;ERBB3;TGFB2;UNC5B;MAZ
prerank,presynapse organization (GO:0099172),-0.5892712719643565,-1.4151921113945554,0.11306532663316583,0.5640535239114621,1.0,5/10,16.06%,WNT5A;NLGN1;FZD1;NLGN3;LRRTM3
prerank,cellular response to cAMP (GO:0071320),0.5642222253949443,1.4151825949515702,0.07651715039577836,0.8793331787035217,1.0,8/30,11.19%,CFTR;RAP1B;RAP1A;DMTN;AANAT;EZR;AQP1;RAPGEF3
prerank,epiboly involved in wound healing (GO:0090505),0.6272516173649016,1.4142043154601305,0.1,0.8806561876831733,1.0,7/16,15.66%,CD44;TMEFF2;TOR1A;RHOA;PDPN;DDR1;FLNA
prerank,regulation of endothelial cell chemotaxis (GO:2001026),-0.5403122848098735,-1.412733352619597,0.08433734939759036,0.5682638929914263,1.0,5/15,5.34%,PRKD1;SEMA5A;NOTCH1;FGF2;THBS1
prerank,artery morphogenesis (GO:0048844),-0.4372487072667123,-1.411555722226385,0.056179775280898875,0.5681717399882291,1.0,11/30,14.37%,PDGFRB;JAG1;ENG;ADAMTS9;NOTCH1;PKD2;TBX2;NF1;HPGD;TBX1;BMPR2
prerank,endothelial cell proliferation (GO:0001935),-0.5221079185796037,-1.410901082693537,0.09846153846153846,0.5663049975575345,1.0,5/17,4.68%,TEK;SEMA5A;ACVRL1;CD34;BMPER
prerank,postsynaptic membrane organization (GO:0001941),-0.4928648733264357,-1.410852029047682,0.1111111111111111,0.5624904263479521,1.0,5/17,12.76%,GPHN;NRXN1;SHANK3;NLGN1;NLGN3
prerank,cardiac cell development (GO:0055006),0.6801058113627836,1.4107564026375556,0.11182108626198083,0.8940744233609452,1.0,1/11,0.07%,CXADR
prerank,peptidyl-proline hydroxylation (GO:0019511),0.6843513378072457,1.4107533219826898,0.11774193548387096,0.8907777666592115,1.0,2/11,7.16%,EGLN3;EGLN2
prerank,lipoprotein transport (GO:0042953),0.6920067573527472,1.4105057818144136,0.11012433392539965,0.8886501438949098,1.0,2/10,5.89%,PRKCB;UNC119
prerank,response to acidic pH (GO:0010447),0.659299179739648,1.4090746202562368,0.10124610591900311,0.8920907720362347,1.0,4/13,11.40%,GPR4;CHP1;RAB11FIP5;PKD2L1
prerank,protein K11-linked ubiquitination (GO:0070979),0.5675815034104086,1.4088290426873293,0.0910344827586207,0.8900759039876891,1.0,1/27,0.05%,FZR1
prerank,N-terminal protein amino acid modification (GO:0031365),0.6353554356531781,1.4085827738535623,0.13260530421216848,0.8880612279909839,1.0,8/14,21.54%,PDF;NAA40;NTMT1;AANAT;NAA15;NAA10;NAA35;METAP1D
prerank,aortic valve development (GO:0003176),-0.41922415001913743,-1.4083410603886672,0.058823529411764705,0.5666656546470146,1.0,15/34,14.37%,ELN;JAG1;NOS3;ROBO1;TIE1;NOTCH1;NFATC1;ROBO2;SLIT2;TGFB1;ROCK1;HEYL;TNFRSF1B;SLIT3;BMPR2
prerank,modulation of chemical synaptic transmission (GO:0050804),-0.3428658775895359,-1.4082400910407493,0.034782608695652174,0.5630800142514856,1.0,47/107,21.36%,GRIK2;CDH2;NRG3;SLC8A3;GRID2;GRM3;SNCAIP;GRM7;LRRC4C;LGI1;GRM8;SLC12A2;MCTP2;DLGAP1;SYT1;LRRK2;GRM5;GRIK3;CLSTN2;NLGN1;LRP8;DGKI;CNTNAP4;GRIK1;GRIK4;TMEM108;NLGN3;DRD2;BDNF;CAMK2A;MCTP1;CLN3;KCNMB4;BAIAP3;CPLX2;GRM1;NPTX1;FMR1;PXK;KCTD13;STX1B;GRIK5;CX3CR1;CACNA1B;TPRG1L;RIMS1;DGKZ
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),0.5832128695273346,1.408182897534707,0.11475409836065574,0.8867228513127889,1.0,5/25,6.82%,CFTR;ANK2;ACTN2;STK39;ANK3
prerank,actin filament depolymerization (GO:0030042),0.6858224296638605,1.4078605365323495,0.11129296235679215,0.8852032427297984,1.0,4/11,7.80%,GSN;MICAL2;TWF1;MICAL1
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),-0.35688885143420235,-1.4073752878604548,0.025806451612903226,0.5619220819602245,1.0,26/75,19.38%,PTPRJ;NR2F2;SLC8A1;SLC8A3;LYN;PKIG;DAB2IP;IRAK3;SH2B3;APC;PIK3CB;LRP6;IPO5;LRP5;PRKAR2B;NF1;RASIP1;CD300A;SORL1;MYOCD;HHEX;INCA1;PRKAR1B;SPRY4;SPRY1;PAQR3
prerank,positive regulation of intracellular protein transport (GO:0090316),0.4564513972580175,1.407095383498273,0.041935483870967745,0.8858734040038575,1.0,42/144,16.88%,CDH1;SREBF2;BBC3;ZC3H12A;MAVS;PMAIP1;CD81;PPP1R13B;ANK3;BAD;PLK3;FZD5;TCF7L2;CHP1;YWHAB;BAG3;MIEF2;ZIC1;YWHAQ;MYO1C;KCNB1;AKAP5;BCAS3;HDAC3;RAPGEF3;SAE1;VPS11;YWHAZ;NPEPPS;RHOU;GSK3A;UBR5;GSK3B;HRAS;ZPR1;ITGB1BP1;RNF31;ITGB2;FLNA;RIPOR1;E2F1;UBE2D3
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),-0.44458434945797715,-1.4069659491507314,0.07462686567164178,0.5593494620511387,1.0,6/27,5.61%,SLC1A3;SLC47A1;SLC6A9;SLC1A2;SLC7A5;SLC1A1
prerank,negative regulation of stress fiber assembly (GO:0051497),0.5766324277677014,1.405338313347338,0.1049645390070922,0.8910809513873592,1.0,7/24,10.78%,PHLDB2;TJP1;ARAP1;TMEFF2;ARHGEF18;RHPN2;DLC1
prerank,nuclear migration (GO:0007097),0.6495040950219353,1.4045512382887766,0.1069078947368421,0.8918178983571089,1.0,9/13,24.60%,DOCK7;SYNE3;PAFAH1B1;DYNC1H1;SUN2;TMEM201;HOOK3;CEP120;PCM1
prerank,regulation of multicellular organism growth (GO:0040014),-0.5315645828135436,-1.4043640419348247,0.09703504043126684,0.5637387254332121,1.0,3/15,2.23%,IGF1;GHR;STAT5B
prerank,regulation of lymphocyte migration (GO:2000401),0.6695269311586893,1.403303254152743,0.1135593220338983,0.894800911962837,1.0,5/10,21.67%,ADTRP;MSN;SLC8B1;JAM2;MIA3
prerank,actin polymerization or depolymerization (GO:0008154),0.5159874383731686,1.4032601904015207,0.08919597989949749,0.8918041000308695,1.0,14/50,12.08%,COBL;VILL;GSN;MICAL2;DIAPH1;CORO7;ENAH;TWF1;AVIL;ANG;MICAL1;MSRB2;ABI1;WASF1
prerank,circulatory system development (GO:0072359),0.4641715232784719,1.402784004340257,0.04371584699453552,0.8909616572483854,1.0,17/118,8.25%,FN1;CXADR;NTRK3;PDLIM5;NXN;CDKN1A;MICAL2;AKAP13;CRB2;STRA6;FOXC2;TSC2;SOX9;RBM20;ERBB3;TGFB2;PKD1
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),-0.39325385514155664,-1.4020742867478206,0.04608294930875576,0.5674381339850592,1.0,21/48,22.81%,ROBO1;GAS6;IRAK3;NR1H3;PARP14;SH2B3;SLIT2;RFFL;SAMHD1;PPARG;NLRC5;PADI2;SLIT3;NR1H2;PELI3;CCDC3;CNOT7;TRAIP;SIGIRR;GPS2;YTHDF2
prerank,cell chemotaxis (GO:0060326),0.49702593115009086,1.4015987478034226,0.08138101109741061,0.8933715049069205,1.0,10/60,5.94%,AGTR1;LPAR1;CCR4;PARVA;CXCR4;ACKR4;ACKR2;CCR10;ACKR3;CCRL2
prerank,positive regulation of glucose metabolic process (GO:0010907),0.6456261177203437,1.4015785163704917,0.1076923076923077,0.8903413629516702,1.0,7/14,19.43%,PPARGC1A;PMAIP1;NNMT;IRS2;PTPN2;DDB1;GPLD1
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),0.653792062111075,1.4010295942604827,0.11605723370429252,0.889907143091639,1.0,2/12,6.56%,SORBS1;ZBTB7B
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),0.5764317243294957,1.4009184924446765,0.09352517985611511,0.8872996718871755,1.0,6/23,8.17%,SMO;GDNF;SOX9;BMP4;WNT5B;SIX1
prerank,actin filament bundle assembly (GO:0051017),0.5406271690934188,1.4006826310376697,0.09694555112881806,0.8853062454206929,1.0,8/33,9.58%,BAIAP2L1;PAWR;CALD1;ESPN;ADD1;DMTN;MICAL1;EZR
prerank,lipoprotein localization (GO:0044872),0.6724248706904322,1.4006087942880499,0.1157167530224525,0.8825705962712262,1.0,2/11,5.89%,PRKCB;UNC119
prerank,intraciliary retrograde transport (GO:0035721),-0.5619491321847252,-1.4003506723365886,0.08461538461538462,0.5689791867537763,1.0,7/12,28.11%,IFT122;TTC21B;WDR19;IFT43;DYNC2LI1;DYNC2I2;IFT140
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),0.605610151543911,1.4000420756330516,0.1037593984962406,0.8823584973874821,1.0,12/18,18.79%,KANK1;RAP1B;PTK2B;RIPOR2;KRIT1;LLGL2;BCAS3;ARFGEF1;CDH5;SHTN1;KIF20B;ROCK2
prerank,positive regulation of cation channel activity (GO:2001259),0.5398251807038033,1.4000149645441557,0.07793923381770146,0.8794495951911635,1.0,7/40,7.99%,ANK2;ACTN2;GAL;STAC3;ANK3;GSTO1;JPH2
prerank,aerobic respiration (GO:0009060),0.5801700000089788,1.3987720003796522,0.10632183908045977,0.8824272701181762,1.0,9/20,17.73%,SDHB;ME3;UQCRC2;MTFR1L;UQCRC1;MDH2;SLC25A14;UQCRH;MTFR2
prerank,cellular response to organic cyclic compound (GO:0071407),0.4558488933198373,1.3969117509228388,0.047261009667024706,0.8880575246740028,1.0,25/141,11.19%,CDH1;CFTR;ADTRP;NCOA3;CCL5;RORC;RAP1B;ZC3H12A;ATP1A2;RAP1A;DIAPH1;CTNNA1;FAM210B;INSIG1;LCOR;DMTN;AANAT;MSN;GOLPH3;ADCY6;ACTB;EZR;ARL6IP5;AQP1;RAPGEF3
prerank,protein localization to membrane (GO:0072657),0.44919668909981725,1.3968632849466305,0.039790575916230364,0.8852641525526734,1.0,36/187,10.18%,CDH1;FGF13;ANK2;TSPAN5;ACTN2;SLMAP;TTC7A;ANK1;EMP2;MAGI2;CAV1;ITGB7;RAP1A;CD81;S100A10;CACNB3;EHD1;ARL3;FYB2;RAMP1;FLOT2;FRMPD1;NPC1;SYNE3;ANK3;CPE;ZFYVE27;PACS1;RAB3B;STXBP1;NDC1;TNFRSF1A;MYO5A;EZR;KCNB1;SYNJ2BP
prerank,cellular response to starvation (GO:0009267),0.4522006590604963,1.396588374776032,0.047872340425531915,0.8836463926152881,1.0,11/147,3.80%,DAPL1;RNF152;PRKAA2;ATP6V1B1;MAP3K5;SREBF2;CDKN1A;ZC3H12A;PMAIP1;FOXO3;SESN2
prerank,positive regulation of phospholipase activity (GO:0010518),0.5774516836406983,1.3962128620030358,0.11078286558345643,0.8822114927525072,1.0,4/22,1.51%,AGTR1;FGFR1;NTRK3;CCL5
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.6735282674485424,1.3957605373908146,0.12762237762237763,0.8814077122048241,1.0,3/10,11.15%,ADTRP;TLR6;TLR4
prerank,steroid hormone biosynthetic process (GO:0120178),0.554323774198649,1.3953717250494362,0.10476190476190476,0.8803582638982345,1.0,6/29,11.13%,STARD3;HSD17B14;DHCR7;SRD5A3;FDX1;HSD17B11
prerank,membrane protein proteolysis (GO:0033619),0.5231186210853956,1.39482222069252,0.09855453350854139,0.8801199565602897,1.0,16/37,20.74%,TMPRSS6;DAG1;ADAM10;AFG3L2;NAPSA;SPPL2B;CTSH;HM13;BACE1;PRTN3;SPPL3;PRKCQ;SPPL2A;ADAM17;RHBDD1;APH1A
prerank,melanosome localization (GO:0032400),0.5695228412448898,1.3942974475544399,0.13153961136023917,0.8797136506020851,1.0,5/21,13.35%,RAB17;BLOC1S6;MLPH;MYO5A;MKKS
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),0.6716833668196696,1.3938013585326323,0.12082670906200318,0.8762698404652661,1.0,3/10,14.45%,KLF4;MAPK7;WNK1
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),0.6716833668196696,1.3938013585326323,0.12082670906200318,0.8762698404652661,1.0,3/10,14.45%,KLF4;MAPK7;WNK1
prerank,positive regulation of positive chemotaxis (GO:0050927),0.6308634602761534,1.3933179168774559,0.10658307210031348,0.8755642573565374,1.0,3/15,2.86%,CDH13;NTRK3;IL16
prerank,ketone body metabolic process (GO:1902224),-0.5825449037914847,-1.3930124068020862,0.13053613053613053,0.5883085325839992,1.0,4/10,9.40%,ACSS3;HMGCLL1;HMGCS2;BDH1
prerank,regulation of lipid biosynthetic process (GO:0046890),0.5473659155794632,1.3929714695323463,0.09510869565217392,0.8742857968713501,1.0,6/32,7.25%,SORBS1;PRKAA2;CREBL2;AVIL;CREB1;EIF6
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.6800949087501841,1.3926980921766234,0.10047846889952153,0.872629810271465,1.0,9/10,30.14%,ACADL;ACADM;IVD;GCDH;ACAD11;ETFDH;ETFA;ETFB;ACADVL
prerank,cholesterol transport (GO:0030301),0.5176000743597512,1.3924770703149163,0.09102730819245773,0.870746707752418,1.0,12/45,18.13%,CLU;LDLR;SOAT1;CAV1;STARD3;NPC1;SOAT2;STARD4;VPS4A;OSBPL5;RELCH;OSBPL2
prerank,transepithelial transport (GO:0070633),0.6231285043351897,1.3909704239525196,0.13210445468509985,0.8749390622139032,1.0,1/15,0.07%,CXADR
prerank,platelet degranulation (GO:0002576),0.4654096450844358,1.3909318812595004,0.06277533039647577,0.8722218842177714,1.0,16/118,8.78%,FN1;CD109;CLU;F5;ACTN2;PHACTR2;SYTL4;SCCPDH;TIMP1;CD9;ANXA5;TEX264;TGFB2;SRGN;STXBP1;VEGFB
prerank,negative regulation of blood pressure (GO:0045776),-0.5469803353796125,-1.390809709844005,0.1271186440677966,0.5913743712413727,1.0,8/13,38.51%,NOS3;DRD2;BMPR2;PRCP;GPR37L1;APLN;NOS2;DRD3
prerank,negative regulation of TORC1 signaling (GO:1904262),0.6472027454893788,1.390650525752075,0.1168,0.8707038629657505,1.0,2/13,3.80%,RNF152;SESN2
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),0.6563015513477366,1.3905009609989216,0.10227272727272728,0.8686679594253739,1.0,4/13,13.96%,B4GALNT2;NAGK;UAP1L1;GFPT1
prerank,negative regulation of defense response to virus (GO:0050687),0.6747943669333769,1.3903680385774952,0.11538461538461539,0.866488030600783,1.0,6/10,24.22%,PPM1B;TARBP2;MUL1;ILRUN;PCBP2;C1QBP
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),0.5890277741358103,1.3901879342200845,0.10998552821997105,0.8645682924517103,1.0,4/20,6.34%,ACTN2;MMP9;EPO;STK39
prerank,positive regulation of biomineral tissue development (GO:0070169),-0.40589591480564274,-1.3901016009395346,0.07346938775510205,0.5898701379655406,1.0,10/40,8.35%,BMP6;ADGRV1;WNT4;SLC8A1;KL;BMPR1B;FBN2;TGFB1;PKDCC;ACVR2A
prerank,actin filament bundle organization (GO:0061572),0.538548043063514,1.3891511934920378,0.1077127659574468,0.8667272043286329,1.0,8/33,9.58%,BAIAP2L1;PAWR;CALD1;ESPN;ADD1;DMTN;MICAL1;EZR
prerank,regulation of insulin receptor signaling pathway (GO:0046626),0.5243191728859277,1.3886755319989672,0.09256844850065189,0.8661531443307338,1.0,6/43,6.56%,PRKCB;SORBS1;KANK1;OGT;TSC2;ZBTB7B
prerank,regulation of ion transmembrane transporter activity (GO:0032412),0.523631891956086,1.3885119152128307,0.10217113665389528,0.8641451534193304,1.0,6/39,6.34%,UTRN;ANK2;FHL1;WWP2;AHCYL1;STK39
prerank,regulation of inclusion body assembly (GO:0090083),-0.5628124406487192,-1.3883496408177227,0.1015625,0.5915921625516608,1.0,7/11,31.24%,SNCAIP;SACS;DNAJB2;BAG5;DNAJB1;HSPA1B;HSPA2
prerank,lamellipodium organization (GO:0097581),0.5515679478734324,1.3874902616475209,0.08671328671328671,0.8659092312171737,1.0,10/29,18.37%,CDH13;ABLIM2;ABLIM1;DMTN;GOLPH3;ARFIP2;WASF1;CCDC88A;VCL;ARHGEF6
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),-0.321563992860894,-1.3871739094067037,0.0,0.591598791867189,1.0,40/138,13.71%,FLT1;PTPRG;ROR1;PDGFRB;EPHA7;TEK;IL31RA;INSR;MERTK;MPZL1;LIFR;LYN;PTK2;AXL;TIE1;PDGFRA;KDR;ACVR1B;EPHB2;EPHB4;ROR2;PIK3CB;NTRK2;JAK2;ACVR2A;ERBB4;FGFR2;RYK;AHI1;KIT;NPR1;BLNK;PTPRT;IGF1R;IL6ST;FGFR4;BDNF;FLT4;RET;EPHA5
prerank,negative regulation of interleukin-8 production (GO:0032717),0.6009918574637068,1.3868344640854586,0.11854103343465046,0.8661203830420192,1.0,4/17,9.18%,KLF4;ANXA4;OTUD7B;TLR6
prerank,regulation of endocytic recycling (GO:2001135),0.6598764201087739,1.3862726590527814,0.11198738170347003,0.8658910891574051,1.0,3/11,10.93%,ACTN2;EHD1;ATP9A
prerank,proton transmembrane transport (GO:1902600),0.5260554193846595,1.3856808799916973,0.107095046854083,0.865763290552388,1.0,14/36,22.83%,SLC36A3;ATP6V1B1;ATP1A2;SLC25A14;SLC25A27;HVCN1;ATP6V0D1;ATP5F1B;SLC9A1;ATP1A3;ATP1A4;ATP1A1;SLC4A11;ATP6V0E1
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.49639425286150946,1.3853416844446074,0.0688836104513064,0.8646825339047648,1.0,17/66,15.77%,CDH1;LIMK2;ZC3H12A;MAVS;SESN2;ORMDL3;LARP7;BAG3;ZIC1;HDAC3;EIF2AK3;PINX1;UBR5;ZPR1;FLNA;TESK1;MEPCE
prerank,estrogen metabolic process (GO:0008210),0.6252530390637997,1.3850984980346366,0.12093023255813953,0.86302439338318,1.0,3/15,11.13%,SULT1A1;HSD17B14;HSD17B11
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.5686604692925914,1.385087871471277,0.11888111888111888,0.860373013159801,1.0,4/24,5.85%,CLU;CD44;ACKR3;BCL2L1
prerank,cardiac muscle cell development (GO:0055013),0.5898965556480391,1.3850845873994495,0.10289855072463767,0.8577195742084948,1.0,3/20,3.66%,CXADR;PDLIM5;CSRP3
prerank,positive regulation of protein sumoylation (GO:0033235),0.6768204138957419,1.3846658112489296,0.127831715210356,0.8568340960285743,1.0,5/10,12.88%,HDAC4;MUL1;SAE1;PIAS1;PIAS3
prerank,regulation of cellular protein localization (GO:1903827),0.5154531704068848,1.3844834070477057,0.1008827238335435,0.8549628740508571,1.0,12/45,11.22%,GPC6;PRKAA2;GPC1;NDEL1;GPC4;GPC3;DVL3;SUMO3;TOR1A;RAB11FIP5;ABCA2;CSNK1E
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),-0.4657806437006942,-1.3843861437197706,0.09032258064516129,0.5968141257913427,1.0,10/21,13.02%,SULF1;HS6ST2;NDST3;HS6ST3;XYLT1;EXTL3;XYLT2;EXT2;HS3ST3B1;B3GAT3
prerank,negative regulation of sprouting angiogenesis (GO:1903671),-0.561370563963233,-1.384223058604995,0.10824742268041238,0.5935264842494865,1.0,5/11,7.45%,SEMA6A;ADAMTS9;EPN2;THBS1;PIK3CB
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),-0.41955257020069514,-1.383994825277276,0.06716417910447761,0.59045118276947,1.0,13/33,18.09%,IGF1;PIK3R1;NYAP2;PIK3CB;PIK3CD;NF1;IGF1R;HTR2A;EDN1;PIK3R5;SIRT2;MYO16;PIK3R2
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.5791100689399489,1.3829449599411459,0.11509715994020926,0.8593380581419147,1.0,3/21,7.53%,PRKCB;CD81;NFAM1
prerank,regulation of response to oxidative stress (GO:1902882),0.6567099890816075,1.3828507552166467,0.12261146496815287,0.8570924433763581,1.0,3/11,5.07%,ABCD1;SELENON;ALOX5
prerank,filopodium assembly (GO:0046847),0.6148518745552605,1.382357659677904,0.11550632911392406,0.8567214147121288,1.0,2/16,0.86%,RAB17;SRGAP2
prerank,manganese ion transport (GO:0006828),-0.5215379832684445,-1.3823045499781659,0.11320754716981132,0.5921287253507108,1.0,6/14,10.96%,SLC30A10;TRPC3;TRPC4;SLC39A8;TRPC6;TRPC5
prerank,"phototransduction, visible light (GO:0007603)",0.6326822590105845,1.3819538081785587,0.11598746081504702,0.8560525460737559,1.0,5/14,15.14%,RP1;GNAQ;CNGB1;PDE6B;GNA11
prerank,extracellular matrix organization (GO:0030198),0.4387309248950426,1.381842652509964,0.02240325865580448,0.8539552571951902,1.0,26/276,3.20%,FN1;CDH1;ADAM12;ITGB4;THSD4;ITGA10;ADAMTS14;COL23A1;COL25A1;CD44;ITGB8;LAMA4;TMPRSS6;LAMC2;MMP9;COL4A3;SH3PXD2A;COL4A4;DAG1;ADAMTS7;ADAMTSL5;ADAM10;GSN;COL5A2;ITGB7;LAMA5
prerank,cell junction organization (GO:0034330),0.4828212509424102,1.3814150000966356,0.08333333333333333,0.8532385653002401,1.0,13/71,9.26%,CXADR;SDK1;TJP2;TJP1;OCLN;LIMS2;MYOT;TGFB2;ILK;CDC42;GRHL2;OPHN1;ACTB
prerank,embryonic appendage morphogenesis (GO:0035113),0.6640880954885806,1.3803898920922317,0.10163934426229508,0.8552446993933336,1.0,2/12,7.38%,MBNL1;TGFB2
prerank,positive regulation of vascular permeability (GO:0043117),0.6488290149448939,1.3803425162649638,0.15284552845528454,0.852893272243024,1.0,4/12,2.01%,ANGPT1;TJP2;TJP1;OCLN
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.6328119860384316,1.379907713223003,0.13848631239935588,0.8522071269244987,1.0,5/13,16.82%,CD44;YJU2;TWIST1;MDM2;KDM1A
prerank,melanocyte differentiation (GO:0030318),-0.5542978022045626,-1.3794674786331935,0.13881748071979436,0.5973247680116567,1.0,6/11,21.21%,ENPP1;MITF;KIT;LRMDA;MREG;SLC24A5
prerank,protein localization to cell junction (GO:1902414),0.5758401178605665,1.3793875804045421,0.11561561561561562,0.8519210155208646,1.0,6/22,11.60%,TJP2;TJP1;BSN;ARHGEF18;PCLO;JAK1
prerank,tricarboxylic acid metabolic process (GO:0072350),0.6463228867011972,1.3783213072164162,0.12735849056603774,0.8539516486900929,1.0,10/12,26.18%,IDH3G;GLUD1;ACO2;IDH3A;ASS1;SIRT4;ACO1;ACLY;IDH1;IDH2
prerank,regulation of cell adhesion (GO:0030155),0.4498063295167855,1.377970339484552,0.06870229007633588,0.8529962368238697,1.0,20/129,7.85%,GPR4;CDH13;ANGPT1;CCL5;PLXNB1;PODXL;EPHA4;ADAM10;PKP4;PLXNA2;CXCR4;PTK2B;PPP2CA;RIPOR2;DUSP1;FBLN1;EFNA5;CBLL1;ERBB3;ZFHX3
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),0.6132410111599529,1.377740902424229,0.13859910581222057,0.8514564188125158,1.0,7/16,19.29%,PIGZ;PIGA;PIGX;DPM2;PIGN;PIGP;PIGQ
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.6045440674148651,1.3766499966137191,0.13043478260869565,0.8538940010863078,1.0,3/16,5.85%,CLU;ACKR3;BCL2L1
prerank,response to cAMP (GO:0051591),0.5289542461783242,1.3763192387433167,0.10512820512820513,0.8526803135331835,1.0,8/37,11.19%,CFTR;RAP1B;RAP1A;DMTN;AANAT;EZR;AQP1;RAPGEF3
prerank,tRNA aminoacylation (GO:0043039),0.5305533778277727,1.3762450136975457,0.10363391655450875,0.8505292007690602,1.0,19/37,21.36%,QARS1;EPRS1;VARS1;FARS2;HARS1;LARS2;AARS1;EEF1E1;HARS2;TARS1;SARS2;SARS1;YARS1;GATB;FARSA;DARS2;FARSB;NARS1;YARS2
prerank,respiratory system development (GO:0060541),-0.4185255412096976,-1.376020129923779,0.04961832061068702,0.6049224166515448,1.0,14/32,18.01%,GLI2;FGF2;CHD7;FGFR2;LOXL3;SPEF2;BASP1;SMCHD1;NPHP3;ZIC3;RBP4;ABCA3;FGF9;DISP1
prerank,signal transduction by p53 class mediator (GO:0072331),0.5510091229450425,1.3758285418703433,0.12321660181582361,0.8498456750537894,1.0,12/30,17.98%,FHIT;NDRG1;DDX5;PMAIP1;SESN2;PPP1R13B;USP10;ATRX;PDK2;POU4F1;NBN;TRIAP1
prerank,positive regulation of chromosome organization (GO:2001252),0.6044029934932861,1.3748264179766032,0.13425925925925927,0.8515704398320065,1.0,7/15,18.15%,FEN1;MRE11;ATRX;PML;NBN;RAD50;PPP1R10
prerank,water-soluble vitamin metabolic process (GO:0006767),0.49028061690818786,1.3748002348859567,0.09386281588447654,0.8491862853954382,1.0,15/68,18.99%,CUBN;AMN;CYB5R3;GSTO1;NNMT;SHMT1;ALDH1L2;PCCA;SLC19A2;ALDH1L1;VNN1;MMAB;PDXK;SLC19A1;MCCC2
prerank,regulation of pH (GO:0006885),0.6466174305024036,1.3741514080743036,0.14166666666666666,0.849691884998737,1.0,7/11,21.08%,ATP6V1B1;SLC9A7;PDK2;SLC26A4;SLC9A1;ATP6AP1;ATP1A4
prerank,cellular response to exogenous dsRNA (GO:0071360),0.6500340024359516,1.3740986151629269,0.11904761904761904,0.8474595672968757,1.0,6/12,19.47%,CAV1;MAVS;MUL1;DHX9;COLEC12;FLOT1
prerank,macrophage differentiation (GO:0030225),0.6355988549941002,1.3735463969968555,0.13833333333333334,0.8475505574790095,1.0,4/13,8.49%,MMP9;IL15;BMP4;CDC42
prerank,cellular response to interleukin-6 (GO:0071354),-0.4285132684519598,-1.372019589816904,0.06227106227106227,0.6138877077712792,1.0,15/26,28.01%,PID1;PTGIS;ST18;IL6R;JAK2;STAT3;PTPRT;IL6ST;YAP1;SMAD4;SOCS3;CBL;SPI1;FER;CEBPA
prerank,regulation of autophagy (GO:0010506),0.4327539628686136,1.371498315163146,0.027892561983471075,0.8538215957485891,1.0,54/216,15.53%,DAPL1;RNF152;PRKAA2;ATP6V1B1;SREBF2;TPCN1;NUPR1;ZC3H12A;EEF1A1;EP300;FOXO3;DAPK3;DAPK1;HSPB1;MTDH;ORMDL3;SH3BP4;USP10;RHEB;HAX1;MAPK15;TRIM21;BAD;TAB3;EXOC7;EXOC4;RUBCN;FZD5;CAPNS1;SMCR8;MTMR3;OSBPL7;EIF4G2;WDR6;FOXK1;TFEB;EXOC8;VDAC1;PIP4K2C;GSK3A;VPS26B;ULK1;GSK3B;EIF4G1;ATP6V1E1;GAPDH;NEDD4;DNM1L;FLCN;ATP6V1D;WASHC1;PLK2;RB1CC1;ATP6V0D1
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),0.6809810677562231,1.3712005820169515,0.13614262560777957,0.8528109320509485,1.0,2/10,6.82%,CAV1;ANK3
prerank,protein polymerization (GO:0051258),0.4917405655744792,1.3705978059760848,0.09079903147699758,0.8530681385281678,1.0,10/55,9.62%,FGF13;COBL;GSN;DIAPH1;CORO7;ANG;MSRB2;CHMP4A;CHMP4B;HDGFL3
prerank,tight junction assembly (GO:0120192),0.49913757875265347,1.369947032597118,0.09759188846641319,0.8534062583275827,1.0,8/49,10.72%,CLDN11;POF1B;OCLN;LSR;PATJ;PARD6B;GRHL2;ACTG1
prerank,monovalent inorganic cation homeostasis (GO:0055067),0.5624252548758625,1.3694696292677175,0.12152269399707175,0.853198572695503,1.0,8/23,16.86%,ATP6V1B1;SLC12A8;SLC9A7;PDK2;SLC12A4;SLC26A4;SLC12A6;SLC9A1
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.5729199586354968,-1.368856798267486,0.10997442455242967,0.6205671590231271,1.0,6/10,34.35%,LGALS9;CX3CR1;ARRB2;FCGR2B;CEACAM1;LILRB1
prerank,response to ATP (GO:0033198),-0.4823273621789852,-1.3687711017697788,0.10465116279069768,0.6170244233614395,1.0,8/18,27.99%,TRPC3;ABCC9;SSH1;P2RY1;P2RY12;DGKQ;CIB2;TAF1
prerank,nucleotide biosynthetic process (GO:0009165),-0.49480512130310716,-1.3687635233277449,0.09696969696969697,0.6133600490441394,1.0,5/18,11.72%,ME1;HPRT1;PRPSAP2;RRM1;PNP
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.6521088555591177,1.3682480560286991,0.1437908496732026,0.8558562670154016,1.0,5/12,11.68%,PPARGC1A;ABCD1;MTLN;TWIST1;IRS2
prerank,aminoglycan biosynthetic process (GO:0006023),0.4991109077933197,1.3682474261154445,0.11428571428571428,0.8534317450125252,1.0,9/49,7.22%,B3GALT1;GPC6;GPC1;HEXA;B4GAT1;GPC4;GCNT2;SDC4;GPC3
prerank,negative regulation of protein secretion (GO:0050709),0.524545681437745,1.368210989253895,0.10966057441253264,0.8512119122192076,1.0,12/38,17.28%,ADTRP;CD200;HMGCR;RAB11FIP3;CYP51A1;KCNB1;RAB11FIP5;SERGEF;RHBDF2;SFRP1;RAB11FIP1;F2R
prerank,negative regulation of cellular catabolic process (GO:0031330),0.4819330488443176,1.3674501069346192,0.0963855421686747,0.8520378350655239,1.0,14/63,14.88%,DAPL1;NUPR1;TIMP4;TIMP1;TIMP2;TAB3;RUBCN;HP;EIF4G2;WDR6;FOXK1;GSK3A;EIF4G1;WASHC1
prerank,regulation of neuronal synaptic plasticity (GO:0048168),-0.425582214166277,-1.3673461661859008,0.09352517985611511,0.6145715957280856,1.0,11/29,15.56%,GRIK2;SLC4A10;SHISA6;EPHB2;NETO1;SHISA9;DRD2;CAMK2A;MCTP1;CLN3;NCDN
prerank,blood circulation (GO:0008015),0.5107532326250787,1.367219230014709,0.09429280397022333,0.8506303700823121,1.0,7/49,4.46%,AGTR1;SGCG;F5;COL4A3;SGCD;CYB5R3;EPO
prerank,blood vessel morphogenesis (GO:0048514),-0.36980435395621114,-1.3668856580939959,0.06179775280898876,0.6123761886165138,1.0,21/54,14.10%,FLT1;ENG;LAMA1;CCBE1;CDH2;GLMN;KDR;COL4A1;CYP1B1;SLC1A1;ID1;TGFB1;SOX17;LRP5;RAMP2;NF1;LOX;RASIP1;FLT4;TBX1;EGFL7
prerank,positive regulation of biosynthetic process (GO:0009891),0.5163535449552529,1.3668404524844793,0.10677083333333333,0.8499855504666232,1.0,8/40,11.15%,SORBS1;CCL5;VIM;CREBL2;CREB1;BMP4;TLR6;TLR4
prerank,positive regulation of insulin secretion (GO:0032024),0.5248629659670985,1.3665296136525302,0.11126005361930295,0.8488555259010651,1.0,14/36,20.24%,CFTR;MCU;GLUD1;BAD;TCF7L2;TRPM4;IRS2;AACS;PLA2G6;NLGN2;STX4;GPER1;GPLD1;SOX4
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.6607858599357624,1.366222452022862,0.1711864406779661,0.8477954970291417,1.0,5/10,14.45%,CCL5;ADAM10;STK39;OXSR1;WNK1
prerank,regulation of transmembrane transport (GO:0034762),0.5366355243386584,1.3654788152520287,0.12244897959183673,0.8487851518458773,1.0,4/31,4.49%,PRKCB;OCLN;WWP2;KCNJ13
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.46113383687640286,1.3649961351154112,0.07424071991001124,0.8485078846394485,1.0,16/95,7.22%,UST;ANGPT1;GPC6;ST3GAL4;GPC1;CHST12;HEXA;B4GAT1;GPC4;GCNT2;DSE;CHST11;SDC4;PRELP;CHPF;GPC3
prerank,very-low-density lipoprotein particle assembly (GO:0034379),0.6510171946239839,1.3649130063495833,0.14890016920473773,0.8464852954038843,1.0,5/12,12.85%,SOAT1;DGAT1;ACSL3;SOAT2;LPCAT3
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),-0.3508080674309242,-1.3643534592591395,0.027210884353741496,0.6170534068722269,1.0,30/75,17.33%,PTPRM;DCN;SULF1;SEMA6A;TEK;WNT4;CLDN5;PDE3B;DAB2IP;THBS1;COL4A2;SEMA3E;RGCC;THBS2;GTF2I;SERPINF1;ROCK1;MECP2;PPARG;ISM1;NPR1;SPARC;AMOT;AGO1;HSPG2;NAXE;STAB1;HHEX;MINAR1;SPRED1
prerank,regulation of tau-protein kinase activity (GO:1902947),0.6619227101696579,1.3638483110397674,0.1616,0.8487495212513714,1.0,1/10,0.40%,CLU
prerank,SNARE complex assembly (GO:0035493),0.6501281631027204,1.3630885237567014,0.1472,0.849673780643711,1.0,5/10,21.68%,STXBP6;STXBP1;VAMP1;UVRAG;VAMP2
prerank,alpha-linolenic acid metabolic process (GO:0036109),0.6232392827431268,1.361745661952968,0.15,0.8528484895073682,1.0,4/12,10.29%,ACOT8;ABCD1;ELOVL1;FADS1
prerank,response to glucocorticoid (GO:0051384),-0.4359895607601142,-1.3617008424095736,0.07272727272727272,0.6223109016674528,1.0,8/26,21.48%,SLIT2;BCL2L11;SLIT3;ADAM9;PDCD7;ZFP36;NR3C1;GOT1
prerank,dendritic spine morphogenesis (GO:0060997),-0.48680103960512855,-1.361571288108124,0.10695187165775401,0.6191943063689783,1.0,4/15,6.15%,SHANK3;DOCK10;PAK3;EPHB2
prerank,maturation of LSU-rRNA (GO:0000470),0.5555932637340032,1.3615651392100812,0.1272475795297372,0.8512952522227505,1.0,8/26,15.15%,NSA2;NOP2;PES1;EIF6;MAK16;RPL10A;RPF1;DDX18
prerank,sensory perception of chemical stimulus (GO:0007606),-0.514167996452562,-1.3613434415146655,0.11081794195250659,0.6163659702439088,1.0,7/15,22.43%,GNAS;UBR3;DRD2;GNAL;BBS4;SYT10;ADCY3
prerank,nucleic acid metabolic process (GO:0090304),0.4754490435392309,1.3609641358021518,0.08561236623067776,0.8515575196144228,1.0,21/69,19.74%,NT5E;GTF2F1;FEN1;RBFOX2;POLR2H;POLR2A;XRN2;HNRNPH2;POLG;DNASE1L2;TOPBP1;DNASE1L1;DUSP11;WTAP;POLR2C;RAD50;HNRNPA3;POLR2E;PTBP1;PCBP2;DXO
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.6099515013421802,1.360442088480298,0.125,0.8515265625226992,1.0,3/15,4.40%,UST;CHST12;DSE
prerank,macrophage chemotaxis (GO:0048246),0.6365922721962954,1.3603241413958052,0.15384615384615385,0.8497685848696139,1.0,3/10,16.75%,CCL5;LGALS3;TAFA4
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),0.5318928244534316,1.3601382813521847,0.12450851900393185,0.848240463406013,1.0,7/37,11.34%,PHLDB2;MAPRE2;PRKAA2;MAP6;EFNA5;GAS2L1;EPHA3
prerank,positive regulation of locomotion (GO:0040017),-0.4338134280016953,-1.3598727026532664,0.09539473684210527,0.6176059452945997,1.0,14/27,32.91%,PDGFRB;SPOCK2;THBS1;TGFB1;CFAP20;RARRES2;P2RY12;CCL19;AKT2;PPM1F;AIF1;TRIM32;TREM2;CAVIN1
prerank,regulation of cellular component movement (GO:0051270),0.5022605084755718,1.3596217931147425,0.11381074168797954,0.848135617621066,1.0,22/49,20.16%,PRAG1;ARAP1;YTHDF1;ARHGAP18;CDK6;DIAPH1;DAPK3;CD9;ERBB3;RAF1;RHOA;ZSWIM8;PDPN;TGFBR3;MEMO1;IGBP1;ACTN4;ABL1;HDAC6;ROCK2;ADAM17;HBEGF
prerank,negative regulation of macrophage activation (GO:0043031),0.6059155247747496,1.3589065415737838,0.12158054711246201,0.8489481030400974,1.0,3/16,2.55%,LDLR;CD200;ZC3H12A
prerank,regulation of cell differentiation (GO:0045595),0.4420121836660476,1.3583646872331148,0.06517094017094018,0.8490311817150259,1.0,25/148,10.29%,PRKCB;PHLDB2;FGFR1;KLF4;MBOAT2;DAG1;RORC;EMP2;CCN2;DDX5;CDK6;NGF;GDNF;PPP2CA;PPP1R13L;FLOT2;LTBP4;ALOX5;PLEKHB2;ZFHX3;SIX1;LGALS3;CDK5RAP1;RAF1;FADS1
prerank,regulation of insulin secretion (GO:0050796),0.45798412528120697,1.3583498987312852,0.08277404921700224,0.8468248488317155,1.0,20/101,14.09%,DPP4;ITPR2;CCL5;CACNA1A;RAP1A;MCU;ALOX5;EFNA5;ABCC8;GLUD1;BAD;CDK16;TCF7L2;KCNB1;ITPR3;RAPGEF3;IRS2;KCNA5;AACS;SFRP1
prerank,regulation of sequestering of calcium ion (GO:0051282),0.6347733928939748,1.3581817790696988,0.13,0.8454177516078965,1.0,4/12,9.52%,ANK2;DIAPH1;PTK2B;MTLN
prerank,Wnt signaling pathway (GO:0016055),0.4661043343887686,1.3570558393404175,0.1044776119402985,0.8478683236698147,1.0,16/92,8.41%,WNT16;WNT1;NXN;WNT10A;WNT11;DIXDC1;GPC4;WNT6;RARG;CPE;WLS;DVL3;WNT5B;FZD5;RBX1;TCF7L2
prerank,response to muscle stretch (GO:0035994),-0.5021697708034842,-1.3568790545398213,0.11661807580174927,0.6237316988642876,1.0,4/15,2.51%,DMD;CDH2;SLC8A1;PTK2
prerank,regulation of fibroblast migration (GO:0010762),-0.46455375568430907,-1.3563622789298657,0.08595988538681948,0.621744537325891,1.0,9/20,17.76%,PTK2;FGF2;THBS1;APPL2;TGFB1;RFFL;GNA12;CLN3;PRR5L
prerank,nitrogen compound transport (GO:0071705),0.44833826854692405,1.3548962797665873,0.049145299145299144,0.855003003998731,1.0,21/141,13.27%,CUBN;SLC7A14;SCAMP5;AMN;RAMP1;SLC48A1;SLC3A1;RAB7A;ARRDC3;NDC1;SLC25A47;ARL6IP5;TOM1;SLC7A6;SLC1A4;AQP1;SCAMP2;SLC25A45;SLC18A1;PDPN;CHMP1A
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),0.5880870469407642,1.354591065163835,0.14157973174366617,0.8541535980096134,1.0,4/17,7.38%,CCL5;PODXL;FOXC2;TGFB2
prerank,regulation of melanin biosynthetic process (GO:0048021),-0.5608786812883433,-1.3544434942341652,0.14025974025974025,0.6242689520619893,1.0,2/10,1.18%,ZEB2;RAPGEF2
prerank,peptidyl-tyrosine modification (GO:0018212),-0.3612225371664523,-1.3544035875331921,0.05188679245283019,0.6209328538719446,1.0,17/56,10.13%,FLT1;PDGFRB;TEK;INSR;LYN;PTK2;TPST1;PDGFRA;KDR;EPHB2;ABI2;PKDCC;JAK2;ERBB4;FGFR2;KIT;ABL2
prerank,regulation of mast cell activation (GO:0033003),-0.569261431536645,-1.3538492691182644,0.15023474178403756,0.6192837606900029,1.0,6/10,30.58%,LYN;PLSCR1;CD84;CRLF2;MILR1;CD300LF
prerank,transport along microtubule (GO:0010970),0.6324488257456391,1.3532553905715838,0.1484992101105845,0.8574379469777687,1.0,4/13,9.27%,DYNC1I1;ARHGAP21;CDC42;BAG3
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.41004355090041955,-1.353142084347524,0.064,0.617855947260532,1.0,7/34,5.29%,FLT1;PRKD1;SEMA6A;VEGFC;KDR;NOTCH1;DAB2IP
prerank,regulation of RNA splicing (GO:0043484),0.4723325009856963,1.35208690914148,0.1018957345971564,0.8601058262925009,1.0,18/69,15.46%,MBNL1;AHNAK;AHNAK2;CELF1;SNRNP70;SON;POLR2A;RBM20;LARP7;HNRNPH2;SRPK2;SRRM4;HABP4;RPS26;SRPK1;ZPR1;GRSF1;MBNL2
prerank,regulation of T cell chemotaxis (GO:0010819),0.6416280983129204,1.3516713986195343,0.1734006734006734,0.8597298917856502,1.0,4/11,8.46%,CCL5;ADAM10;STK39;OXSR1
prerank,bicellular tight junction assembly (GO:0070830),0.4937619772285837,1.3515587936144495,0.10493046776232617,0.8579686207416117,1.0,6/46,8.89%,CLDN11;POF1B;OCLN;PATJ;PARD6B;GRHL2
prerank,extracellular matrix disassembly (GO:0022617),0.4936201423605152,1.3497384328806155,0.10275689223057644,0.8633037015877659,1.0,15/53,13.09%,CD44;TMPRSS6;MMP9;ADAM10;HPN;GSN;TIMP1;TIMP2;KLKB1;CAPN2;LAMC1;CAPNS1;ADAM15;MMP12;EXOC8
prerank,neural tube closure (GO:0001843),0.5292418882473962,1.3492237687055932,0.11748633879781421,0.8631321068844442,1.0,9/34,13.00%,CELSR1;COBL;LMO4;TSC2;TGFB2;DVL3;GRHL2;DLC1;PLXNB2
prerank,positive regulation of cellular protein metabolic process (GO:0032270),0.45612592902035587,1.3485023663173543,0.09201773835920177,0.8639944201777184,1.0,28/101,17.31%,AGTR1;CYFIP2;KLF4;OGT;VIM;SAMD4A;YTHDF1;NFKBIA;RPS4X;PERP;EIF4A3;MSN;UPF3A;EIF6;BAD;EZR;VPS11;POLDIP3;CPEB3;PLXNB2;FXR1;UPF3B;EIF4G1;PYM1;HSP90AA1;EEF2;TBC1D10A;STUB1
prerank,respiratory tube development (GO:0030323),-0.4131150775385247,-1.3484604753075204,0.0625,0.6289296597841008,1.0,10/28,15.71%,PCSK5;GLI2;FGF2;FGFR2;LOXL3;NPHP3;ZIC3;RBP4;ABCA3;FGF9
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),-0.5539801060879186,-1.3475914610690063,0.13031914893617022,0.6280499885941025,1.0,3/11,6.51%,CAMK2D;NOS1AP;BIN1
prerank,arachidonic acid secretion (GO:0050482),-0.5614874523841215,-1.3472988566103592,0.1325,0.6221443836813202,1.0,7/10,41.10%,PNPLA8;ACE;DRD2;NMUR2;PLA2G5;DRD3;BDKRB2
prerank,arachidonate transport (GO:1903963),-0.5614874523841215,-1.3472988566103592,0.1325,0.6221443836813202,1.0,7/10,41.10%,PNPLA8;ACE;DRD2;NMUR2;PLA2G5;DRD3;BDKRB2
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.559321785135632,1.34727255996012,0.1308139534883721,0.8671138626753696,1.0,3/22,8.98%,NFATC2;DUSP10;FOXP3
prerank,regulation of cell death (GO:0010941),0.448610060395308,1.34666193871252,0.08361581920903954,0.8673371164043885,1.0,23/94,15.42%,WNT16;CLU;SRGAP2;CCL5;CCN2;ZC3H12A;WNT11;CELF1;PRR7;CRYAB;CTSZ;GPR75;BMP4;CHMP4B;CHP1;HP;HPR;VPS4B;BNIP3L;DUS2;EIF4G1;SNCB;CHMP2A
prerank,regulation of calcium ion transport (GO:0051924),0.48938395621853453,1.3464978843677151,0.10790464240903387,0.8658397325999537,1.0,6/54,3.42%,ANK2;STIM2;CCL5;IL16;HOMER2;HOMER3
prerank,regulation of blood circulation (GO:1903522),0.5284272680959519,1.3461579779254742,0.13359273670557717,0.86519863470995,1.0,2/34,0.75%,AGTR1;CELF2
prerank,canonical Wnt signaling pathway (GO:0060070),0.4799683061724561,1.3460142506121608,0.09483793517406963,0.8636149852358952,1.0,17/68,14.36%,WNT16;WNT1;WNT10A;WNT11;CAV1;DIXDC1;WNT6;RARG;DVL3;WNT5B;FZD5;TCF7L2;CSNK1E;WNT3;GATA3;SFRP1;GSK3B
prerank,primary neural tube formation (GO:0014020),0.5380325976352612,1.3457895337516284,0.11904761904761904,0.8622962703519735,1.0,8/30,13.00%,CELSR1;COBL;LMO4;TSC2;TGFB2;GRHL2;DLC1;PLXNB2
prerank,triglyceride catabolic process (GO:0019433),-0.47177072638449385,-1.345621258397257,0.11314984709480122,0.62401442744868,1.0,9/19,43.53%,LPL;PNPLA3;FABP7;PNPLA2;LIPH;LIPC;FABP4;FABP12;FABP5
prerank,positive regulation of telomere maintenance (GO:0032206),0.5319183366802174,1.3456144952927598,0.11950549450549451,0.860819416001239,1.0,13/31,19.55%,NEK7;NABP2;MRE11;MAPK15;MAP3K4;ATRX;PML;TNKS2;NBN;PRKCQ;RAD50;PPP1R10;PNKP
prerank,negative regulation of leukocyte migration (GO:0002686),0.6641489570235325,1.3449772237142146,0.13866231647634583,0.8614246533979127,1.0,3/10,4.13%,ADTRP;CD200;BMP5
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.5043378390820303,1.344710154250481,0.12280701754385964,0.8603562288045952,1.0,12/43,12.94%,KLF5;KLF4;DDX5;FOXO3;FOS;SOX9;BMP4;TGFB2;JUN;NFIB;SMARCA4;GATA3
prerank,catecholamine metabolic process (GO:0006584),-0.5002408798326407,-1.3444624166966521,0.10483870967741936,0.6244567617216982,1.0,4/14,24.06%,SNCAIP;DRD2;RNF180;DDC
prerank,regulation of actin filament bundle assembly (GO:0032231),-0.4261887105659226,-1.3443633580484566,0.12056737588652482,0.6214267394720886,1.0,7/26,7.58%,SHANK3;RDX;SYNPO;TSC1;ALMS1;SYNPO2;ROCK1
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),0.6045397463970483,1.3434145691790196,0.15070643642072212,0.8637158652913072,1.0,1/15,0.18%,AGTR1
prerank,response to interleukin-6 (GO:0070741),-0.5481147534214514,-1.3432805795768792,0.12655086848635236,0.6214786967042549,1.0,3/10,11.17%,PID1;PTGIS;PTPRT
prerank,receptor-mediated endocytosis (GO:0006898),0.4466222025954964,1.3432335054693432,0.07549234135667396,0.8622428114129062,1.0,34/132,16.82%,CUBN;LDLR;CAV1;AMN;CD81;CLTB;FCHSD2;AP2A2;ASGR1;GPR107;ACKR3;RAMP1;CD9;CAV2;STAB2;GRK2;HP;HPR;HYOU1;FCER1G;AP2A1;WASF1;LMBR1L;PDLIM7;NEDD4;ARHGAP27;HSP90AA1;HSPH1;ITGB2;AP4E1;LRP3;CANX;COLEC12;LRP2
prerank,positive regulation of glucose import (GO:0046326),0.5616783088611488,1.3420058898789062,0.14222873900293256,0.8655557258837144,1.0,4/21,5.14%,SORBS1;OCLN;CREBL2;RHOQ
prerank,positive regulation of protein metabolic process (GO:0051247),0.44900299056743853,1.3417577519504391,0.08690869086908691,0.8645226342665586,1.0,26/110,19.52%,FZR1;AGTR1;CLU;KLF4;WWP2;NFKBIA;MAPK7;EGLN2;GPC3;RAB7A;ABCA2;GSK3A;RAB1B;GSK3B;EIF4G1;NEDD4;PLK2;DDB1;NSF;PRMT1;ROCK2;RNF41;IDE;APP;KLF2;ASB5
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.47180240307186777,1.3408024456189094,0.11150652431791222,0.8663230570612437,1.0,19/62,18.87%,CLU;MMP9;YBX3;NFE2L2;EPO;HSPB1;ACKR3;BCL2L1;MAPK7;NDUFS3;SOD2;HYOU1;CREB3;OPA1;VNN1;MDM2;ARMC10;PARK7;CDKN2D
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),-0.49346912695758,-1.340760056628233,0.13114754098360656,0.626136894405361,1.0,4/16,3.60%,PDGFRB;PDGFD;PTPRJ;PDGFRA
prerank,negative regulation of cytokine production (GO:0001818),0.4381342240499852,1.3403566589345108,0.06458333333333334,0.8661110066184426,1.0,22/163,10.21%,FN1;KLF4;TRIB2;CD200;ZC3H12A;TWSG1;ABCD1;IKBKE;MAVS;HOMER2;HOMER3;ANXA4;TRIM25;IRF3;OTUD7B;SRGN;LGR4;FOXP3;TLR6;PTPN6;EZR;PPP1R11
prerank,negative regulation of protein localization to cell surface (GO:2000009),0.6463114244882875,1.3400297020565928,0.16025641025641027,0.8654090732908303,1.0,2/11,10.51%,ACTN2;SNX33
prerank,regulation of platelet aggregation (GO:0090330),-0.4673905505061127,-1.339927031093058,0.128,0.6254050980545164,1.0,4/17,7.16%,PRKG1;LYN;SERPINE2;SH2B3
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),-0.4860855802820465,-1.3396223386065407,0.1398176291793313,0.6230551873346367,1.0,5/16,8.12%,HIF1A;NPR3;NOS1AP;PIK3CB;GCH1
prerank,regulation of adenylate cyclase activity (GO:0045761),-0.44373120261365956,-1.339535581528215,0.1320754716981132,0.6201060864556553,1.0,8/22,14.77%,CACNA1C;STIM1;ADGRV1;GRM3;CAP2;NF1;DRD2;EDNRB
prerank,tube closure (GO:0060606),0.5339805493357702,1.3395031378922526,0.1168289290681502,0.8653858511319759,1.0,8/31,13.00%,CELSR1;COBL;LMO4;TSC2;TGFB2;GRHL2;DLC1;PLXNB2
prerank,regulation of neuron differentiation (GO:0045664),-0.34113886332598226,-1.339433828693768,0.050314465408805034,0.6172085779686733,1.0,22/76,13.08%,TCF4;ZEB1;VWC2;NREP;MOSMO;BRINP3;NRCAM;BIN1;LRRK2;DTX1;ZFHX2;NLGN1;ROCK1;ID2;TIAM1;HEYL;IMPACT;BEND6;NEPRO;ARHGEF2;MMD;BDNF
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),-0.3788307628284206,-1.3394081871215557,0.05045871559633028,0.6140846296658408,1.0,9/43,7.46%,ERRFI1;PTPRJ;TGFA;ITGA1;CBLB;DAB2IP;SH3KBP1;ZFYVE28;SOCS5
prerank,L-glutamate transmembrane transport (GO:0015813),-0.5651567613563092,-1.3392454143310284,0.14878048780487804,0.6113778187974509,1.0,3/10,5.61%,SLC1A3;SLC1A2;SLC1A1
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.544116939179206,1.339068988192593,0.13194444444444445,0.8651530328790648,1.0,8/29,14.70%,PLB1;MBOAT2;PLA2G12A;MBOAT7;LPCAT2;TMEM86B;LPCAT3;PLA2G6
prerank,fatty acid beta-oxidation (GO:0006635),0.4903015488671539,1.3388039199208857,0.12407862407862408,0.8641412031422406,1.0,24/51,23.43%,ACOT8;ABCD1;ECHDC1;ACADL;EHHADH;MTLN;ACAT2;HADHA;SLC25A17;CPT2;ECI2;ACADM;AUH;HADHB;IVD;ECHS1;PEX2;DECR2;HSD17B10;CRAT;MECR;GCDH;ACAD11;DECR1
prerank,regulation of leukocyte migration (GO:0002685),0.5870498345462456,1.3387724601749678,0.14641744548286603,0.8621474566479952,1.0,2/16,3.22%,ADTRP;CD81
prerank,negative regulation of protein-containing complex assembly (GO:0031333),0.4975546685402836,1.3383163581064317,0.10090556274256145,0.861841070368369,1.0,15/49,18.46%,CLU;SMAD6;EP300;CRYAB;PPM1A;NLRP2B;CDC42;PYDC1;RAF1;LDLRAD4;ULK1;GSK3B;PRKCZ;HDAC6;PARK7
prerank,negative regulation of lymphocyte migration (GO:2000402),0.6592079061611167,1.3383059690199373,0.1652892561983471,0.8597626118553542,1.0,3/10,5.13%,ADTRP;CD200;RIPOR2
prerank,regulation of protein secretion (GO:0050708),0.4434450478431425,1.3379736335794081,0.08342480790340286,0.8591004660777967,1.0,20/119,10.24%,DPP4;ITPR2;ADTRP;CCL5;SYTL4;CACNA1A;RAP1A;HMGCR;ALOX5;ABCC8;GOLPH3;TGFB2;ANG;CYP51A1;EZR;LLGL2;APBB1;KCNB1;IER3IP1;ITPR3
prerank,positive regulation of cell death (GO:0010942),0.48360808707159464,1.337863844608839,0.11800486618004866,0.8574375557088467,1.0,16/59,15.65%,CLU;DAXX;MAP3K5;EFNB2;ZC3H12A;CELF1;PRR7;FOS;RARG;BMP4;HP;HPR;MARK4;GSK3B;EIF4G1;ITGB2
prerank,regulation of macrophage differentiation (GO:0045649),-0.5005587883978523,-1.3376943659249645,0.12362637362637363,0.6128871948861108,1.0,6/15,18.79%,IL34;ID2;HSF1;RIPK1;C1QC;CSF1
prerank,neutrophil migration (GO:1990266),0.4747592377419513,1.337678040520292,0.12652068126520682,0.8561028662647779,1.0,2/58,1.51%,CXADR;CCL5
prerank,heart development (GO:0007507),0.4334497196405431,1.337421172931756,0.07263157894736842,0.855026265239448,1.0,21/150,7.38%,FN1;CXADR;SGCG;NTRK3;PDLIM5;CDKN1A;SGCD;MICAL2;AKAP13;STRA6;CSRP3;FOXC2;BMP5;TSC2;SOX9;BMP4;MEF2D;RBM20;GPC3;ERBB3;TGFB2
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.5427994688806141,1.336836749848777,0.1396011396011396,0.8553449496573657,1.0,6/24,9.85%,EPHA4;PTK2B;NUB1;LATS1;PKD1;ATP5IF1
prerank,protein homotrimerization (GO:0070207),-0.49979076626986285,-1.3358532429163785,0.15254237288135594,0.6124570994897993,1.0,11/14,37.94%,SLC1A5;SCARA5;SLC1A2;DISP1;MIF;MLKL;PNPT1;STEAP4;ASIC1;ALOX5AP;P2RX3
prerank,protein trimerization (GO:0070206),-0.49979076626986285,-1.3358532429163785,0.15254237288135594,0.6124570994897993,1.0,11/14,37.94%,SLC1A5;SCARA5;SLC1A2;DISP1;MIF;MLKL;PNPT1;STEAP4;ASIC1;ALOX5AP;P2RX3
prerank,regulation of smooth muscle cell migration (GO:0014910),-0.45898214986179825,-1.3354728928549722,0.11246200607902736,0.6105114945141319,1.0,7/20,10.04%,IGF1;PDGFRB;IGFBP5;VTN;ACE;SLIT2;CCN4
prerank,negative regulation of immune system process (GO:0002683),0.5907508968495581,1.3354148510851105,0.1601796407185629,0.8590903052060613,1.0,4/16,8.98%,ADTRP;CD200;SOX9;FOXP3
prerank,renal filtration (GO:0097205),-0.5518182134333793,-1.3341787364337687,0.13670886075949368,0.6111223017743924,1.0,2/10,3.25%,SULF1;CD34
prerank,sodium ion transmembrane transport (GO:0035725),0.45449164874595543,1.3338140937046077,0.09382151029748284,0.8636821572263927,1.0,6/84,2.79%,SLC9A2;SLC9A4;ASIC5;SCN3A;NALCN;ATP1A2
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),-0.429004333060261,-1.3337565473015076,0.10622710622710622,0.6094046435979563,1.0,6/26,7.46%,ERRFI1;TGFA;CBLB;NCK2;ZFYVE28;SOCS5
prerank,sensory perception (GO:0007600),-0.36270436336815803,-1.3333363516954595,0.09045226130653267,0.6078044654504422,1.0,26/45,36.58%,GNAS;ADGRV1;PCDH15;TTC8;RETREG1;ADORA2A;PTGES;MME;GNAL;OPRM1;BBS4;OPRK1;NIPSNAP1;NTSR2;WHRN;TRPA1;CHRNA4;CDH23;CCR2;KCNA2;CCL2;KCNK4;OPRL1;CHRNB2;ALOXE3;CLRN1
prerank,apical junction assembly (GO:0043297),0.48182969231855566,1.3331243861062667,0.11633663366336634,0.8645239345278058,1.0,7/53,8.89%,CLDN11;POF1B;OCLN;CTNNA1;PATJ;PARD6B;GRHL2
prerank,metal ion transport (GO:0030001),-0.32755622447082283,-1.331820949467158,0.05384615384615385,0.6093543807403012,1.0,20/86,14.11%,ITPR1;CACNA1C;CALCRL;SLC8A1;SLC8A3;CACNA1E;TRPC3;TUSC3;PKD2;TRPC4;SLC39A8;PANX1;SELENOK;RAMP2;TPT1;CACNG8;TRPC5;SLC30A1;CAMK2A;RYR2
prerank,negative regulation of cell activation (GO:0050866),0.5921189371811189,1.3312060537192454,0.16825396825396827,0.8707656639285426,1.0,3/14,6.08%,LDLR;CD200;THBD
prerank,regulation of macrophage migration (GO:1905521),0.6409771524284389,1.331101537624737,0.1815126050420168,0.8691209879863077,1.0,4/10,12.19%,CD200;CD81;PTK2B;CD200R1
prerank,positive regulation of lymphocyte activation (GO:0051251),-0.4078195458984062,-1.3307288798184889,0.11070110701107011,0.6098494461882797,1.0,12/28,31.06%,CD47;SH3KBP1;NCKAP1L;CYRIB;HSPD1;TYROBP;NOD2;PYCARD;TNIP2;CCR2;PRKDC;CCL2
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.6217239241408951,1.3306532694219666,0.17488076311605724,0.8688590448416761,1.0,4/11,5.26%,MMP9;GSN;PRR7;PIH1D1
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),-0.5277687163884994,-1.330227644680484,0.12672176308539945,0.6083546682062202,1.0,7/12,19.94%,ABCA1;NR1H3;PPARG;ITGAV;NR1H2;PPARA;ABCG1
prerank,tRNA metabolic process (GO:0006399),0.5916902890614475,1.3292115649331186,0.1347068145800317,0.873057180784027,1.0,10/17,21.36%,FARS2;TRPT1;POP1;THG1L;AARS1;RPP21;DTD1;SARS1;DARS2;YARS2
prerank,negative regulation of hormone secretion (GO:0046888),0.6444826665415389,1.3289243308551035,0.16279069767441862,0.8721929133458634,1.0,3/10,15.61%,RAB11FIP3;RAB11FIP5;RAB11FIP1
prerank,positive regulation of stress fiber assembly (GO:0051496),0.49372787129869605,1.3288537141195609,0.13093709884467267,0.8703762605234419,1.0,18/44,18.79%,LPAR1;CCN2;WNT11;S100A10;PXN;CDC42;ARHGEF5;RAPGEF3;RHOA;ARHGEF10L;SFRP1;CCDC88A;ITGB1BP1;TESK1;PFN2;ABL1;FHOD1;ROCK2
prerank,positive regulation of lipid catabolic process (GO:0050996),0.5760238193538761,1.3286583362888065,0.17620481927710843,0.8691949427235746,1.0,5/19,11.68%,ABCD1;ABHD5;MTLN;TWIST1;IRS2
prerank,regulation of phosphorylation (GO:0042325),0.4368417291779864,1.3281501632929162,0.09201773835920177,0.8693120074198392,1.0,18/120,9.58%,FN1;CCL5;OGT;CDKN1A;EMP2;EP300;SESN2;PPP2CA;KDM4D;HSPB1;NUP93;BMP4;EIF6;ILK;ANG;PML;NDC1;JMJD8
prerank,glycosaminoglycan catabolic process (GO:0006027),0.48310620544533156,1.327463005285016,0.11372064276885044,0.8701695387862474,1.0,15/55,11.11%,CD44;GPC6;GPC1;HEXA;GPC4;NAGLU;SDC4;PRELP;GLB1;GPC3;ARSB;STAB2;CHP1;GUSB;HEXB
prerank,T cell differentiation in thymus (GO:0033077),0.595048077640076,1.327105336418432,0.18578352180936994,0.8695819157944712,1.0,4/14,19.54%,GLI3;RABL3;MR1;ADAM17
prerank,anterograde trans-synaptic signaling (GO:0098916),-0.2942695412428075,-1.3268732027757597,0.0,0.6157906952472286,1.0,70/224,20.93%,PDE7B;SLC1A3;GRIK2;UNC13B;KCND2;NRXN1;NOVA1;CACNA1E;GRM3;GABRG3;GRM7;DLG2;SLC1A2;GRIN2A;GRIA3;CAMK4;GRIA2;CACNB4;PTCHD1;DLGAP1;SLC1A1;SYT1;RIT2;GRIN2B;GABRB1;GRM5;GLRA1;NLGN1;GABRG2;HTR7;GABRG1;LRP6;SLC6A1;CHRM3;PRKAR2B;APBA1;PLP1;SNAP25;DTNA;HCRTR2;MBP;GRIK1;GABRA3;GRIK4;NLGN3;GLRA3;HTR2A;AMPH;KCNMB4;GLRA2;GABRB2;CHRM2;MPZ;KCNQ3;GRM1;PRKAR1B;GABRA1;NPTX1;GLRB;RPS6KA1;RPS6KA3;GABRE;OPRK1;HRH1;KCNK3;SYT10;GRIA4;CACNA1B;KCNIP2;PCDHB16
prerank,peptidyl-threonine dephosphorylation (GO:0035970),0.5537275593135945,1.3266287142954905,0.14553314121037464,0.8696295620802128,1.0,8/22,17.68%,PPP2CA;DUSP10;PPM1B;DUSP1;PPM1A;PPM1D;PPP2CB;PDP1
prerank,release of cytochrome c from mitochondria (GO:0001836),0.5854732159900219,1.3265297533447717,0.17088607594936708,0.8680004500678735,1.0,5/17,10.71%,CLU;BBC3;BCL2L1;BAD;SOD2
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.5757000880041899,1.3265167825594408,0.15773353751914243,0.8660165501634879,1.0,1/17,0.15%,CD55
prerank,dicarboxylic acid catabolic process (GO:0043649),0.6145781303640974,1.3263433951534223,0.1700787401574803,0.8647441518376354,1.0,4/13,10.62%,GLUL;ACOT8;GLUD1;ACSF3
prerank,synapse assembly (GO:0007416),0.4603331845576451,1.3258382962377389,0.11124260355029586,0.8648234159956393,1.0,4/67,1.61%,CDH1;FGF13;SDK1;PLXNB1
prerank,fatty acid oxidation (GO:0019395),0.4758747141506834,1.3254448774323788,0.1329268292682927,0.8645239789983717,1.0,17/57,14.62%,PPARGC1A;ABCD1;ADH7;ECHDC1;ACADL;EHHADH;PECR;MTLN;ACAT2;HADHA;SLC25A17;CPT2;ECI2;ACADM;AUH;ILVBL;HADHB
prerank,negative regulation of macroautophagy (GO:0016242),0.5356073437487021,1.3251168331627705,0.1491108071135431,0.863871486420365,1.0,8/26,9.89%,NRBP2;NUPR1;TSC2;TMEM39A;RUBCN;CHMP4A;CHMP4B;SMCR8
prerank,calcium-mediated signaling (GO:0019722),0.4448445836385745,1.3238691187482299,0.10452961672473868,0.8669006083902427,1.0,14/93,6.38%,AGTR1;NUDT4;ANK2;CCR4;CXCR4;MCU;PTGFR;RCAN1;ACKR4;ACKR2;CCR10;ACKR3;CCRL2;DMTN
prerank,mRNA splice site selection (GO:0006376),0.5232911001604905,1.3233493016196283,0.15168539325842698,0.8670383202073829,1.0,13/30,20.96%,CELF2;CELF1;LUC7L3;KHDC4;SF3A2;SRSF9;ISY1;LUC7L2;SRSF1;SRSF5;SF3A3;SFSWAP;PUF60
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",-0.37370986686521773,-1.3225973409417933,0.0821917808219178,0.6262923683248449,1.0,16/46,12.83%,CDH2;NRXN1;SHANK3;GRM3;GRM7;GRM8;SYT1;LRRK2;GRM5;GRIK3;NLGN1;CACNG8;DGKI;GRIK1;NLGN3;DRD2
prerank,barbed-end actin filament capping (GO:0051016),0.570398828929412,1.3222616564033944,0.16740088105726872,0.8675535769775743,1.0,6/18,6.22%,VILL;GSN;CAPZB;TWF1;AVIL;ADD1
prerank,actin filament capping (GO:0051693),0.570398828929412,1.3222616564033944,0.16740088105726872,0.8675535769775743,1.0,6/18,6.22%,VILL;GSN;CAPZB;TWF1;AVIL;ADD1
prerank,negative regulation of actin filament bundle assembly (GO:0032232),0.527508197754723,1.3210536193682534,0.15491009681881052,0.8706489322491857,1.0,7/27,10.78%,PHLDB2;TJP1;ARAP1;TMEFF2;ARHGEF18;RHPN2;DLC1
prerank,regulation of intracellular protein transport (GO:0033157),0.5140606507251769,1.3207067222312927,0.14522821576763487,0.8699800438032593,1.0,13/32,24.60%,PTPN14;NDEL1;BMP4;PLK3;GCC2;BCAS3;RIPOR1;KIF20B;VAMP2;SIRT7;TPR;ICE1;PCM1
prerank,negative regulation of cell death (GO:0060548),0.45056323016683003,1.3203226251569322,0.09451575262543757,0.8695995764610137,1.0,21/88,15.47%,WNT16;CLU;SRGAP2;PPARGC1A;CD200;CCN2;WNT11;KANK2;BMP4;CHMP4A;CHMP4B;TIGAR;VPS4B;CD200R1;BNIP3L;DUS2;GSK3B;EIF4G1;NENF;CHMP2A;IKBKG
prerank,peripheral nervous system development (GO:0007422),0.5408396848427685,1.3200367561374151,0.1492109038737446,0.8687575951362161,1.0,6/23,10.48%,GPC1;NGF;GDNF;GFRA3;ERBB3;ADGRG6
prerank,protein K63-linked ubiquitination (GO:0070534),0.4969409834211285,1.3198704820297766,0.13421052631578947,0.8675384049694175,1.0,19/41,22.39%,RNF152;WWP2;RNF5;TRIM21;MAGEL2;UBE2B;RNF126;PELI1;NEDD4;BFAR;UBE2N;PRPF19;STUB1;ZFP91;TRIM5;ARIH2;TRAF3IP2;UBE2V1;RNF168
prerank,endothelial cell development (GO:0001885),-0.4366147081320034,-1.3198287737697252,0.12318840579710146,0.6318240594040248,1.0,8/25,4.00%,COL22A1;RAPGEF2;PECAM1;PDE4D;RDX;PPP1R16B;COL18A1;COL15A1
prerank,negative regulation of MAP kinase activity (GO:0043407),-0.37101134410701786,-1.3197341057523304,0.06965174129353234,0.6291117245665221,1.0,15/44,20.88%,PTPRJ;LYN;DAB2IP;IRAK3;SH2B3;PIK3CB;DNAJA1;NF1;CD300A;SORL1;PDCD4;SPRY4;SPRY1;PAQR3;BMP7
prerank,mesenchyme morphogenesis (GO:0072132),-0.46475678535221177,-1.3196282245279023,0.14420062695924765,0.626459047571859,1.0,6/17,9.62%,ENG;NOS3;ACVRL1;NOTCH1;HEYL;TBX2
prerank,positive regulation of reproductive process (GO:2000243),-0.407160669662476,-1.3196133469106144,0.11683848797250859,0.6235381413025359,1.0,5/31,7.24%,PLCB1;PDE3A;LHFPL2;ACVR1B;GLRA1
prerank,vesicle transport along microtubule (GO:0047496),0.5475203989903309,1.3184215041130412,0.15086206896551724,0.8713703573269115,1.0,5/23,10.55%,DYNC1I1;NDEL1;KIF13A;KIF1C;PAFAH1B1
prerank,histone H3-K4 trimethylation (GO:0080182),0.6389673645115326,1.3181920013773534,0.15435139573070608,0.8703056385659689,1.0,3/11,9.03%,OGT;BEND3;KMT2A
prerank,nucleosome assembly (GO:0006334),0.5177623886555952,1.3171387922258169,0.17527173913043478,0.8725554986809769,1.0,10/31,18.29%,DAXX;GRWD1;ASF1A;SOX9;KAT6B;ATRX;UBN1;IPO4;SPTY2D1;H3-3A
prerank,positive regulation of response to stimulus (GO:0048584),0.4995449151459212,1.3166041855939488,0.1450381679389313,0.872849142458022,1.0,13/40,15.32%,IL15;MAVS;SELENON;YPEL3;NSMCE4A;TGFB2;ILK;CDKN2AIP;GATA3;FXR1;MYC;EEF1E1;DHX9
prerank,cellular response to chemokine (GO:1990869),0.4919032531793793,1.316548899773472,0.14451612903225808,0.8711306192611055,1.0,9/46,8.46%,CCL5;ZC3H12A;PTK2B;ACKR3;RIPOR2;DUSP1;GPR75;STK39;OXSR1
prerank,regulation of neural precursor cell proliferation (GO:2000177),-0.4374279124121453,-1.3164049690708193,0.1189710610932476,0.630577213557084,1.0,9/22,15.83%,APPL2;LRRK2;PTPRZ1;ID2;NES;GATA2;TAFA1;TOX;KDM2B
prerank,negative regulation of immune effector process (GO:0002698),0.6127098412287633,1.3161295805230204,0.18524332810047095,0.8709434557969422,1.0,1/13,0.15%,CD55
prerank,establishment of spindle orientation (GO:0051294),0.5130141518939015,1.3160597532829135,0.13324175824175824,0.8693012201196191,1.0,11/28,22.95%,NDEL1;NSFL1C;MAP4;LLGL2;PAFAH1B1;ZW10;INSC;NUMA1;MISP;LLGL1;ITGB1
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.5080346541134464,1.3160000133469227,0.14953271028037382,0.867610938806493,1.0,2/33,3.88%,DPP4;FOXC2
prerank,sterol biosynthetic process (GO:0016126),0.5129552256606135,1.3158338473687692,0.14774281805745554,0.8664032140141797,1.0,13/33,18.18%,FDFT1;DHCR7;FDPS;HMGCR;INSIG1;PMVK;CYP51A1;MSMO1;ACAT2;SQLE;PLPP6;TM7SF2;HMGCS1
prerank,negative regulation of T cell differentiation (GO:0045581),0.6297203446609569,1.3154167638821725,0.17288135593220338,0.8661488266787706,1.0,2/10,6.81%,GLI3;BMP4
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),0.5879846056753,1.3148634937345922,0.18949044585987262,0.8664103020367272,1.0,1/14,0.18%,AGTR1
prerank,regulation of mitochondrial fusion (GO:0010635),-0.5332742693082149,-1.3138989189297992,0.16535433070866143,0.635334821045731,1.0,3/11,11.55%,PID1;TFRC;ZDHHC6
prerank,cellular response to oxidative stress (GO:0034599),0.4354131084034083,1.3137705667316755,0.09249183895538629,0.8689906060822424,1.0,20/118,11.20%,WNT16;PRKAA2;PPARGC1A;MMP9;CPEB2;ZC3H12A;FOXO3;FOS;SESN2;MGAT3;NFE2L2;DAPK1;NUDT2;PXN;ROMO1;JUN;MAPK9;SOD2;AGAP3;PDK2
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.5569239320936571,1.3134033137752856,0.160741885625966,0.8685657575265125,1.0,4/19,5.96%,CLU;RTN1;FLOT2;RTN3
prerank,regulation of apoptotic signaling pathway (GO:2001233),-0.39390302783895037,-1.3121954112441248,0.09504132231404959,0.6376769778231092,1.0,16/36,25.34%,SGMS1;FAS;DAB2IP;DEPTOR;BCL2;TPD52L1;DAPK2;TMBIM6;BDNF;NR4A2;CX3CL1;CX3CR1;TRAF1;CYLD;ASAH2;PYCARD
prerank,morphogenesis of a polarized epithelium (GO:0001738),0.6098381749522924,1.311866316132304,0.18035426731078905,0.8729590176566293,1.0,4/12,10.72%,CELSR1;LAMA5;ACTB;ACTG1
prerank,positive regulation of glucose transmembrane transport (GO:0010828),0.5288988851934803,1.3114425591343155,0.1398002853067047,0.8728020646560776,1.0,4/26,5.14%,SORBS1;OCLN;CREBL2;RHOQ
prerank,regulation of calcium ion import (GO:0090279),-0.4411841146985617,-1.3113487965250963,0.14487632508833923,0.6372881138846751,1.0,3/21,4.78%,PDGFRB;CXCL12;PKD2
prerank,digestive tract morphogenesis (GO:0048546),-0.5021323823070515,-1.3110499194236356,0.13821138211382114,0.6351598676770237,1.0,9/14,17.30%,PDGFRA;GLI1;SOX17;ID2;FGFR2;NIPBL;BBS7;SOX11;EPHB3
prerank,cardiac muscle tissue development (GO:0048738),0.48579514774704957,1.3109870427789727,0.13048780487804879,0.8726697308441612,1.0,8/50,6.81%,SGCG;NOTCH2;SGCD;AKAP13;GJB6;CSRP3;BMP5;BMP4
prerank,positive regulation of glial cell differentiation (GO:0045687),-0.4702072431721444,-1.310655476877499,0.15151515151515152,0.6334908198334984,1.0,8/17,8.73%,IL34;NOTCH1;SERPINE2;BIN1;TGFB1;PTPRZ1;ID2;TENM4
prerank,endoplasmic reticulum tubular network organization (GO:0071786),0.5900721439935119,1.3104505470780998,0.182370820668693,0.872894004755454,1.0,8/15,20.41%,REEP3;RTN3;ZFYVE27;TMEM33;ATL2;REEP4;ARL6IP1;RAB10
prerank,positive regulation of acute inflammatory response (GO:0002675),-0.5043444358076052,-1.309986249752246,0.14206128133704735,0.6328844515883328,1.0,3/14,12.36%,OSMR;PTGS2;IL6ST
prerank,negative regulation of cellular protein localization (GO:1903828),0.5056416651845008,1.3097868604322618,0.15496688741721854,0.8736978387604222,1.0,12/34,20.10%,ACTN2;CTNNA1;RIPOR2;OTUD7B;NSFL1C;LATS1;SNX33;GSK3B;FLCN;ROCK2;ILRUN;MAPT
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),-0.39356839440844466,-1.3095950182997202,0.10921501706484642,0.6313337104172508,1.0,11/33,19.93%,LEF1;IL34;RUNX1;ID2;HSF1;TRAF6;RIPK1;CTNNBIP1;CD74;CSF1;FES
prerank,cell junction assembly (GO:0034329),0.43772059744313707,1.3092933201227102,0.10837988826815642,0.8739297099252523,1.0,13/100,9.26%,FN1;CDH1;SDK1;TJP1;PKP4;LIMS2;ILK;PARD6B;FZD5;CDC42;GRHL2;OPHN1;ACTB
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),-0.32042084804812243,-1.308907643168783,0.042735042735042736,0.6305719916918637,1.0,34/101,19.60%,FLT1;PDGFRB;PDGFD;CEMIP;IL34;RAPGEF2;ROBO1;WNT5A;PKD2;FGF2;DAB2IP;LRRK2;RGCC;DIPK2A;TGFB1;EZH2;TPD52L1;CCNY;PIK3R6;ETAA1;KIT;IRGM;HMGA2;SPDYA;EDN1;PIK3R5;EDN3;INCENP;EGF;MAP2K1;TCIM;CD40;CIB1;MST1R
prerank,regulation of amyloid-beta clearance (GO:1900221),0.577719597736225,1.3082561814472515,0.1552511415525114,0.876203051744741,1.0,3/16,7.75%,CLU;HMGCR;CYP51A1
prerank,regulation of epithelial cell differentiation (GO:0030856),0.5744577010465872,1.3081023870144706,0.15892053973013492,0.8749865776014267,1.0,5/17,12.94%,CAV1;SOX9;KLF7;MAFG;GATA3
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.5540213681518724,1.3078412710344565,0.16288951841359772,0.8741146584193507,1.0,6/20,12.12%,CNOT6;CELF1;MOV10;EIF6;MOV10L1;AJUBA
prerank,negative regulation of biomineral tissue development (GO:0070168),-0.4348922235484367,-1.3069554620222472,0.14102564102564102,0.6336237485718391,1.0,9/21,10.37%,ENPP1;NOS3;GAS6;NOTCH1;ECM1;ASPN;TGFB1;ROCK1;BCOR
prerank,positive regulation of angiogenesis (GO:0045766),0.43546663553377624,1.306764369264227,0.09845132743362832,0.8766643297612611,1.0,24/108,12.28%,PRKCB;ADAM12;ITGB8;KLF4;ANXA3;TJP1;NINJ1;ZC3H12A;GAB1;FOXC2;HSPB1;MTDH;PKM;AGGF1;MYDGF;VEGFB;JMJD8;EMC10;TWIST1;AQP1;RAPGEF3;S100A1;JAK1;SP1
prerank,sequestering of extracellular ligand from receptor (GO:0035581),-0.5107023432757488,-1.3059045677075267,0.15119363395225463,0.6340699161303724,1.0,7/13,15.20%,LTBP1;FBN1;GREM2;FBN2;CD46;NRROS;CHRDL1
prerank,regulation of filopodium assembly (GO:0051489),0.49888693013525753,1.3056327024028593,0.1509933774834437,0.8794745904008349,1.0,11/38,13.39%,RAB17;ARAP1;PALM;RIPOR2;RHOQ;CAPZB;DMTN;CDC42;BCAS3;FXR1;TRPM2
prerank,B cell homeostasis (GO:0001782),-0.542892608458774,-1.3052356358032275,0.15738498789346247,0.6332652194148185,1.0,5/10,21.74%,LYN;DOCK10;NCKAP1L;TNFAIP3;DOCK11
prerank,alanine transport (GO:0032328),0.6325895458768308,1.3051338913226282,0.18739352640545145,0.8796484067414299,1.0,3/10,10.88%,SLC36A3;SLC36A4;SLC1A4
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),0.6178404200718248,1.30490966760056,0.18016528925619835,0.8786653904404133,1.0,3/10,11.20%,OGT;ZNF692;PDK2
prerank,positive regulation of calcium ion transport (GO:0051928),0.4958830831928557,1.3047901367029804,0.13438735177865613,0.8772744168932425,1.0,4/36,2.65%,ANK2;STIM2;CCL5;CAV1
prerank,regulation of potassium ion transport (GO:0043266),0.5155977148285495,1.304497576991439,0.138255033557047,0.8766101738961458,1.0,5/31,6.82%,ANK2;ACTN2;FHL1;PTK2B;ANK3
prerank,cAMP-mediated signaling (GO:0019933),-0.42654038256188986,-1.3034415688155347,0.12758620689655173,0.6361780059136433,1.0,8/24,9.95%,PDE7B;KSR1;PDE3A;RAPGEF2;PDE4D;CAP2;ADCY1;PDE2A
prerank,negative regulation of axonogenesis (GO:0050771),0.5290143593324125,1.3031105505419651,0.16954022988505746,0.8803489685804644,1.0,2/27,0.73%,FGF13;RTN4R
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.5355949573163059,1.3022389048659937,0.17580872011251758,0.8820833303324479,1.0,5/23,9.74%,UACA;ZC3H12A;PPM1B;PPM1A;NMI
prerank,positive regulation of chondrocyte differentiation (GO:0032332),-0.5402924220641921,-1.3021462436257438,0.14030612244897958,0.6373465359868228,1.0,4/10,7.35%,SOX5;ACVRL1;BMPR1B;PKDCC
prerank,regulation of phospholipase activity (GO:0010517),0.6280365466151643,1.3016697107126212,0.19312602291325695,0.8825780276133931,1.0,1/10,0.51%,FGFR1
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),-0.5281481485642426,-1.3016073270991875,0.17359413202933985,0.6361473764173373,1.0,4/12,17.23%,LYN;RUNX1;CD300A;RC3H1
prerank,inositol lipid-mediated signaling (GO:0048017),0.4656762498427583,1.3004350903557342,0.14250309789343246,0.8856645858697627,1.0,13/50,11.76%,PITPNM2;FGFR1;PLCL2;PLCB3;PLCD3;OGT;NGF;PIK3C2B;PLCL1;PI4KA;EZR;IRS2;RHOA
prerank,cholesterol metabolic process (GO:0008203),0.4582846492791837,1.3003785005427106,0.12891566265060242,0.8840541041531693,1.0,19/68,18.18%,FDFT1;SOAT1;STARD3;SULT2B1;DHCR7;FDPS;HMGCR;INSIG1;PMVK;CYP51A1;MSMO1;FDX1;SOAT2;ACAT2;SQLE;OSBPL5;PLPP6;TM7SF2;HMGCS1
prerank,inorganic cation import across plasma membrane (GO:0098659),0.4466133344173398,1.2994461069272172,0.11602870813397129,0.885828857003291,1.0,12/75,14.06%,SLC9A2;SLC9A4;SLC12A8;ATP1A2;KCNJ13;SLC39A6;SLC9A6;SLC9A7;TRPM4;SLC12A4;TRPM2;ATP2B4
prerank,regulation of cell population proliferation (GO:0042127),0.40330472094727116,1.2989643689751662,0.007,0.8859919389014725,1.0,95/691,9.08%,FN1;DPP4;EGLN3;AGTR1;CDH13;CLU;FGFR1;ZBTB7C;PTPN14;CRLF1;CHRM1;IGFBP6;NTRK3;CNOT6;WNT1;KLF4;TFAP2C;LAMC2;TJP1;TFAP2D;COL4A3;PDGFC;EFNB2;GRK5;CDKN1A;ADAM10;SMAD6;EMP2;NIBAN2;CD200;MAGI2;NUPR1;IL15;CDK10;PDF;CELF1;CDK6;CD81;SULT2B1;NGF;RBFOX2;PTGFR;TNFSF13;KANK2;PTK2B;SGK3;TNFRSF8;GDNF;NOP2;HDAC4;BMP5;CLCF1;GCNT2;TIMP1;EPO;PTPRU;CIAO1;DOT1L;NACC1;S100A11;CDK4;RPS4X;RARG;SH3BP4;TSC2;JUND;FOXM1;ZBTB17;KRAS;SOX9;TES;SHC1;CGREF1;DDRGK1;MAPK15;BMP4;CCND2;ERBB3;TGFB2;STAT4;TGFB1I1;SLURP1;ROMO1;FGF22;SIX1;MAZ;JUN;TCF7L2;FBXO5;SSR1;ADAMTS1;PML;IL7R;FOXP3;BRD7
prerank,regulation of cation channel activity (GO:2001257),0.4465347399551496,1.2988881605631302,0.12888377445339472,0.8844846995819702,1.0,11/89,4.46%,FGF13;ANK2;ACTN2;SLMAP;AHNAK;MMP9;CACNB3;PTK2B;SELENON;DAPK1;EPO
prerank,heart process (GO:0003015),0.5866722673787998,1.2980931183318802,0.17700453857791226,0.8858480375349475,1.0,2/14,2.23%,SGCG;SGCD
prerank,positive regulation of gene expression (GO:0010628),0.40533428665147514,1.297789379075144,0.01609657947686117,0.8852192018454087,1.0,87/442,14.63%,FN1;WNT16;CLU;ANGPT1;ANK2;ITGB8;NTRK3;ADTRP;KLF4;PPARGC1A;SMO;VIM;SCAMP5;HPN;OCLN;GSN;SAMD4A;DDX5;YTHDF1;IL15;ZC3H12A;WNT11;EP300;CELF1;NGF;WNT6;NFE2L2;POLR2H;OLFM1;RPS4X;TAF1C;OVOL2;POLR2A;HOXA5;KRAS;MOV10;SOX9;FOXD1;HCFC1;ZBTB7B;DDRGK1;EIF4A3;BMP4;ANK3;RBMS3;MSN;UPF3A;RBM20;EIF6;NFAM1;FGF22;MAZ;POU3F1;MAPK9;TENT4A;TLR6;TXK;ACTB;MAP2K2;EZR;POLR1C;MYO1C;MUSK;TWIST1;SRPK2;HABP4;ACTG1;POLR1E;TLR4;CALCOCO1;POLR1F;POLDIP3;SP1;EIF2AK3;WNT3;CPEB3;PLXNB2;FXR1;MYC;GSK3A;MEF2C;UBR5;UPF3B;GSK3B;PYM1;GAPDH;ZPR1
prerank,muscle cell development (GO:0055001),0.5227846546107306,1.2975233716623211,0.17123287671232876,0.8845639865157742,1.0,3/30,1.59%,CXADR;ANK2;NEBL
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.42583163237158583,-1.2969509154642125,0.1492063492063492,0.6477888513009947,1.0,12/23,22.21%,IFNGR1;IFNGR2;NR1H3;PARP14;JAK2;PPARG;NLRC5;IRGM;NR1H2;CDC37;HSP90AB1;SOCS3
prerank,phospholipid homeostasis (GO:0055091),-0.5156392165466372,-1.2968248767649435,0.19174041297935104,0.645330440956711,1.0,2/11,6.55%,ABCA1;RCN3
prerank,regulation of macrophage cytokine production (GO:0010935),-0.5153106632844424,-1.2966569508323464,0.16944444444444445,0.6430840501193735,1.0,6/13,16.64%,WNT5A;SEMA7A;IRAK3;TGFB1;GPRC5B;CD74
prerank,microtubule nucleation (GO:0007020),-0.46455272169834544,-1.296311878262997,0.16463414634146342,0.6413248754732026,1.0,9/19,15.97%,CLASP2;CCDC57;RANBP9;TUBGCP2;NDE1;TPPP;GOLGA2;CSNK1D;SLAIN2
prerank,interleukin-6-mediated signaling pathway (GO:0070102),-0.4503376336546721,-1.2950754205534443,0.1697530864197531,0.6422430883976822,1.0,12/18,28.01%,ST18;IL6R;JAK2;STAT3;IL6ST;YAP1;SMAD4;SOCS3;CBL;SPI1;FER;CEBPA
prerank,DNA methylation (GO:0006306),0.5391634670333627,1.2947159916173805,0.1844380403458213,0.8939886422621159,1.0,11/23,26.58%,FOS;BEND3;ATRX;ZFP57;DNMT3A;PPM1D;KMT2E;N6AMT1;TEX15;BAZ2A;EHMT1
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),-0.3371021228067002,-1.2944309394212519,0.08743169398907104,0.6415437307340007,1.0,21/67,13.19%,FLT1;GHR;PDGFRB;TEK;INSR;LYN;PTK2;PDGFRA;KDR;EPHB2;ABI2;BMX;PKDCC;JAK2;ERBB4;FGFR2;KIT;ABL2;IGF1R;FGFR4;FLT4
prerank,synaptic membrane adhesion (GO:0099560),0.5812178263609137,1.294169860646301,0.18064516129032257,0.8944318737494412,1.0,4/14,6.86%,GPC6;GPC4;PTPRD;PTPRF
prerank,regulation of cytoplasmic translation (GO:2000765),0.5995542825484915,1.2934991951430515,0.18138801261829654,0.89541055082379,1.0,6/14,15.32%,CPEB2;YBX3;UNK;PKM;CPEB3;DHX9
prerank,regulation of telomere capping (GO:1904353),0.543620758291387,1.2934875523845473,0.17105263157894737,0.8936057235006222,1.0,10/23,20.98%,NEK7;NABP2;MAPK15;MAP3K4;TNKS2;NBN;PRKCQ;RAD50;PNKP;TERF2
prerank,inner mitochondrial membrane organization (GO:0007007),0.47383034027552967,1.2933869046958528,0.14303638644918445,0.8921670990381917,1.0,25/47,26.36%,TIMM10;CHCHD3;MICOS13;AGK;ROMO1;MICOS10;AFG3L2;LETM1;ATP5PF;OPA1;APOO;IMMT;ATP5F1B;MTX1;SPG7;TIMM9;ATP5PD;MTX3;ATP5ME;MAIP1;ATP5F1D;MTX2;ATP5F1C;ATP5MC3;NDUFA13
prerank,connective tissue development (GO:0061448),0.49818089860149595,1.293176394154786,0.17264276228419656,0.8912785884086787,1.0,8/35,8.25%,CD44;ITGB8;RORC;ZBTB16;SOX9;DDRGK1;DYRK1B;PKD1
prerank,response to sterol (GO:0036314),0.6197320766100769,1.2926120836191517,0.19738988580750408,0.8918044996400392,1.0,5/11,12.14%,RORC;INSIG1;PMVK;ABCA2;TGFBR2
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.41982110640511894,1.2922577158186372,0.07974816369359916,0.8913299021125176,1.0,44/173,19.30%,CD55;ANK2;DYNC1I1;F5;NRBP2;ANK1;PEF1;ERGIC1;COPA;SPTBN2;TMED1;TFG;CAPZB;CTSZ;ANK3;ERGIC2;IER3IP1;BCAP31;ZW10;HYOU1;TRAPPC1;SPTAN1;MCFD2;VTI1B;ERGIC3;NAPA;GOLGB1;ARF4;COG8;PREB;VAMP7;RAB1B;CNIH1;ATL2;SEC23A;DYNC1LI2;NSF;DYNC1H1;COPG1;YKT6;TMED5;BET1L;SEC24B;VTI1A
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),0.5710751134521873,1.2922454427332295,0.18668596237337193,0.8895620403879043,1.0,3/16,7.30%,RAET1E;LAMP1;PVR
prerank,neuron apoptotic process (GO:0051402),-0.4491744419481447,-1.2922255951730452,0.15454545454545454,0.645240508047107,1.0,7/19,12.14%,FAS;FAM162A;BCL2;CIT;TNFRSF21;TRPC5;BID
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),-0.49614086451763006,-1.2920682273183244,0.16666666666666666,0.6430034712474877,1.0,4/13,7.46%,ERRFI1;CBLB;ZFYVE28;SOCS5
prerank,protein oxidation (GO:0018158),-0.521376803749454,-1.291447443483783,0.18341708542713567,0.6421025311640904,1.0,4/11,12.29%,LOXL1;TMX3;LOXL3;LOX
prerank,lipid phosphorylation (GO:0046834),-0.5485410524607793,-1.291168072729885,0.19451371571072318,0.6402675424292448,1.0,7/10,23.01%,DGKH;DGKB;DGKI;DGKG;DGKZ;DGKQ;DGKK
prerank,nuclear membrane organization (GO:0071763),0.552081830174072,1.2910334380668842,0.18154761904761904,0.8926571258262178,1.0,9/19,24.71%,NSFL1C;CHMP4B;TOR1A;VPS4A;TOR1AIP1;CHMP2A;GPER1;TMEM43;UBXN2A
prerank,apoptotic process (GO:0006915),0.4135242378287903,1.2909119496143118,0.0875,0.8913149635357441,1.0,49/203,17.53%,EGLN3;RNF152;NOTCH2;CYFIP2;PAWR;OGT;BBC3;EP300;CXCR4;PMAIP1;PTK2B;DAPK3;PPP2CA;DAPK1;ZBTB16;AHCYL1;PPP1R15A;NUDT2;NFKBIA;IRF3;TSC2;BCL2L1;EFNA5;ERBB3;BAD;PLK3;TNFRSF10B;DPF2;RAF1;ADAM15;DLC1;FEM1B;PLSCR3;TGFBR2;FXR1;VDAC1;MYC;ING4;PAX3;YARS1;GAPDH;MDM2;IKBKG;ITGB2;PAK6;PDE1B;ERCC2;SIAH1;PIDD1
prerank,axonal transport of mitochondrion (GO:0019896),-0.5302246005085125,-1.2908943479443709,0.17204301075268819,0.6383795303099188,1.0,5/11,15.90%,HIF1A;SYBU;ACTR10;NEFL;TRAK2
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.5626720748340739,1.2908823686788253,0.18786127167630057,0.8896225803373367,1.0,3/17,7.30%,RAET1E;LAMP1;PVR
prerank,motor neuron axon guidance (GO:0008045),0.5688929125494147,1.2900960725550763,0.1967741935483871,0.8909864523476231,1.0,2/15,1.67%,LAMC2;EPHA4
prerank,positive regulation of T cell cytokine production (GO:0002726),0.5491443480471565,1.2898941002675164,0.17629629629629628,0.8899818817029178,1.0,3/20,8.36%,CD55;CD81;FZD5
prerank,actin filament polymerization (GO:0030041),0.5165341508294811,1.289519927221801,0.174931129476584,0.8896964469728615,1.0,6/29,7.83%,COBL;GSN;DIAPH1;CORO7;ANG;MSRB2
prerank,regulation of stem cell population maintenance (GO:2000036),0.5573372437452127,1.289361676428532,0.1884272997032641,0.8885201189945853,1.0,5/18,13.47%,NCOA3;ESRRB;WDR43;PTN;MYC
prerank,regulation of RNA metabolic process (GO:0051252),0.45897753259963137,1.2889493819278905,0.15106117353308365,0.8884328284175864,1.0,19/59,20.55%,MBNL1;AHNAK;AHNAK2;CELF1;SNRNP70;SON;RBM20;HNRNPH2;SRRM4;RASA1;GRSF1;MBNL2;OAS2;BRDT;IGF2BP3;PTBP1;IGF2BP2;PCBP2;IGF2BP1
prerank,response to estrogen (GO:0043627),0.5066226011614638,1.2887089951594606,0.1586021505376344,0.8876031743649268,1.0,9/31,18.35%,KRT19;CAV1;EP300;TRIM25;BCAS3;GATA3;SFRP1;SFR1;RARA
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.46659036403485304,1.2886889404853152,0.16116751269035534,0.8859061047116934,1.0,17/52,16.88%,SREBF2;BBC3;PMAIP1;PPP1R13B;BAD;FZD5;YWHAB;YWHAQ;SAE1;VPS11;YWHAZ;NPEPPS;RHOU;GSK3A;RNF31;E2F1;UBE2D3
prerank,intestinal absorption (GO:0050892),0.5837155073419286,1.288612799613232,0.19901315789473684,0.884436553158125,1.0,1/13,1.20%,TJP2
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",-0.42157759973335684,-1.2879876732641182,0.15172413793103448,0.644745029807869,1.0,12/25,25.51%,GRID2;GRIN2A;GRIN2B;LRRK2;GLRA1;NLGN3;DRD2;MPP2;RAB3GAP1;INSYN2A;ARRB2;CHRNA4
prerank,positive regulation of GTPase activity (GO:0043547),0.4096269833835224,1.28784337853859,0.08385093167701864,0.8857334296671082,1.0,44/188,17.28%,ARHGAP42;MAPRE2;RTN4R;NTRK3;SRGAP2;ARAP1;NGEF;CCL5;PLXNB1;PKP4;SIPA1L1;WNT11;NDEL1;RAP1A;S100A10;GRTP1;TBC1D16;TIAM2;CAV2;DOCK7;ARHGAP29;CCDC125;DVL3;BCR;ARHGEF5;BCAS3;SNX18;SGSM2;RAPGEF3;TBC1D1;RGS6;ASAP3;SFRP1;GSK3B;HRAS;ARHGAP27;FLCN;USP6NL;RAPGEF1;TBC1D22A;TBC1D10A;PRTN3;RAP1GAP;F2R
prerank,intestinal lipid absorption (GO:0098856),0.5936979058511911,1.2877447892098368,0.19205298013245034,0.8843829730360987,1.0,2/11,8.94%,LDLR;SOAT2
prerank,positive regulation of ERAD pathway (GO:1904294),0.5885049606131088,1.2876001735758138,0.1912479740680713,0.883201951845523,1.0,4/13,10.39%,CAV1;NFE2L2;TMEM259;BCAP31
prerank,positive regulation of monooxygenase activity (GO:0032770),-0.4058152080928323,-1.2870559623593076,0.14035087719298245,0.6449048774041426,1.0,6/26,8.12%,POR;HIF1A;NPR3;NOS1AP;PIK3CB;GCH1
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.5187793420016202,1.2866826181343387,0.1751412429378531,0.8851031458545195,1.0,4/26,7.53%,CFTR;EFNA5;KLF7;CDK16
prerank,cellular response to dsRNA (GO:0071359),0.5834287098431556,1.2860803885525562,0.18923076923076923,0.8857623299809043,1.0,6/15,19.47%,CAV1;MAVS;MUL1;DHX9;COLEC12;FLOT1
prerank,positive regulation of blood coagulation (GO:0030194),0.5671670294831961,1.2860571663207012,0.2021604938271605,0.8841002355170967,1.0,6/17,19.94%,ST3GAL4;THBD;DMTN;ANO6;F2R;USF1
prerank,cellular component disassembly (GO:0022411),0.4688535878415411,1.2858571715647116,0.13962264150943396,0.8831957995230446,1.0,14/53,13.09%,CD44;TMPRSS6;MMP9;ADAM10;GSN;TIMP1;TIMP2;KLKB1;CAPN2;LAMC1;CAPNS1;ADAM15;MMP12;EXOC8
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),0.5507992183788605,1.2852459485768322,0.18335901386748846,0.8838333157965693,1.0,6/17,17.54%,CD44;YJU2;TWIST1;MDM2;KDM1A;ARMC10
prerank,cGMP metabolic process (GO:0046068),-0.500448247705038,-1.284634026081225,0.1656441717791411,0.6493212510695712,1.0,5/12,10.43%,GUCY1B1;GUCY1A1;PDE9A;PDE2A;NPR1
prerank,atrial septum morphogenesis (GO:0060413),0.6199612576506537,1.284456909270339,0.192,0.8852633591939609,1.0,2/10,7.38%,NOTCH2;TGFB2
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),-0.37078013830185463,-1.2841897587116833,0.11946902654867257,0.6479828224625557,1.0,11/40,8.90%,LEF1;JAG1;COL1A1;DAB2;NOTCH1;RGCC;TGFB1;EZH2;GLIPR2;AXIN2;TIAM1
prerank,DNA catabolic process (GO:0006308),0.6224786804875863,1.2827776813555707,0.19901315789473684,0.8901287779215799,1.0,4/11,13.77%,XRN2;DNASE1L2;DNASE1L1;REXO4
prerank,GPI anchor metabolic process (GO:0006505),0.529233429039314,1.282635071870135,0.18181818181818182,0.8889666765655998,1.0,9/26,19.43%,PIGU;PIGZ;PGAP2;PIGA;DPM2;PIGN;PIGP;PIGQ;GPLD1
prerank,regulation of microtubule-based process (GO:0032886),0.5050988417513566,1.2820001637404093,0.1699867197875166,0.8897840779634552,1.0,11/36,17.34%,PHLDB2;PRKAA2;DIAPH1;MAP6;EFNA5;EPHA3;MARK4;GSK3B;MEMO1;IGBP1;HDAC6
prerank,establishment of endothelial intestinal barrier (GO:0090557),0.6083909529732403,1.2816092599183402,0.21402877697841727,0.8895303638807394,1.0,2/11,1.30%,TJP2;TJP1
prerank,regulation of platelet activation (GO:0010543),-0.43632566677676105,-1.2808295859816732,0.14465408805031446,0.6556585047228866,1.0,4/21,3.60%,PLA2G4A;LYN;NOS3;PDGFRA
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),0.5818301598808795,1.2808126788188403,0.20404984423676012,0.890983772446923,1.0,3/13,8.61%,BMP5;ERLIN2;ERLIN1
prerank,regulation of dendritic spine development (GO:0060998),-0.43870399638629476,-1.2804606661745357,0.1559633027522936,0.6540419210033986,1.0,6/19,10.79%,SHANK3;TANC2;PPFIA2;NLGN1;KIF1A;DLG5
prerank,linoleic acid metabolic process (GO:0043651),0.5468700008812871,1.2795810491291997,0.18808777429467086,0.8941633188254065,1.0,6/17,19.39%,ABCD1;ELOVL1;ALOX5;FADS1;GSTM2;FADS2
prerank,regulation of protein localization to nucleus (GO:1900180),0.4824079463881063,1.279044510691952,0.176158940397351,0.8946906934964272,1.0,20/43,23.73%,LIMK2;GLUL;CTNNA1;SESN2;ORMDL3;OTUD7B;BMP4;LATS1;SUMO3;EIF2AK3;GSK3B;FLCN;TESK1;PARK7;CDK5RAP3;ILRUN;BYSL;TPR;LATS2;WWTR1
prerank,dendritic cell chemotaxis (GO:0002407),0.5776667491818136,1.2787358981796808,0.2019704433497537,0.8942505970980242,1.0,4/14,13.39%,CCL5;CXCR4;TRPM4;TRPM2
prerank,acylglycerol homeostasis (GO:0055090),-0.4356667264709563,-1.2783826148408466,0.1582089552238806,0.6578493748524453,1.0,4/20,6.77%,IL18;NR1H3;RORA;PNPLA8
prerank,bile acid and bile salt transport (GO:0015721),-0.42284409977376614,-1.2778154254926943,0.12987012987012986,0.6567340817217151,1.0,4/24,3.43%,ABCC4;SLCO2B1;SLCO1C1;NCOA1
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.4218964582173363,1.2776201300489927,0.1164079822616408,0.896927477832463,1.0,17/108,10.78%,EGLN3;NLRP2;COL4A3;MAP3K5;UACA;GSN;BBC3;PMAIP1;PRR7;NGF;DAPK1;MUL1;BAD;TNFRSF10B;ARL6IP5;BCAP31;DLC1
prerank,spliceosomal complex assembly (GO:0000245),0.46838553565498325,1.2771849307868004,0.17480719794344474,0.8968545088980094,1.0,18/46,21.95%,CELF2;CELF1;DDX39B;LUC7L3;USP39;SRPK2;KHDC4;SF3A2;SRPK1;SRSF9;LUC7L2;PRPF19;PRPF6;SRSF1;SRSF5;SF3A3;PUF60;DDX23
prerank,defense response to bacterium (GO:0042742),0.4343841761264708,1.2770104303996532,0.1310734463276836,0.895768421400227,1.0,23/105,15.49%,ANXA3;GALP;MAVS;SLPI;PGLYRP3;EPX;CFP;SHC1;ANG;ROMO1;STAB2;LBP;TLR6;RNASE3;PPP1R11;AQP1;TLR4;ANKRD17;FCER1G;PLA2G6;TLR3;MR1;OAS2
prerank,plasma membrane invagination (GO:0099024),0.5082473717614719,1.2764757022512003,0.16899441340782123,0.8961464321884315,1.0,9/29,15.65%,GSN;GULP1;CDC42;SNX33;SNX18;RHOA;DOCK1;VAMP7;ITGB2
prerank,positive regulation of telomere capping (GO:1904355),0.56742086113732,1.276115335317685,0.20121951219512196,0.895932522769221,1.0,7/17,19.55%,NEK7;NABP2;MAPK15;MAP3K4;TNKS2;PRKCQ;PNKP
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.5514079879661983,1.2760803986473908,0.19970193740685543,0.89435253609686,1.0,2/18,3.81%,AGTR1;GDNF
prerank,anion transmembrane transport (GO:0098656),-0.3295207156288629,-1.2753450314703434,0.08588957055214724,0.6616835498055424,1.0,10/67,6.08%,SLC1A3;SLC6A13;SLC13A3;SLC16A12;LRRC8C;SLC6A9;SLC1A2;SLC7A5;SLC1A1;SLC39A8
prerank,aerobic electron transport chain (GO:0019646),0.4493109822598355,1.2749674467417322,0.14698795180722893,0.8970498028911675,1.0,25/68,21.44%,NDUFV1;NDUFB11;UQCRC2;COX5A;NDUFB8;COX8A;UQCRC1;NDUFB6;NDUFS3;COX7A2L;COX5B;AFG1L;NDUFAB1;NDUFB7;NDUFV2;NDUFA1;UQCR11;NDUFB4;UQCRH;NDUFB5;NDUFB9;COX4I1;COX10;NDUFA2;NDUFA12
prerank,import into cell (GO:0098657),-0.3573458996952453,-1.2748983625950165,0.125,0.6602906079622352,1.0,9/41,10.59%,SLC1A3;SLC6A13;LRRC8C;SLC47A1;SLC7A5;SLC6A6;SLC29A1;SNAP25;LRRC8A
prerank,positive regulation of amyloid-beta formation (GO:1902004),0.5532647905471024,1.2744628641160407,0.21428571428571427,0.8973372690013948,1.0,5/18,13.53%,CLU;EPHA4;ABCA2;SP1;GSK3A
prerank,in utero embryonic development (GO:0001701),0.5203060557855453,1.2742153659130535,0.1721194879089616,0.8965858875564674,1.0,4/25,8.25%,MBNL1;ADAM10;FUT8;PKD1
prerank,rRNA transcription (GO:0009303),0.551309901685535,1.274172600900399,0.20930232558139536,0.8950562736162498,1.0,10/17,24.50%,ANG;POLR1E;GTF3C3;SPIN1;GTF3C2;GTF3C5;GTF3C4;SIRT7;POLR1G;TCOF1
prerank,nerve growth factor signaling pathway (GO:0038180),0.5958894029434048,1.27408915292454,0.20777027027027026,0.8936793357154086,1.0,3/10,3.27%,MAGI2;RAP1A;NGF
prerank,glycolipid biosynthetic process (GO:0009247),0.48379086078477906,1.2740066263123373,0.18227848101265823,0.8923151218026476,1.0,12/38,19.29%,ST3GAL4;PIGU;SCCPDH;A4GALT;LARGE1;PIGZ;PGAP2;PIGA;DPM2;PIGN;PIGP;PIGQ
prerank,regulation of endocytosis (GO:0030100),0.44952194087998715,1.2737627803475082,0.1694915254237288,0.891644546809684,1.0,17/61,17.29%,RAB17;CDH13;SCAMP5;TSC2;STON1;CBLL1;GPC3;RUBCN;LGALS3;OPHN1;SNX33;EPHA3;SNX12;RAB5C;SYT11;ABL1;PACSIN1
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.44191922612145584,1.273730327745838,0.1543134872417983,0.8900739697939332,1.0,20/65,21.18%,FBXL7;FHL1;NABP2;PSMD11;AVEN;PSMD4;PSMF1;ZFYVE19;RBX1;PSMD7;PSMB5;PINX1;VPS4A;INTS3;PSMD1;PSMC4;CDK5RAP3;PSMD8;NABP1;CHFR
prerank,establishment of apical/basal cell polarity (GO:0035089),0.5795925134981837,1.2736402195740233,0.2118380062305296,0.8887373084318716,1.0,7/14,15.74%,MSN;PATJ;CDC42;OPHN1;EZR;RHOA;FSCN1
prerank,response to organophosphorus (GO:0046683),-0.4650757520404902,-1.2734899006970624,0.19210526315789472,0.6617854804868226,1.0,6/16,21.61%,TRPC3;ABCC9;TYMS;RFC3;DGKQ;VGF
prerank,negative regulation of cell motility (GO:2000146),0.4295987714134474,1.2718814933454023,0.13966480446927373,0.8940149096463531,1.0,18/108,8.39%,CDH1;SRGAP3;SRGAP2;KANK1;EPHA4;DAG1;MAGI2;WNT11;SPINT2;FOXO3;DUSP10;PTPRU;TMEFF2;FBLN1;MAPK15;CCDC125;SLURP1;PIP5KL1
prerank,protein hydroxylation (GO:0018126),0.5803786898181833,1.2713715331361135,0.20977917981072555,0.8943143858110597,1.0,1/15,0.09%,EGLN3
prerank,neuromuscular synaptic transmission (GO:0007274),0.5535976809836034,1.2713341854932496,0.18601190476190477,0.8927877303626468,1.0,4/18,6.66%,FCHSD2;STAC3;FCHSD1;KIF1B
prerank,Golgi ribbon formation (GO:0090161),0.5947467396205635,1.2707745919261761,0.1924342105263158,0.89337590315105,1.0,7/13,19.44%,GOLPH3;GCC2;STX16;FHDC1;TMED5;VTI1A;MYO18A
prerank,lipid oxidation (GO:0034440),0.5861256562372141,1.2703549187518293,0.19642857142857142,0.8933527277769543,1.0,2/12,5.07%,PPARGC1A;ALOX5
prerank,positive regulation of hemostasis (GO:1900048),0.6107596799250804,1.270331954317763,0.2182410423452769,0.8901079729094736,1.0,2/10,6.38%,ST3GAL4;DMTN
prerank,positive regulation of coagulation (GO:0050820),0.6107596799250804,1.270331954317763,0.2182410423452769,0.8901079729094736,1.0,2/10,6.38%,ST3GAL4;DMTN
prerank,ventricular cardiac muscle cell action potential (GO:0086005),0.5572595342001097,1.2691678210216648,0.22074074074074074,0.8930443533268376,1.0,1/17,0.66%,ANK2
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.3990136754282409,1.2684352210608225,0.056968463886063074,0.894282729309379,1.0,48/348,10.72%,FN1;WNT16;CLU;ANGPT1;ANK2;ITGB8;NTRK3;ADTRP;KLF4;PPARGC1A;ANKRD31;SMO;HPN;OCLN;GSN;MAGI2;ZC3H12A;WNT11;CELF1;NGF;WNT6;NFE2L2;OLFM1;OVOL2;HOXA5;KRAS;MOV10;SOX9;FOXD1;HCFC1;ZBTB7B;DDRGK1;BMP4;ANK3;MAPK7;ANXA2;RBMS3;MSN;FGF22;MAZ;POU3F1;MAPK9;TLR6;EZR;MUSK;TWIST1;SRPK2;ACTG1
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.5229954065296776,1.2683582235739501,0.17925925925925926,0.8929758055919995,1.0,2/24,2.09%,PRKCB;NIBAN2
prerank,regulation of ossification (GO:0030278),0.48279530004005866,1.2683472371160784,0.1967654986522911,0.8913770600233775,1.0,11/36,14.09%,ANKH;SMAD6;SGMS2;ZBTB16;SOX9;BMP4;TGFB2;TWIST1;PTN;MEF2C;SFRP1
prerank,positive regulation of cellular amide metabolic process (GO:0034250),0.44240982966547593,1.268222226492187,0.14600231749710313,0.890197256414465,1.0,21/80,14.70%,CLU;VIM;EPHA4;SAMD4A;YTHDF1;RPS4X;EIF4A3;UPF3A;EIF6;TNFRSF1A;ABCA2;POLDIP3;SP1;CPEB3;PLXNB2;FXR1;GSK3A;UPF3B;SMPD2;PYM1;PLA2G6
prerank,calcium ion transmembrane import into cytosol (GO:0097553),-0.3649641173716516,-1.2673984834943735,0.13596491228070176,0.6785634408894461,1.0,12/41,14.11%,ITPR1;SLC8A1;SLC8A3;GRIN2A;PKD2;FGF2;GRIN2B;SLC24A2;CHERP;DRD2;HTR2A;RYR2
prerank,eye photoreceptor cell development (GO:0042462),0.5876887626540996,1.2669737509811947,0.21450617283950618,0.893274375242734,1.0,2/15,3.12%,RP1;CRB2
prerank,cellular response to drug (GO:0035690),-0.39928111041042696,-1.266955125527362,0.1482758620689655,0.6771521678231057,1.0,6/25,10.36%,ACER2;GAS6;AIM2;TFRC;PDE4B;TP53
prerank,positive regulation of hydrolase activity (GO:0051345),0.41378482676600037,1.2661423791557687,0.10911016949152542,0.8949926656683841,1.0,32/137,17.28%,MAPRE2;RTN4R;SRGAP2;ARAP1;CCL5;PLXNB1;PKP4;CD200;WNT11;NDEL1;RAP1A;S100A10;CAV2;DVL3;BCAS3;SNX18;SGSM2;RAPGEF3;RHOA;RGS6;ASAP3;SFRP1;GSK3B;HRAS;ARHGAP27;FLCN;USP6NL;RAPGEF1;CTSH;PRTN3;RAP1GAP;F2R
prerank,ribosomal large subunit biogenesis (GO:0042273),0.4662272157203798,1.2658331772072653,0.16321559074299635,0.8945525241139087,1.0,14/54,15.88%,NSA2;NLE1;NOP2;PES1;PPAN;EIF6;MAK16;SDAD1;NIP7;RPL10A;RPF1;HEATR3;PAK1IP1;RPL14
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),-0.5034389977363195,-1.2651217089474596,0.19953051643192488,0.6802196086229819,1.0,10/12,34.24%,PIK3R1;DAB2IP;BCL2L11;BAX;BOK;ERN1;BAK1;XBP1;PTPN1;ATF6
prerank,positive regulation of phagocytosis (GO:0050766),-0.34918117090824763,-1.264721027322178,0.12149532710280374,0.6788330986152588,1.0,10/47,13.19%,PTPRJ;CD47;MERTK;GAS6;IL15RA;APPL2;GATA2;NCKAP1L;LMAN2;CAMK1D
prerank,positive regulation of protein kinase B signaling (GO:0051897),-0.29057362933170233,-1.2643960918131396,0.046875,0.67707650435829,1.0,34/150,12.69%,PDGFRB;HIP1;PTPRJ;TGFA;ENG;PIK3R1;TEK;INSR;KITLG;SEMA5A;PTK2;ESR1;GAS6;AXL;PDGFRA;MFHAS1;KL;FGF2;THBS1;IL18;IGF2;TGFB1;PIK3CB;GAB2;ERBB4;FGFR2;PIK3AP1;PIK3CD;KIT;MYOC;IGF1R;GRB2;TXN;FGFR4
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.44301797865085296,1.2636604176294037,0.1515513126491647,0.9013243222229999,1.0,25/69,21.44%,NDUFV1;NDUFB11;UQCRC2;COX5A;NDUFB8;COX8A;UQCRC1;NDUFB6;NDUFS3;COX7A2L;COX5B;AFG1L;NDUFAB1;NDUFB7;NDUFV2;NDUFA1;UQCR11;NDUFB4;UQCRH;NDUFB5;NDUFB9;COX4I1;COX10;NDUFA2;NDUFA12
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),0.5275464806595802,1.2635309278582991,0.1926040061633282,0.9001824215606723,1.0,6/22,12.29%,SMARCB1;PIH1D1;UBTF;WDR43;SMARCA4;EIF2AK3
prerank,regulation of cellular component organization (GO:0051128),0.4143463586671263,1.2631666892411713,0.1264864864864865,0.899919638320812,1.0,36/135,18.79%,AGTR1;RAB17;CDH13;TJP1;RAP1B;MLLT3;RAP1A;SGK3;LTBP4;TSC2;ROS1;STON1;HCFC1;SSRP1;EGLN2;LATS1;DCUN1D5;OPHN1;SOCS2;MARK4;CHPT1;SNX12;OGFR;BCAR1;RAB5C;NEDD4;RAPGEF1;HSP90AA1;RAB33B;ABL1;PACSIN1;PRKCQ;PTPN11;STK38L;PARK7;ROCK2
prerank,central nervous system neuron differentiation (GO:0021953),-0.3849548403699341,-1.2630060051981482,0.15,0.6788734945930263,1.0,13/33,20.22%,MAP2;GRID2;NTRK2;LRP6;RYK;KNDC1;GBA2;TOX;MDGA2;FAIM2;NR4A2;SPOCK1;CHD5
prerank,fatty acid catabolic process (GO:0009062),0.4428152622495062,1.2627356125855276,0.1617473435655254,0.8999393106314054,1.0,18/67,14.62%,ADTRP;ACOT8;ABCD1;ECHDC1;ACADL;EHHADH;PECR;MTLN;ACAT2;HADHA;PCCA;SLC25A17;CPT2;ECI2;ACADM;AUH;ILVBL;HADHB
prerank,cardiac muscle cell contraction (GO:0086003),-0.43925237763074065,-1.2626741647980455,0.15950920245398773,0.6772737825384775,1.0,7/19,15.43%,CACNA1C;CAMK2D;KCNJ2;CACNA1G;FGF12;SCN1A;SCN1B
prerank,positive regulation of exosomal secretion (GO:1903543),0.5571889142705283,1.2624268241231662,0.23630672926447574,0.8995446289683416,1.0,8/15,18.00%,SDC4;RAB7A;VPS4B;VPS4A;CHMP2A;PDCD6IP;STAM;TSG101
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),0.4847139800551944,1.2618864912607275,0.18995929443690637,0.9000719363497772,1.0,9/35,14.55%,NR3C2;DAXX;DDX5;RBFOX2;EGLN2;KDM3A;CALCOCO1;UBR5;NEDD4
prerank,divalent inorganic cation homeostasis (GO:0072507),0.5105540703890588,1.2617687084088811,0.18075801749271136,0.8989067077447073,1.0,5/25,7.99%,ATP6V1B1;CAV1;SELENON;ANK3;JPH2
prerank,cytoplasmic sequestering of protein (GO:0051220),0.5713347022230363,1.2614056821267163,0.21647819063004847,0.8987041267799546,1.0,9/13,20.66%,NFKBIA;LATS1;PKD1;YWHAB;GET4;FLNA;KEAP1;SUFU;DBN1
prerank,carboxylic acid catabolic process (GO:0046395),0.585301564472374,1.2611268281177401,0.22705314009661837,0.8982125746807952,1.0,3/12,11.30%,ACOT8;NAGK;PON3
prerank,regulation of protein autophosphorylation (GO:0031952),-0.3655777628939425,-1.261085569717477,0.13076923076923078,0.6793492987281393,1.0,5/36,1.90%,ERRFI1;EPHA7;PDGFD;ENG;ENPP1
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",0.6092282348012378,1.2609193561453376,0.2239057239057239,0.8974157572437663,1.0,7/11,30.34%,UQCRC2;UQCRC1;UQCR11;UQCRH;UQCRFS1;UQCRB;UQCC3
prerank,axon development (GO:0061564),-0.32052405093986114,-1.2607423909320186,0.05755395683453238,0.6777483387068612,1.0,28/78,17.78%,MAP1B;SEMA5A;DCC;PAK3;GRM7;NREP;ZDHHC17;BRSK1;NRCAM;EPHB2;CTNNA2;SLITRK1;S100B;DSCAML1;FGFR2;RYK;NTNG1;PLP1;MAPK8IP3;DRD2;CAMSAP2;DHFR;MTR;MAP1A;SLITRK3;EPHB3;ARHGAP35;ATL1
prerank,regulation of MAPK cascade (GO:0043408),0.404251058509052,1.2606636726226825,0.11914893617021277,0.8968962023869308,1.0,20/157,9.95%,FN1;ADRA1B;FGFR1;LPAR1;NTRK3;JCAD;DAG1;LBH;GDF15;CAV1;DUSP1;CAV2;ROS1;SHC1;MYDGF;IQGAP1;ARHGEF5;PTPN6;MAP2K2;PRDM15
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.594050773831713,1.2606515268714429,0.2347417840375587,0.8937391645932335,1.0,6/12,14.36%,HOMER2;HOMER3;RCAN1;CHP1;ATP2B4;GSK3B
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.594050773831713,1.2606515268714429,0.2347417840375587,0.8937391645932335,1.0,6/12,14.36%,HOMER2;HOMER3;RCAN1;CHP1;ATP2B4;GSK3B
prerank,chondrocyte differentiation (GO:0002062),-0.3800905635410067,-1.25958865141735,0.14074074074074075,0.6786259466372664,1.0,10/32,15.14%,SOX5;SULF1;RUNX1;BMPR1B;RUNX2;TGFB1;HMGA2;CCN3;BMPR2;SOX6
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.49686972875023594,1.2592558584446534,0.1865771812080537,0.8977093980385175,1.0,8/33,9.08%,KLF4;CDKN1A;CDK6;FHL1;KANK2;CDK4;PLK3;BRD7
prerank,regulation of endothelial cell proliferation (GO:0001936),-0.31021893833144526,-1.259053225425259,0.04666666666666667,0.6775103115930913,1.0,29/88,14.37%,PTPRM;SULF1;PRKD1;NR2F2;TEK;SEMA5A;HIF1A;VEGFC;PPP1R16B;AKT3;WNT5A;XDH;ACVRL1;TIE1;KDR;FGF2;THBS1;RGCC;ECM1;ATOH8;STAT5A;PIK3CD;NF1;ATP5F1A;PDCD6;FLT4;SPARC;EGFL7;BMPR2
prerank,positive regulation of actin filament depolymerization (GO:0030836),0.6037826685794243,1.2590201297970693,0.22452504317789293,0.8971204822586056,1.0,1/10,1.06%,ACTN2
prerank,regulation of oxidative phosphorylation (GO:0002082),0.5584233528622912,1.2588395809862898,0.21439509954058192,0.8962299002871632,1.0,3/16,9.90%,NUPR1;ABCD1;COX7A2L
prerank,regulation of B cell receptor signaling pathway (GO:0050855),0.5280477342970904,1.2587871633184216,0.18814814814814815,0.8948664920323464,1.0,3/21,7.53%,PRKCB;CD81;NFAM1
prerank,chordate embryonic development (GO:0043009),0.44830063978285284,1.258121652755957,0.15827338129496402,0.8959768882278294,1.0,9/55,8.89%,MBNL1;KIAA1217;FGFR1;ADAM10;WNT11;BMP5;FUT8;PKD1;GRHL2
prerank,gland development (GO:0048732),0.45036909905041106,1.2579205595669116,0.16829268292682928,0.8951808809270679,1.0,12/59,9.58%,COBL;IGSF3;WNT10A;WNT11;CAV1;STRA6;NKX2-8;SOX9;MSN;LSR;SIX1;EZR
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),-0.3722351431085231,-1.2566310661132796,0.1349206349206349,0.6820392040997652,1.0,11/35,9.95%,PDE7B;IRAG1;KSR1;PDE3A;RAPGEF2;PDE4D;GUCY1B1;CAP2;ADCY1;PDE9A;PDE2A
prerank,positive regulation of wound healing (GO:0090303),0.49406846865201615,1.2561689201660524,0.1755829903978052,0.9002481375981937,1.0,9/36,14.36%,KANK1;ST3GAL4;OCLN;FOXC2;DMTN;ACTG1;RREB1;ARFGEF1;HRAS
prerank,negative regulation of lipid catabolic process (GO:0050995),-0.45212578691049465,-1.2559117389698233,0.15337423312883436,0.6817938528463227,1.0,4/17,15.38%,PDE3B;PRKAA1;MFSD2A;SORL1
prerank,steroid catabolic process (GO:0006706),0.6123319733057788,1.2558862646989841,0.2301038062283737,0.8997362442293166,1.0,3/10,19.56%,HSD17B14;HSD17B11;YWHAH
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.43298133318149756,1.2556255611854599,0.17067307692307693,0.8991195578900918,1.0,10/74,8.41%,EGLN3;EP300;NFE2L2;EPO;PSMD11;ELOB;PSMD4;PSMF1;EGLN2;RBX1
prerank,cellular respiration (GO:0045333),0.4654018655778756,1.254775588942032,0.19121447028423771,0.9008947923946781,1.0,21/41,28.57%,PPARGC1A;SDHB;ME3;UQCRC2;MTFR1L;UQCRC1;MTLN;MDH2;SLC25A14;UQCRH;MTFR2;COX10;UQCRFS1;SURF1;ATP5F1D;MTFR1;ETFDH;ETFA;ETFB;NDUFS4;LYRM7
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.4110722189969539,-1.2541843341039212,0.1564625850340136,0.684525004046692,1.0,5/24,4.78%,DMD;PDE4D;CAMK2D;JPH1;PKD2
prerank,cellular response to ketone (GO:1901655),0.4866998851289229,1.253983735018504,0.19241192411924118,0.9023677890543355,1.0,7/35,11.05%,CFTR;PTGFR;MSN;GOLPH3;ADCY6;ADAM15;AQP1
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.42343668572256155,1.2534859361368493,0.15873015873015872,0.9027022969764922,1.0,25/87,20.24%,FBXL7;KLF4;CDKN1A;CDK6;FHL1;KANK2;CDK4;PSMD11;AVEN;PSMD4;PSMF1;RBX1;FBXO5;BRD7;PSMD7;PSMB5;PINX1;PSMD1;PSMC4;WEE1;GPNMB;CDKN2D;PSMD8;RB1;PRMT2
prerank,eosinophil migration (GO:0072677),0.5538709098432867,1.2531964502230633,0.20941558441558442,0.900630952132303,1.0,2/14,8.27%,CCL5;LGALS3
prerank,eosinophil chemotaxis (GO:0048245),0.5538709098432867,1.2531964502230633,0.20941558441558442,0.900630952132303,1.0,2/14,8.27%,CCL5;LGALS3
prerank,cellular component assembly (GO:0022607),0.39859583794585,1.2530341086881953,0.09266802443991853,0.8996992464758419,1.0,45/253,12.08%,REPS2;BAIAP2L1;RP1;PAWR;PPARGC1A;CALD1;PARVA;OCLN;GSN;YTHDF1;LIMS2;EPRS1;PTK2B;BSN;RHOQ;ESPN;ELOB;RTN3;SYCP2;ADD1;SOX9;DMTN;ANK3;ZFYVE27;ILK;MICAL1;GPAA1;AFG3L2;CFAP206;PARD6B;CDC42;LAMC1;PML;PCLO;GRHL2;KMT2A;OPHN1;ACTB;EZR;TLCD2;ACTG1;ZW10;RHOA;YWHAZ;WASF1
prerank,N-terminal protein amino acid acetylation (GO:0006474),0.5699751593301411,1.2528202424896344,0.21406727828746178,0.8989761910791454,1.0,6/16,13.91%,EP300;NAA40;AANAT;NAA15;NAA20;NAA10
prerank,positive regulation of cell population proliferation (GO:0008284),0.3900120754079398,1.2522063201034435,0.040160642570281124,0.8997944472723406,1.0,57/423,8.80%,FN1;DPP4;CDH13;FGFR1;CRLF1;NTRK3;CNOT6;WNT1;LAMC2;TJP1;CCL5;PDGFC;EFNB2;GRK5;CDKN1A;ADAM10;EMP2;S100A6;IL15;PDF;CDK6;CD81;PTGFR;TNFSF13;PTK2B;GDNF;NOP2;HDAC4;BMP5;CLCF1;GCNT2;TIMP1;EPO;CIAO1;DOT1L;NACC1;CDK4;RPS4X;FOXM1;KRAS;SOX9;SHC1;DDRGK1;MAPK15;BMP4;CCND2;ERBB3;TGFB2;BAD;ROMO1;FGF22;MAZ;TCF7L2;FBXO5;SSR1;LAMC1;IL7R
prerank,neuron remodeling (GO:0016322),-0.5266481681935081,-1.2518922229405895,0.19543147208121828,0.6889562719056627,1.0,8/10,32.35%,ADGRB3;ANKS1A;C1QA;EPHA8;CX3CL1;C3;RND1;FARP2
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),-0.4699271722752386,-1.2518508885861592,0.18181818181818182,0.6864734368668437,1.0,13/14,53.05%,IL18;IL17D;PAEP;CD84;CD80;RASGRP1;ISL1;CARD9;IL23A;IL23R;IL12B;IL17F;IL1B
prerank,negative regulation of endothelial cell proliferation (GO:0001937),-0.37863419669582277,-1.2508633933111386,0.15555555555555556,0.6869005129159543,1.0,11/35,11.59%,FLT1;PTPRM;SULF1;NR2F2;XDH;THBS1;RGCC;ATOH8;PPARG;NF1;ATP5F1A
prerank,calcium ion import across plasma membrane (GO:0098703),-0.46858064820543877,-1.2507401336597752,0.18181818181818182,0.6847492719636948,1.0,3/14,8.59%,SLC8A1;SLC8A3;SLC24A2
prerank,regulation of synapse organization (GO:0050807),0.5145115796599651,1.250225057320239,0.21594202898550724,0.9059235852844816,1.0,3/26,1.67%,RAB17;PDLIM5;EPHA4
prerank,positive regulation of autophagy (GO:0010508),0.4309138759924868,1.2501153379301178,0.14651162790697675,0.9048157346602823,1.0,24/81,17.03%,RNF152;PRKAA2;TPCN1;ZC3H12A;FOXO3;SESN2;DAPK1;MTDH;ORMDL3;SH3BP4;TSC2;TRIM21;BAD;PLK3;TFEB;GSK3A;BNIP3L;ULK1;GSK3B;FLCN;PLK2;IKBKG;SESN1;EIF2AK4
prerank,positive regulation of chromatin organization (GO:1905269),0.5967091336383921,1.2497711146247166,0.23684210526315788,0.9045534123664162,1.0,6/12,23.35%,DAXX;ATRX;UBE2N;H3-3A;TERF2;TINF2
prerank,negative regulation of cell migration (GO:0030336),0.4141759333015178,1.2494023239189163,0.12972972972972974,0.904457991374596,1.0,15/137,4.94%,CDH1;PHLDB2;SRGAP3;SRGAP2;ADTRP;KANK1;EPHA4;DAG1;MAGI2;WNT11;FOXO3;DUSP10;TIMP1;PTPRU;TMEFF2
prerank,negative regulation of chemokine production (GO:0032682),0.5585185368890127,1.2493959721140806,0.21583850931677018,0.9029346907236393,1.0,2/14,6.66%,KLF4;MUL1
prerank,negative regulation of neuron death (GO:1901215),0.4233346670257544,1.2483910507104599,0.16018306636155608,0.9051617882347149,1.0,27/93,18.76%,CRLF1;PPARGC1A;NRBP2;CD200;NGF;PTK2B;GDNF;CLCF1;ERBB3;UNC5B;SIX1;CHMP4A;CHMP4B;SOD2;CD200R1;RASA1;MEF2C;SET;GSK3B;EIF4G1;NENF;IKBKG;POU4F1;F2R;PARK7;GPNMB;TOX3
prerank,ureteric bud morphogenesis (GO:0060675),0.5512180790480304,1.2482703189379392,0.22488038277511962,0.9040596194850895,1.0,7/16,13.47%,WNT11;GDNF;BMP4;SIX1;NPNT;GATA3;MYC
prerank,regulation of protein kinase A signaling (GO:0010738),-0.4272387542445793,-1.2480197762138634,0.19093851132686085,0.6903409345788469,1.0,8/20,22.76%,ADGRV1;LRRK2;PRKAR2B;TCIM;PRKAR1B;AKAP7;MIF;IAPP
prerank,regulation of phagocytosis (GO:0050764),-0.33410842599707746,-1.2478840488716674,0.09693877551020408,0.6881474722480352,1.0,21/53,27.64%,CD47;MERTK;TGM2;GAS6;IL15RA;DYSF;GATA2;PLSCR1;RACK1;LMAN2;CAMK1D;ITGAV;SPHK1;DOCK2;PIP4P2;LYAR;HCK;PYCARD;SLC11A1;FGR;FCGR2B
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),0.5341792183734105,1.247423118005688,0.22270742358078602,0.9057485978013771,1.0,10/20,19.87%,MCU;MCUB;PMPCA;MICU1;AFG3L2;MCUR1;LETM1;SLC8B1;SPG7;STOML2
prerank,DNA methylation or demethylation (GO:0044728),0.5336977183805827,1.2473437675685506,0.20298507462686566,0.9029674613952009,1.0,5/19,12.89%,FOS;BEND3;ATRX;DNMT3A;PPM1D
prerank,DNA alkylation (GO:0006305),0.5336977183805827,1.2473437675685506,0.20298507462686566,0.9029674613952009,1.0,5/19,12.89%,FOS;BEND3;ATRX;DNMT3A;PPM1D
prerank,positive regulation by host of viral transcription (GO:0043923),0.5648302659727112,1.2472136558655103,0.24169184290030213,0.901940778332344,1.0,6/15,12.28%,HPN;EP300;SMARCB1;JUN;SMARCA4;SP1
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),-0.544779633584447,-1.2469181833023337,0.2146341463414634,0.6886298782040707,1.0,4/10,16.47%,ESR1;PSMC6;TP53;HMGB1
prerank,reverse cholesterol transport (GO:0043691),0.5809686021008247,1.246526774206883,0.22580645161290322,0.9030192396926938,1.0,1/13,0.40%,CLU
prerank,regulation of sensory perception of pain (GO:0051930),-0.5017518040364858,-1.2465189203324436,0.20844327176781002,0.6873084115038748,1.0,4/11,13.64%,TMEM100;MGLL;ZFHX2;CCN3
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.4345567016471186,1.246462345310671,0.16844602609727166,0.9017330551823928,1.0,19/74,14.09%,PHLDB2;DAG1;HPN;CRB2;PPP2CA;BMP5;GCNT2;OLFM1;OVOL2;SPRED3;TGFB2;TGFB1I1;TWIST1;EPHA3;LDLRAD4;TGFBR2;PDPN;GATA3;SFRP1
prerank,regulation of TORC1 signaling (GO:1903432),0.4916961909795114,1.2463954366781076,0.1896792189679219,0.9004512232423464,1.0,8/33,16.16%,RNF152;SESN2;PIH1D1;SIK3;SMCR8;KPTN;FLCN;SESN1
prerank,cellular response to nerve growth factor stimulus (GO:1990090),0.528410540410051,1.2457869954071639,0.2015151515151515,0.9011505220908896,1.0,9/22,15.29%,NTRK3;MAGI2;RAP1A;NGF;EHD1;RAB35;WASF1;SH3GL2;RAPGEF1
prerank,morphogenesis of an epithelium (GO:0002009),0.5071514364409828,1.245728680111739,0.21830985915492956,0.8998304017135217,1.0,6/25,10.72%,DAG1;WNT10A;LAMA5;SOX9;ACTB;ACTG1
prerank,bone development (GO:0060348),-0.3517367875514077,-1.2456036636536,0.11934156378600823,0.6875319770838726,1.0,13/39,11.38%,SULF1;GNAS;TGM2;SH3PXD2B;CYP26B1;LRP6;LRP5;FGFR2;NOTUM;SFRP4;TP53;DYM;MYOC
prerank,dendrite morphogenesis (GO:0048813),-0.3676467344596729,-1.2451250324811778,0.13818181818181818,0.6863361879893922,1.0,9/35,8.24%,FARP1;MAP2;SHANK3;DOCK10;PAK3;DCDC2;EPHB2;CTNNA2;SDC2
prerank,cellular response to alkaloid (GO:0071312),-0.4328473426572871,-1.2450860686239842,0.1945288753799392,0.6839596706398169,1.0,8/17,23.83%,SLC8A1;TGM2;CASP7;RYR2;BLM;SPIDR;CASQ2;RAD51
prerank,mature B cell differentiation involved in immune response (GO:0002313),0.5847225865187785,1.2438481106726114,0.21981424148606812,0.905397677502118,1.0,2/12,3.61%,NOTCH2;PTK2B
prerank,regulation of blood coagulation (GO:0030193),0.48992829256633197,1.2437656469705305,0.21782178217821782,0.9042018567034177,1.0,5/27,6.38%,ADTRP;ST3GAL4;CAV1;THBD;DMTN
prerank,negative regulation of reproductive process (GO:2000242),-0.431866394659987,-1.2434974402920265,0.2140845070422535,0.6862299822237624,1.0,2/17,0.61%,IGF1;SULF1
prerank,regulation of neurogenesis (GO:0050767),-0.33608691201714824,-1.2434520077433584,0.11398963730569948,0.6839080360204034,1.0,19/55,22.81%,TGM2;NOTCH1;APPL2;B2M;SERPINF1;HEYL;PRUNE1;MME;BHLHE40;SORL1;SOX11;NUMB;OPRM1;YAP1;CX3CL1;CX3CR1;HEY2;HEY1;YTHDF2
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),0.5070959127903034,1.2434478724247213,0.21297602256699577,0.9039125733134463,1.0,1/25,0.15%,CD55
prerank,signal transduction in response to DNA damage (GO:0042770),0.4589317089512965,1.243276507322633,0.19029374201787994,0.9030147013901184,1.0,17/49,17.98%,WNT1;NDRG1;SESN2;DOT1L;USP10;ATRX;DONSON;USP28;CDC5L;PRPF19;ATR;E2F1;HINFP;ABL1;NBN;CHEK2;TRIAP1
prerank,positive regulation of cell differentiation (GO:0045597),-0.2745253053042488,-1.242267799904429,0.03225806451612903,0.6850075842509737,1.0,50/237,10.04%,TCF4;PLCB1;BMP6;SOX5;IGF1;ZEB1;LEF1;PRKD1;PRKCH;COL1A1;RAPGEF2;CDH2;DAB2;KITLG;WNT4;BOC;ZHX3;MEDAG;VWC2;AR;ACVRL1;CD34;KDR;TMEM100;SLC6A6;BMPR1B;RUNX2;BRINP3;IL18;NRCAM;CTNNA2;RGCC;FBN2;PPARD;TGFB1;PKDCC;IL6R;EZH2;GLIPR2;ID2;ACVR2A;AXIN2;NUDT21;TIAM1;HEYL;LRP5;PPARG;BTG1;IMPACT;CCN4
prerank,carbohydrate derivative transport (GO:1901264),-0.4337578782734566,-1.242162555818606,0.19402985074626866,0.6827764220093272,1.0,7/18,19.94%,PLTP;SLC29A1;MFSD2A;CLN3;SLC10A7;SLC15A2;ABCG1
prerank,regulation of glucose metabolic process (GO:0010906),0.4844931577624478,1.241788011201145,0.20303867403314918,0.9071959731499816,1.0,8/34,12.61%,OGT;RORC;PMAIP1;ZNF692;RUBCNL;PDK2;IRS2;FOXK1
prerank,phosphate-containing compound metabolic process (GO:0006796),0.3975154218089985,1.2417534812471203,0.11740473738414006,0.9058175672428915,1.0,19/198,8.04%,PLPPR2;PLB1;NUDT4;PLCB3;LIMK2;PLCD3;DUSP10;PTPRD;PFKP;HKDC1;DUSP12;IP6K1;INPP4A;AGK;SLC20A1;PFKFB2;NADK;PPIP5K2;PPM1A
prerank,detection of calcium ion (GO:0005513),-0.47159026456222236,-1.2413354618816321,0.21899736147757257,0.6827222869236831,1.0,6/13,22.16%,STIM1;SYT1;RYR2;KCNMB4;KCNIP2;CASQ2
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),0.5502058169377757,1.2406350916391315,0.2310077519379845,0.9084158985226212,1.0,6/16,20.04%,ST3GAL4;ALOX5;RHOA;IRAK1;ITGB2;NFAT5
prerank,postreplication repair (GO:0006301),0.4557819664356865,1.240438388236462,0.1911392405063291,0.9076372786642322,1.0,18/45,22.43%,TRIM25;USP10;REV1;POLK;WDR33;UBE2B;PCLAF;RPA3;POLH;POLD2;PCNA;UBE2N;RPS27A;UBC;RFC1;POLN;UBE2V1;NSMCE1
prerank,regulation of myeloid cell differentiation (GO:0045637),0.4412700455467461,1.24026882866747,0.20884520884520885,0.9067737094381302,1.0,10/62,9.03%,PRKCB;EP300;CDK6;PTK2B;ZBTB16;HOXA5;MOV10;EIF6;LGALS3;KMT2A
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),-0.4616943146574608,-1.2402632845677277,0.19023136246786632,0.6833050522079431,1.0,6/13,24.80%,KDR;IL33;JAK2;EDN1;NOD2;NAMPT
prerank,positive regulation of stem cell proliferation (GO:2000648),-0.43976115919848824,-1.2402192837175638,0.18731117824773413,0.6810060217232871,1.0,4/17,16.49%,N4BP2L2;KAT7;HMGA2;SOX11
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),-0.34647966230278365,-1.2392202648658626,0.14492753623188406,0.6815907469172692,1.0,7/45,8.35%,BMP6;RBPMS;ENG;DAB2;ACVRL1;TGFB1;ACVR2A
prerank,muscle organ development (GO:0007517),0.4479079651837783,1.2391367374456892,0.16892725030826142,0.9096708164622627,1.0,14/54,13.83%,UTRN;SGCG;MRAS;SGCA;SGCD;FHL1;LARGE1;COL6A3;MEF2D;EVC;MEF2B;ZBTB42;FXR1;MEF2C
prerank,regulation of cytoskeleton organization (GO:0051493),0.41500210150813205,1.2391264512226312,0.17194570135746606,0.9081927236105778,1.0,19/108,11.76%,PHLDB2;PRKAA2;CELSR1;TJP1;PLXNB1;ARHGAP18;CDK10;DIAPH1;MAP6;RHOQ;EFNA5;DMTN;CAPN2;IQGAP1;ARHGEF5;EZR;DLC1;EPHA3;RHOA
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),-0.4753536301278397,-1.239122558597453,0.18235294117647058,0.6794976252001943,1.0,3/12,4.92%,DMD;ATP1B1;WNK2
prerank,regulation of macromolecule metabolic process (GO:0060255),0.39863959961606654,1.239002061775479,0.1518987341772152,0.907161601163845,1.0,40/170,19.57%,CDH1;PRDM6;TRIM60;LDLR;ZC3H12A;CDK6;AFF3;TBC1D16;GDNF;CGGBP1;YBX3;TRIM44;CDK4;TOB2;TRIM21;NKAP;TXK;TRIM26;TRIM11;MTMR3;KDM6A;TFEB;RASA1;CDK2;CIAO3;TCF19;MYC;PRDM11;FOXP1;ADNP;HINFP;HMG20B;CAVIN4;ZNF462;IGF2BP3;ROCK2;IGF2BP2;APP;FLOT1;PCBP2
prerank,glucosamine-containing compound metabolic process (GO:1901071),0.569145292168892,1.2385781648939722,0.25249169435215946,0.9072807475251408,1.0,3/13,4.29%,NAGK;MGAT3;LARGE1
prerank,microtubule-based transport (GO:0099111),0.5841525443796447,1.23852368168616,0.23482428115015974,0.9059662333316113,1.0,3/12,15.24%,DYNC1I1;SPAG17;ADCY10
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",-0.5231528507627087,-1.2384207457417487,0.20408163265306123,0.679144067488962,1.0,4/10,16.47%,SH3RF1;RUNX1;NCKAP1L;HMGB1
prerank,negative regulation of inclusion body assembly (GO:0090084),-0.523105511880541,-1.2382160390382893,0.20365535248041775,0.6774208993735982,1.0,6/10,31.24%,SACS;DNAJB2;SORL1;DNAJB1;HSPA1B;HSPA2
prerank,negative regulation of cellular process (GO:0048523),0.38495456604538136,1.23757517620812,0.04604604604604605,0.9081801716679317,1.0,113/521,15.42%,WNT16;CDH13;CLU;ZBTB7C;ANGPT1;PTPN14;IGFBP6;SRGAP2;WNT1;KLF4;COL4A3;PLXNB1;PODXL;CDKN1A;ADAM10;SMAD6;NIBAN2;CD200;PLXNA2;CCN2;MAGI2;NUPR1;WNT11;CDK10;CELF1;CDK6;FHL1;SULT2B1;NGF;KANK2;PTK2B;TNFRSF8;SESN2;PPP2CA;BMP5;EPO;PPP1R13B;PTPRU;ALOX5;RIPOR2;CRYAB;S100A11;CD9;DUSP1;RARG;SH3BP4;TSC2;FBLN1;FOXM1;ZBTB17;TES;CGREF1;MUL1;BMP4;OSGIN2;CBLL1;ERBB3;TGFB2;TGFB1I1;SLURP1;NLRP2B;PSRC1;CHMP4B;FBXO5;NDUFS3;ADAMTS1;PML;FOXP3;BRD7;PTPN6;APBB1;NMI;DACT2;RAF1;ABI1;CASK;ADAM15;SOD2;DLC1;GSDME;SMARCA4;VPS4B;EIF2AK3;WDR6;PTPN2;CDKN2AIP;RASA1;PDPN;LPCAT3;PPM1D;GATA3;PLXNB2;CHMP1A;CAPRIN2;MYC;EEF1E1;BTG2;PRDM11;ING4;PINX1;MYBL1;SFRP1;BNIP3L;TGFBR3;DUS2;HRAS;P3H3;FLCN;ITGB1BP1;LMNA;SYT11;ARHGDIB;CHMP2A
prerank,cellular biogenic amine catabolic process (GO:0042402),0.5932323102840189,1.2375731709650777,0.21561969439728354,0.9066970702240862,1.0,2/10,4.89%,SMOX;DMGDH
prerank,regulation of cellular protein metabolic process (GO:0032268),0.45297680474560276,1.2375644166629804,0.20074812967581046,0.9052595805256798,1.0,4/47,5.36%,AGTR1;KLF4;FOXO3;NFKBIA
prerank,regulation of protein localization to membrane (GO:1905475),0.5005658348254376,1.2362397046109586,0.22873082287308227,0.9088225980157235,1.0,8/28,13.87%,GPC6;GPC1;GSN;GPC4;GPC3;ACTB;VTI1B;VPS4A
prerank,high-density lipoprotein particle remodeling (GO:0034375),-0.45571109647710284,-1.23580144769685,0.23303834808259588,0.6822471591857949,1.0,11/15,50.29%,PLTP;ABCG1;LCAT;ABCA5;APOC1;LIPC;PLA2G3;APOM;SCARB1;APOA1;APOE
prerank,positive regulation of vasculogenesis (GO:2001214),-0.5196715106758338,-1.235692596480004,0.20772946859903382,0.6802306914171198,1.0,4/10,4.75%,RAPGEF2;CD34;KDR;TMEM100
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),0.5159850513633482,1.2355706562227573,0.21664275466284075,0.9099045218550237,1.0,14/23,25.44%,NABP2;ZFYVE19;PLK3;ZW10;VPS4A;PLK2;INTS3;ZWINT;WEE1;CDK5RAP3;NABP1;CHFR;PLK5;PABIR1
prerank,regulation of primary metabolic process (GO:0080090),0.4029117834752278,1.2351694024779227,0.1558011049723757,0.9098686101987741,1.0,39/126,20.66%,LDLR;FDFT1;SREBF2;DHCR7;FDPS;HMGCR;PSMD11;PMVK;RUBCNL;PSMD4;PSMF1;AZIN1;CYP51A1;ELOVL6;NFYC;PSMD7;HDAC3;NCOR1;CERS2;ACACA;GPAM;IRS2;FASN;SP1;PSMB5;NCOR2;SQLE;PSMD1;TM7SF2;PSMC4;HMGCS1;ROCK2;PSAP;PSMD8;PRKAB1;SREBF1;OPA3;PRKAB2;ABCA7
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.43546994873924955,1.2344576068589508,0.18424242424242424,0.911081331321279,1.0,6/63,4.18%,NFATC2;CCL5;SASH3;IL15;CD81;CLCF1
prerank,negative regulation of cartilage development (GO:0061037),0.5583076787762755,1.2340564075023408,0.22397476340694006,0.9111503259952374,1.0,4/13,6.72%,ADAMTS7;WNT11;SOX9;EFEMP1
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),0.5918716163860853,1.2334290376875663,0.2364217252396166,0.9119212251277953,1.0,4/10,14.28%,EMC9;EMC10;EMC6;EMC2
prerank,positive regulation of natural killer cell activation (GO:0032816),-0.46494853702567385,-1.2334006765439236,0.1951219512195122,0.68469883989867,1.0,3/13,5.93%,GAS6;AXL;IL18
prerank,regulation of interleukin-12 production (GO:0032655),-0.3362166040664284,-1.2331556368277874,0.0947867298578199,0.6830578353752853,1.0,5/47,5.53%,PLCB1;CD47;LGALS9;THBS1;IRAK3
prerank,regulation of nucleocytoplasmic transport (GO:0046822),0.5789663646547377,1.2317956627333975,0.24915824915824916,0.9169132945683126,1.0,6/12,22.76%,PTPN14;BMP4;NEDD4;AAAS;SIRT7;TPR
prerank,neuromuscular process controlling balance (GO:0050885),-0.48337153786828696,-1.2316722941242073,0.19658119658119658,0.6850343519948967,1.0,4/12,15.15%,NRXN1;PCDH15;TPP1;CLN3
prerank,regulated exocytosis (GO:0045055),0.4022617535456489,1.2314105265438542,0.13636363636363635,0.9168631146735866,1.0,33/173,15.66%,FN1;CD109;CLU;F5;ACTN2;PHACTR2;SYTL4;OTOF;SCCPDH;TIMP1;CD9;ANXA5;TEX264;TGFB2;SRGN;STXBP1;DNAJC5;SYNGR3;VEGFB;PCLO;STEAP2;HABP4;RAB11FIP5;VTI1B;OLA1;SYT6;VAMP7;ALDOA;SYT11;SYT12;RAB11FIP1;ACTN4;FLNA
prerank,mitochondrial membrane organization (GO:0007006),0.4827952583498492,1.2305424249998855,0.22043010752688172,0.918660302475109,1.0,12/32,18.45%,PMAIP1;CHCHD3;MICOS13;BCL2L1;BAD;MICOS10;OPA1;APOO;IMMT;SLC25A4;MTX1;SPG7
prerank,monocarboxylic acid transport (GO:0015718),-0.32700146200086666,-1.230310560198185,0.1267605633802817,0.6869202539673445,1.0,12/51,7.94%,SLC6A13;SLC16A12;ABCC4;SLCO2B1;SLCO1C1;SLC6A12;NCOA1;SLCO3A1;SLC16A9;SLC16A6;SLC16A1;SLC16A4
prerank,smooth muscle cell differentiation (GO:0051145),-0.4997571635004011,-1.2302301694913897,0.22448979591836735,0.6848003217912996,1.0,9/12,22.26%,MRTFB;TBX18;TMEM204;GATA6;EDNRB;MYOCD;HEY2;APLNR;HEY1
prerank,plasma membrane organization (GO:0007009),0.44818842147527366,1.2299822113095522,0.19597989949748743,0.9194269445992402,1.0,20/61,18.13%,ANK2;AHNAK2;SYTL4;ABCD1;CXCR4;OTOF;A4GALT;CAVIN2;ANK3;CHMP4A;TLCD2;SNX33;PLSCR3;ANO6;FER1L6;SYT11;NSF;PACSIN1;STX4;OSBPL2
prerank,regulation of Ras protein signal transduction (GO:0046578),0.4231902761355308,1.2299449103352398,0.1839080459770115,0.9180648667609441,1.0,23/86,12.78%,STK19;NOTCH2;KANK1;OGT;AKAP13;EPS8L2;NGF;KANK2;EPO;DENND3;RASAL3;FOXM1;ARHGEF18;SHC1;TGFB2;BCR;OPHN1;RAF1;DLC1;IRS2;RABL3;MAPKAP1;SYNGAP1
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.42348506112063583,1.2298622468778426,0.18085106382978725,0.9169325596949933,1.0,14/69,11.76%,PITPNM2;FGFR1;PLCL2;PLCB3;PLCD3;OGT;NGF;PIK3C2B;PLCL1;ERBB3;PI4KA;EZR;IRS2;RHOA
prerank,retina homeostasis (GO:0001895),0.5116046690841041,1.2289398228043134,0.2315340909090909,0.918976641423373,1.0,9/23,20.93%,CRB2;HSPB1;POTEF;ACTB;ACTG1;CNGB1;CDH3;JCHAIN;TULP1
prerank,negative regulation of amyloid-beta formation (GO:1902430),0.5301413893448035,1.2288009185797149,0.24294670846394983,0.9179946881033801,1.0,3/17,5.96%,CLU;RTN1;RTN3
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.48308511386545855,1.2286536113318287,0.21657754010695188,0.9170699657829537,1.0,8/33,12.94%,KLF5;KLF4;FOXO3;FOS;TGFB2;JUN;SMARCA4;GATA3
prerank,positive regulation of cellular metabolic process (GO:0031325),0.4136107419577791,1.2285851905959506,0.16947250280583614,0.9158829510337977,1.0,20/98,14.93%,AGTR1;ANGPT1;KLF4;CCL5;CDKN1A;HPN;MAGI2;ZC3H12A;DHRS4;NFKBIA;ANXA2;ROMO1;ACACA;STARD4;FASN;TGFBR2;GATA3;RAB1B;EIF4G1;DCXR
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),-0.47902294513039306,-1.228382964339399,0.24310776942355888,0.6879738637353565,1.0,10/12,49.69%,IL18;IL17D;PAEP;CD80;RASGRP1;ISL1;CARD9;IL23A;IL23R;IL12B
prerank,sodium ion export across plasma membrane (GO:0036376),0.5543214260422503,1.228222931879347,0.2534351145038168,0.9157828042698073,1.0,7/13,21.09%,ATP1A2;SLC4A4;SLC9A1;ATP1B3;ATP1A3;ATP1A4;ATP1A1
prerank,reticulophagy (GO:0061709),0.5847409376353777,1.2272641368302406,0.2476038338658147,0.9178995208115781,1.0,5/12,16.23%,DDRGK1;TEX264;ULK1;RB1CC1;UFM1
prerank,negative regulation of supramolecular fiber organization (GO:1902904),0.4293920036015963,1.2271726940768823,0.16765755053507728,0.9167611090615774,1.0,9/72,6.27%,FGF13;CLU;KANK1;LDLR;SSH3;PFDN1;CRYAB;TWF1;EML2
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.5823879052907265,1.2270119670790478,0.2368839427662957,0.9159403770570816,1.0,5/13,18.47%,DCTPP1;UPP2;MBD4;NEIL1;NT5M
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.4141119393218812,1.2267353254138824,0.20115606936416186,0.9155019946184368,1.0,13/86,10.46%,EGLN3;EP300;NFE2L2;EPO;PSMD11;ELOB;MAPK7;PSMD4;PSMF1;EGLN2;RBX1;BAG3;PSMD7
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),0.583580240416729,1.2266367879561346,0.2571884984025559,0.914390085755538,1.0,6/11,27.44%,NAGK;UAP1L1;GFPT1;GNPDA2;UAP1;PGM3
prerank,collagen fibril organization (GO:0030199),0.4235792373727391,1.225986785879839,0.17925591882750846,0.915389623225609,1.0,12/88,7.38%,ITGB4;ADAMTS14;COL23A1;COL25A1;LAMC2;COL4A3;COL4A4;COL5A2;COL6A1;COL6A3;PXDN;TGFB2
prerank,positive regulation of B cell proliferation (GO:0030890),0.4959229715321564,1.2251103911326706,0.24686192468619247,0.9171983675950193,1.0,4/29,4.18%,NFATC2;SASH3;CD81;CLCF1
prerank,calcium ion import into cytosol (GO:1902656),-0.45144491204421144,-1.2248961893536134,0.20994475138121546,0.6960992164283847,1.0,3/15,8.59%,SLC8A1;SLC8A3;SLC24A2
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),0.5179867596688033,1.2248334335898114,0.23903177004538578,0.9167842524261615,1.0,1/20,0.14%,NT5E
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),0.470604883854049,1.224776573953233,0.2071611253196931,0.9155460007737884,1.0,5/39,6.82%,FGF13;UTRN;SLMAP;STK39;ANK3
prerank,respiratory electron transport chain (GO:0022904),0.5568587926061284,1.224610301332105,0.24924012158054712,0.9147549258713301,1.0,2/14,4.01%,PPARGC1A;SDHB
prerank,positive regulation of T cell proliferation (GO:0042102),-0.3322566514198973,-1.2243482978073559,0.13658536585365855,0.6953607066036251,1.0,11/55,12.36%,IGF1;IGFBP2;NCK2;VCAM1;IL18;TFRC;IGF2;CD46;NCKAP1L;PNP;IL6ST
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),-0.5183610250098398,-1.2243051613820697,0.22033898305084745,0.6931170697055027,1.0,4/10,27.17%,LYN;KIT;CD40;FGR
prerank,prostanoid biosynthetic process (GO:0046457),-0.45960036101624197,-1.224130793522951,0.21703296703296704,0.6912417093907128,1.0,8/15,19.88%,PLA2G4A;PTGIS;PTGS2;PNPLA8;PTGES;EDN1;CD74;MIF
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.4154797770538222,1.224127441780424,0.18436406067677946,0.9152006075528607,1.0,14/80,11.05%,CD44;NLRP2;KLF4;MAP3K5;UACA;PMAIP1;NGF;DAPK1;BAD;RAF1;ARL6IP5;BCAP31;CARD16;AQP1
prerank,chromatin assembly (GO:0031497),0.4654847035699633,1.2240292539406692,0.22609819121447028,0.9141620345421699,1.0,6/38,8.07%,DAXX;GRWD1;ASF1A;SOX9;KAT6B;ATRX
prerank,dendritic cell migration (GO:0036336),0.5370172721359094,1.2237377262334421,0.24121405750798722,0.9138895050883011,1.0,5/16,13.39%,CCL5;CXCR4;ALOX5;TRPM4;TRPM2
prerank,positive regulation of lipid localization (GO:1905954),0.5954837087885061,1.223529023561988,0.24270353302611367,0.9132238372985714,1.0,2/11,2.72%,ZC3H12A;IKBKE
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.5064568478936342,1.2235050335082505,0.22953216374269006,0.9104931158320093,1.0,7/23,11.77%,BBC3;PMAIP1;PPP1R13B;BAD;YWHAB;YWHAQ;YWHAZ
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.5064568478936342,1.2235050335082505,0.22953216374269006,0.9104931158320093,1.0,7/23,11.77%,BBC3;PMAIP1;PPP1R13B;BAD;YWHAB;YWHAQ;YWHAZ
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.4426204079789452,1.2234003024044324,0.20771144278606965,0.9094977064382317,1.0,10/57,10.39%,CYFIP2;NLRP2;MAP3K5;UACA;PMAIP1;DAPK1;PERP;BAD;ARL6IP5;BCAP31
prerank,mitochondrial transport (GO:0006839),0.4506168364517368,1.2231963753313813,0.19923857868020303,0.9088630155321619,1.0,25/53,26.60%,STARD3;PMAIP1;TIMM10;TIMM44;BCL2L1;TOMM5;BAD;PITRM1;BCAP31;TOMM20;TIMM17B;HSP90AA1;SLC25A4;TMEM14C;SPG7;TIMM9;TOMM40;TSPO;FLVCR1;TIMM23;AIP;MAIP1;ABCB10;MTX2;FBXO7
prerank,regulation of nitric-oxide synthase activity (GO:0050999),-0.35479535323386147,-1.223170982871699,0.14682539682539683,0.6919791443072363,1.0,11/36,14.58%,HIF1A;NPR3;NOS3;NOSTRIN;NOS1AP;NOSIP;PIK3CB;GCH1;CYGB;SPR;DHFR
prerank,N-acetylglucosamine metabolic process (GO:0006044),0.546546743375018,1.2230649197893264,0.24088748019017434,0.9079609417298086,1.0,3/15,4.29%,NAGK;MGAT3;LARGE1
prerank,toll-like receptor 9 signaling pathway (GO:0034162),-0.46839827711188864,-1.2227686198402936,0.24274406332453827,0.6908727624249478,1.0,6/13,16.00%,IRAK2;PIK3AP1;TRAF6;UNC93B1;PIK3C3;TLR7
prerank,positive regulation of epithelial cell migration (GO:0010634),0.4149069534736913,1.2227308287738288,0.18501702610669693,0.9078423263694864,1.0,22/92,14.84%,ANGPT1;MAPRE2;DOCK5;ANXA3;MMP9;ZC3H12A;GFUS;PTK2B;FOXC2;SOX9;BMP4;TGFB2;EMC10;NRP2;BCAS3;BCAR1;GATA3;DOCK1;RREB1;FOXP1;AAMP;ITGB1BP1
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),-0.45566169745752294,-1.2223516845639548,0.20958083832335328,0.689787356775644,1.0,6/15,19.85%,RUVBL1;DKC1;CCT7;CCT2;CCT4;NOP10
prerank,negative regulation of stem cell differentiation (GO:2000737),-0.4682613539183753,-1.222306237998398,0.24653739612188366,0.687609839483328,1.0,3/12,5.69%,JAG1;NOTCH1;N4BP2L2
prerank,negative regulation of heart contraction (GO:0045822),0.5791564830129851,1.2216285529045603,0.2463768115942029,0.9103632113249618,1.0,3/11,10.67%,ZC3H12A;ATP1A2;GRK2
prerank,brain morphogenesis (GO:0048854),-0.47881254600184403,-1.2210950203092767,0.22443890274314215,0.6888754743874209,1.0,7/12,25.04%,SHANK3;CTNNA2;SPEF2;BBS4;VPS51;PAX2;PTEN
prerank,regulation of viral release from host cell (GO:1902186),0.5171193827911614,1.2210648178356573,0.23269513991163476,0.9110808048466781,1.0,10/21,18.00%,TRIM25;VPS37B;TRIM21;PML;TRIM26;TRIM11;VPS4A;CHMP2A;DDB1;TSG101
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.4832209434211965,1.22102235919209,0.22540983606557377,0.9098321079889459,1.0,7/31,11.50%,FDFT1;MOCS3;ALOX5;CYP51A1;NFS1;PYCR3;NOXRED1
prerank,regulation of lymphocyte activation (GO:0051249),0.5590770478027794,1.2208111116087328,0.25811688311688313,0.9092913370449832,1.0,1/12,1.51%,CCL5
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.42479606766942396,1.220607037445693,0.17046818727490998,0.9086698766904909,1.0,19/69,18.76%,CRLF1;PPARGC1A;NRBP2;NGF;PTK2B;GDNF;CLCF1;ERBB3;UNC5B;SIX1;SOD2;RASA1;MEF2C;SET;ZPR1;POU4F1;F2R;PARK7;TOX3
prerank,negative regulation of response to external stimulus (GO:0032102),0.4074621553496146,1.2201603382158077,0.16572077185017026,0.9088984255707391,1.0,28/105,20.25%,CD109;RTN4R;KLF4;EPHA4;PPM1B;ALOX5;MUL1;MAPK7;TRIM21;FEM1A;TNFRSF1A;NMI;CASK;CARD16;CERS2;PTPN2;LPCAT3;GATA3;CRK;CDH5;DUSP3;FNDC4;OTULIN;ILRUN;GPER1;PCBP2;RB1;RTN4RL1
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),0.5918498725548895,1.2200156570497893,0.25,0.9066863346736679,1.0,5/10,17.29%,NUPR1;HDAC4;TIGAR;NCOR1;GIT1
prerank,negative regulation of glycolytic process (GO:0045820),0.5918498725548895,1.2200156570497893,0.25,0.9066863346736679,1.0,5/10,17.29%,NUPR1;HDAC4;TIGAR;NCOR1;GIT1
prerank,beta-catenin destruction complex disassembly (GO:1904886),0.5162948804610716,1.2191378974025482,0.23884892086330936,0.9085431742507566,1.0,4/21,8.36%,WNT1;CAV1;DVL3;FZD5
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.5157404396424787,1.2189584978239592,0.2398843930635838,0.9077868395683472,1.0,4/19,15.53%,EP300;PHLDA3;PML;USP28
prerank,diol metabolic process (GO:0034311),-0.4262635423225168,-1.2184546182724065,0.21036585365853658,0.6945077169469765,1.0,9/19,27.72%,NOS3;DEGS2;GCH1;SPR;SGPP1;SPHK1;PLPP3;ASAH2;PLPP2
prerank,bicarbonate transport (GO:0015701),0.4967101709003338,1.2182095859432516,0.22827687776141384,0.909099935920455,1.0,3/25,6.79%,CFTR;SLC4A2;CYB5RL
prerank,modulation by symbiont of entry into host (GO:0052372),0.5460164907585048,1.2178846022480165,0.25,0.9088399278646118,1.0,5/16,10.47%,CAV1;TRIM25;TRIM21;EXOC7;EXOC2
prerank,central nervous system neuron axonogenesis (GO:0021955),-0.4927902048212949,-1.2175774329778049,0.24193548387096775,0.6947542430152936,1.0,11/12,38.06%,EPHB2;B4GALT5;ARHGAP35;HSP90AB1;MYCBP2;PTEN;EPHB6;EPHB1;CHRNB2;SPTBN4;B4GALT6
prerank,receptor signaling pathway via STAT (GO:0097696),-0.3909199517804296,-1.2174411756062353,0.16666666666666666,0.6928327201426021,1.0,9/25,13.69%,GHR;IL31RA;STAT5B;PKD2;IFNAR2;JAK2;STAT5A;STAT3;STAT6
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),-0.3033739706090825,-1.2173410157491853,0.09565217391304348,0.6908472728398535,1.0,15/86,8.56%,BMP6;RBPMS;ZEB2;SULF1;ENG;DAB2;ACVRL1;NOTCH1;BMPR1B;THBS1;ACVR1B;TGFB1;JAK2;ACVR2A;ING2
prerank,neurotransmitter transport (GO:0006836),-0.32035865871069624,-1.2171699079963754,0.15333333333333332,0.6891036258160064,1.0,14/73,10.46%,SLC1A3;UNC13B;NRXN1;LIN7A;SLC1A2;BRSK1;SLC1A1;SYT1;PPFIA2;SLC29A1;SNAPIN;APBA1;SLC17A6;SNAP25
prerank,DNA damage checkpoint signaling (GO:0000077),0.470559123833336,1.2170808860635205,0.23705722070844687,0.9103839673065575,1.0,14/28,27.29%,DOT1L;DONSON;USP28;CDC5L;PRPF19;ATR;E2F1;HINFP;NBN;CHEK2;TIPRL;RAD9A;STK33;CEP63
prerank,protein tetramerization (GO:0051262),-0.3187396930710948,-1.2166146601951988,0.16993464052287582,0.6885348671474054,1.0,21/67,15.50%,ALDH1A2;PKD2;OXA1L;APPL2;GBP5;GRIN2B;HPRT1;KCNJ2;B2M;UPB1;MCOLN1;NUDT21;SAMHD1;AQP4;ALDH9A1;CPSF6;KCNJ12;GOLGA2;CBY1;KCNC1;ACACB
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.5092245363689484,1.2161537775703677,0.23768115942028986,0.9123986632063694,1.0,8/23,17.29%,NUPR1;EP300;HDAC4;TIGAR;NCOR1;GSK3A;PGP;GIT1
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.4158018375808954,1.2158305130770268,0.18953488372093022,0.9121693948812896,1.0,12/75,10.16%,AGTR1;CDH13;FGFR1;JCAD;NRAS;AGGF1;MYDGF;BMP4;ANG;VEGFB;EMC10;NRP2
prerank,regulation of DNA recombination at telomere (GO:0072695),0.5254822316139381,1.2157855123508605,0.23065476190476192,0.9095686426231746,1.0,4/19,8.07%,DAXX;POLR2H;POLR2A;ATRX
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.5254822316139381,1.2157855123508605,0.23065476190476192,0.9095686426231746,1.0,4/19,8.07%,DAXX;POLR2H;POLR2A;ATRX
prerank,xenobiotic transport (GO:0042908),-0.4333934560557591,-1.2157632834654777,0.22802197802197802,0.688905510232331,1.0,9/17,31.40%,SLC47A1;SLC7A5;ABCA3;SLC15A2;ABCC3;SLC22A2;ABCG2;SLC22A3;ABCC1
prerank,zymogen activation (GO:0031638),0.4673453418817775,1.215463714280921,0.21251629726205998,0.9094657718648441,1.0,8/39,10.78%,CYFIP2;PRSS12;PERP;KLKB1;BAD;KLK1;HP;HPR
prerank,positive regulation of kinase activity (GO:0033674),-0.2830992344941095,-1.2151780374749162,0.09821428571428571,0.6885512554837524,1.0,32/107,13.71%,FLT1;PRKAG2;ROR1;PDGFRB;EPHA7;TEK;RAPGEF2;INSR;MERTK;PTK2;GAS6;AXL;TIE1;PDGFRA;KDR;EPHB2;EPHB4;ROR2;NTRK2;ERBB4;FGFR2;RYK;KIT;ALS2;IGF1R;CCN1;FGFR4;SPDYA;MMD;FLT4;RET;EPHA5
prerank,sulfur compound biosynthetic process (GO:0044272),0.4094065394329846,1.2145552655108123,0.1873589164785553,0.911427905415766,1.0,18/104,12.32%,UST;ANGPT1;ST3GAL4;CHST12;B4GAT1;HAGH;DSE;CHST11;PRELP;CHPF;MGST3;GSTO1;MAT2B;HPGDS;CHST13;CDO1;CHPF2;ST3GAL6
prerank,establishment of protein localization to plasma membrane (GO:0061951),0.47135530438233003,1.2144123669249536,0.22636484687083888,0.9105474059807582,1.0,9/36,10.43%,NECTIN3;AMN;KIF13A;ANK3;GOLPH3;GCC2;RAB7A;GOLGA7;GGA1
prerank,nucleotide-sugar metabolic process (GO:0009225),0.5583397730276043,1.2143124719077107,0.26953748006379585,0.9095638634728048,1.0,3/12,5.86%,B4GALNT2;GFUS;FUT8
prerank,steroid biosynthetic process (GO:0006694),0.4376312941556971,1.2137608326795142,0.22007255139056833,0.9103013269439896,1.0,11/56,11.13%,FDFT1;OSBPL9;ACOT8;DHCR7;HMGCR;INSIG1;PMVK;CYP39A1;CYP51A1;MSMO1;OSBPL7
prerank,positive regulation of supramolecular fiber organization (GO:1902905),0.4209215841761129,1.2135956952999218,0.186307519640853,0.9096579551486789,1.0,8/86,5.14%,CLU;BAIAP2L1;OCLN;CDC42EP4;PTK2B;FCHSD2;CDC42EP5;FCHSD1
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),-0.45948859176786433,-1.213540324177647,0.25936599423631124,0.6910537711456048,1.0,6/14,23.18%,ENTPD1;NUDT1;ENTPD3;ENTPD5;ENTPD6;NUDT16
prerank,cell projection assembly (GO:0030031),0.5004704161617608,1.2133484522194073,0.22159887798036465,0.9092461778495496,1.0,5/22,13.42%,PARVA;GSN;RHOQ;CDC42;RHOU
prerank,protein import into mitochondrial matrix (GO:0030150),0.5377474917740983,1.2130573305643213,0.23208722741433022,0.909008737062271,1.0,9/18,22.77%,TIMM44;DNLZ;ROMO1;TOMM20;TIMM17B;TOMM40L;TOMM40;TIMM50;TIMM23
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),-0.429131056602008,-1.21305706805748,0.2276923076923077,0.6901728123863151,1.0,8/18,25.39%,RUVBL1;DKC1;PARN;CCT7;CCT2;CCT4;NOP10;DCP2
prerank,glycosaminoglycan metabolic process (GO:0030203),0.4369472796406094,1.2129980733634418,0.21544209215442092,0.90787818543589,1.0,11/54,10.09%,GPC6;GPC1;HEXA;GPC4;GCNT2;NAGLU;SDC4;GLB1;GPC3;EXT1;GUSB
prerank,N-glycan processing (GO:0006491),-0.4184320210067002,-1.2128761903804988,0.2012012012012012,0.688533161434777,1.0,7/18,17.07%,MAN1C1;ST8SIA4;MGAT4A;ST8SIA6;MAN2A1;ST8SIA5;ST8SIA2
prerank,positive regulation of lymphocyte differentiation (GO:0045621),-0.42987297280094977,-1.2125464117359879,0.221875,0.6872541360715639,1.0,10/19,30.54%,ZMIZ1;GAS6;AXL;NCKAP1L;CD27;RHOH;BTK;IL7;XBP1;PRKDC
prerank,establishment of epithelial cell polarity (GO:0090162),0.5201702032255336,1.212119124331409,0.2570162481536189,0.9097234976474398,1.0,8/19,19.69%,MSN;GOLPH3;CDC42;OPHN1;EZR;RHOA;MYO18A;PARD3
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.48441404875899824,1.2118892110503616,0.23433242506811988,0.909206534034464,1.0,7/31,9.08%,KLF4;CDKN1A;CDK6;FHL1;KANK2;CDK4;BRD7
prerank,regulation of neuroblast proliferation (GO:1902692),-0.4512839244076929,-1.211827682814997,0.19692307692307692,0.6871208479113421,1.0,7/15,20.54%,SMARCD3;LRRK2;NF1;TAFA1;DRD2;CX3CL1;CX3CR1
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),-0.48141770104119846,-1.211602613921519,0.24871794871794872,0.6855838182192227,1.0,3/12,3.42%,PDE4D;GJD3;CAMK2D
prerank,regulation of protein catabolic process (GO:0042176),0.40775733009146226,1.2106373288883288,0.19308035714285715,0.9123622819545524,1.0,26/99,19.52%,FZR1;EEF1A1;WWP2;HMGCR;EGLN2;GPC3;AZIN1;CYP51A1;RAB7A;BANP;SF3B3;SNX12;WDR91;GSK3A;GSK3B;NEDD4;MDM2;PLK2;FLNA;CENATAC;DDB1;NSF;CHEK2;RNF41;IDE;ASB5
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.549964894199501,1.2106120287515492,0.2496124031007752,0.911110089663273,1.0,6/14,20.08%,ACOT8;ABCD1;EHHADH;ECI2;DECR2;CRAT
prerank,protein-containing complex assembly (GO:0065003),0.3860277900846782,1.2101751851857618,0.12244897959183673,0.9114380651349441,1.0,54/259,15.47%,FN1;REPS2;FBXL7;F5;PPARGC1A;ADAM10;OCLN;ZC3H12A;CAND2;EP300;PEF1;EPRS1;MCU;PTK2B;PPP6R3;PYGO2;TFG;ELOB;CTSZ;SOX9;DMTN;BAD;TRAPPC9;GPAA1;AFG3L2;PARD6B;RBX1;TCF7L2;LAMC1;PML;TNFRSF1A;KMT2A;TLE2;ZW10;SMARCA4;TLE4;TRAPPC1;MCFD2;WASF1;ANO6;NAPA;OPA1;MYC;PREB;RAB1B;GSK3B;CNIH1;DNM1L;ITGB1BP1;SEC23A;ANKRD28;MDM2;DHX9;IKBKG
prerank,protein polyglutamylation (GO:0018095),-0.49453907293566085,-1.209723672222329,0.2340966921119593,0.6890758362074146,1.0,7/11,29.38%,TTLL4;TTLL11;CFAP20;TTLL5;CEP41;TTLL7;TTLL6
prerank,negative regulation of translation (GO:0017148),0.4172180837730898,1.2094547461771985,0.203125,0.9127549600424688,1.0,25/87,19.01%,SAMD4A;CPEB2;YTHDF1;SAMD4B;CELF1;EPRS1;DAPK3;DAPK1;UNK;EIF4A3;EIF4EBP1;SHMT1;EIF2AK3;CPEB3;SYNCRIP;FXR1;BTG2;GAPDH;MEX3D;EIF2AK4;IGF2BP3;YTHDF3;ROCK2;EIF4EBP2;IGF2BP2
prerank,protein targeting to lysosome (GO:0006622),0.511676033026103,1.2094248543756565,0.2430453879941435,0.9115121011838448,1.0,10/20,23.30%,CLU;GCC2;RAB7A;VPS4A;NEDD4;SNX16;AP3M1;M6PR;AP4M1;NCOA4
prerank,iron ion transmembrane transport (GO:0034755),-0.5088842787084068,-1.2093404337922498,0.256857855361596,0.6880161152765237,1.0,3/10,6.08%,SCARA5;SLC40A1;SLC39A8
prerank,dephosphorylation (GO:0016311),0.3943428901807831,1.2089137004716854,0.1657754010695187,0.9120293050579454,1.0,16/147,8.04%,PLPPR2;PTPN14;PPM1L;PPP2CA;DUSP10;PPM1B;PTPRU;PTPRD;DUSP12;DUSP1;UBLCP1;PTPRF;PTPN9;PTPRA;PP2D1;PPM1A
prerank,negative regulation of protein localization to nucleus (GO:1900181),0.5218967105541465,1.2087142768268553,0.233587786259542,0.9114297091670143,1.0,11/18,23.61%,CTNNA1;OTUD7B;LATS1;CHP1;GSK3B;FLCN;UFM1;SUFU;ILRUN;RAB23;LATS2
prerank,negative regulation of osteoblast differentiation (GO:0045668),0.4743889198473556,1.208667943322404,0.2609853528628495,0.9102641258488956,1.0,7/31,11.35%,RANBP3L;SMAD6;CRIM1;CDK6;SOX9;TWIST1;TRPM4
prerank,regulation of heart rate by cardiac conduction (GO:0086091),0.4618691538373109,1.20747187549888,0.24335106382978725,0.9131691892188912,1.0,7/38,13.02%,DSG2;ANK2;CAV1;DSC2;TRPM4;KCNA5;CACNB2
prerank,positive regulation of protein polymerization (GO:0032273),0.43429293203583663,1.2064258980572122,0.19647058823529412,0.9157116043053792,1.0,7/65,5.14%,BAIAP2L1;OCLN;CDC42EP4;PTK2B;FCHSD2;CDC42EP5;FCHSD1
prerank,cellular response to interleukin-15 (GO:0071350),-0.4820650786775971,-1.2057693193593428,0.24079320113314448,0.6941780163983782,1.0,6/13,12.27%,PLCB1;STAT5B;IL15RA;STAT5A;STAT3;GRB2
prerank,interleukin-15-mediated signaling pathway (GO:0035723),-0.4820650786775971,-1.2057693193593428,0.24079320113314448,0.6941780163983782,1.0,6/13,12.27%,PLCB1;STAT5B;IL15RA;STAT5A;STAT3;GRB2
prerank,embryonic digestive tract development (GO:0048566),-0.43462766649735235,-1.2055543165551736,0.22674418604651161,0.6926080659961162,1.0,8/18,9.11%,PCSK5;GLI2;RARB;PDGFRA;SALL1;PKDCC;ID2;FGFR2
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.5382269837755608,1.2052623550480752,0.24397590361445784,0.9187017141592351,1.0,3/16,4.13%,IGFBP6;WNT1;BMP5
prerank,protein insertion into mitochondrial membrane (GO:0051204),0.4923732831432334,1.2052294037008768,0.250733137829912,0.9174787829877998,1.0,6/23,8.23%,PMAIP1;TIMM10;AGK;BAD;ROMO1;HSPA4
prerank,positive regulation of DNA replication (GO:0045740),-0.44620093789545584,-1.2049729862317702,0.23100303951367782,0.6922586812901967,1.0,9/16,27.16%,GLI2;KAT7;GLI1;BCAR3;EGF;CTC1;STN1;FAF1;EGFR
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),0.47507929585127806,1.204784791279107,0.24792243767313019,0.9177421535254543,1.0,13/29,23.35%,PPP6R3;MRE11;GAR1;CDK2;PINX1;ANKRD28;HSP90AA1;RAD50;RFC1;TERF2;PTGES3;SHQ1;TINF2
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),0.5867285064538595,1.204443820878639,0.2684124386252046,0.9176108001672292,1.0,5/10,11.76%,MSN;CDC42;OPHN1;EZR;RHOA
prerank,establishment of vesicle localization (GO:0051650),0.5263285612132306,1.2041227601066251,0.25,0.9174351570612463,1.0,7/18,19.22%,LIMK2;TOR1A;TMEM230;SYT11;IKBKG;TESK1;RAB27A
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),-0.41205147077859916,-1.2038545429977563,0.2138157894736842,0.6934746098661038,1.0,5/21,6.00%,PLA2G4A;OSBPL10;MBOAT1;PLA1A;PLAAT3
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),-0.4695496673836045,-1.2034418780676122,0.23699421965317918,0.6926031766610515,1.0,7/13,27.99%,DDIT3;TMSB4X;SOX11;HEY2;HEY1;SIN3A;TAF1
prerank,negative regulation of phagocytosis (GO:0050765),-0.4264583118773545,-1.2032873377110427,0.23595505617977527,0.6909353192366973,1.0,6/17,16.47%,CD47;DYSF;PLSCR1;RACK1;CD300A;HMGB1
prerank,spinal cord development (GO:0021510),-0.47943362642735016,-1.2032110553080104,0.2702702702702703,0.6890560346097627,1.0,7/12,18.78%,GLI2;PKD2;LOXL3;VIT;NF1;SOX11;SOX12
prerank,chemical synaptic transmission (GO:0007268),-0.25977531252340946,-1.202587615492117,0.0,0.6887011145590417,1.0,83/284,21.33%,PDE7B;SLC1A3;GRIK2;UNC13B;KCND2;NRXN1;NOVA1;GRID2;LIN7A;CACNA1E;GRM3;GABRG3;GRM7;DLG2;SLC1A2;GRIN2A;GRIA3;CAMK4;GRIA2;CACNB4;SHISA6;BRSK1;PTCHD1;DLGAP1;SLC1A1;SYT1;CDH8;RIT2;GRIN2B;GABRB1;GRM5;GRIK3;GLRA1;NLGN1;GABRG2;HTR7;GABRG1;LRP6;SLC6A1;TBC1D24;CHRM3;SNAPIN;PRKAR2B;APBA1;PLP1;SLC17A6;SNAP25;DTNA;HCRTR2;MBP;GRIK1;GABRA3;GRIK4;NLGN3;DRD2;GLRA3;HTR2A;AMPH;KCNMB4;GLRA2;GABRB2;CHRM2;MPZ;KCNQ3;GRM1;PRKAR1B;GABRA1;NPTX1;GLRB;RPS6KA1;RPS6KA3;GABRE;OPRK1;HRH1;KCNK3;SYT10;GRIA4;GRIK5;CACNA1B;KCNIP2;PCDHB16;RIMS1;GABARAP
prerank,telomere maintenance via telomerase (GO:0007004),0.4773178494620621,1.2025085820400965,0.24756606397774686,0.9221220584519045,1.0,13/28,23.35%,PPP6R3;MRE11;GAR1;CDK2;PINX1;ANKRD28;HSP90AA1;RAD50;RFC1;TERF2;PTGES3;SHQ1;TINF2
prerank,positive regulation of actin filament bundle assembly (GO:0032233),0.4419522290525788,1.2022894045656016,0.21223470661672908,0.9215682678074343,1.0,18/51,18.79%,LPAR1;CCN2;WNT11;S100A10;PXN;CDC42;ARHGEF5;RAPGEF3;RHOA;ARHGEF10L;SFRP1;CCDC88A;ITGB1BP1;TESK1;PFN2;ABL1;FHOD1;ROCK2
prerank,chemokine-mediated signaling pathway (GO:0070098),0.4480070798227906,1.2011517898122976,0.23167539267015708,0.9243489886702498,1.0,6/42,8.46%,CCL5;PTK2B;ACKR3;GPR75;STK39;OXSR1
prerank,negative regulation of anoikis (GO:2000811),-0.4579021719392765,-1.2007026786480284,0.24788732394366197,0.6920444078636521,1.0,4/14,6.45%,PTK2;TLE1;NOTCH1;BCL2
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),0.45596428255890226,1.20055043901487,0.2339572192513369,0.9252391571475901,1.0,10/40,14.73%,CLU;MMP9;BBC3;PMAIP1;BCL2L1;BAD;PLSCR3;HRK;OPA1;DNM1L
prerank,mammary gland development (GO:0030879),-0.39673603675486074,-1.1999475713633752,0.2515923566878981,0.6923755632432006,1.0,6/21,9.87%,GLI2;WNT4;TBX3;JAK2;ERBB4;NOTCH4
prerank,negative regulation of type I interferon production (GO:0032480),0.46366982320172695,1.199670942693823,0.24238578680203046,0.9271267649282644,1.0,6/40,5.68%,IKBKE;MAVS;RELB;TRIM25;PPM1B;IRF3
prerank,fatty acid elongation (GO:0030497),0.5548269112594576,1.1994130861038894,0.2848,0.9267346793972905,1.0,4/13,9.24%,ABCD1;ELOVL1;ELOVL6;HACD4
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",-0.47643141413316437,-1.199241599152772,0.24242424242424243,0.692312980978322,1.0,6/12,25.08%,DKC1;CCT7;GNL3L;CCT2;CCT4;WRAP53
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.4689077270035397,1.1990364409173377,0.24079320113314448,0.9267474216697303,1.0,11/31,16.65%,BBC3;PMAIP1;PPP1R13B;BAD;YWHAB;YWHAQ;ZNF205;YWHAZ;GSK3A;GSK3B;E2F1
prerank,positive regulation of transmembrane transport (GO:0034764),-0.46556077767870085,-1.1990199400250814,0.24664879356568364,0.6908854343069759,1.0,8/13,23.46%,AZIN2;ACSL1;ACSL5;CA2;SLC26A6;C2CD5;NR4A3;C3
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),-0.5076453658805447,-1.19889131101014,0.23037974683544304,0.6891844589519186,1.0,5/10,13.02%,XYLT1;CSGALNACT1;XYLT2;PXYLP1;B3GAT3
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),0.5546001490851892,1.1985512089277048,0.2830820770519263,0.9271746475398187,1.0,4/12,11.35%,DSG2;CAV1;DSC2;TRPM4
prerank,neutrophil degranulation (GO:0043312),0.37549317747051886,1.1980278481880555,0.08835341365461848,0.9278268173662727,1.0,92/425,17.07%,CD55;CD44;ANXA3;MMP9;ADAM10;GSN;CPPED1;RAP1B;NBEAL2;SLPI;EEF1A1;RAP1A;CYB5R3;DIAPH1;RAB9B;TMC6;DGAT1;MGAM;AP2A2;UNC13D;EPX;IMPDH2;LAMP1;ORMDL3;ALOX5;S100A11;MOSPD2;PSMD11;TIMP2;RAB44;PLEKHO2;DPP7;PKM;CTSZ;NRAS;CFP;PGM2;MLEC;DDOST;ANXA2;GLB1;NFAM1;GLIPR1;ARSB;LGALS3;DNAJC5;IQGAP1;RAB7A;MANBA;NAPRT;GOLGA7;PTPN6;DERA;ILF2;RNASE3;GUSB;STOM;PSMD7;TOM1;HP;HEXB;PTGES2;TRAPPC1;SPTAN1;FCER1G;MVP;RHOA;COMMD3;ANO6;AP1M1;TRPM2;DNASE1L1;RAB5C;LTA4H;VAMP7;ALDOA;COMMD9;DNAJC3;ATP6V1D;VNN1;HVCN1;HSP90AA1;RAP2C;ITGB2;ARL8A;EEF2;CTSH;ARMC8;CAND1;VCL;DYNC1H1;PRTN3
prerank,metal ion homeostasis (GO:0055065),0.45378003887075546,1.1978512734673585,0.24115334207077327,0.9271277459224413,1.0,8/40,11.71%,ATP6V1B1;SLC12A8;CAV1;SELENON;ANK3;JPH2;LETM1;SLC12A4
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.5386231212331827,1.1976771555376702,0.2649310872894334,0.9264547812930641,1.0,1/17,0.66%,ANK2
prerank,cellular response to reactive oxygen species (GO:0034614),0.42942871175975433,1.1969164420379959,0.22194199243379573,0.9279705800424483,1.0,17/59,18.46%,MMP9;MAP3K5;FOS;NFE2L2;PXN;MAPK7;ROMO1;JUN;MAPK9;AGAP3;AQP1;PDK2;TRPM2;CHUK;ABL1;HDAC6;PARK7
prerank,secretory granule organization (GO:0033363),-0.5017736158435364,-1.1967271803739965,0.25365853658536586,0.6932492587478681,1.0,4/10,10.86%,ABCA1;LYST;DTNBP1;VPS33B
prerank,regulation of cytokine production involved in immune response (GO:0002718),-0.4020331198096595,-1.196687022605148,0.22641509433962265,0.6913045619088386,1.0,11/22,34.35%,WNT5A;SLC7A5;TNFRSF1B;TRIL;NOD2;TRIM6;BTK;CCR2;LACC1;TNFRSF14;LILRB1
prerank,cellular response to growth factor stimulus (GO:0071363),-0.27613321813795483,-1.1965280358207673,0.03333333333333333,0.6897087580289233,1.0,45/151,15.14%,FLT1;BMP6;SOX5;ADAMTS12;PDE3A;PRKD1;SEMA6A;RAPGEF2;PDE8A;WNT4;WWOX;STAT5B;WNT5A;ACVRL1;STMN2;NDNF;KDR;NOTCH1;TMEM100;CLEC3B;BMPR1B;RUNX2;DAB2IP;APPL2;ACVR1B;MTSS2;TGFB1;CRKL;PTPN12;NTRK2;ACVR2A;RPS6KB1;RAMP2;PDE2A;GAREM1;ACAP2;RACK1;VSTM2A;FLT4;HYAL1;TBX1;SMAD3;BMPR2;DUSP22;SOX6
prerank,neutrophil activation involved in immune response (GO:0002283),0.3749232859375653,1.1952766243955977,0.0963855421686747,0.9326812953051982,1.0,92/428,17.07%,CD55;CD44;ANXA3;MMP9;ADAM10;GSN;CPPED1;RAP1B;NBEAL2;SLPI;EEF1A1;RAP1A;CYB5R3;DIAPH1;RAB9B;TMC6;DGAT1;MGAM;AP2A2;UNC13D;EPX;IMPDH2;LAMP1;ORMDL3;ALOX5;S100A11;MOSPD2;PSMD11;TIMP2;RAB44;PLEKHO2;DPP7;PKM;CTSZ;NRAS;CFP;PGM2;MLEC;DDOST;ANXA2;GLB1;NFAM1;GLIPR1;ARSB;LGALS3;DNAJC5;IQGAP1;RAB7A;MANBA;NAPRT;GOLGA7;PTPN6;DERA;ILF2;RNASE3;GUSB;STOM;PSMD7;TOM1;HP;HEXB;PTGES2;TRAPPC1;SPTAN1;FCER1G;MVP;RHOA;COMMD3;ANO6;AP1M1;TRPM2;DNASE1L1;RAB5C;LTA4H;VAMP7;ALDOA;COMMD9;DNAJC3;ATP6V1D;VNN1;HVCN1;HSP90AA1;RAP2C;ITGB2;ARL8A;EEF2;CTSH;ARMC8;CAND1;VCL;DYNC1H1;PRTN3
prerank,Golgi to plasma membrane transport (GO:0006893),0.43992064116567214,1.195248862179708,0.23647798742138365,0.9314468528719312,1.0,17/47,17.51%,STXBP6;AMN;KIF13A;ARL3;ANK3;GOLPH3;GCC2;EXOC4;GOLGA7;STEAP2;GGA1;EXOC2;EXOC8;OSBPL5;CCDC22;NSF;ARFRP1
prerank,regulation of actin filament polymerization (GO:0030833),0.4222536775656892,1.1952346605373725,0.2211764705882353,0.9301778336529763,1.0,12/69,7.60%,BAIAP2L1;KANK1;ARHGAP18;SSH3;CDC42EP4;PTK2B;FCHSD2;CDC42EP5;FCHSD1;TWF1;HAX1;LATS1
prerank,regulation of osteoblast differentiation (GO:0045667),-0.2972998997405459,-1.1952206265884806,0.13333333333333333,0.6916302965764535,1.0,19/82,10.04%,BMP6;IGF1;PRKD1;SMOC1;WNT4;ZHX3;PTK2;NOTCH1;RORB;BMPR1B;RUNX2;FBN2;IL6R;ACVR2A;LRP5;FGFR2;PPARG;TWIST2;CCN4
prerank,mitotic sister chromatid cohesion (GO:0007064),-0.43057888563249935,-1.1951400125974445,0.25471698113207547,0.6897802659043161,1.0,7/16,33.20%,PDS5B;NIPBL;BOD1;NAA50;RAD21;SGO1;DSCC1
prerank,protein homooligomerization (GO:0051260),-0.2839944540165262,-1.1950629276356886,0.1111111111111111,0.6879502483145755,1.0,40/114,21.03%,ALDH1A2;SLC1A5;SCARA5;SLC1A2;PKD2;EHD4;IKZF4;APPL2;GBP5;HPRT1;KCNJ2;EHD3;B2M;UPB1;MCOLN1;GSDMD;SAMHD1;AQP11;JMJD6;AQP4;ALDH9A1;TRMT61B;ALS2;KCNJ12;G3BP2;GLRA3;GOLGA2;CBY1;MPP2;ACACB;TIFA;BLM;ATL1;DISP1;HCN1;CBR4;RNF135;MIF;CRYZ;MLKL
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",0.5306272498032512,1.1948411492352884,0.26785714285714285,0.930308060900574,1.0,9/16,27.68%,DDX5;SRSF9;DHX9;SRSF1;PUF60;SFPQ;CELF4;CDK13;HNRNPM
prerank,sprouting angiogenesis (GO:0002040),0.4356202501237213,1.1948156298954369,0.2191958495460441,0.9290751816488324,1.0,7/51,3.61%,CDH13;ANGPT1;ADTRP;EFNB2;PARVA;RSPO3;PTK2B
prerank,protein homotetramerization (GO:0051289),-0.33264787907589427,-1.1943981613369306,0.1691542288557214,0.6877312931333295,1.0,18/49,18.47%,ALDH1A2;PKD2;APPL2;GBP5;HPRT1;KCNJ2;B2M;UPB1;MCOLN1;SAMHD1;AQP4;ALDH9A1;KCNJ12;GOLGA2;CBY1;ACACB;HCN1;CBR4
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.3861327058799124,1.1942045429728676,0.20063694267515925,0.9300463986202816,1.0,19/152,11.36%,ADRA1B;GPR4;LPAR1;GRK5;ADCY9;PTGFR;ADGRL2;ADGRD1;CRHR2;RAMP1;ADCY6;LGR4;ADGRG2;HTR1B;AKAP5;ADGRG6;GNAO1;GNAQ;GNA13
prerank,sulfur compound transport (GO:0072348),-0.3699481860326704,-1.194053605125932,0.2,0.6866784547662008,1.0,4/27,4.99%,SLC6A13;SLC26A7;SLC35F3;SLC6A6
prerank,cristae formation (GO:0042407),0.4740914660137886,1.193837109464257,0.24393530997304583,0.9300318163764121,1.0,14/27,26.15%,CHCHD3;MICOS13;AFG3L2;LETM1;ATP5PF;APOO;IMMT;ATP5F1B;SPG7;ATP5PD;ATP5ME;ATP5F1D;ATP5F1C;ATP5MC3
prerank,regulation of exocytosis (GO:0017157),0.44388385098197675,1.1935490406256624,0.23809523809523808,0.9298310230445862,1.0,14/46,20.41%,CFTR;STXBP6;SYTL4;UNC13D;RAB3B;CPLANE2;NSF;RAB8B;STX4;RAB2B;RAB27A;RAB9A;ATP6AP1;RAB10
prerank,negative regulation of apoptotic process (GO:0043066),0.3694223488458937,1.1933630446929515,0.10220440881763528,0.9292210567085608,1.0,96/444,17.28%,ANGPT1;CD44;CRLF1;NOTCH2;PRKAA2;WNT1;KLF4;PPARGC1A;TJP1;NRBP2;MMP9;GRK5;ADAM10;HPN;SMAD6;NIBAN2;NUPR1;ZC3H12A;TNFAIP8;WNT11;CAV1;QARS1;NGF;PTK2B;GDNF;CLCF1;SH3RF2;ANXA4;HSPB1;MTDH;BAG1;SON;CRYAB;NFKBIA;ANXA5;AVEN;BCL2L1;MRE11;SOX9;HAX1;SHC1;MYDGF;DDRGK1;DDAH2;BMP4;GOLPH3;CCND2;ERBB3;ARHGAP10;PLK3;UNC5B;SIX1;MAZ;BAG3;RAF1;CARD16;HDAC3;SOD2;PTMA;AQP1;SOCS2;HYPK;YWHAZ;NAA15;COPS5;OPA1;ERCC5;RASA1;PDPN;ARF4;CBX4;VDAC1;MYC;IRAK1;MEF2C;ZFAND6;SFRP1;BNIP3L;SET;GSK3B;DNAJC3;PLK2;BFAR;DSTYK;IGBP1;FLNA;MAEA;CTSH;UFM1;RPS27A;UBC;POU4F1;LRP2;CIAPIN1;XIAP;F2R
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.5479066972775191,1.1930364223968886,0.2611464968152866,0.9290959784124252,1.0,6/13,19.24%,PMAIP1;VDAC2;BAD;BLOC1S2;BNIP3L;RHOT2
prerank,response to organic cyclic compound (GO:0014070),-0.32875269968433407,-1.1926234874636659,0.12365591397849462,0.6888373283235233,1.0,15/52,14.58%,STAT5B;ESR1;IGFBP5;GGT5;CYP1B1;ALPL;SLC1A1;IL18;LRRK2;TGFB1;PAQR8;STAT3;FGFR4;DRD2;DHFR
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),0.5536273926648235,1.1911071082315654,0.30033003300330036,0.9348211783094126,1.0,5/11,14.09%,RSPO3;MLLT3;WNT5B;CSNK1E;SFRP1
prerank,modified amino acid transport (GO:0072337),-0.4342289300524817,-1.1910880553033485,0.25806451612903225,0.6913585034781138,1.0,2/15,1.07%,SLC6A13;SLC16A12
prerank,regulation of neuron projection development (GO:0010975),0.387617828889713,1.1910230586368837,0.18365180467091294,0.9337681335765844,1.0,24/163,7.81%,RAB17;LPAR1;RTN4R;NTRK3;TBR1;KANK1;PDLIM5;PRAG1;EPHA4;EFNB2;PTK7;MAGI2;SIPA1L1;NDEL1;ITM2C;EP300;RAP1A;PTK2B;TWF1;AVIL;PTPN9;SRCIN1;ADCY6;ARSB
prerank,response to nutrient levels (GO:0031667),0.525151851241904,1.1900442383916265,0.28134556574923547,0.9359136315303239,1.0,4/17,14.38%,PRKAA2;KCNB1;ULK1;EIF4G1
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.3933276300452046,1.1897463696461072,0.21070234113712374,0.9357396337686015,1.0,16/114,10.46%,TNFRSF11B;EDA2R;EDA;TNFSF13;PTK2B;FOXO3;TNFRSF8;NFKBIA;PSMD11;PSMD4;COMMD7;PSMF1;ILK;TNFRSF1A;PYDC1;PSMD7
prerank,regulation of cholesterol biosynthetic process (GO:0045540),0.5130982730462942,1.1895529599464165,0.27326440177252587,0.9351487185383828,1.0,5/17,12.85%,SREBF2;ERLIN2;ERLIN1;ABCA2;LPCAT3
prerank,negative regulation of programmed cell death (GO:0043069),0.3703376158551733,1.1893073633278675,0.11995967741935484,0.9347187000419791,1.0,80/355,17.27%,ANGPT1;CD44;NOTCH2;PRKAA2;WNT1;TJP1;MMP9;GRK5;ADAM10;HPN;SMAD6;NIBAN2;NUPR1;TNFAIP8;WNT11;NGF;KANK2;PTK2B;GDNF;SH3RF2;ANXA4;HSPB1;MTDH;BAG1;SON;CRYAB;NFKBIA;ANXA5;AVEN;BCL2L1;MRE11;SOX9;HAX1;SHC1;MYDGF;DDRGK1;DDAH2;BMP4;GOLPH3;CCND2;ARHGAP10;PLK3;RAB7A;BAG3;RAF1;TIGAR;HDAC3;PTMA;AQP1;SOCS2;HYPK;YWHAZ;NAA15;COPS5;OPA1;ERCC5;RASA1;PDPN;ARF4;CBX4;VDAC1;MYC;IRAK1;ZFAND6;SFRP1;BNIP3L;GSK3B;DNAJC3;PLK2;BFAR;DSTYK;FLNA;CTSH;UFM1;RPS27A;UBC;POU4F1;LRP2;CIAPIN1;XIAP
prerank,lipid biosynthetic process (GO:0008610),0.41284973725581964,1.1892444694957003,0.22860492379835873,0.93367173795652,1.0,14/77,11.79%,PRKAA2;FDFT1;OLAH;HMGCR;ALOX5;CYP51A1;PDSS2;ACSM3;FADS1;NDUFAB1;ACSF3;ACACA;GPAM;SCD5
prerank,calcineurin-mediated signaling (GO:0097720),0.5768566611068937,1.1892354736529078,0.2864406779661017,0.9311190362129189,1.0,1/10,0.33%,NFATC2
prerank,calcineurin-NFAT signaling cascade (GO:0033173),0.5768566611068937,1.1892354736529078,0.2864406779661017,0.9311190362129189,1.0,1/10,0.33%,NFATC2
prerank,neurogenesis (GO:0022008),0.4406126526603577,1.1881371227996225,0.24168797953964194,0.9337679522754669,1.0,5/43,8.17%,LPAR1;CXCR4;CDK6;TGFB2;SIX1
prerank,ameboidal-type cell migration (GO:0001667),0.43791401908259253,1.1880966404271713,0.2376237623762376,0.9326002027738256,1.0,6/51,3.81%,SEMA3D;SRGAP2;FAT2;SEMA3B;ITGB7;GDNF
prerank,glutamate metabolic process (GO:0006536),0.5140993624582817,1.1880080945915168,0.273542600896861,0.9316293162055064,1.0,6/19,20.90%,GLUL;GLUD1;PRODH;DGLUCY;ALDH18A1;GAD1
prerank,regulation of chemokine production (GO:0032642),-0.3504369018162544,-1.187988589219143,0.18907563025210083,0.6983810136497561,1.0,17/36,31.92%,HIF1A;WNT5A;LGALS9;IL18;IL6R;IL33;TLR7;CD74;LPL;SIGIRR;PYCARD;ACKR1;IL7;AIF1;SNAI2;HMOX1;TREM2
prerank,negative regulation of ion transport (GO:0043271),0.4917954136514024,1.1879473106271357,0.26880222841225626,0.9305678514812682,1.0,6/24,15.27%,ACTN2;PTK2B;HTR1B;WNK1;NEDD4;SYT11
prerank,ventricular septum morphogenesis (GO:0060412),-0.37332722760297216,-1.1874884101063554,0.22895622895622897,0.6978153164957068,1.0,13/27,22.26%,ZFPM2;ROBO1;NOTCH1;ROBO2;SLIT2;HEYL;SLIT3;BMPR2;SOX11;SMAD4;HEY2;APLNR;HEY1
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),-0.3147711844749669,-1.1872533113923778,0.19487179487179487,0.6965655701490905,1.0,9/56,8.35%,BMP6;RBPMS;ENG;DAB2;ACVRL1;SNX25;BMPER;TGFB1;ACVR2A
prerank,RNA splicing (GO:0008380),0.40319158740186845,1.1872467258670716,0.20159453302961275,0.9317567089388227,1.0,32/95,23.24%,MBNL1;PPARGC1A;SRSF2;YJU2;PPP2CA;SNRPB;LSM4;DDX39B;RBM8A;DBR1;LUC7L3;SF3B3;USP39;SRPK2;SRSF7;DDX47;SRPK1;SYNCRIP;RNPS1;MAGOHB;MAGOH;PRPF6;PTBP1;ZMAT5;WBP4;SF3A3;PRPF8;SFPQ;DDX23;U2AF1;NRDE2;SRRM1
prerank,macrophage migration (GO:1905517),0.5219605841007628,1.1872439919014672,0.27697262479871176,0.9304873716586575,1.0,2/13,8.27%,CCL5;LGALS3
prerank,chondroitin sulfate metabolic process (GO:0030204),0.472423811584174,1.1871278724030991,0.26265389876880985,0.929621691338946,1.0,9/30,11.88%,CHST12;HEXA;DSE;CHST11;CHPF;ARSB;HEXB;CHST13;CHPF2
prerank,microtubule polymerization or depolymerization (GO:0031109),0.4882584876314717,1.1865500742896682,0.25811001410437234,0.9304127890009075,1.0,2/24,3.02%,FGF13;KIF2A
prerank,positive regulation of protein localization to membrane (GO:1905477),0.3967720276329593,1.1863765120989338,0.2152619589977221,0.9297784028274918,1.0,29/98,19.56%,SORBS1;BBC3;PMAIP1;CD81;PPP1R13B;STAC3;ANK3;PTPN9;BAD;LGALS3;CHP1;YWHAB;MIEF2;YWHAQ;MYO1C;KCNB1;AKAP5;CNPY4;EPHA3;YWHAZ;ATP2B4;HRAS;ITGB1BP1;ITGB2;E2F1;STX4;NECAB2;GPER1;YWHAH
prerank,positive regulation of response to wounding (GO:1903036),0.49226615699760784,1.1863336470366175,0.26598837209302323,0.9286574541376127,1.0,7/24,14.36%,KANK1;OCLN;DMTN;ACTG1;PTN;ARFGEF1;HRAS
prerank,limb morphogenesis (GO:0035108),0.5015474708413199,1.1861313114773202,0.26995645863570394,0.9281154890133346,1.0,3/20,7.38%,MBNL1;GLI3;TGFB2
prerank,mitochondrion organization (GO:0007005),0.3834940269624211,1.1860715162761135,0.17584745762711865,0.927039204562087,1.0,69/165,26.88%,CXADR;PPARGC1A;GABPB1;TIMM10;TIMM44;CHCHD3;AGTPBP1;CAV2;BCL2L1;HCFC1;HAX1;NRF1;MUL1;SLIRP;TOMM5;MTFR1L;AFG3L2;PITRM1;MIEF2;THG1L;COX7A2L;AFG1L;BCAP31;NIPSNAP2;WASF1;TOMM20;OPA1;BNIP3L;TIMM17B;DNM1L;VPS13D;ATP5F1B;SLC25A4;MTX1;CLUH;MTFR2;SPG7;PARK7;PISD;RHOT2;TIMM9;STOML2;HSD17B10;TOMM40;TSPO;TWNK;TIMM50;SIRT4;MIEF1;GABPA;LONP1;TFAM;TIMM23;MTX3;IFIT2;AIP;AIFM2;ADCK1;DNAJA3;ATP5F1D;MTX2;RAB32;MTFR1;RHOT1;FANCG;FBXO7;COX7A2;PARP1;ESRRA
prerank,protein stabilization (GO:0050821),0.38777287826681245,1.185779181262579,0.18345705196182396,0.9268382169850197,1.0,30/168,12.25%,CLU;ANK2;PPARGC1A;EPHA4;PARVA;CDKN1A;EP300;CREBL2;BAG1;LAMP1;FLOT2;TRIM44;CRYAB;FKBPL;CREB1;HCFC1;MUL1;DNLZ;IFT46;DVL3;CHP1;USP19;GOLGA7;BAG3;UBE2B;GNAQ;HYPK;RABL3;COA8;NAA15
prerank,regulation of T cell migration (GO:2000404),0.5174759925922021,1.1857018820911067,0.24814264487369986,0.9258464118138401,1.0,5/18,12.19%,CCL5;CD200;RIPOR2;RHOA;CD200R1
prerank,regulation of kinase activity (GO:0043549),-0.29746234971583935,-1.1856717181095757,0.12878787878787878,0.6990233479925453,1.0,27/89,13.71%,FLT1;ROR1;PDGFRB;EPHA7;TEK;INSR;MERTK;PLCE1;AXL;TIE1;PDGFRA;KDR;RBL1;EPHB2;EPHB4;ROR2;NTRK2;ERBB4;FGFR2;RYK;NLRC5;KIT;IGF1R;FGFR4;FLT4;RET;EPHA5
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),0.4221194980257525,1.185034937727217,0.23212045169385195,0.9268823336014653,1.0,10/55,13.84%,FBXL7;FHL1;PSMD11;AVEN;PSMD4;PSMF1;RBX1;PSMD7;PSMB5;PINX1
prerank,negative regulation of autophagosome assembly (GO:1902902),0.5516768766566886,1.1840402095484868,0.30092592592592593,0.9291997767770388,1.0,5/13,9.89%,NUPR1;TMEM39A;CHMP4A;CHMP4B;SMCR8
prerank,central nervous system myelination (GO:0022010),0.5548482440567691,1.18400137222791,0.28501628664495116,0.9280956334811604,1.0,1/11,0.40%,CLU
prerank,hyaluronan catabolic process (GO:0030214),0.5190797554315736,1.1836563511581117,0.26646706586826346,0.9280345017500736,1.0,6/18,11.11%,CD44;HEXA;STAB2;CHP1;GUSB;HEXB
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),0.4798689118776534,1.183146606482881,0.25072463768115943,0.9286238471061414,1.0,5/25,11.15%,CLU;KLF4;DDAH2;TLR6;TLR4
prerank,positive regulation of synaptic transmission (GO:0050806),-0.3048243325025964,-1.1829732156533297,0.15286624203821655,0.7047077705718403,1.0,16/72,10.17%,GRIK2;NRXN1;SHANK3;SLC8A3;GRIN2A;LGI1;SYT1;EPHB2;GRIN2B;CLSTN2;NLGN1;ADCY1;DTNBP1;SLC24A2;NFATC4;CACNG8
prerank,positive regulation of cell migration (GO:0030335),0.3694291688203441,1.1828982932431433,0.17864476386036962,0.9281985380249844,1.0,30/253,8.60%,FN1;SEMA3D;CDH13;DOCK5;NTRK3;LAMC2;TJP1;SMO;MMP9;CCL5;PODXL;PDGFC;ADAM10;GAB1;WNT11;CAV1;SEMA3B;PTK2B;GCNT2;SH3RF2;S100A11;SOX9;DMTN;DDRGK1;CBLL1;TGFB2;WNT5B;MAZ;ELP5;FBXO5
prerank,regulation of mitochondrion organization (GO:0010821),0.44455536401881485,1.1827995143240693,0.24870466321243523,0.9273000160579072,1.0,22/47,22.37%,PPARGC1A;SREBF2;EP300;HAX1;MUL1;GOLPH3;FZD5;MIEF2;PLSCR3;VDAC1;GSK3A;GSK3B;DNM1L;FLCN;HDAC6;PISD;RHOT2;SREBF1;MAPT;FBXW7;SIRT7;INF2
prerank,regulation of embryonic development (GO:0045995),0.46223183239307003,1.1827933974902294,0.25679347826086957,0.9260747168896521,1.0,5/34,4.23%,PHLDB2;DAG1;NIBAN2;CRB2;RBM19
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.42619791322129674,1.1824213749677581,0.22981366459627328,0.9262612727067426,1.0,15/50,20.20%,CD44;KLF4;MMP9;NGF;PIH1D1;RAF1;CARD16;AQP1;IGBP1;XIAP;TRIAP1;PARK7;CDKN2D;BEX3;ARL6IP1
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.40948934537533643,1.1823066605967336,0.21689497716894976,0.9254303609960235,1.0,17/84,14.53%,CLU;RTN1;SAMD4A;SAMD4B;EPRS1;DAPK3;DAPK1;ORMDL3;RTN3;EIF4A3;SHMT1;EIF2AK3;CPEB3;SYNCRIP;FXR1;BTG2;GAPDH
prerank,regulation of supramolecular fiber organization (GO:1902903),-0.40148890643446666,-1.1821528252745421,0.23183391003460208,0.7049550552318954,1.0,8/22,15.91%,MAP2;MAP1B;AEBP1;PRUNE1;GBA2;CAMSAP2;GPX1;MAP1A
prerank,vascular process in circulatory system (GO:0003018),0.565255375032928,1.1813916212038658,0.27813504823151125,0.9262615732616207,1.0,1/13,0.18%,AGTR1
prerank,regulation of tube diameter (GO:0035296),0.565255375032928,1.1813916212038658,0.27813504823151125,0.9262615732616207,1.0,1/13,0.18%,AGTR1
prerank,triglyceride homeostasis (GO:0070328),-0.37878198899068555,-1.1812389290951615,0.20066889632107024,0.7055829201644653,1.0,10/26,29.69%,IL18;NR1H3;RORA;PNPLA8;LPL;NR1H4;DGAT2;FITM2;ANGPTL4;XBP1
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.520771184532919,1.180928942595283,0.2831050228310502,0.9266701955277198,1.0,7/16,16.85%,IMPDH2;NUDT2;PAICS;GMPS;GART;AMPD2;ADSS2
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.39347674512063063,1.1807452760155526,0.22272215973003376,0.9261007053761784,1.0,14/110,11.36%,ADRA1B;GPR4;LPAR1;ADCY9;PTGFR;ADGRL2;ADGRD1;RAMP1;ADCY6;LGR4;ADGRG2;ADGRG6;GNAQ;GNA13
prerank,regulation of programmed necrotic cell death (GO:0062098),0.5047024094457164,1.1802235660705584,0.2549618320610687,0.9267868504459132,1.0,8/20,19.47%,OGT;NUPR1;FLOT2;PELI1;HSP90AA1;STUB1;PDCD6IP;FLOT1
prerank,muscle cell differentiation (GO:0042692),-0.3515050771173712,-1.1801765498925796,0.2196969696969697,0.7068614164061767,1.0,12/32,13.45%,DMD;SYNE1;MRTFB;GLMN;MEGF10;TBX18;RORA;SPEG;TMEM204;GATA6;SGCZ;TBX1
prerank,response to thyroid hormone (GO:0097066),0.5442536780417196,1.1801523864943224,0.29093799682034976,0.9258149200694141,1.0,2/13,2.00%,THRB;HPN
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.5604631054210611,1.179628551278912,0.2882447665056361,0.9265300304317698,1.0,3/11,11.01%,SMARCB1;PIH1D1;SMARCA4
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.44521319707375867,1.1795657191078115,0.2614980289093298,0.9255266916096714,1.0,16/38,22.71%,SREBF2;HAX1;FZD5;ATP5IF1;SIAH3;SAE1;VPS11;NPEPPS;RHOU;GSK3A;RNF31;UBE2D3;SREBF1;FBXW7;ARIH2;MICALL2
prerank,regulation of membrane repolarization (GO:0060306),0.5444243543296908,1.1795290046958997,0.2859375,0.9244403005022754,1.0,2/13,3.47%,CAV1;CACNB3
prerank,positive regulation of MAP kinase activity (GO:0043406),-0.3036854571479494,-1.1794353661268433,0.1712707182320442,0.706987352448178,1.0,15/66,10.65%,FLT1;PDGFRB;SASH1;PDGFD;IL34;ROBO1;FGF2;DAB2IP;LRRK2;TGFB1;EZH2;TPD52L1;PIK3R6;KIT;TRAF6
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.4349222718836324,1.1791318433635174,0.25862068965517243,0.92460918305082,1.0,5/52,3.48%,MBNL1;CELF2;DDX5;CELF1;RBFOX2
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),-0.4736470996253879,-1.179087889370772,0.2634146341463415,0.7060110548865997,1.0,8/11,37.00%,TP53;DDIT3;ATF3;ATF4;HSPA5;ATF6;CREB3L1;ATF6B
prerank,positive regulation of glycogen metabolic process (GO:0070875),0.5408936493074727,1.1788859652832218,0.2739938080495356,0.9242541759202192,1.0,1/13,0.14%,SORBS1
prerank,regulation of GTPase activity (GO:0043087),0.3810710762489605,1.1788574042570643,0.18029350104821804,0.923123860251436,1.0,47/177,17.28%,MAPRE2;RTN4R;SRGAP2;ARAP1;NGEF;CCL5;PLXNB1;EPHA4;PKP4;PLXNA2;CPEB2;SIPA1L1;WNT11;NDEL1;RAP1A;S100A10;ADAP1;SH3BP4;CAV2;EFNA5;DVL3;ARHGEF5;BCAS3;SNX18;SGSM2;RAPGEF3;EPHA3;RGS6;PLXNB2;ASAP3;OCRL;ARFGEF1;SFRP1;GSK3B;HRAS;WNK1;ARHGAP27;FLCN;ITGB1BP1;USP6NL;RAPGEF1;PLXNA3;CRK;FICD;PRTN3;RAP1GAP;F2R
prerank,neutrophil mediated immunity (GO:0002446),0.36932843929578274,1.178823544322764,0.11144578313253012,0.922020137780351,1.0,92/432,17.07%,CD55;CD44;ANXA3;MMP9;ADAM10;GSN;CPPED1;RAP1B;NBEAL2;SLPI;EEF1A1;RAP1A;CYB5R3;DIAPH1;RAB9B;TMC6;DGAT1;MGAM;AP2A2;UNC13D;EPX;IMPDH2;LAMP1;ORMDL3;ALOX5;S100A11;MOSPD2;PSMD11;TIMP2;RAB44;PLEKHO2;DPP7;PKM;CTSZ;NRAS;CFP;PGM2;MLEC;DDOST;ANXA2;GLB1;NFAM1;GLIPR1;ARSB;LGALS3;DNAJC5;IQGAP1;RAB7A;MANBA;NAPRT;GOLGA7;PTPN6;DERA;ILF2;RNASE3;GUSB;STOM;PSMD7;TOM1;HP;HEXB;PTGES2;TRAPPC1;SPTAN1;FCER1G;MVP;RHOA;COMMD3;ANO6;AP1M1;TRPM2;DNASE1L1;RAB5C;LTA4H;VAMP7;ALDOA;COMMD9;DNAJC3;ATP6V1D;VNN1;HVCN1;HSP90AA1;RAP2C;ITGB2;ARL8A;EEF2;CTSH;ARMC8;CAND1;VCL;DYNC1H1;PRTN3
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),-0.44541357593190756,-1.1786904593927945,0.2611111111111111,0.7052046300414073,1.0,10/14,37.29%,FIP1L1;NUDT21;CPSF6;CPSF1;CPSF4;NCBP1;ERN1;NCBP2;CPSF4L;CPSF2
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),-0.3365553619899741,-1.1785338477312972,0.19838056680161945,0.7037070876066086,1.0,9/41,8.02%,TGFA;IL34;DOCK3;GAS6;NOX4;GRM5;ACE;LRP8;NTRK2
prerank,ribonucleoprotein complex assembly (GO:0022618),0.38998586777831995,1.1783588890828616,0.20810514786418402,0.9224939254143218,1.0,56/132,28.19%,CELF2;NLE1;CELF1;NOP2;PPAN;SNRPB;TARBP2;MRPS7;EIF6;LSM4;DDX39B;RPSA;EIF4B;LUC7L3;USP39;SRPK2;KHDC4;PWP2;SF3A2;SRPK1;SRSF9;GEMIN6;ISY1;DHX9;HSP90AA1;LUC7L2;PRPF19;CLP1;PRPF6;SRSF1;SNUPN;SRSF5;RPL6;RPS28;DDX20;PUF60;PTGES3;DDX23;GEMIN5;SHQ1;EIF2S2;CELF4;CLNS1A;CPSF7;GEMIN8;GEMIN2;RPS27;NOP53;RRS1;MDN1;XRCC5;SNRPD2;SNRPD1;SF1;RPL24;RSL24D1
prerank,nucleosome organization (GO:0034728),0.4259884936764917,1.178064752202355,0.24969400244798043,0.9223934478554862,1.0,17/55,18.29%,DAXX;GRWD1;SMARCB1;ASF1A;SOX9;KAT6B;ATRX;SMARCA4;SRCAP;SMARCD2;SET;SMARCC1;SPTY2D1;LIN54;BRDT;ZNHIT1;H3-3A
prerank,regulation of apoptotic process (GO:0042981),0.3629403866606367,1.1780068980129916,0.088,0.9213995596257493,1.0,144/676,17.31%,EGLN3;CLU;ANGPT1;CD44;NOTCH2;PRKAA2;DAXX;WNT1;PAWR;ACTN2;TJP1;MMP9;NGEF;MAP3K5;GRK5;ADAM10;HPN;SMAD6;NIBAN2;NDRG1;ARHGEF17;NUPR1;AKAP13;TNFAIP8;WNT11;PMAIP1;ARHGEF12;PRR7;NGF;PHLDA3;PTK2B;FOXO3;TNFRSF8;DAPK3;GDNF;TIAM2;DAPK1;SH3RF2;ANXA4;HSPB1;PPP1R13B;OLFM1;MTDH;BAG1;UTP11;SON;CRYAB;NFKBIA;ANXA5;RARG;AVEN;IRF3;PERP;BCL2L1;HOXA5;ARHGEF18;MRE11;SOX9;HAX1;SHC1;MYDGF;DDRGK1;DDAH2;BMP4;PNMA2;EGLN2;GOLPH3;CCND2;ARHGAP10;BAD;PLK3;LATS1;TNFRSF10B;NLRP2B;JUN;PIP5KL1;ADAMTSL4;ARHGEF5;BAG3;PTPN6;TRIO;APBB1;RAF1;IER3IP1;ARL6IP5;HDAC3;PTMA;USP42;AQP1;GNA13;SOCS2;PLSCR3;HYPK;YWHAZ;GADD45B;ANKRD13C;BCAR1;ANO6;NAA15;COPS5;HRK;OPA1;ERCC5;RASA1;PDPN;SOS2;ARF4;LGALS1;CBX4;RNPS1;VDAC1;MYC;EEF1E1;ING4;IRAK1;MEF2C;ZFAND6;SFRP1;BNIP3L;GSK3B;DNM1L;FLCN;DNAJC3;PLK2;HSP90AA1;BFAR;DSTYK;ACTN4;FLNA;IP6K2;CTSH;UFM1;ARHGEF1;FRZB;RPS27A;UBC;E2F1;ABL1;LRP2;SIGMAR1;CIAPIN1;SIAH1;XIAP;PLEKHG2
prerank,regulation of lamellipodium assembly (GO:0010591),0.45770016012561776,1.1774057741164043,0.2784636488340192,0.9222728783706481,1.0,7/34,8.49%,WNT1;OCLN;CAPZB;TWF1;AVIL;DMTN;CDC42
prerank,prostaglandin metabolic process (GO:0006693),-0.38236907169383993,-1.177281680453708,0.21033210332103322,0.7053712847389991,1.0,9/26,16.64%,PLA2G4A;PTGIS;PTGS2;PNPLA8;PTGES;ACOX1;HPGD;EDN1;CD74
prerank,regulation of gene expression (GO:0010468),0.36390932669889475,1.1771103252627273,0.036,0.9220662299663569,1.0,149/903,14.36%,FN1;CDH1;WNT16;MBNL1;BNC2;NFATC2;CLU;ANGPT1;ANK2;NOTCH2;ITGB8;PRDM6;PRKAA2;NTRK3;FOXN3;DAXX;TRIM60;ADTRP;KLF4;TFAP2C;PPARGC1A;AHNAK;SMO;AHNAK2;ADAM10;HPN;OCLN;GSN;ZC3H12A;WNT11;EP300;CELF1;HDAC5;CDK6;NGF;AFF3;DAPK3;GDNF;ZNF219;PPP2CA;CREBL2;CGGBP1;WNT6;HDAC4;YBX3;NFE2L2;GCNT2;WWP2;OLFM1;FLOT2;SNRNP70;TRIM44;SON;IGSF1;MLF2;CDK4;ESRRB;PRRX2;OVOL2;PATZ1;PHF1;POLR2A;HOXA5;KRAS;MOV10;SOX9;FOXD1;HCFC1;ZBTB7B;KAT6B;DDRGK1;EFEMP1;BMP4;ANK3;RBMS3;MSN;RBM20;TOB2;TRIM21;TGFB2;NKAP;ZFHX3;FGF22;ATRX;SIX1;MAZ;POU3F1;MAPK9;PML;FOXP3;HNRNPH2;TLR6;TXK;MYCBP;TRIM26;MAP2K2;TRIM11;EZR;APBB1;SMCR8;MUSK;FADS1;NFYC;TWIST1;SRPK2;ZNF205;SRRM4;ACTG1;GON4L;MYT1;TLR4;CALCOCO1;KDM6A;AJUBA;SNX12;SFMBT2;SP1;EIF2AK3;ZNF148;TAF5;WNT3;TFEB;SPIN1;SH3GL2;CHD3;GATA3;RREB1;SBNO2;GPBP1;CDK2;CIAO3;NFIA;TCF19;MYC;GSK3A;PRDM11;REXO4;MEF2C;TLE5;MYBL1;ATP2B4;SFRP1;SRRT;FOXP1;UBR5;PTP4A3;IRF2;GSK3B;HRAS
prerank,sterol homeostasis (GO:0055092),0.4163574457090613,1.1768847996461906,0.2376357056694813,0.9216479924333688,1.0,13/65,11.07%,LDLR;SOAT1;CAV1;ABCD1;TTC39B;EHD1;INSIG1;NPC1;CYP39A1;RALY;SOAT2;ACSM3;ABCA2
prerank,endoplasmic reticulum organization (GO:0007029),0.41338385338881156,1.176853086832147,0.23583815028901733,0.9205446012287634,1.0,29/72,23.98%,SPTSSB;OTOF;REEP3;CAV2;RTN3;MAPK15;GET4;TMEM33;EIF2AK3;LPCAT3;DNM1L;ATL2;CCDC47;REEP4;SHTN1;RNF112;TLE6;SEC31B;APP;SMPD4;RAB10;TMCC1;MIA3;VAMP2;SEC16A;SGTA;SEC31A;VAPA;TOR1AIP2
prerank,regulation of bone mineralization (GO:0030500),-0.3207718787242355,-1.1765955026947346,0.15048543689320387,0.705328132057026,1.0,14/55,10.37%,BMP6;ADGRV1;WNT4;SLC8A1;ENPP1;KL;BMPR1B;FBN2;ECM1;TGFB1;PKDCC;ACVR2A;NOTUM;BCOR
prerank,negative regulation of interleukin-2 production (GO:0032703),0.5138352262782103,1.1765089830229574,0.26706231454005935,0.9205577866722271,1.0,4/18,9.58%,HOMER2;HOMER3;FOXP3;EZR
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.4688791370095149,1.1762680540962283,0.2625,0.9201911155791372,1.0,8/29,14.09%,HPN;PPP2CA;BMP5;OVOL2;SPRED3;LDLRAD4;GATA3;SFRP1
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),-0.43796184630522306,-1.1762648191728824,0.28184281842818426,0.7043702072712876,1.0,7/15,25.53%,KCNN2;ATP1B1;KCNJ2;KCNJ8;KCNIP2;YWHAE;KCNJ3
prerank,positive regulation of actin nucleation (GO:0051127),0.5603337480693916,1.176225858311891,0.2964169381107492,0.9191534846092133,1.0,3/11,12.08%,GSN;FCHSD2;WASF1
prerank,engulfment of apoptotic cell (GO:0043652),-0.4464579567686119,-1.1762047494259933,0.2696629213483146,0.7025279377658374,1.0,4/15,9.85%,RHOBTB1;MEGF10;THBS1;XKR6
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.39050007366191297,1.176098519216447,0.21951219512195122,0.9184030012674372,1.0,13/104,8.04%,CD109;WNT1;VEPH1;SMAD6;MAGI2;NBL1;CRIM1;TRIM33;CAV1;IGSF1;SPRED3;TGFB1I1;PPM1A
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.4824638289492811,-1.1752907427071613,0.28641975308641976,0.7031875630482886,1.0,5/11,26.65%,HIF1A;NONO;RACK1;NR4A3;ATF4
prerank,pore complex assembly (GO:0046931),0.501716238506777,1.1749735976759728,0.293591654247392,0.9212106268631884,1.0,5/19,12.23%,ADAM10;NUP93;BAD;NDC1;ANO6
prerank,carnitine metabolic process (GO:0009437),0.5455576811931414,1.1743359764990176,0.29356357927786497,0.9222700148583935,1.0,5/12,13.29%,ACADL;CPT1B;SHMT1;CPT2;ACADM
prerank,positive regulation of cartilage development (GO:0061036),-0.4253313928089534,-1.1739008703211957,0.2565597667638484,0.7052483795264106,1.0,6/17,15.14%,SOX5;ACVRL1;BMPR1B;PKDCC;BMPR2;SOX6
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),0.5107201473844025,1.1737505112949833,0.26409495548961426,0.9232004416277374,1.0,3/19,6.85%,KLF4;HPN;MAPK7
prerank,regulation of ruffle assembly (GO:1900027),0.4736390864416253,1.173565374062615,0.26055312954876275,0.9226428315405575,1.0,4/23,2.87%,KANK1;EPS8L2;CAV1;NDEL1
prerank,histone H3-K9 demethylation (GO:0033169),0.5587247789733129,1.1732285911084168,0.30629139072847683,0.922659592796045,1.0,5/11,16.82%,KDM4D;KDM4B;KDM3A;KDM4C;KDM1A
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.37371374509511035,1.172749680305457,0.1671794871794872,0.923158696223681,1.0,60/234,19.56%,PRKCB;CLU;WNT1;ANXA3;PPARGC1A;SMO;EDA2R;EDA;TSSK4;CD200;CAV1;IKBKE;MAVS;EP300;HDAC5;HDAC4;TRIM25;MTDH;FLOT2;SMARCB1;NFKBIA;ZIC2;DDRGK1;TRIM41;TRIM21;LPAR5;NFAM1;TAB3;RAB7B;ARHGEF5;TLR6;TRIM26;CARD16;SMARCA4;TLR4;COPS5;MAP3K13;IRAK1;CHUK;DHX9;IKBKG;RNF31;UBE2N;RPS27A;UBC;PRKCZ;RELN;KDM1A;PIDD1;TAB2;TRIM37;PRKCQ;PARK7;ATF2;FZD2;PRKD2;NFKB2;APP;FLOT1;ZBTB7A
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.5112798905245887,1.172721313627036,0.2837209302325581,0.9220574675103145,1.0,4/17,12.23%,CCL5;MOSPD2;CREB3;ANO6
prerank,negative regulation of interferon-beta production (GO:0032688),0.5722708092018316,1.172407758147557,0.30456026058631924,0.9219443943719754,1.0,2/10,4.64%,RELB;PPM1B
prerank,regulation of neurotransmitter secretion (GO:0046928),-0.3621597376802178,-1.172106501408321,0.2066420664206642,0.7083801816635318,1.0,16/32,23.00%,SNCAIP;MCTP2;LRRK2;DTNBP1;PREPL;SNAPIN;SLC30A1;CAMK2A;MCTP1;KCNMB4;BAIAP3;CPLX2;FMR1;STX1B;RIMS1;RIMS3
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.40079856120772067,1.1720862219792252,0.23076923076923078,0.9218878435975153,1.0,22/85,17.31%,CLU;TRIB2;NUPR1;ZYG11B;SH3RF2;TMEM259;NUB1;ELOB;DDRGK1;RBX1;SUMO2;COP1;HSPBP1;OSBPL7;CSNK1E;PIAS1;DDA1;GSK3A;GSK3B;MDM2;KEAP1;STUB1
prerank,peptidyl-lysine methylation (GO:0018022),0.4798762511801787,1.1717972247208766,0.2897727272727273,0.9217816602699022,1.0,13/26,27.18%,EEF2KMT;SMYD3;EEF1AKMT3;TRMT112;SETD7;SMYD1;ATPSCKMT;ANTKMT;KMT5A;N6AMT1;SMYD2;EHMT1;EEF1AKMT2
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),0.47479252202714317,1.1716232664561221,0.27450980392156865,0.921213027302393,1.0,7/27,13.02%,ANK2;AHNAK;CACNB3;SELENON;JPH2;JPH3;CACNB2
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.5031146024174521,1.1715522298183192,0.2894356005788712,0.9202550137646663,1.0,8/21,24.63%,ANK2;KCNA5;FLNA;SCN4B;SNTA1;GJA5;KCNH2;CACNA2D1
prerank,plasma membrane repair (GO:0001778),0.54158533337912,1.1715291491131092,0.3055091819699499,0.9191646760695429,1.0,2/13,2.30%,AHNAK2;SYTL4
prerank,clathrin coat assembly (GO:0048268),-0.4327688204887392,-1.1714959890577383,0.2568306010928962,0.7081776155897195,1.0,7/15,21.13%,HIP1;CLTA;SGIP1;EPS15;FCHO2;CALY;HIP1R
prerank,peptide hormone secretion (GO:0030072),0.46999868138690226,1.171288330688284,0.2605042016806723,0.9188517209338659,1.0,3/26,7.53%,GAL;LTBP4;CDK16
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.408514118825165,1.1710196765840701,0.2536057692307692,0.9185839515849666,1.0,21/72,17.98%,CNOT6;CDKN1A;NDRG1;EP300;SESN2;USP10;FOXM1;PLK3;ATRX;PML;BTG2;ING4;MDM2;PLK2;PCNA;E2F1;NBN;PRMT1;CHEK2;PIDD1;TRIAP1
prerank,mesonephros development (GO:0001823),0.56114882256782,1.1707589286627218,0.31528662420382164,0.9183041984831573,1.0,3/11,12.94%,ZBTB16;BMP4;GATA3
prerank,cellular response to estradiol stimulus (GO:0071392),0.5051433156199961,1.1706685560671013,0.26998491704374056,0.9174382040259224,1.0,6/18,19.14%,NCOA3;FAM210B;LCOR;SFRP1;POU4F1;GPER1
prerank,secretion (GO:0046903),-0.44611888691657625,-1.1704164733594062,0.29333333333333333,0.709411441115563,1.0,7/14,30.33%,FBLN5;NPR1;RIMS1;SLC22A6;SLC22A2;GUCA1B;PRKCI
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.39438597903020034,1.1702035763663483,0.2409778812572759,0.9178238911429141,1.0,16/84,19.73%,FZR1;PSMD11;PSMD4;PSMF1;FBXO5;FBXO31;PSMD7;PSMB5;ANAPC4;CDK2;RPS27A;UBC;PSMD1;PSMC4;PSMD8;RB1
prerank,regulation of exosomal secretion (GO:1903541),0.4985281446978874,1.1700666188468,0.2850678733031674,0.9171487086003527,1.0,9/19,18.00%,SDC4;RAB7A;ATP9A;VPS4B;VPS4A;CHMP2A;PDCD6IP;STAM;TSG101
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.4094379583994081,1.1700641272996026,0.2641509433962264,0.9159951106798355,1.0,17/73,12.89%,TFAP2C;EP300;HDAC5;CGGBP1;HDAC4;POLR2H;TAF1C;PHF1;ZFP57;ACTB;DNMT3A;POLR1C;MYO1C;POLR1E;AEBP2;POLR1F;PPM1D
prerank,regulation of actin filament-based movement (GO:1903115),0.5675978427070297,1.1700372044214662,0.3026315789473684,0.9149375682059749,1.0,1/10,0.66%,ANK2
prerank,autophagosome maturation (GO:0097352),-0.3623778896377656,-1.1698119774756206,0.22053231939163498,0.7091484437490005,1.0,13/32,17.60%,ATP2A2;VMP1;LAMP2;UBQLN1;SNX14;CHMP3;VPS16;VPS33B;LIX1;MAP1LC3A;CLN3;VPS33A;TECPR1
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),-0.30629859165102896,-1.169322503272171,0.17964071856287425,0.7086443472600601,1.0,14/67,7.58%,FLT1;SULF1;PRKD1;PIK3R1;VAV3;VEGFC;PTK2;AXL;KDR;NCK2;CLEC14A;DAB2IP;PIK3CB;ROCK1
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.4128005010274631,1.1692619294165352,0.2589928057553957,0.916331314671122,1.0,18/67,17.02%,RAB17;PODXL;RABEP2;CAV1;TBC1D16;CAPZB;TWF1;DMTN;MAPK15;CDC42;TBC1D1;ODAD3;FXR1;TRPM2;USP6NL;FSCN1;TBC1D22A;TBC1D10A
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),0.5612709862324796,1.1692267078411192,0.33277310924369746,0.915272252052737,1.0,2/10,8.98%,ZC3H12A;FOXP3
prerank,regulation of sodium ion transmembrane transport (GO:1902305),0.47961892103117065,1.1689520556146507,0.2669491525423729,0.9150132893513715,1.0,2/27,1.19%,UTRN;SLMAP
prerank,acylglycerol catabolic process (GO:0046464),-0.36384623795085175,-1.168930102291278,0.21153846153846154,0.7079233750930234,1.0,8/30,26.68%,MGLL;LIPE;ABHD12;ABHD2;LPL;PNPLA3;FABP7;PNPLA2
prerank,response to purine-containing compound (GO:0014074),-0.4256612936810912,-1.1688947757036436,0.2506811989100817,0.7060862002610927,1.0,6/17,21.61%,TRPC3;ABCC9;RYR2;P2RY1;DGKQ;VGF
prerank,regulation of MHC class II biosynthetic process (GO:0045346),-0.4809898123028429,-1.1688125238477542,0.28287841191067,0.7044221766979836,1.0,7/11,42.44%,JAK2;TMEM106A;HDAC2;XBP1;TAF7;PF4;IL4
prerank,neuron differentiation (GO:0030182),0.3763006049663845,1.1684797013759287,0.2094736842105263,0.9155526557593711,1.0,15/165,9.21%,WNT16;WNT1;PBX3;PBX1;NRBP2;WNT10A;WNT11;ITM2C;WNT6;PTPRD;TGFB2;WNT5B;FZD5;ACSL3;OPHN1
prerank,stress-activated protein kinase signaling cascade (GO:0031098),0.46404956025800775,1.1683382437460874,0.25677603423680456,0.914876269802213,1.0,6/27,16.57%,MAP3K8;MAP3K5;CHUK;IKBKG;RPS27A;UBC
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),0.5278518832527633,1.1680972270612044,0.3064516129032258,0.9145800586557286,1.0,6/14,15.66%,EMP2;LIMS2;TIMP1;DMTN;ITGB1BP1;FLNA
prerank,regulation of interferon-gamma production (GO:0032649),-0.2883927333332378,-1.1671566388161987,0.15527950310559005,0.7072509910441459,1.0,9/71,8.36%,IL1R1;CD47;PDE4D;GAS6;AXL;SLC7A5;LGALS9;IL18;PDE4B
prerank,post-translational protein modification (GO:0043687),0.36733339494743894,1.1671468989143101,0.15826612903225806,0.9167010492970675,1.0,69/332,17.60%,FN1;MSLN;FBXL7;F5;FAM20C;FBXW8;PRSS23;ADAM10;PENK;ASB14;FBXL20;SPSB4;SERPINC1;ZBTB16;TIMP1;PSMD11;NUB1;ANO8;ELOB;KLHL21;BMP4;PSMD4;PSMF1;GPC3;FEM1C;FEM1A;SUMF1;WSB2;FBXL18;RBX1;FBXO31;LAMC1;LAMB2;COP1;PSMD7;FBXW9;FEM1B;SUMF2;DCUN1D1;SOCS2;CALU;KLHL13;COPS5;DCAF6;CP;PSMB5;UBXN7;LGALS1;DDA1;ASB7;CHML;SOCS6;DCAF17;TULP4;RAB1B;DNAJC3;PRKCSH;ASB6;CCDC22;FBXL15;ASB8;DDB1;CAND1;ASB3;CUL9;KEAP1;PTP4A2;UBE2F;PSMD1
prerank,negative regulation of glucose transmembrane transport (GO:0010829),0.5791320483278768,1.1669630718385313,0.2897350993377483,0.9161441335395192,1.0,1/10,0.09%,PRKCB
prerank,carboxylic acid transport (GO:0046942),-0.31655050728758577,-1.1664557153517712,0.1956521739130435,0.7073006346165058,1.0,13/55,7.94%,SLC6A13;SLC13A3;SLC16A12;SLC1A5;SLC6A12;SLC6A9;SLC7A5;SLC16A9;SLC6A6;SLC16A6;SLC1A1;SLC16A1;SLC16A4
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),0.5511061628468332,1.1664556622610875,0.28846153846153844,0.9167483959653802,1.0,1/12,0.14%,SORBS1
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),0.5034456423168616,1.1664207347476465,0.30364963503649633,0.9157155596467509,1.0,4/20,9.08%,PRKAA2;PPARGC1A;FOXP3;BRD7
prerank,inner ear receptor cell stereocilium organization (GO:0060122),-0.4887050245971586,-1.1659360108230274,0.2887139107611549,0.7069358688894347,1.0,6/10,26.61%,ADGRV1;PLS1;SOD1;TSKU;WHRN;IFT88
prerank,inner ear morphogenesis (GO:0042472),0.48926774428010306,1.1655535992524935,0.2895480225988701,0.9177326850314435,1.0,5/22,9.46%,ATP6V1B1;HPN;SOX9;SIX1;ZIC1
prerank,protein N-linked glycosylation via asparagine (GO:0018279),0.46091169029642126,1.165278256832321,0.26021798365122617,0.9175107529853522,1.0,10/30,17.61%,B4GALNT2;ASGR1;MGAT1;FUT8;DDOST;MCFD2;DPM2;ALG5;UBE2J1;RPN2
prerank,skeletal muscle tissue development (GO:0007519),0.4595398952765761,1.1650913510274499,0.2803129074315515,0.9170219214546773,1.0,6/32,8.17%,CAV1;CSRP3;SELENON;LMOD3;CAV2;SIX1
prerank,peptidyl-lysine trimethylation (GO:0018023),0.48025187168719735,1.1650716162236985,0.29901269393511987,0.9159642034649386,1.0,4/26,9.03%,OGT;EEF2KMT;BEND3;KMT2A
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),-0.2923121175182841,-1.1646470669102245,0.17006802721088435,0.7087941028947694,1.0,17/75,9.51%,FARP1;MAP2;MAP1B;DCC;PAK3;DCDC2;ZDHHC17;BRSK1;NRCAM;CTNNA2;SLITRK1;S100B;DSCAML1;SDC2;FGFR2;RYK;NTNG1
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.4022555414001184,1.1646028180949477,0.24497041420118343,0.9164913130033466,1.0,20/73,19.38%,CD44;NTRK3;CAV1;NGF;CREBL2;DOCK7;HAX1;LATS1;RAF1;RAPGEF3;CAPRIN2;ATP2B4;EIF4G1;HSP90AA1;PFN2;HDAC6;MTCP1;PARK7;PRKD2;APP
prerank,neuron projection development (GO:0031175),-0.26420596792110473,-1.1627807784857966,0.09615384615384616,0.7121617921965242,1.0,44/168,13.82%,PTPRM;CNTNAP2;RAPGEF2;MAP2;ADGRV1;DCLK1;SHANK3;TNIK;LYN;NRK;DOCK10;PAK3;GRM7;FRY;STMN2;NYAP2;SGK1;LGI1;LAMB1;DAB2IP;EPB41L3;LRP12;EPHB2;LRRK2;NLGN1;ROCK1;DTNBP1;TBC1D24;RYK;SNAPIN;PLP1;MAP4K4;NCKAP1L;ALS2;MYOC;MAPK8IP3;TBC1D23;MANF;TMEM108;BDNF;CNTNAP1;ATXN10;PPP1R9A;STMN3
prerank,DNA synthesis involved in DNA repair (GO:0000731),0.42903864635672784,1.161731020544422,0.258148631029987,0.925348822776202,1.0,14/42,20.27%,TRIM25;USP10;REV1;POLK;PCLAF;RPA3;POLH;POLD2;PCNA;RPS27A;UBC;RFC1;CDKN2D;POLN
prerank,response to nitric oxide (GO:0071731),-0.4501235881702946,-1.1607921026083463,0.26208651399491095,0.7161426025585285,1.0,5/13,15.59%,GUCY1B1;FOXO1;EGLN1;TXN;MTR
prerank,keratan sulfate catabolic process (GO:0042340),0.5438591707227697,1.1607797563086326,0.3108974358974359,0.9274227944071656,1.0,4/11,11.11%,HEXA;PRELP;GLB1;HEXB
prerank,protein targeting to mitochondrion (GO:0006626),0.4238741196932755,1.1603180987435129,0.27350427350427353,0.9278673161273672,1.0,18/52,20.95%,TIMM10;TIMM44;PMPCA;AGK;TOMM5;DNLZ;ROMO1;HSPA4;PITRM1;BCAP31;TOMM20;TIMM17B;HSP90AA1;TOMM40L;TIMM9;TOMM40;TSPO;TIMM50
prerank,negative regulation of response to cytokine stimulus (GO:0060761),0.5605566019605929,1.1600918332146413,0.3257328990228013,0.9275893032280226,1.0,3/10,14.01%,KLF4;MAPK7;TLE5
prerank,regulation of B cell activation (GO:0050864),-0.37557668845957776,-1.1600213883973047,0.24915824915824916,0.7164120070756104,1.0,12/25,38.36%,SH3KBP1;TNFAIP3;NOD2;AHR;TNIP2;FCGR2B;BANK1;FOXJ1;SAMSN1;IL4I1;IKZF3;THEMIS2
prerank,amino sugar biosynthetic process (GO:0046349),0.5413442375847032,1.1598496398394391,0.29595015576323985,0.9272702416344921,1.0,6/12,27.44%,NAGK;UAP1L1;GFPT1;GNPDA2;UAP1;PGM3
prerank,positive regulation of epidermal cell differentiation (GO:0045606),0.5127138399435807,1.1597789538899537,0.3200636942675159,0.9263683952936628,1.0,3/15,6.81%,NCOA3;SULT2B1;BMP4
prerank,negative regulation of cilium assembly (GO:1902018),0.5441068691081498,1.1597777611258289,0.3198707592891761,0.9252312209588425,1.0,3/12,6.97%,LIMK2;CDK10;MAP4
prerank,negative regulation of ossification (GO:0030279),0.47584471723922955,1.1596032774668945,0.30389221556886226,0.9247450207193108,1.0,7/23,14.09%,SMAD6;PTK2B;SOX9;SRGN;TRPM4;MEF2C;SFRP1
prerank,negative regulation of axon extension (GO:0030517),0.4597692972060929,1.1592269007035,0.2696011004126547,0.9248902947950786,1.0,3/30,2.81%,SEMA3D;RTN4R;SEMA3B
prerank,proteasome assembly (GO:0043248),0.5597075737243966,1.1591594223495,0.3088235294117647,0.923994574900543,1.0,3/11,7.00%,PSMD11;POMP;PSMD4
prerank,regulation of monocyte chemotaxis (GO:0090025),0.47332714375650553,1.1588225238526066,0.3011527377521614,0.9239941951538628,1.0,6/24,12.23%,CCL5;NBL1;MOSPD2;DUSP1;CREB3;ANO6
prerank,dopaminergic neuron differentiation (GO:0071542),-0.40448542517046615,-1.1586058876807293,0.23943661971830985,0.7184443432308769,1.0,12/19,46.74%,LRP6;RYK;MANF;NR4A2;LMX1A;WNT2;SHH;VEGFA;FOXA1;EN1;FOXA2;CDNF
prerank,nucleotide-sugar biosynthetic process (GO:0009226),0.4970420023679874,1.1584452145662016,0.3016344725111441,0.9241228169710178,1.0,9/19,27.44%,NAGK;NANS;UAP1L1;GFPT1;GNPDA2;PMM1;UAP1;PMM2;PGM3
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),0.46604751830373137,1.1583495238066546,0.27363896848137537,0.9233358532943349,1.0,5/26,11.15%,CLU;KLF4;DDAH2;TLR6;TLR4
prerank,early endosome to late endosome transport (GO:0045022),0.5029162705552794,1.1582103604284701,0.3128654970760234,0.9226430765423372,1.0,6/20,14.68%,EMP2;RAB7A;LMTK2;HOOK1;WDR91;SNX16
prerank,hyaluronan metabolic process (GO:0030212),0.4874618501095158,1.1573625075096068,0.27232796486090777,0.9244182851171778,1.0,6/23,11.11%,CD44;HEXA;STAB2;CHP1;GUSB;HEXB
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.48386601493473264,1.1562994820608736,0.30520393811533053,0.9269690904272145,1.0,3/21,2.93%,CNOT6;SAMD4A;SAMD4B
prerank,glycosphingolipid biosynthetic process (GO:0006688),-0.42345972918107677,-1.1560552242759945,0.26420454545454547,0.7238934588283359,1.0,5/16,8.01%,ST6GALNAC3;ST3GAL5;ST8SIA4;ST6GALNAC5;ST8SIA6
prerank,regulation of response to biotic stimulus (GO:0002831),0.45895362974142767,1.1560432702853092,0.2838983050847458,0.9267171299943371,1.0,1/28,0.15%,CD55
prerank,positive regulation of translation (GO:0045727),0.3895877309148678,1.155753410187506,0.24655963302752293,0.9266216286670604,1.0,27/94,20.72%,CCL5;VIM;SAMD4A;YTHDF1;YBX3;RPS4X;PKM;EIF4A3;UPF3A;EIF6;MRPS27;HABP4;POLDIP3;CPEB3;PLXNB2;FXR1;BOLL;UPF3B;PYM1;DHX9;JMJD4;EEF2;USP16;YTHDF3;TRUB2;SOX4;ZCCHC4
prerank,regulation of microglial cell activation (GO:1903978),0.5092564730239821,1.155716697573373,0.29233226837060705,0.925611719475662,1.0,1/15,1.18%,LDLR
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),-0.3955244248639862,-1.155703881168964,0.2593856655290102,0.7211559708639231,1.0,5/20,5.29%,IGF1;INSR;ZBTB20;HIF1A;PRKAA1
prerank,positive regulation of glycolytic process (GO:0045821),-0.3955244248639862,-1.155703881168964,0.2593856655290102,0.7211559708639231,1.0,5/20,5.29%,IGF1;INSR;ZBTB20;HIF1A;PRKAA1
prerank,glycine transport (GO:0015816),0.5705155145170351,1.1554463076777344,0.32689210950080516,0.9254744028612798,1.0,2/10,10.52%,SLC36A3;SLC25A38
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),-0.33518290375971416,-1.1549569940454223,0.2271062271062271,0.7213657529259064,1.0,16/37,28.20%,PRKAG2;CEMIP;TGFB1;IRGM;S1PR2;SIRT2;SPRED1;EGF;SPHK1;BMP7;DGKQ;STOX1;TRIM6;CADM4;RIPK2;CALM3
prerank,positive regulation of BMP signaling pathway (GO:0030513),-0.3723773672275523,-1.154896830467562,0.24381625441696114,0.719657026091068,1.0,12/25,20.36%,SULF1;ENG;ACVRL1;NOTCH1;BMPR1B;ACVR2A;ZNF423;CCN1;BMPR2;SOX11;UBE2O;SMAD4
prerank,myelination (GO:0042552),-0.3265531250156575,-1.1546007006226282,0.20179372197309417,0.7186710791954084,1.0,20/46,16.99%,SLC8A3;MAL;EPB41L3;TNFRSF21;NFASC;CMTM8;GAL3ST1;PLP1;NF1;PLLP;MBP;MYOC;TPPP;CNTNAP1;ABCD2;B4GALT5;MYRF;SIRT2;ACSBG1;MPZ
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.4376528465610408,1.154283073047141,0.2914507772020725,0.9283058094286865,1.0,14/38,21.44%,NDUFV1;NDUFB11;NDUFB8;NDUFB6;NDUFS3;NDUFAB1;NDUFB7;NDUFV2;NDUFA1;NDUFB4;NDUFB5;NDUFB9;NDUFA2;NDUFA12
prerank,DNA modification (GO:0006304),0.4883435207824863,1.154160568378947,0.30158730158730157,0.9275728474164623,1.0,13/22,29.99%,PARP3;EXOSC3;MUTYH;MBD4;NEIL1;PARP2;TERF2;TINF2;EXOSC4;PARP1;TERF1;TERF2IP;TDG
prerank,photoreceptor cell development (GO:0042461),0.539738540886258,1.1539884069535276,0.3166144200626959,0.9270542008798202,1.0,2/14,4.77%,RP1;ARL3
prerank,translesion synthesis (GO:0019985),0.427877815337637,1.1539309680271954,0.28258064516129033,0.9261350163510778,1.0,15/42,21.91%,TRIM25;USP10;REV1;POLK;PCLAF;NPLOC4;RPA3;POLH;POLD2;PCNA;RPS27A;UBC;RFC1;POLN;RCHY1
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.37306181681837125,1.1537846904406173,0.23326359832635984,0.9255199240443903,1.0,37/158,15.95%,PRKCB;LPAR1;EDA2R;AKAP13;IKBKE;MAVS;TRIM25;MTDH;TFG;SLC20A1;MUL1;CC2D1A;WLS;TRIM21;TAB3;TNFRSF10B;PPM1A;TNFRSF1A;TLR6;JMJD8;CARD16;ANKRD17;RHOA;MIB2;EEF1D;PELI1;LGALS1;IRAK1;CHUK;GAPDH;GPR89A;PLK2;IKBKG;RNF31;FLNA;UBE2N;CCDC22
prerank,positive regulation of response to external stimulus (GO:0032103),0.38039623642970816,1.1537525691805741,0.2386117136659436,0.9244971144654726,1.0,22/128,15.83%,AGTR1;GPR4;NAPEPLD;CCL5;IL17RA;NINJ1;IL15;IL16;NFKBIA;THBD;FEM1A;POLR3B;TNFRSF1A;NMI;TLR4;ANKRD17;PTN;POLR3C;TNIP1;TLR3;DHX9;POLR3G
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.4649432498224619,1.1537418387642857,0.2958748221906117,0.92341342611261,1.0,4/25,5.61%,LIMK2;KANK1;CDK10;CAPZB
prerank,positive regulation of intracellular transport (GO:0032388),0.43771278259441,1.1533891869032094,0.2785622593068036,0.9234543345682954,1.0,13/38,24.60%,ACTN2;EHD1;PLK3;BCAS3;NEDD4;RIPOR1;DYNC1H1;NUMA1;KIF20B;VAMP2;TPR;ICE1;PCM1
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),-0.39837675937210937,-1.152833434107948,0.2871287128712871,0.7220841430499116,1.0,5/21,3.42%,CACNA1C;DMD;SLC8A1;PDE4D;CAMK2D
prerank,leukocyte tethering or rolling (GO:0050901),0.5048212520506691,1.152259739873482,0.3192771084337349,0.9261906648597243,1.0,3/17,7.17%,PODXL2;ITGB7;GOLPH3
prerank,embryonic organ morphogenesis (GO:0048562),-0.32594082937402896,-1.1521189343235947,0.22321428571428573,0.7222071743099565,1.0,16/42,17.95%,FBN1;MFAP5;PDGFRA;FBN2;DSCAML1;SOX17;ID2;FGFR2;MEGF8;RBP4;TBX1;NIPBL;RYR2;SOX11;HOXC4;HOXD3
prerank,diol biosynthetic process (GO:0034312),-0.4328501765923145,-1.1519074891841994,0.27988338192419826,0.7209923774590609,1.0,9/15,33.30%,ACER2;GCH1;SPR;DHFR;SPHK1;ASAH2;SPTLC2;ACER3;SPTLC3
prerank,purine ribonucleotide transport (GO:0015868),-0.4224108958786183,-1.1517766862550411,0.28169014084507044,0.7195361261694686,1.0,2/16,1.29%,LRRC8C;ABCC4
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),0.4757698464923332,1.1513304412347267,0.2927170868347339,0.9282143247377466,1.0,5/23,9.66%,DYNC1I1;MAP6;KIF1C;KIF1B;HOOK1
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.4031877721472762,1.1512237442156474,0.2779700115340254,0.9274334644654267,1.0,17/76,15.64%,NR3C2;UACA;ZC3H12A;EP300;PPM1B;TRIM44;NFKBIA;ILK;PPM1A;EZR;NMI;TLR4;RHOA;IRAK1;PTP4A3;TLR3;ACTN4
prerank,homologous chromosome segregation (GO:0045143),0.48943188475296956,1.151174459344354,0.3231441048034934,0.9264845992933173,1.0,1/20,1.16%,ANKRD31
prerank,actin filament organization (GO:0007015),0.37465371459421226,1.150955812292203,0.22424892703862662,0.9260825975454874,1.0,22/151,10.17%,BAIAP2L1;POF1B;COBL;NEBL;TMOD3;MYO1H;VILL;EMP2;GSN;MPRIP;TMOD2;MCU;CORO7;LMOD3;ENAH;AVIL;DMTN;CDC42;MYO5A;GAS2L1;MYO1C;ABI1
prerank,cellular response to hypoxia (GO:0071456),0.37910060656443484,1.150366062044996,0.2425249169435216,0.9269021820085026,1.0,32/126,18.10%,EGLN3;NDRG1;CPEB2;EP300;PMAIP1;EPO;PSMD11;ELOB;PSMD4;PSMF1;EGLN2;BAD;PLK3;RBX1;TWIST1;CARD16;TIGAR;PSMD7;AQP1;HYOU1;PSMB5;NPEPPS;MYC;SFRP1;BNIP3L;LMNA;MDM2;RPS27A;UBC;STUB1;PSMD1;PSMC4
prerank,glycoprotein catabolic process (GO:0006516),-0.41853727909444094,-1.1499399563914128,0.2761627906976744,0.7227801319252269,1.0,2/17,1.30%,ADAMTS12;ADAMTS9
prerank,toll-like receptor 3 signaling pathway (GO:0034138),0.5459394312342551,1.1495563692611528,0.32310177705977383,0.928532992831241,1.0,1/11,0.58%,SCARA3
prerank,neural tube development (GO:0021915),-0.42778717725293397,-1.1494929544978876,0.27298850574712646,0.7221685057581602,1.0,4/15,7.31%,ALDH1A2;PKD2;DACT1;TGFB1
prerank,plasma membrane bounded cell projection organization (GO:0120036),-0.26967260001012733,-1.1494411220468803,0.12149532710280374,0.7204327868226353,1.0,35/124,17.39%,PTPRM;CNTNAP2;RAPGEF2;MAP2;LYN;FRY;STMN2;LIMA1;LGI1;PKD2;LAMB1;LRP12;CEP78;NLGN1;ROCK1;DTNBP1;ARMC2;TBC1D24;RYK;FAM161A;SNAPIN;PLP1;MYOC;TBC1D23;MANF;TMEM108;KIFAP3;ATXN10;PPP1R9A;STMN3;NCDN;ATCAY;HMGB1;RASGRF1;WDPCP
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),-0.39214176266824163,-1.1493588656378217,0.24919093851132687,0.718768600579291,1.0,6/20,9.13%,TGM2;CAMK2D;ATP2A2;BCL2;SELENOK;FIS1
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.4623971653864302,1.1492482666106194,0.28,0.928530774691167,1.0,6/24,12.85%,CLU;ALOX5;BCL2L1;CREB3;OPA1;LPCAT3
prerank,response to axon injury (GO:0048678),-0.41023913368995096,-1.1492312577585704,0.30346820809248554,0.7173107011065782,1.0,8/18,21.75%,NREP;MAPK8IP3;DHFR;MTR;SARM1;SOD1;P2RY12;TYROBP
prerank,negative regulation of multicellular organismal process (GO:0051241),0.36907535408794595,1.1488673248425656,0.240625,0.928699785547406,1.0,48/199,15.61%,PLCL2;LAMA4;HPN;SMAD6;IL15;GDF15;WNT11;TWSG1;FOXC2;PPP2CA;DUSP10;BMP5;TIMP1;HMGCR;PROCR;RAB11FIP3;IP6K1;OVOL2;DOCK7;SPRED3;SOX9;RHEB;BMP4;KLF7;PARP3;PLCL1;CYP51A1;SRGN;LGR4;ARRDC3;GRHL2;FOXP3;NFIB;PPP1R11;RAB11FIP5;TLR4;LDLRAD4;GATA3;GSK3A;MEF2C;ATP2B4;SFRP1;GSK3B;FLCN;SYT11;ARHGDIB;ABHD6;RAB11FIP1
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.41172803449630985,1.1482601921235323,0.2747524752475248,0.9296774998566785,1.0,18/63,17.98%,CNOT6;CDKN1A;EP300;PLK3;FBXO31;PML;SDE2;CCND1;CDK2;BTG2;MDM2;PLK2;PCNA;E2F1;PRMT1;CHEK2;PIDD1;TRIAP1
prerank,positive regulation of vasculature development (GO:1904018),0.3861793040598894,1.1480437576769127,0.26539753639417696,0.9292957778747745,1.0,16/94,11.19%,PRKCB;ADAM12;ITGB8;ANXA3;NINJ1;ZC3H12A;GAB1;HSPB1;MTDH;AGGF1;MYDGF;VEGFB;EMC10;TWIST1;AQP1;RAPGEF3
prerank,response to UV (GO:0009411),0.38792895395396765,1.147738397453341,0.26704545454545453,0.9291973579964602,1.0,33/95,24.76%,SCARA3;FEN1;EP300;MAP3K4;REV1;POLK;SDE2;UBE2B;CCND1;PCLAF;AQP1;ERCC5;MYC;POLH;NEDD4;USP28;PCNA;ATR;ERCC2;KDM1A;EIF2AK4;TRIAP1;COPS9;CDKN2D;ERCC4;USF1;RHBDD1;YY1;MEN1;RPL26;CDC25A;EIF2S1;PTPRK
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.4547143400804767,1.1476966184382194,0.2832618025751073,0.9282447494535304,1.0,5/28,11.13%,CLU;NUPR1;DDRGK1;ATP5IF1;OSBPL7
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),-0.42895320176154283,-1.1471326180461243,0.26273458445040215,0.7215025532922795,1.0,8/14,31.83%,THBS1;RGCC;ITGA4;PDCD4;CD40;PRKCI;CCL2;PLCG1
prerank,recombinational repair (GO:0000725),0.4006310512306283,1.1466458846701075,0.27699530516431925,0.9306293904495231,1.0,29/77,22.43%,FEN1;RECQL4;KDM4D;NABP2;RNF138;MRE11;RMI1;HUS1B;NSMCE2;MMS22L;ERCC5;RPA3;MCM8;FAN1;UBE2N;LIG3;SFR1;SMC6;NBN;RAD50;ZFYVE26;NUCKS1;ERCC4;NABP1;POLN;YY1;SFPQ;SWI5;NSMCE1
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.3571649308731627,1.146644319827129,0.14914914914914915,0.929536640123395,1.0,94/509,15.75%,FN1;ADRA1B;WNT16;PRKCB;CDH13;FGFR1;NR3C2;ANGPT1;LPAR1;NTRK3;CCL5;JCAD;EDA2R;PLXNB1;PDGFC;NUPR1;BBC3;GDF15;AKAP13;GAB1;WNT11;CAV1;IKBKE;MAVS;EP300;PMAIP1;GCNT2;EPO;TRIM25;MTDH;TRIM44;TFG;CAV2;BCL2L1;SLC20A1;SOX9;RHEB;HAX1;SHC1;MYDGF;MUL1;CC2D1A;WLS;GOLPH3;ERBB3;TRIM21;TGFB2;BAD;TAB3;ILK;TNFRSF10B;UNC5B;FGF22;PPM1A;MAZ;TCF7L2;IQGAP1;TNFRSF1A;TLR6;PTPN6;JMJD8;NMI;SMCR8;BCAP31;CARD16;HDAC3;GSDME;TLR4;ANKRD17;IRS2;RHOA;MIB2;GATA3;EEF1D;PELI1;LGALS1;IRAK1;CHUK;PTP4A3;HRAS;GAPDH;NEDD4;DNM1L;FLCN;ITGB1BP1;GPR89A;TLR3;PLK2;HSP90AA1;IKBKG;RNF31;ACTN4;FLNA;UBE2N
prerank,oligodendrocyte differentiation (GO:0048709),-0.4024674292369788,-1.1465116715706578,0.2676923076923077,0.72135760422974,1.0,7/19,15.62%,SLC8A3;SOX13;EIF2B3;PTPRZ1;TPPP;SOX6;MYRF
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.4001662964087188,1.1463524131739762,0.2906178489702517,0.9294419135933545,1.0,19/80,15.74%,WNT1;ARAP1;OCLN;EPS8L2;NDEL1;CDC42EP4;PALM;CDC42EP5;RIPOR2;RHOQ;AVIL;CDC42;BCAS3;PLEKHM1;MARK4;HRAS;CCDC88A;WASHC1;FSCN1
prerank,semaphorin-plexin signaling pathway (GO:0071526),0.4414713599649739,1.1463405919342247,0.29326287978863935,0.9283940723543683,1.0,4/35,2.81%,SEMA3D;PLXNB1;PLXNA2;SEMA3B
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),-0.44368478893805124,-1.145398409436579,0.2841225626740947,0.7226077504199693,1.0,6/13,22.02%,FIP1L1;NUDT21;CPSF6;CPSF1;CPSF4;NCBP1
prerank,negative regulation of TOR signaling (GO:0032007),0.4384384324693206,1.1448198157296678,0.30303030303030304,0.9324170603741962,1.0,5/36,5.70%,RNF152;PRKAA2;SESN2;SH3BP4;TSC2
prerank,negative regulation of protein localization to cell periphery (GO:1904376),-0.3869583544141002,-1.1445916371400406,0.2696969696969697,0.7229732744879289,1.0,3/20,7.31%,PID1;DAB2;TGFB1
prerank,long-chain fatty acid import into cell (GO:0044539),-0.48915487298848903,-1.1445274654930668,0.3033419023136247,0.7213227972695109,1.0,3/10,9.55%,SLC2A1;ACSL1;RPS6KB1
prerank,regulation of mitotic nuclear division (GO:0007088),-0.31512400482557507,-1.1444744448140314,0.20994475138121546,0.719634529318508,1.0,14/55,17.58%,IGF1;PDGFRB;TGFA;INSR;RGCC;IGF2;LRP5;RCC1;ANAPC15;TOM1L1;EDN1;BORA;EDN3;EGF
prerank,regulation of cell-matrix adhesion (GO:0001952),0.40374246123385327,1.144413766048392,0.2608695652173913,0.9326822215959242,1.0,20/64,17.85%,CDH13;UTRN;EMP2;CDK6;PTK2B;DAPK3;EFNA5;PTPRA;CASK;ADAM15;ACTG1;EPHA3;RHOA;RASA1;SFRP1;GSK3B;VCL;SLC9A1;DUSP3;PEAK1
prerank,nervous system development (GO:0007399),0.3589297810502104,1.1443412415692176,0.1715145436308927,0.9318522388448677,1.0,48/429,9.50%,FN1;CDH1;MBNL1;FGF13;SDK1;LPAR1;NOTCH2;CHRM1;CELSR1;SMO;ZIC4;PDGFC;PCDHA8;SREBF2;GSN;NBL1;CRIM1;NINJ1;EP300;CXCR4;TMOD2;NGF;RBFOX2;GDNF;GLIS2;HDAC4;ZBTB16;UTP11;HMGCR;PCDHB12;NAGLU;GFRA3;UNC119;AVIL;EFNA5;EIF2B2;ZIC2;LRCH4;ERBB3;CYP51A1;PKD1;FZD5;POU3F1;GRHL2;OPHN1;DPF2;ZIC1;PCDHA4
prerank,cardiac conduction system development (GO:0003161),0.4729694096831395,1.144244151868232,0.31550068587105623,0.931098712519792,1.0,3/24,6.81%,NOTCH2;GJB6;BMP4
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.45386017026110415,1.1438938717453246,0.2853146853146853,0.9312167971311011,1.0,12/30,22.71%,SREBF2;FZD5;SAE1;VPS11;NPEPPS;RHOU;GSK3A;RNF31;UBE2D3;FBXW7;ARIH2;MICALL2
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.5124461204590605,1.143828887052679,0.32142857142857145,0.9303484581524855,1.0,5/16,11.27%,ERLIN2;SOX9;ACADL;ERLIN1;NCOR1
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.41457715387038646,1.1436577261248104,0.29865361077111385,0.9298058372275246,1.0,8/55,7.91%,AGTR1;CDKN1A;ZC3H12A;DHRS4;ALOX5;FOXM1;EIF6;ROMO1
prerank,calcium ion transport into cytosol (GO:0060402),-0.38940719637679755,-1.1432322083544932,0.254071661237785,0.7213799768629452,1.0,5/21,6.26%,CACNA1C;SLC8A1;GRIN2A;JPH1;GRIN2B
prerank,regulation of cholesterol metabolic process (GO:0090181),0.4828213246054782,1.1432112406123511,0.3238805970149254,0.9302054533213214,1.0,5/20,12.85%,SREBF2;TTC39B;ACADL;ABCA2;LPCAT3
prerank,cellular response to calcium ion (GO:0071277),-0.2887901919676892,-1.1430146507834151,0.20224719101123595,0.7202074402404041,1.0,13/67,7.83%,CPNE8;ADGRV1;WNT5A;CAMK2D;RASGRP2;CPNE4;PKD2;SYT9;PRKAA1;SYT1;NLGN1;ADCY1;MCOLN1
prerank,negative regulation of mononuclear cell migration (GO:0071676),0.5373258692056746,1.1427168734919966,0.3333333333333333,0.9308796201071272,1.0,4/12,5.44%,ADTRP;NBL1;BMP5;DUSP1
prerank,negative regulation of endopeptidase activity (GO:0010951),0.4268775568947169,1.1426635959214682,0.2833545108005083,0.9299902769500556,1.0,8/47,8.77%,ANXA8;ANXA8L1;CRB2;TIMP4;SERPINC1;TIMP1;TIMP2;SERPINB8
prerank,protein localization to endoplasmic reticulum (GO:0070972),0.5180202188120939,1.14253693429688,0.3277439024390244,0.9293524353452802,1.0,4/16,10.39%,ANK2;PPP1R15A;DDRGK1;BCAP31
prerank,peptidyl-asparagine modification (GO:0018196),0.4500204911721599,1.142465775186928,0.2872628726287263,0.9285038378752373,1.0,10/31,17.61%,B4GALNT2;ASGR1;MGAT1;FUT8;DDOST;MCFD2;DPM2;ALG5;UBE2J1;RPN2
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),0.5399298203562506,1.1424627648447876,0.3317757009345794,0.9274383044666437,1.0,3/13,7.48%,CYFIP2;PERP;BAD
prerank,eye photoreceptor cell differentiation (GO:0001754),-0.45210813800698474,-1.1420920106788037,0.31746031746031744,0.7209457235342087,1.0,4/12,10.70%,SDK2;PROM1;RORB;STAT3
prerank,regulation of lipid metabolic process (GO:0019216),0.38797196378701043,1.1420694127176885,0.2626728110599078,0.9276307443000478,1.0,21/88,12.28%,FDFT1;SREBF2;RORC;CAV1;DHCR7;FDPS;HMGCR;PMVK;RUBCNL;CYP51A1;ELOVL6;NFYC;HDAC3;NCOR1;CERS2;ACACA;GPAM;MBOAT7;IRS2;FASN;SP1
prerank,regulation of DNA-dependent DNA replication (GO:0090329),-0.4472314687304464,-1.1412792398484473,0.2803970223325062,0.7215940589012145,1.0,4/12,16.81%,KAT7;TIPIN;WRNIP1;BLM
prerank,regulation of ERBB signaling pathway (GO:1901184),0.5088024242059491,1.1412669297550353,0.3338632750397456,0.9292480632399379,1.0,1/15,0.37%,CDH13
prerank,neuron projection extension (GO:1990138),0.4495703424209966,1.1409485392880858,0.31713900134952766,0.9292129358456416,1.0,11/32,17.94%,ALCAM;FLRT1;IQGAP1;SLC9A6;NRP2;SH3GL2;FLRT3;ULK1;HSP90AA1;EIF2AK4;SEMA3A
prerank,blood vessel endothelial cell migration (GO:0043534),0.4696787401482886,1.1405292563352674,0.30906389301634474,0.929524224084214,1.0,3/22,2.06%,ADTRP;EFNB2;EMP2
prerank,positive regulation of JNK cascade (GO:0046330),0.4045126225762303,1.1403123432180855,0.2689987937273824,0.92918416122917,1.0,6/70,4.38%,WNT16;MAP3K5;EDA2R;CCN2;PTK2B;SH3RF2
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),-0.44802779048947805,-1.1400349812889683,0.3175,0.7232261062241022,1.0,3/12,2.85%,PRKG1;DOCK4;IGFBP5
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),0.5308644878045645,1.1397474142151152,0.3146964856230032,0.9300542623233671,1.0,3/11,7.91%,TIMM10;AGK;ROMO1
prerank,regulation of coagulation (GO:0050818),0.5327687229981898,1.1392725695328272,0.33222591362126247,0.9306286510384804,1.0,2/11,5.19%,CAV1;PROCR
prerank,response to exogenous dsRNA (GO:0043330),0.49580773611080386,1.1391808545922675,0.31004366812227074,0.9298341598588378,1.0,7/18,19.47%,CAV1;MAVS;MUL1;TLR3;DHX9;COLEC12;FLOT1
prerank,insulin receptor signaling pathway (GO:0008286),0.40005852507802825,1.1390832102280724,0.2745803357314149,0.9290768379624849,1.0,17/69,15.53%,SORBS1;ATP6V1B1;GAB1;FOXC2;RHOQ;CAV2;SHC1;AP3S1;PDK2;IRS2;BCAR1;PTPN2;GSK3A;GSK3B;ATP6V1E1;ATP6V1D;ATP6V0D1
prerank,positive regulation of cellular process (GO:0048522),0.35486293161589477,1.13906968412418,0.15963855421686746,0.9280592991073178,1.0,84/565,12.14%,FN1;DPP4;FGFR1;CRLF1;PRKAA2;NTRK3;CNOT6;WNT1;LAMC2;TJP1;CCL5;EPHA4;PDGFC;EFNB2;GRK5;ADAM10;HPN;EMP2;CCN2;NUPR1;IL15;ZC3H12A;CAV1;PDF;CELF1;CD81;PRR7;PTGFR;TNFSF13;PTK2B;GDNF;NOP2;PPP1R13L;HDAC4;BMP5;CLCF1;GCNT2;TIMP1;EPO;CIAO1;DOT1L;NACC1;CDK4;RPS4X;NSMCE4A;FOXM1;KRAS;SOX9;HCFC1;SHC1;DDRGK1;MAPK15;BMP4;CCND2;ERBB3;TRIM21;TGFB2;ZFHX3;ROMO1;FGF22;MAZ;CDC42;FBXO5;SSR1;IL7R;LBP;PTPN6;MTLN;CAPNS1;CCND1;SRPK2;HP;HPR;KDM4C;TLR4;TBRG4;TRPM4;ANKRD17;ACACA;FCER1G;IRS2;FASN;EIF4G2;TGFBR2
prerank,organic substance transport (GO:0071702),0.38015048020812786,1.1390184397161889,0.2703296703296703,0.9271441991347047,1.0,15/121,11.49%,CUBN;SLCO2A1;SCAMP5;ABCD1;AMN;RAMP1;SLC48A1;SLC22A18;RAB7A;ARRDC3;NDC1;ARL6IP5;TOM1;ABCA2;SCAMP2
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-0.43739682074787817,-1.1389223802200823,0.30140845070422534,0.7244663350625001,1.0,6/14,16.64%,WNT5A;SEMA7A;CAMK4;KIT;GPRC5B;CD74
prerank,positive regulation of histone acetylation (GO:0035066),0.475595984874871,1.1387687315120107,0.32590529247910865,0.9268777559063207,1.0,5/23,9.08%,PPARGC1A;SMARCB1;PIH1D1;FOXP3;BRD7
prerank,regulation of acute inflammatory response (GO:0002673),-0.39791254469821113,-1.1384596008800707,0.3003003003003003,0.7239075426118202,1.0,3/18,12.36%,OSMR;PTGES;IL6ST
prerank,mammary gland epithelium development (GO:0061180),-0.4276434709944035,-1.1384506566764778,0.31232876712328766,0.7221257396100529,1.0,4/14,8.78%,WNT4;JAK2;ID2;ERBB4
prerank,sensory perception of smell (GO:0007608),-0.46924120410209036,-1.1383351815772582,0.30861244019138756,0.720650906288447,1.0,6/11,28.82%,UBR3;DRD2;BBS4;SYT10;ADCY3;SLC24A4
prerank,excitatory postsynaptic potential (GO:0060079),-0.3965842259117478,-1.1380852936399484,0.2887537993920973,0.7195782535028243,1.0,6/19,14.94%,GRID2;GRIN2A;GRIN2B;LRRK2;DRD2;MPP2
prerank,supramolecular fiber organization (GO:0097435),0.35899973271234725,1.1379181244570575,0.18970736629667004,0.9286118281531056,1.0,40/333,10.70%,ITGB4;FGF13;PGM5;ADAMTS14;COL23A1;TNXB;COL25A1;POF1B;TSPAN5;LAMC2;COL4A3;COL4A4;VIM;TMOD3;MYO1H;ADAM10;EMP2;GSN;COL5A2;MPRIP;TMOD2;KIF2A;CORO7;COL6A1;LMOD3;COL6A3;AVIL;PXDN;CLIP4;TGFB2;PLK3;CDC42;CHP1;MYO5A;HDGFL3;HOOK1;MYO1C;KLHL24;GGA1;PLEC
prerank,establishment of mitotic spindle orientation (GO:0000132),0.4648557719877284,1.1378440595314134,0.30158730158730157,0.9277955952741013,1.0,7/23,18.67%,NDEL1;NSFL1C;PAFAH1B1;ZW10;INSC;NUMA1;MISP
prerank,acyl-CoA biosynthetic process (GO:0071616),0.5005060789407638,1.1378227691921192,0.31703703703703706,0.9268011644321335,1.0,8/16,22.88%,SLC25A1;ACACA;SCD5;FASN;PPT2;ACLY;GCDH;MLYCD
prerank,negative regulation of secretion by cell (GO:1903531),0.4355780901205491,1.1376328695832436,0.30997304582210244,0.9263519469335371,1.0,10/38,15.37%,ADTRP;STXBP6;HMGCR;CYP51A1;TNFRSF1A;HTR1B;SERGEF;RHBDF2;SYT11;PNKD
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.4487166725888455,1.1376059106942855,0.31874145006839943,0.9253964423900851,1.0,5/32,9.98%,GALP;PGLYRP3;ANG;ROMO1;RNASE3
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),0.51692525881211,1.137211179015184,0.33121019108280253,0.9256980873032659,1.0,4/13,12.14%,GLI3;ZBTB7B;NKAP;TGFBR2
prerank,positive regulation of triglyceride metabolic process (GO:0090208),0.5077206626370248,1.1370796551090097,0.312210200927357,0.9250521163351306,1.0,2/16,3.17%,LDLR;ABHD5
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),0.5293568113993888,1.1368785406765745,0.3404605263157895,0.9246812321290857,1.0,4/12,21.67%,ADTRP;WNK1;ASS1;MIA3
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),-0.4661509013815532,-1.1367849971607733,0.30569948186528495,0.7214978727319054,1.0,3/10,8.18%,KDR;IL33;JAK2
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.44657974190675387,1.1361398410626515,0.3198887343532684,0.9259893131384678,1.0,10/29,16.88%,IKBKE;IRF3;TLR6;TLR4;CHUK;TLR3;IKBKG;RPS27A;UBC;UBE2D3
prerank,fatty acid derivative biosynthetic process (GO:1901570),-0.3411078563754705,-1.1361397459113134,0.2647058823529412,0.7215575963740682,1.0,8/35,12.20%,PAM;ACSS3;GGT5;HMGCLL1;FAR2;HMGCS2;BDH1;HPGD
prerank,Rap protein signal transduction (GO:0032486),0.5639532019940169,1.136063323672475,0.36363636363636365,0.9251620758380574,1.0,6/10,15.44%,RAP1B;RAP1A;RAPGEF3;RAPGEF1;PLK2;RAP2C
prerank,embryonic hemopoiesis (GO:0035162),-0.4461025355213277,-1.1359642247051374,0.30412371134020616,0.7202945852823042,1.0,8/12,26.65%,KITLG;KDR;SH2B3;KIT;FLT3LG;TAL1;THOC5;ATF4
prerank,cardiac muscle tissue morphogenesis (GO:0055008),-0.3496263118799271,-1.1359518602391931,0.2808988764044944,0.7185724203295244,1.0,4/29,9.11%,ENG;NOTCH1;TGFB1;FGFR2
prerank,regulation of defense response to virus by host (GO:0050691),0.44558101468477873,1.1355785384993562,0.3081081081081081,0.9257809907606931,1.0,8/30,17.03%,ZC3H12A;MAVS;TRIM44;TARBP2;MUL1;DHX9;HSP90AA1;EIF2AK4
prerank,cellular response to lipid (GO:0071396),0.3626437812052675,1.1349476445271813,0.25732217573221755,0.9267336728013034,1.0,32/191,14.09%,CFTR;ADTRP;NCOA3;VIM;RORC;PTK7;ZC3H12A;WNT11;ATP1A2;FAM210B;PTK2B;WNT6;INSIG1;LCOR;CREB1;SOX9;MSN;TRIM41;ADCY6;WNT5B;LBP;CARD16;ADAM15;AQP1;TLR4;EPHA3;RHOA;WNT3;SBNO2;IRAK1;MEF2C;SFRP1
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.5120887993894012,1.134881722374262,0.33647798742138363,0.9258927164171246,1.0,6/15,19.18%,CD44;MDM2;KDM1A;ARMC10;TRIAP1;TAF9B
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.5045267052705108,1.134313740060015,0.32,0.9266362211717045,1.0,4/15,11.15%,NLRP2B;PYDC1;TLR6;TLR4
prerank,cellular response to light stimulus (GO:0071482),0.397779963113201,1.134304494916676,0.2857142857142857,0.9256185173815535,1.0,23/66,24.76%,OPN1SW;EP300;POLK;SDE2;AQP1;CNGB1;MYC;PDE6B;NEDD4;USP28;PCNA;ATR;KDM1A;EIF2AK4;TRIAP1;COPS9;ERCC4;RHBDD1;YY1;RPL26;CDC25A;EIF2S1;PTPRK
prerank,response to X-ray (GO:0010165),-0.4389929466706665,-1.134295152731094,0.2898172323759791,0.7214905868901469,1.0,4/14,16.81%,BRCC3;NIPBL;IKBIP;BLM
prerank,response to cytokine (GO:0034097),-0.2671344528741374,-1.1339473324967388,0.13793103448275862,0.7207689570052869,1.0,35/141,14.03%,PID1;LEF1;ALDH1A2;OSMR;IL1R1;SP100;IL1RAPL1;TIMP3;LIFR;IRAK2;GGT5;LGALS9;XAF1;ADAR;PTPN4;IRAK3;IFNAR2;BCL2;IL6R;PTPN12;IFITM3;GCH1;JAK2;CXCL16;TBK1;PLSCR1;TRAF6;STAT3;RIPK1;IL6ST;KLHL20;MME;SMAD3;YTHDC2;ADAM9
prerank,cellular response to sterol (GO:0036315),0.5253713706972487,1.133942942127987,0.32125984251968503,0.9257290542053715,1.0,4/13,11.13%,SMO;RORC;INSIG1;OSBPL7
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),0.45656086316434774,1.1338073934178523,0.29707112970711297,0.9251437941223186,1.0,10/27,18.32%,PRKCB;KANK1;TSC2;PTPRE;PTPN2;PIP4K2C;GSK3A;PRKCZ;PRKCQ;SLC27A4
prerank,positive regulation of T cell migration (GO:2000406),0.4799819041773524,1.133789065592658,0.3121301775147929,0.9241868512079573,1.0,8/20,19.54%,CCL5;ADAM10;STK39;OXSR1;RHOA;WNK1;APP;ADAM17
prerank,epithelial to mesenchymal transition (GO:0001837),-0.31443172208392905,-1.133386867762271,0.225,0.7207486382161139,1.0,15/47,11.92%,LEF1;ENG;WNT4;HIF1A;WNT5A;TBX3;NOTCH1;TGFB1;ROCK1;TASOR;HEYL;LOXL3;NOTCH4;DLG5;HMGA2
prerank,glycolipid metabolic process (GO:0006664),0.41547097828409885,1.1328584811066669,0.29781771501925547,0.9262226697033086,1.0,13/47,14.99%,ST3GAL4;HEXA;SCCPDH;GLB1;SUMF1;ABCA2;HEXB;SUMF2;ST3GAL6;ESYT2;SMPD2;NAGA;ST6GALNAC4
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),-0.38895289748320916,-1.1328189619196412,0.2772585669781931,0.7206401756310411,1.0,4/20,7.35%,PID1;DAB2;TGFB1;PKDCC
prerank,mitochondrion transport along microtubule (GO:0047497),-0.4434217143016251,-1.1323652132338038,0.32526881720430106,0.7202779288238609,1.0,4/13,11.82%,HIF1A;SYBU;NEFL;LRPPRC
prerank,cellular response to steroid hormone stimulus (GO:0071383),0.4960316538085887,1.1319492903074377,0.3160453808752026,0.9281795068638045,1.0,3/17,6.81%,ADTRP;ATP1A2;BMP4
prerank,anterograde synaptic vesicle transport (GO:0048490),0.5058974129059682,1.1318068500331007,0.3363774733637747,0.9265954878644032,1.0,8/15,23.89%,BLOC1S6;AP3B1;AP3S1;BLOC1S2;AP3S2;AP3M1;AP3D1;BLOC1S5
prerank,synaptic vesicle transport along microtubule (GO:0099517),0.5058974129059682,1.1318068500331007,0.3363774733637747,0.9265954878644032,1.0,8/15,23.89%,BLOC1S6;AP3B1;AP3S1;BLOC1S2;AP3S2;AP3M1;AP3D1;BLOC1S5
prerank,negative regulation of protein autophosphorylation (GO:0031953),-0.46812139759528437,-1.131595475532962,0.31155778894472363,0.7207980401101843,1.0,3/10,1.90%,ERRFI1;ENG;ENPP1
prerank,regulation of androgen receptor signaling pathway (GO:0060765),0.4491883619125415,1.1309940809736927,0.3161559888579387,0.9282253875990645,1.0,14/30,20.24%,DDX5;EP300;KDM4C;SMARCA4;NCOR1;SFRP1;FOXP1;NCOR2;KDM1A;HDAC6;H3-3A;PARK7;ZBTB7A;PRMT2
prerank,kidney development (GO:0001822),0.40305343594773213,1.1309090950207685,0.29066985645933013,0.9274505728011314,1.0,11/65,8.25%,AGTR1;STRA6;KANK2;GDNF;ZBTB16;PYGO2;ARL3;BMP4;TGFB2;SIX1;PKD1
prerank,defense response to protozoan (GO:0042832),-0.4573148798421198,-1.1308700933943387,0.2796833773087071,0.7210601360910117,1.0,6/12,26.82%,LYST;GBP6;CD40;GBP2;GBP4;SLC11A1
prerank,response to interleukin-4 (GO:0070670),-0.48176338377386185,-1.130837994286377,0.3072916666666667,0.7194297925034836,1.0,1/10,0.48%,LEF1
prerank,embryonic eye morphogenesis (GO:0048048),-0.46191479449288764,-1.1306923264140698,0.3013698630136986,0.7181148142177038,1.0,5/11,9.62%,FBN1;MFAP5;FBN2;LRP6;TBX2
prerank,phosphatidylglycerol metabolic process (GO:0046471),-0.36985188074322456,-1.1306535562860578,0.2814569536423841,0.7165016629909445,1.0,5/24,13.29%,PLA2G4A;PNPLA8;SERAC1;CDS2;ABCA3
prerank,cell differentiation in spinal cord (GO:0021515),-0.4646613862469508,-1.1304972577157382,0.3208020050125313,0.7152673782808634,1.0,3/10,16.01%,SOX13;SOX6;MDGA2
prerank,regulation of establishment of protein localization (GO:0070201),-0.43012120064795006,-1.1297957227489008,0.32142857142857145,0.7154336679892942,1.0,9/13,34.82%,CORO2B;DNAJA1;SPIDR;CTSD;CEP135;SCFD1;GAPVD1;TREM2;CEP295
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.4402749098739015,1.1295386640085037,0.33933518005540164,0.930818097277839,1.0,10/30,16.88%,IKBKE;IRF3;TLR6;TLR4;CHUK;TLR3;IKBKG;RPS27A;UBC;UBE2D3
prerank,lung development (GO:0030324),-0.33741398145550533,-1.1287831721462516,0.25193798449612403,0.7166019588677269,1.0,12/33,16.49%,ERRFI1;GLI2;FGF2;RCN3;FGFR2;LOXL3;NPHP3;ZIC3;RBP4;ABCA3;FGF9;SOX11
prerank,cartilage development (GO:0051216),0.41466918833811844,1.128777829984781,0.3118556701030928,0.9322745613602781,1.0,9/49,10.02%,CD44;ITGB8;ZBTB16;SOX9;DDRGK1;BMP4;WNT5B;PKD1;NFIB
prerank,positive regulation of potassium ion transport (GO:0043268),0.43068836916602776,1.1287650607774113,0.30160857908847183,0.9312784758910195,1.0,3/38,3.11%,ANK2;ACTN2;FHL1
prerank,positive regulation of isotype switching (GO:0045830),0.5111573306169035,1.1287172387833224,0.32407407407407407,0.9304277374565953,1.0,4/15,9.55%,TNFSF13;CLCF1;SHLD2;RIF1
prerank,positive regulation of receptor internalization (GO:0002092),0.47611658726301503,1.1285655938409083,0.3037593984962406,0.9298945426047811,1.0,2/22,2.29%,ANGPT1;MAGI2
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),-0.3777407142189936,-1.1280813252342698,0.2771929824561403,0.7169007378238959,1.0,5/23,5.29%,IGF1;INSR;ZBTB20;HIF1A;PRKAA1
prerank,regulation of necroptotic process (GO:0060544),0.47428456556290255,1.127725308657271,0.3253012048192771,0.9315730103803662,1.0,10/23,20.56%,OGT;YBX3;FLOT2;PELI1;HSP90AA1;SLC25A4;STUB1;PDCD6IP;FLOT1;ZBP1
prerank,regulation of synapse maturation (GO:0090128),-0.4857057253580556,-1.1274947221810436,0.3324396782841823,0.71686382947574,1.0,3/10,7.33%,NRXN1;DAB2IP;ARHGEF15
prerank,negative regulation of DNA recombination (GO:0045910),0.42262999757277153,1.127357451332573,0.31047865459249674,0.9318342732894591,1.0,8/43,9.55%,DAXX;POLR2H;SHLD2;POLR2A;PARP3;ATRX;KLHL15;RIF1
prerank,positive regulation of immune response (GO:0050778),0.40094760505247645,1.1271128130918024,0.2920245398773006,0.9316170048422823,1.0,13/64,17.89%,CCL5;SASH3;IL15;CD81;TGFB2;POLR3B;NMI;POLR3C;DHX9;ITGB2;POLR3G;EIF2AK4;STX4
prerank,"base-excision repair, gap-filling (GO:0006287)",0.43188234272917847,1.1266738293741936,0.31025299600532624,0.9320681773703816,1.0,12/35,19.55%,FEN1;MUTYH;POLG;MBD4;RPA3;POLD2;PCNA;LIG3;NEIL1;PARG;RFC1;PNKP
prerank,membrane depolarization (GO:0051899),0.4364111807800202,1.126553681670357,0.31843575418994413,0.9314048528349156,1.0,4/32,3.47%,SCN3A;CACNA1A;CAV1;CACNB3
prerank,keratan sulfate metabolic process (GO:0042339),0.4404815108609758,1.1265305700701236,0.31275720164609055,0.9304578139780907,1.0,7/31,12.32%,ST3GAL4;HEXA;B4GAT1;PRELP;GLB1;HEXB;ST3GAL6
prerank,regulation of AMPA receptor activity (GO:2000311),-0.36567284481991125,-1.1264104942893083,0.28431372549019607,0.718246837023076,1.0,6/25,12.76%,SHANK3;SHISA6;NLGN1;CACNG8;SHISA9;NLGN3
prerank,regulation of cellular respiration (GO:0043457),-0.3977608196410614,-1.125947149024209,0.30434782608695654,0.7177910546338551,1.0,12/17,42.44%,PRDM16;CBFA2T3;NOA1;SHMT2;PNPT1;TRAP1;IL10RB;IFNLR1;IFNAR1;NOS2;VCP;IL4
prerank,negative regulation of organelle assembly (GO:1902116),0.4357560158402423,1.1255491157692394,0.32545931758530183,0.9326539447410291,1.0,12/35,20.15%,LIMK2;NUPR1;CDK10;TMEM39A;CHMP4A;CHMP4B;SMCR8;TESK1;FEZ1;TRIM37;NBDY;PHF23
prerank,regulation of organelle organization (GO:0033043),0.39576135171272503,1.1255055247625676,0.29239766081871343,0.9317523120280741,1.0,23/80,15.46%,TJP1;PLXNB1;MAVS;EP300;DIAPH1;MUL1;MAPK15;MSN;GOLPH3;CAPN2;ARHGEF5;MIEF2;MYO5A;EZR;TMEM33;VPS11;ARMH3;CPLANE2;PREB;DNM1L;USP6NL;SYT11;RAB33B
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),-0.39029094264655434,-1.1252863078253417,0.309375,0.7178732451511957,1.0,4/21,3.83%,DMD;PDE4D;GPD1L;NCK2
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),0.4973285777374618,1.125211559270195,0.30293159609120524,0.9317173390885609,1.0,4/16,9.55%,KDM4D;SHLD2;PARP3;RIF1
prerank,cellular response to decreased oxygen levels (GO:0036294),0.4036091453160469,1.1251269332081006,0.3027744270205066,0.9310025476590307,1.0,17/65,15.23%,EGLN3;NDRG1;CPEB2;PMAIP1;EGLN2;BAD;TWIST1;CARD16;TIGAR;AQP1;HYOU1;NPEPPS;MYC;SFRP1;BNIP3L;LMNA;MDM2
prerank,negative regulation of locomotion (GO:0040013),0.530377331979423,1.124568943381768,0.3505654281098546,0.9318410450192263,1.0,7/12,17.81%,SPINT2;FBLN1;CCDC125;PTPN2;GATA3;CRK;DUSP3
prerank,regulation of dendritic spine morphogenesis (GO:0061001),0.4436672840560278,1.1245227062543848,0.3127629733520337,0.9309800570881372,1.0,4/31,2.48%,PDLIM5;NGEF;EPHA4;SIPA1L1
prerank,regulation of cell motility (GO:2000145),0.372338922750915,1.1244700980106463,0.26206140350877194,0.930143716729349,1.0,30/121,17.08%,PRAG1;PLXNB1;PLXNA2;ARHGAP18;CDK6;KIF2A;SPINT2;DIAPH1;LMO4;SGK3;DAPK3;MGAT3;FBLN1;CCDC125;ERBB3;SRCIN1;FGF22;PARD6B;RAF1;TWIST1;RHOA;GATA3;PLXNB2;MEMO1;LMNA;FLNA;PLXNA3;CRK;ABL1;TBCCD1
prerank,positive regulation of catabolic process (GO:0009896),0.3990470015050751,1.124049644363081,0.317016317016317,0.9304811040271268,1.0,14/65,19.52%,FZR1;WWP2;EGLN2;GPC3;RAB7A;GSK3A;GSK3B;NEDD4;PLK2;DDB1;NSF;RNF41;IDE;ASB5
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),0.5151044390303138,1.1239308339392426,0.3468118195956454,0.9298418711318378,1.0,6/14,16.85%,IMPDH2;ADK;PAICS;GMPS;GART;ADSS2
prerank,endomembrane system organization (GO:0010256),0.3683324958205171,1.123139211155401,0.26798748696558916,0.9314433159129356,1.0,53/178,19.58%,SPTSSB;FBXW8;ANXA8;ANXA8L1;SYP;OTOF;TJAP1;A4GALT;REEP3;TMED1;CAV2;NUP93;MAPK15;ATP8B2;ANK3;NSFL1C;GOLPH3;ARHGAP21;SRGN;CDC42;HOOK1;TLCD2;TOR1A;BCAS3;SNX33;ZW10;VPS11;EIF2AK3;PHETA2;GOLGB1;EXOC8;ARFGEF1;NPLOC4;VPS18;PLEKHJ1;FER1L6;VPS4A;PHETA1;DNM1L;ATL2;USP6NL;REEP4;PI4K2A;WASHC4;SUN2;SEC23IP;OSBPL2;TMED5;RNF112;SEC31B;HOOK3;MYO18A;SMPD4
prerank,negative regulation of cell-substrate junction organization (GO:0150118),0.4945760093305698,1.122924113689816,0.32653061224489793,0.9301000623872829,1.0,4/16,10.78%,PHLDB2;DMTN;BCAS3;DLC1
prerank,negative regulation of focal adhesion assembly (GO:0051895),0.4945760093305698,1.122924113689816,0.32653061224489793,0.9301000623872829,1.0,4/16,10.78%,PHLDB2;DMTN;BCAS3;DLC1
prerank,protein transmembrane import into intracellular organelle (GO:0044743),0.44295941344415524,1.1226213572704633,0.31805929919137466,0.9300823395860807,1.0,12/31,22.77%,PEX26;TIMM44;DNLZ;ROMO1;TOMM20;TIMM17B;PEX6;PEX2;TOMM40L;TOMM40;TIMM50;TIMM23
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.45518207296304,1.1224379065451655,0.3124108416547789,0.9296320794465373,1.0,7/28,12.66%,DAXX;NGF;TNFRSF10B;TNFRSF1A;BAG3;DDX47;BLOC1S2
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),-0.3749078953983265,-1.122358824817237,0.3117283950617284,0.7243086788978778,1.0,7/22,10.12%,GHR;NOTCH1;CYP1B1;ERBB4;OCIAD1;MGAT5;KIT
prerank,apical protein localization (GO:0045176),0.5346032592749473,1.1222156266856977,0.347008547008547,0.9292784585549883,1.0,3/10,11.04%,CELSR1;ACTB;INSC
prerank,positive regulation of cell adhesion (GO:0045785),-0.28423007503314257,-1.1222034600907542,0.22435897435897437,0.7230041935478582,1.0,18/74,15.07%,FRMD5;PTPRJ;CD47;TGM2;CXCL12;NDNF;MEGF10;JAK2;VIT;NCKAP1L;RSU1;PPP3CA;HYAL1;RET;FBLN2;ADAM9;ITGAV;TFE3
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.5071361696022527,1.1221486074507754,0.33541341653666146,0.928508992300781,1.0,6/13,17.94%,PLXNB1;PLXNA2;NRP2;PLXNB2;PLXNA3;SEMA3A
prerank,polarized epithelial cell differentiation (GO:0030859),0.5231618295372252,1.1219159098172984,0.3562300319488818,0.9282495874584495,1.0,5/13,11.76%,MSN;CDC42;OPHN1;EZR;RHOA
prerank,embryonic limb morphogenesis (GO:0030326),0.4372571770480086,1.1218700944742712,0.3311432325886991,0.9274046745178853,1.0,6/34,10.33%,MBNL1;GLI3;AFF3;RARG;TGFB2;TWIST1
prerank,oligodendrocyte development (GO:0014003),-0.4177021558339974,-1.1216956208445361,0.2906666666666667,0.7226593273924087,1.0,6/15,15.62%,EIF2B3;PLP1;TPPP;CNTNAP1;B4GALT5;MYRF
prerank,regulation of myoblast fusion (GO:1901739),0.5333800604609737,1.121633737305403,0.3611111111111111,0.9271737735391683,1.0,2/11,5.13%,EHD1;RIPOR2
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),0.5177877192529269,1.1210572763695599,0.33129770992366414,0.9280627342415321,1.0,5/12,13.18%,PLK3;FBXO31;SDE2;CCND1;CDK2
prerank,cellular biogenic amine biosynthetic process (GO:0042401),0.49845200914793547,1.1209344704142783,0.350547730829421,0.927464241369636,1.0,3/15,6.98%,SMOX;TPH2;AANAT
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.3633352686219596,1.120841473412903,0.27167019027484146,0.9267390141296702,1.0,47/166,20.72%,SORBS1;CLU;KLF4;PPARGC1A;LDLR;CCL5;VIM;SAMD4A;YTHDF1;RPS4X;EIF4A3;DDAH2;UPF3A;EIF6;NNMT;CHP1;TLR6;ZNF205;TLR4;STARD4;IRS2;POLDIP3;SP1;PTPN2;CPEB3;PLXNB2;FXR1;MYC;UPF3B;PYM1;DHX9;HSP90AA1;PCNA;EEF2;DDB1;PRMT1;ASS1;CDH3;PARK7;YTHDF3;PRKD2;GPLD1;KLF2;SREBF1;SOX4;PAOX;ZCCHC4
prerank,organelle fusion (GO:0048284),0.4685908587193537,1.1208065753538792,0.33237410071942447,0.9258746718800758,1.0,10/22,21.30%,CHCHD3;AFG3L2;MIEF2;THG1L;VPS11;OPA1;VPS18;STX4;SPG7;MIEF1
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),0.41561323507944065,1.1206087977074666,0.3143939393939394,0.9254965452512611,1.0,10/46,8.89%,PLCL2;LAMA4;IL15;FOXC2;IP6K1;DOCK7;RHEB;PLCL1;LGR4;ARRDC3
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",0.4841858475960486,1.1203375766900614,0.31587057010785824,0.9253755067136772,1.0,5/17,10.36%,COX5A;COX8A;COX7A2L;COX5B;AFG1L
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.38316570432406655,1.1198297796859331,0.2889908256880734,0.9260556733533085,1.0,9/87,7.99%,FGFR1;CD44;CCL5;FLRT1;GTF2F1;RBFOX2;POLR2H;POLR2A;FGF22
prerank,regulation of anoikis (GO:2000209),-0.39627222929428463,-1.1196493392681504,0.308411214953271,0.7266312323895273,1.0,5/19,6.45%,PTK2;TLE1;NOTCH1;SIK1;BCL2
prerank,positive regulation of axonogenesis (GO:0050772),0.41577687908887884,1.119215382195217,0.31170483460559795,0.9269943649584216,1.0,10/43,13.17%,ISLR2;PLXNB1;PLXNA2;NGF;TIAM2;MAP6;ZFYVE27;RHOA;PLXNB2;MAP3K13
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),0.47101632737697513,1.1190175086700132,0.34087481146304677,0.9265806171626008,1.0,5/20,13.80%,CCL5;MTDH;LBP;TLR4;IRAK1
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.39047662377806175,1.1187716555423448,0.2966396292004635,0.9263636414787445,1.0,18/84,15.98%,MBNL1;CELF2;DDX5;CELF1;RBFOX2;SON;LARP7;RBM8A;SRPK2;SRRM4;SRSF7;SRPK1;FXR1;DAZAP1;RNPS1;SRSF9;MBNL2;MAGOH
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),-0.4628057593833764,-1.1186742410067083,0.335978835978836,0.7276224702787423,1.0,6/10,32.05%,DKC1;CCT7;CCT2;CCT4;WRAP53;CCT3
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),-0.41292681291635175,-1.1184740418470014,0.2953846153846154,0.7265000762146187,1.0,3/14,4.92%,DMD;ATP1B1;WNK2
prerank,myotube differentiation (GO:0014902),0.48338018162801716,1.1182442018579837,0.3500738552437223,0.9271065003976188,1.0,1/17,0.10%,ADAM12
prerank,tryptophan metabolic process (GO:0006568),0.5306507930473608,1.118022455863516,0.35714285714285715,0.926798557784365,1.0,4/11,24.54%,TDO2;HAAO;KYAT1;KMO
prerank,regulation of neuroinflammatory response (GO:0150077),0.47568375633006665,1.1173802750911939,0.3194029850746269,0.9279151348585667,1.0,3/19,2.39%,MMP9;CD200;NUPR1
prerank,indolalkylamine catabolic process (GO:0046218),0.5359146898814748,1.117251687304449,0.36597110754414125,0.9273444477182048,1.0,4/10,24.54%,TDO2;HAAO;KYAT1;KMO
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),0.49777773664719205,1.1170408671084757,0.34222919937205654,0.9270372316732977,1.0,6/16,13.47%,GDNF;FOXD1;BMP4;SIX1;NPNT;MYC
prerank,Rac protein signal transduction (GO:0016601),0.47312621266761756,1.1167737244625828,0.332824427480916,0.9269105828781345,1.0,1/18,0.37%,CDH13
prerank,regulation of proteolysis (GO:0030162),0.41284206324358785,1.1163661834686087,0.3176178660049628,0.9272960555565892,1.0,6/48,7.48%,CYFIP2;OGT;CAV1;LTBP4;PERP;BAD
prerank,cellular response to retinoic acid (GO:0071300),0.41796133194353746,1.116166285917799,0.3201581027667984,0.9269825143701654,1.0,10/42,12.43%,PTK7;WNT11;PTK2B;WNT6;CREB1;SOX9;WNT5B;AQP1;EPHA3;WNT3
prerank,cellular response to copper ion (GO:0071280),0.48411629321219396,1.1158374558727004,0.33762057877813506,0.927075526824569,1.0,2/16,11.05%,DAXX;AQP1
prerank,cardiac muscle cell action potential (GO:0086001),-0.3475174180149826,-1.1158183886273378,0.2692307692307692,0.7323860080734431,1.0,10/30,15.43%,CACNA1C;DMD;SLC8A1;ATP1B1;KCNJ2;CACNA1G;FGF12;HCN2;SCN1A;SCN1B
prerank,cellular response to UV (GO:0034644),0.38003986731650324,1.1155860159944082,0.29452852153667053,0.9269106061606184,1.0,19/76,18.18%,OPN1SW;MMP9;CDKN1A;EP300;TIMP1;POLK;SDE2;CARD16;AQP1;MYC;NEDD4;USP28;PCNA;DDB1;ATR;KDM1A;EIF2AK4;TRIAP1;COPS9
prerank,positive regulation of mitochondrion organization (GO:0010822),0.400780096118449,1.1155546210193512,0.3009950248756219,0.9260270123705991,1.0,14/57,15.12%,PPARGC1A;MMP9;BBC3;PMAIP1;MCU;MUL1;BAD;MIEF2;ZNF205;HRK;GSK3A;GSK3B;DNM1L;DDHD1
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.48192324761323313,1.1155068540156896,0.3388804841149773,0.9252006887663421,1.0,5/18,14.84%,KANK1;RIPOR2;CCDC125;DLC1;FLCN
prerank,response to zinc ion (GO:0010043),-0.3615733964627284,-1.1153269443828824,0.28619528619528617,0.7320747835021449,1.0,14/25,36.67%,PAM;GLRA1;CRIP1;GLRA2;D2HGDH;SLC30A3;MT1A;MT1H;MT1M;MT1E;MT1G;MT1X;MT1B;MT1F
prerank,protein localization to lysosome (GO:0061462),0.4477374525265478,1.1152800397703768,0.3547486033519553,0.9249735037480967,1.0,13/28,23.30%,CD81;SH3BP4;GCC2;RAB7A;KPTN;VPS4A;NEDD4;SNX16;AP3M1;M6PR;SZT2;AP4M1;NCOA4
prerank,negative regulation of hippo signaling (GO:0035331),-0.4345554724667985,-1.1152494307511176,0.30749354005167956,0.7306457037739791,1.0,6/12,22.14%,WWC2;CIT;DLG5;LIMD1;MAPK14;WWC1
prerank,regulation of metal ion transport (GO:0010959),0.49568415030226953,1.115059263260852,0.3401574803149606,0.9246737635115008,1.0,2/16,2.86%,ANK2;IL16
prerank,regulation of axonogenesis (GO:0050770),0.4045797584509725,1.114971529542452,0.3096446700507614,0.9239931989135627,1.0,8/51,4.76%,RTN4R;PLXNB1;EPHA4;PLXNA2;SIPA1L1;NGF;TIAM2;MAP6
prerank,regulation of protein kinase C signaling (GO:0090036),-0.4237362511172684,-1.1149003535995727,0.33240997229916897,0.7298741857690597,1.0,6/14,18.30%,ADGRV1;WNT5A;GPD1L;FLT4;DGKG;CD40
prerank,glycerolipid metabolic process (GO:0046486),-0.44636150475378655,-1.1148395209647985,0.32160804020100503,0.7283872820840723,1.0,8/11,26.56%,DGKB;GAL3ST1;DGKG;PNPLA3;PIP5K1A;DGKZ;DGKQ;PLA2G15
prerank,positive regulation of extracellular matrix organization (GO:1903055),-0.38340480614623,-1.1147093987445782,0.3151862464183381,0.7270524354519519,1.0,4/18,7.31%,CLASP2;RUNX1;RGCC;TGFB1
prerank,renal water homeostasis (GO:0003091),-0.37134599627630016,-1.1144296654959,0.29276315789473684,0.7262482919886367,1.0,12/23,22.44%,ADCY5;ADCY7;RAB11FIP2;ADCY1;ADCY4;AQP4;PRKAR2B;MYO5B;ADCY2;PRKAR1B;ADCY3;ADCY8
prerank,toxin transport (GO:1901998),0.5463688604054728,1.1144176279631146,0.3679727427597956,0.924797668821924,1.0,2/10,5.63%,ADAM10;ANTXR1
prerank,cardiac muscle cell membrane repolarization (GO:0099622),-0.4584587321707232,-1.1134605212820046,0.34545454545454546,0.7273625577348991,1.0,5/11,25.53%,ATP1B1;KCNJ2;KCNIP2;YWHAE;KCNJ3
prerank,peptide metabolic process (GO:0006518),-0.2826088958553134,-1.1133975803336447,0.22666666666666666,0.7259130750489406,1.0,17/75,13.30%,DMD;PCSK5;AEBP1;CPD;GSTZ1;ACE;GSTT1;CPXM2;TPP1;CPXM1;SPCS2;NLN;CPQ;BACE2;ETHE1;ENPEP;MME
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),-0.39065481903056715,-1.1133961106723242,0.3076923076923077,0.7242804212368361,1.0,6/20,4.54%,CACNA1C;DMD;SLC8A1;CAMK2D;ATP2A2;ATP1B1
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),-0.2550305413042616,-1.1128658188233647,0.22,0.7241396521404689,1.0,42/161,16.15%,BICC1;MCC;FZD6;DAB2;IGFBP2;SOX13;WNT5A;DKK3;STK3;ANKRD6;TLE1;TMEM131L;ZNRF3;SHISA6;DAB2IP;HECW1;CHD8;PSMC6;TBX18;JADE1;DACT1;PSMA6;GLI1;APC;AMER1;SOX17;FZD4;LRP6;AXIN2;IGFBP4;NOTUM;SFRP4;INVS;NPHP3;DDIT3;CCDC88C;NKD2;TMEM64;PSME1;PSMB10;APC2;PSMD5
prerank,intracellular pH reduction (GO:0051452),0.4293035928216815,1.1128593170769598,0.339699863574352,0.9287392971950581,1.0,10/33,19.75%,ATP6V1B1;RAB7A;DMXL2;ATP6V1E1;ATP6V1D;GPR89B;GPR89A;ATP6V0D1;ATP6V1B2;ATP6V0B
prerank,ganglioside metabolic process (GO:0001573),-0.371993279016595,-1.1127091136438911,0.31085043988269795,0.7229710800390187,1.0,9/20,19.52%,ST6GALNAC3;ST3GAL5;ST8SIA4;ST6GALNAC5;ST8SIA6;NEU1;ST8SIA2;GM2A;NEU3
prerank,cell cycle checkpoint signaling (GO:0000075),0.5237323830609751,1.1121861074425072,0.35176651305683565,0.9299090718634089,1.0,7/12,21.18%,NABP2;ZW10;PLK2;ZWINT;WEE1;NABP1;CHFR
prerank,endocardial cushion morphogenesis (GO:0003203),-0.393923556429989,-1.1119202451365076,0.29721362229102166,0.7235035809859597,1.0,6/18,9.62%,ENG;NOS3;ACVRL1;NOTCH1;HEYL;TBX2
prerank,regulation of sprouting angiogenesis (GO:1903670),0.4324347165574352,1.1116127570915992,0.3395472703062583,0.930840808157277,1.0,9/33,11.60%,KLF4;TJP1;GLUL;ALOX5;PKM;JMJD8;SYNJ2BP;S100A1;JAK1
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),0.5188087579962758,1.1113236781154707,0.3488,0.9308333461066535,1.0,5/12,16.85%,IMPDH2;PAICS;GMPS;GART;ADSS2
prerank,myelination in peripheral nervous system (GO:0022011),-0.4250590983795972,-1.1109317775753658,0.31648936170212766,0.724599989559515,1.0,8/13,25.76%,NF1;MYOC;CNTNAP1;SIRT2;SOD1;DICER1;PRX;NCMAP
prerank,regulation of cell division (GO:0051302),0.39069745277962886,1.1108930386765827,0.32167832167832167,0.9312039325631362,1.0,21/72,20.47%,NCOA3;MLLT3;KIF13A;ESRRB;RAB11FIP3;BCL2L1;KLHL21;PLK3;AURKC;PRDM15;INSC;KLHL13;MYC;FLCN;PLK2;GIT1;ZFYVE26;TLE6;UVRAG;CSPP1;PIK3R4
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),-0.3900919288444916,-1.1108825651286416,0.31871345029239767,0.7231308271737833,1.0,6/19,9.13%,PTPRJ;KDR;VCAM1;STIMATE;GRM5;FIS1
prerank,proteolysis (GO:0006508),0.3510167098225961,1.1107241542067918,0.27477017364657813,0.9307460445643863,1.0,49/252,18.60%,DPP4;CPB1;TMPRSS6;CPA4;CPA3;MMP9;OGT;ADAMTS7;ADAM10;HPN;TINAGL1;ADAM33;DPP7;NAALAD2;CTSZ;KLKB1;CPE;DESI2;DESI1;CAPN2;SRGN;AFG3L2;PITRM1;SDE2;SPCS3;MMP12;RNF123;NAPSA;PSMB5;NPEPPS;PGPEP1;TRABD2B;TASP1;PGPEP1L;MDM2;SPPL2B;CTSH;HM13;BACE1;ATG4B;PRTN3;FBXL2;SPPL3;USP25;PSMC4;SPPL2A;SUFU;SPG7;CAPN15
prerank,myoblast differentiation (GO:0045445),0.5053533203648792,1.1099269859151049,0.35285053929121724,0.9322786990156585,1.0,2/14,2.31%,MBNL1;DDX5
prerank,ribosomal large subunit assembly (GO:0000027),0.4656093765897389,1.1098842461570768,0.352773826458037,0.9314406931886684,1.0,3/24,4.65%,NLE1;NOP2;PPAN
prerank,cellular response to hydrogen peroxide (GO:0070301),0.43338039868739375,1.1089791136878457,0.3357041251778094,0.9333892308153228,1.0,13/33,23.91%,MAP3K5;NFE2L2;MAPK7;AQP1;TRPM2;ABL1;SIGMAR1;HDAC6;PARK7;RNF112;SIRPA;RHOB;IL6
prerank,regulation of interferon-beta production (GO:0032648),0.4157781547220786,1.108905892079651,0.3561643835616438,0.9326651484203607,1.0,18/46,24.55%,MAVS;RELB;PPM1B;IRF3;POLR3B;TLR4;POLR3C;TLR3;DHX9;HSP90AA1;OAS2;POLR3G;PTPN11;FLOT1;YY1;POLR3F;SIRPA;POLR3D
prerank,adenine nucleotide transport (GO:0051503),-0.398484656478248,-1.108446850085226,0.31671554252199413,0.7280906399259574,1.0,2/17,1.29%,LRRC8C;ABCC4
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.3884794009048327,1.10836945392513,0.33253873659118,0.9334216315852213,1.0,24/72,19.88%,ZC3H12A;FEN1;MRE11;RBX1;POLK;XRN2;DNASE1L2;ERCC5;RPA3;DNASE1L1;REXO4;DCP1A;POLD2;PCNA;FAN1;DDB1;RPS27A;UBC;ERCC2;RNASE4;RAD50;RFC1;DXO;ERCC4
prerank,triglyceride biosynthetic process (GO:0019432),0.480232339189568,1.1080963462319142,0.34970238095238093,0.9333077132235154,1.0,7/18,24.23%,DGAT1;MOGAT3;MOGAT1;GPAM;PCK2;GPAT3;LPIN1
prerank,positive regulation of dendrite development (GO:1900006),0.5359871587751198,1.1075036927310924,0.3767123287671233,0.9342499375345165,1.0,4/10,17.29%,COBL;BMP5;PTN;PACSIN1
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),-0.4323051709254019,-1.1070149720674738,0.3,0.7304273747047616,1.0,2/13,0.18%,PLCB1;IGF1
prerank,chromatin remodeling (GO:0006338),0.3721843507596794,1.1068169668158676,0.3216704288939052,0.9354888084782124,1.0,33/100,19.73%,DAXX;HDAC5;HDAC4;KDM4D;SMARCB1;PIH1D1;KDM4B;SOX9;HCFC1;KDM5C;ATRX;FOXP3;ACTB;KDM4C;SMARCA4;DR1;SRCAP;KDM6A;ACTL6B;MPND;MYSM1;BAZ2B;CHD3;SMARCD2;MYC;GATAD2B;SMARCC1;GATAD1;BRDT;ARID1B;PBRM1;ZBTB7A;RB1
prerank,negative regulation of cell population proliferation (GO:0008285),0.34827298828153946,1.1065352551767103,0.2591093117408907,0.935490989706827,1.0,68/351,14.97%,CDH13;ZBTB7C;PTPN14;IGFBP6;KLF4;COL4A3;PLXNB1;CDKN1A;HPN;SMAD6;NIBAN2;CD200;MAGI2;NUPR1;CDK10;CELF1;CDK6;SULT2B1;NGF;KANK2;PTK2B;TNFRSF8;DUSP10;BMP5;PTPRU;S100A11;RARG;SH3BP4;TSC2;FBLN1;SLC16A2;ZBTB17;SOX9;TES;CGREF1;BMP4;TGFB2;ANG;TGFB1I1;SLURP1;ADAMTS1;PML;FOXP3;BRD7;PTPN6;NMI;RAF1;ABI1;SOD2;DLC1;GSDME;WDR6;PTPN2;PDPN;PPM1D;GATA3;MYC;EEF1E1;BTG2;ING4;PINX1;SFRP1;TGFBR3;HRAS;P3H3;FLCN;ITGB1BP1;LMNA
prerank,establishment of protein localization to extracellular region (GO:0035592),-0.3197465089756141,-1.106463605369692,0.30660377358490565,0.7303021273338374,1.0,9/39,11.91%,ABCA1;STEAP3;MTTP;RCN3;SEL1L;TVP23B;PPY;TMEM167A;TANGO2
prerank,O-glycan processing (GO:0016266),-0.2948839819163548,-1.1062751714557972,0.2346368715083799,0.729220894042701,1.0,15/54,18.27%,ST3GAL1;GALNT7;ST3GAL3;GALNT13;GALNT15;C1GALT1;GXYLT2;POMGNT1;GALNT2;GALNT14;B4GALT5;GCNT1;C1GALT1C1;POFUT1;GALNT9
prerank,activation of GTPase activity (GO:0090630),0.3762631913553265,1.1062360200296057,0.3141542002301496,0.9354900945215624,1.0,15/89,11.87%,ARHGAP42;NTRK3;NGEF;SIPA1L1;GRTP1;TBC1D16;TIAM2;DOCK7;ARHGAP29;CCDC125;BCR;ARHGEF5;BCAS3;SGSM2;TBC1D1
prerank,positive regulation of interleukin-10 production (GO:0032733),-0.3398002643552272,-1.106042092983987,0.3102189781021898,0.7282405376524111,1.0,11/30,28.86%,CD34;LGALS9;CD46;STAT3;HMGB1;HSPD1;NOD2;PYCARD;PIBF1;ISG15;PLCG2
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.46342091368590144,1.1059859676246733,0.35131195335276966,0.935320419338655,1.0,4/22,7.99%,ANK2;STAC3;GSTO1;JPH2
prerank,protein localization to microtubule organizing center (GO:1905508),-0.39467616436056907,-1.1059407733614908,0.3255208333333333,0.7269321771392309,1.0,8/15,27.82%,CCDC14;C2CD3;NEDD1;CSNK1D;BBS4;CEP131;SPAG5;PIBF1
prerank,positive regulation of transforming growth factor beta production (GO:0071636),-0.45137690349425985,-1.1058901522687927,0.3394736842105263,0.7254626500371059,1.0,6/11,13.26%,CD34;LGALS9;THBS1;PTGS2;CD46;GATA6
prerank,positive chemotaxis (GO:0050918),0.48132557882931715,1.1052833334907948,0.3561643835616438,0.936604190547594,1.0,3/17,8.27%,ANGPT1;TSC2;LGALS3
prerank,T cell proliferation (GO:0042098),-0.425568636120785,-1.1052050371561308,0.3013698630136986,0.7257249063854541,1.0,4/13,8.64%,CADM1;DOCK8;CTPS1;PPP3CB
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.3740544687048054,1.105020700153047,0.31548311990686845,0.9364510738743214,1.0,24/87,16.81%,NOTCH2;CELSR1;ARHGAP18;CDK10;PTK2B;DAPK3;RHOQ;TWF1;EFNA5;DMTN;IQGAP1;ARHGEF5;EZR;DLC1;RAPGEF3;EPHA3;RHOA;TRPM2;CCDC88A;ARHGDIB;TESK1;FSCN1;CRK;ABL1
prerank,protein kinase A signaling (GO:0010737),0.5113310817390924,1.1049080728830494,0.35993485342019543,0.9358291758017373,1.0,2/12,9.58%,GAL;EZR
prerank,negative regulation of cell growth (GO:0030308),0.36879858624820533,1.1048551600224903,0.3222591362126246,0.9350292559923301,1.0,28/121,16.35%,FGF13;RTN4R;OSTN;CDKN1A;WNT11;FHL1;SESN2;PPP2CA;SH3BP4;MUL1;OSGIN2;TGFB2;PSRC1;NDUFS3;PML;APBB1;ADAM15;SMARCA4;CDKN2AIP;CAPRIN2;GSK3A;PRDM11;SFRP1;ULK1;FLCN;IP6K2;CCDC85B;FRZB
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.5214868770067411,1.1046178433355032,0.3711507293354943,0.9348334433433707,1.0,5/13,16.52%,DDX5;PMAIP1;SPRED3;EEF1E1;ATR
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",-0.3201057211606994,-1.1046027622104109,0.2857142857142857,0.7258176256579151,1.0,13/36,15.44%,PLCB1;LEF1;FZD6;WNT5A;NFATC1;FZD4;PPP3R1;PPP3CB;TNRC6A;PPP3CA;CAMK2A;AGO1;GNB1
prerank,skeletal muscle organ development (GO:0060538),0.45301501393757215,1.103898498898842,0.3447802197802198,0.9361619814680672,1.0,7/26,13.83%,CAV1;STRA6;CSRP3;LARGE1;SIX1;FXR1;MEF2C
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.3631428065304791,1.1038013380251808,0.3077742279020234,0.9354921393311689,1.0,21/138,12.35%,NR3C2;THRB;NOTCH2;PPARGC1A;RORC;CCN2;GTF2F1;HDAC5;NR6A1;POLR2H;ESRRB;RARG;POLR2A;RXRB;MAZ;NR2C1;HDAC3;NCOR1;DR1;GTF2E1;TAF5
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.37494802791948745,1.1036017446434792,0.3058690744920993,0.935147312007767,1.0,16/94,11.20%,MAP3K5;CDKN1A;FHIT;DDX5;BBC3;IKBKE;PMAIP1;TMEM117;PPP1R13B;PPP1R15A;BCL2L1;BAD;TNFRSF10B;PML;ARL6IP5;PDK2
prerank,sphingosine metabolic process (GO:0006670),-0.3984177346450965,-1.1034919189842423,0.33532934131736525,0.7272718276443798,1.0,9/17,33.30%,ACER2;SGPP1;SPHK1;PLPP3;ASAH2;PLPP2;SPTLC2;ACER3;SPTLC3
prerank,positive regulation of interferon-beta production (GO:0032728),0.4322998965629071,1.1033139410881296,0.3632760898282695,0.935072788179289,1.0,12/33,19.47%,MAVS;IRF3;POLR3B;TLR4;POLR3C;TLR3;DHX9;HSP90AA1;OAS2;POLR3G;PTPN11;FLOT1
prerank,retinol metabolic process (GO:0042572),-0.41466715086547234,-1.1030005319291327,0.33773087071240104,0.7270011949534881,1.0,6/14,16.82%,CYP1B1;RDH10;DHRS3;RBP4;ADH1A;RDH11
prerank,positive regulation of interferon-alpha production (GO:0032727),0.4741648982815643,1.1027518328782235,0.34334763948497854,0.9358732191863585,1.0,6/19,15.32%,MAVS;IRF3;TLR4;CHUK;TLR3;DHX9
prerank,positive regulation of neuron differentiation (GO:0045666),-0.32608689319214446,-1.1026557358107667,0.27310924369747897,0.7263509177881904,1.0,14/40,17.95%,TCF4;ZEB1;VWC2;BRINP3;NRCAM;HEYL;IMPACT;BEND6;ARHGEF2;MMD;GPRC5B;BRINP2;SOX11;HOXD3
prerank,regulation of muscle cell differentiation (GO:0051147),-0.34416371060772155,-1.1023870669842724,0.2937062937062937,0.725448661807508,1.0,7/31,9.11%,CDH2;BOC;MEGF10;CTNNA2;IGF2;ID2;FGFR2
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.38103750708282885,1.1023456439738355,0.32201405152224827,0.9362138241401455,1.0,20/76,17.31%,CLU;TRIB2;ZYG11B;SH3RF2;NUB1;ELOB;DDRGK1;RBX1;SUMO2;COP1;HSPBP1;CSNK1E;PIAS1;DDA1;GSK3A;GSK3B;MDM2;CCDC22;KEAP1;STUB1
prerank,positive regulation of type I interferon production (GO:0032481),0.3901322722751602,1.1023006508611193,0.3309941520467836,0.9354129437218199,1.0,23/73,20.56%,MAVS;EP300;POLR2H;IRF3;MRE11;POLR3B;POLR1C;TLR4;POLR3C;IRAK1;CHUK;GAPDH;TLR3;DHX9;HSP90AA1;OAS2;POLR3G;PTPN11;POLR3H;POLR2E;NFKB2;FLOT1;ZBP1
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),-0.42816992306213425,-1.1021958272536518,0.3342036553524804,0.7243990721793591,1.0,5/13,15.15%,GRIK2;SLC4A10;SHISA6;SHISA9;CLN3
prerank,negative regulation of actin filament polymerization (GO:0030837),0.46312251522376374,1.1016872429860265,0.3456614509246088,0.9364195414247172,1.0,4/22,6.02%,KANK1;GSN;SSH3;TWF1
prerank,cellular response to radiation (GO:0071478),0.4118590912774517,1.1016421167825454,0.33467202141900937,0.9356160432879933,1.0,3/40,4.50%,OPN1SW;CDKN1A;KDM4D
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),0.4905668099537881,1.1014772081988995,0.3626543209876543,0.9351637322095029,1.0,7/17,22.91%,EMC9;EMC10;GET4;EMC6;EMC2;SGTA;MMGT1
prerank,response to insulin (GO:0032868),0.3795855322063664,1.1013154952739461,0.335632183908046,0.9347244129972426,1.0,10/80,7.25%,SORBS1;OGT;CPEB2;HDAC5;EPRS1;RHOQ;INSIG1;PKM;ZBTB7B;EIF6
prerank,cholesterol homeostasis (GO:0042632),0.3905212522599533,1.1007536851867645,0.3276699029126214,0.9355336056390519,1.0,12/64,11.07%,LDLR;SOAT1;CAV1;TTC39B;EHD1;INSIG1;NPC1;CYP39A1;RALY;SOAT2;ACSM3;ABCA2
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.41716825805423075,1.0997351977809522,0.33064516129032256,0.9378526676918646,1.0,8/37,10.84%,NUPR1;BBC3;CAV1;PMAIP1;BCL2L1;BAD;BCAP31;GSDME
prerank,protein ADP-ribosylation (GO:0006471),-0.3522626067836894,-1.0996746195872564,0.3151750972762646,0.7296460953923782,1.0,6/28,9.01%,ZC3HAV1;PARP12;ART3;PARP14;PARP8;TNKS
prerank,cellular response to tumor necrosis factor (GO:0071356),0.35082239164887996,1.099639442456219,0.3232533889468196,0.9371972570859495,1.0,28/175,14.21%,TNFRSF11B;CCL5;EDA2R;EDA;ADAMTS7;ZC3H12A;TNFSF13;PTK2B;FOXO3;TNFRSF8;YBX3;NFE2L2;NFKBIA;PSMD11;PSMD4;COMMD7;PSMF1;ILK;TNFRSF1A;PYDC1;PSMD7;GSDME;NPNT;PSMB5;GATA3;ZFAND6;SFRP1;CHUK
prerank,generation of neurons (GO:0048699),0.35364265845261456,1.099633484625505,0.31145833333333334,0.9362695408328836,1.0,19/190,9.21%,WNT16;FGF13;FGFR1;CELSR1;WNT1;NRBP2;WNT10A;WNT11;ITM2C;CDK6;WNT6;PTPRD;DOCK7;TGFB2;WNT5B;SIX1;FZD5;ACSL3;OPHN1
prerank,actin crosslink formation (GO:0051764),0.5161686522346616,1.0994262379105437,0.3550488599348534,0.9359885222326388,1.0,1/12,0.43%,BAIAP2L1
prerank,regulation of vacuole organization (GO:0044088),-0.37854554428024323,-1.099421427983208,0.32326283987915405,0.7287120214239439,1.0,6/20,10.44%,TBC1D12;SCARB2;MTM1;LAPTM4B;TBC1D14;NPRL3
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.42666035310034434,1.0994018065199054,0.348993288590604,0.9351269062926227,1.0,12/33,20.24%,DDX5;EP300;DDRGK1;LATS1;KDM4C;GPAM;UFM1;KDM1A;HDAC6;H3-3A;PARK7;PRMT2
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.35102127812698564,1.0992378988528113,0.29393627954779034,0.9347126988259036,1.0,45/208,15.95%,PRKCB;LPAR1;EDA2R;AKAP13;ZC3H12A;IKBKE;MAVS;TRIM59;HSPB1;TRIM25;PPM1B;MTDH;TFG;USP10;SLC20A1;OTUD7B;MUL1;CC2D1A;WLS;TRIM21;TAB3;TNFRSF10B;PPM1A;TNFRSF1A;TLR6;JMJD8;CARD16;ANKRD17;RHOA;MIB2;EEF1D;PELI1;LGALS1;IRAK1;ZFAND6;CHUK;GAPDH;TNIP1;GPR89A;PLK2;IKBKG;RNF31;FLNA;UBE2N;CCDC22
prerank,cellular response to chemical stress (GO:0062197),0.36965052140591587,1.0991722201539116,0.31737193763919824,0.933970891758028,1.0,10/96,5.23%,PRKAA2;PPARGC1A;CPEB2;ZC3H12A;CAV1;FOXO3;SESN2;MGAT3;NFE2L2;NUDT2
prerank,cellular biogenic amine metabolic process (GO:0006576),-0.4405605897883035,-1.0987622478442731,0.34673366834170855,0.7289578845459594,1.0,6/12,35.48%,MAOA;HNMT;DDC;SMS;SLC22A3;SLC29A4
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.48688162966212484,1.0985341359793193,0.35669781931464173,0.9350635555506245,1.0,1/17,0.15%,CD55
prerank,histone H4-K16 acetylation (GO:0043984),0.4679704320617511,1.0983433619442644,0.35542168674698793,0.9347831607192546,1.0,7/19,16.02%,OGT;HCFC1;KMT2A;JADE2;ING4;MSL2;MEAF6
prerank,regulation of trans-synaptic signaling (GO:0099177),-0.33328744648170144,-1.0981646607929547,0.3104693140794224,0.7290201642544862,1.0,15/33,20.63%,GRIK2;NRG3;GRID2;LRRC4C;GRIK3;NLGN1;LRP8;GRIK1;GRIK4;NLGN3;BDNF;PXK;GRIK5;CX3CR1;CACNA1B
prerank,positive regulation of interferon-gamma production (GO:0032729),-0.299856192174611,-1.0978502553350002,0.26540284360189575,0.7283254276318024,1.0,6/48,8.36%,IL1R1;PDE4D;SLC7A5;LGALS9;IL18;PDE4B
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.5141330316302728,1.0975709590261362,0.3579454253611557,0.9361933020612268,1.0,2/13,3.24%,SULT1A1;SULT2B1
prerank,endocardial cushion development (GO:0003197),-0.3687534923555488,-1.0973184171016446,0.3211920529801324,0.7282394939219042,1.0,6/21,9.62%,ENG;NOS3;ACVRL1;NOTCH1;HEYL;TBX2
prerank,negative regulation of endocytosis (GO:0045806),0.4518746971376275,1.096744471009718,0.3507246376811594,0.9378949295485844,1.0,7/24,11.34%,SCAMP5;CAV1;UNC119;RUBCN;LGALS3;SNX33;EPHA3
prerank,regulation of cell migration (GO:0030334),0.34065249091805894,1.0967044820551892,0.2701612903225806,0.9370861053662617,1.0,47/382,8.51%,CDH1;SEMA3D;CDH13;PHACTR1;NTRK3;SRGAP3;SRGAP2;KANK1;LAMC2;TJP1;SMO;MMP9;CCL5;PLXNB1;PODXL;EPHA4;PDGFC;DAG1;ADAM10;PLXNA2;MAGI2;WNT11;CAV1;SEMA3B;KIF2A;PTK2B;FOXO3;LMO4;SGK3;DUSP10;MGAT3;GCNT2;SH3RF2;PTPRU;TMEFF2;DDRGK1;MAPK15;CBLL1;SRCIN1;ARSB;SLURP1;WNT5B;FGF22;PARD6B;MAZ;PIP5KL1;ELP5
prerank,response to chemokine (GO:1990868),0.5179106667159439,1.0965586220902526,0.3859375,0.9366440597533054,1.0,7/13,14.45%,ZC3H12A;RIPOR2;DUSP1;STK39;OXSR1;RHOA;WNK1
prerank,tetrahydrobiopterin metabolic process (GO:0046146),-0.44326347249969134,-1.0955123308399004,0.3680203045685279,0.7315005489414657,1.0,4/11,14.58%,NOS3;GCH1;SPR;DHFR
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.48182952131389983,1.095483552262797,0.358609794628752,0.9390380266274861,1.0,4/15,10.61%,ZC3H12A;KHNYN;POP1;LACTB2
prerank,regulation of telomerase activity (GO:0051972),0.4134266228519557,1.0952089083747159,0.35152284263959394,0.9389603444872173,1.0,15/45,22.09%,KLF4;NEK7;NABP2;MAPK15;MAP3K4;GRHL2;MYC;PINX1;HSP90AA1;HMBOX1;PRKCQ;PNKP;ERCC4;PTGES3;MEN1
prerank,positive regulation of protein catabolic process (GO:0045732),0.37475335438012114,1.094725106896574,0.3310734463276836,0.939525882617461,1.0,21/84,19.52%,FZR1;WWP2;MSN;EGLN2;GPC3;PLK3;RAB7A;EZR;SNX33;VPS11;GSK3A;GSK3B;NEDD4;PLK2;HSP90AA1;DDB1;NSF;RNF41;IDE;GPLD1;ASB5
prerank,"synaptic transmission, glutamatergic (GO:0035249)",-0.3871205994474838,-1.0946536063708352,0.3136094674556213,0.7324984298349457,1.0,9/18,11.93%,GRIK2;UNC13B;GRID2;GRIA2;CDH8;GRIK3;SLC17A6;GRIK1;GRIK4
prerank,regulation of translational initiation (GO:0006446),0.38931912509997474,1.0945395692560544,0.33584905660377357,0.9391493887568957,1.0,21/63,18.94%,CCL5;YTHDF1;HSPB1;EIF2B2;EIF4B;EIF4EBP1;HABP4;EIF4G2;EIF2AK3;BOLL;EIF4G1;PAIP1;DNAJC3;EIF5B;EIF3B;EIF1;EIF2AK4;CTIF;EIF4A2;YTHDF3;EIF4EBP2
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.4495636543695476,1.0939159094038369,0.35745296671490595,0.940240869870419,1.0,4/25,9.21%,EPHA4;PSMF1;PML;OPHN1
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),-0.45783462933050795,-1.093771851309388,0.3677581863979849,0.733440483310684,1.0,5/10,12.51%,PDE8A;LRRK2;GPR37;RIPK1;TXN
prerank,regulation of NMDA receptor activity (GO:2000310),-0.33793290456959413,-1.0935383339018445,0.2992957746478873,0.7325635302740507,1.0,10/32,8.60%,SLC6A9;DLG2;GRIN2A;GRIA3;GRIA2;LRRC7;EPHB2;GRIN2B;NLGN1;NEFL
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.4471290257603829,1.0934120768956241,0.3556851311953353,0.9409168890370168,1.0,6/25,14.73%,MMP9;BBC3;PMAIP1;BAD;HRK;DNM1L
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.38455761220849644,1.0932715937048836,0.3352803738317757,0.9404297700884069,1.0,20/76,18.96%,NLRP2;KLF4;CD200;ZC3H12A;ANXA4;NFKBIA;COMMD7;TRIM21;NLRP2B;CHP1;FOXP3;PYDC1;COMMD6;IRAK1;CHUK;CCDC22;MTURN;TRIM37;OTULIN;CDK5RAP3
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),0.419550547144856,1.0929977446350685,0.3442622950819672,0.9403354205162661,1.0,12/36,19.02%,QARS1;DUSP10;SH3RF2;DUSP1;FOXM1;EZR;HDAC3;NCOR1;MYC;IGBP1;DUSP3;TAOK3
prerank,myotube cell development (GO:0014904),0.5331109327015093,1.0928802894913061,0.3648,0.9397701800543903,1.0,4/10,8.17%,SELENON;LMOD3;CAV2;SIX1
prerank,regulation of cellular protein catabolic process (GO:1903362),-0.3975185338132216,-1.0928477032218626,0.35798816568047337,0.7329512624347488,1.0,6/18,7.62%,RDX;RIC1;DAB2IP;DACT1;VPS35;AMER1
prerank,mitochondrion morphogenesis (GO:0070584),-0.4571197678058152,-1.0926139164014355,0.35537190082644626,0.7320256221667208,1.0,3/11,9.13%,PID1;MTM1;FIS1
prerank,telomere organization (GO:0032200),0.40998040384623446,1.0925322891685487,0.3346303501945525,0.9399556954778711,1.0,24/43,28.17%,RECQL4;DOT1L;MRE11;PARP3;RIF1;HUS1B;RPA3;POLD2;PCNA;ATR;NBN;RAD50;H3-3A;ERCC4;TERF2;PTGES3;TINF2;APEX1;RPA2;PARP1;POLD1;XRCC5;TERT;TERF1
prerank,Ras protein signal transduction (GO:0007265),0.35936001505209086,1.0925302105279902,0.3108695652173913,0.9390327099861515,1.0,34/137,16.31%,AGTR1;CDH13;CELSR1;CDKN1A;MRAS;RAP1B;EPS8L2;RAP1A;CDC42EP4;CDC42EP5;NRAS;KRAS;SHC1;ARHGAP29;JUN;RALGDS;RAPGEF3;GNA13;RHOA;WASF1;PDPN;RREB1;CDK2;SHC2;BRAP;HRAS;SETDB1;RAPGEF1;ARHGDIB;PLK2;RAP2C;USP28;RIPOR1;ARHGEF1
prerank,metanephric mesenchyme development (GO:0072075),-0.45844923354747574,-1.0922523368724004,0.37393767705382436,0.7314321831205504,1.0,3/10,10.69%,WNT4;PKD2;BASP1
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),0.4390077314346049,1.0920395945980703,0.3412256267409471,0.9396372819651361,1.0,10/28,18.32%,PRKCB;KANK1;TSC2;PTPRE;PTPN2;PIP4K2C;GSK3A;PRKCZ;PRKCQ;SLC27A4
prerank,positive regulation of translational initiation (GO:0045948),0.4666689186715167,1.0903047878579468,0.3501577287066246,0.9439973700040141,1.0,4/18,13.46%,CCL5;YTHDF1;HABP4;BOLL
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.43950465084341467,1.0899628255046605,0.36522911051212936,0.9441584220208927,1.0,2/29,6.12%,ANKRD31;SYCP2
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.3824953266114034,1.0899424730084613,0.3281061519903498,0.9433063033374015,1.0,27/69,24.82%,GTF2F1;POLR2H;NABP2;POLR2A;INTS2;RPRD2;GTF2E1;SP1;TAF5;ELL;SRRT;INTS3;POLR2C;INTS13;POLR2E;INTS6;TAF8;TBP;NABP1;SNAPC3;GTF2E2;TAF6;INTS1;CDK9;ICE1;ELL2;POLR2K
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.5248575733014256,1.0898836678767556,0.38287560581583197,0.9425564586422276,1.0,1/11,0.58%,CD44
prerank,ion transport (GO:0006811),0.3624242842404904,1.0898702786896863,0.32963374028856823,0.9416861182456205,1.0,21/111,16.86%,SLC9A2;SLC9A4;TRPM3;SLC4A2;CTNS;SLC20A1;VDAC2;CNGB3;SLC9A6;SLC9A7;PKD2L1;SLC12A4;ANO6;CNGB1;VDAC1;SLC26A4;WNK1;SLC9A8;SLC12A6;SLC8B1;SLC9A1
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),0.4734196145475652,1.0895078614989993,0.39156626506024095,0.9418868211489169,1.0,3/18,7.17%,PODXL2;ITGB7;GOLPH3
prerank,smooth muscle tissue development (GO:0048745),0.5378892097942349,1.089495728654397,0.38841567291311757,0.9409983911052474,1.0,3/10,6.81%,SMO;STRA6;BMP4
prerank,copper ion homeostasis (GO:0055070),0.4637357374874434,1.0888978146673598,0.3873343151693667,0.9419280577049879,1.0,7/17,23.38%,COX19;SLC31A2;CCDC22;XIAP;ABCB6;APP;MT2A
prerank,cellular glucan metabolic process (GO:0006073),-0.4397862584626425,-1.0888545292145546,0.3425,0.7392147832727028,1.0,4/11,17.90%,PRKAG2;PHKA1;UGP2;GBE1
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.4030465106862507,1.0887245252101159,0.3555276381909548,0.9415467248554523,1.0,11/49,12.29%,MMP9;NUPR1;BBC3;CAV1;PMAIP1;BCL2L1;BAD;NDUFS3;BCAP31;GSDME;EIF2AK3
prerank,pulmonary valve morphogenesis (GO:0003184),0.47139667536618135,1.0884782565768576,0.37142857142857144,0.9414234451905836,1.0,5/17,7.38%,NOTCH2;SMAD6;STRA6;BMP4;TGFB2
prerank,negative regulation of protein ubiquitination (GO:0031397),0.4007986647948313,1.0884366578326383,0.3337468982630273,0.9406398171540814,1.0,7/50,8.66%,NXN;OGT;CAV1;PRR7;SH3RF2;FBXO5;CHP1
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),0.4149208564704062,1.0881433460605017,0.33378016085790885,0.9406000337243527,1.0,12/38,19.45%,CLU;KLF4;ZC3H12A;CAV1;DDAH2;TLR6;TLR4;ATP2B4;HSP90AA1;ASS1;ROCK2;KLF2
prerank,cell proliferation in forebrain (GO:0021846),0.5215877532363308,1.088075875846814,0.3964285714285714,0.9398903757701841,1.0,6/10,26.74%,DOCK7;AKNA;HOOK3;CEP120;PCM1;NUMBL
prerank,regulation of mRNA catabolic process (GO:0061013),0.35448156847377665,1.087424399868692,0.34063526834611174,0.940993658376546,1.0,31/121,19.45%,VIM;SAMD4A;YTHDF1;ZC3H12A;SAMD4B;TNFSF13;HSPB1;PSMD11;MOV10;PSMD4;PSMF1;EXOSC3;YWHAB;PSMD7;YWHAZ;PSMB5;FXR1;CARHSP1;DCP1A;TNPO1;SET;EIF4G1;RPS27A;UBC;MAPKAPK2;PSMD1;PSMC4;IGF2BP3;YTHDF3;IGF2BP2;PSMD8
prerank,positive regulation of protein processing (GO:0010954),0.45884687588673206,1.0867989617232936,0.37632776934749623,0.9420590450949378,1.0,5/19,13.98%,HPN;GSN;KLKB1;LPCAT3;PLGRKT
prerank,natural killer cell mediated cytotoxicity (GO:0042267),0.4734455731900225,1.0867534781513366,0.37315634218289084,0.9413056329201132,1.0,5/16,23.03%,RAET1E;VAMP7;ULBP1;VAMP2;ARL8B
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),-0.40858272000915635,-1.086629345875859,0.34408602150537637,0.7435956575100319,1.0,3/14,9.87%,RAPGEF2;PKIG;PRKAR2B
prerank,positive regulation of histone deacetylation (GO:0031065),-0.43889763386434033,-1.0865209249230823,0.3651226158038147,0.7423907069219374,1.0,4/12,13.56%,PRKD1;SAP30BP;ING2;NIPBL
prerank,positive regulation of developmental process (GO:0051094),0.3530262589212963,1.0864950645981168,0.329153605015674,0.9411506350995708,1.0,29/164,13.17%,PHLDB2;FGFR1;NCOA3;COBL;DAG1;NIBAN2;CCN2;MCU;GDNF;PPP1R13L;BMP5;RBM19;ZBTB16;SHLD2;ESRRB;SOX9;FOXD1;MUL1;BMP4;DVL3;FBXO5;MIEF2;RIF1;RAPGEF3;TRPM4;PTN;CPEB3;RREB1;MAP3K13
prerank,regulation of inflammatory response (GO:0050727),0.35207100527469676,1.086484043332383,0.31899265477439664,0.9402752784589526,1.0,29/190,15.32%,AGTR1;GPR4;NAPEPLD;KLF4;MMP9;CCL5;CD200;IL17RA;NINJ1;IL15;IL16;CELF1;ALOX5;NFKBIA;AKNA;MAPK7;FEM1A;TNFRSF1A;NMI;TLR4;CD200R1;PTPN2;LPCAT3;GATA3;SBNO2;FOXP1;TNIP1;TLR3;DHX9
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.4422642671425635,1.086479525829538,0.38273381294964026,0.9393775537171257,1.0,2/27,1.38%,NAPEPLD;ETNK2
prerank,phagosome acidification (GO:0090383),0.43227595545083775,1.0861469141816515,0.3678977272727273,0.9395287310128291,1.0,7/26,19.75%,ATP6V1B1;RAB7A;ATP6V1E1;ATP6V1D;ATP6V0D1;ATP6V1B2;ATP6V0B
prerank,carnitine shuttle (GO:0006853),0.5005356010483019,1.0855747600452217,0.38474295190713104,0.9403059635838366,1.0,4/11,12.64%,PRKAA2;CPT1B;ACACA;CPT2
prerank,gliogenesis (GO:0042063),0.4901234581750197,1.0851483294498818,0.36281859070464767,0.9407467505445241,1.0,4/15,10.02%,CDK6;CD9;TGFB2;NFIB
prerank,negative regulation of cell aging (GO:0090344),0.47664699098229996,1.0845155866906768,0.37400950871632327,0.9417677218647508,1.0,9/16,21.57%,WNT1;CDK6;FOXM1;FBXO5;TWIST1;MAP3K3;ZKSCAN3;TERF2;YBX1
prerank,protein depolymerization (GO:0051261),0.44563027624177154,1.0844434270046943,0.36428571428571427,0.9410941536813191,1.0,6/27,11.70%,GSN;MICAL2;KIF2A;TWF1;MICAL1;VPS4B
prerank,negative regulation of neuroinflammatory response (GO:0150079),0.48922170967268686,1.0843374118907292,0.39553429027113235,0.9405271473539215,1.0,2/14,2.15%,LDLR;CD200
prerank,carbohydrate catabolic process (GO:0016052),0.4156798078716069,1.0841919071029913,0.3654891304347826,0.940059703233635,1.0,11/38,16.09%,HKDC1;PKM;PFKFB2;MANBA;DERA;ENO2;HK1;ALDOA;GAPDH;NAGA;TPI1
prerank,negative regulation of viral release from host cell (GO:1902187),0.5047546511485452,1.0839640429884,0.3971518987341772,0.9398921093058115,1.0,4/13,9.40%,TRIM21;PML;TRIM26;TRIM11
prerank,granulocyte differentiation (GO:0030851),0.46914570993676563,1.0838676658839952,0.3630862329803328,0.9392954461600539,1.0,7/18,18.35%,CDKN1A;EP300;CDK4;PML;CDK2;E2F1;RARA
prerank,protein K48-linked ubiquitination (GO:0070936),0.3879405647807823,1.08377337147117,0.35,0.938693254133164,1.0,12/54,16.88%,RNF152;RNF5;UBE2G2;RBX1;RNF146;UBE2B;RNF126;PELI1;UBR5;UBE2H;BFAR;UBE2D3
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.453295381163393,1.0836786109058079,0.37375178316690444,0.9381131679592092,1.0,5/22,13.53%,CLU;EPHA4;ABCA2;SP1;GSK3A
prerank,negative regulation of phosphatase activity (GO:0010923),0.44333673937262713,1.0832007752401485,0.3615819209039548,0.938732083479145,1.0,8/25,15.10%,SH3RF2;PPP1R15A;TGFB2;CRY2;CHP1;PPP1R11;GSK3B;PPP1R1B
prerank,"wound healing, spreading of cells (GO:0044319)",0.43630628512684116,1.0831403081575752,0.3831360946745562,0.9380313985465206,1.0,8/24,15.66%,CD44;TMEFF2;TOR1A;RHOA;MMP12;PDPN;DDR1;FLNA
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),-0.3350345144532647,-1.0830026013297795,0.324,0.7504696942122143,1.0,9/30,15.43%,CACNA1C;GJC1;GPD1L;KCNJ2;CACNA1G;FGF12;SCN1A;RYR2;SCN1B
prerank,establishment of endothelial barrier (GO:0061028),0.42857391260287064,1.082901819989798,0.36916548797736914,0.9378742994573216,1.0,10/29,15.44%,TJP2;TJP1;RAP1B;RAP1A;MSN;EZR;RAPGEF3;RAB1B;RAPGEF1;RAP2C
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),-0.4437210274968759,-1.0826173148076261,0.3581267217630854,0.7499369070414326,1.0,5/11,37.35%,NOS1AP;KCNIP2;TREM2;RNF207;ALG10B
prerank,regulation of neurotransmitter transport (GO:0051588),-0.40149662054276036,-1.0824675832188608,0.3323943661971831,0.7487452482469129,1.0,8/16,21.20%,SNCAIP;MCTP2;CAMK2A;MCTP1;KCNMB4;CPLX2;FMR1;RIMS1
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.36410382806300967,1.0824649425189854,0.34772462077012833,0.9382990771832511,1.0,15/85,12.90%,CELSR1;WNT1;MAGI2;WNT11;AP2A2;PSMD11;PSMD4;PSMF1;DVL3;FZD5;CDC42;PSMD7;AP2A1;RHOA;PSMB5
prerank,regulation of axon extension (GO:0030516),0.41754896744102715,1.0822894666562248,0.35636856368563685,0.9379344466678455,1.0,11/37,20.66%,ISLR2;RTN4R;OLFM1;ZFYVE27;MAP3K13;GSK3B;ABL1;SHTN1;SEMA3A;MAPT;DBN1
prerank,positive regulation of cardiocyte differentiation (GO:1905209),0.5101370657550703,1.0822867043949858,0.36622073578595316,0.9370544328125665,1.0,4/11,19.14%,EFNB2;TGFB2;MEF2C;GPER1
prerank,histone lysine demethylation (GO:0070076),0.44262127601832757,1.0822016752402295,0.38202247191011235,0.9364182774890206,1.0,7/25,12.10%,KDM4D;KDM4B;KDM5C;KDM3A;RIOX2;KDM4C;KDM6A
prerank,endocytic recycling (GO:0032456),0.3960356729217051,1.082142316026022,0.36953807740324596,0.9356907086866468,1.0,11/50,16.18%,RAB17;EHD1;RAB11FIP3;RAB7A;LMTK2;RAB35;SNX12;VPS52;WASHC1;CCDC22;VPS50
prerank,regulation of nuclear division (GO:0051783),0.46654181997082195,1.0818946704250068,0.3889695210449927,0.9355518353713949,1.0,6/20,18.49%,DAPK3;CAV2;FBXO5;PKMYT1;CUL9;KIF20B
prerank,positive regulation of B cell activation (GO:0050871),0.4057729213556158,1.0818054485037942,0.3548795944233207,0.9349358964386741,1.0,5/50,4.72%,NFATC2;SASH3;CD81;CLCF1;SHLD2
prerank,glycolytic process (GO:0006096),0.43656768973867344,1.0817288793070012,0.36337625178826893,0.934290966953084,1.0,8/28,16.09%,HKDC1;PKM;PFKFB2;ENO2;HK1;ALDOA;GAPDH;TPI1
prerank,outer dynein arm assembly (GO:0036158),0.4835867377911841,1.081663014013868,0.37538940809968846,0.9335954735877068,1.0,6/14,26.70%,LRRC49;ODAD3;DNAAF5;ODAD2;DNAH5;DNAAF4
prerank,response to ethanol (GO:0045471),-0.40558572615113675,-1.081600659319477,0.3673469387755102,0.749651118773635,1.0,8/14,25.90%,GRIN2A;ADCY7;GRIN2B;GLRA1;GLRA2;SOD1;GRIN3A;GOT2
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.4732812008241532,1.0815511936937956,0.3869565217391304,0.9330518019275743,1.0,6/18,14.55%,DDX5;ZC3H12A;BMP4;MAP2K2;NCOR1;NCOR2
prerank,axon guidance (GO:0007411),0.3431894927982901,1.0811283756732641,0.3217665615141956,0.9335071955622117,1.0,35/201,11.68%,ALCAM;SEMA3D;NOTCH2;LAMC2;SMO;GPC1;PLXNB1;EPHA4;EFNB2;DAG1;NIBAN2;PLXNA2;GAB1;SEMA3B;CXCR4;LAMA5;DOK6;GDNF;SPTBN2;ENAH;GFRA3;EFNA5;SHC1;MAPK7;KLF7;PTPRA;UNC5B;OPHN1;EZR;NFIB;NRP2;SEMA4F;EPHA3;SPTAN1;IRS2
prerank,cellular response to metal ion (GO:0071248),0.3552632907365845,1.0811101948228377,0.35635964912280704,0.9326801520833484,1.0,22/123,15.27%,CDH1;PRKAA2;DAXX;MMP9;FOS;ADD1;DMTN;ANK3;JUN;IQGAP1;MAPK9;TIGAR;AQP1;SLC41A1;CPNE2;TRPM2;MEF2C;SYT6;CHUK;HVCN1;SYT11;SYT12
prerank,sensory perception of light stimulus (GO:0050953),-0.26456249678897714,-1.080693392978269,0.291044776119403,0.7505721159557635,1.0,11/87,4.93%,COL1A1;ADGRV1;PCDH15;SLC4A10;COL18A1;RP2;ATXN7;EYA4;MYO9A;GRM8;COL11A1
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),-0.45531836587209873,-1.0805093160360513,0.37597911227154046,0.7494492885874364,1.0,2/10,7.75%,PTPRJ;PTPN12
prerank,negative regulation of response to stimulus (GO:0048585),0.3830901934699449,1.0804270604388893,0.3576555023923445,0.9338601099843671,1.0,14/60,14.20%,CLU;KLF4;CDK6;ALOX5;MAPK7;KLF7;ERBB3;FBXO5;FOXP3;CASK;TWIST1;LPCAT3;TLE5;BRAP
prerank,regulation of interferon-alpha production (GO:0032647),0.4492115201642966,1.0801763870080174,0.36541143654114366,0.9337183864470465,1.0,6/23,15.32%,MAVS;IRF3;TLR4;CHUK;TLR3;DHX9
prerank,protein deacylation (GO:0035601),0.4436867386379249,1.0801047641783506,0.36363636363636365,0.9330320427361555,1.0,8/23,22.27%,HDAC5;HDAC4;ABHD10;HDAC3;HDAC6;LYPLAL1;ABHD17C;SIRT7
prerank,regulation of SMAD protein signal transduction (GO:0060390),-0.36854400997432774,-1.0795772481552235,0.3373493975903614,0.7503230623207132,1.0,5/21,8.18%,BMP6;RBPMS;DAB2;TGFB1;JAK2
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.40682748424289616,1.0795219397572713,0.35331632653061223,0.9339455057967909,1.0,6/40,8.79%,CLU;PTK2B;NUB1;DESI1;LATS1;PML
prerank,steroid hormone mediated signaling pathway (GO:0043401),0.4865399055886452,1.0794694875404784,0.3782894736842105,0.9332275322188978,1.0,3/13,11.84%,NR3C2;BMP4;CALCOCO1
prerank,ventricular cardiac muscle tissue development (GO:0003229),0.4428975489039146,1.0794263258437908,0.36496350364963503,0.9324623600180459,1.0,1/23,0.32%,DSG2
prerank,regulation of isotype switching (GO:0045191),0.48313365178148093,1.079005104127573,0.37205651491365777,0.9329391397062815,1.0,3/14,9.55%,SHLD2;PARP3;RIF1
prerank,lytic vacuole organization (GO:0080171),-0.3392127067816385,-1.0788278364169928,0.32916666666666666,0.7508827700659771,1.0,10/32,17.80%,ABCA1;CLVS2;LRRK2;GAA;TPP1;SNAPIN;LAMTOR1;CLN3;TMEM106B;CLVS1
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),-0.3753538905199786,-1.078595640231857,0.3343558282208589,0.7499949506898349,1.0,4/19,4.00%,PARD3B;DLG2;ERBIN;LRRC7
prerank,phosphate ion transport (GO:0006817),0.4691322434471826,1.078446734755361,0.3853503184713376,0.9338147871598681,1.0,4/16,14.52%,SLC25A3;SLC20A1;SLC25A14;SLC37A1
prerank,negative regulation of metabolic process (GO:0009892),0.3920880691034297,1.0780496175173506,0.3712871287128713,0.9341823458640802,1.0,10/54,8.89%,PLCL2;LAMA4;IL15;FOXC2;IP6K1;DOCK7;RHEB;PLCL1;LGR4;ARRDC3
prerank,negative regulation by host of viral process (GO:0044793),0.5313231110316006,1.0778279767719467,0.3890845070422535,0.9340209192640921,1.0,6/10,32.64%,ZC3H12A;EIF2AK4;VAPA;PRKN;PSMC3;CCNK
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.4547845859771669,1.0777184784076643,0.38088012139605465,0.9334806676511427,1.0,6/21,11.24%,HKDC1;PGM2;PGD;DERA;HK1;RPIA
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),0.40622919039668715,1.0773128450741574,0.3530183727034121,0.9338335832800029,1.0,3/40,2.29%,CLU;ANGPT1;MAGI2
prerank,positive regulation of phospholipase C activity (GO:0010863),0.4051457459341841,1.077280860922428,0.36265223274695535,0.9330524372246121,1.0,3/40,0.84%,FGFR1;LPAR1;NTRK3
prerank,oligosaccharide metabolic process (GO:0009311),0.4014397268184678,1.077249239408301,0.3851091142490372,0.9322857200515472,1.0,8/46,14.99%,B3GALT1;ST3GAL4;B4GALNT2;FUT8;MANBA;ST3GAL6;NAGA;ST6GALNAC4
prerank,positive regulation of filopodium assembly (GO:0051491),0.45030389572856366,1.0771418497824243,0.3849493487698987,0.9317546508189548,1.0,6/24,10.45%,ARAP1;PALM;RIPOR2;RHOQ;CDC42;BCAS3
prerank,double-strand break repair via homologous recombination (GO:0000724),0.3699581135518127,1.0769743495833233,0.35129068462401797,0.9314151011249169,1.0,33/95,22.43%,FEN1;RECQL4;KDM4D;NABP2;RNF138;MRE11;RAD54L;RMI1;HUS1B;NSMCE2;MMS22L;ERCC5;RPA3;MCM8;FAN1;UBE2N;LIG3;SFR1;MCM6;SMC6;NBN;MCM7;RAD50;ZFYVE26;NUCKS1;ERCC4;NABP1;POLN;YY1;SFPQ;MCM4;SWI5;NSMCE1
prerank,regulation of protein transport (GO:0051223),0.4215120448503126,1.0768832584784274,0.3730496453900709,0.9308128281358268,1.0,6/27,13.93%,NDEL1;WWP2;CHP1;LLGL2;SNX12;RHBDF2
prerank,cell projection organization (GO:0030030),0.41964324067315717,1.0765821168850536,0.3724966622162884,0.9308569852291417,1.0,6/30,16.16%,PARVA;GSN;RHOQ;CDC42;RHOU;KIF17
prerank,acylglycerol metabolic process (GO:0006639),-0.3176243942107068,-1.0765181868507363,0.3148936170212766,0.7540477103433713,1.0,18/37,27.41%,DGKH;DGKB;PLAAT3;MGLL;SEL1L;DGKI;ABHD12;DGKG;ABHD2;LPL;PNPLA3;DGAT2;DGKZ;DGKQ;DGKK;GK5;PNPLA2;AWAT2
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.400044032668038,1.0765077201519575,0.3611111111111111,0.930219453912543,1.0,17/46,23.64%,TIMM10;TIMM44;TOMM5;DNLZ;ROMO1;PITRM1;HK1;BCAP31;TOMM20;TIMM17B;TOMM40L;TIMM9;TOMM40;TSPO;TIMM50;TIMM23;AIP
prerank,regulation of protein export from nucleus (GO:0046825),0.4368967790535381,1.0764466003103197,0.39285714285714285,0.9295361087502536,1.0,9/23,22.76%,PTPN14;TCF7L2;BAG3;RAPGEF3;GSK3B;PARK7;XPO4;SIRT7;TPR
prerank,retrograde axonal transport (GO:0008090),-0.4080063106983721,-1.0764110469684105,0.37714285714285717,0.7528091302381765,1.0,7/16,18.91%,DLG2;ACTR10;NEFL;KIF1A;TMEM108;MAP1A;SOD1
prerank,protein destabilization (GO:0031648),0.41667473010095923,1.0762441116105674,0.35182679296346414,0.9292729148802177,1.0,8/32,18.72%,GSN;EP300;MUL1;TRIM21;SERF2;MDM2;CTSH;PEX2
prerank,cellular zinc ion homeostasis (GO:0006882),-0.3374200636415812,-1.0761085353593394,0.33933933933933935,0.752137755821914,1.0,5/26,12.48%,SLC30A10;SLC39A12;SLC39A8;SLC39A10;SLC30A1
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.3410040223132983,1.076059478149421,0.33987603305785125,0.9289844542113754,1.0,17/214,6.53%,FN1;ANGPT1;CD44;NOTCH2;NTRK3;CCL5;PDGFC;CCN2;RAP1A;PTK2B;DUSP10;GCNT2;ACKR3;ROS1;FBLN1;SPRED3;SHC1
prerank,negative regulation of programmed necrotic cell death (GO:0062099),0.5199684408283737,1.0760388081784333,0.4006677796327212,0.928177333268943,1.0,4/11,16.55%,NUPR1;YBX3;PELI1;SLC25A4
prerank,cellular protein modification process (GO:0006464),0.3338334872426568,1.0758600407549932,0.206,0.9278784819101629,1.0,205/983,17.76%,FN1;EGLN3;PRKCB;MSLN;UST;FGFR1;PTPN14;STK19;FBXL7;B3GALT1;PRKAA2;F5;LIMK2;FAM20C;PRAG1;FBXW8;ST3GAL4;NRBP2;MAP3K5;TRIB2;PRSS23;GRK5;ADAM10;TSSK6;TSSK4;PENK;PIGU;WNT11;IKBKE;NEK7;CDK10;PDF;ASB14;CDK6;PPM1L;FBXL20;MKNK2;PTK2B;SGK3;DAPK3;PPP2CA;SPSB4;ATE1;DUSP10;SERPINC1;GCNT2;LARGE1;DAPK1;ZBTB16;TIMP1;WWP2;PPM1B;PTPRU;PTPRD;CDKL2;CDK4;DUSP12;DUSP1;PSMD11;NUB1;ANO8;UBLCP1;MGAT1;ROS1;ELOB;CREB1;RNASEL;PHKA2;KLHL21;STK39;NPC1;MACROD1;SIK3;DDOST;CSK;BMP4;PTPRF;PTPN9;PSMD4;PARP3;PTPRA;CPE;PSMF1;TGM5;GPC3;TGFB2;PP2D1;FEM1C;FEM1A;CDK16;ILK;LATS1;SUMF1;WSB2;DYRK1B;PPM1A;GPAA1;FBXL18;RBX1;OXSR1;MAPK9;AURKC;FBXO31;LAMC1;MANBA;BCR;LMTK2;TXK;PTPN6;LAMB2;MTMR3;SRPK2;PIGT;COP1;PSMD7;CDKL4;GRK2;FBXW9;FEM1B;PDK2;CSNK1E;SUMF2;DCUN1D1;PARP6;PTPRE;SOCS2;JAK1;ALG1;CALU;YWHAZ;KLHL13;MARK4;TGFBR2;EIF2AK3;COPS5;ST3GAL6;PPP1CB;DCAF6;CDK18;SRPK1;CP;PPM1D;PSMB5;UBXN7;ARF4;MAP3K13;CDK2;LGALS1;DDA1;GSK3A;ASB7;ALG5;IRAK1;CHML;SOCS6;DCAF17;CHUK;TULP4;ULK1;SERP2;RAB1B;GSK3B;WNK1;NUS1;NTAQ1;DNAJC3;PIGS;CDC42BPA;PPP2CB;PLK2;JMJD4;PRKCSH;ASB6;DUSP11;CCDC22;TNKS2;AAK1;FBXL15;ASB8;DDB1;PAK6;CAND1;ASB3;PRKCZ;ATG4B;CUL9;ABL1;UBE2D3;PRKAG1;MAP3K6;MAPK6;CDC25B;EIF2AK4;PTPN13;KEAP1;PTP4A2;MAPKAPK2;UBE2F;CHEK2;FBXL2;PSMD1;RPN2;PDP1;USP25;BMPR1A
prerank,mitotic recombination (GO:0006312),-0.40368312733076306,-1.0758300888305232,0.36231884057971014,0.751419608985825,1.0,10/15,27.74%,MSH3;RAD51D;RAD54B;SMC5;RAD51;ERCC1;TEP1;TPRKB;GEN1;RAD52
prerank,regulation of mitochondrial membrane permeability (GO:0046902),0.4699125579850399,1.0752528163651196,0.39060205580029367,0.9288395401883116,1.0,4/18,7.48%,PMAIP1;BCL2L1;MUL1;BAD
prerank,maintenance of blood-brain barrier (GO:0035633),0.42182179592158164,1.0746520496570828,0.36464088397790057,0.9297016900473672,1.0,8/30,10.72%,TJP2;TJP1;OCLN;GJB6;LSR;LAMC1;ACTB;ACTG1
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),-0.4331689388992901,-1.074420507314478,0.3712121212121212,0.7538125327990657,1.0,3/12,12.17%,CYP26B1;EZH2;DHRS3
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),-0.39943922350722966,-1.0743672801211839,0.35097493036211697,0.7524386084474698,1.0,6/14,32.79%,MRNIP;FANCB;WDR48;ERCC6;WRAP53;RAD51AP1
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.5095351303869066,1.0740154545755494,0.3745819397993311,0.9306922590993115,1.0,5/11,22.07%,MAP3K5;ARL6IP5;PRODH;STK24;DIABLO
prerank,translational termination (GO:0006415),0.36185396955683063,1.0740014409555654,0.34841628959276016,0.9298799620501991,1.0,43/95,28.38%,MRPS16;MRPL38;MRPL24;MRPL37;MRPL2;MRPL49;MRPL33;MRPS7;MRPS34;GSPT2;MRPS23;MRPS33;MRPS27;MRPL9;MRPL57;MRPS15;MRPL50;MRPS18C;MRPS28;MRPS35;GADD45GIP1;TRMT112;MTRF1L;ETF1;MRPL19;MRPL14;MRPL32;AURKAIP1;N6AMT1;MRPL39;MRPS25;MRPS30;MRPL54;MRPS21;MRPS22;MRPS12;MRPL35;GFM2;PTCD3;MRPL44;MRPL18;MRPS6;MRPS24
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.3916524653516901,1.0739176461965323,0.380352644836272,0.9292665517146076,1.0,14/54,17.98%,CNOT6;CDKN1A;EP300;PLK3;PML;BTG2;MDM2;PLK2;PCNA;E2F1;PRMT1;CHEK2;PIDD1;TRIAP1
prerank,histone H4 acetylation (GO:0043967),0.3921801686205182,1.0732620519048777,0.35853976531942633,0.9304081788149227,1.0,16/47,18.47%,OGT;EP300;NAA40;BEND3;HCFC1;MORF4L2;KMT2A;APBB1;ACTL6B;JADE2;ING4;MSL2;MEAF6;TRRAP;TRIM16;ATF2
prerank,cochlea morphogenesis (GO:0090103),0.5245455747196917,1.0731361983831331,0.38870967741935486,0.9299422707161136,1.0,2/10,6.28%,HPN;SOX9
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.3480794406921703,1.0730090383959299,0.34932221063607927,0.9294772167109779,1.0,25/166,12.35%,NR3C2;THRB;NOTCH2;PPARGC1A;RORC;CCN2;GTF2F1;HDAC5;NR6A1;POLR2H;ESRRB;TAF1C;RARG;POLR2A;RXRB;MAZ;UBTF;NR2C1;POLR1C;HDAC3;POLR1E;NCOR1;GTF2E1;POLR1F;TAF5
prerank,mitochondrial gene expression (GO:0140053),0.4018651181292865,1.0728740396408436,0.37659033078880405,0.9290467033757314,1.0,11/42,17.40%,MRPS16;FOXO3;MRPL2;HARS1;MRPS7;MRPS34;LARS2;MRPL57;MRPS15;MRPS28;GATB
prerank,regulation of cell cycle phase transition (GO:1901987),0.3543465310227124,1.0721275560674737,0.36292134831460676,0.9304563474965647,1.0,14/91,18.10%,FZR1;CDKN1A;PSMD11;PSMD4;PSMF1;FBXO5;PSMD7;PSMB5;ANAPC4;ATP2B4;DDB1;ERCC2;PSMD1;PSMC4
prerank,activation of phospholipase C activity (GO:0007202),0.4237324416500112,1.0720873187453863,0.364656381486676,0.9297239890450296,1.0,4/29,11.30%,LPAR1;ANG;TXK;GNAQ
prerank,regulation of pseudopodium assembly (GO:0031272),0.5204680168974305,1.0719368114256371,0.40498442367601245,0.9284828209934419,1.0,4/10,14.88%,CDC42EP4;CDC42EP5;CDC42;WASHC1
prerank,positive regulation of pseudopodium assembly (GO:0031274),0.5204680168974305,1.0719368114256371,0.40498442367601245,0.9284828209934419,1.0,4/10,14.88%,CDC42EP4;CDC42EP5;CDC42;WASHC1
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.39432287014123113,1.071899141105076,0.3706030150753769,0.9277551707281699,1.0,8/47,12.14%,AGTR1;CDKN1A;ZC3H12A;DHRS4;ROMO1;TLR6;TLR4;TGFBR2
prerank,cellular copper ion homeostasis (GO:0006878),0.4771592586085044,1.0718251496277698,0.3786707882534776,0.9271356991153288,1.0,6/14,23.38%,COX19;SLC31A2;CCDC22;ABCB6;APP;MT2A
prerank,positive regulation of developmental growth (GO:0048639),-0.29545407814911856,-1.071566901126221,0.3317307692307692,0.7588748350635598,1.0,9/49,13.08%,PLCB1;GHR;INSR;SEMA7A;SYT1;CDKL5;ITSN2;MACF1;BDNF
prerank,regulation of fatty acid oxidation (GO:0046320),0.4758946298381146,1.0712878630803297,0.40144927536231884,0.9278925170589032,1.0,4/16,7.49%,PPARGC1A;ABCD1;SOX9;ACADL
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.5083867076354674,1.0712055264599043,0.40483870967741936,0.9273092985891076,1.0,1/12,0.58%,CD44
prerank,hematopoietic progenitor cell differentiation (GO:0002244),-0.3330373978690353,-1.0711016002304374,0.33568904593639576,0.7585949101781498,1.0,7/30,13.19%,FLT1;KDR;ACE;TGFB1;KIT;TP53;FLT4
prerank,membrane lipid biosynthetic process (GO:0046467),0.3832917727054555,1.0710223089063386,0.35574572127139364,0.9270341828603019,1.0,6/58,4.19%,SPTSSB;ST3GAL4;SGMS2;PPM1L;SCCPDH;ELOVL1
prerank,negative regulation of B cell activation (GO:0050869),-0.362896938551767,-1.0709721809828734,0.38801261829652994,0.7573830019103229,1.0,11/21,32.51%,LYN;TNFRSF21;ID2;CD300A;RC3H1;TNFAIP3;TYROBP;FCGR2B;BANK1;FOXJ1;SAMSN1
prerank,androgen receptor signaling pathway (GO:0030521),0.5148958084503484,1.0709055381304964,0.41196581196581195,0.9265646806353484,1.0,2/11,2.31%,DAXX;DDX5
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.3375684969006171,-1.0707111633968558,0.3244274809160305,0.7566079564961565,1.0,13/30,19.51%,NOS3;FAS;RFFL;TNFSF10;CFLAR;ARHGEF2;RIPK1;GPX1;ICAM1;RNF34;FAIM2;TRADD;TNFAIP3
prerank,pentose-phosphate shunt (GO:0006098),0.5120801554566706,1.0706679149847156,0.41,0.9264115306044766,1.0,5/11,16.40%,PGM2;PGD;DERA;RPIA;RBKS
prerank,interleukin-27-mediated signaling pathway (GO:0070106),0.4875796143866578,1.0704986356226651,0.40348101265822783,0.9260542185144055,1.0,4/13,16.44%,CRLF1;JAK1;OAS2;CANX
prerank,phosphate ion transmembrane transport (GO:0035435),0.4994526212792184,1.0704867105986124,0.39558573853989815,0.9252530521785567,1.0,4/12,14.52%,SLC25A3;SLC20A1;SLC25A14;SLC37A1
prerank,phosphatidylinositol metabolic process (GO:0046488),-0.2553640002559617,-1.0703771462865486,0.3069306930693069,0.7560109098467849,1.0,20/109,8.54%,PLCB1;PDGFRB;PLA2G4A;PIK3R1;INPP4B;PIP5K1B;INPP5D;PIP4K2A;SYNJ2;FGF2;ARF3;PLAAT3;MTMR14;MTM1;PLEKHA8;BMX;PLEKHA2;PIK3CB;PLEKHA4;PIK3R6
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.39508358673454363,1.0702197174781856,0.35705045278137126,0.9251940990385437,1.0,8/43,9.63%,CDH13;MMP9;CCL5;BMP4;MEF2D;JUN;ADAMTS1;HTR1B
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.4865983399772816,1.070202321180484,0.3893249607535322,0.9244167133129068,1.0,5/14,18.02%,KLF4;HDAC5;RHOA;ITGB1BP1;MEOX2
prerank,mitotic cytokinetic process (GO:1902410),0.44288067437871886,1.069707086093861,0.37920937042459735,0.9251034328966373,1.0,12/20,26.59%,CHMP4A;CHMP4B;VPS4B;RHOA;CHMP1A;VPS4A;CHMP2A;PDCD6IP;MITD1;KLHDC8B;CHMP5;CHMP1B
prerank,brain development (GO:0007420),-0.24414443358419413,-1.069421386244611,0.2987012987012987,0.7570155485637731,1.0,35/136,15.58%,EPHA7;ARNT2;CNTNAP2;RAPGEF2;CDH2;ADGRL3;SHANK3;EML1;GRIN2A;AFF2;COL4A1;SYNJ2;CHD8;ROBO2;GRIN2B;CTNNA2;ZFHX2;DSCAML1;TUBGCP2;UBE3A;NES;SPEF2;NNAT;NF1;PAFAH1B2;EEF1AKMT4-ECE2;MEIS1;TBC1D23;PCDH18;NIPBL;MFSD2A;TMX2;SOX6;MEIS2;HSPG2
prerank,ciliary basal body-plasma membrane docking (GO:0097711),-0.26177254774140485,-1.0692725894515265,0.2571428571428571,0.7558853361019694,1.0,29/94,23.55%,CEP250;IQCB1;CCP110;CEP78;ALMS1;TMEM67;NDE1;AHI1;CEP162;PRKAR2B;TCTN1;C2CD3;NEDD1;SCLT1;CSNK1D;SDCCAG8;TCTN2;TCTN3;CKAP5;B9D1;NPHP4;CEP41;MAPRE1;HAUS4;RPGRIP1L;HAUS7;CEP72;YWHAE;SSNA1
prerank,RNA processing (GO:0006396),0.3413876299629786,1.069143364345054,0.37407797681770283,0.9258740866695356,1.0,47/176,20.32%,MBNL1;CELF2;PPARGC1A;SRSF2;CELF1;YJU2;PPP2CA;SON;SNRPB;RNASEL;LSM4;DDX39B;RBM8A;TENT4A;XRN2;LUC7L3;SF3B3;USP39;SRPK2;SRRM4;SRSF7;DDX47;SF3A2;ZCCHC8;SRPK1;HNRNPUL1;SYNCRIP;TUT7;RNPS1;SRSF9;PABPN1;DUSP11;MAGOHB;MAGOH;CLP1;PRPF6;TSEN2;RBMS2;SRSF1;PTBP1;SRSF5;ZMAT5;CSTF3;WBP4;SF3A3;DDX20;THOC1
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),-0.41716617749045104,-1.069098754388587,0.3665768194070081,0.7548040990173804,1.0,5/13,12.51%,PDE8A;LRRK2;GPR37;RACK1;TXN
prerank,regulation of tissue remodeling (GO:0034103),-0.37758538645145157,-1.068584897671515,0.36684782608695654,0.7546652800735412,1.0,6/18,16.84%,LEPR;RUNX1;IL18;TGFB1;FLT4;SUCO
prerank,regulation of cholesterol efflux (GO:0010874),0.42102254088830904,1.0684953349938007,0.3888888888888889,0.9269882142303971,1.0,4/30,5.36%,SREBF2;CAV1;TTC39B;NFKBIA
prerank,regulation of synapse assembly (GO:0051963),0.39280046202455277,1.0682716949466393,0.3581514762516046,0.9268250464902306,1.0,5/46,4.84%,RAB17;GPC6;PDLIM5;GPC4;PTPRD
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.3338914330936303,1.0679763744688506,0.3532994923857868,0.9268588819871018,1.0,56/259,18.72%,RAB17;CDH13;CYS1;SRGAP2;ABLIM2;ACTN2;ABLIM1;PARVA;EMP2;GSN;RAP1B;RAP1A;EHD1;CNGA2;ARL3;INPP5E;CCDC28B;RAB11FIP3;AVIL;DMTN;GOLPH3;IFT46;EXOC7;CFAP54;EXOC4;PKD1;CC2D2A;IFT80;OPHN1;EZR;EXOC2;ARFIP2;ANO6;CPLANE2;CNGB1;EXOC8;ARF4;OCRL;MKKS;CCDC88A;ATP6V1D;RAP2C;ATP6V0D1;FLNA;FSCN1;TMEM138;PTPDC1;VCL;RAB8B;HDAC6;RILPL1;SHTN1;FHDC1;ARHGEF6;WDR35;GALNT11
prerank,organic hydroxy compound transport (GO:0015850),-0.3089926594657719,-1.067808136138869,0.35144927536231885,0.7553223276283184,1.0,5/36,7.18%,ABCC4;SLCO2B1;SLCO1C1;NCOA1;SLC16A1
prerank,positive regulation of cellular catabolic process (GO:0031331),0.34890190155007195,1.0667541360657038,0.36344314558979807,0.9296199991620573,1.0,31/132,15.37%,RNF152;PRKAA2;TPCN1;ZC3H12A;ABCD1;ABHD5;FOXO3;DAPK1;MTDH;ORMDL3;SH3BP4;MOV10;PFKFB2;MSN;TRIM21;BAD;MTLN;EZR;TWIST1;SNX33;VPS11;IRS2;ZSWIM8;TFEB;GSK3A;ULK1;GSK3B;FLCN;GRSF1;PLK2;HSP90AA1
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),-0.4546364017362725,-1.0666147311759784,0.37662337662337664,0.7570719342988891,1.0,4/11,9.56%,NOVA1;NOVA2;ZNF445;PCBP3
prerank,cellular response to oxygen-containing compound (GO:1901701),0.3374058277216831,1.0665496274638286,0.3346938775510204,0.9294415204175737,1.0,52/291,14.21%,CFTR;NCOA3;MMP9;VIM;RORC;PTK7;RAP1B;ZC3H12A;WNT11;RAP1A;FAM210B;PTK2B;FOS;SESN2;WNT6;DAPK1;SH3BP4;INSIG1;LCOR;CREB1;SOX9;DMTN;PXN;AANAT;TRIM41;CAPN2;ADCY6;ROMO1;WNT5B;JUN;MAPK9;LBP;SHMT1;ACTB;EZR;CARD16;AGAP3;AQP1;TLR4;RAPGEF3;PDK2;EPHA3;RHOA;WNT3;CPEB3;SBNO2;CDK2;IRAK1;MEF2C;ATP2B4;SFRP1;CHUK
prerank,response to reactive oxygen species (GO:0000302),0.3857467353438913,1.0664539706183922,0.38238993710691827,0.9288932940417968,1.0,14/54,14.95%,MMP9;FOS;PXN;PLK3;ROMO1;JUN;MAPK9;SOD2;HP;AGAP3;PDK2;COA8;CHUK;APTX
prerank,cell part morphogenesis (GO:0032990),-0.42549061493874635,-1.066394744364951,0.3905325443786982,0.7561874218886401,1.0,3/13,9.13%,PID1;MTM1;FIS1
prerank,potassium ion transport (GO:0006813),0.34878512916679844,1.066176102452724,0.3500545256270447,0.9288904087053398,1.0,17/120,14.04%,SLC9A2;SLC9A4;HPN;NALCN;ATP1A2;KCNJ13;ABCC8;CHP1;KCNA4;SLC9A6;SLC9A7;KCNB1;AQP1;PKD2L1;KCNA5;KCNQ5;TMEM175
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),0.5006594922078621,1.0656473010857859,0.3868378812199037,0.9295836124796448,1.0,3/12,8.61%,ERLIN2;ACADL;ERLIN1
prerank,peptide catabolic process (GO:0043171),-0.34333045566597103,-1.065273329987099,0.36977491961414793,0.757616179696058,1.0,6/23,12.62%,ECE1;GGT5;ACE;TPP1;CPQ;ENPEP
prerank,negative regulation of coagulation (GO:0050819),0.4860804842526587,1.0651425425341887,0.4097560975609756,0.9301919785222591,1.0,3/14,6.08%,ADTRP;PROCR;THBD
prerank,regulation of amyloid-beta formation (GO:1902003),0.40512915733010324,1.06474499572992,0.3853211009174312,0.9305646821439513,1.0,7/34,13.53%,CLU;RTN1;EPHA4;RTN3;ABCA2;SP1;GSK3A
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),-0.3525063981502985,-1.0647219681503657,0.3433734939759036,0.7576549733884728,1.0,7/23,10.12%,GHR;NOTCH1;CYP1B1;JAK2;ERBB4;OCIAD1;KIT
prerank,translation (GO:0006412),0.34065287635108293,1.064703020443274,0.3624091381100727,0.9298607688756697,1.0,88/208,28.38%,MRPS16;EEF1A1;QARS1;EPRS1;MRPL24;MRPL37;MRPL2;VARS1;FARS2;HARS1;TMA7;RPS4X;MRPS7;ABCF1;RPL31;RPSA;MRPS34;LARS2;GSPT2;RPL22;AARS1;MRPS33;RPL28;SRBD1;RPS26;MRPL9;COPS5;MRPL57;EEF1D;EEF1E1;HARS2;TARS1;RPL10A;MRPS15;SARS2;SARS1;EIF4G1;YARS1;TNIP1;MRPS18C;MRPS28;RPL14;RRBP1;EEF2;RPS27A;GATB;FARSA;HBS1L;IGF2BP3;DARS2;EIF4EBP2;RPL6;FARSB;TRMT112;RPS28;ETF1;RPL41;NARS1;EEF2K;RPLP2;YARS2;RPLP1;RPL7;IGHMBP2;MRPL32;RPL21;N6AMT1;RPL26;KARS1;MRPS21;RPS27;MRPS12;RPS12;FTSJ1;RPL18;MRPL35;RPS17;GFM2;PTCD3;RPS3;LARS1;RPL22L1;MRPL18;MRPS6;RPL24;RSL24D1;EEF1A2;MRPS24
prerank,mitochondrial translational termination (GO:0070126),0.3614670572443138,1.0645949786694417,0.3641552511415525,0.9293452593401119,1.0,39/88,28.38%,MRPS16;MRPL38;MRPL24;MRPL37;MRPL2;MRPL49;MRPL33;MRPS7;MRPS34;MRPS23;MRPS33;MRPS27;MRPL9;MRPL57;MRPS15;MRPL50;MRPS18C;MRPS28;MRPS35;GADD45GIP1;MTRF1L;MRPL19;MRPL14;MRPL32;AURKAIP1;MRPL39;MRPS25;MRPS30;MRPL54;MRPS21;MRPS22;MRPS12;MRPL35;GFM2;PTCD3;MRPL44;MRPL18;MRPS6;MRPS24
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.3939145646918456,1.0645355539344072,0.36164736164736166,0.9286835651276545,1.0,12/44,20.20%,CD44;KLF4;NGF;RAF1;CARD16;AQP1;IGBP1;XIAP;TRIAP1;CDKN2D;BEX3;ARL6IP1
prerank,cytoplasmic microtubule organization (GO:0031122),0.3838652335463126,1.064454869176632,0.3686131386861314,0.928114243195843,1.0,20/54,24.70%,LIMK2;CLIP4;PLK3;CHP1;EZR;HOOK1;VPS4B;RHOA;CCDC88A;CAMSAP1;DYNC1H1;NUMA1;KATNAL2;TUBGCP5;HOOK3;MAPT;TRPV4;PCM1;SLK;CEP126
prerank,snRNA transcription (GO:0009301),0.37256966383300233,1.0642197521381662,0.3745498199279712,0.9279802676823663,1.0,27/70,24.82%,GTF2F1;POLR2H;NABP2;POLR2A;INTS2;RPRD2;GTF2E1;SP1;TAF5;ELL;SRRT;INTS3;POLR2C;INTS13;POLR2E;INTS6;TAF8;TBP;NABP1;SNAPC3;GTF2E2;TAF6;INTS1;CDK9;ICE1;ELL2;POLR2K
prerank,organelle transport along microtubule (GO:0072384),0.424899166518044,1.0642132300098828,0.4041666666666667,0.927174840001236,1.0,9/31,20.10%,DYNC1I1;NDEL1;ARHGAP21;CDC42;PAFAH1B1;COPG1;TMEM201;RHOT2;MAPT
prerank,activation of protein kinase activity (GO:0032147),-0.2513492982518272,-1.0628772631375552,0.2391304347826087,0.7612304007200277,1.0,24/106,12.51%,IGF1;GHR;INSR;ADCY5;TNIK;NRK;PAK3;WNT5A;GAS6;STK3;ADCY7;CARD10;IL18;ADCY1;ADCY4;JAK2;PRRC1;STRADA;PRKAR2B;MAP4K4;TRAF6;TIRAP;TOM1L1;TXN
prerank,pulmonary valve development (GO:0003177),0.4608690195823838,1.061924875737712,0.40978593272171254,0.9331488904868024,1.0,6/18,9.01%,NOTCH2;SMAD6;STRA6;BMP4;TGFB2;TNFRSF1A
prerank,positive regulation of telomerase activity (GO:0051973),0.4200853328128482,1.061849381723245,0.38866930171277997,0.9325238107692788,1.0,10/33,19.55%,KLF4;NEK7;MAPK15;MAP3K4;GRHL2;MYC;HSP90AA1;HMBOX1;PRKCQ;PNKP
prerank,long-chain fatty acid metabolic process (GO:0001676),0.3806971690250039,1.0618410058989503,0.38118214716525933,0.9317270746498814,1.0,13/64,13.94%,ADTRP;ACOT8;ABCD1;EPHX1;ELOVL1;ALOX5;SLC27A3;ACADL;ELOVL6;ACSL3;FADS1;CPT2;LTA4H
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),-0.29347945709102075,-1.061191439022629,0.3238095238095238,0.7644077812432776,1.0,8/51,7.48%,IL34;VEGFC;PTK2;CXCL12;GAS6;LGALS9;THBS1;IL6R
prerank,protein kinase B signaling (GO:0043491),0.4375175878797507,1.0608888154575176,0.40615835777126097,0.9337375703177977,1.0,4/23,7.56%,ADTRP;CCL5;TSC2;PLK3
prerank,tryptophan catabolic process (GO:0006569),0.501272010624588,1.0605614885066696,0.42857142857142855,0.9338632975192953,1.0,4/11,24.54%,TDO2;HAAO;KYAT1;KMO
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),0.49292410532858766,1.0604833014405646,0.415748031496063,0.9332784778943081,1.0,3/13,7.67%,CD81;INSIG1;GCC2
prerank,negative regulation of catabolic process (GO:0009895),0.3962522254696674,1.0598551804923262,0.38028169014084506,0.9343705601828627,1.0,10/47,12.17%,NUPR1;HDAC4;HMGCR;AZIN1;CYP51A1;BANP;SF3B3;TIGAR;NCOR1;SNX12
prerank,anion transport (GO:0006820),-0.32256866437317766,-1.0597991183930096,0.3473282442748092,0.7667763896856891,1.0,4/33,1.71%,SLC13A3;LRRC8C;SLC26A7;SLCO2B1
prerank,lymphocyte chemotaxis (GO:0048247),-0.3135903677835258,-1.059781969953121,0.3319838056680162,0.7653243654810545,1.0,15/34,32.57%,CYP7B1;GAS6;SLC12A2;CXCL16;PIK3CD;CCL13;CX3CL1;GPR183;CCL19;ADAM8;HSD3B7;PIK3CG;CCL2;CXCL10;CCL14
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),-0.2683376543152678,-1.059695023516794,0.31875,0.7640936187386544,1.0,29/72,25.34%,LIFR;GAS6;AXL;IRAK2;RUNX1;IRAK3;IFNGR1;IFNGR2;IFNAR2;JAK2;CFLAR;RBCK1;RIPK1;RACK1;CD74;CDC37;VRK2;TRADD;TNFAIP3;AGPAT2;HSP90AB1;TRAF1;SPHK1;SOCS3;CYLD;SIGIRR;BIRC2;AGPAT1;PYCARD
prerank,positive regulation of brown fat cell differentiation (GO:0090336),0.4890175330222657,1.0596836487327854,0.41961414790996787,0.9340680227877837,1.0,4/13,13.11%,NAPEPLD;ZBTB7B;SIX1;RREB1
prerank,positive regulation of programmed cell death (GO:0043068),0.3330671099031412,1.0594167092109439,0.3631739572736521,0.934008889459608,1.0,70/272,20.74%,CLU;PAWR;NGEF;MAP3K5;ARHGEF17;AKAP13;TNFAIP8;PMAIP1;ARHGEF12;PRR7;NGF;PHLDA3;FOXO3;TNFRSF8;DAPK3;TIAM2;DAPK1;OLFM1;UTP11;RARG;HOXA5;ARHGEF18;BMP4;PNMA2;BAD;LATS1;TNFRSF10B;NLRP2B;JUN;PIP5KL1;ADAMTSL4;ARHGEF5;TRIO;APBB1;ARL6IP5;GNA13;GADD45B;MARK4;ANO6;HRK;SOS2;RNPS1;EEF1E1;ING4;SFRP1;BNIP3L;DNM1L;FLCN;IP6K2;ARHGEF1;FRZB;RPS27A;UBC;E2F1;ABL1;SIAH1;PLEKHG2;HDAC6;PIDD1;SLC27A4;ARHGEF6;GPER1;MTCH1;GPLD1;UBE2Z;DDX20;SOX4;PRMT2;ZBP1;APH1A
prerank,pyruvate metabolic process (GO:0006090),0.3785916921217256,1.0592824333263153,0.3836477987421384,0.9335775534138496,1.0,13/52,16.09%,HAGH;ME3;HKDC1;PKM;LDHB;PFKFB2;LDHAL6B;ENO2;HK1;VDAC1;ALDOA;GAPDH;TPI1
prerank,regulation of brown fat cell differentiation (GO:0090335),0.4701055798283249,1.0592335657773704,0.4268104776579353,0.9329089100858543,1.0,5/16,14.84%,NAPEPLD;ZBTB7B;SIX1;RREB1;FLCN
prerank,cellular response to organic substance (GO:0071310),-0.2532557010489334,-1.0585749241462215,0.2619047619047619,0.765876471188034,1.0,26/116,10.70%,PID1;GHR;LEF1;IL1RAPL1;STAT5B;IGFBP5;ACVRL1;NCOA1;CYP1B1;CLEC3B;BMPR1B;PTPN4;SLC1A1;ACVR1B;ROBO2;IL18;LRRK2;SLIT2;TGFB1;PTPN12;ACVR2A;TBK1;RPS6KB1;RAMP2;TRAF6;STAT3
prerank,membrane assembly (GO:0071709),0.4148514165320785,1.0584931645095985,0.4100135317997294,0.9342711001993455,1.0,14/34,19.47%,EMP2;S100A10;PTPRD;FLOT2;ANK3;ANXA2;NSFL1C;CHMP4B;TLCD2;VPS4A;CHMP2A;NLGN2;STX4;FLOT1
prerank,positive regulation of protein acetylation (GO:1901985),0.49369280914895863,1.0584797083343525,0.3925081433224756,0.9334955565968914,1.0,1/12,0.82%,PRKAA2
prerank,regulation of Notch signaling pathway (GO:0008593),0.36882610391393134,1.058452947964173,0.39211136890951276,0.9327493088665602,1.0,8/76,4.47%,TSPAN5;WNT1;PRAG1;ELF3;SREBF2;NIBAN2;EP300;WWP2
prerank,cell-cell junction assembly (GO:0007043),0.37507964610075606,1.0584299111325197,0.39009661835748793,0.9319947764276808,1.0,11/63,11.76%,CLDN11;TJP1;PKP4;CTNNA1;GJB6;CD9;PATJ;PARD6B;ACTB;ACTG1;RHOA
prerank,cytoskeleton organization (GO:0007010),-0.25599252527509125,-1.0578169986670074,0.3142857142857143,0.7665115085740817,1.0,26/114,13.42%,MAST4;MARK1;RHOBTB1;SEMA6A;FGD5;TNIK;PLCE1;RND3;FMNL3;PALLD;MICAL3;LRCH3;EPB41L3;SH3KBP1;RANBP9;BIN1;ABI2;RHOBTB3;FGD3;ARAP3;ZMYM3;CNN2;KLHL20;DES;CNTNAP1;CECR2
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),0.5039646148776709,1.0574761253598448,0.4206081081081081,0.9339943498273109,1.0,2/11,12.21%,HPN;BCAR1
prerank,negative regulation of viral process (GO:0048525),0.38390338840336646,1.0571444908670766,0.39828431372549017,0.9341176604049901,1.0,14/57,16.62%,CCL5;MAVS;SLPI;RNASEL;TRIM21;LARP7;PML;TRIM26;TRIM11;SRPK2;SRPK1;TNIP1;OAS2;HEXIM1
prerank,protein import (GO:0017038),0.3641714048548386,1.0570730144359575,0.38207547169811323,0.9335265796898798,1.0,23/84,18.72%,CLU;PEX26;ABCD1;IPO7;TSC2;NUP93;HSPA4;TNPO2;SNX33;MMP12;SLC25A17;TNPO1;NXT2;RANBP6;HEATR3;PXMP4;HSP90AA1;IPO4;RAB8B;CSE1L;PPP1R10;PEX3;PEX2
prerank,negative regulation of binding (GO:0051100),0.35601656057172476,1.0564179735673158,0.383054892601432,0.9346999860233427,1.0,23/81,19.05%,CFHR1;SMO;CDKN1A;GTF2F1;CAV1;SLPI;NFKBIA;CTSZ;JUN;SUMO3;ACTB;CARD16;HABP4;CSNK1E;TLE5;GSK3B;ITGB1BP1;E2F1;KDM1A;BTAF1;WAPL;PARK7;ILRUN
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),0.49088633521075586,1.0562765459008008,0.42924528301886794,0.9342935226638059,1.0,3/12,8.45%,PODXL;MAGI2;IQGAP1
prerank,regulation of vasculogenesis (GO:2001212),-0.4057867492821376,-1.0559209897898232,0.37393767705382436,0.7703713288396459,1.0,5/14,4.75%,RAPGEF2;XDH;CD34;KDR;TMEM100
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.43557082412260506,1.0554346605123823,0.40109140518417463,0.9358346804391698,1.0,2/25,2.17%,B3GALT1;B4GAT1
prerank,ERK1 and ERK2 cascade (GO:0070371),-0.3572640228169772,-1.0550856643969118,0.38801261829652994,0.7713151565756252,1.0,7/21,18.72%,IGF1;KDR;LGALS9;ITGAV;EGF;MAP2K1;PTGER4
prerank,positive regulation of fat cell differentiation (GO:0045600),0.38854493554743424,1.05467167382275,0.39272271016311167,0.9371564380978357,1.0,12/47,14.09%,NAPEPLD;ZC3H12A;CREBL2;ZBTB16;CREB1;WDFY2;ZBTB7B;AAMDC;SIX1;TRPM4;RREB1;SFRP1
prerank,response to endoplasmic reticulum stress (GO:0034976),0.3521558458734973,1.054283303244457,0.3972602739726027,0.9374625604525211,1.0,31/107,22.34%,CFTR;MAP3K5;SCAMP5;BBC3;TMEM117;RNF5;TMEM259;PPP1R15A;DDRGK1;TNFRSF10B;JUN;USP19;BCAP31;TMEM33;HYOU1;EIF2AK3;GSK3B;DNAJC10;CCDC47;CREB3L2;UFM1;FICD;ERP27;CDK5RAP3;FLOT1;RHBDD1;GORASP2;TMX1;PPP1R15B;SEC16A;THBS4
prerank,regulation of interleukin-4 production (GO:0032673),-0.3532419202149436,-1.0540249794751422,0.35668789808917195,0.7726882879243178,1.0,3/21,4.50%,LEF1;SLC7A5;LGALS9
prerank,microglial cell activation (GO:0001774),0.45069172573702077,1.0537845903407825,0.4196969696969697,0.9381558233740361,1.0,1/21,0.40%,CLU
prerank,RNA interference (GO:0016246),0.4591495595720919,1.053582086642436,0.40294117647058825,0.9378899149267195,1.0,5/17,16.64%,CELF1;TARBP2;TSNAX;DHX9;CLP1
prerank,negative regulation of calcium ion transport (GO:0051926),0.4785902212662699,1.0533717017792914,0.415625,0.9376944394709095,1.0,2/15,4.46%,ATP1A2;EPO
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.42737648524750094,1.0532589510123755,0.4051355206847361,0.9372213887395259,1.0,4/27,7.78%,CPA4;EP300;KAT6B;MORF4L2
prerank,pharyngeal system development (GO:0060037),0.4705140172062527,1.0527089129483547,0.4318529862174579,0.9380012768152189,1.0,5/15,17.76%,BMP5;BMP4;TGFB2;GATA3;BMPR1A
prerank,protein autoprocessing (GO:0016540),-0.37239796242735873,-1.0526573819791902,0.35522388059701493,0.7751119708597456,1.0,7/17,22.35%,FAM111A;CASP4;CTSL;FXN;MYRF;HTRA2;SPRTN
prerank,regulation of protein phosphorylation (GO:0001932),0.3327278433139294,1.0525490373650066,0.3858751279426817,0.9376907595475107,1.0,34/256,10.49%,FN1;ANGPT1;NTRK3;LIMK2;DAXX;ADTRP;MMP9;OCLN;ZC3H12A;MAVS;SESN2;PPP2CA;KDM4D;HSPB1;FBLN1;TWF1;EFNA5;KRAS;SOX9;WDFY2;MYDGF;BMP4;CCND2;ILK;DVL3;FGF22;PIP5KL1;CHP1;VEGFB;PML;FKBP8;CCND1;MUSK;HDAC3
prerank,regulation of cartilage development (GO:0061035),0.45236725100322644,1.0524387944341103,0.40029542097488924,0.9371845068188881,1.0,5/18,6.81%,MBOAT2;WNT11;ZBTB16;SOX9;BMP4
prerank,mononuclear cell differentiation (GO:1903131),-0.34758142829429767,-1.052270919843022,0.35275080906148865,0.7746537169330804,1.0,4/24,2.88%,IL31RA;LYN;GAS6;AXL
prerank,regulation of keratinocyte differentiation (GO:0045616),-0.33725311360798516,-1.0520192159316577,0.38390092879256965,0.7738816851695427,1.0,9/24,18.58%,ERRFI1;PRKCH;RUNX1;ROCK1;HOXA7;CTSL;SGPP1;ZFP36;NME2
prerank,regulation of mast cell degranulation (GO:0043304),-0.405843933031534,-1.0517722769563371,0.3698630136986301,0.7730990031880084,1.0,8/14,27.17%,LYN;LGALS9;GAB2;CD300A;CD84;FES;FER;FGR
prerank,histone H4-K5 acetylation (GO:0043981),0.4656615687907826,1.0517570440423227,0.4201550387596899,0.9375504606114068,1.0,5/15,16.02%,OGT;HCFC1;JADE2;ING4;MEAF6
prerank,histone H4-K8 acetylation (GO:0043982),0.4656615687907826,1.0517570440423227,0.4201550387596899,0.9375504606114068,1.0,5/15,16.02%,OGT;HCFC1;JADE2;ING4;MEAF6
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.36880054534209195,1.0514437319271763,0.40946745562130177,0.9375728314058166,1.0,10/76,10.45%,BAIAP2L1;NTRK3;CDC42EP4;PTK2B;FCHSD2;CDC42EP5;FCHSD1;HAX1;CDC42;BCAS3
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.4482910475598324,1.0514196490358407,0.4,0.9368247908020131,1.0,8/20,16.85%,IMPDH2;PAICS;NT5C2;GMPS;AK3;GART;AMPD2;ADSS2
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),-0.4419977266891011,-1.0506603886363954,0.41687979539641945,0.7748009715866044,1.0,2/10,4.05%,LYN;FAS
prerank,activation of protein kinase B activity (GO:0032148),-0.33223214133866924,-1.0505673685510837,0.38910505836575876,0.7735392438491119,1.0,5/29,5.93%,IGF1;INSR;WNT5A;GAS6;IL18
prerank,response to cholesterol (GO:0070723),0.4519438718916732,1.0504232431665281,0.3949329359165425,0.9388937337031178,1.0,5/17,12.14%,SMO;PMVK;ABCA2;OSBPL7;TGFBR2
prerank,regulation of mRNA metabolic process (GO:1903311),0.5081033071171998,1.0503848994973877,0.42164781906300486,0.9381989406826471,1.0,5/11,19.78%,SLTM;SRPK2;SRPK1;DHX9;CDK11B
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.36488633687261257,1.0503828332030667,0.3867924528301887,0.9365898035467921,1.0,18/78,17.02%,DYNC1I1;KIF2A;AP2A2;SPTBN2;CAPZB;RAB7A;KLC1;AP1S3;FCER1G;AP2A1;SH3GL2;AP1M1;AP1S2;SEC23A;DYNC1LI2;AP1B1;CANX;DYNC1H1
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.36488633687261257,1.0503828332030667,0.3867924528301887,0.9365898035467921,1.0,18/78,17.02%,DYNC1I1;KIF2A;AP2A2;SPTBN2;CAPZB;RAB7A;KLC1;AP1S3;FCER1G;AP2A1;SH3GL2;AP1M1;AP1S2;SEC23A;DYNC1LI2;AP1B1;CANX;DYNC1H1
prerank,translational elongation (GO:0006414),0.35428274397779774,1.050271200233452,0.3843537414965986,0.9361012238488025,1.0,23/101,16.10%,MRPS16;MRPL38;EEF1A1;MRPL24;MRPL37;MRPL2;MRPL49;MRPL33;MRPS7;MRPS34;MRPS23;LTN1;MRPS33;MRPS27;MRPL9;MRPL57;EEF1D;MRPS15;MRPL50;MRPS18C;MRPS28;MRPS35;EEF2
prerank,modification-dependent protein catabolic process (GO:0019941),0.3340864416782376,1.0502572071944751,0.38259958071278827,0.9353301348858264,1.0,34/193,17.31%,FZR1;FBXL7;PCYOX1;RNF43;SPSB4;RNF5;TRIM25;PSMD11;NUB1;PSMF1;FEM1C;FEM1A;KLHL15;UBE2G2;RBX1;RNF146;UBE2B;PPP1R11;RNF126;WDR91;ANAPC4;NPLOC4;UBE4A;NEDD4;UBE2H;MDM2;BFAR;UBA6;DDB1;RPS27A;UBC;SIAH1;KEAP1;STUB1
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.3861857076069731,1.0501484148854887,0.4037735849056604,0.9348195972382717,1.0,5/48,4.59%,FGFR1;ANGPT1;JCAD;FOXC2;HSPB1
prerank,negative regulation of developmental process (GO:0051093),0.366909251365116,1.0500420130252686,0.3813953488372093,0.9343141945244453,1.0,10/69,7.03%,WNT1;KANK1;WNT11;CDK6;FOXM1;SOX9;MUL1;BMP4;KLF7;PARP3
prerank,apoptotic mitochondrial changes (GO:0008637),0.4093396553829246,1.0497175154879803,0.41689373297002724,0.9344259736770826,1.0,5/32,10.71%,CLU;BBC3;BCL2L1;BAD;SOD2
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.3585178267390202,1.0495408058233935,0.39819004524886875,0.9341173960084457,1.0,12/93,10.22%,WNT16;MAP3K5;EDA2R;CCN2;ZC3H12A;PTK2B;SH3RF2;MAP3K4;TGFB2;RELL1;EMC10;ARL6IP5
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.4165118262591328,1.0493199257796855,0.3784530386740331,0.9339597623099755,1.0,10/30,19.01%,CAV1;PPP2CA;DMTN;SRCIN1;PTPN6;MVP;PTPN2;SFRP1;PRKCZ;SH3BP5L
prerank,chaperone-mediated protein complex assembly (GO:0051131),0.44627199801132417,1.0492140263055765,0.4106628242074928,0.9334602166069744,1.0,5/20,15.68%,CLU;HSPA4;MKKS;HSP90AA1;PTGES3L
prerank,glucose catabolic process to pyruvate (GO:0061718),0.4364609129907112,1.0489019118352445,0.41836734693877553,0.9327798491095182,1.0,8/24,16.09%,PFKP;PKM;ENO2;HK1;FOXK1;ALDOA;GAPDH;TPI1
prerank,canonical glycolysis (GO:0061621),0.4364609129907112,1.0489019118352445,0.41836734693877553,0.9327798491095182,1.0,8/24,16.09%,PFKP;PKM;ENO2;HK1;FOXK1;ALDOA;GAPDH;TPI1
prerank,exit from mitosis (GO:0010458),-0.4064563985370315,-1.0488645849360134,0.3878116343490305,0.776828548179095,1.0,5/12,16.69%,CLASP2;EPS8;UBE2S;CTDP1;CHMP7
prerank,telomere maintenance via telomere lengthening (GO:0010833),0.4080517982570463,1.048789078093851,0.4066666666666667,0.9322978294395896,1.0,14/33,24.26%,PPP6R3;MRE11;GAR1;CDK2;PINX1;ANKRD28;HSP90AA1;RAD50;RFC1;TERF2;PTGES3;SHQ1;TINF2;ZBTB48
prerank,fatty acid transmembrane transport (GO:1902001),0.4456461460386475,1.048720990221747,0.42452830188679247,0.9317269336174739,1.0,5/19,12.64%,PRKAA2;ABCD1;CPT1B;ACACA;CPT2
prerank,ceramide metabolic process (GO:0006672),0.3807685921383097,1.0472528209624916,0.4030037546933667,0.9350428113110932,1.0,5/49,5.85%,SPTSSB;SGMS2;PPP2CA;ORMDL3;AGK
prerank,positive regulation of immune effector process (GO:0002699),-0.33532679860347375,-1.0472084149246428,0.4035714285714286,0.7799780155281373,1.0,5/27,9.92%,PTPRJ;LGALS9;APPL2;DDX60;CD46
prerank,sensory perception of sound (GO:0007605),0.36518544454224955,1.0466334033807427,0.4129692832764505,0.9359336717552201,1.0,17/88,14.02%,ATP6V1B1;USP53;COL4A3;HPN;EPS8L2;TIMM10;HOMER2;TPRN;RIPOR2;EML2;EYA1;TMC2;PDZD7;GSDME;MKKS;SLC26A4;PAX3
prerank,modulation of excitatory postsynaptic potential (GO:0098815),-0.33832474446375005,-1.046600404198937,0.4013840830449827,0.7801597598543957,1.0,8/26,12.76%,NRXN1;SHANK3;SLC8A3;LRRK2;NLGN1;MTMR2;TMEM108;NLGN3
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),0.4685302686809195,1.0463991523283154,0.43238993710691825,0.935788227335985,1.0,2/15,5.85%,CLU;BCL2L1
prerank,regulation of cell aging (GO:0090342),0.49550186478701763,1.046241459097352,0.44155844155844154,0.9354440052824512,1.0,2/11,6.11%,WNT1;FOXM1
prerank,ethanol metabolic process (GO:0006067),0.4893145972410962,1.0457019678394768,0.41205211726384366,0.936182276452396,1.0,2/12,2.95%,SULT1A1;ADH7
prerank,error-prone translesion synthesis (GO:0042276),0.43686784173325566,1.045649553805876,0.40088757396449703,0.9355335375383115,1.0,8/21,18.65%,REV1;POLK;RPA3;POLH;PCNA;RPS27A;UBC;RFC1
prerank,organic hydroxy compound biosynthetic process (GO:1901617),0.3942423056091535,1.0455724416397687,0.4105793450881612,0.9349784264667657,1.0,14/44,20.01%,OSBPL9;ACOT8;DHCR7;HMGCR;INSIG1;PMVK;CYP39A1;MSMO1;OSBPL7;SQLE;TM7SF2;OSBPL2;PARK7;HSD17B10
prerank,regulation of dendrite morphogenesis (GO:0048814),-0.3171415962271022,-1.0453874975704829,0.3843283582089552,0.7821032315299629,1.0,8/32,11.59%,ADGRB3;IL1RAPL1;RAPGEF2;TNIK;HECW1;SDC2;KNDC1;CDKL5
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),-0.32200545627805743,-1.0453828682773851,0.3978102189781022,0.7806401219425635,1.0,8/29,10.70%,GHR;IL31RA;STAT5B;PKD2;IFNAR2;JAK2;STAT5A;STAT3
prerank,regulation of muscle contraction (GO:0006937),0.4240982953606794,1.0453318032514225,0.39943342776203966,0.9348671826627798,1.0,3/26,3.76%,CAV1;ATP1A2;DAPK3
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.38300562802035365,1.0453201867315232,0.4022140221402214,0.9341095098581507,1.0,7/54,8.66%,NXN;OGT;CAV1;PRR7;SH3RF2;TRIM21;CHP1
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.45249540461204263,1.0450667626977663,0.41807044410413474,0.9340587598734174,1.0,5/17,14.97%,NFE2L2;HSPB1;MAPK7;SOD2;VNN1
prerank,negative regulation of epithelial cell differentiation (GO:0030857),0.4766166951144375,1.0450176156882796,0.42443729903536975,0.9334095163558842,1.0,3/14,6.26%,MMP9;CAV1;SPRED3
prerank,organic anion transport (GO:0015711),0.3612680075617687,1.0449811572871759,0.4,0.9327203224102535,1.0,7/76,7.92%,CFTR;SLCO2A1;SLC4A2;SLC35A2;SLC16A2;CYB5RL;SLC2A8
prerank,regulation of myoblast differentiation (GO:0045661),-0.3232760420056632,-1.0444354315720144,0.3745019920318725,0.7818362854283493,1.0,8/32,10.88%,PLCB1;BOC;TBX3;NOTCH1;TGFB1;BTG1;LRRC8A;SRA1
prerank,regulation of B cell proliferation (GO:0030888),0.39935212823445554,1.0441021117789075,0.4198966408268734,0.9344066725861545,1.0,4/44,4.18%,NFATC2;SASH3;CD81;CLCF1
prerank,regulation of lipid storage (GO:0010883),0.4429220563537242,1.0440865893122373,0.40974212034383956,0.9336617718061724,1.0,8/22,23.91%,ZC3H12A;IKBKE;NFKBIA;PTPN2;HILPDA;FBXW7;FTO;IL6
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.4748085753510867,1.0440041899640389,0.42790697674418604,0.9331244984080741,1.0,3/15,11.19%,EHD1;RIPOR2;RAPGEF3
prerank,regulation of establishment of protein localization to telomere (GO:0070203),-0.41752398951898556,-1.0438143528338564,0.4250681198910082,0.7820360940530792,1.0,6/11,32.05%,DKC1;CCT7;CCT2;CCT4;WRAP53;CCT3
prerank,zinc ion homeostasis (GO:0055069),-0.3214210980385654,-1.0437245618159756,0.3772455089820359,0.7807969071834506,1.0,5/28,12.48%,SLC30A10;SLC39A12;SLC39A8;SLC39A10;SLC30A1
prerank,fatty-acyl-CoA metabolic process (GO:0035337),0.44601965135678256,1.043419887796369,0.4144542772861357,0.9340282031065994,1.0,6/20,11.91%,DGAT1;SLC25A1;ACSL3;ACACA;SCD5;FASN
prerank,cation transport (GO:0006812),0.333305077731302,1.043245611885584,0.39747634069400634,0.9337242449849447,1.0,24/167,13.39%,FGF13;TRPM3;SLC36A3;SCN3A;ATP1A2;TRPM8;SLC66A1;KCNJ13;ABCC8;SLC36A4;CNGB3;SLC22A18;CHP1;KCNA4;TRPM6;SLC7A6;AQP1;TRPM4;PKD2L1;SLC41A1;ANO6;KCNA5;CNGB1;TRPM2
prerank,positive regulation of epithelial cell differentiation (GO:0030858),-0.37306328310649706,-1.0431130983989974,0.41260744985673353,0.7809598379686047,1.0,8/17,10.34%,TMEM100;FGF2;VEZF1;ATOH8;BTG1;AHI1;SFRP4;RFX3
prerank,regulation of lipid kinase activity (GO:0043550),-0.4351204547968266,-1.0427667339705509,0.41265822784810124,0.7805881625048897,1.0,4/11,18.09%,PIK3R1;RBL1;PIK3R3;PIK3R2
prerank,positive regulation of apoptotic process (GO:0043065),0.3272139583955639,1.0425271553008508,0.4054878048780488,0.9349593027709041,1.0,65/293,17.53%,CLU;PAWR;NGEF;MAP3K5;ARHGEF17;NUPR1;AKAP13;ZC3H12A;TNFAIP8;PMAIP1;ARHGEF12;PRR7;NGF;PHLDA3;FOXO3;TNFRSF8;DAPK3;TIAM2;DAPK1;OLFM1;UTP11;RARG;HOXA5;ARHGEF18;BMP4;PNMA2;TGFB2;BAD;LATS1;TNFRSF10B;NLRP2B;JUN;PIP5KL1;ADAMTSL4;ARHGEF5;TRIO;APBB1;ARL6IP5;SRPK2;DLC1;GNA13;GADD45B;ANO6;HRK;SOS2;RNPS1;EEF1E1;PRDM11;ING4;TLE5;SFRP1;BNIP3L;DNM1L;FLCN;IP6K2;ARHGEF1;FRZB;BACE1;RPS27A;UBC;E2F1;ABL1;SIAH1;PLEKHG2;PIDD1
prerank,carboxylic acid transmembrane transport (GO:1905039),-0.2928296564984444,-1.042476590351654,0.35714285714285715,0.7799352548210471,1.0,8/40,10.92%,SLC7A11;SLC13A3;SLC7A5;SLC16A1;SLC7A7;SLC16A7;SLC38A11;SLC38A9
prerank,regulation of response to external stimulus (GO:0032101),0.34772629066499866,1.0423307024294617,0.4129244249726177,0.9347391796093609,1.0,9/121,6.42%,CD55;AGTR1;EFNB2;GUCY2F;CAV1;CELF1;CXCR4;ALOX5;AKNA
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.443922815176873,1.0420940133440344,0.39969135802469136,0.9346508859416165,1.0,6/18,21.67%,ADTRP;WNK1;ASS1;DUSP3;GPNMB;MIA3
prerank,ribosome assembly (GO:0042255),0.39438897136192985,1.0420568594954807,0.4094488188976378,0.9339699969861954,1.0,19/47,28.54%,NLE1;NOP2;PPAN;MRPS7;EIF6;RPSA;PWP2;RPL6;RPS28;EFL1;C1QBP;EIF2A;RPS27;NOP53;RRS1;MDN1;RPL24;RSL24D1;DDX3X
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),0.4135267458594207,1.041607683080363,0.4051841746248295,0.9344955072308867,1.0,3/27,8.53%,AGTR1;NFKBIA;MAPK9
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),-0.42120507938567886,-1.0414195281827734,0.3898305084745763,0.781263230534942,1.0,3/12,12.09%,INSR;IRGM;IGF1R
prerank,positive regulation of MAPK cascade (GO:0043410),0.3305157568705965,1.0413953145866792,0.3903192584963955,0.9342889554093136,1.0,19/245,6.63%,ADRA1B;FGFR1;ANGPT1;CD44;LPAR1;NOTCH2;NTRK3;CCL5;JCAD;PDGFC;CCN2;GDF15;RAP1A;PTK2B;GCNT2;ACKR3;CAV2;SHC1;MYDGF
prerank,response to copper ion (GO:0046688),0.4357442379612388,1.041354999752365,0.41641337386018235,0.9336150474949583,1.0,1/20,0.93%,DAXX
prerank,activation of protein kinase A activity (GO:0034199),-0.38264112026278674,-1.0411905503807155,0.4027777777777778,0.7804527605037666,1.0,10/16,22.44%,ADCY5;ADCY7;ADCY1;ADCY4;PRRC1;PRKAR2B;ADCY2;PRKAR1B;ADCY3;ADCY8
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.41536107735899475,1.0411105342663696,0.4209809264305177,0.933505687228611,1.0,5/30,6.53%,STK19;NOTCH2;NGF;EPO;SHC1
prerank,hippo signaling (GO:0035329),0.41818657221032174,1.0410385818837442,0.41595441595441596,0.9329304151721863,1.0,4/26,8.94%,TJP2;TJP1;LATS1;YWHAB
prerank,negative regulation of vascular permeability (GO:0043116),-0.40899641395429154,-1.041037989835582,0.3989071038251366,0.77942461647733,1.0,6/12,9.95%,PTPRJ;PDE3A;CLDN5;SLIT2;RAMP2;PDE2A
prerank,negative regulation of viral genome replication (GO:0045071),0.3974722504055254,1.0409479667024244,0.40516129032258064,0.9323850518434448,1.0,9/40,15.49%,CCL5;MAVS;SLPI;RNASEL;SRPK2;SRPK1;SETDB1;TNIP1;OAS2
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.4561799388235266,1.040922318387585,0.4217252396166134,0.9316827338499275,1.0,3/16,12.58%,ZC3H12A;MOV10;CPEB3
prerank,positive regulation of cell-substrate junction organization (GO:0150117),-0.33895636353252806,-1.0403172196149837,0.38,0.7798876309720123,1.0,8/24,11.38%,PTPRJ;PIK3R1;TEK;KDR;TSC1;ROCK1;MAP4K4;MYOC
prerank,negative regulation of myeloid cell differentiation (GO:0045638),0.4366988439501855,1.0402533108732253,0.413391557496361,0.9327934155293369,1.0,4/20,6.12%,CDK6;PTK2B;ZBTB16;HOXA5
prerank,protein-DNA complex disassembly (GO:0032986),0.4573843548539925,1.040171420506022,0.4040247678018576,0.9322552995358165,1.0,7/16,16.27%,GRWD1;SMARCB1;SMARCA4;SMARCD2;MYC;SET;SMARCC1
prerank,glycoprotein biosynthetic process (GO:0009101),0.359891478291792,1.0397126213165246,0.39976958525345624,0.9327824320836707,1.0,17/79,14.90%,B3GALT1;ST3GAL4;CHST12;GCNT2;LARGE1;CHST11;MGAT1;NPC1;DDOST;GOLPH3;CHST13;ALG1;ST3GAL6;ALG5;SERP2;NUS1;TNIP1
prerank,regulation of cell cycle (GO:0051726),0.3278916329514054,1.0395868077055936,0.4034552845528455,0.9323778422290226,1.0,69/271,20.02%,NOTCH2;GRK5;CDKN1A;ADAM10;MAGI2;NUPR1;NEK7;CDK10;EP300;CDK6;DAPK3;PES1;PPP1R13B;PPP1R15A;SON;CDK4;DUSP1;TSC2;JUND;FOXM1;ZBTB17;SOX9;HCFC1;BMP4;TRIM21;TGFB2;NLRP2B;PKD1;JUN;TCF7L2;IQGAP1;FBXO5;PML;GAS2L1;APBB1;CCND1;PCLAF;SRPK2;TBRG4;ANKRD17;GADD45B;EIF4G2;WDR6;GATA3;CHMP1A;MYC;PRDM11;ING4;SFRP1;HRAS;MDM2;MAEA;POU4F1;ABL1;LIN54;NBN;XIAP;INTS13;CAMK2N1;GADD45GIP1;RARA;KIF20B;RNF112;CDKN2D;CDK5RAP3;GPER1;RB1;CDK11B;CENPF
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.34327610247341606,1.0395113572870436,0.4177777777777778,0.931833998930057,1.0,15/121,7.64%,ANGPT1;CD44;CRLF1;CCL5;EPHA4;IL15;CD81;PTK2B;CLCF1;EPO;UNC119;EFNA5;HAX1;ERBB3;SRCIN1
prerank,response to fatty acid (GO:0070542),-0.37079649537520476,-1.039487980151796,0.3888888888888889,0.7807247759591097,1.0,2/17,3.91%,PID1;FOXO1
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),-0.2702341909374043,-1.0394026674086754,0.34868421052631576,0.7795386399573409,1.0,24/74,20.10%,IGF1;SH3RF1;AR;NOS3;EYA4;FAS;THBS1;BCL2;RFFL;TNFSF10;CFLAR;ARHGEF2;RIPK1;ITGA6;ITGAV;GPX1;PELI3;ICAM1;ZMYND11;RNF34;FAIM2;TRADD;TNFAIP3;SIAH2
prerank,snRNA metabolic process (GO:0016073),0.4462730622869473,1.0393409523419215,0.40337423312883436,0.931531195333965,1.0,8/17,22.46%,INTS2;MTREX;ZCCHC8;MEPCE;INTS3;INTS6;TUT1;INTS1
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),-0.4269008759446761,-1.0393077813630769,0.398989898989899,0.7783381579173044,1.0,1/10,0.68%,TGFA
prerank,positive regulation of myelination (GO:0031643),-0.4224973817201957,-1.0392747304766072,0.39058171745152354,0.7769925899953571,1.0,6/11,25.76%,TENM4;TPPP;TNFRSF1B;MYRF;DICER1;NCMAP
prerank,membrane repolarization during action potential (GO:0086011),-0.40614631394626277,-1.0392411008540476,0.4,0.775650103605339,1.0,4/13,23.55%,ATP1B1;KCNJ2;KCNIP2;YWHAE
prerank,mitochondrial calcium ion homeostasis (GO:0051560),0.4384462673010432,1.038449057564489,0.40778097982708933,0.9332470310249716,1.0,7/21,11.63%,MCU;MCUB;MICU1;AFG3L2;BCAP31;MCUR1;LETM1
prerank,DNA integrity checkpoint signaling (GO:0031570),0.39428080538884336,1.0384217993769649,0.4037940379403794,0.932548640830601,1.0,11/36,17.49%,DOT1L;HUS1B;DONSON;USP28;CDC5L;PRPF19;ATR;E2F1;HINFP;NBN;CHEK2
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.3518331978577824,1.038223562165493,0.4160090191657272,0.9323821771647401,1.0,20/100,15.23%,CLU;OGT;TRIB2;FHIT;ZYG11B;SH3RF2;NUB1;ELOB;DDRGK1;DESI1;RBX1;SUMO2;COP1;HSPBP1;CSNK1E;PIAS1;DDA1;GSK3A;GSK3B;MDM2
prerank,cellular response to osmotic stress (GO:0071470),0.43186505121196983,1.038149765755328,0.4057142857142857,0.931793849948698,1.0,5/21,11.05%,YBX3;EPO;STK39;OXSR1;AQP1
prerank,blood vessel diameter maintenance (GO:0097746),0.4024884840773695,1.03763717262202,0.4251012145748988,0.9325046232552798,1.0,1/34,0.18%,AGTR1
prerank,histone H3-K4 methylation (GO:0051568),0.4202869666741339,1.0374512882561322,0.41725601131541723,0.9322682299267664,1.0,10/26,23.67%,OGT;BEND3;KMT2A;KDM6A;DYDC2;MEN1;KMT2B;CTR9;KMT2C;CXXC1
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),-0.315454741799429,-1.037365218194771,0.3931297709923664,0.7794236958670568,1.0,5/31,9.11%,ENG;ZFPM2;NOTCH1;TGFB1;FGFR2
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.3668574793002914,1.0372232571892104,0.4190012180267966,0.932159780865093,1.0,13/66,9.74%,KLF4;LSM10;CDKN1A;CDK6;FHL1;KANK2;CDK4;CCND2;PKD1;ADAMTS1;BRD7;PTPN6;CCND1
prerank,cytosolic calcium ion transport (GO:0060401),0.4183422413744068,1.0371478070398625,0.412568306010929,0.9316119686806075,1.0,9/28,11.89%,MCU;CACNB3;MCUB;MICU1;JPH2;AFG3L2;ITPR3;MCUR1;JPH3
prerank,negative regulation of T-helper cell differentiation (GO:0045623),0.4928617617630622,1.0371177170193076,0.43399339933993397,0.9309295468063163,1.0,2/11,8.98%,ZC3H12A;FOXP3
prerank,regulation of glycogen biosynthetic process (GO:0005979),0.426120345420851,1.0370443207596698,0.4067321178120617,0.9303828269761825,1.0,1/24,0.14%,SORBS1
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.3733363495485778,1.0367375352456718,0.4289340101522843,0.9304466102096709,1.0,8/52,11.34%,SORBS1;STAC3;PTPN9;LGALS3;ACSL3;AKAP5;CNPY4;EPHA3
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),0.4481084488394914,1.0366377776287352,0.40126382306477093,0.9299524832706665,1.0,2/17,1.77%,ADTRP;EFNB2
prerank,phosphatidylcholine biosynthetic process (GO:0006656),-0.3121248190224953,-1.0366195290702676,0.4125,0.7801279665673284,1.0,17/32,34.20%,ABHD3;SLC44A2;PCYT1A;LPIN2;MFSD2A;SLC44A1;STARD10;PCTP;SLC44A5;LCAT;CHAT;SLC44A3;CSNK2B;PEMT;LPIN3;CSNK2A1;CSNK2A2
prerank,regulation of vasculature development (GO:1901342),-0.32448204259701996,-1.0363205728356102,0.3776223776223776,0.7794772373310586,1.0,7/26,13.51%,SP100;BMPER;FGF2;TSPAN12;NF1;EGLN1;RNH1
prerank,regulation of nervous system development (GO:0051960),-0.30519835949177454,-1.0362132085476448,0.37349397590361444,0.7783270471602844,1.0,14/37,22.81%,PTPRZ1;TENM4;HEYL;PRUNE1;NPHP3;TNFRSF1B;BHLHE40;SIRT2;YAP1;CX3CL1;CX3CR1;HEY2;HEY1;YTHDF2
prerank,determination of bilateral symmetry (GO:0009855),-0.3432158398018068,-1.0357020124642529,0.4343065693430657,0.7781366801582569,1.0,8/24,18.26%,NOTCH1;PKD2;NPHP3;ZIC3;TBX1;BBS7;DNAH11;KIF3B
prerank,negative regulation of cellular protein catabolic process (GO:1903363),0.4949975874887046,1.035630170165569,0.44350758853288363,0.9320319216231179,1.0,2/10,6.89%,EPHA4;ANXA2
prerank,macromolecule catabolic process (GO:0009057),-0.33543882565128436,-1.0353680676181516,0.4098939929328622,0.7776665564251105,1.0,16/26,36.18%,SNX25;TGFB1;SH3GLB1;TPP1;MVB12A;CLPX;USE1;SMURF1;CLN6;CLN8;TRIM24;PPT1;UCHL3;CAPN3;BECN1;LGMN
prerank,ER-associated misfolded protein catabolic process (GO:0071712),0.48752764012375693,1.0350531454032712,0.43882544861337686,0.9327949915283621,1.0,2/11,9.99%,RNF5;TOR1A
prerank,regulation of mRNA stability (GO:0043488),0.33320671010357356,1.034657676769191,0.41621621621621624,0.9331677137796219,1.0,36/145,19.45%,VIM;SAMD4A;YTHDF1;SAMD4B;CELF1;TNFSF13;GDNF;HSPB1;PSMD11;PSMD4;PSMF1;EXOSC3;YWHAB;PSMD7;TBRG4;YWHAZ;PSMB5;FXR1;CARHSP1;DCP1A;TNPO1;SET;EIF4G1;PAIP1;MEX3D;RPS27A;UBC;E2F1;MAPKAPK2;PSMD1;PSMC4;IGF2BP3;YTHDF3;ROCK2;IGF2BP2;PSMD8
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),0.377654261337059,1.034537230964223,0.4248447204968944,0.9327752476502584,1.0,15/53,16.52%,DDX5;EYA2;PMAIP1;NSMCE4A;SPRED3;EYA1;TIGAR;ABRAXAS1;FXR1;MYC;EEF1E1;DHX9;PCNA;UBE2N;ATR
prerank,positive regulation of cellular component organization (GO:0051130),-0.24249701730424023,-1.0345219410789435,0.39285714285714285,0.7785573214644217,1.0,29/107,16.12%,FRMPD4;INSR;NRXN1;DAB2;SHANK3;ASAP1;AR;SLF1;RUNX1;DAB2IP;FNIP1;TFRC;TGFB1;SH3GLB1;TIRAP;TPPP;BCL2L11;IGF1R;BID;RACK1;HYAL1;BMF;SLF2;SURF4;FNIP2;CDC42EP2;BAX;GPX1;GNL3L
prerank,mitochondrial translational elongation (GO:0070125),0.3511890068207721,1.034080793993386,0.4218928164196123,0.9332925458771135,1.0,38/88,28.38%,MRPS16;MRPL38;MRPL24;MRPL37;MRPL2;MRPL49;MRPL33;MRPS7;MRPS34;MRPS23;MRPS33;MRPS27;MRPL9;MRPL57;MRPS15;MRPL50;MRPS18C;MRPS28;MRPS35;GADD45GIP1;MRPL19;MRPL14;MRPL32;AURKAIP1;MRPL39;MRPS25;MRPS30;MRPL54;MRPS21;MRPS22;MRPS12;MRPL35;GFM2;PTCD3;MRPL44;MRPL18;MRPS6;MRPS24
prerank,cAMP metabolic process (GO:0046058),-0.4170128855804131,-1.034046290829113,0.42328042328042326,0.7784043393830306,1.0,9/13,22.44%,ADCY5;PDE4D;ADCY7;ADCY1;ADCY4;PTHLH;ADCY2;ADCY3;ADCY8
prerank,regulation of systemic arterial blood pressure (GO:0003073),0.4584175979732883,1.0329717013450221,0.44510385756676557,0.9355933539666814,1.0,3/16,13.53%,PLCB3;KLK1;GSK3A
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.413144329517154,1.0324850406175519,0.4083694083694084,0.9361925304809278,1.0,9/26,14.55%,KANK2;CRY2;SMARCA4;NCOR1;VPS11;VPS18;SFRP1;FOXP1;NCOR2
prerank,phosphatidylserine metabolic process (GO:0006658),-0.3070436843079738,-1.0323338263984845,0.4037735849056604,0.7816357421969061,1.0,6/32,6.00%,PLA2G4A;OSBPL10;MBOAT1;PLA1A;PTDSS1;PLAAT3
prerank,regulation of long-term synaptic potentiation (GO:1900271),0.41124993117030734,1.0321846300474922,0.4019073569482289,0.936220376908405,1.0,10/28,20.34%,EPHA4;YTHDF1;AKAP5;PTN;GSK3B;RELN;ABL1;EIF2AK4;APP;AGER
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.42580307666117906,1.0317367454247932,0.41654571843251087,0.936703282756663,1.0,4/24,8.49%,WNT1;OCLN;AVIL;CDC42
prerank,regulation of actomyosin structure organization (GO:0110020),0.4690731232426361,1.0313589560532088,0.43730886850152906,0.9369826713762685,1.0,7/13,18.79%,AKAP13;CDC42;ACTG1;ASAP3;SLC9A1;FHOD1;ROCK2
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",-0.3946399887679685,-1.0312526208898076,0.4046997389033943,0.7831318144799106,1.0,6/13,20.52%,RCL1;UTP20;NOP9;RPS21;TBL3;KRI1
prerank,regulation of protein targeting to membrane (GO:0090313),0.41362870606043856,1.030839249443034,0.43568464730290457,0.9376651285505527,1.0,9/28,15.65%,DMTN;ANK3;CHP1;MIEF2;MYO1C;KCNB1;HRAS;ITGB1BP1;ITGB2
prerank,regulation of defense response (GO:0031347),-0.2647261932007249,-1.030622578220393,0.39097744360902253,0.7834175556003193,1.0,18/76,11.65%,ADAMTS12;IL1R1;WNT5A;SEMA7A;NR1D2;APPL2;MGLL;PTGS2;PSMA6;ELMOD2;LRP8;BRD4;JAK2;SAMHD1;PIK3AP1;PTGES;TIRAP;CASP4
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),-0.35341830074899094,-1.0300722823647694,0.3952802359882006,0.7835416558214581,1.0,9/20,22.26%,ENG;ACVRL1;TBX3;NOTCH1;HEYL;PDCD4;SPRY1;HEY2;HEY1
prerank,error-free translesion synthesis (GO:0070987),0.4305666523143864,1.0297622068419439,0.41910631741140214,0.9399181322211325,1.0,11/22,27.15%,REV1;NPLOC4;RPA3;POLH;PCNA;RPS27A;UBC;RFC1;RCHY1;RPA2;POLD1
prerank,regulation of cell-substrate junction assembly (GO:0090109),0.4372479322551224,1.0296404972006752,0.4211287988422576,0.9395286982846661,1.0,11/21,18.79%,DAPK3;EFNA5;PTPRA;ACTG1;EPHA3;RHOA;VCL;SLC9A1;DUSP3;PEAK1;ROCK2
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.31279338791746997,-1.0289583596213316,0.3920265780730897,0.7851264514538742,1.0,14/29,32.28%,UTP6;NGDN;UTP20;RRP36;NOP9;RPS21;DHX37;TBL3;KRI1;WDR46;NOL10;ABT1;MRPS11;HELB
prerank,positive regulation of dendrite extension (GO:1903861),-0.368484434763492,-1.0289111418024848,0.42265193370165743,0.7838430800503079,1.0,10/17,36.54%,SYT1;ITSN2;SMURF1;RIMS1;CPNE9;RNF157;CPNE5;RASAL1;SYT17;SYT4
prerank,calcium ion transmembrane transport (GO:0070588),0.34854520425618546,1.0287295935249408,0.4127708095781072,0.9412532399433755,1.0,20/86,14.06%,TRPM3;CACNA1A;NALCN;TRPM8;MCU;CACNB3;MCUB;PMPCA;CACNA2D4;TMEM165;MICU1;AFG3L2;PKD1;TRPM6;MCUR1;TRPM4;LETM1;ANO6;TRPM2;ATP2B4
prerank,myelin assembly (GO:0032288),0.48936804032670467,1.0286744937377506,0.4316309719934102,0.9406340927344874,1.0,3/10,11.07%,GPC1;CD9;ABCA2
prerank,protein autophosphorylation (GO:0046777),-0.23292744011907282,-1.0284025819286942,0.3387096774193548,0.7837606181162976,1.0,33/157,13.62%,FLT1;PDGFRB;PRKD1;TEK;INSR;TNIK;LYN;PTK2;CAMK2D;PDGFRA;CAMK4;KDR;SIK1;WNK2;CDK12;ACVR1B;LRRK2;EPHB4;BMX;NTRK2;JAK2;ERBB4;DAPK2;FGFR2;KIT;STK17B;CDKL5;IGF1R;RIPK1;NEK6;FGFR4;FLT4;CAMK2A
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),-0.3541410671276065,-1.0280425466377727,0.4540059347181009,0.7833595190543615,1.0,5/19,9.87%,BMP6;NEXMIF;NOTCH1;RGCC;NOTCH4
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.46092522134766517,1.0276619220795782,0.4305993690851735,0.9426394913873343,1.0,6/16,23.68%,SHOC1;CENPS;RMI1;ERCC4;TOP2B;FANCM
prerank,mitochondrial fusion (GO:0008053),0.4472891859580256,1.0274310168171963,0.4177583697234352,0.9425374422234536,1.0,8/18,21.30%,CHCHD3;AFG3L2;MIEF2;THG1L;OPA1;SPG7;STOML2;MIEF1
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),-0.39573892086417806,-1.027095067781651,0.42735042735042733,0.7845697543959921,1.0,2/13,2.50%,PID1;NOS3
prerank,nucleic acid-templated transcription (GO:0097659),0.38780532397846235,1.0269011154618966,0.41992433795712486,0.9432340300080548,1.0,10/42,18.69%,THRB;CREBL2;POLR2H;NKX2-8;POLR2A;PTMA;RNPS1;E2F1;POLR2C;POLR2E
prerank,multivesicular body organization (GO:0036257),0.39883273318545676,1.0265548004410845,0.4359673024523161,0.9433834429411855,1.0,13/31,20.10%,VPS37B;CHMP4A;CHMP4B;VPS4B;CHMP1A;VPS4A;CHMP2A;PDCD6IP;STAM;TSG101;RAB27A;VPS37A;IST1
prerank,cellular protein metabolic process (GO:0044267),0.3226383575749132,1.0264607682848448,0.43373493975903615,0.9428796441244934,1.0,89/396,19.54%,FN1;MSLN;IGFBP6;F5;FAM20C;PRSS23;ADAM10;PENK;MRPS16;EEF1A1;MRPL24;MRPL37;SFTPC;SERPINC1;TIMP1;WWP2;RNF5;DENND3;HARS1;RPS4X;DUSP12;ANO8;MRPS7;PHKA2;BMP4;CPE;TGM5;GPC3;MSRB2;AFG3L2;UBE2G2;ABCF1;LAMC1;FDX1;MANBA;RPL31;RPSA;GSPT2;RPL22;LAMB2;MRPS33;SPCS3;RPL28;CALU;SRBD1;RPS26;MRPL9;COPS5;ST3GAL6;NAPSA;CP;LGALS1;HARS2;RPL10A;LTA4H;MRPS15;SARS1;EIF4G1;NTAQ1;DNAJC3;TNIP1;MRPS18C;PRKCSH;RPL14;RRBP1;CTSH;HM13;RPS27A;ABL1;UBE2D3;SEC11A;CHEK2;FBXL2;RPN2;SPPL3;USP25;HBS1L;IGF2BP3;YES1;SPG7;GALNT11;EIF4EBP2;RPL6;FARSB;IDE;APP;SFTPA1;SFTPA2;ADAM17
prerank,membrane organization (GO:0061024),0.3259476789292016,1.0263843451896022,0.4205128205128205,0.94232622216273,1.0,54/227,18.13%,CFTR;REPS2;ANK2;LDLR;SYP;OTOF;CLTB;A4GALT;AP2A2;REEP3;NUP93;NPC1;ANK3;NSFL1C;SLC2A8;CHMP4A;CHMP4B;CHP1;IL7R;ACTB;AGFG1;TLCD2;TOR1A;TMEM33;ACTG1;VPS4B;AP2A1;LPCAT2;VTI1B;NAPA;OPA1;SH3GL2;LPCAT3;STX11;CHMP1A;OCRL;FER1L6;VPS4A;VAMP7;TOR1AIP1;CCDC88A;DNM1L;CHMP2A;REEP4;CERT1;AAK1;RPS27A;UBC;LRP2;ARPC2;PDCD6IP;STAM;SUN2;OSBPL2
prerank,neuropeptide signaling pathway (GO:0007218),0.3695169094343733,1.0262617857969163,0.43101343101343104,0.9419192728687439,1.0,5/58,8.84%,SORCS2;GAL;PENK;CPE;HCRTR1
prerank,cytosolic transport (GO:0016482),0.34673554939283363,1.026052371130321,0.4223463687150838,0.9417567518970376,1.0,35/108,19.80%,EMP2;RAB9B;CORO7;VPS13A;LAMP1;GCC2;MAGEL2;MON2;RAB7A;LMTK2;HOOK1;GGA1;VPS54;AP2A1;VTI1B;RNF126;PHETA2;WDR91;VPS26B;VPS52;PLEKHJ1;PHETA1;STX16;SNX16;WASHC1;VPS50;TBC1D10A;ARFRP1;YKT6;TMEM87B;BET1L;HOOK3;RAB9A;VTI1A;TBC1D17
prerank,intracellular lipid transport (GO:0032365),0.4317224704231512,1.025971218663923,0.44664634146341464,0.9412327183900546,1.0,6/21,15.83%,PRKAA2;ABCD1;CPT1B;ACACA;CPT2;CERT1
prerank,negative regulation of protein catabolic process (GO:0042177),0.389887940130419,1.0250866913060694,0.4316069057104914,0.9429374758655826,1.0,10/40,12.17%,TIMP4;TIMP1;HMGCR;SNRNP70;TIMP2;AZIN1;CYP51A1;BANP;SF3B3;SNX12
prerank,natural killer cell mediated immunity (GO:0002228),0.4612316753724106,1.0243976878779313,0.44242424242424244,0.9441587053264393,1.0,1/15,1.91%,RAET1E
prerank,stress granule assembly (GO:0034063),0.43362226556132455,1.0240222091187836,0.434971098265896,0.944448231712653,1.0,7/20,20.10%,YTHDF1;PRRC2C;ATXN2L;DYNC1H1;UBAP2L;YTHDF3;MAPT
prerank,regulation of chromatin binding (GO:0035561),0.4977521670846977,1.023894586421893,0.4527027027027027,0.9440367620146434,1.0,4/10,18.45%,KDM4D;HMBOX1;BTAF1;WAPL
prerank,positive regulation of Wnt signaling pathway (GO:0030177),0.3357615977028788,1.023778162865728,0.4183783783783784,0.9436012925620152,1.0,32/152,14.45%,SCEL;KANK1;RSPO3;PTK7;CAV1;TMEM198;RNF220;DAPK3;PPM1B;PSMD11;PSMD4;WLS;PSMF1;GPC3;ILK;WNT5B;LGR4;PPM1A;RNF146;UBE2B;ADGRA2;PRDM15;PSMD7;SMARCA4;CSNK1E;TRPM4;SPIN1;PSMB5;CAPRIN2;SFRP1;UBR5;WNK1
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.35334200703313634,1.02368223890377,0.4425087108013937,0.9431347278255955,1.0,7/73,7.62%,EGLN3;COL4A3;BBC3;NGF;MUL1;BAD;TNFRSF10B
prerank,cellular response to insulin stimulus (GO:0032869),0.33871266627017066,1.023562516310665,0.43838604143947657,0.9427316464189331,1.0,33/124,20.41%,SORBS1;ATP6V1B1;CPEB2;GAB1;HDAC5;EPRS1;FOXC2;RHOQ;CAV2;INSIG1;PKM;SHC1;AP3S1;MYO5A;PDK2;IRS2;BCAR1;PTPN2;GSK3A;GSK3B;ATP6V1E1;ATP6V1D;ATP6V0D1;RAB8B;ATP6V1B2;PCK2;SLC27A4;IDE;GPLD1;ATP6V0B;USF1;ATP6AP1;RAB10
prerank,positive regulation of interleukin-12 production (GO:0032735),-0.3130412466784539,-1.023368639904813,0.3857677902621723,0.7933540494790118,1.0,11/31,28.86%,PLCB1;LGALS9;TIRAP;HMGB1;CD40;HSPD1;MAPK14;CCL19;RIPK2;MAPK11;PLCG2
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.35448217309779184,1.0231043682842358,0.4209905660377358,0.9432203294881089,1.0,18/79,17.02%,DYNC1I1;KIF2A;AP2A2;SPTBN2;CAPZB;RAB7A;KLC1;AP1S3;FCER1G;AP2A1;SH3GL2;AP1M1;AP1S2;SEC23A;DYNC1LI2;AP1B1;CANX;DYNC1H1
prerank,positive regulation of viral process (GO:0048524),0.36589943868426894,1.0225093003102328,0.44363636363636366,0.94408802533442,1.0,16/60,18.97%,CCL5;GTF2F1;POLR2H;TARBP2;POLR2A;TMEM39A;RAB7A;SRPK2;SRPK1;VPS4A;DHX9;DDB1;NELFB;POLR2C;POLR2E;NELFA
prerank,synaptic vesicle endocytosis (GO:0048488),-0.31725637981435295,-1.0223694342219816,0.4326530612244898,0.7946720101084821,1.0,10/33,14.77%,DNAJC6;DNM3;SYNJ2;SYT1;NLGN1;ITSN2;STON2;NLGN3;AMPH;FCHO2
prerank,ventricular septum development (GO:0003281),-0.3000738368108545,-1.0223336286932243,0.4256198347107438,0.7933619764666158,1.0,15/37,22.26%,ZFPM2;ROBO1;NOTCH1;ROBO2;SALL1;SLIT2;HEYL;PDE2A;SLIT3;BMPR2;SOX11;SMAD4;HEY2;APLNR;HEY1
prerank,positive regulation of cytokine production (GO:0001819),-0.21854268720580988,-1.0223283451314524,0.5,0.7919649802779984,1.0,51/292,14.06%,PLCB1;SULF1;IL1R1;CCBE1;AFAP1L2;PDE4D;NOD1;PLA2R1;CADM1;HIF1A;WNT5A;TMED10;SLC7A5;CD34;GLMN;LGALS9;CYP1B1;RUNX1;SPTBN1;RFTN1;GBP5;IL18;PTGS2;RGCC;RORA;TGFB1;LRRFIP1;IL6R;IL33;PDE4B;TBK1;CRCP;PIK3CD;CD46;TRAF6;STAT3;MBP;TIRAP;ARHGEF2;PNP;POLR3A;RIPK1;IL6ST;DDIT3;DRD2;IL17D;POLR2F;FLT4;POU2F2;STAT6;CYRIB
prerank,regulation of cell communication by electrical coupling (GO:0010649),-0.3984339329645291,-1.0222932728551415,0.42857142857142855,0.7906804945855743,1.0,3/13,3.42%,SLC8A1;PDE4D;CAMK2D
prerank,positive regulation of integrin activation (GO:0033625),0.47931707477178076,1.0220643190450858,0.4591194968553459,0.9445352361576084,1.0,1/11,2.26%,RAP1B
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),-0.4192998136730987,-1.0218422585400253,0.4424552429667519,0.7905065989118564,1.0,3/11,11.44%,LYN;MFHAS1;TIRAP
prerank,cardiac atrium morphogenesis (GO:0003209),0.45245802889344133,1.0215369661307214,0.43909774436090226,0.9452200133811064,1.0,2/16,7.38%,NOTCH2;TGFB2
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),0.43431413569002936,1.0214380903831302,0.43377001455604075,0.9447575518916973,1.0,8/20,19.73%,NIBAN2;EP300;DDRGK1;TWIST1;GATA3;POU4F1;PARK7;RB1
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.33934124844415897,1.0209682286606327,0.4196035242290749,0.945297217388403,1.0,28/129,14.45%,SCEL;KANK1;PTK7;CAV1;TMEM198;RNF220;DAPK3;PPM1B;PSMD11;PSMD4;WLS;PSMF1;GPC3;ILK;LGR4;PPM1A;RNF146;UBE2B;ADGRA2;PRDM15;PSMD7;CSNK1E;TRPM4;PSMB5;CAPRIN2;SFRP1;UBR5;WNK1
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.4020067917626966,1.0204906888497607,0.4344919786096257,0.9458383948028418,1.0,6/33,8.41%,ANGPT1;NUPR1;NFE2L2;MAPK7;KRIT1;TCF7L2
prerank,pteridine-containing compound metabolic process (GO:0042558),-0.39330225176181116,-1.0204188241181578,0.42480211081794195,0.7930042658977823,1.0,3/13,12.79%,NOS3;GCH1;SPR
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),0.3958285487874825,1.020393651799103,0.4386422976501306,0.9453710198640153,1.0,5/36,9.21%,OGT;FHIT;DDRGK1;PSMF1;OPHN1
prerank,regulation of presynapse organization (GO:0099174),0.4375222297178302,1.0202384600033565,0.45454545454545453,0.9442856473443898,1.0,7/18,19.38%,GPC6;GPC4;PTPRD;IL1RAPL2;EIF4G1;MDGA1;APP
prerank,regulation of presynapse assembly (GO:1905606),0.4375222297178302,1.0202384600033565,0.45454545454545453,0.9442856473443898,1.0,7/18,19.38%,GPC6;GPC4;PTPRD;IL1RAPL2;EIF4G1;MDGA1;APP
prerank,response to interferon-beta (GO:0035456),-0.3413893773576918,-1.020146453407064,0.41509433962264153,0.7923489331711252,1.0,11/22,26.70%,XAF1;AIM2;IFNAR2;IFITM3;PLSCR1;IRGM;SHFL;HTRA2;BST2;TRIM6;IFITM1
prerank,regulation of ATP metabolic process (GO:1903578),0.36727776444475946,1.0201367509811334,0.44458281444582815,0.9438276970916548,1.0,10/54,9.90%,OGT;ABCD1;EP300;BEND3;NUP93;EIF6;NDC1;JMJD8;ATP5IF1;COX7A2L
prerank,positive regulation of nervous system process (GO:0031646),-0.3526545787355289,-1.020014923875944,0.40425531914893614,0.7912757443067119,1.0,8/18,25.76%,UNC13B;TENM4;TPPP;TNFRSF1B;MYRF;RIMS1;DICER1;NCMAP
prerank,negative regulation of interleukin-12 production (GO:0032695),-0.3820979046399221,-1.0199579528984977,0.4074074074074074,0.7900250397948955,1.0,2/14,5.53%,THBS1;IRAK3
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.4223887820678894,1.0199366715265545,0.43705799151343705,0.9436143213857553,1.0,3/23,7.30%,RAET1E;LAMP1;PVR
prerank,positive regulation of behavior (GO:0048520),-0.43709140444456407,-1.019857015591322,0.4631578947368421,0.7889472474231108,1.0,5/10,9.37%,NLGN1;NPAS2;AGRP;SGIP1;CFAP20
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.48100839334801154,1.0197929539431572,0.45440251572327045,0.943297532235546,1.0,3/12,14.17%,KLF4;TLR4;FOXP1
prerank,amino acid transmembrane transport (GO:0003333),-0.2838346599191828,-1.0195632530680858,0.45495495495495497,0.7884700436702433,1.0,8/45,10.92%,SLC7A11;SLC6A13;SLC47A1;SLC7A5;SLC6A6;SLC7A7;SLC38A11;SLC38A9
prerank,response to retinoic acid (GO:0032526),0.3664322495351561,1.0191940679155105,0.44569288389513106,0.9441538010148779,1.0,12/59,12.43%,PTK7;WNT11;PTK2B;WNT6;RARG;CREB1;RXRB;SOX9;WNT5B;AQP1;EPHA3;WNT3
prerank,positive regulation of cellular respiration (GO:1901857),0.48069125465178725,1.0190935489052002,0.43485342019543977,0.9436824903488434,1.0,1/11,2.39%,NUPR1
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.3515502279655826,1.0190046166299074,0.4274193548387097,0.9431931039241144,1.0,17/76,17.31%,ANGPT1;ZC3H12A;CAV1;HDAC4;MUL1;CENPS;DCUN1D5;HDAC3;HSPBP1;SAE1;DCUN1D1;PIAS1;PIAS3;GSK3A;TNIP1;XIAP;STUB1
prerank,cellular response to interleukin-4 (GO:0071353),-0.4337367994491783,-1.0189816291068468,0.4300254452926209,0.7886592382064103,1.0,1/10,0.48%,LEF1
prerank,glucan catabolic process (GO:0009251),0.46047484308862874,1.0188503281733017,0.44036697247706424,0.942896449570926,1.0,4/15,11.00%,MGAM;PHKA2;PGM2;PHKB
prerank,positive regulation of defense response to virus by host (GO:0002230),0.41478615610825953,1.0186832586168915,0.4384949348769899,0.9426018281828187,1.0,3/24,5.02%,ZC3H12A;MAVS;TRIM44
prerank,positive regulation of ruffle assembly (GO:1900029),0.4640904351334519,1.018674926464152,0.44605475040257647,0.9418821098264589,1.0,4/13,14.36%,EPS8L2;NDEL1;PLEKHM1;HRAS
prerank,positive regulation of dendrite morphogenesis (GO:0050775),0.4402356538443689,1.0185789739723266,0.4395924308588064,0.9413784811059835,1.0,8/19,20.66%,FBXW8;PTPRD;CAPRIN2;SS18L2;RELN;SS18L1;CAMK2B;DBN1
prerank,cellular response to glucagon stimulus (GO:0071377),-0.3658196993585856,-1.0180540331786585,0.42134831460674155,0.7899049132871586,1.0,10/17,22.44%,ADCY5;ADCY7;ADCY1;ADCY4;PRKAR2B;CYSLTR2;ADCY2;PRKAR1B;ADCY3;ADCY8
prerank,immunoglobulin mediated immune response (GO:0016064),0.4981404348620084,1.0179754348739922,0.46243739565943237,0.9422479509989143,1.0,2/10,11.65%,CD81;FCER1G
prerank,negative regulation of tumor necrosis factor production (GO:0032720),-0.29379649183293544,-1.017821308302173,0.45089285714285715,0.7891501718857296,1.0,5/41,5.53%,IGF1;GAS6;CD34;LGALS9;IRAK3
prerank,protein modification by small protein conjugation (GO:0032446),0.3192183694607391,1.0177690251465932,0.44779116465863456,0.9420312466237574,1.0,116/361,25.47%,RNF152;FBXL7;TRIM60;FBXW8;TRIM33;CAND2;RNF43;RNF220;SPSB4;NFE2L2;WWP2;MOCS3;TRIM44;NUB1;ELOB;RNF138;NUP93;KLHL21;DDRGK1;MUL1;EYA1;CBLL1;TRIM41;TRIM21;UBE2G2;RBX1;DCUN1D5;NDC1;SDE2;SUMO2;SUMO3;TRIM47;TRIM26;TRIM11;UBE2B;RNF182;PCNP;KLHL24;SAE1;TRPM4;DCUN1D1;VPS11;KLHL13;NSMCE2;MIB2;ZSWIM8;PIAS1;PIAS3;DTX3;VPS18;BRAP;NEDD4;UBE2H;MDM2;PCNA;UBE2N;CCDC22;MSL2;FBXL15;UFM1;UBA6;DDB1;CAND1;RPS27A;UBC;CUL9;DTX2;UBE2D3;KEAP1;STUB1;UBE2F;FBXL2;AAAS;PDZRN3;OTULIN;RAE1;PEX2;CDK5RAP3;RNF41;UBE2Z;ASB5;FBXO9;CHFR;VHL;FBXW7;CUL2;TRIM5;UBE2E1;RCHY1;ARIH2;POM121;SMURF2;RNF168;DET1;TPR;RNF213;CTR9;RNF14;RNF7;CDC23;URM1;RANBP2;LEO1;FBXO4;NUP42;GAN;ATG3;UBA7;TMEM129;RANGAP1;UBE2M;NUP62;FBH1;TRIM39;TSPAN17;SEH1L
prerank,ESCRT complex disassembly (GO:1904896),0.49433126462214333,1.0174063070205295,0.4773109243697479,0.941453922850116,1.0,7/10,26.59%,VPS4B;CHMP1A;VPS4A;CHMP2A;IST1;CHMP5;CHMP1B
prerank,ESCRT III complex disassembly (GO:1904903),0.49433126462214333,1.0174063070205295,0.4773109243697479,0.941453922850116,1.0,7/10,26.59%,VPS4B;CHMP1A;VPS4A;CHMP2A;IST1;CHMP5;CHMP1B
prerank,phosphorylation (GO:0016310),0.3177031046042462,1.016749954540177,0.45883534136546184,0.9424498586046258,1.0,97/385,20.03%,PRKCB;FGFR1;STK19;PRKAA2;LIMK2;FAM20C;PRAG1;NRBP2;MAP3K5;TRIB2;GRK5;ADAM10;TSSK6;TSSK4;WNT11;IKBKE;NEK7;CDK10;CDK6;MKNK2;PTK2B;SGK3;DAPK3;DAPK1;CDKL2;CDK4;ROS1;AGK;CREB1;RNASEL;STK39;SIK3;CSK;NADK;TGFB2;CDK16;ILK;LATS1;DYRK1B;OXSR1;MAPK9;AURKC;PI4KA;BCR;LMTK2;TXK;HK1;SRPK2;CDKL4;DGKA;GRK2;PDK2;CSNK1E;JAK1;YWHAZ;MARK4;TGFBR2;EIF2AK3;CDK18;SRPK1;MAP3K13;CDK2;GSK3A;IRAK1;CHUK;ULK1;GSK3B;WNK1;CDC42BPA;PLK2;AAK1;PAK6;PRKCZ;ABL1;PRKAG1;MAP3K6;MAPK6;CDC25B;EIF2AK4;MAPKAPK2;CHEK2;BMPR1A;PEAK1;RSKR;RARA;STK38L;STK24;ROCK2;TAOK3;PRKD2;APP;PNKP;MAP3K1;CDK11B;PRKAB1;TBCK;CDC42BPG
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.3364392412549914,1.0167090191686923,0.44432432432432434,0.9418081108687886,1.0,37/140,17.31%,SRGAP3;SRGAP2;ARAP1;NGEF;ARHGEF17;ARHGAP18;AKAP13;ARHGEF12;ARAP2;TIAM2;RHOQ;FOXM1;ARHGEF18;ARHGAP29;ARHGAP21;ARHGAP10;CDC42;BCR;ARHGEF5;OPHN1;TRIO;DLC1;GNA13;RHOA;RABL3;SOS2;INPP5B;OCRL;ARHGAP31;RHOU;FLCN;ARHGDIB;ARHGEF1;TAGAP;RELN;ARHGAP33;PLEKHG2
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.3828237982844657,1.016346115735278,0.4397905759162304,0.942047369174501,1.0,12/39,15.64%,WNT1;KANK1;GCNT2;FBLN1;EFNA5;DMTN;CASK;ADAM15;RHOA;RASA1;ITGB1BP1;ACTN4
prerank,carboxylic acid metabolic process (GO:0019752),-0.3108009327971084,-1.016178185473567,0.408,0.7922197490281873,1.0,5/33,5.08%,PLA2G4A;ST3GAL1;SLC2A1;PTGIS;CSGALNACT1
prerank,COPII-coated vesicle budding (GO:0090114),0.36010753278292024,1.0153633855444135,0.4368231046931408,0.944008375025908,1.0,24/68,23.85%,F5;PEF1;PPP6R3;TFG;CTSZ;TRAPPC9;TRAPPC1;MCFD2;NAPA;PREB;RAB1B;CNIH1;SEC23A;ANKRD28;NSF;SEC23IP;SEC24B;SEC31B;MIA3;SEC16A;SEC31A;VAPA;GRIA1;SEC24D
prerank,substrate-dependent cell migration (GO:0006929),-0.38472906978513266,-1.0153183315502758,0.42016806722689076,0.7931051741677441,1.0,5/14,19.69%,VEGFC;ITGA11;ANKS1A;EPHA8;P2RY12
prerank,inorganic cation transmembrane transport (GO:0098662),0.3166234773263094,1.0150328572145577,0.47298674821610603,0.9441749103637591,1.0,39/268,15.07%,SLC9A2;SLC9A4;TRPM3;SLC36A3;ATP6V1B1;ASIC5;SCN3A;HPN;CACNA1A;NALCN;ATP1A2;TRPM8;CACNA2D4;TMEM165;ABCC8;SLC39A3;PKD1;SLC39A6;KCNA4;TRPM6;SLC9A6;SLC9A7;KCNB1;TRPM4;PKD2L1;SLC41A1;ANO6;KCNA5;SLC25A14;TRPM2;SLC39A13;KCNQ5;SLC6A7;TMEM175;ATP2B4;SLC25A27;SLC30A6;HVCN1;SLC9A8
prerank,positive regulation of innate immune response (GO:0045089),0.3974731716086112,1.0149285319052197,0.44579945799457993,0.943735467107031,1.0,8/30,15.83%,CCL5;MAVS;POLR3B;LBP;NMI;POLR3C;DHX9;POLR3G
prerank,sterol metabolic process (GO:0016125),0.36605472058426175,1.0148777671425608,0.45,0.943130091671639,1.0,12/60,8.94%,SOAT1;STARD3;SULT2B1;DHCR7;HMGCR;INSIG1;PMVK;CYP39A1;CYP51A1;MSMO1;FDX1;SOAT2
prerank,DNA replication-independent nucleosome organization (GO:0034724),0.4862226249848445,1.0140398305453517,0.45662847790507366,0.9446551496881086,1.0,6/11,21.65%,ASF1A;ATRX;UBN1;IPO4;H3-3A;HAT1
prerank,regulation of axon guidance (GO:1902667),0.48587567856992403,1.0138150552209284,0.45840407470288624,0.9445049702142225,1.0,3/10,13.79%,YTHDF1;ZSWIM8;TUBB2B
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),0.4342986662439247,1.0136588702100497,0.4507462686567164,0.9441795179141544,1.0,2/20,2.81%,SEMA3D;SEMA3B
prerank,fatty acid biosynthetic process (GO:0006633),0.359625220286958,1.0136214303270468,0.44657863145258103,0.9435385963126554,1.0,13/63,13.94%,ABCD1;OLAH;ELOVL1;ALOX5;ELOVL6;ACSM3;HACD4;FADS1;NDUFAB1;ACSF3;ACACA;SCD5;LTA4H
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),-0.2888713393614362,-1.0132695816108233,0.4642857142857143,0.7970616832622895,1.0,5/43,5.53%,IGF1;GAS6;CD34;LGALS9;IRAK3
prerank,regulation of protein metabolic process (GO:0051246),0.3676577294277477,1.0123484313721915,0.44025157232704404,0.9461532336290481,1.0,12/44,21.82%,KLF4;LDLR;LTBP4;MAPK7;MDM2;CENATAC;CHEK2;ROCK2;APP;KLF2;ABCA7;SPOPL
prerank,amyloid precursor protein catabolic process (GO:0042987),0.4618680862296935,1.0123075595144617,0.48042168674698793,0.9455557425942372,1.0,6/14,23.99%,ADAM10;BACE1;ADAM17;ABCA7;APH1A;PSEN1
prerank,polyamine metabolic process (GO:0006595),0.4520773958144157,1.0122184299474182,0.46037099494097805,0.9450586057494365,1.0,1/13,1.39%,SMOX
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.3287757949362922,1.012132120052436,0.46048472075869334,0.9445529971246289,1.0,36/149,19.56%,PRKCB;CLU;EDA2R;EDA;CAV1;EP300;TRIM25;MTDH;FLOT2;NFKBIA;DDRGK1;TRIM21;TAB3;RAB7B;TLR6;CARD16;TLR4;MAP3K13;IRAK1;CHUK;DHX9;IKBKG;RNF31;UBE2N;RPS27A;UBC;PRKCZ;PIDD1;TAB2;TRIM37;PRKCQ;PRKD2;NFKB2;APP;FLOT1;ZBTB7A
prerank,fructose 6-phosphate metabolic process (GO:0006002),0.4893305217114403,1.0119368016959636,0.4651567944250871,0.9443644625476061,1.0,3/10,13.96%,PFKP;HK1;GFPT1
prerank,mesonephric tubule development (GO:0072164),0.4484183612117465,1.0117990128542196,0.45792880258899676,0.9439970495366287,1.0,5/15,12.04%,WNT11;BMP4;SIX1;PKD1;NPNT
prerank,protein-containing complex subunit organization (GO:0043933),0.33755758919614093,1.0115192973286136,0.45374449339207046,0.9440143923700296,1.0,15/109,9.03%,REPS2;PPARGC1A;OCLN;EPRS1;PTK2B;ELOB;SOX9;DMTN;GPAA1;AFG3L2;PARD6B;LAMC1;PML;NDC1;KMT2A
prerank,negative regulation of DNA replication (GO:0008156),0.46165110076864696,1.0112194121650924,0.45701357466063347,0.9440754720276051,1.0,6/13,28.67%,S100A11;ATR;WAPL;GTPBP4;TERF1;CDC6
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),-0.4118281243459507,-1.0111694501640627,0.4576719576719577,0.8015679284578521,1.0,5/11,25.33%,GRK3;ARRB1;ADM;SAG;ARRB2
prerank,"base-excision repair, AP site formation (GO:0006285)",0.43945029245559786,1.0110052350194756,0.44624447717231225,0.9438901893786877,1.0,9/17,29.99%,MUTYH;ERCC5;MBD4;NEIL1;TERF2;TINF2;TERF1;TERF2IP;TDG
prerank,protein O-linked mannosylation (GO:0035269),0.4274459859984424,1.0109896032329513,0.4442793462109955,0.9432007705153735,1.0,3/18,4.29%,B4GAT1;TMTC1;LARGE1
prerank,lung epithelium development (GO:0060428),0.48995881091309246,1.01095654834273,0.4682926829268293,0.9425637364713443,1.0,4/10,8.89%,STRA6;BMP4;PKD1;GRHL2
prerank,regulation of type I interferon production (GO:0032479),0.3527417042498148,1.010852366735916,0.43742824339839265,0.9421052602978861,1.0,22/84,20.56%,IKBKE;MAVS;EP300;POLR2H;TRIM25;IRF3;MRE11;TRIM21;POLR3B;POLR1C;POLR3C;NPLOC4;IRAK1;GAPDH;DHX9;POLR3G;POLR3H;POLR2E;ILRUN;NFKB2;PCBP2;ZBP1
prerank,regulation of astrocyte differentiation (GO:0048710),0.47142477152468804,1.0106811652431766,0.4864864864864865,0.9418371672118915,1.0,2/12,4.18%,EPHA4;CLCF1
prerank,cellular macromolecule biosynthetic process (GO:0034645),0.3190484399567661,1.0106677859689734,0.47551020408163264,0.9411468605905303,1.0,72/306,19.17%,THRB;ST3GAL4;MRPS16;FEN1;GRWD1;EEF1A1;MRPL24;MRPL37;CREBL2;LARGE1;RECQL4;POLR2H;HARS1;RPS4X;NKX2-8;MRPS7;POLR2A;MRE11;GOLPH3;PTMS;REV1;ABCF1;RPL31;RPSA;GSPT2;RPL22;EXT1;PCLAF;MRPS33;PTMA;RMI1;RPL28;SRBD1;TOPBP1;RPS26;EIF4G2;MRPL9;COPS5;EEF1D;CDK2;RNPS1;ING4;RPA3;HARS2;RPL10A;MRPS15;SET;SARS1;EIF4G1;DONSON;TNIP1;POLD2;MCM8;MRPS18C;RPL14;RRBP1;EEF2;MCM6;ATR;RPS27A;E2F1;NBN;MCM7;POLR2C;RAD50;HBS1L;IGF2BP3;NT5M;POLR2E;EIF4EBP2;RPL6;FARSB
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",0.4542215767098927,1.01013602648448,0.45858895705521474,0.9418436477035117,1.0,6/15,16.61%,USP46;ZDHHC12;NPS;STXBP1;NLGN2;SYN3
prerank,regulation of angiogenesis (GO:0045765),0.3235037407912286,1.0098307352910045,0.4857744994731296,0.9419357779887624,1.0,29/192,11.19%,PRKCB;ADAM12;ITGB8;KLF4;ANXA3;COL4A3;EMP2;NIBAN2;GLUL;NINJ1;ZC3H12A;GAB1;HSPB1;MTDH;ALOX5;HOXA5;AGGF1;MYDGF;TGFB2;KRIT1;VEGFB;ADAMTS1;PML;EMC10;ADGRA2;SYNJ2BP;TWIST1;AQP1;RAPGEF3
prerank,RNA 3'-end processing (GO:0031123),0.3573018810192048,1.009661878194833,0.4460260972716489,0.9416823619481441,1.0,24/69,21.01%,SRSF2;EIF4A3;DDX39B;RBM8A;TENT4A;WDR33;RPRD2;SRSF7;POLDIP3;THOC7;TUT7;RNPS1;CSTF1;SRSF9;UPF3B;PABPN1;MAGOHB;MAGOH;CLP1;SRSF1;SRSF5;CSTF3;THOC1;TUT1
prerank,sensory organ development (GO:0007423),0.3664023038128298,1.0094444804220226,0.4445812807881773,0.9415497143602829,1.0,4/51,3.16%,PBX3;PBX1;WNT10A;STRA6
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.3961040295389618,1.0094046436604336,0.45108695652173914,0.940927743829775,1.0,4/32,3.88%,KLF4;JCAD;HDAC5;FOXC2
prerank,regulation of monooxygenase activity (GO:0032768),-0.33370538992114623,-1.0091816766715669,0.4416403785488959,0.8055923158030285,1.0,7/23,12.79%,POR;NOS3;NOSTRIN;NOS1AP;NOSIP;CYGB;SPR
prerank,nuclear export (GO:0051168),0.34723645886954796,1.0090922992466382,0.44300822561692127,0.9410560473904453,1.0,29/80,23.24%,RANBP3L;SRSF2;EIF4A3;DESI1;PKD1;DDX39B;CHP1;RBM8A;SRSF7;POLDIP3;THOC7;RNPS1;SRSF9;UPF3B;MAGOHB;MAGOH;RITA1;WASHC4;CSE1L;SRSF1;RAE1;SRSF5;XPO4;THOC1;RANBP3;POM121;U2AF1;TPR;SRRM1
prerank,cellular modified amino acid biosynthetic process (GO:0042398),-0.3483978242620197,-1.0079235935179705,0.4258064516129032,0.807677925439436,1.0,5/20,12.08%,PLOD2;GATM;PTDSS1;PLSCR1;CNDP2
prerank,regulation of JUN kinase activity (GO:0043506),0.39201856883041153,1.0076634863138574,0.4473684210526316,0.9440256019646688,1.0,6/33,9.18%,MAP3K5;DUSP10;MAP3K4;DVL3;ARHGEF5;TLR6
prerank,L-amino acid transport (GO:0015807),0.4021920952766947,1.0074727855962953,0.4697986577181208,0.9438057380917522,1.0,8/28,15.33%,SLC36A3;CTNS;SLC36A4;SFXN1;ARL6IP5;SLC1A4;SLC25A12;SLC7A3
prerank,cellular response to nitrogen compound (GO:1901699),0.42374574276390675,1.0071268330601555,0.456490727532097,0.9439725364101396,1.0,7/20,23.80%,DAXX;ATRX;ATP2B4;ROCK2;DDI2;EPG5;RTF2
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),-0.430605128515974,-1.0071001657896663,0.45476190476190476,0.808572757542548,1.0,7/10,31.46%,NUDT21;CPEB1;HSF1;PAF1;NCBP1;DHX36;NCBP2
prerank,nuclear envelope organization (GO:0006998),0.4309424014750368,1.0066619576255473,0.44561933534743203,0.94445457976912,1.0,7/20,17.81%,REEP3;NUP93;TOR1A;VPS4A;TOR1AIP1;REEP4;SUN2
prerank,negative regulation of microtubule depolymerization (GO:0007026),0.4284693331947857,1.006399194316072,0.45626822157434405,0.9444334442298882,1.0,1/21,0.23%,FGF13
prerank,inositol phosphate-mediated signaling (GO:0048016),0.4313472383745843,1.0062455259484944,0.46096096096096095,0.9441654750949312,1.0,1/19,0.33%,NFATC2
prerank,regulation of protein neddylation (GO:2000434),-0.41972208191536964,-1.0059800705445154,0.4562334217506631,0.8102534142675818,1.0,5/10,17.57%,HIF1A;EPAS1;RPL11;DCUN1D3;DCUN1D2
prerank,production of siRNA involved in RNA interference (GO:0030422),0.4898712946424656,1.0059045528555945,0.4668820678513732,0.9443383020099566,1.0,2/10,7.97%,TARBP2;TSNAX
prerank,ureteric bud development (GO:0001657),0.4385184174479578,1.0049020560730086,0.4781906300484653,0.9462204201600323,1.0,5/17,12.04%,WNT11;BMP4;GPC3;SIX1;NPNT
prerank,renal system development (GO:0072001),0.3694535273199428,1.0047959782644957,0.4583333333333333,0.9457726432236504,1.0,8/52,8.25%,AGTR1;STRA6;PYGO2;ARL3;BMP4;TGFB2;SIX1;PKD1
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.41874997755370935,1.0047744331476762,0.4632352941176471,0.9451111384721446,1.0,10/20,26.05%,ADAM10;SPPL2B;HM13;SPPL2A;ADAM17;RHBDD1;APH1A;PSEN1;MBTPS2;RELA
prerank,neuron projection regeneration (GO:0031102),-0.4230496707498492,-1.00446876652861,0.45454545454545453,0.8129725970373677,1.0,4/10,15.59%,NREP;MAPK8IP3;DHFR;MTR
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.4803770993244621,1.0044389295289302,0.4662379421221865,0.9452442497777838,1.0,1/10,0.76%,CHRM1
prerank,sympathetic nervous system development (GO:0048485),0.44350464876091966,1.004293767984658,0.4576271186440678,0.9449135646591365,1.0,5/15,20.24%,GDNF;NRP2;GATA3;SEMA3A;SOX4
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.47282967702223244,1.004188704254037,0.4532488114104596,0.9445027837629167,1.0,6/11,20.66%,SOAT1;ITM2C;ABCA2;NECAB3;NECAB2;ABCA7
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.46345956488363205,1.0035909532255078,0.45454545454545453,0.9453872190178768,1.0,4/12,19.22%,TLR6;ZNF205;TLR4;RAB27A
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",0.346983868487238,1.0034925817139149,0.460093896713615,0.9449556424410095,1.0,28/80,19.80%,RAB9B;SNX8;GCC2;MAGEL2;RAB7B;RAB7A;GGA1;VPS54;SGSM2;VTI1B;RNF126;SNX12;PHETA2;VPS26B;VPS52;PLEKHJ1;PHETA1;STX16;WASHC1;VPS50;TBC1D10A;ARFRP1;YKT6;TMEM87B;BET1L;RAB9A;VTI1A;TBC1D17
prerank,regulation of axon extension involved in axon guidance (GO:0048841),0.41272409691851153,1.0033573680080616,0.45809248554913296,0.9446051323416831,1.0,2/24,2.81%,SEMA3D;SEMA3B
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),-0.35825564258644516,-1.0033325392284858,0.46153846153846156,0.8147352535630005,1.0,2/17,9.18%,PLA2G4A;SERAC1
prerank,regulation of fatty acid beta-oxidation (GO:0031998),0.460551316439496,1.0032296848424156,0.47791798107255523,0.9442544007481917,1.0,4/14,11.68%,ABCD1;MTLN;TWIST1;IRS2
prerank,microtubule polymerization (GO:0046785),0.4073699433030009,1.0031264384292802,0.45569620253164556,0.9438209042887841,1.0,2/28,2.87%,FGF13;NDEL1
prerank,negative regulation of protein localization to membrane (GO:1905476),-0.3206853099385157,-1.003118972646126,0.4520547945205479,0.8139419825538934,1.0,2/24,1.46%,PID1;DAB2
prerank,negative regulation of protein binding (GO:0032091),0.3450352440304977,1.003030737483412,0.459727385377943,0.9433535693551316,1.0,14/71,14.84%,CFHR1;CDKN1A;GTF2F1;CAV1;SLPI;CTSZ;PTPRF;ACTB;CARD16;ADAM15;CSNK1E;TLE5;GSK3B;ITGB1BP1
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),0.3503196752664086,1.0024740765311877,0.4684466019417476,0.9441164873562193,1.0,28/71,21.79%,ADAMTS7;PMAIP1;ATE1;ZYG11B;CTSZ;OTUD7B;CAPN2;CHMP4B;VPS4B;RNF123;VPS4A;SOCS6;MDM2;PRPF19;CTSH;HM13;DDB1;RPS27A;UBC;STUB1;HDAC6;PDCD6IP;RNF41;IDE;RHBDD1;CHFR;CTSK;LONP1
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.36022282011508244,1.002205330517754,0.44282238442822386,0.9427120517599354,1.0,17/61,19.08%,F5;PEF1;PPP6R3;TFG;CTSZ;TRAPPC9;TRAPPC1;MCFD2;NAPA;PREB;RAB1B;CNIH1;SEC23A;ANKRD28;NSF;SEC23IP;SEC24B
prerank,COPII vesicle coating (GO:0048208),0.36022282011508244,1.002205330517754,0.44282238442822386,0.9427120517599354,1.0,17/61,19.08%,F5;PEF1;PPP6R3;TFG;CTSZ;TRAPPC9;TRAPPC1;MCFD2;NAPA;PREB;RAB1B;CNIH1;SEC23A;ANKRD28;NSF;SEC23IP;SEC24B
prerank,vesicle coating (GO:0006901),0.36022282011508244,1.002205330517754,0.44282238442822386,0.9427120517599354,1.0,17/61,19.08%,F5;PEF1;PPP6R3;TFG;CTSZ;TRAPPC9;TRAPPC1;MCFD2;NAPA;PREB;RAB1B;CNIH1;SEC23A;ANKRD28;NSF;SEC23IP;SEC24B
prerank,positive regulation of Notch signaling pathway (GO:0045747),0.378978267724725,1.0012989418540947,0.45489690721649484,0.9444278455944941,1.0,4/39,2.90%,TSPAN5;WNT1;ELF3;EP300
prerank,negative regulation of interleukin-6 production (GO:0032715),0.40790259375431065,1.0011423481688508,0.46236559139784944,0.9441226480032107,1.0,6/27,15.27%,CD200;ZC3H12A;PTPN6;TLR4;CD200R1;SYT11
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.32299783168412505,1.0009630428483347,0.4726890756302521,0.9438753422631048,1.0,54/182,22.02%,NOTCH2;ITGB8;PRKAA2;KLF4;LDLR;SMO;ADAM10;OCLN;ZC3H12A;CELF1;WWP2;OLFM1;FLOT2;OVOL2;MOV10;DDRGK1;BMP4;RBMS3;TGFB2;MAP2K2;SMCR8;SNX12;SFMBT2;ZNF148;SH3GL2;MEF2C;TLE5;ATP2B4;SFRP1;FOXP1;HRAS;SETDB1;FLCN;TET1;RIN3;LRP3;POU4F1;HINFP;BMPR1A;PARK7;ROCK2;GPER1;APP;RB1;MAPT;SLC2A10;TERF2;VHL;WDR54;YY1;FBXW7;AP1AR;DLG4;PGR
prerank,regulation of cholesterol storage (GO:0010885),0.44318576232485074,1.00059078351145,0.45412130637636083,0.9441643040145402,1.0,3/15,3.69%,SREBF2;TTC39B;EHD1
prerank,organic acid transport (GO:0015849),0.3416821240211138,1.0005856698072044,0.4463087248322148,0.9434704708373891,1.0,11/94,13.17%,SLC7A14;SLC10A5;SLC27A3;SLC3A1;SLC25A47;SLC7A6;SLC1A4;SLC25A45;SLC25A17;PDPN;SLC25A14
prerank,positive regulation of cell motility (GO:2000147),0.3146023084735689,1.0005583050028977,0.47713097713097713,0.9428223295575034,1.0,17/205,4.38%,SEMA3D;CDH13;NTRK3;LAMC2;TJP1;SMO;MMP9;CCL5;PODXL;PDGFC;ADAM10;WNT11;CAV1;SEMA3B;PTK2B;GCNT2;SH3RF2
prerank,positive regulation of protein maturation (GO:1903319),-0.4100820826548895,-1.0005563345384496,0.45885286783042395,0.8196629306233367,1.0,4/11,25.77%,CCBE1;NKD2;BAG2;ADAM8
prerank,regulation of response to cytokine stimulus (GO:0060759),0.4236035811751318,1.000385642644221,0.47172619047619047,0.9425886348846957,1.0,6/19,15.32%,KLF4;MAVS;MAPK7;IRAK1;TLE5;DHX9
prerank,lysosome organization (GO:0007040),-0.30051123115878,-0.9998627626135925,0.41150442477876104,0.8201475404434944,1.0,11/36,17.80%,ABCA1;CLVS2;LRRK2;GAA;TPP1;SNAPIN;LAMTOR1;CLN3;TMEM106B;VPS33A;CLVS1
prerank,positive regulation of endothelial cell migration (GO:0010595),0.34275895083162883,0.9998014001991606,0.4730195177956372,0.9434342823138626,1.0,19/84,14.84%,FGFR1;ANGPT1;ANXA3;ZC3H12A;GFUS;PTK2B;FOXC2;HSPB1;BMP4;EMC10;NRP2;BCAS3;BCAR1;SP1;GATA3;FOXP1;NUS1;AAMP;ITGB1BP1
prerank,negative regulation of phosphorylation (GO:0042326),0.3384212320039597,0.9996008028982172,0.47337962962962965,0.9432717647657876,1.0,22/85,18.96%,NTRK3;CDKN1A;OCLN;NUPR1;ZC3H12A;HDAC4;FBLN1;BMP4;PIP5KL1;CHP1;FKBP8;TIGAR;NCOR1;IRS2;SH3GL2;DNAJC10;TESK1;PTPN13;GIT1;PARK7;CDKN2D;CDK5RAP3
prerank,homocysteine metabolic process (GO:0050667),-0.4062300568154946,-0.9992478211024546,0.45918367346938777,0.8204275510236052,1.0,7/11,43.28%,NOX4;MTHFR;CTH;MMUT;CBS;DPEP1;TST
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.32673641589374036,0.9992034622230855,0.48004314994606256,0.943555431096439,1.0,11/151,4.60%,ANGPT1;CD44;NOTCH2;NTRK3;CCL5;PDGFC;CCN2;RAP1A;PTK2B;GCNT2;ACKR3
prerank,positive regulation of RNA metabolic process (GO:0051254),0.36620564313968573,0.9979655120357414,0.46064516129032257,0.9461371555436313,1.0,11/45,14.96%,DDX5;BUD23;POLR2A;BMP4;RBM20;MAP2K2;WDR43;HABP4;HRAS;ZPR1;GRSF1
prerank,protein localization to vacuole (GO:0072665),0.45752324738750777,0.9978981131092116,0.4601328903654485,0.9456195812501721,1.0,9/13,30.46%,CD81;SH3BP4;KPTN;SZT2;GLMP;LAMTOR5;RTN4;ATP13A2;RNF128
prerank,positive regulation of neuroblast proliferation (GO:0002052),-0.41592112816709215,-0.9978318036907675,0.4645669291338583,0.822870109652227,1.0,4/10,20.54%,SMARCD3;DRD2;CX3CL1;CX3CR1
prerank,neurotrophin signaling pathway (GO:0038179),0.4190305935216176,0.9977173945517149,0.46060606060606063,0.9453515324336932,1.0,10/21,23.95%,MAGI2;RAP1A;NGF;ZFYVE27;BCAR1;RAPGEF1;KIDINS220;CASP3;SOS1;FRS2
prerank,calcium ion transport (GO:0006816),0.32745763352527996,0.9974787365315249,0.4827968923418424,0.9452932432195585,1.0,21/113,14.06%,TRPM3;ANK2;STIM2;CCL5;CACNA1A;CAV1;NALCN;TRPM8;CACNB3;RAMP1;CACNA2D4;TMEM165;MICU1;PKD1;TRPM6;MCUR1;TRPM4;ANO6;CACNB2;TRPM2;ATP2B4
prerank,regulation of cell development (GO:0060284),0.3851791371342086,0.9970029240393892,0.45285524568393093,0.9458678305492854,1.0,5/36,12.43%,NOTCH2;DOCK7;RHEB;ADGRA2;WNT3
prerank,cellular response to virus (GO:0098586),0.3870975364133237,0.9968689164811563,0.47289972899729,0.9455204160731067,1.0,7/30,15.37%,CCL5;ZC3H12A;IRF3;LGALS8;GSDME;CHUK;HSP90AA1
prerank,regulation of immune response (GO:0050776),0.32921446530392595,0.9959914305689591,0.48743169398907105,0.9471067136609829,1.0,9/135,7.38%,CXADR;RAET1E;CD200;IL15;ITGB7;CD81;CSK;PVR;TGFB2
prerank,fat cell differentiation (GO:0045444),0.36069607513414836,0.9955768826093663,0.46335403726708074,0.947490590127877,1.0,6/57,8.41%,KLF4;PPARGC1A;SMAD6;EP300;WNT5B;TCF7L2
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.48414346629043525,0.995421599970903,0.47704918032786886,0.9471707531652873,1.0,3/11,9.40%,DDX5;BMP4;MAP2K2
prerank,positive regulation of JUN kinase activity (GO:0043507),0.41168621206173833,0.9953469644966739,0.45345345345345345,0.9466598993663208,1.0,5/23,9.18%,MAP3K5;MAP3K4;DVL3;ARHGEF5;TLR6
prerank,megakaryocyte differentiation (GO:0030219),-0.40988547391772406,-0.9952272374013725,0.4830097087378641,0.8282836257527559,1.0,6/11,40.44%,SH2B3;KIT;TAL1;CDKN2B;IL11;THPO
prerank,carbohydrate derivative biosynthetic process (GO:1901137),0.4121399305472703,0.9950790670412379,0.4703389830508475,0.9466421573409841,1.0,4/26,7.17%,ST3GAL4;SCCPDH;LARGE1;GOLPH3
prerank,potassium ion transmembrane transport (GO:0071805),0.32597187473146433,0.9945492137267342,0.4809575625680087,0.9472811654344526,1.0,17/135,14.04%,SLC9A2;SLC9A4;HPN;SLC12A8;NALCN;ATP1A2;KCNJ13;ABCC8;KCNA4;SLC9A6;SLC9A7;KCNB1;PKD2L1;SLC12A4;KCNA5;KCNQ5;TMEM175
prerank,regulation of urine volume (GO:0035809),-0.41301518155669814,-0.993587475795826,0.4584450402144772,0.8313652481978338,1.0,5/10,27.62%,NPR3;NPR1;ADM;HYAL2;HAS2
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),0.42084705869203226,0.9933361722796812,0.49130434782608695,0.9497417053811117,1.0,7/22,18.96%,DDX5;PMAIP1;SPRED3;EEF1E1;ATR;HEXIM1;CDK5RAP3
prerank,protein deubiquitination (GO:0016579),0.3138082168951595,0.9930894583872467,0.5082815734989649,0.9496549028528201,1.0,72/242,24.43%,CFTR;OGT;MINDY2;ZC3H12A;EP300;USP46;USP29;OTUD1;NFKBIA;PSMD11;USP10;USP32;OTUD7B;HCFC1;PSMD4;PSMF1;DESI2;USP19;ACTB;USP20;ENY2;USP24;PSMD7;USP42;USP3;RHOA;RNF123;COPS5;ABRAXAS1;TOMM20;FOXK1;MYSM1;PSMB5;GATA3;MYC;TNIP1;MDM2;IKBKG;USP28;RPS27A;UBC;OTUD6B;KEAP1;TRRAP;PSMD1;USP25;STAM;OTULIN;PSMC4;USP21;USP16;TAF9B;PSMD8;INO80D;USP22;INO80C;USP2;YY1;USP11;INO80E;SMURF2;WDR20;MDM4;PSMA7;TADA3;USP13;TFPT;MBD6;BIRC3;CDC25A;STAM2;USP34
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),0.4703354463119648,0.9930240565489836,0.4935897435897436,0.9491250223962923,1.0,3/11,14.16%,TGFB2;TGFBR2;TGFBR3
prerank,heart contraction (GO:0060047),0.38259287368049255,0.9928773252412653,0.4683053040103493,0.9488173630753258,1.0,4/41,3.66%,SGCG;SGCD;ATP1A2;CSRP3
prerank,regulation of programmed cell death (GO:0043067),0.3195657659667306,0.9926314180581707,0.49518716577540106,0.9487556128237523,1.0,22/161,12.21%,CLU;DAXX;ACTN2;NDRG1;PMAIP1;KANK2;DAPK3;DAPK1;PPP1R13B;RARG;IRF3;PERP;SOX9;HAX1;TNFRSF10B;PTPN6;RAF1;TIGAR;USP42;PLSCR3;MARK4;BCAR1
prerank,cyclic purine nucleotide metabolic process (GO:0052652),-0.33270227110153316,-0.9923168675830508,0.4557377049180328,0.8335498414356064,1.0,7/21,10.43%,ADCY5;GUCY1B1;ADCY7;GUCY1A1;ADCY1;ADCY4;NPR1
prerank,NADH dehydrogenase complex assembly (GO:0010257),0.3592468432449053,0.992300330774979,0.4742647058823529,0.9481678030277602,1.0,19/56,23.40%,NDUFV1;NDUFB11;NDUFB8;NDUFB6;NDUFS3;NDUFAB1;NDUFB7;NDUFV2;NDUFA1;NDUFB4;NDUFAF4;NDUFB5;NDUFB9;DMAC2;NDUFA2;NDUFA12;TMEM126A;NDUFAF5;NDUFB10
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),0.3592468432449053,0.992300330774979,0.4742647058823529,0.9481678030277602,1.0,19/56,23.40%,NDUFV1;NDUFB11;NDUFB8;NDUFB6;NDUFS3;NDUFAB1;NDUFB7;NDUFV2;NDUFA1;NDUFB4;NDUFAF4;NDUFB5;NDUFB9;DMAC2;NDUFA2;NDUFA12;TMEM126A;NDUFAF5;NDUFB10
prerank,L-serine metabolic process (GO:0006563),0.4845708220034287,0.9920133637178532,0.4983221476510067,0.9481841618416001,1.0,3/10,9.13%,SERINC5;PHGDH;SHMT1
prerank,positive regulation of signal transduction (GO:0009967),0.31503335538370575,0.9918611788408735,0.48466257668711654,0.9478754018911456,1.0,23/238,7.59%,PRKCB;SORBS1;TSPAN5;NTRK3;WNT1;KANK1;SMO;JCAD;ELF3;RSPO3;EMP2;EP300;LIMS2;PTK2B;TRIM44;SMARCB1;PIH1D1;CAV2;DMTN;ZBTB7B;WLS;TGFB2;ILK
prerank,regulation of alcohol biosynthetic process (GO:1902930),0.4627817255233691,0.9918106484877152,0.4886731391585761,0.9473159706669155,1.0,3/12,12.85%,SREBF2;ABCA2;LPCAT3
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),-0.30920652215695754,-0.9912267232112073,0.4418604651162791,0.8351796206216482,1.0,12/28,20.57%,CLASP2;MAP2;MAP1B;STMN2;PRUNE1;GBA2;STMN3;CAMSAP2;MAP1A;FKBP4;STMN4;MAPRE1
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),0.45006498775823345,0.9908435571918964,0.4638364779874214,0.9490756413137794,1.0,3/13,8.80%,PIGU;DOT1L;IL7R
prerank,positive regulation of viral genome replication (GO:0045070),0.39649876991158606,0.9907057089364263,0.4738292011019284,0.9487472254114206,1.0,13/29,28.54%,CCL5;TARBP2;TMEM39A;SRPK2;SRPK1;DDB1;TOP2B;PABPC1;PPID;PDE12;PPIE;LARP1;DDX3X
prerank,calcium ion homeostasis (GO:0055074),0.336895249486351,0.9905686863510846,0.4745762711864407,0.9483872407024565,1.0,11/95,8.09%,ANK2;ATP6V1B1;STIM2;CCL5;CAV1;CSRP3;SELENON;ATP13A3;TMEM165;JPH2;ATP13A4
prerank,negative regulation of protein processing (GO:0010955),-0.3823768625453151,-0.9900826283091214,0.4466501240694789,0.83691630599048,1.0,3/12,6.54%,THBS1;SERPINE2;LRRK2
prerank,negative regulation of chondrocyte differentiation (GO:0032331),0.4489613395315385,0.9899477222618328,0.4750778816199377,0.9493124840129861,1.0,3/14,6.72%,ADAMTS7;SOX9;EFEMP1
prerank,cellular polysaccharide catabolic process (GO:0044247),0.4462476812541504,0.9898781774393287,0.4717557251908397,0.9487962336413132,1.0,4/16,11.00%,MGAM;PHKA2;PGM2;PHKB
prerank,microtubule bundle formation (GO:0001578),0.37241797338094523,0.9898040111196262,0.4518147684605757,0.9482967278801326,1.0,6/42,12.06%,RP1;CFAP206;PSRC1;CHP1;GAS2L1;MARK4
prerank,cytokine-mediated signaling pathway (GO:0019221),0.30549781998284103,0.9892221262869778,0.5295295295295295,0.9491590021557034,1.0,70/532,11.77%,FN1;TNFRSF11B;CD44;CRLF1;MAP3K8;MMP9;CCL5;IL17RE;EDA2R;VIM;EDA;CDKN1A;RORC;IL17RA;RAP1B;IL15;IL16;LAMA5;TNFSF13;PTK2B;FOXO3;TNFRSF8;FOS;CLCF1;TIMP1;EPO;ACKR3;IL3RA;TRIM25;ALOX5;NFKBIA;PSMD11;IRF3;BCL2L1;RNASEL;GPR75;SHC1;CSK;GSTO1;ANXA2;PSMD4;MSN;COMMD7;PSMF1;MTAP;TRIM21;STAT4;TAB3;ILK;RBX1;NDN;CDC42;PML;IL7R;LBP;TNFRSF1A;PYDC1;TRIM26;PTPN6;CCND1;TWIST1;PSMD7;SOD2;SMARCA4;IL1R2;SOCS2;JAK1;FCER1G;IRS2;YWHAZ
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.35604050878739046,-0.9892202489217551,0.4666666666666667,0.8377343790317954,1.0,2/17,0.77%,PDGFRB;ITGA1
prerank,glutamine family amino acid metabolic process (GO:0009064),0.3868441037238027,0.9891085927475461,0.45394736842105265,0.9487891444319234,1.0,12/33,26.32%,GLUL;DDAH2;GLUD1;PYCR3;PRODH;DGLUCY;KYAT1;ALDH18A1;SIRT4;PYCR2;DDAH1;ALDH5A1
prerank,heterocycle biosynthetic process (GO:0018130),0.44462953950117806,0.9886052243224256,0.46296296296296297,0.949395248970661,1.0,5/14,11.50%,MOCS3;ALOX5;NFS1;PYCR3;NOXRED1
prerank,positive regulation of keratinocyte differentiation (GO:0045618),0.47462266315130147,0.988554000499375,0.4890016920473773,0.9488344393166376,1.0,1/10,1.24%,NCOA3
prerank,regulation of Rac protein signal transduction (GO:0035020),-0.35542937296043625,-0.988437993537403,0.4772727272727273,0.83841735311142,1.0,8/16,21.33%,ARHGAP24;AUTS2;PIK3CB;ALS2;STMN3;RASGRF1;ARF6;GABARAP
prerank,DNA metabolic process (GO:0006259),0.31339304763938114,0.9883920254335952,0.49693251533742333,0.9485358701201055,1.0,74/270,22.46%,NT5E;FEN1;RECQL4;DOT1L;SMARCB1;NABP2;ASF1A;NSMCE4A;MRE11;PARP3;DCTPP1;CENPS;INIP;RAD54L;TCF7L2;POLK;RIF1;UBE2B;MUTYH;POLG;DNASE1L2;SRPK2;POLE4;USP3;CSNK1E;HUS1B;TOPBP1;ERCC5;CDK2;MBD4;PWWP3A;BTG2;RPA3;DNASE1L1;REXO4;POLH;ENDOV;POLD2;MCM8;PRIM2;PCNA;FAN1;UBE2N;LIG3;DDB1;MCM6;ATR;RPS27A;UBC;HINFP;NEIL1;NBN;MCM7;INTS3;TRRAP;PARG;RAD50;PARP2;PARK7;RFC1;PNKP;UVRAG;ERCC4;NABP1;ORC2;TERF2;TOP2B;MCM4;PTGES3;LONP1;DDX23;MEN1;SIRT7;IGHMBP2
prerank,positive regulation of cell projection organization (GO:0031346),0.3317899066867736,0.9882095021479771,0.49328859060402686,0.948290561088739,1.0,17/115,7.81%,NTRK3;FBXW8;PLXNB1;PTK7;PLXNA2;MAGI2;EP300;RAP1A;NGF;PTK2B;TIAM2;MAP6;PTPRD;TWF1;AVIL;DVL3;ARSB
prerank,cellular response to hormone stimulus (GO:0032870),0.3433296581830057,0.9879924940175925,0.49110320284697506,0.9481620298408262,1.0,6/69,4.95%,THRB;ADTRP;NCOA3;CAV1;ATP1A2;RAMP1
prerank,multivesicular body assembly (GO:0036258),0.3862511395913109,0.9878840596108955,0.46143250688705234,0.9477562123492975,1.0,12/30,20.10%,VPS37B;CHMP4A;CHMP4B;VPS4B;CHMP1A;VPS4A;CHMP2A;PDCD6IP;STAM;TSG101;VPS37A;IST1
prerank,protein modification by small protein conjugation or removal (GO:0070647),0.46546150817370613,0.9876044531195312,0.49429037520391517,0.9478275447686618,1.0,8/13,30.37%,DESI2;DESI1;SAE1;UBA6;UBA7;UBA3;UBA2;SENP6
prerank,hematopoietic stem cell differentiation (GO:0060218),0.48238853322434805,0.9873930152665081,0.49836065573770494,0.9476649955551104,1.0,3/10,14.09%,MLLT3;LMBR1L;SFRP1
prerank,synapse organization (GO:0050808),0.32609248580191796,0.9866105799048596,0.5104740904079382,0.9489995074066825,1.0,12/125,8.49%,CDH1;SDK1;GPC6;UNC13C;GPC4;CACNB3;PTPRD;MYOT;ANK3;PTPRF;FZD5;CDC42
prerank,organophosphate catabolic process (GO:0046434),-0.41035002843566715,-0.9861024018052027,0.4659400544959128,0.8433536955177648,1.0,2/11,12.70%,ENPP2;ABHD12
prerank,regulation of translation (GO:0006417),0.32150482533160635,0.9857522983829694,0.5125523012552301,0.9504985187536226,1.0,47/173,20.72%,VIM;SAMD4A;YTHDF1;SAMD4B;EPRS1;FOXO3;DAPK3;DAPK1;HSPB1;RPS4X;EIF2B2;EIF4A3;UPF3A;EIF6;EIF4B;SHMT1;LTN1;POLDIP3;EIF4G2;EIF2AK3;CPEB3;SYNCRIP;PLXNB2;FXR1;BTG2;UPF3B;EIF4G1;PYM1;GAPDH;PAIP1;DHX9;EIF5B;EIF3B;EEF2;EIF1;EIF2B4;EIF2AK4;CTIF;EIF4A2;IGF2BP3;YTHDF3;IGF2BP2;APP;ETF1;SOX4;IGF2BP1;ZCCHC4
prerank,long-chain fatty acid transport (GO:0015909),0.3887122994420817,0.9854615211402687,0.4888888888888889,0.9505244606266623,1.0,6/30,12.64%,PRKAA2;ABCD1;CPT1B;ACSL3;ACACA;CPT2
prerank,regulation of signal transduction (GO:0009966),0.3137101733716629,0.9852809302024087,0.5139607032057911,0.9502856077371216,1.0,31/190,12.94%,CD55;CLU;IGFBP6;PRAG1;OGT;SREBF2;GRK5;VEPH1;RSPO3;GDNF;PPP2CA;TIMP1;TSC2;FRMPD1;OVOL2;CSK;PXN;ERBB3;ILK;UBTF;FOXP3;ZIC1;LLGL2;USP20;SYNJ2BP;GRK2;SOCS2;PTPN2;CDKN2AIP;RGS6;GATA3
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.3916873910632539,0.9851314484537634,0.4844804318488529,0.949960828809254,1.0,11/29,23.02%,FEM1A;FBXO5;ARRDC3;DCUN1D5;FEM1B;DCUN1D1;UBE2N;ABL1;PARK7;FBXW7;TRIB3
prerank,regulation of T cell differentiation in thymus (GO:0033081),-0.3684353940369619,-0.9848323979103822,0.46438746438746437,0.8453797620930626,1.0,5/13,18.91%,GLI2;CAMK4;TOX;CLPTM1;SOD1
prerank,regulation of vesicle-mediated transport (GO:0060627),0.33399034809791833,0.9847298587772871,0.4818181818181818,0.9503060766840492,1.0,17/91,17.89%,RAB17;CDH13;TSC2;STON1;RAB3B;OPHN1;MAP2K2;ATP9A;SNX12;CPLANE2;RAB5C;RAB33B;ABL1;NSF;RAB8B;PACSIN1;STX4
prerank,vesicle organization (GO:0016050),0.3688023880357317,0.9846860003809212,0.4849246231155779,0.9497362333887247,1.0,13/46,13.88%,ANXA8;ANXA8L1;CAV1;CAV2;SRGN;HOOK1;SNX33;VPS11;PHETA2;EXOC8;VPS18;PLEKHJ1;PHETA1
prerank,cellular response to glucose starvation (GO:0042149),0.36720279784144116,0.9844730196320405,0.4740834386852086,0.949595483841665,1.0,5/41,3.80%,PRKAA2;ZC3H12A;PMAIP1;FOXO3;SESN2
prerank,triglyceride metabolic process (GO:0006641),0.3614429895589483,0.984061598139274,0.49875,0.9499567360468328,1.0,4/48,5.71%,CAV1;DGAT1;MOGAT3;MOGAT1
prerank,regulation of histone acetylation (GO:0035065),0.38875089716524247,0.9839794578897112,0.4851994851994852,0.9495022739818852,1.0,8/33,14.84%,PPARGC1A;HDAC5;FOXP3;KMT2A;BRD7;RAPGEF3;SET;FLCN
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),0.4269976394944161,0.9838089277588269,0.4782608695652174,0.9492582024977725,1.0,5/18,17.37%,COX19;COX16;COX20;COA8;SMIM20
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),0.40242310579273355,0.9838019967679699,0.4715909090909091,0.9485996034082698,1.0,3/23,5.09%,EFNB2;NIBAN2;LMOD3
prerank,protein localization to cilium (GO:0061512),-0.30835813985560256,-0.983431815098753,0.49615384615384617,0.8477840620644143,1.0,13/32,19.18%,IFT122;TTC21B;TULP3;RAB29;TCTN1;ZNF423;INVS;WDR19;BBS1;CSNK1D;TCTN2;NPHP4;BBS4
prerank,regulation of neuron migration (GO:2001222),0.40384654232566863,0.982577330495641,0.49707602339181284,0.9510591679563197,1.0,2/26,0.86%,PHACTR1;SRGAP2
prerank,response to histamine (GO:0034776),-0.41334578882994205,-0.982512399560422,0.48984771573604063,0.8489009392815061,1.0,6/10,22.04%,GABRB1;GABRG2;DRD2;GABRB2;HRH1;GABRB3
prerank,positive regulation of immunoglobulin production (GO:0002639),0.39143058296398237,0.9823428030391645,0.4738292011019284,0.9509873599140131,1.0,4/31,9.55%,SASH3;CLCF1;SHLD2;RIF1
prerank,cortical actin cytoskeleton organization (GO:0030866),0.4081342769397477,0.9822627058720196,0.49846625766871167,0.9505038109794193,1.0,4/20,9.59%,FMNL2;RHOQ;STRIP1;LLGL2
prerank,positive regulation of embryonic development (GO:0040019),0.422233582423035,0.9822289214687285,0.4813664596273292,0.949913254188595,1.0,3/19,4.23%,WNT1;NIBAN2;RBM19
prerank,maintenance of protein location in nucleus (GO:0051457),-0.33875503189145156,-0.9820447054588501,0.4793650793650794,0.8486964094804504,1.0,3/20,8.37%,SP100;SYNE1;TOPORS
prerank,positive regulation of signaling receptor activity (GO:2000273),-0.2803400197569501,-0.9820354201653088,0.44813278008298757,0.84732152483651,1.0,9/36,17.61%,TGFA;SHANK3;HIF1A;EPHB2;JAK2;NLGN3;EDN1;EGF;HDAC2
prerank,negative regulation of centrosome duplication (GO:0010826),-0.40111229082445893,-0.9818787126621601,0.4852216748768473,0.846353743602752,1.0,6/11,27.51%,TMEM67;RBM14;CCNF;KAT2B;BRCA1;NPM1
prerank,inflammatory response (GO:0006954),0.31495543875424836,0.981754351828253,0.5150571131879543,0.9504168940224887,1.0,20/195,11.33%,AGTR1;CD44;CCL5;ELF3;HDAC5;CXCR4;PTGFR;FOS;RELB;HDAC4;CCRL2;NFAM1;ABCF1;TNFRSF1A;TLR6;TAC4;HP;HPR;TLR4;CDO1
prerank,Notch signaling pathway (GO:0007219),0.3506639780841884,0.9814828230759389,0.48034398034398035,0.9504760906124887,1.0,5/59,2.90%,NOTCH2;PBX1;ADAM10;NLE1;EP300
prerank,negative regulation of gene expression (GO:0010629),0.3110197891617533,0.9811081124379712,0.5369059656218402,0.9507430258717774,1.0,57/302,14.84%,NOTCH2;ITGB8;PRKAA2;KLF4;SMO;ADAM10;OCLN;SAMD4A;ZC3H12A;TWSG1;SAMD4B;CELF1;EPRS1;DAPK3;DAPK1;WWP2;OLFM1;FLOT2;OVOL2;PHF1;MOV10;DDRGK1;EIF4A3;BMP4;RBMS3;TGFB2;SRGN;LGR4;FOXP3;SHMT1;MAP2K2;DNMT3A;SMCR8;PPP1R11;NCOR1;AEBP2;RPS26;SNX12;SFMBT2;EIF2AK3;ZNF148;CPEB3;SH3GL2;SYNCRIP;PPM1D;FXR1;BTG2;MEF2C;TLE5;ATP2B4;SFRP1;FOXP1;HRAS;GAPDH;NCOR2;SETDB1;FLCN
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",0.4419837784865286,0.9810459411264226,0.48738170347003157,0.9502215531061503,1.0,10/14,29.48%,NABP2;ATRX;PINX1;TNKS2;ATR;TERF2;TINF2;XRCC5;TERT;TERF2IP
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),-0.3400983822015342,-0.9807165739895112,0.4584615384615385,0.8481086394333573,1.0,11/18,34.74%,AQP4;SPEF2;RFX3;NPHP3;CFAP53;CCDC39;ROPN1L;SPA17;DNAAF2;ODAD4;NEK10
prerank,glucose import (GO:0046323),-0.38448566915342386,-0.9804970078741494,0.4807692307692308,0.8473650995784706,1.0,2/13,8.80%,SLC2A1;SORT1
prerank,regulation of cellular component biogenesis (GO:0044087),0.36558707080540326,0.9802308764633252,0.48825065274151436,0.9516296834297411,1.0,13/39,18.79%,TJP1;RAP1B;RAP1A;HCFC1;MSN;LATS1;EZR;VPS11;RAPGEF1;HSP90AA1;SPTY2D1;PTPN11;ROCK2
prerank,negative regulation of fat cell differentiation (GO:0045599),-0.29212555251774475,-0.9802151611984328,0.5082644628099173,0.8466707389817993,1.0,9/34,9.53%,RUNX1T1;ZFPM2;ENPP1;WNT5A;FOXO1;RORA;TGFB1;BBS12;GATA2
prerank,peptidyl-lysine acetylation (GO:0018394),0.47984742882252457,0.9801774838888945,0.49750415973377704,0.9510898571267352,1.0,1/10,2.90%,EP300
prerank,sodium-independent organic anion transport (GO:0043252),0.4758650328461609,0.9801012466959568,0.4768211920529801,0.9505997702007871,1.0,2/10,6.03%,SLCO2A1;SLC16A2
prerank,regulation of potassium ion transmembrane transport (GO:1901379),-0.26487277661971786,-0.9798648835464538,0.49473684210526314,0.8462535997800058,1.0,15/54,15.44%,DPP10;KCNN2;NOS1AP;KCNIP4;KCNIP3;KCNJ2;BIN1;KCNIP1;KCNJ12;DPP6;KCNJ6;KCNJ10;KCNMB4;KCNMA1;GNB1
prerank,mRNA destabilization (GO:0061157),0.3705027512651992,0.9796913752703821,0.4986737400530504,0.9509380022135582,1.0,9/38,18.79%,YTHDF1;ZC3H12A;CELF1;MOV10;CPEB3;TUT7;MEX3D;YTHDF3;ROCK2
prerank,regulation of cell size (GO:0008361),-0.3307970336431,-0.9794082254596396,0.4888888888888889,0.846113982167008,1.0,8/23,18.19%,VAV3;RDX;DEPTOR;PRR16;MTPN;EDN1;AKT1S1;VAV1
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),-0.23232105161431252,-0.9793420400454049,0.5294117647058824,0.8449185177151626,1.0,51/116,33.67%,ADCY5;CALCRL;LYN;GGT5;ADCY7;ADCY1;ADCY4;HTR7;ADORA2A;RAMP2;PRKAR2B;GPR45;CYSLTR1;PTHLH;GNB1;ADM;CYSLTR2;MC5R;ADCY2;PTGDR;PRKAR1B;PTGER4;GLP2R;RXFP1;MAPK14;VIPR2;ADCY3;ADCY8;IAPP;ADCYAP1R1;GPR27;HCK;NPSR1;CALCA;GNG2;HRH2;FGR;TSHR;FCGR2B;CD247;ADRB1;PLCG2;LHCGR;PLCG1;TREM2;PTH2R;GPR20;CD163;HTR6;GIPR;CRHR1
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),-0.2586247819232847,-0.9793328778608739,0.47593582887700536,0.8435644621626729,1.0,20/63,20.74%,IGF1;SH3RF1;SP100;WWOX;AR;FAS;THBS1;DEPTOR;TNFSF10;CFLAR;RIPK1;BID;ITGA6;ITGAV;PELI3;ZMYND11;TRADD;SIAH2;TNFSF12;TRAF1
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.3188941498451848,-0.9793221253857196,0.4755700325732899,0.8408365280671815,1.0,4/23,8.56%,ZEB2;DAB2;THBS1;ING2
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.3188941498451848,-0.9793221253857196,0.4755700325732899,0.8408365280671815,1.0,4/23,8.56%,ZEB2;DAB2;THBS1;ING2
prerank,receptor catabolic process (GO:0032801),-0.31442331438831095,-0.9792342535322976,0.47266881028938906,0.8396805209593193,1.0,7/24,8.81%,SNX25;ZNRF3;CLTA;MYLIP;TGFB1;AP2B1;SH3GLB1
prerank,axoneme assembly (GO:0035082),0.39334860401182875,0.9790817181372201,0.4822404371584699,0.9518405702770212,1.0,2/30,8.14%,RP1;CFAP206
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.3389639747582386,0.9790308846965071,0.5084541062801933,0.9512964663319778,1.0,10/65,12.26%,CD109;VEPH1;SMAD6;CAV1;SPRED3;TGFB1I1;PPM1A;LDLRAD4;TGFBR2;DAND5
prerank,regulation of DNA biosynthetic process (GO:2000278),-0.31350378126466705,-0.9789730872598525,0.48028673835125446,0.8389862371341161,1.0,9/27,14.37%,PDGFRB;DACH1;ACVRL1;FGF2;RGCC;TNKS;TOM1L1;FGFR4;BMPR2
prerank,organelle organization (GO:0006996),0.30715350829063726,0.9789303345812279,0.5424242424242425,0.9508684873684455,1.0,94/388,20.19%,CXADR;SPTSSB;PPARGC1A;FMNL2;FBXW8;ANK1;MICAL2;YTHDF1;GABPB1;CAV1;ABCD1;DIAPH1;TJAP1;ZMYM6;NCKIPSD;TMED1;AGTPBP1;CAPZB;CAV2;DMTN;HCFC1;HAX1;NRF1;SYNE3;MAPK15;ATP8B2;NSFL1C;GOLPH3;ARHGAP21;ARHGAP10;MICAL1;STRIP1;CHMP4A;CHMP4B;CDC42;RAB7A;CENPT;PCLO;MIEF2;TOR1A;AFG1L;BCAS3;NIPSNAP2;ZW10;VPS11;VPS4B;MARK4;AJUBA;EIF2AK3;ZMYM4;OPA1;GOLGB1;CHMP1A;RHOU;MYC;ARFGEF1;NPLOC4;VPS18;VPS4A;DNM1L;ATL2;VPS13D;USP6NL;CHMP2A;PEX6;ATP5F1B;PAK6;MTX1;CAMSAP1;PI4K2A;CFAP61;PACSIN1;CLUH;NUMA1;PDCD6IP;MTFR2;STX4;SEC23IP;PEX3;ODF2;WTIP;PARK7;TMED5;RNF112;PEX2;YTHDF3;SEC31B;RHOT2;MYO18A;SMPD4;STOML2;HSD17B10;MNS1;HILPDA
prerank,negative regulation of viral entry into host cell (GO:0046597),0.45820491858320106,0.9782605197700763,0.4975609756097561,0.9518398958714357,1.0,3/12,9.40%,GSN;TRIM26;TRIM11
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.3293850560577418,0.9782232066739543,0.5238636363636363,0.9512587926006549,1.0,11/95,8.04%,CD109;VEPH1;SMAD6;TRIM33;CAV1;EP300;LTBP4;SPRED3;LATS1;TGFB1I1;PPM1A
prerank,positive regulation of multicellular organismal process (GO:0051240),0.30774331068840144,0.9777721918866756,0.5528455284552846,0.9517645945133503,1.0,45/308,13.17%,ADRA1B;PPARGC1A;NCOA3;SMO;OGT;PDGFC;SCAMP5;NIBAN2;IL15;CAV1;TRPM8;CXCR4;CRB2;GDNF;RBM19;GCNT2;ZBTB16;OLFM1;SHLD2;ESRRB;SOX9;FOXD1;ZBTB7B;BMP4;TGFB2;BAD;ACADL;NFAM1;TGFB1I1;ELOVL6;SIX1;FBXO5;LBP;TXK;RIF1;TWIST1;KDM3A;HDAC3;TRPM4;TGFBR2;PTN;CPT2;PDPN;RREB1;MAP3K13
prerank,midbody abscission (GO:0061952),0.4146525020105057,0.9777604513305599,0.48444444444444446,0.9511166259299166,1.0,10/17,26.59%,CHMP4A;CHMP4B;VPS4B;CHMP1A;VPS4A;CHMP2A;PDCD6IP;MITD1;CHMP5;CHMP1B
prerank,melanosome organization (GO:0032438),0.3909325816441811,0.977719967932812,0.48756906077348067,0.950532335872215,1.0,6/26,14.31%,KIF13A;BLOC1S6;AP3B1;BLOC1S2;AP1M1;PMEL
prerank,positive regulation of growth (GO:0045927),-0.25516601084358714,-0.9773802075659583,0.5095541401273885,0.8417990684154653,1.0,14/64,13.67%,PLCB1;INSR;LGI1;RFTN1;BCL2;SLC25A33;BRAT1;CXCL16;FXN;EXOSC2;HYAL1;KLHL22;MTPN;MFSD2A
prerank,organic cation transport (GO:0015695),-0.332848596528319,-0.9772113299774636,0.48231511254019294,0.8409065582524919,1.0,10/20,36.92%,SLC47A1;SLC44A2;SLC44A1;SLC5A7;SLC22A2;SLC25A26;SLC22A3;SLC22A5;SLC29A4;PDZK1
prerank,regulation of establishment of planar polarity (GO:0090175),0.32647834732004033,0.9763273704100641,0.4988532110091743,0.953324910977696,1.0,14/88,12.90%,CELSR1;WNT1;WNT11;AP2A2;PSMD11;PSMD4;PSMF1;DVL3;FZD5;CDC42;PSMD7;AP2A1;RHOA;PSMB5
prerank,regulation of immunoglobulin production (GO:0002637),0.4070804213483388,0.9759497327514896,0.4921090387374462,0.9536130469836237,1.0,2/23,4.18%,SASH3;CLCF1
prerank,icosanoid metabolic process (GO:0006690),-0.27686754577567946,-0.9758143345775755,0.48623853211009177,0.8432071849483902,1.0,7/40,6.77%,PLA2G4A;PTGIS;GGT5;CYP1B1;MGLL;PTGS2;PNPLA8
prerank,protein peptidyl-prolyl isomerization (GO:0000413),0.41577422296108,0.9754293666097389,0.49707602339181284,0.9542554222524563,1.0,3/20,10.83%,FKBP5;NKTR;PPIC
prerank,mesoderm development (GO:0007498),-0.34529964722122997,-0.9752360883035899,0.46296296296296297,0.8433660735796135,1.0,6/18,13.64%,TBX3;TIE1;BMX;JAK2;TBX1;MEST
prerank,nuclear pore complex assembly (GO:0051292),0.47533453217747096,0.9749528821351143,0.49506578947368424,0.9547949296788895,1.0,2/10,8.97%,NUP93;NDC1
prerank,metal ion export (GO:0070839),-0.2975958380301268,-0.9747924958582392,0.4881889763779528,0.8432401153061346,1.0,4/31,5.94%,KCNT2;KCNK5;ATP1B1;SLC40A1
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),0.462870377433621,0.9747403947126593,0.5132013201320133,0.9546766778210103,1.0,1/11,1.18%,LDLR
prerank,negative regulation of interleukin-10 production (GO:0032693),0.4398653168527873,0.974479681359633,0.5075757575757576,0.9546196821290104,1.0,2/16,8.98%,TRIB2;FOXP3
prerank,ncRNA transcription (GO:0098781),0.4456452538488375,0.9744340637443586,0.48936170212765956,0.9540779070202131,1.0,5/13,22.27%,ANG;SPIN1;SNAPC3;SIRT7;POLR1G
prerank,cellular glucose homeostasis (GO:0001678),-0.2893171990485533,-0.9743511343641371,0.5112107623318386,0.8430639860677656,1.0,12/41,12.35%,PIK3R1;UNC13B;ZBTB20;HIF1A;GAS6;FOXO1;FOXK2;PRKAA1;HK2;LRRC8A;IGF1R;RACK1
prerank,B cell activation (GO:0042113),0.345042310691796,0.9743137521475176,0.5102286401925391,0.9537079848716977,1.0,11/68,16.19%,PRKCB;HDAC5;HDAC4;CLCF1;NFAM1;CR2;RABL3;PTPN2;MEF2C;KLF6;TPD52
prerank,myeloid leukocyte differentiation (GO:0002573),0.3417446282731076,0.9741899037044829,0.49144254278728605,0.9533490944507335,1.0,17/65,18.82%,MMP9;CDKN1A;IL15;EP300;CDK4;BMP4;CDC42;PML;TGFBR2;SBNO2;CDK2;FOXP1;E2F1;PDE1B;PRTN3;RARA;BATF2
prerank,prostaglandin biosynthetic process (GO:0001516),-0.3437023044573893,-0.97358579224082,0.49096385542168675,0.8437761533094322,1.0,8/18,19.88%,PLA2G4A;PTGIS;PTGS2;PNPLA8;PTGES;EDN1;CD74;MIF
prerank,nuclear membrane reassembly (GO:0031468),0.35291612082524465,0.9735718451316012,0.4975429975429975,0.9542454609345786,1.0,12/54,15.81%,CC2D1B;PPP2CA;REEP3;NUP93;NSFL1C;CHMP4A;CHMP4B;NDC1;VPS4A;LMNA;CHMP2A;REEP4
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.44674095566407696,0.9734759123547035,0.48746081504702193,0.9537873395224703,1.0,1/13,0.51%,FGFR1
prerank,protein localization to mitochondrion (GO:0070585),-0.3867918952679293,-0.9734706712563295,0.4776902887139108,0.8427036636176038,1.0,3/11,7.96%,LRRK2;HK2;DNAJA1
prerank,protein complex oligomerization (GO:0051259),-0.23776402349068732,-0.9729712237033925,0.5041322314049587,0.842738689225011,1.0,26/85,18.12%,LRRC8C;PKD2;EHD4;IKZF4;OXA1L;EHD3;MAT2A;UPB1;GSDMD;NUDT21;AQP11;JMJD6;TRMT61B;LRRC8A;WDCP;ALS2;CPSF6;G3BP2;CLDN1;GLRA3;KCNC1;MPP2;TIFA;BLM;ATL1;BOK
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),0.4583871990861467,0.9725798029948016,0.5041186161449753,0.9553114272776565,1.0,1/11,1.03%,WNT1
prerank,positive regulation of myoblast differentiation (GO:0045663),-0.3611937684803167,-0.9725066295064393,0.5013927576601671,0.8425758338210766,1.0,4/16,10.59%,PLCB1;BOC;BTG1;LRRC8A
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),-0.3351410137651893,-0.9724977195301262,0.4940119760479042,0.8412611452257326,1.0,4/20,6.35%,SLC8A1;ATP1B1;SLC12A2;KCNJ2
prerank,telomere maintenance (GO:0000723),0.353698874283891,0.9723864438078823,0.4794520547945205,0.9551117270261718,1.0,25/50,28.17%,RECQL4;MRE11;PARP3;RIF1;HUS1B;NSMCE2;RPA3;POLD2;PCNA;ATR;SMC6;NBN;RAD50;ERCC4;TERF2;PTGES3;TINF2;APEX1;ZBTB48;RPA2;PARP1;POLD1;XRCC5;TERT;TERF1
prerank,regulation of calcium-mediated signaling (GO:0050848),0.3966977842169589,0.9722032113295045,0.5029411764705882,0.9548794904771183,1.0,1/25,0.37%,CDH13
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.34123084108301877,0.971391806533119,0.501779359430605,0.9562733123952026,1.0,7/72,7.99%,FGFR1;FLRT1;GTF2F1;RBFOX2;POLR2H;POLR2A;FGF22
prerank,alpha-amino acid metabolic process (GO:1901605),0.3639042590397035,0.9713758720624345,0.4835443037974684,0.9556473379982109,1.0,15/45,24.63%,GLUL;NAALAD2;DDAH2;GLUD1;PYCR3;THAP4;SLC25A12;ASS1;KYAT1;ALDH18A1;PYCR2;GPT2;KMO;DDAH1;KYAT3
prerank,macrophage activation (GO:0042116),0.37879026496395846,0.9712898640593406,0.49657064471879286,0.9552054891704188,1.0,10/34,20.34%,CLU;LBP;NMI;TLR4;SBNO2;FOXP1;ITGB2;APP;MAPT;AGER
prerank,secondary alcohol metabolic process (GO:1902652),0.36302786193379666,0.9711658512075473,0.5167525773195877,0.9548297088819381,1.0,9/42,16.03%,SOAT1;STARD3;SULT2B1;IDH3G;FDX1;SOAT2;SQLE;OSBPL5;IDH3A
prerank,RNA destabilization (GO:0050779),0.419092040943842,0.9708624657138439,0.5052473763118441,0.9549094986998637,1.0,7/18,23.13%,YTHDF1;CELF1;MEX3D;YTHDF3;ROCK2;DXO;FTO
prerank,mesenchymal cell development (GO:0014031),-0.34753882932736163,-0.9708217495383697,0.5015105740181269,0.8443975883930126,1.0,9/18,25.44%,CDH2;NOTCH1;HEYL;PDCD6;SOX11;NOLC1;HEY2;KBTBD8;KLHL12
prerank,gluconeogenesis (GO:0006094),0.366736963467869,0.9706825367367163,0.49866310160427807,0.9546943698798346,1.0,9/39,18.22%,PPARGC1A;SLC25A1;ENO2;MDH2;ALDOA;GAPDH;SLC25A12;TPI1;PCK2
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),0.4196675578848109,0.9706445713573566,0.5121951219512195,0.9541071215601552,1.0,6/18,14.36%,RAP1B;RAP1A;SYN1;RIMS4;VPS18;GSK3B
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.3432895486246781,0.9703768321990506,0.5095465393794749,0.9540810165536866,1.0,23/64,24.82%,MLLT3;GTF2F1;POLR2H;ELOB;POLR2A;SSRP1;ELP4;POLR1E;ELL;TCEA2;ELP2;ERCC2;NELFB;POLR2C;POLR2E;NELFA;ELOF1;AFF4;CTR9;CDK9;LEO1;MNAT1;POLR2K
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),-0.32866744728483827,-0.970191405628574,0.4942528735632184,0.8447023504248717,1.0,3/21,6.26%,EPHA7;AIM2;GRIN2B
prerank,nucleosome disassembly (GO:0006337),0.43849906501590885,0.9701865746299181,0.48796147672552165,0.9532246179780706,1.0,6/14,16.27%,GRWD1;SMARCB1;SMARCA4;SMARCD2;SET;SMARCC1
prerank,chromatin disassembly (GO:0031498),0.43849906501590885,0.9701865746299181,0.48796147672552165,0.9532246179780706,1.0,6/14,16.27%,GRWD1;SMARCB1;SMARCA4;SMARCD2;SET;SMARCC1
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),-0.2963462137830102,-0.9701220498449987,0.4693140794223827,0.8435419588164836,1.0,6/33,7.53%,PLCB1;RDX;UBE2E2;RGCC;GLI1;EZH2
prerank,regulation of leukocyte chemotaxis (GO:0002688),-0.341392446709727,-0.9700669370059412,0.4613003095975232,0.8423611219562728,1.0,6/18,16.50%,LYN;SLIT2;IL6R;MTUS1;CAMK1D;EDN3
prerank,histone H3-K36 demethylation (GO:0070544),0.4703059369859285,0.970021980408919,0.5160202360876898,0.9529892408052043,1.0,3/10,10.86%,KDM4B;RIOX2;KDM4C
prerank,glycoprotein metabolic process (GO:0009100),-0.26594609231589594,-0.9698889334827262,0.46111111111111114,0.841492310268243,1.0,15/53,18.35%,ST6GALNAC3;MAN1C1;ADAMTS9;HIF1A;ST8SIA4;MGAT4A;ST8SIA6;MAN2A1;MAN2B1;B4GALT5;GCNT1;ST8SIA5;B4GALT7;ST8SIA2;PCSK6
prerank,sensory perception of mechanical stimulus (GO:0050954),0.33795155263130056,0.9698517961157741,0.5159817351598174,0.9527348044102603,1.0,10/85,6.90%,ATP6V1B1;USP53;COL4A3;EPS8L2;TIMM10;HOMER2;TPRN;RIPOR2;EML2;EYA1
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),-0.3555740551008789,-0.9697334079344812,0.5057142857142857,0.8405524995747637,1.0,14/16,51.52%,CYRIB;STX7;CEACAM1;LILRB1;FADD;IL12A;IL12RB1;IL23A;KLRD1;IL23R;IL12B;RIPK3;XCL1;KLRC1
prerank,negative regulation of leukocyte activation (GO:0002695),0.4324948142726909,0.9696995735097519,0.5166163141993958,0.9524350559022738,1.0,2/15,2.55%,CD200;ZC3H12A
prerank,"DNA-templated transcription, termination (GO:0006353)",0.34020326500319836,0.9695153377259201,0.4803804994054697,0.952211090322379,1.0,18/68,19.85%,LSM10;POLR2H;SNRPB;TAF1C;POLR2A;MAZ;UBTF;WDR33;POLR1C;POLR1E;POLR1F;CSTF1;PABPN1;CLP1;ERCC2;POLR2E;CSTF3;TBP
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),-0.32066694932575474,-0.9694894764969936,0.4967741935483871,0.8399053627760252,1.0,5/22,6.31%,LYN;MFHAS1;DAB2IP;APPL2;NR1H3
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),-0.3476304453288172,-0.9693459490617695,0.48717948717948717,0.8389230687670265,1.0,2/17,6.00%,PLA2G4A;PLAAT3
prerank,gonad development (GO:0008406),-0.2766349482515245,-0.969174704840188,0.48717948717948717,0.8380348112188181,1.0,8/41,10.69%,NR2F2;KITLG;WNT4;AR;WNT5A;SALL1;KIT;BASP1
prerank,cellular response to thyroid hormone stimulus (GO:0097067),0.45672835200074413,0.9684542356580632,0.5072697899838449,0.9541252383819997,1.0,1/12,0.55%,THRB
prerank,regulation of focal adhesion assembly (GO:0051893),0.3499792331998666,0.9680353404309002,0.4896719319562576,0.9544617631822419,1.0,19/54,18.79%,PHLDB2;S100A10;DAPK3;EFNA5;DMTN;PTPRA;BCAS3;ACTG1;DLC1;EPHA3;RHOA;SFRP1;ITGB1BP1;VCL;ABL1;SLC9A1;DUSP3;PEAK1;ROCK2
prerank,regulation of neuron projection arborization (GO:0150011),-0.3523628069210751,-0.9675328608637291,0.45879120879120877,0.8410587243259344,1.0,6/15,13.67%,WNT5A;MYO9A;FZD4;NTNG1;MACF1;MFSD2A
prerank,tRNA processing (GO:0008033),0.34026718923845767,0.9675311040040955,0.5129151291512916,0.9550793376476249,1.0,23/61,24.33%,FARS2;LCMT2;TRPT1;ELP5;TRIT1;POP1;THG1L;AARS1;ANKRD16;RPP21;SARS1;TRNT1;CTU1;CLP1;TSEN2;TRMT10B;CTU2;TYW5;RPP40;NSUN6;FAM98B;URM1;KARS1
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),0.3995636393725974,0.9673065062916283,0.4985549132947977,0.9549513809757028,1.0,8/25,16.09%,PFKP;PKM;ENO2;HK1;FOXK1;ALDOA;GAPDH;TPI1
prerank,neural crest cell development (GO:0014032),0.36062495123597926,0.9672216115829477,0.5165816326530612,0.9545011329578919,1.0,4/44,3.81%,SEMA3D;SEMA3B;PEF1;GDNF
prerank,regulation of protein ubiquitination (GO:0031396),0.32708853545894606,0.9670299093004002,0.5161649944258639,0.9543489658240568,1.0,27/108,22.27%,ANGPT1;DAXX;NXN;OGT;CAV1;PRR7;SH3RF2;CENPS;CHP1;HDAC3;HSPBP1;DCUN1D1;GSK3A;PINX1;WASHC1;HSP90AA1;UBE2N;XIAP;STUB1;PARK7;CDK5RAP3;PHF23;SOX4;FBXW7;SPOPL;RCHY1;SIRT7
prerank,regulation of store-operated calcium entry (GO:2001256),0.463495242457137,0.9670164404037752,0.5145797598627787,0.9537174161562717,1.0,2/10,3.42%,HOMER2;HOMER3
prerank,peptidyl-methionine modification (GO:0018206),0.45673628895001295,0.9668714215901433,0.4919093851132686,0.9534188537650392,1.0,3/12,13.24%,PDF;NAA15;NAA20
prerank,regulation of viral genome replication (GO:0045069),0.3519070751437357,0.9665790225560249,0.5252774352651048,0.9534745764729662,1.0,11/56,16.37%,CCL5;MAVS;SLPI;TARBP2;RNASEL;TMEM39A;SRPK2;SRPK1;TNIP1;OAS2;DDB1
prerank,mRNA metabolic process (GO:0016071),0.3268284145203246,0.9660034097646766,0.5245901639344263,0.9542436582197374,1.0,23/90,21.55%,PPARGC1A;LSM10;DDX5;SRSF2;CELF1;SON;SNRPB;USP39;SRRM4;TBRG4;SRSF7;SF3A2;SRSF9;RNASE4;SRSF1;PTBP1;SRSF5;PCBP2;DXO;CSTF3;SF3A3;PRPF8;SFPQ
prerank,eye morphogenesis (GO:0048592),-0.3358493104306205,-0.9655377192399855,0.5111821086261981,0.8450768065790939,1.0,8/19,13.56%,FBN1;MFAP5;COL5A1;IFT122;FBN2;NF1;STAT3;NIPBL
prerank,skeletal system development (GO:0001501),0.3145485980666951,0.9651628953644826,0.5333333333333333,0.9556669827397449,1.0,16/148,8.25%,TNFRSF11B;KIAA1217;FGFR1;CD44;ITGB8;WNT1;ANKH;AKAP13;WNT11;BMP5;ZBTB16;SOX9;PRELP;DDRGK1;TGFB2;PKD1
prerank,histone H3 deacetylation (GO:0070932),0.42982509921239054,0.9649422637093058,0.5031948881789138,0.9555379553446067,1.0,7/15,25.08%,HDAC4;HDAC3;SFPQ;SIRT7;PER1;PER2;HDAC8
prerank,Notch signaling involved in heart development (GO:0061314),0.45474227314583515,0.9648563375082729,0.49596122778675283,0.9550925264333888,1.0,1/11,0.72%,NOTCH2
prerank,neuron migration (GO:0001764),0.3625672540285592,0.9648014843391921,0.5051282051282051,0.9545655392859709,1.0,3/48,0.88%,FGF13;FGFR1;CELSR1
prerank,peroxisomal membrane transport (GO:0015919),0.39044312327326786,0.9645857800091032,0.5225988700564972,0.9544265876444925,1.0,8/27,18.72%,PEX26;ABCD1;SLC25A17;PXMP4;PEX6;RAB8B;PEX3;PEX2
prerank,protein neddylation (GO:0045116),0.44282515716870946,0.964527579629915,0.4984375,0.9539117245470435,1.0,8/13,29.64%,RBX1;DCUN1D5;DCUN1D1;UBE2F;RNF7;UBE2M;UBA3;NEDD8
prerank,receptor clustering (GO:0043113),0.38660033366808033,0.9643787995905093,0.4963924963924964,0.9536278590933513,1.0,8/27,15.66%,MAGI2;ITGB7;SYNJ2BP;MUSK;PTN;ITGB1BP1;ITGB2;FLNA
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),-0.2531954435627914,-0.9640659714940444,0.4973821989528796,0.8477229170597161,1.0,17/65,14.78%,ERRFI1;HIP1;PTPRJ;TGFA;ITGA1;AFAP1L2;MVB12B;DAB2IP;SH3KBP1;ZFYVE28;PTPN12;PTPN3;GRB2;CNOT9;BCAR3;EPS15;MVB12A
prerank,regulation of protein sumoylation (GO:0033233),0.42412491388564494,0.9638663242815829,0.507396449704142,0.954240326804326,1.0,5/17,12.88%,HDAC4;MUL1;SAE1;PIAS1;PIAS3
prerank,regulation of JNK cascade (GO:0046328),0.3274764282148124,0.9635815977180293,0.5313568985176739,0.9542807725403548,1.0,7/101,4.38%,WNT16;MAP3K5;EDA2R;CCN2;PTK2B;DUSP10;SH3RF2
prerank,cellular response to fatty acid (GO:0071398),-0.3901452060208595,-0.9633454549453849,0.4676056338028169,0.8482297152487027,1.0,1/12,0.08%,PID1
prerank,regulation of phospholipase C activity (GO:1900274),0.43492477504011506,0.9633209345324968,0.5033557046979866,0.9542897932412397,1.0,2/15,0.84%,FGFR1;NTRK3
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),0.3293435526869266,0.962974609159783,0.5137299771167048,0.9544937046905384,1.0,34/87,28.57%,COX19;NDUFV1;NDUFB11;COX16;NDUFB8;NDUFB6;NDUFS3;NDUFAB1;COX20;COA8;NDUFB7;NDUFV2;NDUFA1;NDUFB4;NDUFAF4;SMIM20;NDUFB5;SDHAF3;NDUFB9;DMAC2;NDUFA2;NDUFA12;TMEM126A;NDUFAF5;NDUFB10;UQCRFS1;SURF1;TIMMDC1;NDUFA13;COX14;NDUFAF7;NDUFB3;NDUFS4;LYRM7
prerank,embryonic digit morphogenesis (GO:0042733),-0.3308047605314858,-0.962659387278998,0.5073746312684366,0.8486573590888171,1.0,7/18,17.61%,ECE1;TBX3;SALL1;TBX2;INTU;WDPCP;HDAC2
prerank,regulation of cell cycle process (GO:0010564),0.3282217682317529,0.9625584628957852,0.5263157894736842,0.9548907444025029,1.0,28/104,20.47%,KIF13A;DAPK3;RAB11FIP3;CAV2;BCL2L1;SOX9;KLHL21;PLK3;CDC42;AURKC;FBXO5;USP19;PKMYT1;KLHL13;MARK4;SFRP1;FLCN;PLK2;MAD1L1;CUL9;DYNC1H1;GIT1;NUMA1;ZFYVE26;KIF20B;GPER1;UVRAG;PIK3R4
prerank,Golgi to plasma membrane protein transport (GO:0043001),0.3863105400207875,0.9621602736078818,0.5020463847203275,0.9551837975249045,1.0,14/30,24.01%,AMN;KIF13A;ANK3;GOLPH3;GCC2;GOLGA7;GGA1;NSF;ARFRP1;RAB10;VAMP2;SEC16A;RAB31;GOLPH3L
prerank,glucose homeostasis (GO:0042593),0.3286321456238314,0.9621107393105663,0.5230224321133412,0.954654911863531,1.0,15/83,12.61%,PRKAA2;PPARGC1A;MCU;ALOX5;HKDC1;HECTD4;KLF7;BAD;TCF7L2;CRY2;HK1;KCNB1;PDK2;PTPN2;FOXK1
prerank,negative regulation of smoothened signaling pathway (GO:0045879),-0.31593590574681085,-0.9620178725444986,0.5202492211838006,0.8489667020086967,1.0,11/23,19.13%,ENPP1;MOSMO;IFT122;TULP3;MEGF8;RACK1;KCTD21;BTRC;KIF7;ULK3;PTCH2
prerank,mitochondrial translation (GO:0032543),0.32091890235972154,0.9616892277383062,0.5283018867924528,0.9550795711035651,1.0,39/104,27.05%,MRPS16;MRPL38;MRPL24;MRPL37;MRPL2;HARS1;MRPL49;MRPL33;MRPS7;MRPS34;LARS2;MRPS23;MRPS33;MRPS27;MRPL9;MRPL57;MRPS15;MRPL50;MRPS18C;MRPS28;MRPS35;GATB;GADD45GIP1;MTRF1L;MRPL19;MRPL14;MRPL32;AURKAIP1;MRPL39;MRPS25;MRPS30;MRPL54;MRPS21;MRPS22;MRPS12;MRPL35;GFM2;PTCD3;MRPL44
prerank,peptidyl-proline modification (GO:0018208),0.3953395002291764,0.9612920229976292,0.5063649222065064,0.9554038148695273,1.0,4/25,10.83%,FKBP5;NTMT1;NKTR;PPIC
prerank,cellular response to ATP (GO:0071318),-0.35462115041895836,-0.9612589418517689,0.5094850948509485,0.8496522724955407,1.0,5/14,27.99%,SSH1;P2RY1;P2RY12;CIB2;TAF1
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.37105941522674857,0.9610702567634206,0.5122897800776197,0.9553271898390905,1.0,4/37,8.79%,OGT;FHIT;DDRGK1;PML
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),0.38972010601249024,0.9607833410913574,0.5146036161335188,0.9553924184586954,1.0,1/25,0.66%,ANK2
prerank,development of primary male sexual characteristics (GO:0046546),-0.28607602027892587,-0.9606586232439734,0.48739495798319327,0.8498314741426276,1.0,5/34,2.84%,KITLG;WNT4;AR;WNT5A;LHFPL2
prerank,positive regulation of protein-containing complex assembly (GO:0031334),-0.2297303597346882,-0.9600876630378237,0.5339805825242718,0.8499723607778054,1.0,31/113,17.68%,ABCA1;UNC13B;ASAP1;SLF1;ESR1;CUL4B;DAB2IP;PSMC6;GBP5;FNIP1;TFRC;TGFB1;SH3GLB1;TP53;TIRAP;TPPP;BCL2L11;BID;RACK1;RASIP1;BMF;SLF2;FNIP2;CDC42EP2;BAX;TTBK1;ERCC3;GNL3L;SKAP1;GTF2H3;SPIDR
prerank,polyol metabolic process (GO:0019751),0.36159676260989426,0.9599707894826263,0.5306122448979592,0.9567683519930541,1.0,11/46,15.85%,NUDT4;PLCB3;PLCD3;IP6K1;INPP4A;PPIP5K2;INPP5B;OCRL;PLCD4;PLCD1;IP6K2
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),0.4123144497690362,0.9594515600483684,0.5105740181268882,0.9573865425824755,1.0,2/18,1.46%,FGFR1;COL4A3
prerank,regulation of protein-containing complex assembly (GO:0043254),0.3111906327389602,0.9594316029327612,0.5297356828193832,0.9567842252141716,1.0,27/110,18.46%,CLU;GSN;EP300;PIH1D1;CRYAB;HCFC1;MAPK15;LATS1;STXBP1;LGALS3;CDC42;MTLN;RAF1;AJUBA;HRK;NAPA;NAPB;PREB;TRABD2B;ULK1;GSK3B;HSP90AA1;PRKCZ;HDAC6;CDH5;PTPN11;PARK7
prerank,glycerophospholipid biosynthetic process (GO:0046474),-0.21623694444316838,-0.9593549087114176,0.6382978723404256,0.8506720412019002,1.0,54/172,21.50%,PLA2G4A;PIK3R1;INPP4B;ETNK1;PIP5K1B;DGKH;GPD1L;INPP5D;DGKB;PIP4K2A;SYNJ2;FGF2;PLD1;ARF3;ABHD3;PTDSS1;MTMR14;MTM1;PLEKHA8;BMX;PLEKHA2;PIK3CB;PLEKHA4;PIK3R6;CDS2;PIK3CD;SLC44A2;PLSCR1;PCYT1A;LPIN2;MTMR7;MTMR2;DGKG;PIK3R3;MFSD2A;SLC44A1;PI4K2B;PIK3C3;CLN3;PIK3R5;RUFY1;AGPAT3;STARD10;PCTP;FIG4;PIK3R2;INPPL1;PNPLA3;AGPAT2;PLA2G4C;PIP4K2B;PIP5K1A;DGKZ;DGKQ
prerank,ribosomal small subunit assembly (GO:0000028),0.425086963545472,0.9592432904172191,0.5181674565560821,0.9566149340901643,1.0,8/16,30.81%,MRPS7;RPSA;PWP2;RPS28;RPS27;XRCC5;RPS15;ERAL1
prerank,regulation of receptor binding (GO:1900120),0.45740878290299264,0.9592342668015732,0.5204081632653061,0.9559875993070229,1.0,3/10,10.44%,MMP9;PTPRF;ADAM15
prerank,mitotic chromosome condensation (GO:0007076),0.3858733350549365,0.9592123196331147,0.49722222222222223,0.9553921880832114,1.0,10/26,23.01%,TENT4A;NCAPD3;CHMP1A;SET;NCAPH2;RB1;PHF13;NCAPH;SMC4;KMT5A
prerank,negative regulation of cell communication (GO:0010648),-0.32240554786033987,-0.958888990550602,0.5047318611987381,0.8505869058368016,1.0,4/21,12.47%,UBASH3B;GLRA1;SOCS5;KIF26A
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.2992003922397937,0.958642148842117,0.6008146639511202,0.9560827897823015,1.0,60/314,17.60%,FZR1;FBXL7;FBXL20;SPSB4;NFE2L2;WWP2;RNF5;TRIM25;ERLIN2;PSMD11;NSFL1C;PSMD4;PSMF1;FEM1C;FEM1A;KLHL15;UBE2G2;RMND5B;FBXL18;RBX1;FBXO5;FBXO31;ERLIN1;USP19;PML;RNF121;UBE2B;LTN1;PCNP;SIAH3;COP1;PSMD7;AGAP3;FEM1B;RNF126;ZSWIM8;PSMB5;ANAPC4;CDK2;PELI1;GSK3A;NPLOC4;RHBDD2;UBE4A;DNAJC10;NEDD4;MDM2;BFAR;MAEA;FBXL15;DDB1;ARMC8;RPS27A;UBC;UBE2D3;SIAH1;STUB1;UBE2J1;FBXL2;PSMD1
prerank,endosome organization (GO:0007032),0.360796524649439,0.9584794658063137,0.5282051282051282,0.955827417706384,1.0,14/41,19.22%,ANXA8;ANXA8L1;HOOK1;SNX33;VPS11;PHETA2;EXOC8;VPS18;PLEKHJ1;PHETA1;PI4K2A;WASHC4;HOOK3;RAB27A
prerank,positive regulation of ATP metabolic process (GO:1903580),0.37403805981541327,0.9584347170883102,0.5353805073431241,0.9552966902735921,1.0,5/32,6.60%,PRKAA2;PPARGC1A;NUPR1;BEND3;PFKFB2
prerank,ear morphogenesis (GO:0042471),0.41014170885509293,0.9582162732741947,0.5217391304347826,0.9552031944840952,1.0,4/20,10.33%,ATP6V1B1;SIX1;ZIC1;TWIST1
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.4310377136936605,0.9580695711824974,0.5070422535211268,0.9549038339544343,1.0,2/15,4.59%,FGFR1;HSPB1
prerank,regulation of glucose import (GO:0046324),0.383494724366544,0.9580670190479025,0.5227272727272727,0.9542638100520692,1.0,4/30,5.14%,SORBS1;OCLN;CREBL2;RHOQ
prerank,regulation of bicellular tight junction assembly (GO:2000810),0.40383810822996846,0.9575157129027243,0.5137614678899083,0.9550216162478307,1.0,2/19,2.01%,TJP1;OCLN
prerank,regulation of T cell differentiation (GO:0045580),0.3715575921234032,0.95742804001681,0.5101763907734057,0.9545839205937586,1.0,1/33,0.33%,NFATC2
prerank,nuclear transport (GO:0051169),-0.35073662089345764,-0.9573310460282483,0.501432664756447,0.8532488364145242,1.0,8/16,28.54%,XPO1;NUTF2;NXT1;NUP205;BANF1;RSRC1;NPM1;PSIP1
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.3300645040774346,0.9571561186419592,0.5345622119815668,0.9546187794015182,1.0,7/79,2.47%,WNT1;GPC1;SMAD6;NIBAN2;NBL1;CRIM1;TRIM33
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),-0.31690108416748486,-0.957025308228983,0.5242718446601942,0.8527456365190459,1.0,5/23,7.46%,ERRFI1;CBLB;SH3BP5;ZFYVE28;SOCS5
prerank,regulation of protein binding (GO:0043393),0.3145194009556706,0.9563043842467086,0.5490417136414881,0.9560014356013545,1.0,28/114,19.47%,CFHR1;CDKN1A;GTF2F1;CAV1;SLPI;HDAC5;PPP2CA;HDAC4;CTSZ;ADD1;BMP4;TRIM21;PKD1;TCF7L2;ACTB;CARD16;CSNK1E;CAPRIN2;TLE5;GSK3B;ITGB1BP1;CRK;KDM1A;SPPL3;PARK7;IDE;APP;FLOT1
prerank,intraciliary transport involved in cilium assembly (GO:0035735),-0.2801857486160535,-0.9561495941982484,0.539622641509434,0.8537677198464478,1.0,18/37,28.73%,IFT81;IFT122;TTC21B;IFT74;WDR19;KIFAP3;IFT43;KIF3B;CLUAP1;DYNC2LI1;DYNLL2;DYNC2I2;IFT27;KIF3C;IFT88;CEP131;IFT140;IFT22
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.3297728362413759,0.9561351832369956,0.5278422273781903,0.9557396227710107,1.0,10/77,8.68%,CLU;MMP9;QARS1;PIH1D1;BCL2L1;BMP4;LGALS3;MAZ;TCF7L2;NDUFS3
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),0.471688063030131,0.9557747462979108,0.5281090289608177,0.9559806620165201,1.0,1/10,0.82%,PRKAA2
prerank,response to peptide hormone (GO:0043434),0.35457648086182625,0.9557664399789529,0.5076335877862596,0.9553556513331753,1.0,7/43,7.42%,OGT;CAV1;CREB1;EIF2B2;ZBTB7B;EIF6;STAT4
prerank,regulation of smoothened signaling pathway (GO:0008589),-0.26117949074835434,-0.9556761925495507,0.5970873786407767,0.8537032932100859,1.0,20/50,20.46%,DCDC2;IFT81;MOSMO;IFT122;RORA;TULP3;GLI1;ARMC9;FGFR2;MEGF8;DLG5;RACK1;KCTD21;BTRC;KIF7;INTU;ULK3;PTCH2;GAS1;FUZ
prerank,pre-miRNA processing (GO:0031054),-0.3568013985181023,-0.9551765744047352,0.49299719887955185,0.853640620616281,1.0,6/14,21.85%,TUT4;ADAR;DROSHA;AGO1;AGO4;DICER1
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.34408127090301505,0.9546342330451287,0.5208333333333334,0.9574011797679083,1.0,19/56,21.72%,ARL3;SON;UNC119;ANK3;CHMP4B;RAB35;SNX33;SNX18;RHOA;EFHC2;JTB;RASA1;SEPTIN9;VPS4A;PDCD6IP;ROCK2;IST1;MITD1;RHOC
prerank,vasculogenesis (GO:0001570),-0.28948693848470275,-0.9544215725032948,0.5020408163265306,0.854356709683879,1.0,13/32,17.33%,PDGFRB;ENG;GLMN;KDR;NOTCH1;TGFB1;SOX17;RAMP2;RASIP1;EGFL7;ADM;SOX18;SPRED1
prerank,regulation of viral transcription (GO:0046782),0.3603061017328681,0.9541268539177393,0.5231362467866324,0.957916766649397,1.0,13/39,18.97%,GTF2F1;POLR2H;TARBP2;POLR2A;TRIM21;LARP7;TRIM11;DHX9;HEXIM1;NELFB;POLR2C;POLR2E;NELFA
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.38403390712467883,0.9540811007912035,0.518970189701897,0.9573819216389691,1.0,3/29,7.30%,RAET1E;LAMP1;PVR
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.3785248958816249,0.9540007634953755,0.5163487738419619,0.9569192441817005,1.0,8/31,11.76%,ANK1;CRB2;MSN;CDC42;OPHN1;EZR;SYNJ2BP;RHOA
prerank,negative regulation of myotube differentiation (GO:0010832),0.44636031491526323,0.9539954386741267,0.5143312101910829,0.9562856914138952,1.0,3/12,10.49%,HDAC5;HDAC4;HDAC3
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.38007562401566075,0.9538766961303232,0.5084745762711864,0.9559303995115424,1.0,5/28,7.62%,MAP3K5;BBC3;TMEM117;PPP1R15A;TNFRSF10B
prerank,bile acid metabolic process (GO:0008206),0.38742912267043195,0.9537425823955319,0.5236111111111111,0.9555982416922284,1.0,5/27,11.13%,OSBPL9;ACOT8;NPC1;CYP39A1;OSBPL7
prerank,modulation by host of viral genome replication (GO:0044827),0.43781473065183,0.9537392650598869,0.5210608424336973,0.9549648488878343,1.0,5/13,23.49%,ZC3H12A;EIF2AK4;FBXL2;NUCKS1;VAPA
prerank,sodium ion transport (GO:0006814),0.32671826696797385,0.9535635641721072,0.5450399087799316,0.9547222954213975,1.0,5/85,2.79%,FGF13;ASIC5;SCN3A;NALCN;ATP1A2
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),0.4471347743833907,0.952927706300166,0.5103011093502378,0.9556233204180887,1.0,1/12,0.83%,UNC13C
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.3441878419237714,0.9528530631368111,0.5316301703163017,0.9551619895570784,1.0,6/57,4.46%,CRLF1;CCL5;IL15;PPP2CA;CLCF1;EPO
prerank,microtubule anchoring at centrosome (GO:0034454),-0.3927546339834017,-0.9523886957120089,0.5156626506024097,0.8585820045031394,1.0,4/10,21.12%,NIN;BBS4;CCDC68;CEP19
prerank,protein mannosylation (GO:0035268),0.3919661012200607,0.9520051364836847,0.5222551928783383,0.9565304286205399,1.0,3/22,4.29%,B4GAT1;TMTC1;LARGE1
prerank,positive regulation of protein ubiquitination (GO:0031398),0.32590585860124843,0.9519354144629657,0.5371428571428571,0.9560737543034759,1.0,24/80,24.13%,ANGPT1;CAV1;PEF1;SPSB4;CENPS;RBX1;ARRDC3;DCUN1D5;HDAC3;HSPBP1;DCUN1D1;GSK3A;UBE2N;KDM1A;XIAP;STUB1;CDK5RAP3;PHF23;FBXW7;RCHY1;TRIB3;FBXO4;FANCM;BIRC3
prerank,protein heterooligomerization (GO:0051291),-0.34337019164701754,-0.951823682043051,0.5229357798165137,0.8587538591956022,1.0,5/17,11.71%,PKD2;GRIN2B;MAT2A;NUDT21;CPSF6
prerank,positive regulation of cellular protein localization (GO:1903829),0.3384773391164607,0.9514350387562925,0.5340501792114696,0.9566577350862272,1.0,26/69,25.06%,PRKAA2;LIMK2;SESN2;ORMDL3;DDRGK1;SNX33;MARK4;EIF2AK3;GSK3B;CCDC88A;SYT11;TESK1;NUMA1;STX4;PARK7;NECAB2;CDK5RAP3;CROCC;MAPT;ABCA7;TM9SF4;WWTR1;GAS8;FYN;STX3;NUP62
prerank,regulation of mitochondrial fission (GO:0090140),-0.3071378941701192,-0.9514317829052774,0.5051546391752577,0.858454924891688,1.0,7/24,14.17%,DCN;KDR;LRRK2;VPS35;FIS1;CYRIB;SPIRE1
prerank,negative regulation of viral life cycle (GO:1903901),0.4285007028734528,0.9513955565147426,0.5235849056603774,0.9561445794981451,1.0,3/15,9.40%,GSN;TRIM26;TRIM11
prerank,positive regulation of regulated secretory pathway (GO:1903307),0.41523248413559033,0.9509448935709837,0.5117004680187207,0.9566051889922199,1.0,3/17,10.08%,SCAMP5;UNC13D;KCNB1
prerank,mRNA 3'-end processing (GO:0031124),0.33035981273190324,0.9506823234953645,0.5361305361305362,0.9566150457694045,1.0,29/78,23.49%,SRSF2;AHCYL1;EIF4A3;DDX39B;RBM8A;WDR33;RPRD2;SRSF7;POLDIP3;THOC7;RNPS1;CSTF1;SRSF9;UPF3B;GRSF1;PABPN1;MAGOHB;MAGOH;CLP1;SRSF1;SRSF5;APP;CSTF3;THOC1;TUT1;U2AF1;PABPC1;SRRM1;LEO1
prerank,protein transport (GO:0015031),0.29890373584847757,0.9506182183070884,0.6119554204660588,0.9561419730728725,1.0,69/332,18.13%,PRKCB;RAB17;CLU;ATP6V1B1;SCAMP5;AMN;GRTP1;KIF13A;TBC1D16;EHD1;ARL4A;COPA;AP3B1;SNX8;RAMP1;SIL1;TMED1;UNC119;ANK3;WLS;GOLPH3;GCC2;RAB3B;STXBP1;RAB7A;ARRDC3;NDC1;LMTK2;GOLGA7;MON1A;ARL6IP5;GGA1;SNX33;TOM1;SGSM2;SCAMP2;AP2A1;ARFIP2;RABL3;TBC1D1;NAPA;VIPAS39;STX11;ARF4;CHMP1A;NAPB;VPS26B;PREB;RAB5C;RAB1B;ATP6V1E1;STX16;ATP6V1D;USP6NL;NECAB3;CHMP2A;ATP6V0D1;TBC1D22A;CANX;LRP2;NSF;TBC1D10A;RAB8B;HDAC6;ARFRP1;COPG1;STX4;SEC23IP;ATP6V1B2
prerank,histone monoubiquitination (GO:0010390),-0.30395623100741315,-0.950524143356039,0.5161290322580645,0.8594527947958209,1.0,8/24,23.37%,CUL4B;WAC;BCOR;DTX3L;KDM2B;PAF1;RYBP;RNF2
prerank,negative regulation of hemostasis (GO:1900047),0.4450268199146411,0.9504286489391335,0.523728813559322,0.9559372706735761,1.0,2/12,6.08%,ADTRP;THBD
prerank,aspartate family amino acid metabolic process (GO:0009066),-0.3444625017291991,-0.9499340352695189,0.5285285285285285,0.8597243292587164,1.0,9/18,25.90%,MSRA;ASPG;FOLH1;MTHFR;ADI1;ASNS;GOT1;SMS;GOT2
prerank,mitochondrial protein processing (GO:0034982),0.4542331647674659,0.9499031656837259,0.5041736227045075,0.9565758298932907,1.0,4/11,19.87%,PMPCA;AFG3L2;SPG7;STOML2
prerank,digestive tract development (GO:0048565),0.3766036540561695,0.9499019664975026,0.5406125166444741,0.9559446146482347,1.0,6/32,8.25%,COBL;SMO;GLI3;STRA6;TGFB2;PKD1
prerank,photoperiodism (GO:0009648),-0.29471367793551223,-0.9497739115913569,0.5771812080536913,0.8588786249311487,1.0,7/28,13.93%,PPP1CC;SIK1;ID2;CRY1;TP53;PER3;BHLHE40
prerank,insulin secretion (GO:0030073),0.40530667348514726,0.9491711645128926,0.5067264573991032,0.9570903470344755,1.0,7/19,27.59%,GAL;RAB11FIP5;PARK7;ADCYAP1;CYB5R4;PTPRN;PTPRN2
prerank,microtubule depolymerization (GO:0007019),-0.3360858190440208,-0.9491161909899287,0.521613832853026,0.859282435748201,1.0,11/17,34.31%,STMN2;NCKAP5;KIF18A;STMN3;CKAP5;STMN4;KIF18B;KIF14;NCKAP5L;CCSAP;KIF19
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),-0.3729593781921363,-0.948433126384667,0.5315068493150685,0.8597003769784308,1.0,3/13,7.66%,SHANK3;EPHB2;ADCY1
prerank,regulation of interleukin-1 production (GO:0032652),-0.35414099710179836,-0.9482175274084553,0.49404761904761907,0.8589796407486667,1.0,2/15,3.04%,GAS6;TMED10
prerank,protein sumoylation (GO:0016925),0.3488935017551308,0.9480966648643565,0.5276073619631901,0.9588840057014434,1.0,19/49,25.47%,NUP93;EYA1;NDC1;SUMO2;SUMO3;SAE1;TRPM4;NSMCE2;PIAS1;PIAS3;AAAS;RAE1;POM121;TPR;RANBP2;NUP42;RANGAP1;NUP62;SEH1L
prerank,regulation of cytokinesis (GO:0032465),0.3282343965457599,0.9478872543354554,0.543859649122807,0.958709132704141,1.0,21/78,20.47%,PKP4;KIF13A;RAB11FIP3;BCL2L1;KLHL21;ZFYVE19;PLK3;CDC42;AURKC;RHOA;KLHL13;VPS4A;FLCN;PLK2;CDC25B;GIT1;ZFYVE26;KIF20B;UVRAG;CSPP1;PIK3R4
prerank,unsaturated fatty acid metabolic process (GO:0033559),0.35569842671037305,0.9478350949732727,0.5223097112860893,0.9582065769693133,1.0,7/41,11.79%,ACOT8;ABCD1;EPHX1;ELOVL1;ALOX5;FADS1;SCD5
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.42879137070518064,0.9473802430068563,0.5152,0.958657509216401,1.0,6/13,25.50%,PPP1R15A;DDRGK1;BFAR;ABCA7;PPP1R15B;NCK1
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.4267209460772332,0.9473291017184674,0.5292307692307693,0.9581372398160362,1.0,2/16,2.68%,ZC3H12A;ABCD1
prerank,dorsal/ventral pattern formation (GO:0009953),-0.32208569953814775,-0.9471707246376091,0.5349544072948328,0.8603993156641395,1.0,4/20,7.55%,GLI2;ACVRL1;BMPR1B;DSCAML1
prerank,positive regulation of proteolysis (GO:0045862),0.3409102892724014,0.9471263885754431,0.5492788461538461,0.9579646370202016,1.0,14/55,20.36%,CYFIP2;OGT;ZC3H12A;PERP;BAD;ATP5IF1;SNX33;TNIP1;CTSH;TBC1D10A;STUB1;GPLD1;IST1;RHBDD1
prerank,inositol phosphate metabolic process (GO:0043647),0.3565907622071673,0.9470866724009325,0.5534351145038168,0.9574244974083799,1.0,11/46,15.85%,NUDT4;PLCB3;PLCD3;IP6K1;INPP4A;PPIP5K2;INPP5B;OCRL;PLCD4;PLCD1;IP6K2
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.37049937590827475,0.9466627416483899,0.5275167785234899,0.9578143766726541,1.0,9/35,14.84%,KANK1;RIPOR2;RASAL3;CCDC125;TGFB2;DLC1;MAPKAP1;SYNGAP1;FLCN
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.3482212977326707,0.946304817333515,0.5489199491740788,0.9580214134738145,1.0,5/49,4.46%,CRLF1;CCL5;IL15;CLCF1;EPO
prerank,membrane depolarization during action potential (GO:0086010),-0.3130088053079212,-0.9461206430908743,0.5567010309278351,0.8619369773990797,1.0,8/26,15.43%,CACNA1C;SLC8A1;SCN7A;KCNJ2;CACNA1G;HCN2;SCN1A;SCN1B
prerank,regulation of neurotransmitter receptor activity (GO:0099601),-0.2524694635406697,-0.9456469877780267,0.5466666666666666,0.8618494146056661,1.0,13/57,11.50%,DLG2;GRIN2A;GRIA3;GRIA2;LRRC7;SHISA6;DLGAP1;GRIN2B;NLGN1;NEFL;NETO1;CACNG8;SHISA9
prerank,positive regulation of cation transmembrane transport (GO:1904064),0.3599461637006905,0.9454653460163711,0.535483870967742,0.9593732033528201,1.0,2/41,1.06%,ANK2;ACTN2
prerank,regulation of autophagosome maturation (GO:1901096),0.44025911110675015,0.9452358963140093,0.526813880126183,0.9592881238546482,1.0,5/13,20.15%,TMEM39A;RUBCN;SMCR8;UVRAG;PHF23
prerank,striated muscle cell differentiation (GO:0051146),-0.33799541544469813,-0.9449377226598625,0.5457142857142857,0.8623106458308643,1.0,6/16,16.09%,MYEF2;KDM6B;SIK1;SORT1;CBY1;MYOCD
prerank,regulation of striated muscle contraction (GO:0006942),0.3870219050404317,0.9448682575338527,0.5246132208157525,0.9595324006639284,1.0,2/27,2.79%,ANK2;ATP1A2
prerank,mismatch repair (GO:0006298),0.3839654717959084,0.9448126345893227,0.53,0.9590313013320233,1.0,7/27,16.81%,MLH1;MUTYH;MLH3;RPA3;POLD2;PCNA;ABL1
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),-0.339372944253629,-0.9447652124152068,0.519774011299435,0.8614514289783795,1.0,8/17,23.42%,SULF1;ZDHHC17;SLIT2;SFRP4;TMEM204;PCSK6;FSTL3;DOK5
prerank,peptidyl-lysine monomethylation (GO:0018026),0.4625897410694989,0.9447629163751329,0.5273037542662116,0.9585393590144612,1.0,7/10,30.76%,SETD7;KMT5A;SMYD2;EHMT1;EEF1AKMT2;METTL18;SETD6
prerank,heart looping (GO:0001947),0.35889293918740833,0.9446086278718657,0.5160051216389244,0.9582976126636534,1.0,3/39,2.24%,TBR1;SMO;MICAL2
prerank,negative regulation of BMP signaling pathway (GO:0030514),0.34578618319975785,0.9443943802864481,0.5498154981549815,0.9581593328207041,1.0,5/51,2.47%,WNT1;SMAD6;NBL1;CRIM1;TRIM33
prerank,epithelial tube morphogenesis (GO:0060562),-0.28384731901429355,-0.9441810220848604,0.5294117647058824,0.8617523658373466,1.0,9/32,14.11%,GLI2;ACVRL1;COL4A1;PKD2;SLIT2;SOX17;MEGF8;RASIP1;RYR2
prerank,regulation of phospholipid metabolic process (GO:1903725),-0.3958074260961838,-0.944117451173798,0.5132530120481927,0.8606280670950526,1.0,6/10,26.67%,DNAJC19;MTMR2;ABCA3;MFSD2A;MTMR4;PHB2
prerank,cGMP biosynthetic process (GO:0006182),-0.3981322495621308,-0.9440687469864534,0.5465465465465466,0.8594632010478706,1.0,3/10,10.43%,GUCY1B1;GUCY1A1;NPR1
prerank,regulation of macroautophagy (GO:0016241),0.3153347252546334,0.9440221271080415,0.5551801801801802,0.9584035488734144,1.0,35/105,23.17%,PRKAA2;ATP6V1B1;NRBP2;SESN2;TSC2;RHEB;EXOC7;EXOC4;CAPNS1;SMCR8;EXOC8;VPS26B;BNIP3L;ULK1;ATP6V1E1;GAPDH;NEDD4;ATP6V1D;IKBKG;RB1CC1;ATP6V0D1;SESN1;PRKAG1;HDAC6;LZTS1;ATP6V1B2;ATP6V0B;PRKAB1;PRKAB2;CDK5R1;GNAI3;VPS26A;UBQLN2;ATP6V0E1;CASP3
prerank,actin-myosin filament sliding (GO:0033275),0.36562608312842504,0.9434680537595311,0.5355263157894737,0.9584368843915864,1.0,2/38,1.66%,ACTN2;VIM
prerank,muscle filament sliding (GO:0030049),0.36562608312842504,0.9434680537595311,0.5355263157894737,0.9584368843915864,1.0,2/38,1.66%,ACTN2;VIM
prerank,regulation of DNA binding (GO:0051101),0.3473635620895125,0.9434315099278942,0.5411311053984575,0.9578958248975097,1.0,8/44,10.68%,SMO;MMP9;NGF;DOT1L;NFKBIA;JUN;SUMO3;HABP4
prerank,heme biosynthetic process (GO:0006783),0.38974874679077487,0.9432569758267765,0.5164520743919886,0.9576626067374264,1.0,10/22,21.24%,NFE2L1;UROS;ATP5IF1;SLC25A38;HMBS;PPOX;ABCB6;TSPO;FLVCR1;COX10
prerank,energy derivation by oxidation of organic compounds (GO:0015980),-0.3095724506135139,-0.9430840218143793,0.5143769968051118,0.8607230689406561,1.0,2/24,0.85%,PID1;LEPR
prerank,positive regulation of cell cycle (GO:0045787),0.336361682356163,0.9430173477404337,0.5793357933579336,0.9576234771459083,1.0,21/62,21.46%,NUPR1;CDK4;HCFC1;CCND2;TRIM21;TGFB2;PSRC1;PKD1;USP19;EIF4EBP1;CCND1;SRPK2;ANKRD17;MDM2;CDC25B;DUSP3;RARA;APP;ADAM17;USP22;USP2
prerank,amyloid precursor protein metabolic process (GO:0042982),0.4139394856540813,0.9425558730130614,0.5451851851851852,0.9580594428636042,1.0,5/18,23.99%,ADAM10;BACE1;ADAM17;APH1A;PSEN1
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),0.411106010007794,0.9425013856954858,0.517515923566879,0.9575512161887426,1.0,3/16,7.16%,DDX5;RBFOX2;EGLN2
prerank,spermatid development (GO:0007286),-0.27861763628921343,-0.9424283613602794,0.5655430711610487,0.8611727975817277,1.0,7/32,20.00%,ING2;YTHDC2;ZMYND15;BBS4;CIB1;RFX2;NME5
prerank,response to hydrogen peroxide (GO:0042542),0.3513965880314498,0.9422892519721109,0.5446071904127829,0.9574233219944135,1.0,18/45,27.53%,MAP3K5;NFE2L2;MAPK7;HP;AQP1;TRPM2;APTX;ABL1;HDAC6;PARK7;STK24;SIRPA;RHOB;IL6;FYN;RELA;RPS3;STK25
prerank,epithelial cell morphogenesis (GO:0003382),0.4077271194213603,0.9421605481366104,0.5479876160990712,0.9571185313651224,1.0,5/17,17.43%,POF1B;GRHL2;DACT2;CNMD;RILPL1
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),-0.27770795004462223,-0.9420560313361702,0.5064377682403434,0.860859725915387,1.0,15/38,19.51%,SP100;NOS3;FAS;THBS1;RFFL;TNFSF10;CFLAR;ARHGEF2;RIPK1;GPX1;ICAM1;RNF34;FAIM2;TRADD;TNFAIP3
prerank,chromatin organization (GO:0006325),0.30913765626572004,0.9419878826891215,0.5732899022801303,0.9568854357901414,1.0,26/132,13.51%,DAXX;HDAC5;HDAC4;KDM4D;SMARCB1;PIH1D1;KDM4B;PHF1;SOX9;HCFC1;KDM5C;ATRX;FOXP3;HDAC3;KDM4C;SMARCA4;DR1;KDM6A;ACTL6B;MPND;MYSM1;BAZ2B;SMARCD2;HMGN1;MYC;PWWP3A
prerank,establishment of protein localization to membrane (GO:0090150),0.3306897188523158,0.9419632540869646,0.5418660287081339,0.9563216495906266,1.0,8/66,9.73%,NECTIN3;ZDHHC12;VPS37B;FRMPD1;NPC1;SYNE3;GOLGA7;MYO1C
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.44903281569119335,0.9415682438465757,0.5502471169686985,0.9566221179846387,1.0,3/11,11.60%,CCL5;ANK3;JAK1
prerank,positive regulation of macrophage chemotaxis (GO:0010759),-0.3549414945034344,-0.9414108511826028,0.5251396648044693,0.8611558504849776,1.0,3/14,5.34%,IL34;PTK2;THBS1
prerank,electron transport chain (GO:0022900),0.42561123128247236,0.9410405707603143,0.5317577548005908,0.9572391742219064,1.0,3/15,9.43%,PPARGC1A;SDHB;CYB561
prerank,DNA strand elongation (GO:0022616),0.4151688123774098,0.9407188980226198,0.5455904334828101,0.9573789760071403,1.0,7/18,21.60%,MRE11;POLD2;NBN;MCM7;RAD50;GINS3;MCM4
prerank,leukotriene biosynthetic process (GO:0019370),-0.35404488334615164,-0.9406045297733686,0.5331412103746398,0.8618615207825544,1.0,2/14,3.96%,PLA2G4A;GGT5
prerank,positive regulation of DNA binding (GO:0043388),0.3706947760889553,0.9405098702087699,0.55359565807327,0.9572466070056352,1.0,9/31,19.73%,MMP9;NIBAN2;NGF;TWIST1;GATA3;PINX1;POU4F1;PARK7;RB1
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),0.37685522356407414,0.9401387215909414,0.5317679558011049,0.957465635554408,1.0,8/29,11.91%,ELOVL1;SLC25A1;ELOVL6;ACSL3;ACSF3;ACACA;SCD5;FASN
prerank,positive regulation of ERBB signaling pathway (GO:1901186),0.3811795986870963,0.9398371662315786,0.5171919770773639,0.9575340444137876,1.0,2/25,1.44%,ARAP1;MMP9
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.4547296085708558,0.9396348991961897,0.5363036303630363,0.9573779748513809,1.0,1/10,1.03%,WNT1
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.2906632965251892,0.9396058766852824,0.687374749498998,0.9568225919291143,1.0,108/572,16.88%,THRB;PRDM6;TMPRSS6;KLF4;TFAP2C;SREBF2;RORC;FOXP2;GLI3;DDX5;TRIM33;HIVEP1;KLF12;CAV1;FOXP4;ZNF436;EP300;HDAC5;ZMYM5;ZNF692;MXD4;KANK2;FOXO3;FOXC2;ZNF219;GLIS2;CGGBP1;HDAC4;NR6A1;ZBTB16;EPO;WWP2;MTDH;BEND3;RARG;PHF21A;LCOR;FOXM1;SOX9;OTUD7B;HCFC1;ZBTB7B;BMP4;CC2D1A;KLF7;NKAP;PLK3;ZFHX3;LARP7;PPM1A;ATRX;MAZ;JUN;TCF7L2;CRY2;ZFP57;FOXP3;DPF2;BAG3;NR2C1;DNMT3A;RIF1;EZR;APBB1;CCND1;NFIB;SAP130;TWIST1;HDAC3;ZNF205;NFIC;SP2;SMARCA4;NCOR1;DR1;ZNF148;MIER2;MAFK;CPEB3;CHD3;GATA3;RREB1;CBX4;MYC;ZNF177;MEF2C;TLE5;PCGF2;FOXP1;SARS1;IRF2;NCOR2;NEDD4;GATAD2B;FLCN;MDM2;IGBP1;HMBOX1;TCF25;ZGPAT;IRF2BP2;RPS27A;UBC;HEXIM1;E2F1;POU4F1;KDM1A;UBE2D3
prerank,regulation of cation transmembrane transport (GO:1904062),-0.292133266541015,-0.9395240483234266,0.5272727272727272,0.863335197099077,1.0,7/29,13.20%,DPP10;KCNN2;KCNIP4;KCNIP3;FGF12;KCNIP1;DPP6
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.3500867017546241,0.9392485758919803,0.5675340768277571,0.9570149251951668,1.0,11/50,15.64%,NR3C2;EP300;TRIM44;ILK;NMI;TLR4;RHOA;IRAK1;PTP4A3;TLR3;ACTN4
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.3601552032593745,0.9392395379711147,0.5481283422459893,0.9564154479831759,1.0,6/37,11.15%,IL17RA;ZC3H12A;ABCD1;ALOX5;TLR6;TLR4
prerank,regulation of dendrite extension (GO:1903859),0.4004606870563487,0.9391493802637789,0.5407066052227343,0.9560077558041521,1.0,1/18,0.95%,OSTN
prerank,negative regulation of catalytic activity (GO:0043086),-0.30260195390812056,-0.9389439334337604,0.5254237288135594,0.8636083656353057,1.0,7/24,15.15%,NOTCH1;OXA1L;NOSIP;NES;TP53;CAMK2A;CLN3
prerank,regulation of BMP signaling pathway (GO:0030510),0.32668073249302215,0.9380735819339675,0.564042303172738,0.9579259297533903,1.0,19/73,17.76%,WNT1;SMAD6;NBL1;CRIM1;TRIM33;TWSG1;CRB2;FOXD1;BMP4;DAND5;RBPMS2;FBXL15;LRP2;UBE2D3;XIAP;SMAD5;CDH5;NUMA1;BMPR1A
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),-0.23556072671991396,-0.9379614288777239,0.6642335766423357,0.864826661290696,1.0,29/75,24.28%,PLCB1;PLCE1;RGS5;KCTD8;RGS3;NMT2;MGLL;TULP3;GIT2;ROCK1;RIC8B;CRY1;RGS12;CAMK2A;FNTB;EDN1;MRAP2;RGS16;SAG;RGS4;DGKQ;RPGRIP1L;METAP2;PDE6H;GNG7;RGS20;C3;PDE6A;RNF157
prerank,regulation of phosphate metabolic process (GO:0019220),0.4183341592040774,0.9378785974279534,0.5494505494505495,0.9577650735658213,1.0,6/16,23.99%,SMG7;TIGAR;IGBP1;MCM7;IKBKB;PSEN1
prerank,negative regulation of dephosphorylation (GO:0035305),0.41116229912497737,0.9375895172584537,0.5393939393939394,0.957805976676485,1.0,4/18,8.94%,SH3RF2;PPP1R15A;CHP1;YWHAB
prerank,GTP metabolic process (GO:0046039),0.41191910025695866,0.93756628327256,0.523168908819133,0.9572399964052937,1.0,7/15,22.63%,IMPDH2;RHOQ;AK3;OPA1;GNAI3;RAB23;EFL1
prerank,protein-containing complex disassembly (GO:0032984),0.33862277898806187,0.9375662382400963,0.555,0.9566228203921374,1.0,16/54,19.80%,WNT1;CAV1;RUBCNL;DVL3;FZD5;VTI1B;VIPAS39;MYC;VPS4A;VAMP7;GSK3B;PYM1;MAP1LC3B;TSG101;FZD2;UVRAG
prerank,response to glucagon (GO:0033762),-0.33130167121133763,-0.9374433417659025,0.5029585798816568,0.8648875951469694,1.0,11/19,22.44%,ADCY5;ADCY7;ADCY1;ADCY4;CRY1;PRKAR2B;CYSLTR2;ADCY2;PRKAR1B;ADCY3;ADCY8
prerank,entrainment of circadian clock by photoperiod (GO:0043153),-0.2952347081540527,-0.9371771931863834,0.5719063545150501,0.864252925325574,1.0,7/27,13.93%,PPP1CC;SIK1;ID2;CRY1;TP53;PER3;BHLHE40
prerank,neurotransmitter uptake (GO:0001504),0.4314490992734009,0.9371252458361123,0.5504,0.9569898272452179,1.0,2/12,2.79%,GLUL;ATP1A2
prerank,gastrulation (GO:0007369),-0.3558463160284786,-0.9368753308577392,0.5518207282913166,0.8637303894876636,1.0,4/15,12.12%,TASOR;LRP5;MEGF8;NPHP3
prerank,negative regulation of cellular component organization (GO:0051129),0.3225349441204556,0.9363689270348391,0.5644599303135889,0.9581374430639175,1.0,17/74,17.34%,CLU;SCAMP5;EP300;TMEFF2;CRYAB;RUBCN;LGALS3;CDC42;RAF1;SNX33;RAPGEF3;EPHA3;ULK1;GSK3B;SYT11;PRKCZ;HDAC6
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),-0.2835057293269812,-0.9361960700123516,0.5842696629213483,0.864215240782329,1.0,13/36,19.67%,HIF1A;WNT5A;GAS6;AXL;PARP14;NLRC5;IRGM;CASP4;RIPK1;EDN1;CD74;CSF1;AGPAT2
prerank,chondroitin sulfate biosynthetic process (GO:0030206),0.39637660686451737,0.9359404894616249,0.5523952095808383,0.9585049223745539,1.0,5/21,11.88%,CHST12;CHST11;CHPF;CHST13;CHPF2
prerank,catecholamine biosynthetic process (GO:0042423),-0.38743510256685365,-0.9356224394770927,0.5762273901808785,0.8644148897999623,1.0,2/11,8.12%,MOXD1;GCH1
prerank,regulation of fat cell differentiation (GO:0045598),0.32773161043191507,0.9355951711129231,0.5478971962616822,0.958705043717262,1.0,21/74,19.14%,WNT1;TRIB2;RORC;ZC3H12A;CREBL2;ZBTB16;ALOX5;CREB1;WDFY2;AAMDC;TRIO;TRPM4;GATA3;SFRP1;CCDC85B;LRP3;FRZB;E2F1;CDS1;TAF8;GPER1
prerank,mitotic cytokinesis (GO:0000281),0.34624883231467113,0.935506305085415,0.5497448979591837,0.9582652723900691,1.0,11/47,12.79%,ARL3;SON;UNC119;ANK3;CHMP4B;RAB35;SNX33;SNX18;EFHC2;JTB;RASA1
prerank,regulation of histone deacetylation (GO:0031063),-0.3590247535716631,-0.9349742695439628,0.5142118863049095,0.8647934706617116,1.0,6/13,22.66%,CAMK2D;SAP30BP;ING2;NIPBL;APLNR;PRMT6
prerank,odontogenesis of dentin-containing tooth (GO:0042475),0.42466035087440734,0.9347660467947309,0.5304212168486739,0.9594052892497072,1.0,2/15,4.06%,EDA;WNT6
prerank,negative regulation of cytoskeleton organization (GO:0051494),0.37139578027342857,0.9345404977896817,0.5421853388658368,0.9593249261879427,1.0,4/29,6.02%,KANK1;TJP1;SSH3;TWF1
prerank,cognition (GO:0050890),-0.26918094838728335,-0.9343687741726474,0.5892857142857143,0.8649902111970252,1.0,12/42,13.67%,SOBP;RP9;TUSC3;SETD5;PTCHD1;GRM5;TTC8;CHD7;NF1;CHMP2B;NIPBL;MFSD2A
prerank,negative regulation of microtubule polymerization (GO:0031115),-0.37804609284104784,-0.9342541528509312,0.5579514824797843,0.8640680464382151,1.0,2/12,3.31%,MAP2;STMN2
prerank,positive regulation of secretion by cell (GO:1903532),0.3287707404907417,0.9336665766284498,0.5612980769230769,0.9607765821247465,1.0,11/70,10.67%,CFTR;SYTL4;UNC13D;GOLPH3;TGFB2;ANG;EZR;APBB1;KCNB1;IER3IP1;GRK2
prerank,toll-like receptor signaling pathway (GO:0002224),0.31692708861377666,0.9335573454396191,0.5594405594405595,0.9604264779844917,1.0,34/84,25.98%,SCARA3;TAB3;LBP;TLR6;NMI;CNPY3;TLR4;S100A1;IRAK1;CHUK;TNIP1;TLR3;IKBKG;ITGB2;RPS27A;UBC;COLEC12;UBE2D3;MAPKAPK2;TAB2;SFTPA1;SFTPA2;IRAK4;MAP3K1;PIK3R4;CTSK;TLR1;EPG5;TLR5;IKBKB;BIRC3;LY96;CASP8;TAB1
prerank,regulation of fatty acid biosynthetic process (GO:0042304),0.37906435179165343,0.9335498397989861,0.5272727272727272,0.9598277750775851,1.0,5/26,8.61%,PRKAA2;ERLIN2;EIF6;ACADL;ERLIN1
prerank,regulation of keratinocyte proliferation (GO:0010837),0.39221722853249874,0.9335279311484116,0.545985401459854,0.9592565735161899,1.0,1/22,0.72%,NOTCH2
prerank,positive regulation of lamellipodium organization (GO:1902745),0.36139609726680433,0.9335165770668793,0.5409153952843273,0.9586625658764927,1.0,7/32,17.05%,WNT1;OCLN;AVIL;CDC42;RREB1;FSCN1;ARPC2
prerank,sodium ion homeostasis (GO:0055078),-0.3156719203688682,-0.9333555453639805,0.5151515151515151,0.8650510987924078,1.0,3/21,4.92%,SLC8A1;ATP1B1;SLC12A2
prerank,cellular amino acid catabolic process (GO:0009063),0.32043137723252024,0.9332026537957382,0.5870307167235495,0.9587330177900613,1.0,26/87,22.70%,GLUL;CARNMT1;TDO2;PIPOX;GLUD1;ABAT;SHMT1;CARNS1;AMT;SLC25A44;SLC25A21;AUH;OGDH;BCAT2;IVD;DLST;HAAO;PRODH;ECHS1;MCCC2;KYAT1;HSD17B10;GAD1;SARDH;BLMH;GCDH
prerank,negative regulation of proteolysis (GO:0045861),0.36143237341209394,0.9332006379638992,0.5459459459459459,0.9581235854415474,1.0,5/34,7.37%,EPHA4;TIMP4;TIMP1;TIMP2;TRIM21
prerank,regulation of cellular biosynthetic process (GO:0031326),0.37344100241211353,0.9324386415669484,0.5433854907539118,0.959301585077901,1.0,5/28,7.25%,PRKAA2;CCL5;CTNS;AVIL;EIF6
prerank,cellular response to glucose stimulus (GO:0071333),-0.2863879407880653,-0.9323141293911856,0.5603112840466926,0.8665460595461371,1.0,8/30,12.35%,UNC13B;ZBTB20;GAS6;PRKAA1;RAB11FIP2;RAB11B;IGF1R;RACK1
prerank,cellular sodium ion homeostasis (GO:0006883),-0.35632159148296405,-0.9321901721013449,0.543859649122807,0.8656035593864712,1.0,3/15,4.92%,SLC8A1;ATP1B1;SLC12A2
prerank,positive regulation of viral transcription (GO:0050434),0.3741481112942386,0.932159664695313,0.5470668485675307,0.9593327891536856,1.0,8/25,18.97%,GTF2F1;POLR2H;POLR2A;DHX9;NELFB;POLR2C;POLR2E;NELFA
prerank,C21-steroid hormone biosynthetic process (GO:0006700),0.43542627886435803,0.9321362033727385,0.5251215559157212,0.9587742346910553,1.0,2/12,8.74%,STARD3;FDX1
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.3834834476369784,0.9318936411857379,0.5327635327635327,0.9587037090715234,1.0,8/24,15.65%,ANK3;CHP1;MIEF2;MYO1C;KCNB1;HRAS;ITGB1BP1;ITGB2
prerank,mRNA processing (GO:0006397),0.29378182251112744,0.9317418821078999,0.6276703967446592,0.9584515166554494,1.0,93/287,25.56%,PPARGC1A;DDX5;GTF2F1;SRSF2;CELF1;RBM19;POLR2H;SNRNP70;SON;SNRPB;POLR2A;SRRM2;EIF4A3;RALY;LSM4;DDX39B;RBM8A;HNRNPH2;WDR33;PHF5A;DBR1;RPRD2;SF3B3;USP39;MTREX;SRRM4;TBRG4;SRSF7;SF3A2;POLDIP3;ZCCHC8;THOC7;FRG1;HNRNPUL1;GPATCH1;SYNCRIP;RBM10;RNPS1;PNN;CSTF1;SRSF9;SRRT;UPF3B;GEMIN6;PLRG1;ISY1;DHX9;PABPN1;CWC15;CDC5L;MAGOHB;MAGOH;PRPF19;CLP1;ERCC2;PRPF40B;PRPF6;POLR2C;HNRNPA3;SRSF1;PPIL1;POLR2E;PTBP1;SRSF5;ZMAT5;PCBP2;CSTF3;WBP4;SF3A3;THOC1;PUF60;PRPF8;SFPQ;YBX1;DDX23;GEMIN5;U2AF1;PABPC1;RBM15;SPEN;SRRM1;AURKAIP1;PRKACA;CMTR2;DDX46;CWF19L1;SNRPB2;MNAT1;POLR2K;CPSF7;GEMIN2;RBM15B;LSM5
prerank,cardiac ventricle development (GO:0003231),-0.3221641620605371,-0.9315580663138988,0.545751633986928,0.8659844790273731,1.0,5/20,9.95%,ENG;NOTCH1;SALL1;HEYL;PDE2A
prerank,negative regulation of cellular component movement (GO:0051271),0.417416974708722,0.9313940706860936,0.5590062111801242,0.9586597601622613,1.0,7/15,16.38%,SPINT2;CD9;FBLN1;CCDC125;GATA3;TGFBR3;CRK
prerank,mRNA modification (GO:0016556),-0.3128954681734034,-0.9311354251066121,0.5559322033898305,0.8658253306401831,1.0,6/22,16.23%,METTL8;PUS7;METTL16;TRMT61B;DKC1;TRMT6
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.4326712657705359,0.931087916407872,0.5290322580645161,0.9587779247694491,1.0,3/12,12.08%,INSIG1;GPAA1;ANKRD13C
prerank,icosanoid biosynthetic process (GO:0046456),0.4559805363994356,0.9306705051877492,0.5797101449275363,0.9591494074558116,1.0,4/10,13.94%,ALOX5;MGST3;FADS1;LTA4H
prerank,positive regulation of protein kinase activity (GO:0045860),0.29947559466510987,0.9303019843964965,0.5911542610571737,0.9593814465402183,1.0,17/148,9.40%,CLU;DAXX;CCL5;EPHA4;CDKN1A;EMP2;RAP1A;PTK2B;PPP2CA;PIH1D1;UNC119;CAMKK1;ERBB3;TGFB2;SRCIN1;IQGAP1;MAP2K2
prerank,regulation of receptor internalization (GO:0002090),0.36327753557640663,0.9299760935115954,0.5515394912985274,0.959531123542285,1.0,2/35,2.29%,ANGPT1;MAGI2
prerank,lipoprotein biosynthetic process (GO:0042158),-0.37718957374010514,-0.9297850197299679,0.5655737704918032,0.868067218679986,1.0,3/11,18.16%,UGCG;PIK3C3;ATG10
prerank,response to steroid hormone (GO:0048545),0.36319260485726246,0.9292734888270433,0.5466101694915254,0.9605733162077931,1.0,5/31,11.07%,ADTRP;CAV1;ATP1A2;TGFB2;ABCA2
prerank,regulation of interleukin-2 production (GO:0032663),-0.257681021950734,-0.9283702067381454,0.6136363636363636,0.8702894576312611,1.0,8/43,11.72%,PDE4D;CD34;GLMN;RUNX1;SPTBN1;PDE4B;TRAF6;PNP
prerank,regulation of cellular catabolic process (GO:0031329),0.3259649023051436,0.9282254036176657,0.5662650602409639,0.9623978828472173,1.0,17/62,17.51%,NUPR1;ABCD1;EP300;DAPK3;DAPK1;HSPB1;USP10;MAPK15;SMCR8;MTMR3;OSBPL7;WDR91;PIP4K2C;ABL1;KEAP1;HDAC6;FBXL2
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.2854855853709966,0.9280379998292724,0.835,0.9622259092452096,1.0,256/1646,14.34%,CDH1;PRKCB;BNC2;NFATC2;ZBTB7C;NR3C2;KLF5;FOXN3;DAXX;TMPRSS6;TBR1;WNT1;KLF4;TFAP2C;PBX3;PPARGC1A;PBX1;KLF3;ZIC4;TFAP2D;DMRT2;MAP3K5;ELF3;OGT;LBH;SREBF2;CDKN1A;RORC;SMAD6;NIBAN2;FOXP2;GLI3;DDX5;MLLT3;HOXA4;TRIM33;HIVEP1;CAND2;WNT11;KLF12;FOXP4;ZNF436;EP300;ZFHX4;TOX4;HDAC5;ZNF692;MXD4;QARS1;RBFOX2;CC2D1B;FOXO3;FOS;DAPK3;PCGF6;RELB;MGA;FOXC2;SP5;ZNF219;GLIS2;NOP2;PPP2CA;KLF16;CREBL2;PPP1R13L;HDAC4;NFE2L2;NR6A1;ZBTB16;ZBTB8A;ANXA4;EPO;WWP2;MTDH;CIAO1;TRIM44;SMARCB1;IGSF1;FOXD2;POU2F3;NFE2L1;NACC1;MLF2;CRYAB;ESRRB;RFX7;IRF3;PRRX2;BICRA;SLTM;JUND;OVOL2;NKX2-8;PATZ1;PHF1;POLR2A;LCOR;CREB1;ZBTB46;ZIK1;FOXM1;HOXA5;ZBTB17;RXRB;PCGF3;SOX9;FOXD1;HCFC1;ZIC2;NRF1;SHC1;KDM5C;ZBTB7B;KAT6B;EFEMP1;PHF10;BMP4;MEF2D;CC2D1A;KLF7;COMMD7;MED30;STAT4;NKAP;CDK16;ILK;TGFB1I1;DVL3;ZNF471;ZFHX3;DYRK1B;ZNF418;MAGEL2;CIC;PPM1A;L3MBTL3;ATRX;SIX1;PSRC1;MAZ;JUN;POU3F1;TCF7L2;FBXO5;CRY2;ELP4;ZFP57;PML;GRHL2;FOXP3;KMT2A;POU5F2;BRD7;SCML2;DPF2;NR2C1;MYCBP;MAP2K2;ZIC1;YWHAQ;HDGFL3;PHF5A;APBB1;MED29;ILF2;PRDM15;ENY2;NFIB;ZNF467;FADS1;NFYC;TWIST1;KDM3A;HDAC3;ARID4A;ZNF205;NFE2L3;NFIC;SOD2;GON4L;TLE2;BCL7A;SP2;KDM4C;MYT1;SMARCA4;ABCA2;MAMLD1;ARID3B;CREB3L4;CREB3;NCOR1;AEBP2;CALCOCO1;MEF2B;SRCAP;AJUBA;MED8;HOXB5;SFMBT2;NAA15;MAFG;SP1;ZBTB42;ZNF148;ACTL6B;TAF5;CDK18;MAFK;FOXK1;CCNL2;MED12;TFEB;SPIN1;BAZ2B;PIAS1;PIAS3;ZFP30;CHD3;GATA3;SMARCD2;ZSCAN20;TSC22D4;RREB1;SBNO2;GPBP1;NFIA;CHMP1A;BEND5;MED21;TCEA2;CBX4;MYC;POLR3C;ZNF177;PRDM11;MED24;ING4;REXO4;ZFP1;MEF2C;TLE5;PAX3;ZFP92;MYBL1;ATP2B4;SFRP1;SRRT;FOXP1;CHUK;SET;TASP1;ZXDC;PTP4A3;IRF2
prerank,base-excision repair (GO:0006284),0.3426802997102123,0.9279034749505548,0.561314791403287,0.9619206594626345,1.0,14/48,20.44%,FEN1;MUTYH;POLG;ERCC5;MBD4;RPA3;POLD2;PCNA;LIG3;NEIL1;PARG;RFC1;PNKP;APEX2
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",0.38424573827301156,0.9278487868609678,0.5480480480480481,0.9614389655336,1.0,8/24,18.65%,POLK;RPA3;POLD2;PCNA;LIG3;RPS27A;UBC;RFC1
prerank,negative regulation of myoblast differentiation (GO:0045662),-0.3629002506703206,-0.927452287502011,0.5652173913043478,0.871415936609364,1.0,4/13,10.88%,TBX3;NOTCH1;TGFB1;SRA1
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.45147366956329543,0.9270220070872781,0.5618556701030928,0.9626672097943407,1.0,3/10,14.55%,ATP1A2;STK39;NEDD4
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.40135479834199017,0.9269564154820982,0.5699558173784978,0.9622246195965736,1.0,6/18,18.46%,NFE2L2;HSPB1;MAPK7;SOD2;VNN1;PARK7
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.3096886360192094,0.9268819490195597,0.5907079646017699,0.961780704285083,1.0,14/118,8.33%,PHLDB2;PDLIM5;FMNL2;EPHA4;DAG1;EMP2;SIPA1L1;CRB2;GDNF;ZMYM6;CAPZB;EFNA5;SRCIN1;STRIP1
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.3301884510996066,0.9263868196579094,0.5684848484848485,0.9622682301392425,1.0,15/59,16.71%,CDKN1A;CDK4;MOV10;SOX9;MED30;JUN;TCF7L2;CCND1;TWIST1;MED8;MED12;PPM1D;MED24;MED6;MED27
prerank,cortical cytoskeleton organization (GO:0030865),-0.26339593447936516,-0.926226878923492,0.5580524344569289,0.8732049880340876,1.0,8/41,7.58%,RHOBTB1;RND3;FHOD3;FMNL3;EPB41L3;NLGN1;RHOBTB3;ROCK1
prerank,amyloid fibril formation (GO:1990000),0.33802130766776056,0.9255007284014443,0.5626566416040101,0.96362897672619,1.0,13/51,20.74%,TSPAN5;ADAM10;GSN;GGA1;MDM2;BACE1;RPS27A;UBC;SIAH1;H3-3A;APP;MAPT;APH1A
prerank,cardiac right ventricle morphogenesis (GO:0003215),-0.38186162596230844,-0.9254359332256056,0.5631313131313131,0.8738910088465638,1.0,2/11,1.33%,JAG1;ZFPM2
prerank,endocrine system development (GO:0035270),-0.3214021818889215,-0.9254281070068817,0.5862068965517241,0.8726576027429712,1.0,6/21,13.45%,GLI2;WNT4;DKK3;SALL1;NF1;TBX1
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),-0.3587847841530746,-0.9251885999520362,0.5702005730659025,0.8720528832815401,1.0,5/13,17.82%,EIF4ENIF1;TNRC6A;POLR2G;CNOT7;ZFP36
prerank,ephrin receptor signaling pathway (GO:0048013),0.3157662402513992,0.9251802709215488,0.5654205607476636,0.9637135003439041,1.0,22/82,18.79%,MMP9;NGEF;EPHA4;EFNB2;SIPA1L1;AP2A2;EFNA5;CDC42;ACTB;ACTG1;EPHA3;AP2A1;RHOA;RASA1;HRAS;EFNA4;CRK;ARPC2;GIT1;PTPN11;YES1;ROCK2
prerank,mitotic nuclear membrane reassembly (GO:0007084),0.3356446125001849,0.9249411784642326,0.5698393077873919,0.9630663939317912,1.0,11/51,15.81%,CC2D1B;PPP2CA;REEP3;NUP93;CHMP4A;CHMP4B;NDC1;VPS4A;LMNA;CHMP2A;REEP4
prerank,mitotic nuclear membrane organization (GO:0101024),0.3356446125001849,0.9249411784642326,0.5698393077873919,0.9630663939317912,1.0,11/51,15.81%,CC2D1B;PPP2CA;REEP3;NUP93;CHMP4A;CHMP4B;NDC1;VPS4A;LMNA;CHMP2A;REEP4
prerank,negative regulation of epithelial cell proliferation (GO:0050680),0.3266231901436717,0.9248828974647897,0.5866188769414575,0.9625923387800699,1.0,17/66,14.16%,HPN;NUPR1;CAV1;CDK6;DUSP10;ALOX5;CAV2;SOX9;TGFB2;KRIT1;ATP5IF1;NFIB;CASK;SYNJ2BP;GATA3;SFRP1;TGFBR3
prerank,transcription by RNA polymerase II (GO:0006366),0.290216132841537,0.9247958280438804,0.6582661290322581,0.9622020491297574,1.0,65/305,20.19%,NR3C2;THRB;NOTCH2;PPARGC1A;LSM10;RORC;CCN2;DDX5;MLLT3;GTF2F1;HDAC5;NR6A1;POLR2H;NABP2;ESRRB;SNRPB;TAF1C;RARG;ELOB;NKX2-8;POLR2A;RXRB;ZBTB7B;SSRP1;MAZ;ELP4;NR2C1;WDR33;INTS2;RPRD2;HDAC3;NFE2L3;NFIC;NCOR1;GTF2E1;SP1;TAF5;ELL;RREB1;RPAP1;CSTF1;SRRT;NCOR2;PABPN1;ELP2;TBPL1;CLP1;MED27;ERCC2;NELFB;INTS3;POLR2C;INTS13;RARA;POLR2E;INTS6;NELFA;TAF8;TAF9B;CSTF3;TBP;MED7;TEAD1;MNT;NABP1
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.29213035817376365,0.9243219025718511,0.6289500509683996,0.9626534184387394,1.0,103/264,28.42%,DDX5;GTF2F1;SRSF2;RBM19;POLR2H;SNRNP70;SNRPB;POLR2A;SRRM2;EIF4A3;RALY;LSM4;DDX39B;RBM8A;HNRNPH2;WDR33;PHF5A;DBR1;SF3B3;USP39;SRPK2;MTREX;SRSF7;SF3A2;ZCCHC8;FRG1;SRPK1;HNRNPUL1;GPATCH1;SYNCRIP;RBM10;RNPS1;PNN;CSTF1;SRSF9;SRRT;UPF3B;GEMIN6;PLRG1;ISY1;DHX9;PABPN1;CWC15;CDC5L;MAGOHB;MAGOH;PRPF19;CLP1;PRPF40B;PRPF6;POLR2C;HNRNPA3;SRSF1;SNUPN;PPIL1;POLR2E;PTBP1;SRSF5;ZMAT5;PCBP2;CSTF3;WBP4;SF3A3;DDX20;PUF60;PRPF8;SFPQ;YBX1;DDX23;GEMIN5;U2AF1;PABPC1;RBM15;SPEN;DCPS;SRRM1;CELF4;DDX46;CWF19L1;SNRPB2;CLNS1A;POLR2K;CPSF7;GEMIN8;GEMIN2;RBM15B;LSM5;PPIL3;CDK13;PRPF40A;DDX42;PPIE;GPKOW;RBM6;SNRPD2;SNRPD1;SF1;HNRNPM;HNRNPR;CSTF2;SF3B2;HNRNPH1;HSPA8
prerank,odontogenesis (GO:0042476),0.352793427741781,0.9241495717594845,0.5521796565389696,0.9624228401642498,1.0,6/35,11.05%,EDA;WNT10A;WNT6;BMP4;TGFB2;AQP1
prerank,ruffle organization (GO:0031529),-0.33681735134257595,-0.9240097635114595,0.5873925501432665,0.873749486965289,1.0,5/16,22.78%,LIMA1;AIF1L;ARF6;PIP5K1A;CORO1B
prerank,response to calcium ion (GO:0051592),-0.22333733710738987,-0.9239756907658507,0.6666666666666666,0.8725679591179464,1.0,16/102,7.83%,CPNE8;STIM1;ADGRV1;TRPC3;WNT5A;CAMK2D;RASGRP2;CPNE4;PKD2;SYT9;PRKAA1;THBS1;SYT1;NLGN1;ADCY1;MCOLN1
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.33420268826032296,0.9239075523970166,0.5749086479902558,0.9623822944148096,1.0,6/57,10.21%,LPAR1;CHRM1;ADCY9;ADCY6;HTR1B;AKAP5
prerank,double-strand break repair (GO:0006302),0.3006403808577574,0.9235829644255581,0.6089743589743589,0.9625083443014079,1.0,44/158,22.43%,FEN1;RECQL4;KDM4D;NABP2;KDM4B;RNF138;MRE11;EYA1;PARP3;TENT4A;RIF1;APBB1;RMI1;HUS1B;MDC1;NSMCE2;ABRAXAS1;MMS22L;ERCC5;PAXX;RPA3;APTX;MCM8;FAN1;UBE2N;PRPF19;DCLRE1C;LIG3;SFR1;SMC6;NBN;CHEK2;RAD50;PARP2;ZFYVE26;NUCKS1;ERCC4;NABP1;POLN;YY1;SFPQ;SWI5;RNF168;NSMCE1
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.30716191406396115,0.9235672678574081,0.5995525727069351,0.9619373061423516,1.0,10/102,7.66%,SORBS1;CPEB2;ADCY9;CAV1;HDAC5;EPRS1;RHOQ;INSIG1;PKM;ADCY6
prerank,positive regulation of phosphatase activity (GO:0010922),-0.31734851679703446,-0.9235611594588705,0.5514018691588785,0.872343784632044,1.0,2/21,0.77%,PDGFRB;ITGA1
prerank,positive regulation of response to biotic stimulus (GO:0002833),-0.2695391462747768,-0.9233847490394284,0.6188524590163934,0.8715246784787494,1.0,5/38,10.17%,BMP6;SASH1;GBP5;DDX60;PLSCR1
prerank,negative regulation of cell junction assembly (GO:1901889),0.3706610162898287,0.9233404560184415,0.5372492836676218,0.9618990097705368,1.0,4/25,10.78%,PHLDB2;DMTN;BCAS3;DLC1
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),-0.26170198887033486,-0.9232147647081298,0.6218905472636815,0.8707223376697666,1.0,7/46,6.41%,TIMP3;SEMA6A;LYN;WNK2;DAB2IP;EPHB2;RANBP9
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.33165526171260395,0.9231747635479274,0.5683453237410072,0.9616640224752468,1.0,10/59,11.52%,OSBPL9;ACOT8;ALOX5;GAMT;CYP39A1;ACSM3;NDUFAB1;ACSF3;OSBPL7;ACACA
prerank,positive regulation of protein dephosphorylation (GO:0035307),-0.2762137239179026,-0.9228635519012296,0.5848375451263538,0.8702927294993584,1.0,3/32,2.43%,PDGFRB;ITGA1;PPP1R16B
prerank,isotype switching (GO:0045190),0.4482613596552205,0.9227566228863376,0.561344537815126,0.9619588230118026,1.0,5/10,30.44%,EXOSC3;RNF168;RNF8;MSH2;MSH6
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.3183405234196774,0.9223126405688823,0.5949074074074074,0.9623117052090266,1.0,26/88,16.32%,STXBP6;CORO7;BLOC1S6;VPS13A;ARL3;EXOC4;MON2;GOLGA7;MYO5A;STEAP2;EXOC2;AP1S3;SCAMP2;AP2A1;NAPA;SH3GL2;GOLGB1;AP1M1;EXOC8;AP1S2;VAMP7;OSBPL5;CHMP2A;AP4E1;CCDC22;AP1B1
prerank,regulation of glycolytic process (GO:0006110),0.32521409472614593,0.9221037824890254,0.590047393364929,0.9621949711489597,1.0,12/68,11.27%,PRKAA2;OGT;NUPR1;EP300;HDAC4;NUP93;PFKFB2;EIF6;NDC1;JMJD8;TIGAR;NCOR1
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.3099993579897637,0.9219653694162002,0.5924657534246576,0.9619355446587129,1.0,22/93,19.38%,CD44;NTRK3;CAV1;NGF;CREBL2;DOCK7;DMTN;HAX1;LATS1;NLRP2B;RAF1;RAPGEF3;CAPRIN2;ATP2B4;EIF4G1;HSP90AA1;PFN2;HDAC6;MTCP1;PARK7;PRKD2;APP
prerank,anterior/posterior pattern specification (GO:0009952),-0.2574015107777136,-0.9216855038856528,0.5760869565217391,0.8720220123155729,1.0,20/53,26.31%,PCSK5;HEYL;LRP5;BASP1;HOXA7;DDIT3;TBX1;BHLHE40;BMPR2;HOXB7;HHEX;HOXC4;HOXB6;HOXD3;HEY2;HEY1;BHLHE41;HOXC5;SMAD2;HOXB9
prerank,glutathione derivative biosynthetic process (GO:1901687),0.391902034361591,0.9216367835666218,0.538109756097561,0.9614629417639871,1.0,5/20,15.84%,MGST3;GSTO1;HPGDS;GSTK1;GSTM2
prerank,glutathione derivative metabolic process (GO:1901685),0.391902034361591,0.9216367835666218,0.538109756097561,0.9614629417639871,1.0,5/20,15.84%,MGST3;GSTO1;HPGDS;GSTK1;GSTM2
prerank,positive regulation of interleukin-8 production (GO:0032757),-0.253242475055523,-0.9216269424163409,0.6871794871794872,0.8709119047560305,1.0,11/49,16.64%,AFAP1L2;NOD1;LGALS9;STAT3;TIRAP;RIPK1;DDIT3;IL17D;TLR7;HMGB1;CD74
prerank,COPII-coated vesicle cargo loading (GO:0090110),0.421493988162715,0.9215909451375527,0.555735056542811,0.9609596064906599,1.0,6/14,23.85%,SEC23A;SEC24B;SEC31B;MIA3;SEC31A;SEC24D
prerank,cellular response to DNA damage stimulus (GO:0006974),0.28990363678467335,0.9215589985764555,0.6956521739130435,0.9604376942938918,1.0,76/336,18.47%,NFATC2;WNT1;SUSD6;CDKN1A;ZC3H12A;IKBKE;FEN1;RECQL4;DOT1L;PPP1R15A;NABP2;USP10;IRF3;BCL2L1;PHF1;ASF1A;NSMCE4A;MRE11;MACROD1;MAPK15;PARP3;CENPS;PLK3;INIP;RAD54L;FBXO31;POLK;PML;DCUN1D5;RIF1;UBE2B;APBB1;CCND1;MUTYH;PCLAF;TIGAR;MTREX;USP3;CSNK1E;TOPBP1;CDKN2AIP;MBD4;PAXX;MYC;PWWP3A;BTG2;REXO4;FOXP1;UBR5;POLH;ENDOV;APTX;MCM8;IKBKG;USP28;FAN1;UBA6;DDB1;ATR;E2F1;HINFP;ABL1;SMC6;NBN;MCM7;XIAP;INTS3;MAPKAPK2;TRRAP;CHEK2;PIDD1;RAD50;PARP2;USP16;PARK7;ATF2
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.4453584766141955,0.9214412578432348,0.5516074450084603,0.9601114493097349,1.0,2/10,8.88%,NINJ1;LBP
prerank,positive regulation of catalytic activity (GO:0043085),-0.27177328965457775,-0.921355205538945,0.5793991416309013,0.8704120846106599,1.0,13/37,23.33%,AZIN2;MSH3;IGF2;ABL2;NHEJ1;FGFR4;FXN;B3GAT3;SLC5A3;SOD1;CIB1;MAPK14;NOD2
prerank,protein localization to organelle (GO:0033365),0.3068598330517045,0.9211269450920277,0.6118918918918919,0.9602434610524863,1.0,47/133,25.37%,ANK2;LAMP5;OTOF;CSRP3;EHD1;ARL3;LAMP1;PPP1R15A;DDRGK1;BMP4;GCC2;SIX1;BANP;GET4;TOR1A;RAB35;DCP1A;TOR1AIP1;ATP6V1D;LMNA;MDM2;DHX9;RAB33B;CCDC47;RIPOR1;FAM83H;ARFRP1;WDR35;APP;ZBTB7A;CROCC;ABCA7;TULP1;TULP2;YBX1;VAMP2;SGTA;MTCH2;VAPA;ARL6;ARL1;SIX4;GABARAPL2;TIA1;CYB5A;SNX10;TSPAN17
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",-0.3721673169290075,-0.9210521915975989,0.5685785536159601,0.8687153434854792,1.0,5/11,21.64%,NOTCH4;TNRC6A;AGO1;ZFP36;AGO4
prerank,miRNA mediated inhibition of translation (GO:0035278),-0.3721673169290075,-0.9210521915975989,0.5685785536159601,0.8687153434854792,1.0,5/11,21.64%,NOTCH4;TNRC6A;AGO1;ZFP36;AGO4
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.35026110297481994,0.9208204574270663,0.5742705570291777,0.9603382086584976,1.0,5/38,6.66%,DAG1;MAGI2;PHLDA3;TSC2;MUL1
prerank,regulation of actin filament-based process (GO:0032970),0.32121596882943004,0.9207521564372495,0.5843520782396088,0.9598797749539234,1.0,19/70,18.79%,CELSR1;ARHGAP18;CDK10;RHOQ;EFNA5;DMTN;IQGAP1;ARHGEF5;EZR;DLC1;EPHA3;RHOA;CCDC88A;TESK1;FSCN1;CRK;ABL1;ARHGAP44;ROCK2
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.36937751354752807,0.9204220576009732,0.5473071324599709,0.960033299358594,1.0,6/25,17.34%,ZYG11B;RNF5;KLHL15;TOR1A;STUB1;HDAC6
prerank,wound healing (GO:0042060),-0.24599470461805872,-0.9203422445369753,0.6647058823529411,0.8692855359671307,1.0,22/62,24.28%,IGF1;WNT5A;PDGFRA;DYSF;FGF2;MYOF;CFLAR;NF1;PPP3CA;MACF1;CLDN1;SMAD3;ANXA6;DCBLD2;PRCP;TSKU;EPB41L4B;JAML;SRF;CORO1B;DSP;PAK1
prerank,protein targeting to peroxisome (GO:0006625),0.36793533489300667,0.920257972280347,0.5653370013755158,0.9598181761547518,1.0,9/29,18.72%,PEX26;ABCD1;SLC25A17;ZFAND6;PXMP4;PEX6;RAB8B;PEX3;PEX2
prerank,positive regulation of cell cycle process (GO:0090068),-0.22847921836796153,-0.9199004116733362,0.6496350364963503,0.8691619030126629,1.0,12/91,10.25%,IGF1;SVIL;PDGFRB;TGFA;INSR;CDC14A;RGCC;CIT;IGF2;LRP5;PLSCR1;GPSM2
prerank,negative regulation of cell differentiation (GO:0045596),0.2966225024292884,0.9197554039471735,0.6428571428571429,0.9603699998421034,1.0,21/181,6.81%,WNT1;RANBP3L;TRIB2;ADAMTS7;HPN;SMAD6;COL5A2;CRIM1;CAV1;CDK6;PTK2B;PPP2CA;BMP5;ZBTB16;NFKBIA;ESRRB;OVOL2;SPRED3;SOX9;EFEMP1;BMP4
prerank,protein modification by small protein removal (GO:0070646),0.29070620007143566,0.9196843983858604,0.6541666666666667,0.9599317921612763,1.0,72/252,24.43%,CFTR;OGT;ZC3H12A;EP300;USP46;USP29;OTUD1;NFKBIA;PSMD11;USP10;USP32;OTUD7B;HCFC1;PSMD4;PSMF1;DESI2;DESI1;USP19;ACTB;USP20;TOR1A;USP24;PSMD7;USP42;USP3;RHOA;RNF123;COPS5;ABRAXAS1;TOMM20;FOXK1;MYSM1;PSMB5;GATA3;SENP3;MYC;TNIP1;MDM2;IKBKG;USP28;RPS27A;UBC;OTUD6B;KEAP1;TRRAP;PSMD1;USP25;STAM;PSMC4;USP21;USP16;TAF9B;PSMD8;INO80D;USP22;INO80C;USP2;YY1;USP11;INO80E;SMURF2;WDR20;MDM4;PSMA7;TADA3;USP13;TFPT;MBD6;BIRC3;CDC25A;STAM2;USP34
prerank,transcription by RNA polymerase III (GO:0006383),0.36951922579374724,0.9194325882981993,0.5639204545454546,0.9599161106077777,1.0,13/27,28.25%,GTF3C3;ELL;POLR3G;GTF3C2;GTF3C5;POLR3H;TBP;SNAPC3;GTF3C4;ICE1;POLR2K;ZC3H8;BRF1
prerank,amide transport (GO:0042886),-0.2997566043526114,-0.9194129398172038,0.576,0.8690514446483346,1.0,12/26,32.98%,PLTP;TAP2;PLEKHA8;AQP11;DISP1;SLC5A6;SLC14A1;PLEKHA3;ABCG2;ABCA13;SLC38A5;CPTP
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),-0.3148857813779562,-0.918953363322213,0.5678233438485805,0.8689441426397956,1.0,7/20,18.30%,PLA2R1;THBS1;RGCC;ITGA4;SFRP4;PDCD4;CD40
prerank,gene silencing by miRNA (GO:0035195),0.35818067851454605,0.9185241084461484,0.5949868073878628,0.9613090609488953,1.0,4/32,7.25%,CNOT6;TARBP2;MOV10;EIF6
prerank,protein localization to phagophore assembly site (GO:0034497),0.4339966103822736,0.917914969074157,0.53,0.9621034741491139,1.0,11/11,56.63%,PACS2;WIPI2;TRAPPC8;WDR45;WIPI1;ATG13;STX17;WDR45B;MFN2;ATG9A;ATG9B
prerank,defense response to Gram-positive bacterium (GO:0050830),0.34758263879419393,0.9178928360041588,0.5697522816166884,0.9615638214517978,1.0,7/40,10.21%,PGLYRP3;ANG;ROMO1;STAB2;LBP;RNASE3;PPP1R11
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),0.37323292947555564,0.9177888496302621,0.5655270655270656,0.9611895247101143,1.0,11/24,21.24%,NFE2L1;UROS;ATP5IF1;SLC25A38;HMBS;PPOX;ABCB6;TSPO;FLVCR1;SUCLA2;COX10
prerank,negative regulation of mitochondrion organization (GO:0010823),0.3564366665397314,0.9172509616008574,0.5642384105960265,0.9618173383966485,1.0,3/33,6.66%,CLU;BCL2L1;MUL1
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),0.4002940451435725,0.9172054749243245,0.5867895545314901,0.9613230518375515,1.0,6/17,17.81%,UBASH3A;LGALS3;EZR;PTPN2;SH2D1A;DUSP3
prerank,sphingolipid biosynthetic process (GO:0030148),0.3226473829427747,0.9170913960527929,0.5786314525810324,0.9609955993557882,1.0,9/71,9.24%,SPTSSB;SGMS2;PPM1L;A4GALT;ELOVL1;LARGE1;AGK;ELOVL6;HACD4
prerank,synaptic vesicle transport (GO:0048489),0.43662104804456164,0.9165159807474482,0.5779527559055118,0.9617437444985429,1.0,7/11,30.77%,TOR1A;TMEM230;RAB27A;KIF5A;SYNJ1;KIF5C;DNM2
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.3541776485662132,0.9161205929206538,0.5617977528089888,0.9619984231084917,1.0,9/32,14.84%,PHLDB2;DMTN;CASK;ADAM15;BCAS3;DLC1;MMP12;RASA1;ITGB1BP1
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.33647815660100894,0.9158020821795961,0.579874213836478,0.9621015646863581,1.0,9/47,14.06%,ZC3H12A;CAV1;EP300;ERLIN2;ACADL;ERLIN1;ABCA2;PGP;ATP2B4
prerank,neuromuscular junction development (GO:0007528),0.3756178817559014,0.9153756492806158,0.5421853388658368,0.9624260739713907,1.0,8/24,17.71%,UNC13C;CACNB3;ANK3;MUSK;CACNB2;NEDD4;F2R;PDZRN3
prerank,maturation of SSU-rRNA (GO:0030490),-0.27911776954855083,-0.9152949929342377,0.5938697318007663,0.8765844510967249,1.0,16/34,32.78%,UTP6;NGDN;NAT10;RRP36;LSM6;DHX37;TSR3;NOB1;WDR3;SNU13;RIOK2;WDR46;NOL10;MRPS11;HELB;NOL11
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),0.400485162130422,0.914857831404933,0.5511111111111111,0.962975822947717,1.0,4/18,15.47%,NUP93;ENY2;POLDIP3;PABPN1
prerank,protein localization to centrosome (GO:0071539),-0.3125557365764668,-0.9147096271173818,0.5782122905027933,0.8767394145884188,1.0,8/17,27.82%,CCDC14;C2CD3;NEDD1;CSNK1D;BBS4;CEP131;SPAG5;PIBF1
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",-0.3219554507698001,-0.9146163134287044,0.6,0.8757105047656369,1.0,5/18,12.76%,NRXN1;SHANK3;NLGN1;CACNG8;NLGN3
prerank,protein localization to synapse (GO:0035418),0.4279019286321488,0.9143734488848246,0.5548172757475083,0.9634368960801007,1.0,6/12,21.85%,ZDHHC12;BSN;PCLO;NLGN2;SHANK1;DLG4
prerank,positive regulation of neuron projection development (GO:0010976),0.3121789032133443,0.9143273901477732,0.5892448512585813,0.9629452651056079,1.0,11/85,7.81%,NTRK3;COBL;PTK7;MAGI2;EP300;RAP1A;PTK2B;BMP5;TWF1;AVIL;ARSB
prerank,IRE1-mediated unfolded protein response (GO:0036498),0.3344501665371246,0.9142815279142111,0.5789473684210527,0.9624481341171295,1.0,14/52,15.53%,ZBTB17;ADD1;SHC1;MYDGF;FKBP14;SSR1;HYOU1;DNAJB11;GSK3A;PREB;GFPT1;DNAJC3;LMNA;ATP6V0D1
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),-0.2895257987624556,-0.914248243362999,0.568904593639576,0.8753793857582103,1.0,10/25,22.07%,TMEM50A;LYST;CHMP3;LAPTM4B;SORT1;CHMP2B;MVB12A;CHMP7;UBXN6;CHMP4C
prerank,positive regulation of cellular protein catabolic process (GO:1903364),0.3940043802214178,0.9142474634187807,0.5812220566318927,0.9619320935279356,1.0,7/18,15.37%,CD81;MSN;EZR;ATP5IF1;ABCA2;VPS11;HSP90AA1
prerank,chromatin remodeling at centromere (GO:0031055),-0.27602313661193284,-0.9141635757227086,0.5818815331010453,0.8743538228240095,1.0,17/31,33.60%,RUVBL1;ITGB3BP;CENPP;HJURP;NASP;HELLS;MIS18BP1;KNL1;CENPU;CENPX;NPM1;CENPI;MIS18A;CENPN;CENPA;SMARCA5;CENPV
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.3674628162130595,0.9140922696838187,0.5879194630872483,0.9616830865218012,1.0,3/30,6.65%,OGT;FHIT;DDRGK1
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.3245310075158178,0.9136824758595979,0.5626535626535627,0.9619820907665403,1.0,7/52,11.34%,SORBS1;STAC3;PTPN9;LGALS3;AKAP5;CNPY4;EPHA3
prerank,regulation of hydrolase activity (GO:0051336),0.3216594495484987,0.913664366379084,0.6040428061831153,0.9614264895572691,1.0,20/71,17.97%,NGEF;PLXNB1;EPHA4;PLXNA2;SIPA1L1;CAV1;ADAP1;EFNA5;ARHGEF5;ATP5IF1;PAFAH1B1;EPHA3;PLXNB2;OCRL;ARHGAP27;ITGB1BP1;PLXNA3;CRK;RAP1GAP;ARHGAP44
prerank,carbohydrate homeostasis (GO:0033500),0.31826264819542976,0.9135594969034088,0.5813106796116505,0.9610717627789058,1.0,11/67,12.51%,PRKAA2;MCU;ALOX5;HECTD4;KLF7;BAD;TCF7L2;CRY2;KCNB1;PDK2;PTPN2
prerank,peptidyl-glutamic acid modification (GO:0018200),-0.29887356076398724,-0.9135396176773152,0.607773851590106,0.8746803922562351,1.0,12/24,29.38%,TTLL4;TTLL11;CFAP20;AGBL4;TTLL5;CEP41;VKORC1;GGCX;TTLL7;TTLL8;AGBL5;TTLL6
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.36259156888586597,0.9133531373018281,0.5682137834036568,0.9609205824614647,1.0,5/29,12.23%,CCL5;MOSPD2;LGALS3;CREB3;ANO6
prerank,mitochondrion distribution (GO:0048311),-0.35750582664442965,-0.9132948293081744,0.6106666666666667,0.8740617430818515,1.0,5/12,16.83%,LRRK2;MTM1;TRAK2;ATCAY;MSTO1
prerank,protein mono-ADP-ribosylation (GO:0140289),-0.3740381480057112,-0.9130466554559528,0.5601023017902813,0.8734560697162677,1.0,3/11,7.87%,PARP12;PARP14;PARP8
prerank,regulation of protein kinase activity (GO:0045859),0.3073663369185622,0.9128721644809807,0.6006787330316742,0.961397392378411,1.0,25/106,19.80%,DAXX;TRIB2;CDKN1A;RAP1A;QARS1;PTK2B;HSPB1;TARBP2;TSC2;CAMKK1;IQGAP1;CHP1;PYDC1;SMCR8;GNAQ;JTB;ITGB1BP1;RAP2C;RELN;PRKAG1;TAB2;CAMK2N1;PARK7;RB1;UVRAG
prerank,protein maturation (GO:0051604),0.31017482345917324,0.9127673799998661,0.6270996640537514,0.9610500146169806,1.0,20/95,17.31%,TSPAN5;OGT;ADAM10;NAA40;CIAO1;AANAT;CPE;SRGN;AFG3L2;PITRM1;SDE2;NDUFAB1;ISCA1;NAA15;DNAJB11;NAA10;TASP1;BACE1;LMF2;STUB1
prerank,gene expression (GO:0010467),0.286358388983971,0.9126129632539827,0.6919191919191919,0.9608013962378352,1.0,78/348,19.17%,THRB;TSPAN5;CELF2;MRPS16;SRSF2;EEF1A1;MRPL24;MRPL37;CREBL2;POLR2H;HARS1;RPS4X;NKX2-8;MRPS7;POLR2A;RNASEL;NUP93;EIF4A3;GOLPH3;SMG7;ABCF1;DDX39B;RBM8A;XRN2;RPL31;RPSA;NDC1;GSPT2;WDR33;RPL22;AGFG1;MRPS33;PTMA;RPL28;SRSF7;SRBD1;RPS26;POLDIP3;MRPL9;COPS5;THOC7;HNRNPUL1;SYNCRIP;DNAJB11;RNPS1;HARS2;RPL10A;SRSF9;MRPS15;SARS1;TASP1;UPF3B;EIF4G1;TNIP1;PABPN1;MRPS18C;RPL14;DUSP11;RRBP1;MAGOHB;MAGOH;RPS27A;CLP1;E2F1;LMF2;STUB1;AAAS;POLR2C;HBS1L;IGF2BP3;RBMS2;SRSF1;RAE1;POLR2E;SRSF5;EIF4EBP2;RPL6;FARSB
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),-0.30450792206323696,-0.9125148197086803,0.5523255813953488,0.8735478044830842,1.0,10/22,27.32%,ESR1;PSMC6;MED4;TP53;PAXIP1;MED16;SRF;SUB1;MED14;DHX36
prerank,regulation of telomere maintenance (GO:0032204),0.3638580391517445,0.912241148955536,0.5685997171145686,0.9610268649388195,1.0,11/26,25.08%,MRE11;ATRX;PML;MYC;NBN;RAD50;PPP1R10;ERCC4;TERF2;TINF2;HDAC8
prerank,arachidonic acid metabolic process (GO:0019369),-0.27031440066086754,-0.9118157647924482,0.6396761133603239,0.8740463213357407,1.0,7/35,9.27%,PLA2G4A;PTGIS;CYP1B1;MGLL;PTGS2;PNPLA8;PTGES
prerank,nitric oxide biosynthetic process (GO:0006809),0.41662910963708266,0.9116345965427733,0.5521669341894061,0.9617746611437689,1.0,3/13,7.65%,CYB5R3;DDAH2;CYB5B
prerank,positive regulation of chemotaxis (GO:0050921),0.34041423841541385,0.9111411532698221,0.5714285714285714,0.962281004486882,1.0,3/43,4.59%,CDH13;NTRK3;HSPB1
prerank,Golgi to endosome transport (GO:0006895),0.40308697063594245,0.9109065278685959,0.5772727272727273,0.9622266168468024,1.0,4/16,11.70%,CORO7;VPS13A;MON2;AP2A1
prerank,nucleoside diphosphate metabolic process (GO:0009132),-0.3487884185652139,-0.9101634763937513,0.5914634146341463,0.8767552383417199,1.0,7/15,20.98%,ENTPD1;CMPK2;NME2;AK4;ENTPD3;ENTPD5;ENTPD6
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.3000658704611451,0.9101147706995363,0.6138079827400216,0.9633487271538895,1.0,18/136,9.13%,NLRP2;KLF4;CD200;NUPR1;ZC3H12A;GLIS2;HDAC4;ANXA4;WWP2;NFKBIA;COMMD7;TRIM21;NLRP2B;PKD1;TCF7L2;CHP1;FOXP3;PYDC1
prerank,purine-containing compound biosynthetic process (GO:0072522),0.3717778284004747,0.909859846468843,0.5758865248226951,0.963314923941532,1.0,10/25,22.64%,ADK;PAICS;GMPS;SHMT1;GART;AMPD2;DGUOK;PRPS1L1;PRPS1;APRT
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),-0.2802334375414347,-0.9097050491636945,0.6040816326530613,0.8766292885443363,1.0,6/34,7.85%,PTPRB;PTPRJ;UBASH3B;TNS2;PTPN12;PTPRZ1
prerank,positive regulation of macroautophagy (GO:0016239),0.33508416828449755,0.90967977426175,0.5951776649746193,0.9631342866485879,1.0,13/48,16.55%,PRKAA2;SESN2;TSC2;HSPB8;BAG3;SMCR8;VDAC1;PIP4K2C;BNIP3L;VPS13D;IKBKG;SESN1;SLC25A4
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.3950405629443778,0.909597309821768,0.55,0.9627213067447093,1.0,2/19,3.24%,SULT1A1;SULT2B1
prerank,mitochondrial genome maintenance (GO:0000002),-0.367931144606668,-0.9094888732186894,0.5955678670360111,0.8759236103346806,1.0,3/11,12.36%,AKT3;SLC25A33;TOP3A
prerank,genitalia development (GO:0048806),-0.35994376186750693,-0.909394735391823,0.5803108808290155,0.8749337243521956,1.0,4/12,7.99%,WNT5A;TBX3;CHD7;DNAJC19
prerank,chemical homeostasis (GO:0048878),-0.2368946998264983,-0.9089517728998646,0.6764705882352942,0.8748358864338257,1.0,11/61,9.65%,ZBTB20;SLC4A10;KLHL3;NR1D2;WNK2;NR1H3;PNPLA8;AQP11;AQP4;PPARG;ACOX1
prerank,positive regulation of cell killing (GO:0031343),-0.3489554928751688,-0.9089207001450395,0.550531914893617,0.8737304945570494,1.0,1/13,2.77%,WNT5A
prerank,cellular protein localization (GO:0034613),0.2894641734900508,0.9088961475040257,0.6851282051282052,0.9636641138063179,1.0,56/285,18.08%,RAB17;ANGPT1;ANK2;CELSR1;OCLN;EMP2;PIGU;WNT11;GRTP1;KIF13A;TBC1D16;CSRP3;EHD1;ARL4A;COPA;AP3B1;PTPRU;SNX8;SIL1;TMED1;ARMCX3;CPE;WLS;UNC50;STXBP1;GGA1;TM9SF1;SGSM2;AP2A1;ARFIP2;RABL3;TBC1D1;MESD;NAPA;CPLANE2;VIPAS39;STX11;ARF4;SEPTIN9;NAPB;VPS26B;RAB5C;RAB1B;STX16;USP6NL;FLNA;PRPF19;TBC1D22A;VCL;NSF;TBC1D10A;PACSIN1;HDAC6;ARFRP1;STX4;SEC23IP
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",0.3412505039804603,0.9085755420046079,0.559322033898305,0.9637460395339197,1.0,13/39,19.88%,RBX1;POLK;ERCC5;RPA3;POLD2;PCNA;FAN1;DDB1;RPS27A;UBC;ERCC2;RFC1;ERCC4
prerank,phospholipid biosynthetic process (GO:0008654),0.35476616020129376,0.9085610266180042,0.5867549668874172,0.9631899358642451,1.0,8/36,14.45%,SGMS2;FDPS;AGK;SRD5A3;FADS1;GPAM;DOLK;NUS1
prerank,secondary palate development (GO:0062009),-0.34335701491082343,-0.9085414648121783,0.5921052631578947,0.8734385670177643,1.0,4/14,8.72%,LEF1;WNT5A;CHD7;LRRC32
prerank,lymphocyte proliferation (GO:0046651),-0.300577931098284,-0.9084646679236077,0.6112852664576802,0.8724089097639258,1.0,8/22,21.32%,ELF4;BCL2;CTPS1;PPP3CB;HELLS;CD40;HSPD1;FLT3
prerank,hepaticobiliary system development (GO:0061008),0.38618895584763896,0.908450537635169,0.5841726618705037,0.962820707500971,1.0,6/20,18.96%,COBL;NKX2-8;LSR;TGFBR3;PRKCSH;CDK5RAP3
prerank,lymphocyte migration (GO:0072676),0.3503173945876183,0.9083103976052294,0.5889487870619946,0.9625464762164491,1.0,3/32,12.94%,CCL5;MSN;GATA3
prerank,atrioventricular valve morphogenesis (GO:0003181),0.39600130371905085,0.9082960954902067,0.5809379727685325,0.9620047476813169,1.0,9/19,24.30%,SMAD6;OLFM1;TGFB2;TGFBR2;BMPR1A;SOX4;EFNA1;MDM4;ZFPM1
prerank,intracellular cholesterol transport (GO:0032367),0.40600552865576217,0.9081902187958689,0.5856697819314641,0.961659161893228,1.0,6/15,18.13%,LDLR;NPC1;STARD4;VPS4A;RELCH;OSBPL2
prerank,embryonic skeletal system development (GO:0048706),0.35064894303763483,0.9081456588579776,0.6040540540540541,0.9611637100551238,1.0,3/35,2.61%,KIAA1217;HOXA4;WNT11
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),0.43839911868569637,0.9079465719346725,0.5957792207792207,0.9609998825931,1.0,3/10,13.02%,CACNB3;NIPSNAP2;CACNB2
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.36455948563630036,0.9078985725084223,0.5689900426742532,0.9605354477276022,1.0,5/26,10.40%,PPM1B;MUL1;TRIM21;NMI;CARD16
prerank,negative regulation of transferase activity (GO:0051348),0.36154415635202,0.907875467389436,0.5833333333333334,0.9600145689362002,1.0,11/28,22.09%,FBXO5;IRS2;GSK3A;PINX1;GSK3B;ABL1;EIF4A2;PARK7;ERCC4;MAPT;MEN1
prerank,long-term synaptic potentiation (GO:0060291),-0.3034027858460134,-0.9078179951285757,0.597444089456869,0.8727988795639321,1.0,5/21,8.77%,SLC8A3;GRIN2A;GRIN2B;SLC24A2;NFATC4
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),-0.282942319457189,-0.9072379089707826,0.6167247386759582,0.8730410364282034,1.0,7/27,9.51%,MARK1;IL1RAPL1;MBOAT1;BRSK1;CTNNA2;VPS35;NTNG1
prerank,nuclear pore organization (GO:0006999),0.4147602813819025,0.9071599834446881,0.5965732087227414,0.9609659465566397,1.0,8/14,28.94%,NUP93;NDC1;TPR;SEH1L;NUP133;TMEM170A;RTN4;NUP35
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),0.4030154064153576,0.9070959378004231,0.5683563748079877,0.9605299408957234,1.0,3/17,5.38%,MCU;RIPOR2;MOSPD2
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),0.42745520713708984,0.906981343759866,0.5742251223491027,0.9601932894272173,1.0,1/11,1.77%,EFNB2
prerank,presynapse assembly (GO:0099054),-0.32792659011435893,-0.9069166064878617,0.5903954802259888,0.872567761612599,1.0,6/16,16.06%,IL1RAPL1;WNT5A;NLGN1;FZD1;NLGN3;LRRTM3
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),0.39555284989837547,0.9068753898493161,0.5623100303951368,0.9598223243834499,1.0,3/19,5.38%,MCU;RIPOR2;MOSPD2
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),0.33668730071796255,0.9065772314193056,0.5950520833333334,0.9598639945972803,1.0,7/45,8.45%,REPS2;GAB1;PTK2B;SOX9;SHC1;EFEMP1;IQGAP1
prerank,regulation of lipase activity (GO:0060191),-0.35383459434178866,-0.9065674040065244,0.5788043478260869,0.8722310789495515,1.0,1/13,0.56%,PCSK5
prerank,nitric oxide metabolic process (GO:0046209),0.412100715675773,0.9064827878417517,0.573015873015873,0.959484107586794,1.0,3/14,7.65%,CYB5R3;DDAH2;CYB5B
prerank,clathrin-dependent endocytosis (GO:0072583),0.37609907170491613,0.9060424637420414,0.5904486251808972,0.9598778720897397,1.0,4/26,4.41%,CLTB;FCHSD2;AP2A2;GPR107
prerank,motile cilium assembly (GO:0044458),-0.35741852962030246,-0.9059716744360078,0.6,0.8724633687658612,1.0,8/12,46.03%,BBOF1;DNAAF3;CCDC39;RSPH9;CCDC40;E2F4;RSPH6A;DNAAF1
prerank,regulation of cell growth (GO:0001558),0.290339914747433,0.9055027124534751,0.6787941787941788,0.9604724079539256,1.0,39/204,16.35%,AGTR1;CDKN1A;ADAM10;HPN;WNT11;FHL1;SGK3;SESN2;PPP2CA;LTBP4;SH3BP4;ROS1;MUL1;OSGIN2;EGLN2;TGFB2;PSRC1;CDC42;NDUFS3;PML;DCUN1D5;APBB1;ADAM15;SMARCA4;SOCS2;EIF4G2;CHPT1;OGFR;BCAR1;CDKN2AIP;CAPRIN2;PRDM11;SFRP1;EIF4G1;FLCN;RAB33B;IP6K2;CCDC85B;FRZB
prerank,synaptic vesicle exocytosis (GO:0016079),0.34463921060559755,0.9053249869385653,0.5817245817245817,0.9602611390569561,1.0,5/40,8.85%,UNC13C;OTOF;BLOC1S6;DNAJC5;PCLO
prerank,RNA stabilization (GO:0043489),-0.27322450265297105,-0.9049655626275092,0.6070038910505836,0.8737373488854817,1.0,14/33,29.03%,TENT5A;ZCCHC17;EIF4ENIF1;AXIN2;DKC1;PARN;TENT5D;NOCT;TENT2;PHAX;SLC11A1;DHX36;RBM24;ELAVL1
prerank,intracellular protein transmembrane transport (GO:0065002),0.3398379387102973,0.9048513546064911,0.5809768637532133,0.9607127771315087,1.0,12/42,22.77%,PEX26;TIMM44;DNLZ;ROMO1;TOMM20;TIMM17B;PEX6;PEX2;TOMM40L;TOMM40;TIMM50;TIMM23
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.42482731716265,0.9046345837041849,0.5902668759811617,0.9605862622584073,1.0,5/12,22.39%,LARP7;HEXIM1;NELFB;NELFA;RNF168
prerank,negative regulation of interleukin-1 beta production (GO:0032691),0.3830419012662288,0.9043266429968639,0.5707964601769911,0.9606731714255421,1.0,4/19,10.40%,ZC3H12A;NLRP2B;PYDC1;CARD16
prerank,potassium ion homeostasis (GO:0055075),0.3768247669464121,0.9043066522396159,0.5955882352941176,0.9601360221146796,1.0,8/23,21.09%,SLC12A8;ATP1A2;SLC12A4;SLC12A6;ATP1B3;ATP1A3;ATP1A4;ATP1A1
prerank,regulation of microtubule depolymerization (GO:0031114),0.37110720662098756,0.9041088619560123,0.5952380952380952,0.9599642629909493,1.0,1/25,0.23%,FGF13
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.32192177312725184,0.9039172078437068,0.6009615384615384,0.9597802213733854,1.0,21/62,24.82%,MLLT3;GTF2F1;POLR2H;ELOB;POLR2A;SSRP1;ELP4;ELL;ELP2;ERCC2;NELFB;POLR2C;POLR2E;NELFA;ELOF1;AFF4;CTR9;CDK9;LEO1;MNAT1;POLR2K
prerank,protein secretion (GO:0009306),-0.242418865909411,-0.9034664494628805,0.6491228070175439,0.8760694104550352,1.0,10/56,11.91%,ABCA1;PCSK5;STEAP3;MTTP;RCN3;SEL1L;TVP23B;PPY;TMEM167A;TANGO2
prerank,DNA double-strand break processing (GO:0000729),0.39659668253125163,0.9033341969117483,0.5752773375594294,0.9604438839913435,1.0,5/18,18.05%,RNF138;MRE11;UBE2N;NBN;RAD50
prerank,regulation of steroid metabolic process (GO:0019218),0.3770037608750931,0.9032284661706528,0.5734870317002881,0.9601005961559869,1.0,4/23,11.07%,RORC;TTC39B;ACADL;ABCA2
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),-0.33658129017692306,-0.9031176954942882,0.5671641791044776,0.8757243190665638,1.0,6/14,24.80%,AUTS2;WDR5;PAXIP1;PRDM9;SMAD4;BRCA1
prerank,sulfur amino acid catabolic process (GO:0000098),0.43374722593194004,0.9029041551653392,0.5785256410256411,0.9602272550955424,1.0,3/10,22.36%,ADO;TXN2;BLMH
prerank,chromatin organization involved in regulation of transcription (GO:0034401),-0.3513607944569289,-0.9026972854484508,0.592896174863388,0.8755008371923223,1.0,7/13,26.31%,ZMIZ1;ARID1A;PADI2;SERTAD2;SMARCD1;SPI1;CHEK1
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),-0.2723410666284069,-0.9026372263811542,0.6186770428015564,0.8744603807249511,1.0,9/33,9.23%,ACVRL1;NOTCH1;FGF2;THBS1;CARD10;RGCC;TGFB1;MECP2;PPARG
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.3312702399208388,0.9025778963580674,0.5952677459526775,0.960360288584815,1.0,6/48,7.99%,ANK2;DIAPH1;PTK2B;SELENON;GSTO1;JPH2
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.3343688157770555,0.902397751600213,0.5824742268041238,0.9601569941305653,1.0,18/48,22.27%,EP300;POLR2H;TAF1C;ASF1A;ACTB;POLR1C;MYO1C;POLR1E;POLR1F;SERTAD1;CDCA4;ZMIZ2;POLR2E;ARID1B;TBP;ELOF1;PHF2;POLR1G
prerank,protein heterotetramerization (GO:0051290),-0.3468046691809137,-0.9022405432780762,0.5741239892183289,0.8742036462331274,1.0,5/13,18.47%,PKD2;GRIN2B;NUDT21;CPSF6;CBR4
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.2779599448559649,0.9022238879058447,0.898,0.9599444613767549,1.0,295/1668,16.88%,PRKCB;NFATC2;CDH13;ZBTB7C;NR3C2;KLF5;THRB;PRDM6;TMPRSS6;TBR1;KLF4;TFAP2C;PBX3;PPARGC1A;NCOA3;PBX1;KLF3;GAL;ZIC4;TFAP2D;DMRT2;ELF3;OGT;SREBF2;CDKN1A;RORC;SMAD6;FOXP2;GLI3;DDX5;GTF2F1;HOXA4;TRIM33;HIVEP1;ZC3H12A;GABPB1;GABPB2;KLF12;CAV1;FOXP4;MAVS;ZNF436;EP300;ZFHX4;TOX4;HDAC5;ZMYM5;ZNF692;MXD4;CD81;CC2D1B;KANK2;FOXO3;CSRP3;FOS;GDNF;PCGF6;RELB;MGA;FOXC2;SP5;ZNF219;GLIS2;NOP2;KLF16;CGGBP1;PPP1R13L;HDAC4;BMP5;NFE2L2;NR6A1;ZBTB16;ZBTB8A;ANXA4;EPO;WWP2;SSBP3;MTDH;CIAO1;DOT1L;SMARCB1;RHOQ;FOXD2;POU2F3;NFE2L1;NACC1;NFKBIA;BEND3;CDK4;ESRRB;RARG;RFX7;PHF21A;IRF3;PRRX2;SLTM;JUND;OVOL2;NKX2-8;PATZ1;LCOR;CREB1;ZBTB46;ZIK1;FOXM1;HOXA5;ZBTB17;RXRB;RNASEL;MOV10;PCGF3;SOX9;OTUD7B;FOXD1;HCFC1;AKNA;ZIC2;HAX1;NRF1;ZBTB7B;KAT6B;MYDGF;DDRGK1;PHF10;BMP4;MEF2D;MAPK7;CC2D1A;KLF7;MED30;STAT4;NKAP;PLK3;DVL3;FIZ1;ZNF471;ZFHX3;ZNF418;LARP7;CIC;PPM1A;ATRX;SIX1;PKD1;MAZ;JUN;FZD5;POU3F1;TCF7L2;CRY2;ELP4;ZFP57;GRHL2;FOXP3;TNFRSF1A;KMT2A;POU5F2;BRD7;TXK;DPF2;NR2C1;DNMT3A;ZIC1;RIF1;EZR;HDGFL3;APBB1;CCND1;MED29;PRDM15;ENY2;NFIB;SAP130;ZNF467;NFYC;TWIST1;BCAS3;KDM3A;HDAC3;ARID4A;ZNF205;NFE2L3;NFIC;SOD2;SP2;KDM4C;MYT1;SMARCA4;ABCA2;MAMLD1;ARID3B;TLR4;CREB3L4;CREB3;NCOR1;AEBP2;DR1;CALCOCO1;MEF2B;SRCAP;MMP12;MED8;HOXB5;MAFG;SP1;ZBTB42;COPS5;ZNF148;ACTL6B;MIER2;DCAF6;MAFK;CPEB3;FOXK1;CCNL2;MPND;MED12;TFEB;MYSM1;BAZ2B;PIAS1;PIAS3;PPM1D;ZFP30;CHD3;GATA3;SMARCD2;ZSCAN20;RREB1;ARF4;SBNO2;NFIA;CAPRIN2;MED21;CBX4;MYC;ZNF177;MED24;ZFP1;MEF2C;TLE5;PAX3;PCGF2;ZFP92;MYBL1;ATP2B4;FOXP1;CHUK;SARS1;ZXDC;IRF2;HRAS;NCOR2;SS18L2;GATAD2B;ATMIN;FLCN;ITGB1BP1;TNIP1;RFXAP;ZFP3;MDM2;TLR3;DHX9;MED6;ZMIZ2;TET1;IKBKG;ELP2;IGBP1;KLF6;HMBOX1;RCOR2;TCF25;CDC5L;ZGPAT;IRF2BP2;CREB3L2;IFRD1;SMARCC1;CRK;RNF10;RPS27A;UBC;HEXIM1;E2F1;POU4F1;HINFP;MED27;ABL1;KDM1A;MLLT6;SLC9A1;CAMTA2;UBE2D3
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),-0.23034650514966767,-0.9020958958307806,0.6518987341772152,0.8733876286382775,1.0,22/73,25.54%,KITLG;TCF12;LMO2;RUNX1;PSMC6;PSMA6;PUS7;GATA2;PSME1;PSMB10;PSMD5;PSMD3;TAL1;PSMA4;YAP1;PSMB9;PSMA8;PSMB7;YTHDF2;PSMA3;SPI1;PSMD10
prerank,positive regulation of smooth muscle cell migration (GO:0014911),0.3958246328887478,0.9017631486825393,0.5693311582381729,0.9603563446898108,1.0,5/17,8.79%,DOCK5;CCL5;S100A11;DOCK7;ADAMTS1
prerank,cellular response to BMP stimulus (GO:0071773),0.3247067286730691,0.9010354700632306,0.6115023474178404,0.9613157744907018,1.0,9/66,7.38%,ADAMTS7;SMAD6;DDX5;HIVEP1;GDF15;BMP5;SOX9;BMP4;TGFB2
prerank,regulation of chromatin organization (GO:1902275),0.41716605194419004,0.9003142559925339,0.5842349304482226,0.9622580928231942,1.0,2/14,7.02%,MLLT3;SSRP1
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.3575431214563893,0.9002146752318764,0.5735099337748344,0.9619029454431967,1.0,15/32,30.06%,NEK7;MAPK15;MAP3K4;HMBOX1;TNKS2;ATR;PRKCQ;PNKP;FBXO4;CCT5;XRCC5;NAF1;CTNNB1;CCT8;CCT6A
prerank,termination of RNA polymerase I transcription (GO:0006363),0.3629009322745947,0.900047440557074,0.601889338731444,0.9617136377941901,1.0,14/30,26.40%,POLR2H;TAF1C;UBTF;POLR1C;POLR1E;POLR1F;ERCC2;POLR2E;TBP;POLR1G;MNAT1;POLR2K;POLR1B;TTF1
prerank,protein acetylation (GO:0006473),0.3593070616512106,0.8999471316096683,0.5880758807588076,0.9613515599686088,1.0,9/30,21.65%,EP300;NAA40;AANAT;NAA15;ING4;NAA10;MAPT;NAA35;HAT1
prerank,monosaccharide transmembrane transport (GO:0015749),0.40048182599118776,0.8996315416340354,0.5749235474006116,0.9614448606940625,1.0,3/16,12.58%,SLC2A12;SLC2A8;SLC2A9
prerank,anterograde axonal transport (GO:0008089),0.3486022294872201,0.8994713109431364,0.6049543676662321,0.9612060348585039,1.0,6/37,6.68%,BLOC1S6;AP3B1;HSPB1;KIF1C;KIF1B;AP3S1
prerank,defense response to Gram-negative bacterium (GO:0050829),0.3386337254449585,0.8993278762279842,0.5797872340425532,0.9609456852222118,1.0,6/42,11.15%,GALP;ROMO1;LBP;RNASE3;AQP1;TLR4
prerank,negative regulation of transport (GO:0051051),0.332258799976984,0.8992763892654244,0.584516129032258,0.9604953881643716,1.0,11/51,12.17%,SCAMP5;WWP2;CRYAB;ERBB3;RUBCN;LGALS3;RAB7A;ARL6IP5;SNX33;EPHA3;SNX12
prerank,cellular lipid catabolic process (GO:0044242),-0.28069967541889823,-0.8991682024528223,0.6267605633802817,0.8790225835897671,1.0,7/27,15.80%,CYP1B1;ENPP2;PPARD;ACOX1;LPIN2;ABHD12;SIRT2
prerank,axon extension (GO:0048675),0.36955807421783154,0.8989716452086316,0.5914285714285714,0.9605842654091367,1.0,1/23,0.20%,ALCAM
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",-0.33479801756950456,-0.8986583283950206,0.5853658536585366,0.8791108250664657,1.0,4/14,16.46%,SRSF4;SAP18;SRSF10;SRSF12
prerank,sphingolipid metabolic process (GO:0006665),0.3021009888217081,0.8986397400330112,0.6363636363636364,0.9607330471803973,1.0,16/108,11.50%,SPTSSB;HEXA;SGMS2;PPM1L;PPP2CA;ELOVL1;ORMDL3;AGK;GLB1;SUMF1;ELOVL6;HACD4;ABCA2;HEXB;SUMF2;CERS2
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.27836122818053327,0.8985906983257943,0.7336024217961655,0.9602548635962578,1.0,71/390,15.53%,SORBS1;FGFR1;ANGPT1;CYFIP2;NTRK3;ATP6V1B1;MMP9;NGEF;EPHA4;PDGFC;EFNB2;HPN;FLRT1;GTF2F1;SIPA1L1;GDF15;GAB1;SHB;NGF;RBFOX2;PTK2B;FOXC2;AP2A2;POLR2H;RHOQ;TSC2;CAV2;ROS1;POLR2A;EFNA5;SHC1;AP3S1;PXN;ZFYVE27;ERBB3;FGF22;STYK1;CDC42;VEGFB;LMTK2;ACTB;NRP2;ABI1;MUSK;ACTG1;PDK2;EPHA3;SOCS2;IRS2;MVP;AP2A1;RHOA;BCAR1;EIF2AK3;PTPN2;RASA1;DDR1;DOCK1;GSK3A;FLRT3;SHC2;GSK3B;HRAS;NUS1;ATP6V1E1;EFNA4;AAMP;ATP6V1D;RAPGEF1;HSP90AA1;ATP6V0D1
prerank,positive regulation of organelle organization (GO:0010638),0.3540688382697995,0.8985571807823997,0.5691056910569106,0.9597637296352182,1.0,4/32,14.36%,PPARGC1A;ANXA2;SMCR8;GSK3B
prerank,positive regulation of axon extension (GO:0045773),0.37557976332380266,0.8985306930773971,0.5931232091690545,0.9592449860470125,1.0,6/22,20.66%,ISLR2;ZFYVE27;MAP3K13;SHTN1;MAPT;DBN1
prerank,regulation of epidermal cell differentiation (GO:0045604),-0.307876590665735,-0.898020552869598,0.6045751633986928,0.8793947129149738,1.0,8/21,18.73%,ERRFI1;RUNX1;ROCK1;SFRP4;CTSL;SGPP1;ZFP36;MAFF
prerank,determination of heart left/right asymmetry (GO:0061371),0.3373303058215574,0.8979474038902734,0.5864661654135338,0.959942997171712,1.0,3/42,2.24%,TBR1;SMO;MICAL2
prerank,protein N-linked glycosylation (GO:0006487),0.3155879077020376,0.8978802525199069,0.6136363636363636,0.9595391459268192,1.0,15/66,13.96%,B4GALNT2;ASGR1;MGAT3;TMEM165;MGAT1;FUT8;DDOST;SRD5A3;ALG1;MCFD2;MGAT4C;DPM2;ALG12;ALG5;GFPT1
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.2843418676690034,0.8977652753523495,0.6892307692307692,0.9592131558027716,1.0,71/241,23.24%,DDX5;GTF2F1;SRSF2;RBM19;POLR2H;SNRNP70;SNRPB;POLR2A;SRRM2;EIF4A3;RALY;LSM4;DDX39B;RBM8A;HNRNPH2;WDR33;PHF5A;DBR1;SF3B3;USP39;MTREX;SRSF7;SF3A2;ZCCHC8;FRG1;HNRNPUL1;GPATCH1;SYNCRIP;RBM10;RNPS1;PNN;CSTF1;SRSF9;SRRT;UPF3B;GEMIN6;PLRG1;ISY1;DHX9;PABPN1;CWC15;CDC5L;MAGOHB;MAGOH;PRPF19;CLP1;PRPF40B;PRPF6;POLR2C;HNRNPA3;SRSF1;PPIL1;POLR2E;PTBP1;SRSF5;ZMAT5;PCBP2;CSTF3;WBP4;SF3A3;PUF60;PRPF8;SFPQ;YBX1;DDX23;GEMIN5;U2AF1;PABPC1;RBM15;SPEN;SRRM1
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.29762062004904744,0.8974529400652103,0.6320346320346321,0.9592924092881723,1.0,29/119,19.29%,PITPNM2;TTC7A;PIGU;PITPNM3;MTMR12;PIK3C2B;INPP5E;IP6K1;INPP4A;PI4KA;PIGZ;PGAP2;MTMR3;SOCS2;MBOAT7;PIGA;OCRL;PIP4K2C;EFR3A;DPM2;SOCS6;PIGN;IP6K2;PI4K2A;PTPN13;CDS1;CDIPT;PIGP;PIGQ
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.38019205716656346,0.8974103619864384,0.5942249240121581,0.958822901032486,1.0,3/20,10.67%,CCL5;YWHAB;GRK2
prerank,innate immune response (GO:0045087),0.2866287256546711,0.897247092851745,0.6934984520123839,0.9585973944609465,1.0,33/217,15.47%,TRIM60;PPP1R14B;SERINC5;MAVS;SLPI;PGLYRP3;PTK2B;RELB;TRIM59;TRIM25;NUB1;CFP;TRIM21;ANG;STYK1;PML;LBP;PYDC1;TRIM26;TRIM11;RNASE3;SRPK2;CR2;ADAM15;TLR4;ANKRD17;FCER1G;SRPK1;IRAK1;CHUK;VNN1;TLR3;IKBKG
prerank,protein autoubiquitination (GO:0051865),0.3158991217900768,0.8970437035782889,0.6156626506024097,0.9584253763330572,1.0,16/61,19.09%,RNF220;SH3RF2;WWP2;TRIM21;RNF146;UBE2B;KLHL24;RNF141;MDM2;BFAR;RNF10;UBE2D3;STUB1;TRIM37;RNF112;RNF41
prerank,organelle assembly (GO:0070925),0.27987491942274156,0.89665145686126,0.7267267267267268,0.958665651185689,1.0,83/384,20.10%,RAB17;PGM5;MAPRE2;CYS1;ABLIM1;PARVA;TMOD3;GSN;YTHDF1;NEK7;TMOD2;EHD1;CNGA2;ARL3;INPP5E;VPS37B;LMOD3;CCDC28B;RAB11FIP3;AVIL;NSFL1C;IFT46;PRRC2C;EXOC7;CFAP54;EXOC4;LSM4;PKD1;CHMP4A;CHMP4B;CC2D2A;IFT80;RAB7A;CENPT;EXOC2;HDAC3;EMC6;NCOR1;VPS4B;CPLANE2;CNGB1;EXOC8;ARF4;CHMP1A;OCRL;MKKS;VPS4A;ULK1;RAB1B;ATP6V1D;SQLE;MAP1LC3B;CHMP2A;RB1CC1;ATP6V0D1;FLNA;TMEM41B;ATXN2L;TMEM138;PTPDC1;ATG16L2;DYNC1H1;RAB8B;HDAC6;RILPL1;CDS1;PDCD6IP;PATL1;ZFYVE1;STAM;TSG101;FHDC1;WDR35;UBAP2L;GALNT11;YTHDF3;TUBGCP5;ABCB6;VPS37A;TXNDC15;CENPF;MAPT;IST1
prerank,myeloid cell development (GO:0061515),-0.3168100258931202,-0.896649445445094,0.6,0.8813854465395328,1.0,5/18,11.25%,ALAS1;SH2B3;KIT;NCKAP1L;NRROS
prerank,regulation of glycogen metabolic process (GO:0070873),0.4172524152855471,0.8965788481512552,0.6026272577996716,0.9582443491984995,1.0,5/12,28.47%,RUBCNL;PPP1R3F;PPP1R3C;PPP1R3B;AKT1
prerank,chromosome condensation (GO:0030261),0.3414279412232888,0.8964668896265627,0.5930851063829787,0.9579187078073802,1.0,12/36,23.01%,ACIN1;TENT4A;NCAPD3;CHMP1A;SET;NCAPH2;GPER1;RB1;PHF13;NCAPH;SMC4;KMT5A
prerank,magnesium ion transport (GO:0015693),0.41538263221834304,0.8964619381904937,0.5920398009950248,0.9573688023731843,1.0,5/12,22.91%,NIPAL3;SLC41A1;NIPA2;CNNM4;MMGT1
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),-0.30046417548229276,-0.8962565453017722,0.6390728476821192,0.8811106600174157,1.0,4/23,6.77%,PLA2G4A;MBOAT1;PLAAT3;PNPLA8
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.2781581740378839,0.896233473710978,0.7678391959798995,0.9572790677587861,1.0,78/476,14.30%,CDH1;NFATC2;WNT1;KLF4;PPARGC1A;MAP3K5;LBH;RORC;NIBAN2;GLI3;MLLT3;CAND2;WNT11;EP300;FOXO3;FOS;FOXC2;GLIS2;CREBL2;HDAC4;ZBTB16;EPO;TRIM44;ESRRB;BICRA;CREB1;FOXM1;RXRB;SOX9;HCFC1;ZIC2;SHC1;KAT6B;BMP4;MED30;ILK;TGFB1I1;DVL3;ZFHX3;DYRK1B;PPM1A;SIX1;PSRC1;MAZ;JUN;POU3F1;PML;FOXP3;KMT2A;BRD7;MAP2K2;ZIC1;PHF5A;APBB1;ILF2;ENY2;NFIB;KDM3A;SMARCA4;CALCOCO1;NAA15;SP1;FOXK1;MED12;TFEB;SPIN1;GATA3;RREB1;MYC;PRDM11;MED24;MEF2C;PAX3;MYBL1;SFRP1;CHUK;TASP1;ZXDC
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),0.41312695484145634,0.8962107754930787,0.6016260162601627,0.9567680647581632,1.0,3/13,9.24%,ELOVL1;ELOVL6;HACD4
prerank,negative regulation of growth (GO:0045926),0.2977694107669931,0.8959212763837303,0.646273637374861,0.9568092607734325,1.0,25/121,16.35%,NOTCH2;CDKN1A;WNT11;FHL1;SESN2;PPP2CA;SH3BP4;MUL1;OSGIN2;TGFB2;PSRC1;NDUFS3;PML;APBB1;ADAM15;SMARCA4;CDKN2AIP;CAPRIN2;PRDM11;ING4;SFRP1;FLCN;IP6K2;CCDC85B;FRZB
prerank,interleukin-12-mediated signaling pathway (GO:0035722),0.3305686172837554,0.8954766846646368,0.6027742749054225,0.9571996867019887,1.0,9/46,11.60%,RAP1B;GSTO1;ANXA2;MSN;MTAP;STAT4;CDC42;SOD2;JAK1
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.4004537580072743,0.8951813681560139,0.5808823529411765,0.9572981791215139,1.0,1/15,1.13%,PPARGC1A
prerank,glutathione biosynthetic process (GO:0006750),0.42526105809223397,0.8949434577339531,0.5887096774193549,0.9572477052989455,1.0,1/11,3.31%,HAGH
prerank,positive regulation of sodium ion transport (GO:0010765),0.42132701618346347,0.8943951702607683,0.5793650793650794,0.9578004822086005,1.0,2/12,6.82%,AHCYL1;ANK3
prerank,histone modification (GO:0016570),0.30011863785622883,0.8941946292140632,0.6375838926174496,0.9576638199692815,1.0,30/109,21.56%,CPA4;EYA2;EP300;HDAC5;HDAC4;NTMT1;KAT6B;EYA1;MORF4L2;AURKC;UBE2B;ENY2;USP3;MIER2;CDK2;RCOR2;UBE2N;PRMT1;HDAC6;TRRAP;SGF29;PARP2;USP21;USP16;PARK7;MRGBP;PRMT2;RCOR3;USP22;TAF6
prerank,regulation of p38MAPK cascade (GO:1900744),0.34569799005998686,0.8940020348351121,0.6146540027137042,0.9574895892674528,1.0,8/35,11.96%,ZC3H12A;DUSP10;DUSP1;MAP3K4;RELL1;EZR;EMC10;GADD45B
prerank,negative regulation of mRNA processing (GO:0050686),-0.3261604197711449,-0.8935801717994404,0.6260387811634349,0.8860405851875249,1.0,4/15,16.46%,SRSF4;SAP18;SRSF10;SRSF12
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.3413593995929078,0.8933643748580317,0.5884665792922673,0.9582350084147704,1.0,6/38,8.04%,ZC3H12A;TRIM59;PPM1B;USP10;OTUD7B;PPM1A
prerank,cellular response to cytokine stimulus (GO:0071345),0.2785094717057863,0.8932027933994289,0.7595190380761523,0.9580299208697218,1.0,80/416,17.13%,FN1;PTPN14;CRLF1;MMP9;CCL5;VIM;ADAMTS7;CDKN1A;RORC;ZC3H12A;IL16;CXCR4;LAMA5;EPRS1;FOXO3;FOS;DAPK3;CLCF1;YBX3;NFE2L2;DAPK1;TIMP1;IL3RA;ALOX5;RIPOR2;DUSP1;USP10;BCL2L1;SOX9;STK39;HAX1;SHC1;CSK;PTPN9;STAT4;UBE2G2;OXSR1;NDN;LBP;TNFRSF1A;SHMT1;PTPN6;CCND1;TWIST1;GSDME;TLR4;IL1R2;SOCS2;JAK1;RHOA;YWHAZ;NPNT;ST3GAL6;PTPN2;SYNCRIP;GATA3;SBNO2;RHOU;MYC;GSK3A;IRAK1;ZFAND6;SFRP1;SOCS6;CHUK;GSK3B;WNK1;GAPDH;RAPGEF1;DHX9;HSP90AA1;ITGB2;FSCN1;CRK;RPS27A;UBC;POU4F1;PDE1B;PRTN3;PTPN13
prerank,protein polyubiquitination (GO:0000209),0.27894933914337744,0.893088671733232,0.7113613101330604,0.9577010772534749,1.0,74/297,23.51%,FZR1;RNF152;FBXL7;FBXW8;FBXL20;LONRF1;WWP2;RNF5;PSMD11;MUL1;PSMD4;PSMF1;TRIM21;MAGEL2;UBE2G2;FBXL18;RBX1;RNF146;FBXO31;UBE2B;PSMD7;FBXW9;UBE2Q1;RNF126;MIB2;PSMB5;ANAPC4;NPEPPS;PELI1;DDA1;UBE4A;UBR5;NEDD4;UBE2H;MDM2;BFAR;RNF31;UBE2N;PRPF19;TNKS2;FBXL15;TPP2;RPS27A;UBC;UBE2D3;SIAH1;STUB1;UBE2J1;PSMD1;PSMC4;RNF41;PSMD8;UBE3C;FBXO9;THOP1;RMND5A;ZFP91;CHFR;FBXW7;TRIM5;UBE2E1;FBXW2;ARIH2;TRAF3IP2;UBE2V1;SMURF2;BLMH;RNF168;RNF213;TRIM3;RNF14;CDC23;PSMA7;FBXO4
prerank,cellular macromolecule catabolic process (GO:0044265),0.33072471961487665,0.8928537467767851,0.6257982120051085,0.9576488373174565,1.0,9/49,10.46%,RNF5;DENND3;SIDT2;UBE2G2;MANBA;XRN2;RNASE3;DNASE1L2;MTREX
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),-0.3322182839693969,-0.8926815462490697,0.5952380952380952,0.886971298330802,1.0,6/15,25.77%,TNFRSF1B;ADAM9;PACSIN3;SNX9;SH3D19;ADAM8
prerank,somite development (GO:0061053),0.43173874330047207,0.8924514573626149,0.5949152542372881,0.957983257742308,1.0,1/11,1.40%,SMO
prerank,chromosome organization (GO:0051276),0.3012946830398204,0.8922901565029325,0.6453423120089786,0.9577579712884852,1.0,26/99,21.28%,HDAC5;DOT1L;PHF1;LATS1;RBX1;TCF7L2;CENPT;HDAC3;SMARCA4;COPS5;ACTL6B;HMGN1;CENPH;MYC;PWWP3A;DDB1;RPS27A;UBC;ABL1;GATAD1;H3-3A;RAE1;ZBTB7A;NUCKS1;SETD7;TOP2B
prerank,cellular response to nutrient levels (GO:0031669),0.3220746245221161,0.892103363298053,0.6219512195121951,0.9575826607193155,1.0,17/62,20.86%,PRKAA2;SREBF2;GAS2L1;KCNB1;FADS1;PDK2;TFEB;SFRP1;ULK1;EIF4G1;FLCN;MAP1LC3B;RIPOR1;ZFYVE1;STK24;SREBF1;KLF10
prerank,histone acetylation (GO:0016573),0.3121716949077229,0.8921002310684245,0.6398046398046398,0.9570354938366034,1.0,19/69,18.95%,CPA4;EP300;NAA40;BEND3;KAT6B;MORF4L2;APBB1;DR1;ACTL6B;TAF5;JADE2;BRD1;ING4;MEAF6;TRRAP;SGF29;TRIM16;ATF2;MRGBP
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.29186215363621304,0.8920004767163976,0.6811440677966102,0.9567066413082257,1.0,41/148,23.01%,PRKAA2;DAXX;EP300;NOP2;PPP1R13L;PPP1R13B;MRE11;SSRP1;PLK3;PML;BANP;BRD7;RMI1;TOPBP1;TAF5;MAPKAP1;CHD3;CDK2;RPA3;MDM2;PAK1IP1;MEAF6;ATR;HEXIM1;POU4F1;CCNG1;PRKAG1;NBN;CHEK2;RAD50;CDK5RAP3;TAF9B;TBP;PRKAB1;PRKAB2;USP2;CDK5R1;TAF6;PIP4P1;MDM4;KMT5A
prerank,erythrocyte development (GO:0048821),-0.37900686981894954,-0.8916859836470122,0.6121951219512195,0.8881724836892001,1.0,3/10,10.80%,ALAS1;SH2B3;NCKAP1L
prerank,leukotriene metabolic process (GO:0006691),0.3768990947924905,0.8914561872295043,0.5875542691751086,0.9572939684908386,1.0,5/19,17.33%,ABCC10;ALOX5;MGST3;LTA4H;MAPKAPK2
prerank,protein import into peroxisome membrane (GO:0045046),0.38008150024590404,0.8913202393767734,0.6085043988269795,0.9570051417426547,1.0,7/22,18.72%,PEX26;ABCD1;SLC25A17;PXMP4;RAB8B;PEX3;PEX2
prerank,negative regulation of RNA splicing (GO:0033119),-0.303112504965492,-0.891276524288924,0.6307692307692307,0.8879670518346144,1.0,6/19,19.70%,SRSF4;SAP18;SRSF10;TMBIM6;SRSF12;PTBP2
prerank,cardiocyte differentiation (GO:0035051),-0.3773476892945308,-0.8912124965589576,0.592797783933518,0.8869252732961831,1.0,6/10,16.09%,KDM6B;SIK1;EEF1AKMT4-ECE2;GATA6;CBY1;MYOCD
prerank,response to ketone (GO:1901654),-0.28850273008193505,-0.8909147493337081,0.6302250803858521,0.8864084538521424,1.0,10/24,22.96%,THBS1;NR1H3;SLIT2;TGFB1;UBE3A;SLIT3;CATSPER3;ABHD2;YAP1;CCL19
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),0.4281295025417955,0.8907868836990079,0.5980551053484603,0.9575639480432309,1.0,2/11,5.44%,NBL1;DUSP1
prerank,microtubule anchoring (GO:0034453),0.4161728661082086,0.8907782229366942,0.5959438377535101,0.9570287461429097,1.0,2/12,7.67%,DAG1;GCC2
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),-0.353579293133207,-0.8905026323884587,0.62,0.8861887016707126,1.0,4/12,21.12%,NIN;BBS4;CCDC68;CEP19
prerank,negative regulation of telomere maintenance (GO:0032205),0.39341168929736203,0.890501441032203,0.5863095238095238,0.9570612539703881,1.0,9/15,29.48%,PINX1;TNKS2;NBN;RAD50;ERCC4;TERF2;PARP1;TERF1;TERF2IP
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.28266706947033304,0.8904652627253221,0.693564862104188,0.9565919817953829,1.0,48/248,14.45%,SCEL;IGFBP6;KANK1;PTK7;GLI3;AMER3;MLLT3;WNT11;CAV1;TMEM198;RNF220;DAPK3;PPM1B;PTPRU;AMER2;PSMD11;SOX9;RBMS3;PSMD4;WLS;PSMF1;GPC3;ILK;LATS1;DVL3;LGR4;PPM1A;RBX1;TCF7L2;RNF146;UBE2B;ADGRA2;PRDM15;PSMD7;TLE2;CSNK1E;TLE4;GNAQ;TRPM4;PSMB5;CAPRIN2;GSK3A;LMBR1L;TLE5;SFRP1;UBR5;GSK3B;WNK1
prerank,organelle fission (GO:0048285),0.3673787380968006,0.8903951214488933,0.5872340425531914,0.9561824836094411,1.0,9/24,21.30%,ACOT8;MUL1;PEX11G;MTFR1L;OPA1;DNM1L;MTFR2;TMCC1;MIEF1
prerank,interleukin-2-mediated signaling pathway (GO:0038110),0.4240101506684923,0.8903632542451372,0.5861513687600645,0.9551466363821539,1.0,3/11,11.60%,PTK2B;SHC1;JAK1
prerank,cellular response to interleukin-2 (GO:0071352),0.4240101506684923,0.8903632542451372,0.5861513687600645,0.9551466363821539,1.0,3/11,11.60%,PTK2B;SHC1;JAK1
prerank,positive regulation of chemokine production (GO:0032722),-0.25552048495907714,-0.8902626074835236,0.6699507389162561,0.8855748932153,1.0,12/44,17.63%,HIF1A;WNT5A;LGALS9;IL18;IL6R;IL33;MBP;TIRAP;TLR7;HMGB1;CD74;LPL
prerank,metanephros development (GO:0001656),0.36339647591488355,0.8901278041842358,0.5977961432506887,0.9550572873836259,1.0,5/26,8.25%,GDNF;FOXD1;BMP4;SIX1;PKD1
prerank,positive regulation of endopeptidase activity (GO:0010950),-0.28152862990280775,-0.8900456784438611,0.6,0.8848876366731513,1.0,8/26,17.91%,LYN;AIM2;GRIN2B;STAT3;MBP;PSME1;TTBK1;APH1B
prerank,positive regulation of macrophage migration (GO:1905523),-0.30835035121094423,-0.8900221671343129,0.6299435028248588,0.8837858381303753,1.0,7/19,20.44%,IL34;PTK2;THBS1;CSF1;RARRES2;P2RY12;CX3CL1
prerank,regulation of gene expression by genetic imprinting (GO:0006349),0.4489514557163375,0.8898553916615081,0.6029654036243822,0.955097705051539,1.0,3/10,9.42%,PCGF3;ZFP57;DNMT3A
prerank,zinc ion transmembrane transport (GO:0071577),-0.29392538785109723,-0.8893972564014042,0.6142857142857143,0.8840185941879367,1.0,5/22,12.48%,SLC30A10;SLC39A12;SLC39A8;SLC39A10;SLC30A1
prerank,termination of RNA polymerase II transcription (GO:0006369),0.3452365687465251,0.8893607633760487,0.585464333781965,0.9555428976714405,1.0,7/33,16.64%,LSM10;SNRPB;MAZ;WDR33;CSTF1;PABPN1;CLP1
prerank,phagosome maturation (GO:0090382),0.3412272573731386,0.8892538925710212,0.6143250688705234,0.9552087733862537,1.0,12/35,27.02%,ATP6V1B1;RAB7A;ATP6V1E1;ATP6V1D;ATP6V0D1;ATP6V1B2;ATP6V0B;ATP6V0E1;RAB31;RAB32;ATP6V0E2;ATP6V0D2
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.3845630841781823,0.8889402561672005,0.5838509316770186,0.9552954259719795,1.0,2/17,2.79%,ANK2;ATP1A2
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),-0.37363556739195225,-0.8883789625466647,0.59,0.8851413428749132,1.0,7/10,43.52%,DRD2;FMR1;CALM3;CRHR1;GPR35;DRD3;GNB5
prerank,bile acid biosynthetic process (GO:0006699),0.3678575604915719,0.8882678546401023,0.5768688293370945,0.9561152376935759,1.0,4/24,11.13%,OSBPL9;ACOT8;CYP39A1;OSBPL7
prerank,negative regulation of lymphocyte proliferation (GO:0050672),-0.27531132149610416,-0.8882425112038357,0.625,0.8843022506257948,1.0,14/31,34.56%,LYN;GLMN;TNFRSF21;DLG5;CD300A;SOX11;RC3H1;TYROBP;FCGR2B;CD86;LST1;CD80;LILRB1;IL4I1
prerank,regulation of hormone secretion (GO:0046883),-0.3295213573743978,-0.887830007899671,0.6274509803921569,0.8840739638561125,1.0,12/15,52.56%,EDN1;SOX11;EDN3;NMB;IL11;LIF;VAMP3;SNX6;FGF23;OSM;FFAR2;SCG5
prerank,ether lipid metabolic process (GO:0046485),0.4027967286419019,0.8877439657056279,0.593423019431988,0.9566309025715343,1.0,4/14,14.70%,DHRS7B;PAFAH1B1;TMEM86B;PLA2G6
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),0.366015489384028,0.8875392079885426,0.6048158640226629,0.9565004652493735,1.0,4/24,7.62%,ANGPT1;NFE2L2;MAPK7;KRIT1
prerank,cellular response to unfolded protein (GO:0034620),0.35307458089263316,0.8875140480207738,0.6054913294797688,0.9559907520470029,1.0,4/26,9.27%,DAXX;HSPB8;HSPA14;BAG3
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.35389844632160805,0.8869580038477175,0.6016260162601627,0.9566061127907263,1.0,7/29,16.23%,KANK2;DDRGK1;LATS1;VPS11;GPAM;VPS18;UFM1
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.4069020167793378,0.8868117796707775,0.5955766192733017,0.9563560529785392,1.0,6/13,26.05%,RHOA;IRAK1;ITGB2;NFAT5;IL6;RELA
prerank,hexose biosynthetic process (GO:0019319),0.33131172224817007,0.8867224994701534,0.6245059288537549,0.9560172913177025,1.0,10/42,18.34%,PPARGC1A;SLC25A1;ENO2;MDH2;ALDOA;GAPDH;SLC25A12;TPI1;PCK2;CHST15
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),0.40359800543230967,0.886685997785237,0.5869218500797448,0.955545511515003,1.0,1/14,1.38%,ETNK2
prerank,negative regulation of MAPK cascade (GO:0043409),0.3001914144770665,0.886595997304097,0.6354285714285715,0.955172845600825,1.0,25/87,20.66%,DAG1;CAV1;QARS1;DUSP10;DUSP1;FBLN1;FOXM1;SPRED3;BMP4;EZR;PRDM15;SYNJ2BP;TLR4;PTPN2;MYC;FLCN;ITGB1BP1;TNIP1;IGBP1;DUSP3;CAMK2N1;CDK5RAP3;GPER1;RGS2;ABCA7
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.27352797442922716,0.8859347043975817,0.886,0.9560539896816974,1.0,202/1082,17.49%,CDH1;NFATC2;CDH13;KLF5;THRB;TMPRSS6;WNT1;KLF4;TFAP2C;PPARGC1A;NCOA3;PBX1;GAL;MAP3K5;ELF3;OGT;LBH;SREBF2;RORC;NIBAN2;GLI3;MLLT3;GTF2F1;HIVEP1;ZC3H12A;CAND2;WNT11;GABPB1;GABPB2;MAVS;EP300;HDAC5;CD81;FOXO3;CSRP3;FOS;GDNF;FOXC2;GLIS2;CREBL2;HDAC4;BMP5;NFE2L2;ZBTB16;EPO;SSBP3;DOT1L;TRIM44;SMARCB1;RHOQ;FOXD2;POU2F3;NFKBIA;ESRRB;RARG;IRF3;BICRA;JUND;NKX2-8;ASF1A;CREB1;FOXM1;HOXA5;ZBTB17;RXRB;RNASEL;SOX9;HCFC1;AKNA;ZIC2;HAX1;NRF1;SHC1;KAT6B;MYDGF;DDRGK1;PHF10;BMP4;MEF2D;MAPK7;KLF7;MED30;ILK;TGFB1I1;DVL3;FIZ1;ZFHX3;DYRK1B;PPM1A;ATRX;SIX1;PSRC1;PKD1;MAZ;JUN;FZD5;POU3F1;TCF7L2;UBTF;DDX39B;PML;GRHL2;FOXP3;TNFRSF1A;KMT2A;BRD7;TXK;DPF2;MAP2K2;ZIC1;PHF5A;APBB1;ILF2;PRDM15;ENY2;NFIB;TWIST1;BCAS3;KDM3A;HDAC3;WDR43;NFIC;SMARCA4;TLR4;CREB3L4;CREB3;DR1;CALCOCO1;MEF2B;MMP12;NAA15;SP1;EIF2AK3;COPS5;ELL;DCAF6;FOXK1;MPND;MED12;TFEB;MYSM1;SPIN1;GATA3;SMARCD2;RREB1;ARF4;HMGN1;SBNO2;NFIA;CAPRIN2;MED21;MYC;PRDM11;MED24;SERTAD1;MEF2C;PAX3;MYBL1;SFRP1;CHUK;TASP1;ZXDC;IRF2;HRAS;ZPR1;SS18L2;ATMIN;FLCN;ITGB1BP1;TNIP1;RFXAP;CDCA4;TLR3;DHX9;MED6;ZMIZ2;TET1;IKBKG;KLF6;CDC5L;CREB3L2;SMARCC1;SFR1;RNF10;RPS27A;UBC;E2F1;POU4F1;HINFP;ABL1;KDM1A;MLLT6;SLC9A1;CAMTA2;RGMB;PRPF6;BCLAF3;F2R;SMAD5;PITHD1;HSF2;CHEK2
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.3772763414344382,0.8859026645651661,0.5851851851851851,0.9555756002744714,1.0,5/20,11.07%,BMP5;ERLIN2;ACADL;ERLIN1;ABCA2
prerank,protein alkylation (GO:0008213),0.3731471193706996,0.8858182230104458,0.6156111929307806,0.9552058319706345,1.0,9/22,27.18%,EEF2KMT;SNRPB;PRMT1;ETF1;PRMT2;FAM98B;FAM98A;CAMKMT;EEF1AKMT2
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),0.28842970959605296,0.8856379557902592,0.694560669456067,0.9550297710524454,1.0,48/168,24.09%,CNOT6;SAMD4A;DDX5;ZC3H12A;SAMD4B;PPP2CA;RPS4X;EIF4A3;UPF3A;SMG7;RBM8A;XRN2;RPL31;RPSA;GSPT2;RPL22;RPL28;RPS26;TUT7;RNPS1;RPL10A;DCP1A;UPF3B;EIF4G1;PYM1;RPL14;MAGOHB;MAGOH;RPS27A;CTIF;PATL1;PELO;RPL6;NBDY;DXO;RPS28;SMG9;ETF1;RPL41;TUT1;RPLP2;RPLP1;RPL7;PABPC1;DCPS;RPL21;PAN3;RPL26
prerank,cellular response to interferon-gamma (GO:0071346),0.30057435995009874,0.8851673016954984,0.6372881355932203,0.9554487739532759,1.0,16/88,15.49%,CD44;CCL5;EPRS1;DAPK3;DAPK1;TRIM25;IRF3;TRIM21;PML;TRIM26;TLR4;JAK1;SYNCRIP;IRF2;GAPDH;OAS2
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),0.38943605517402025,0.8850747300611711,0.6071964017991005,0.955106967669968,1.0,2/17,2.90%,PBX1;EP300
prerank,apoptotic DNA fragmentation (GO:0006309),-0.3260966560839996,-0.8850532669041982,0.6094674556213018,0.8893205148825659,1.0,9/16,37.03%,CECR2;DNASE2;HMGB1;EXOG;DICER1;FOXL2;KPNB1;ENDOG;DFFB
prerank,inorganic anion transmembrane transport (GO:0098661),0.31316636914375834,0.8847421953690958,0.6242350061199511,0.9552093448219426,1.0,10/63,14.52%,CFTR;SLC12A8;SLC25A3;SLC20A1;ANO7;SLC12A4;ANO6;SLC25A14;ANO3;SLC37A1
prerank,eye development (GO:0001654),0.320701723563138,0.8847134930575177,0.6253071253071253,0.9547239996393213,1.0,6/54,7.38%,PBX3;PBX1;COL5A2;STRA6;EFEMP1;TGFB2
prerank,protein phosphorylation (GO:0006468),0.2752338465119048,0.8844827781800144,0.7811244979919679,0.9546694572226805,1.0,112/479,20.14%,PRKCB;FGFR1;STK19;PRKAA2;LIMK2;FAM20C;PRAG1;NRBP2;MAP3K5;TRIB2;EPHA4;GRK5;ADAM10;TSSK6;TSSK4;WNT11;IKBKE;NEK7;CDK10;CDK6;MKNK2;PTK2B;SGK3;DAPK3;DAPK1;CDKL2;CDK4;ROS1;CREB1;RNASEL;STK39;SIK3;CSK;MAPK15;EFEMP1;BMP4;TGFB2;CDK16;ILK;LATS1;DYRK1B;STK16;PKD1;OXSR1;MAPK9;AURKC;BCR;LMTK2;TXK;PTPN6;ABI1;MUSK;SRPK2;CDKL4;GRK2;TLR4;PDK2;CSNK1E;EPHA3;JAK1;YWHAZ;MARK4;TGFBR2;EIF2AK3;CDK18;SRPK1;DDR1;MAP3K13;CDK2;GSK3A;IRAK1;TGFBR3;CHUK;ULK1;GSK3B;WNK1;CDC42BPA;TLR3;PLK2;AAK1;PAK6;TTK;ATR;PRKCZ;RELN;ABL1;PRKAG1;MAP3K6;MAPK6;CDC25B;EIF2AK4;MAPKAPK2;CHEK2;BMPR1A;PEAK1;PRKCQ;MAP3K3;RSKR;RARA;STK38L;STK24;ROCK2;CAB39;TAOK3;PRKD2;APP;MAP3K1;CDK11B;PRKAB1;TBCK;CDC42BPG;PRKX
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.3392195511426655,0.8844725064495169,0.6040816326530613,0.9541487141800473,1.0,4/35,4.91%,CCL5;PIGU;CAV1;DOT1L
prerank,transition metal ion homeostasis (GO:0055076),0.35603314994237684,0.884154150036276,0.6013986013986014,0.9542638606209127,1.0,4/28,12.84%,TMPRSS6;NEO1;HEPH;CP
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.34691111386184764,0.8838972057593697,0.5899581589958159,0.9542673945676956,1.0,4/27,10.61%,ZC3H12A;KHNYN;POP1;LACTB2
prerank,metallo-sulfur cluster assembly (GO:0031163),0.36809794427228093,0.8838109489324812,0.6086330935251798,0.9539010393282604,1.0,7/22,20.22%,CIAO1;NFS1;ISCA1;IBA57;CIAO3;CIAPIN1;ISCA2
prerank,visual system development (GO:0150063),0.3379009920686757,0.8834402644750707,0.6162943495400789,0.9541218323353676,1.0,2/37,1.28%,PBX3;PBX1
prerank,regulation of sodium ion transport (GO:0002028),0.3410002310355182,0.8833781597472247,0.5947368421052631,0.9536927038480415,1.0,15/34,24.98%,SLMAP;AHCYL1;ANK3;ATP2B4;WNK1;NEDD4;YWHAH;SCN4B;ATP1A1;WNK4;SNTA1;NKAIN4;NKAIN1;PER1;P2RX4
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),0.3815189046470098,0.883359813282191,0.6053412462908012,0.9531940510712756,1.0,4/18,13.53%,HDAC5;HDAC4;HDAC3;GSK3A
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",-0.37200652343314256,-0.8833153988713107,0.5851318944844125,0.8921638109697239,1.0,3/10,13.14%,SP100;TP53;RPS6KA6
prerank,DNA duplex unwinding (GO:0032508),0.32500282971482625,0.8831836908204721,0.6176853055916776,0.9530074522234342,1.0,14/50,21.60%,RECQL4;MRE11;RBX1;DHX9;DDB1;MCM6;RPS27A;UBC;ERCC2;NBN;MCM7;RAD50;TWNK;MCM4
prerank,thyroid hormone generation (GO:0006590),-0.3668311516283778,-0.8830937277722286,0.648578811369509,0.8914525777380546,1.0,5/10,33.11%,CPQ;SLC5A5;FOXE1;DIO2;TG
prerank,embryonic heart tube morphogenesis (GO:0003143),0.33418043870285796,0.88294772200458,0.5943877551020408,0.9529378067741456,1.0,3/43,2.24%,TBR1;SMO;MICAL2
prerank,positive regulation of histone methylation (GO:0031062),0.3612796175320468,0.8829350008219834,0.6086956521739131,0.9524223931948073,1.0,4/24,9.55%,OGT;PHF1;KMT2A;RIF1
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.276005586089537,0.8828734654041467,0.799,0.9520078364967092,1.0,87/497,14.55%,FOXN3;DAXX;TMPRSS6;TBR1;KLF4;ELF3;LBH;CDKN1A;NIBAN2;SAMD4A;FOXP2;GLI3;TRIM33;WNT11;SAMD4B;HDAC5;QARS1;EPRS1;RBFOX2;DAPK3;PCGF6;ZNF219;GLIS2;HDAC4;DAPK1;ZBTB16;WWP2;NACC1;CRYAB;S100A11;PATZ1;FOXM1;SOX9;FOXD1;ZIC2;SHC1;KDM5C;KAT6B;EIF4A3;PHF10;BMP4;COMMD7;NKAP;MAGEL2;CIC;L3MBTL3;JUN;TCF7L2;CRY2;PML;FOXP3;BRD7;SCML2;SHMT1;DPF2;YWHAQ;TWIST1;HDAC3;ARID4A;TLE2;BCL7A;SMARCA4;NCOR1;SFMBT2;EIF2AK3;ZNF148;CPEB3;FOXK1;SYNCRIP;GATA3;TSC22D4;FXR1;SBNO2;CHMP1A;BEND5;CBX4;GSK3A;BTG2;PRDM11;ING4;TLE5;SFRP1;FOXP1;SET;GSK3B;GAPDH;NCOR2
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.2734399676105499,0.8827739064660233,0.7657200811359026,0.9516708818734841,1.0,59/341,18.10%,FZR1;FBXL7;RNF43;SPSB4;ATE1;NFE2L2;WWP2;RNF5;TRIM25;VPS37B;PSMD11;NUB1;OTUD7B;NSFL1C;PSMD4;PSMF1;FEM1C;FEM1A;TGFB1I1;KLHL15;UBE2G2;RMND5B;RBX1;RNF146;PML;UBE2B;PCNP;PPP1R11;SIAH3;COP1;PSMD7;AGAP3;FEM1B;VPS4B;RNF126;ZSWIM8;WDR91;PSMB5;ANAPC4;PELI1;GSK3A;NPLOC4;VPS4A;UBE4A;NEDD4;UBE2H;MDM2;BFAR;MAEA;UBA6;DDB1;ARMC8;UBE2D3;SIAH1;KEAP1;STUB1;PSMD1;TSG101;PSMC4
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.2727985225957859,0.8819360516322092,0.864,0.9527860564919804,1.0,149/807,16.88%,THRB;PRDM6;FOXN3;DAXX;TMPRSS6;TBR1;KLF4;TFAP2C;ELF3;LBH;SREBF2;RORC;NIBAN2;FOXP2;GLI3;DDX5;TRIM33;HIVEP1;WNT11;KLF12;CAV1;FOXP4;ZNF436;EP300;HDAC5;ZMYM5;ZNF692;MXD4;QARS1;RBFOX2;KANK2;FOXO3;PCGF6;FOXC2;ZNF219;GLIS2;CGGBP1;HDAC4;NR6A1;ZBTB16;EPO;WWP2;MTDH;NACC1;CRYAB;BEND3;RARG;PHF21A;PATZ1;LCOR;CREB1;FOXM1;SOX9;OTUD7B;FOXD1;HCFC1;ZIC2;SHC1;KDM5C;ZBTB7B;KAT6B;PHF10;BMP4;KLF7;COMMD7;NKAP;PLK3;ZFHX3;MAGEL2;LARP7;CIC;PPM1A;L3MBTL3;MAZ;JUN;TCF7L2;CRY2;ZFP57;PML;FOXP3;BRD7;SCML2;DPF2;NR2C1;DNMT3A;YWHAQ;RIF1;EZR;APBB1;CCND1;SAP130;TWIST1;HDAC3;ARID4A;ZNF205;NFIC;TLE2;BCL7A;SP2;SMARCA4;NCOR1;DR1;SFMBT2;ZNF148;MIER2;MAFK;CPEB3;FOXK1;CHD3;GATA3;TSC22D4;RREB1;SBNO2;CHMP1A;BEND5;CBX4;MYC;ZNF177;PRDM11;ING4;MEF2C;TLE5;PCGF2;SFRP1;FOXP1;SET;SARS1;IRF2;NCOR2;GATAD2B;FLCN;MDM2;IGBP1;HMBOX1;FLNA;RCOR2;TCF25;ZGPAT;IRF2BP2;NAB2;CCDC85B;RPS27A;UBC;HEXIM1;E2F1;POU4F1;HINFP;KDM1A;UBE2D3
prerank,mitotic cell cycle phase transition (GO:0044772),-0.19479843644396402,-0.8816935943275706,0.88,0.893486823580912,1.0,42/203,16.69%,PLCB1;CDK14;CLASP2;CEP250;EPS8;USP37;CUL4B;BRSK1;CCP110;ACVR1B;CCDC57;CCNH;CEP78;ALMS1;GSPT1;TPD52L1;CCNY;TAF2;NES;RPS6KB1;NDE1;PRKAR2B;UBE2S;RCC1;CTDP1;ANAPC7;NASP;SPDYA;NEDD1;PPME1;CAMK2A;BTRC;CSNK1D;CUL5;CCNJ;CRLF3;SDCCAG8;BORA;DBF4;CUL1;MASTL;CHMP7
prerank,positive regulation of neutrophil migration (GO:1902624),0.3878962098710239,0.8814674582584499,0.586890243902439,0.9532256823329808,1.0,3/18,5.38%,MCU;RIPOR2;MOSPD2
prerank,regulation of mRNA polyadenylation (GO:1900363),-0.31333246845629054,-0.8806495947505794,0.6411042944785276,0.8947775008286729,1.0,6/17,22.02%,NUDT21;CPEB1;HSF1;CPSF6;NELFE;NCBP1
prerank,organophosphate ester transport (GO:0015748),0.3646711997349541,0.8806108959374818,0.6017069701280228,0.9544292083842013,1.0,3/24,6.32%,LDLR;PITPNC1;PRELID3B
prerank,positive regulation of transferase activity (GO:0051347),0.29022721310125726,0.880146829451935,0.6898395721925134,0.9548151673881494,1.0,29/142,15.75%,FGFR1;NTRK3;KLF4;EPHA4;SERINC5;CD200;NEK7;LMO4;ROS1;MRE11;MAPK15;ERBB3;MAP3K4;ARRDC3;GRHL2;DCUN1D5;LMTK2;MUSK;EPHA3;DCUN1D1;DDR1;MYC;GSK3A;HSP90AA1;DSTYK;PABPN1;HMBOX1;PCNA;UBE2N
prerank,endoderm development (GO:0007492),0.3986067197899988,0.8798590432532184,0.6197411003236246,0.9548537316916741,1.0,2/13,8.72%,DUSP1;LAMC1
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.36937322787798965,0.8796226846511705,0.6205882352941177,0.95479069242169,1.0,5/21,9.63%,MMP9;MEF2D;JUN;ADAMTS1;HTR1B
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),0.31806149047568455,0.8793524858581011,0.6128625472887768,0.9547871678706565,1.0,9/55,10.84%,NUPR1;BBC3;CAV1;PMAIP1;BCL2L1;BAD;PML;BCAP31;GSDME
prerank,synaptic vesicle membrane organization (GO:0048499),0.3883347621062349,0.8793029562699286,0.6021180030257186,0.9543459181570118,1.0,7/17,24.78%,SYP;TOR1A;STX11;STX4;AP3D1;SNAP23;STX3
prerank,regulation of epithelial cell proliferation (GO:0050678),0.3023849376179128,0.8792056569316014,0.6575963718820862,0.954003193081248,1.0,12/85,8.72%,ANGPT1;HPN;NUPR1;CDK6;DUSP10;BMP5;SOX9;BMP4;TGFB2;BAD;TCF7L2;LAMC1
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.40829887271879817,0.8788122258235619,0.5949152542372881,0.9542671622828687,1.0,2/13,10.08%,SCAMP5;KCNB1
prerank,regulation of ERAD pathway (GO:1904292),0.4165555649902781,0.8787219739406993,0.5986394557823129,0.953912557679595,1.0,4/11,23.79%,TMEM259;USP19;USP25;USP13
prerank,regulation of viral entry into host cell (GO:0046596),0.3527997057102278,0.8781741249971193,0.6371308016877637,0.9544804921154244,1.0,6/30,13.38%,GSN;TRIM25;TRIM21;TRIM26;TRIM11;LGALS1
prerank,regulation of response to interferon-gamma (GO:0060330),-0.33059718444747593,-0.8779117087259297,0.6127167630057804,0.899841181927391,1.0,6/14,22.21%,IFNGR1;IFNGR2;JAK2;CDC37;HSP90AB1;SOCS3
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.3507419297545174,0.8777045867791647,0.5988538681948424,0.9549293018153395,1.0,7/26,19.22%,ABCD1;ALOX5;TLR6;TLR4;COA8;PARK7;RAB27A
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.2888792406952671,0.8774484519093702,0.6692139737991266,0.9548866124156203,1.0,22/113,14.36%,CDH13;NOTCH2;HPN;BMP5;NRAS;SOX9;AGGF1;MYDGF;BMP4;BAD;ANG;TCF7L2;LAMC1;VEGFB;EMC10;NRP2;MMP12;PTN;RREB1;MYC;SFRP1;HRAS
prerank,positive regulation of dendritic spine development (GO:0060999),-0.30203757086285965,-0.8773372443783999,0.6728971962616822,0.9000078054185605,1.0,4/20,10.79%,SHANK3;NLGN1;LRP8;DLG5
prerank,regulation of nervous system process (GO:0031644),-0.3190296179800406,-0.8772107590524039,0.6656976744186046,0.8991407630565276,1.0,3/18,5.51%,SLC8A3;NOS3;DLGAP1
prerank,regulation of small molecule metabolic process (GO:0062012),0.3502658834029605,0.8769587328469571,0.6033287101248266,0.9553570208798409,1.0,6/28,14.55%,RORC;TTC39B;ACADL;PDK2;FOXK1;NCOR2
prerank,dicarboxylic acid metabolic process (GO:0043648),0.3214908788095054,0.8769124135451414,0.651307596513076,0.9549112947809518,1.0,19/52,26.32%,ACOT8;ME3;SHMT1;ALDH1L2;MDH2;ALDH1L1;OGDH;ASS1;DLST;HAAO;SLC19A1;SDHAF3;DGLUCY;ALDH18A1;ACLY;IDH1;GPT2;IDH2;ALDH5A1
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.3711524028626795,0.8768008326744251,0.6162790697674418,0.9545865196649068,1.0,3/20,4.24%,EP300;SESN2;NFE2L2
prerank,detection of mechanical stimulus (GO:0050982),-0.3063925201260892,-0.8766597265435095,0.6446540880503144,0.8992038837674186,1.0,3/19,4.78%,CDH2;PTK2;PKD2
prerank,protein insertion into membrane (GO:0051205),-0.2643841439877041,-0.876516374971631,0.6730769230769231,0.8983703621350335,1.0,6/32,8.65%,ALDH3A2;OXA1L;TRAM1;STX5;REEP1;SERP1
prerank,embryonic organ development (GO:0048568),0.314723939061967,0.876030232122622,0.6432038834951457,0.9555946870262552,1.0,6/61,3.81%,PBX3;COBL;PBX1;GLI3;STRA6;GDNF
prerank,negative regulation of protein depolymerization (GO:1901880),0.3666141608886916,0.8759641030116474,0.61863173216885,0.9552019366632943,1.0,1/24,0.23%,FGF13
prerank,positive regulation of secretion (GO:0051047),0.42048437156332497,0.8756158452088612,0.6180327868852459,0.9553880445502708,1.0,3/11,19.43%,ACSL3;AQP1;GPLD1
prerank,extracellular transport (GO:0006858),0.412150704424072,0.8754176402242414,0.6029411764705882,0.9552517912443202,1.0,4/12,18.00%,WWP2;SPAG17;ADCY10;TSG101
prerank,positive regulation of interleukin-13 production (GO:0032736),-0.3720213825757025,-0.8753432407297426,0.6059850374064838,0.8997733564338385,1.0,2/10,5.93%,LGALS9;IL18
prerank,regulation of superoxide anion generation (GO:0032928),-0.33555988364321365,-0.87528163844594,0.6542553191489362,0.8987563893772909,1.0,5/14,26.34%,AATF;TGFB1;SOD1;TYROBP;ITGAM
prerank,lymphocyte differentiation (GO:0030098),0.3099494280415637,0.8752121966971139,0.6520681265206812,0.9551301485350782,1.0,20/68,20.24%,PBX1;HDAC5;RELB;HDAC4;CLCF1;NFAM1;CR2;RABL3;PTPN2;GATA3;LMBR1L;GPR89B;GPR89A;KLF6;TPD52;ADAM17;ZBTB7A;IKZF1;DCAF1;SOX4
prerank,androgen metabolic process (GO:0008209),0.3800850465478335,0.8748056755914951,0.6273653566229985,0.9553737848880585,1.0,3/18,20.01%,SRD5A3;HSD17B11;HSD17B10
prerank,regulation of cardiac conduction (GO:1903779),0.32050655053917554,0.8747224408220863,0.6496894409937888,0.9550061399040367,1.0,4/54,4.79%,ITPR2;ANK2;ATP1A2;AHCYL1
prerank,positive regulation of cytoplasmic transport (GO:1903651),-0.3583686301779355,-0.8740469131290273,0.620253164556962,0.9003254865223425,1.0,4/11,15.38%,DAB2;RDX;MTMR2;SORL1
prerank,protein import into peroxisome matrix (GO:0016558),0.4020490866065414,0.8738392050129331,0.607085346215781,0.9563110253785677,1.0,3/12,18.72%,PEX26;PEX6;PEX2
prerank,negative regulation of histone acetylation (GO:0035067),-0.3556342818085404,-0.8737263186781926,0.6217616580310881,0.8998779748755164,1.0,5/11,25.12%,THAP7;NOC2L;SIN3A;BRCA1;SPI1
prerank,C4-dicarboxylate transport (GO:0015740),-0.33063600475232335,-0.8735420718075793,0.6143617021276596,0.899161267670233,1.0,2/14,5.61%,SLC1A2;SLC1A1
prerank,regulation of endothelial cell migration (GO:0010594),0.2981138501338755,0.8735221926873793,0.6544811320754716,0.9564365230352596,1.0,20/85,14.84%,ANGPT1;ANXA3;EMP2;GLUL;ZC3H12A;GFUS;PTK2B;FOXC2;BMP4;KRIT1;EMC10;NRP2;SYNJ2BP;BCAS3;BCAR1;PTN;GATA3;FOXP1;AAMP;ITGB1BP1
prerank,neutral amino acid transport (GO:0015804),0.3494211741987929,0.8730720066243347,0.6246648793565683,0.9568042118227253,1.0,6/28,13.71%,SLC36A3;CTNS;SLC36A4;LLGL2;SLC1A4;SLC6A7
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.2911425173239196,0.8726013011488885,0.686084142394822,0.9571953223475231,1.0,23/122,16.10%,SORBS1;KLF4;VIM;SAMD4A;YTHDF1;RPS4X;EIF4A3;UPF3A;EIF6;TGFB2;TLR4;IRS2;POLDIP3;CPEB3;PLXNB2;FXR1;MYC;UPF3B;PYM1;DHX9;HSPH1;PCNA;EEF2
prerank,regulation of protein acetylation (GO:1901983),0.4047105647471445,0.8724829414512026,0.596694214876033,0.9568897252055402,1.0,7/12,30.62%,RAPGEF3;GSK3B;PARK7;KAT5;DDX3X;TERF2IP;TAOK1
prerank,relaxation of muscle (GO:0090075),0.3982345617672865,0.8724251224216811,0.6352,0.9564715325099657,1.0,2/13,2.79%,GSN;ATP1A2
prerank,regulation of chondrocyte differentiation (GO:0032330),0.35908090481385924,0.8723962312519654,0.6255259467040674,0.9559951555446257,1.0,5/24,6.72%,MBOAT2;ADAMTS7;ZBTB16;SOX9;EFEMP1
prerank,plasma membrane tubulation (GO:0097320),0.40303062290879615,0.8723184223087379,0.6144,0.9556133170077483,1.0,4/13,17.29%,CAVIN2;CHMP4A;SNX33;PACSIN1
prerank,UV-damage excision repair (GO:0070914),-0.3658023059599983,-0.8720387813507036,0.6195652173913043,0.9013942285969667,1.0,7/12,38.21%,CUL4B;ACTR5;ERCC1;POLA1;DDB2;POLD3;INO80
prerank,cellular response to leucine starvation (GO:1990253),0.428176529667629,0.8719905609551399,0.6479338842975206,0.9557403722298616,1.0,4/10,19.72%,SESN2;SESN1;EIF2AK4;GCN1
prerank,sphingolipid catabolic process (GO:0030149),-0.32201082610170695,-0.8719321223688377,0.6574585635359116,0.9004768033680903,1.0,2/15,4.73%,ACER2;ENPP2
prerank,positive regulation of phosphorylation (GO:0042327),0.2736552594812397,0.8709452296304638,0.7274590163934426,0.9572802664653196,1.0,32/240,10.49%,FGFR1;ANGPT1;PRKAA2;NTRK3;LIMK2;DAXX;ADTRP;MMP9;CCL5;EPHA4;MAVS;LMO4;ROS1;EFNA5;KRAS;MRE11;SOX9;WDFY2;PFKFB2;MYDGF;BMP4;CCND2;ERBB3;ILK;ANG;DVL3;FGF22;VEGFB;LMTK2;CCND1;MUSK;HDAC3
prerank,positive regulation of protein phosphorylation (GO:0001934),0.2704550708304791,0.8708229822916367,0.7766599597585513,0.9569955147779561,1.0,39/348,8.78%,ANGPT1;CD44;NTRK3;LIMK2;DAXX;ADTRP;MMP9;PDGFC;CDKN1A;IL15;GDF15;CAV1;TWSG1;MAVS;RAP1A;CD81;NGF;PTK2B;CREBL2;BMP5;DOCK7;EFNA5;CAMKK1;KRAS;MRE11;SOX9;HAX1;WDFY2;MYDGF;DDRGK1;BMP4;CCND2;TGFB2;ILK;LATS1;DVL3;FGF22;IQGAP1;VEGFB
prerank,phosphatidylcholine metabolic process (GO:0046470),0.30450053661609694,0.8707977164301202,0.6601382488479263,0.9565091335579515,1.0,8/70,12.85%,PLB1;MBOAT2;PLA2G12A;MBOAT7;LPCAT2;CHPT1;TMEM86B;LPCAT3
prerank,regulation of stem cell differentiation (GO:2000736),-0.21409303792897375,-0.8706696672992345,0.8402777777777778,0.9021598338468693,1.0,24/89,22.81%,JAG1;TCF12;PDGFRA;LMO2;NOTCH1;RUNX1;PSMC6;PSMA6;PUS7;NUDT21;OCIAD1;GATA2;PSME1;PSMB10;PSMD5;PSMD3;TAL1;PSMA4;YAP1;PSMB9;PSMA8;PSMB7;SP7;YTHDF2
prerank,regulation of mitochondrial membrane potential (GO:0051881),0.32583606494820905,0.8698236068350216,0.6425806451612903,0.9578850135071025,1.0,8/40,10.22%,ABCD1;PMAIP1;BCL2L1;BAD;PIP5KL1;MTLN;ATP5IF1;ARL6IP5
prerank,negative regulation of kinase activity (GO:0033673),0.3066076131394642,0.8696936246297068,0.6456310679611651,0.9576296111917459,1.0,10/62,11.68%,TRIB2;QARS1;HSPB1;TARBP2;TSC2;CHP1;PYDC1;SMCR8;GNAQ;IRS2
prerank,regulation of osteoclast differentiation (GO:0045670),-0.2674747699381944,-0.8691171015816718,0.6771653543307087,0.9043998681259208,1.0,3/33,3.70%,FBN1;UBASH3B;CAMK4
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.3039050757396715,0.8689588120930806,0.6603995299647474,0.9585081345841405,1.0,22/72,19.88%,EP300;POLR2H;POLR2A;RBX1;POLK;COPS5;ERCC5;HMGN1;RPA3;POLD2;ISY1;PCNA;PRPF19;LIG3;DDB1;RPS27A;UBC;ERCC2;POLR2C;RFC1;POLR2E;ERCC4
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.29170263319574186,0.8688849741880038,0.6666666666666666,0.9581205400483983,1.0,19/88,21.72%,FBXL7;FBXL20;PSMD11;PSMD4;PSMF1;FBXL18;RBX1;FBXO31;PSMD7;PSMB5;FBXL15;FBXL2;PSMD1;PSMC4;PSMD8;FBXO9;DMAC2;FBXW7;CUL2
prerank,cardiac myofibril assembly (GO:0055003),0.3956798282641597,0.8688794246486833,0.6287878787878788,0.957604619019209,1.0,2/15,3.66%,NEBL;CSRP3
prerank,cholesterol efflux (GO:0033344),0.3719436425613348,0.8687780293418714,0.6340740740740741,0.9572646972571722,1.0,3/20,8.94%,SOAT1;NPC1;SOAT2
prerank,regulation of cellular senescence (GO:2000772),-0.2715240339532966,-0.8684864998132705,0.6925925925925925,0.9046279666324832,1.0,8/28,12.55%,SLC30A10;AKT3;RBL1;B2M;ING2;RSL1D1;HMGA2;NEK6
prerank,regulation of mitochondrial translation (GO:0070129),-0.29315112260470544,-0.868065938813052,0.6294117647058823,0.9044031720603707,1.0,10/21,32.51%,RPUSD4;FASTKD2;TSFM;TRMT10C;FASTKD3;ALKBH1;RMND1;SHMT2;MPV17L2;COA3
prerank,regulation of response to stress (GO:0080134),-0.3753578850543282,-0.8669488043027601,0.6303797468354431,0.9056377007508476,1.0,4/10,22.44%,CORO2B;OPRM1;STOX1;ADCY8
prerank,MAPK cascade (GO:0000165),0.27086738460250714,0.8667939211625729,0.7686034658511722,0.9606774670264289,1.0,46/295,14.36%,FGF13;FGFR1;ANGPT1;MAP3K8;ACTN2;CCL5;MAP3K5;MRAS;GDNF;IL3RA;SPTBN2;PSMD11;GFRA3;RASAL3;BCL2L1;NRAS;KRAS;SOX9;SHC1;PSMD4;PTPRA;PSMF1;ERBB3;FGF22;RBX1;RALGDS;YWHAB;RASA2;GOLGA7;MAP2K2;RAF1;PSMD7;SPTAN1;JAK1;IRS2;PPP1CB;SYNGAP1;RASA1;PSMB5;RASA3;MYC;MEF2C;SHC2;BRAP;CHUK;HRAS
prerank,relaxation of cardiac muscle (GO:0055119),0.3967853156849461,0.8666081804843981,0.631578947368421,0.9605015700245865,1.0,2/13,2.79%,GSN;ATP1A2
prerank,cellular response to purine-containing compound (GO:0071415),-0.36139267477455295,-0.8664057477595676,0.624390243902439,0.9056578087585757,1.0,4/10,22.16%,SLC8A1;RYR2;P2RY1;CASQ2
prerank,regulation of membrane depolarization (GO:0003254),0.37071393371473044,0.866153827978773,0.6098654708520179,0.9608457909179019,1.0,2/18,3.11%,ABCD1;FHL1
prerank,regulation of mononuclear cell migration (GO:0071675),0.35381617374284813,0.8659346305238201,0.6248196248196248,0.9607320003937554,1.0,4/23,8.27%,CCL5;BMP5;MSN;LGALS3
prerank,regulation of dendrite development (GO:0050773),0.32631574688720616,0.8655644827167508,0.6422872340425532,0.9609506755815845,1.0,3/37,4.13%,RAB17;COBL;BMP5
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),0.36226522533231964,0.8647431998902769,0.6433666191155493,0.9620055313646388,1.0,3/22,4.75%,AHNAK;CACNB3;STAC3
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.4251424003324732,0.864556900037651,0.610648918469218,0.961846369378411,1.0,2/10,7.94%,DLGAP4;NPTX2
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.374151341636685,0.8645001979042857,0.6263565891472869,0.9614267678386181,1.0,7/18,24.20%,CDK4;FBXO5;CCND1;VPS4B;CDC25B;RCC2;CDC25A
prerank,cyclooxygenase pathway (GO:0019371),0.4072495639259032,0.8642519392023688,0.6307947019867549,0.9613901271440931,1.0,3/10,11.23%,PTGDS;HPGDS;PTGES2
prerank,neuron projection morphogenesis (GO:0048812),0.2813128002314216,0.8640653902496109,0.6946564885496184,0.9612583647922803,1.0,20/137,10.06%,ALCAM;SRGAP2;PLXNB1;FLRT1;NBL1;S100A6;NGF;MAP6;DOCK7;ANK3;KLF7;AFG3L2;PARD6B;IQGAP1;CDC42;LMTK2;ACTB;TRIO;APBB1;SLC9A6
prerank,regulation of steroid biosynthetic process (GO:0050810),-0.3614473255750587,-0.8637754413653347,0.64,0.910228893873792,1.0,5/11,23.18%,WNT4;FGFR4;NR1H4;DGKQ;STAR
prerank,regulation of organelle assembly (GO:1902115),0.304499470324367,0.8633409739884814,0.662227602905569,0.9621483561464201,1.0,20/72,18.00%,GSN;RABEP2;TBC1D16;MAPK15;MSN;CEP76;EZR;MTMR3;VPS11;TBC1D1;ODAD3;RAB1B;USP6NL;PLK2;ATXN2L;TBC1D22A;TBC1D10A;PDCD6IP;STAM;TSG101
prerank,protein glycosylation (GO:0006486),0.2835003649175921,0.8632970789931123,0.6933911159263272,0.9617005566177873,1.0,13/125,6.59%,B3GALT1;ST3GAL4;OGT;B4GAT1;GALNT1;MGAT3;GCNT2;LARGE1;TMEM165;MGAT1;FUT8;NPC1;DDOST
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.3769822946583565,0.8632772426011254,0.6478658536585366,0.961219942488491,1.0,2/17,6.81%,NOTCH2;BMP4
prerank,positive regulation of protein export from nucleus (GO:0046827),0.37808945080654477,0.8632753996190871,0.6303680981595092,0.9606956536456539,1.0,6/15,22.76%,TCF7L2;BAG3;RAPGEF3;GSK3B;XPO4;TPR
prerank,C21-steroid hormone metabolic process (GO:0008207),0.36458122224314016,0.8630806656950256,0.6278735632183908,0.9605580887395782,1.0,4/20,20.44%,STARD3;FDX1;HSD17B10;TSPO
prerank,neuron development (GO:0048666),0.2819366979070101,0.863044786692404,0.7135250266240681,0.9601028762347814,1.0,28/141,14.55%,RP1;PBX3;PBX1;EHD1;GDNF;BLOC1S6;ARL3;UNK;DOCK7;MAP4;ZFYVE27;TGFB2;CDK16;OPHN1;HDGFL3;TOR1A;RAB35;SRRM4;ACTL6B;BLOC1S2;SH3GL2;BTG2;FLRT3;MEF2C;ULK1;GSK3B;WNK1;NEDD4
prerank,DNA replication (GO:0006260),0.29213988857224166,0.8629257667325265,0.6901734104046243,0.9598094263892061,1.0,25/105,19.55%,FEN1;GRWD1;RECQL4;MRE11;PTMS;REV1;PCLAF;POLG;RMI1;TOPBP1;CDK2;ING4;RPA3;SET;DONSON;POLD2;MCM8;MCM6;ATR;NBN;MCM7;RAD50;NT5M;RFC1;PNKP
prerank,heme catabolic process (GO:0042167),-0.3317029503028247,-0.8628956156251518,0.651685393258427,0.9098542241674196,1.0,6/14,35.88%,SLCO2B1;ABCG2;SLCO1B1;ABCC1;HMOX1;BLVRB
prerank,porphyrin-containing compound catabolic process (GO:0006787),-0.3317029503028247,-0.8628956156251518,0.651685393258427,0.9098542241674196,1.0,6/14,35.88%,SLCO2B1;ABCG2;SLCO1B1;ABCC1;HMOX1;BLVRB
prerank,membrane fusion (GO:0061025),0.33366605926919785,0.8628675185086323,0.6171352074966533,0.9593943273222136,1.0,13/33,24.71%,OTOF;NSFL1C;CHP1;VTI1B;NAPA;OPA1;STX11;DNM1L;NSF;VAMP2;SNAP23;VAPA;UBXN2A
prerank,glutamine family amino acid catabolic process (GO:0009065),0.4022541103376712,0.8626762676341924,0.617737003058104,0.9592468915986687,1.0,2/13,7.09%,GLUL;GLUD1
prerank,T cell migration (GO:0072678),-0.3361582567291029,-0.8626322251730906,0.6285714285714286,0.909252814100727,1.0,7/13,31.42%,SLC12A2;CXCL16;PIK3CD;GPR183;S1PR1;PIK3CG;CXCL10
prerank,positive regulation of stem cell differentiation (GO:2000738),-0.31105004964783517,-0.8623544127191172,0.6648199445983379,0.9087287141430559,1.0,1/16,0.12%,SOX5
prerank,negative regulation of protein polymerization (GO:0032272),0.34559444442259396,0.8622358024421145,0.6451612903225806,0.9596011077480692,1.0,8/27,17.48%,KANK1;SSH3;TWF1;EML2;ARFGEF1;KANK4;PFN2;CDH5
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",-0.3528246886526526,-0.8619429024965415,0.6328502415458938,0.9084766335305534,1.0,3/11,13.14%,SP100;TP53;RPS6KA6
prerank,axonogenesis (GO:0007409),0.27147419076486146,0.861196104640891,0.753099173553719,0.9610242344084047,1.0,38/237,11.68%,SEMA3D;NOTCH2;GPC1;EPHA4;EFNB2;DAG1;NIBAN2;S100A6;GAB1;SEMA3B;CXCR4;LAMA5;DOK6;GDNF;SPTBN2;ENAH;GFRA3;DOCK7;EFNA5;SHC1;ANK3;MAPK7;KLF7;PTPRA;UNC5B;AFG3L2;PARD6B;LMTK2;OPHN1;ACTB;EZR;APBB1;SLC9A6;NRP2;SEMA4F;EPHA3;SPTAN1;IRS2
prerank,positive regulation of lymphocyte migration (GO:2000403),0.40017453168193257,0.8611818924582825,0.6256077795786061,0.9605240773457594,1.0,4/12,19.38%,CCL5;RHOA;JAM2;APP
prerank,"phagocytosis, engulfment (GO:0006911)",0.3331150228865814,0.8609828769969602,0.6526458616010855,0.9603855781197104,1.0,7/36,15.65%,GSN;GULP1;XKR4;CDC42;DOCK1;VAMP7;ITGB2
prerank,ATP transport (GO:0015867),-0.3636518685083059,-0.8608741224424142,0.6587301587301587,0.9096820173557977,1.0,1/10,1.03%,CD47
prerank,response to light stimulus (GO:0009416),0.31005788942188145,0.8605856252855343,0.6521739130434783,0.9605929480999308,1.0,12/55,19.94%,OPN1SW;AANAT;REV1;CPT1B;CRY2;UBE2B;PCLAF;ERCC5;ERCC2;CDKN2D;ERCC4;USF1
prerank,chloride transmembrane transport (GO:1902476),0.3169536019073948,0.8605162857323333,0.6442185514612452,0.960211552731875,1.0,2/48,2.32%,CFTR;SLC12A8
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.33245019425977324,0.8604041431002688,0.6364883401920439,0.9598977982151897,1.0,9/33,19.24%,CD81;UBASH3A;LGALS3;EZR;PTPN2;IKBKG;SH2D1A;DUSP3;PRKD2
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.4206112368249209,0.860341063690627,0.6508474576271186,0.9594917308320822,1.0,3/10,19.43%,PMAIP1;IRS2;GPLD1
prerank,regulation of cardiac muscle contraction (GO:0055117),0.33728244385262807,0.8603161290487344,0.6544502617801047,0.9590249110891127,1.0,2/34,2.55%,ANK2;ZC3H12A
prerank,negative regulation of peptidase activity (GO:0010466),0.31965986510551747,0.8600610382426286,0.6303797468354431,0.9589845642900194,1.0,6/47,8.77%,CRB2;TIMP4;SERPINC1;TIMP1;TIMP2;SERPINB8
prerank,negative chemotaxis (GO:0050919),0.3357569126734768,0.8599517608833159,0.6460055096418733,0.9586781106817749,1.0,2/33,2.81%,SEMA3D;SEMA3B
prerank,positive regulation of T-helper cell differentiation (GO:0045624),-0.3216833477791402,-0.8598476119627636,0.6529562982005142,0.9106872911322165,1.0,8/14,37.36%,IL18;SOCS5;CCL19;CD86;MALT1;CD80;NFKBID;NLRP3
prerank,positive regulation of erythrocyte differentiation (GO:0045648),-0.2758824956611893,-0.8598292488702712,0.6688102893890675,0.9095786717154681,1.0,6/25,10.80%,STAT5B;HIF1A;ACVR1B;ACVR2A;STAT3;NCKAP1L
prerank,ion homeostasis (GO:0050801),-0.2661654907522284,-0.8598058107660528,0.6959706959706959,0.9084868822937546,1.0,5/30,7.70%,SLC4A10;CAMK2D;KLHL3;WNK2;UNC80
prerank,response to tumor necrosis factor (GO:0034612),0.29445323603116536,0.8597699769740437,0.6996625421822272,0.9585163472636132,1.0,16/91,15.58%,CCL5;ADAMTS7;ADAM10;ZC3H12A;AFF3;YBX3;NFE2L2;NUB1;GSDME;NPNT;GATA3;ZFAND6;SFRP1;CHUK;DHX9;IGBP1
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),-0.20283032132575024,-0.8597398815294532,0.7959183673469388,0.9075010991022866,1.0,50/117,33.67%,ADCY5;CALCRL;LYN;GGT5;ADCY7;ADCY1;ADCY4;HTR7;ADORA2A;RAMP2;PRKAR2B;GPR45;CYSLTR1;PTHLH;GNB1;ADM;CYSLTR2;MC5R;ADCY2;PTGDR;PRKAR1B;PTGER4;GLP2R;RXFP1;MAPK14;VIPR2;ADCY3;ADCY8;IAPP;ADCYAP1R1;GPR27;HCK;NPSR1;CALCA;GNG2;HRH2;FGR;TSHR;CD247;ADRB1;PLCG2;LHCGR;PLCG1;TREM2;PTH2R;GPR20;CD163;HTR6;GIPR;CRHR1
prerank,protein-DNA complex assembly (GO:0065004),0.2854497797644963,0.8597161968087738,0.7086092715231788,0.9581002460008624,1.0,25/116,18.29%,DAXX;GRWD1;PSMD11;ASF1A;SOX9;KAT6B;PSMD4;PSMF1;ATRX;RBX1;PSMD7;ERCC5;PSMB5;RPA3;MCM8;DDB1;MCM6;RPS27A;UBC;ERCC2;SPTY2D1;MCM7;PSMD1;PSMC4;H3-3A
prerank,microvillus assembly (GO:0030033),0.39552252822387024,0.859598457165396,0.6317460317460317,0.9577947721205451,1.0,4/14,9.58%,RAP1B;RAP1A;ESPN;EZR
prerank,regulation of mesenchymal cell proliferation (GO:0010464),-0.34957921189707014,-0.8594038885250442,0.6570048309178744,0.9070818406317375,1.0,5/11,16.45%,WNT5A;LRP5;FGFR2;TBX1;CTNNBIP1
prerank,negative regulation of protein phosphorylation (GO:0001933),0.276628873145543,0.8593686200062913,0.7082429501084598,0.9577697767827658,1.0,30/150,14.86%,NTRK3;TRIB2;OCLN;SMAD6;ZC3H12A;CAV1;QARS1;HSPB1;TARBP2;TSC2;FBLN1;SPRED3;DMTN;NLRP2B;PIP5KL1;CHP1;PYDC1;FKBP8;PTPN6;SMCR8;TWIST1;GNAQ;LDLRAD4;MVP;SH3GL2;SFRP1;EIF4G1;DNAJC10;ITGB1BP1;DNAJC3
prerank,ncRNA processing (GO:0034470),0.27488083198259194,0.8593195700119175,0.7479253112033195,0.9573488235455515,1.0,57/200,22.55%,DGCR8;PES1;UTP11;FARS2;PIH1D1;TARBP2;TRPT1;KRR1;POP4;WDR55;XRN2;RPL31;EXOSC3;POP1;RPL22;INTS2;THG1L;AARS1;RRP12;MPHOSPH6;BMS1;MTREX;WDR43;WDR36;RPL28;PWP2;DDX47;RPP21;ZCCHC8;TUT7;NOC4L;SENP3;RPL10A;NOL6;RRP9;SRRT;SARS1;RPF1;UTP14A;UTP4;IMP4;RPL14;INTS3;PDCD11;IMP3;INTS6;RPL6;RPS28;RPL41;TUT1;RPLP2;DDX52;BYSL;RPLP1;RPL7;INTS1;WDR74
prerank,regulation of dephosphorylation (GO:0035303),0.3866836560593254,0.8592364451595106,0.6240126382306477,0.9569897952825346,1.0,5/15,18.96%,SMG7;PPP1R16A;MTMR3;IGBP1;CDK5RAP3
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.3864669061342517,0.8586342399968467,0.6176470588235294,0.9576405240042566,1.0,3/16,12.51%,CAV1;PPP2CA;PTPN2
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.280537118773031,0.8582526316204545,0.7181719260065288,0.9578763547826744,1.0,20/124,14.09%,PLCB3;CELSR1;WNT1;WNT11;AP2A2;PSMD11;MOV10;PSMD4;PSMF1;DVL3;FZD5;TCF7L2;CDC42;PSMD7;GNAO1;AP2A1;RHOA;PSMB5;PDE6B;SFRP1
prerank,response to amino acid (GO:0043200),-0.26690021063600794,-0.8580667513115549,0.7034220532319392,0.9087873005187115,1.0,11/31,18.93%,GLRA1;IPO5;CPEB1;SLC38A9;TMBIM6;LAMTOR1;GLRA3;RRAGD;GLRA2;RRAGA;GLRB
prerank,negative regulation of defense response (GO:0031348),0.2983796603754215,0.8580263685258818,0.6773428232502966,0.9578018574278359,1.0,19/77,19.73%,KLF4;PPM1B;ALOX5;MUL1;MAPK7;TRIM21;FEM1A;TNFRSF1A;NMI;PTPN2;LPCAT3;GATA3;CDH5;FNDC4;OTULIN;ILRUN;GPER1;PCBP2;RB1
prerank,central nervous system projection neuron axonogenesis (GO:0021952),0.40345945388113735,0.8577268505920237,0.6183333333333333,0.9578667903323428,1.0,3/12,10.55%,EPHA4;NFIB;PAFAH1B1
prerank,response to muramyl dipeptide (GO:0032495),0.401071537455684,0.8573384802692416,0.6153846153846154,0.9581080312267917,1.0,2/12,7.26%,VIM;TRIM41
prerank,epithelial cell-cell adhesion (GO:0090136),-0.3417095717284102,-0.8571942796617882,0.6708542713567839,0.9095067306528217,1.0,7/11,29.33%,PLEKHA7;KIT;CCN3;KIFC3;DSP;JUP;CAMSAP3
prerank,negative regulation of insulin secretion (GO:0046676),0.37603487437952776,0.8567998925456864,0.6562962962962963,0.9586209599188916,1.0,10/17,32.96%,KLF7;KCNB1;SFRP1;SIRT4;BMP8A;CHGA;PRKN;PSMD9;REST;MIDN
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),-0.2958967318458616,-0.8567822136417393,0.6981132075471698,0.9092260699523386,1.0,7/20,18.12%,DCC;FAS;BCL2;CASP9;ITGAV;BAX;BOK
prerank,cardiolipin metabolic process (GO:0032048),-0.33304794193871035,-0.856395682250348,0.6648648648648648,0.9088916335652122,1.0,2/13,6.77%,PLA2G4A;PNPLA8
prerank,regulation of fatty acid metabolic process (GO:0019217),0.3752310601098295,0.8563210351385452,0.6291079812206573,0.9590103253328993,1.0,4/17,11.27%,PRKAA2;CAV1;EIF6;NCOR1
prerank,lipid homeostasis (GO:0055088),0.3037501267252022,0.8563174139478565,0.6865127582017011,0.9584962592551344,1.0,8/57,11.68%,PRKAA2;ABCD1;ABHD5;ORMDL3;THADA;TLCD2;ABCA2;IRS2
prerank,substantia nigra development (GO:0021762),0.3255120203616053,0.8554966615141953,0.6554959785522788,0.9595527743672022,1.0,11/37,12.55%,GLUD1;SYNGR3;CDC42;NDUFS3;ACTB;YWHAQ;S100A1;RHOA;ZNF148;ATP5PF;MAPKAP1
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),0.325897284328737,0.8554371988107895,0.6608811748998665,0.9591531996583234,1.0,2/44,1.06%,ANK2;ACTN2
prerank,response to UV-B (GO:0010224),0.39418843661018854,0.8551580255707814,0.632890365448505,0.9591844630968314,1.0,1/12,1.93%,CDKN1A
prerank,regulation of cell projection organization (GO:0031344),-0.32853726402189076,-0.8548011012528487,0.6537467700258398,0.911098783314628,1.0,4/13,13.67%,MYO9A;NTNG1;MACF1;MFSD2A
prerank,cellular defense response (GO:0006968),-0.24417961272811348,-0.8547637610565776,0.7242798353909465,0.9100513626513947,1.0,7/40,15.78%,DCDC2;LSP1;CCR9;VEZF1;ADORA2A;NCF2;IL1RL2
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),-0.35584422001907523,-0.8547259055305644,0.6544117647058824,0.9089977123414018,1.0,2/10,5.46%,CAMK2D;HECW1
prerank,morphogenesis of an epithelial sheet (GO:0002011),-0.35483820564902263,-0.8544510511975437,0.6024691358024692,0.9084509195350203,1.0,6/10,25.64%,NOTCH1;LRP6;SOX11;BMP7;LIN7C;DLL4
prerank,signal peptide processing (GO:0006465),-0.3448562752424388,-0.8543177538189908,0.650990099009901,0.9076070921618448,1.0,2/11,9.97%,PCSK5;SPCS2
prerank,prostanoid metabolic process (GO:0006692),-0.3274113040657386,-0.8541956362482,0.6583333333333333,0.9067615836329354,1.0,5/13,25.59%,PTGES;ACOX1;HPGD;CYP2S1;PTGR1
prerank,chromatin-mediated maintenance of transcription (GO:0048096),-0.35237965147221184,-0.8541171623146859,0.6737400530503979,0.9057963438132268,1.0,5/11,20.24%,ZMIZ1;ARID1A;PADI2;SERTAD2;SMARCD1
prerank,monocarboxylic acid catabolic process (GO:0072329),-0.2874325425193214,-0.8541066331785383,0.6908517350157729,0.9046917468365651,1.0,4/21,11.84%,CYP26B1;PPARD;ACOX1;LPIN2
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.267902704390758,0.8540669738785246,0.8152284263959391,0.9607569316218375,1.0,67/327,18.47%,BNC2;NFATC2;FOXN3;DAXX;PPARGC1A;EP300;DAPK3;ZNF219;PPP2CA;CREBL2;IGSF1;MLF2;ESRRB;PRRX2;PATZ1;PHF1;POLR2A;HCFC1;KAT6B;EFEMP1;RALY;ZFHX3;ATRX;SIX1;PML;FOXP3;MYCBP;APBB1;FADS1;NFYC;ZNF205;GON4L;MYT1;AJUBA;SP1;TAF5;TFEB;SPIN1;CHD3;RREB1;SBNO2;GPBP1;NFIA;REXO4;MEF2C;MYBL1;SRRT;PTP4A3;IRF2;UTP4;ACTN4;NAB2;PAK6;E2F1;HINFP;SPTY2D1;ABL1;MLLT6;LIN54;TRRAP;CHEK2;PRKCQ;BRDT;APBB3;SUFU;WTIP;ATF2
prerank,regulation of heart contraction (GO:0008016),0.2943730359350898,0.8534494529186462,0.696528555431131,0.9614041038068692,1.0,5/90,4.79%,ITPR2;ANK2;CELF2;ATP1A2;AHCYL1
prerank,heart trabecula morphogenesis (GO:0061384),-0.3028014130602068,-0.8533295549952438,0.6925566343042071,0.9052461024836074,1.0,3/18,4.22%,ENG;TEK;NOTCH1
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),-0.2221856187404646,-0.8530936076054185,0.7771084337349398,0.904640412159439,1.0,19/70,22.81%,TCF12;LMO2;RUNX1;N4BP2L2;PSMC6;PSMA6;PUS7;GATA2;PSME1;PSMB10;PSMD5;PSMD3;TAL1;PSMA4;YAP1;PSMB9;PSMA8;PSMB7;YTHDF2
prerank,regulation of phosphatase activity (GO:0010921),0.3513461062424666,0.8528494525996406,0.6162624821683309,0.9620024173229244,1.0,3/24,8.66%,PPP6R3;SH3RF2;CHP1
prerank,positive regulation of rRNA processing (GO:2000234),0.4059790896673474,0.8527688769663847,0.6568627450980392,0.9616320161194865,1.0,4/10,22.27%,BUD23;WDR43;TRMT112;SIRT7
prerank,regulation of interleukin-10 production (GO:0032653),-0.23480887929265,-0.852455679406291,0.7668161434977578,0.9047910518786543,1.0,17/44,29.88%,CD47;CD34;LGALS9;TNFRSF21;CD46;STAT3;HMGB1;HSPD1;TYROBP;NOD2;JAK3;PYCARD;FCGR2B;PIBF1;ISG15;PLCG2;VSIR
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.32409370687178296,0.852326842222925,0.6437086092715232,0.9619531971032871,1.0,12/37,19.88%,RBX1;POLK;ERCC5;RPA3;POLD2;PCNA;DDB1;RPS27A;UBC;ERCC2;RFC1;ERCC4
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),-0.30370905182549995,-0.8517725366406736,0.6780626780626781,0.9051085791404773,1.0,1/17,0.03%,PRKG1
prerank,neuronal action potential (GO:0019228),0.348616043182839,0.8514547494187366,0.6423357664233577,0.9631315379944119,1.0,6/22,21.42%,SCN3A;ANK3;SCN9A;GPER1;KCNMB2;KCNMB3
prerank,positive regulation of signaling (GO:0023056),-0.2530437843288537,-0.8508440800174826,0.7709923664122137,0.9058192712762664,1.0,12/37,23.00%,GRIK2;ECE1;LGI1;SYT1;CLSTN2;RAB29;EDN1;SOX11;EDN3;KCTD13;RIMS1;RIMS3
prerank,negative regulation of inflammatory response (GO:0050728),-0.18928211010984797,-0.8506580837349964,0.9545454545454546,0.9050639443025507,1.0,54/182,25.69%,IGF1;TEK;ADCY5;CALCRL;LYN;PTGIS;MFHAS1;GGT5;ADCY7;NR1H3;RORA;VPS35;PPARD;ADCY1;ADCY4;HTR7;ENPP3;ADORA2A;PPARG;RAMP2;PRKAR2B;GPR45;CYSLTR1;TNFRSF1B;CCN3;PTHLH;MVK;GNB1;ADM;CYSLTR2;MC5R;PPARA;ADCY2;PTGDR;PRKAR1B;PTGER4;GLP2R;RXFP1;TNFAIP3;NR1H4;LRFN5;MAPK14;VIPR2;ADCY3;ADCY8;GPS2;IAPP;ADCYAP1R1;GPR27;HCK;NPSR1;CALCA;GNG2;SMPDL3B
prerank,lysosome localization (GO:0032418),0.32896452671301774,0.850116000145894,0.6767123287671233,0.9651704636191427,1.0,13/37,24.99%,SYTL4;NDEL1;MAP6;PLEKHM1;BLOC1S2;TFEB;FLCN;HDAC6;BORCS6;PIP4P1;ARL8B;KLC2;FAM98A
prerank,regulation of intracellular signal transduction (GO:1902531),0.2664344503586998,0.8498613870929201,0.8482412060301507,0.9651604704054412,1.0,109/420,21.86%,PRKAA2;NTRK3;SRGAP3;SRGAP2;MOB3B;DAXX;ARAP1;NGEF;LBH;ARHGEF17;ARHGAP18;AKAP13;EP300;ARHGEF12;ARAP2;TIAM2;NOP2;PPP1R13L;HSPB1;PPP1R13B;RHOQ;NFKBIA;ROS1;ARHGEF18;MRE11;GRM2;ARHGAP29;SSRP1;ARHGAP21;ARHGAP10;PLK3;CDC42;PML;BCR;ARHGEF5;BANP;BRD7;OPHN1;TRIO;EZR;AKAP5;DLC1;RMI1;GNA13;RHOA;TOPBP1;TAF5;MAPKAP1;SOS2;CHD3;INPP5B;CDK2;OCRL;ARHGAP31;RHOU;PIP4K2C;PRDM11;RPA3;ZFAND6;PRKAR2A;FLCN;MDM2;ARHGDIB;PAK1IP1;IKBKG;MEAF6;ARHGEF1;CRK;PAK6;TAGAP;ATR;POU4F1;ARHGAP33;CCNG1;PRKAG1;NBN;PTPN13;XIAP;PLEKHG2;CHEK2;FBXL2;PIDD1;ARHGAP44;RAD50;TMEM127;ARHGEF6;TAOK3;RNF41;TAF9B;PRKD2;RHOT2;FBXO9;TBP;PRKAB1;TBCK;MAPT;ATP6AP2;AGER;PRKAB2;TRAF4;CASTOR2;CMKLR1;USP2;WDR54;CDK5R1;TAF6;ARHGEF11;RHOC;TPTE
prerank,mesenchymal cell differentiation (GO:0048762),0.3110981741645306,0.8497375045351847,0.6711327649208283,0.9648683133902916,1.0,6/51,7.38%,FGFR1;RANBP3L;DDX5;SOX9;AKNA;TGFB2
prerank,regulation of cilium assembly (GO:1902017),0.3033525991198637,0.8493112636369093,0.6859504132231405,0.9651191911203191,1.0,21/62,24.32%,LIMK2;RABEP2;CDK10;TBC1D16;MAPK15;TBC1D1;MARK4;ODAD3;CCDC88A;USP6NL;TESK1;TBC1D22A;TBC1D10A;TBC1D17;CROCC;CEP97;RABGAP1;TAPT1;CEP120;ODF2L;ATG3
prerank,visual perception (GO:0007601),0.292559539478476,0.8489773624570812,0.691764705882353,0.9652488453943562,1.0,9/84,6.72%,ABLIM1;GUCY2F;CRYBB3;CACNA2D4;CRYBG3;UNC119;EML2;ZIC2;EFEMP1
prerank,positive regulation of T cell differentiation (GO:0045582),-0.24780452656657836,-0.8489697363352008,0.7075098814229249,0.9075214592443069,1.0,6/36,11.72%,LEF1;GLI2;ZMIZ1;CD46;NCKAP1L;PNP
prerank,positive regulation of transporter activity (GO:0032411),0.3860943008420534,0.848764633401596,0.6509433962264151,0.9651461671976561,1.0,3/13,9.03%,STK39;SYNGR3;KMT2A
prerank,cellular response to mechanical stimulus (GO:0071260),0.3103305691888043,0.8485385546235668,0.6762860727728983,0.9650531797766043,1.0,8/46,11.15%,TNFRSF8;SOX9;BAD;TNFRSF10B;TNFRSF1A;HABP4;AQP1;TLR4
prerank,regulation of mitotic cell cycle (GO:0007346),0.27430872519041893,0.8483676489111338,0.7598299681190224,0.9648693225620392,1.0,32/171,19.78%,FZR1;NEK7;CDK10;DAPK3;PSMD11;CAV2;PSMD4;PSMF1;IQGAP1;FBXO5;EIF4EBP1;PSMD7;PKMYT1;PSMB5;ANAPC4;BTG2;MDM2;MAEA;DDB1;ERCC2;CUL9;CDC25B;PSMD1;DUSP3;INTS13;PSMC4;KIF20B;CDK5RAP3;APP;PSMD8;RB1;CDK11B
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.30839317300853114,0.8480990735939399,0.6733416770963705,0.9648627179923976,1.0,8/53,11.13%,NUPR1;DDRGK1;PSMF1;DESI1;PKD1;USP19;OPHN1;OSBPL7
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),-0.25529947005530107,-0.8476070205653603,0.7222222222222222,0.9092364025370503,1.0,2/33,2.85%,PRKG1;IGFBP5
prerank,rRNA processing (GO:0006364),0.27363578054322857,0.8474689549142114,0.7528916929547844,0.9655241098150389,1.0,33/172,15.88%,NSA2;NOP2;PES1;UTP11;PIH1D1;EIF6;KRR1;MAK16;POP4;WDR55;XRN2;RPL31;EXOSC3;RPL22;RRP12;MPHOSPH6;BMS1;MTREX;WDR43;WDR36;RPL28;PWP2;DDX47;NOC4L;SENP3;RPL10A;NOL6;RRP9;RPF1;UTP14A;UTP4;IMP4;RPL14
prerank,small GTPase mediated signal transduction (GO:0007264),0.2857552918172282,0.8471234856537854,0.7064732142857143,0.9656356048829037,1.0,26/103,15.53%,CDKN1A;MRAS;ARHGAP18;TIAM2;ARL3;ARHGEF18;NRAS;KRAS;RHEB;SHC1;KRIT1;JUN;CHP1;BCR;RALGDS;ARFIP2;RREB1;CDK2;ARHGAP31;SHC2;BRAP;HRAS;CCDC88A;SETDB1;PLK2;USP28
prerank,positive regulation of heart contraction (GO:0045823),0.3636990540344957,0.8471117978178715,0.6453576864535768,0.9651455300093483,1.0,4/19,13.53%,ATP1A2;TGFB2;TRPM4;GSK3A
prerank,negative regulation of cell cycle (GO:0045786),0.29553382302377956,0.847030261792273,0.6898203592814371,0.9647854359774204,1.0,13/73,13.57%,NUPR1;CDK6;PPP1R13B;IPO7;DUSP1;ZBTB17;BMP4;LATS1;NLRP2B;CDK5RAP1;GATA3;CHMP1A;BTG2
prerank,regulation of myelination (GO:0031641),-0.2688321053576842,-0.8470262156401958,0.7147540983606557,0.9092798329541567,1.0,7/25,15.80%,TNFRSF21;PTPRZ1;TENM4;TPPP;TNFRSF1B;MYRF;SIRT2
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.3212705139817988,0.8470146676873134,0.6653061224489796,0.9643048217834513,1.0,14/38,22.99%,EPHA4;CAV1;UNC119;SHC1;ERBB3;SRCIN1;MVP;RAP2C;RELN;SH3BP5L;APP;DLG4;EFNA1;FCGR1A
prerank,cellular response to lectin (GO:1990858),0.2794342422236595,0.8468712451806074,0.7144432194046306,0.9635517192824148,1.0,19/104,18.10%,EP300;RELB;PSMD11;NRAS;KRAS;PSMD4;PSMF1;MUC6;TAB3;RAF1;PSMD7;FCER1G;PSMB5;CHUK;HRAS;IKBKG;PSMD1;TAB2;PSMC4
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.2794342422236595,0.8468712451806074,0.7144432194046306,0.9635517192824148,1.0,19/104,18.10%,EP300;RELB;PSMD11;NRAS;KRAS;PSMD4;PSMF1;MUC6;TAB3;RAF1;PSMD7;FCER1G;PSMB5;CHUK;HRAS;IKBKG;PSMD1;TAB2;PSMC4
prerank,acylglycerol biosynthetic process (GO:0046463),0.3502896826037054,0.8468658169824065,0.6532951289398281,0.9630487052098422,1.0,5/23,11.59%,DGAT1;MOGAT3;MOGAT1;ANG;GPAM
prerank,response to unfolded protein (GO:0006986),0.31202466313856986,0.8463772648524501,0.6910994764397905,0.9634600737617368,1.0,10/48,15.88%,DAXX;HSPB1;HSPB2;HSPB8;HSPA4;HSPA14;BAG3;HSP90AA1;HSPH1;DNAJC4
prerank,regulation of actin nucleation (GO:0051125),0.39460759791785915,0.8463086113646585,0.6519685039370079,0.9630713509367201,1.0,2/12,11.72%,GSN;ARFIP2
prerank,regulation of microtubule-based movement (GO:0060632),-0.3391406309500056,-0.8462670907124996,0.645,0.9097332830760433,1.0,2/11,5.62%,MAP2;TTC21B
prerank,neuron maturation (GO:0042551),-0.29907770783470206,-0.8460541641049061,0.6705539358600583,0.9090396655496351,1.0,7/18,23.46%,ADGRB3;ANKS1A;B4GALT5;C1QA;EPHA8;CX3CL1;C3
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.30811994599349174,0.8456652448897283,0.6858974358974359,0.9637809236111726,1.0,8/48,10.44%,OGT;EP300;NUP93;RUBCNL;EIF6;NDC1;JMJD8;TIGAR
prerank,regulation of cellular response to stress (GO:0080135),0.2802689224109896,0.845638247347377,0.7494456762749445,0.9633237631635649,1.0,38/115,25.77%,NUPR1;ABCD1;EP300;BAG1;ALOX5;CRYAB;HSPB8;NUP93;CHORDC1;USP19;NDC1;BAG3;AJUBA;RPA3;GSK3B;EIF4G1;HSP90AA1;HSPH1;ATR;ABL1;MAPKAPK2;AAAS;RAE1;ROCK2;MAPT;CAMK2B;HIKESHI;PTGES3;POM121;TPR;RANBP2;ARMT1;NUP42;AIFM2;NUP62;SLC38A2;SEH1L;MBTPS2
prerank,negative regulation of immune response (GO:0050777),-0.19581237044084984,-0.8451320045533294,0.9242424242424242,0.9099014302466858,1.0,69/154,34.41%,ADCY5;CALCRL;LYN;GGT5;ADCY7;IRAK3;ADCY1;ADCY4;HTR7;ENPP3;ADORA2A;RAMP2;PRKAR2B;GPR45;CYSLTR1;MAPKBP1;PTHLH;CD300A;GNB1;SIRT2;ADM;CYSLTR2;MC5R;RC3H1;ADCY2;PTGDR;PRKAR1B;PTGER4;GLP2R;RXFP1;TNFAIP3;MAPK14;VIPR2;ADCY3;ADCY8;IAPP;LYAR;ADCYAP1R1;GPR27;SPI1;HCK;NPSR1;CALCA;GNG2;HRH2;FER;FGR;TSHR;FCGR2B;CD247;ADRB1;TRIM27;PLCG2;CCR2;LHCGR;DHX58;PLCG1;TREM2;PTH2R;SAMSN1;TYRO3;GPR20;RNF26;CD163;HTR6;GIPR;CRHR1;LILRB1;GLP1R
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",-0.3617943230141825,-0.8451115275690012,0.6412213740458015,0.9088389372282359,1.0,4/10,23.46%,APPL2;NCKAP1L;CD300A;C3
prerank,cellular protein catabolic process (GO:0044257),0.3009943859227446,0.8450834870564475,0.6813186813186813,0.9638846000281005,1.0,17/59,19.31%,ADAMTS7;AP2A2;RNF5;DENND3;CTSZ;CAPN2;UBE2G2;RAB7A;AFG1L;AP2A1;RNF123;BNIP3L;MDM2;CTSH;CHEK2;PISD;IDE
prerank,keratan sulfate biosynthetic process (GO:0018146),0.3475893776587372,0.8448875059777824,0.6442166910688141,0.9637455745514849,1.0,3/26,6.64%,ST3GAL4;B4GAT1;PRELP
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.354958152100022,0.8448828532581752,0.6425406203840472,0.9632427431886307,1.0,8/22,19.25%,VPS37B;VPS4B;RNF126;VPS4A;NEDD4;STAM;TSG101;VPS37A
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.2701701951650646,0.8448335889255478,0.7805139186295503,0.9628195234025032,1.0,27/163,18.10%,PRKCB;NFATC2;ZC3H12A;FYB2;PSMD11;EIF2B2;CSK;PSMD4;PSMF1;NFAM1;TXK;PSMD7;BCAR1;PSMB5;GATA3;MEF2C;CHUK;WNK1;IKBKG;RNF31;UBE2N;EIF2B4;PSMD1;TAB2;SPPL3;PRKCQ;PSMC4
prerank,regulation of postsynapse organization (GO:0099175),0.3418514699854625,0.8445247607010425,0.6584362139917695,0.9628667555706277,1.0,3/28,2.48%,PDLIM5;EPHA4;SIPA1L1
prerank,negative regulation of lymphocyte activation (GO:0051250),-0.28172937756371896,-0.8440686341428414,0.6978851963746223,0.9099516224674413,1.0,13/21,36.10%,PAG1;SOX11;TNFAIP3;JAK3;FCGR2B;PIBF1;BANK1;LST1;FOXJ1;SAMSN1;LAX1;IL4I1;PTPN22
prerank,positive regulation of neurogenesis (GO:0050769),0.298113339484131,0.8438945806116834,0.6862026862026862,0.963532728597694,1.0,7/68,4.84%,FBXW8;PLXNB1;PLXNA2;NGF;TIAM2;MAP6;PTPRD
prerank,carbohydrate derivative catabolic process (GO:1901136),-0.3003763448084402,-0.8438233978428071,0.7023121387283237,0.9093682503366557,1.0,3/18,8.78%,ADAMTS9;BPGM;SAMHD1
prerank,mRNA export from nucleus (GO:0006406),0.2832039719095789,0.8434052809541391,0.7130242825607064,0.9639295571211128,1.0,33/102,25.54%,SRSF2;NUP93;EIF4A3;SMG7;DDX39B;RBM8A;NDC1;WDR33;AGFG1;ENY2;SRSF7;POLDIP3;THOC7;RNPS1;SRSF9;UPF3B;PABPN1;MAGOHB;MAGOH;AAAS;SRSF1;RAE1;SRSF5;THOC1;POM121;U2AF1;TPR;SRRM1;RANBP2;NUP42;NUP62;SEH1L;RBM15B
prerank,negative regulation of signaling (GO:0023057),-0.2748394897739391,-0.8434036835832782,0.6875,0.9091466939746955,1.0,6/25,21.40%,UBASH3B;GLRA1;SOCS5;KIF26A;OPRM1;OPTN
prerank,regulation of granulocyte chemotaxis (GO:0071622),-0.29416943219016845,-0.843400289036309,0.6656891495601173,0.9080595461699067,1.0,3/19,5.34%,IL34;PTK2;THBS1
prerank,regulation of ceramide biosynthetic process (GO:2000303),0.37595072439203875,0.8433972990749096,0.6376146788990825,0.9634405844130742,1.0,4/15,14.70%,ORMDL3;TNFRSF1A;SMPD2;PLA2G6
prerank,vesicle cytoskeletal trafficking (GO:0099518),0.3223728528336748,0.8433161120617856,0.6545924967658473,0.9630751649087093,1.0,6/39,10.55%,DYNC1I1;MYO1H;NDEL1;MYO5A;MYO1C;PAFAH1B1
prerank,pyrimidine nucleobase metabolic process (GO:0006206),-0.33257569215436295,-0.843055568330701,0.6738544474393531,0.9076560483880195,1.0,3/12,10.54%,ALDH6A1;CTPS1;DPYSL5
prerank,positive regulation of protein secretion (GO:0050714),0.2969710094039869,0.8425207800828032,0.7053892215568862,0.9640549301041043,1.0,22/69,20.53%,SYTL4;MCU;GLUD1;WLS;GOLPH3;TGFB2;BAD;ANG;TCF7L2;EZR;APBB1;IER3IP1;TLR4;IRS2;AACS;DNM1L;NLGN2;APBB3;GPER1;MYO18A;SOX4;FRMD4A
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.27834772844318195,0.8423185781193211,0.7298787210584344,0.9639085970321984,1.0,19/105,18.10%,EP300;RELB;PSMD11;NRAS;KRAS;PSMD4;PSMF1;MUC6;TAB3;RAF1;PSMD7;FCER1G;PSMB5;CHUK;HRAS;IKBKG;PSMD1;TAB2;PSMC4
prerank,establishment of mitotic spindle localization (GO:0040001),0.3314355787257095,0.8419753456451059,0.6563814866760168,0.9640689964283476,1.0,7/28,18.67%,NDEL1;NSFL1C;PAFAH1B1;ZW10;INSC;NUMA1;MISP
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",0.28278490967121067,0.8417855213254393,0.7106430155210643,0.9639448471536419,1.0,34/110,24.09%,PPP2CA;RPS4X;EIF4A3;UPF3A;SMG7;RBM8A;RPL31;RPSA;GSPT2;RPL22;RPL28;RPS26;RNPS1;RPL10A;DCP1A;UPF3B;EIF4G1;PYM1;RPL14;MAGOHB;MAGOH;RPS27A;CTIF;RPL6;RPS28;SMG9;ETF1;RPL41;RPLP2;RPLP1;RPL7;PABPC1;RPL21;RPL26
prerank,regulation of mitotic spindle organization (GO:0060236),0.3241397228392091,0.8417840980046779,0.668,0.9634401082834727,1.0,15/35,26.59%,PARP3;PSRC1;CHMP4B;VPS4B;CHMP1A;CHMP2A;DYNC1H1;NUMA1;PDCD6IP;RAE1;CEP97;TPR;CHMP5;NUP62;CHMP1B
prerank,protein ubiquitination (GO:0016567),0.2612992165696219,0.8415707854119646,0.8592964824120602,0.9633373866975504,1.0,124/471,23.51%,RNF152;FBXL7;TRIM60;FBXW8;TRIM33;CAND2;RNF43;FBXL20;RNF220;SPSB4;NFE2L2;LONRF1;SH3RF2;WWP2;TRIM25;TRIM44;PSMD11;NUB1;ELOB;RNF138;KLHL21;MUL1;PSMD4;CBLL1;PSMF1;TRIM41;TRIM21;UBE2G2;FBXL18;RBX1;RNF146;FBXO31;SDE2;TRIM47;TRIM26;TRIM11;UBE2B;RNF182;PCNP;KLHL24;PSMD7;FBXW9;UBE2Q1;VPS11;KLHL13;RNF126;MIB2;ZSWIM8;RNF141;PSMB5;DTX3;NPEPPS;PELI1;DDA1;VPS18;UBE4A;BRAP;UBR5;NEDD4;UBE2H;MDM2;BFAR;RNF31;PCNA;UBE2N;CCDC22;MSL2;PRPF19;TNKS2;FBXL15;UBA6;DDB1;TPP2;RNF10;CAND1;RPS27A;UBC;CUL9;DTX2;UBE2D3;SIAH1;KEAP1;STUB1;UBE2J1;FBXL2;PSMD1;PDZRN3;TRIM37;OTULIN;PSMC4;RNF112;PEX2;RNF41;PSMD8;UBE2Z;ASB5;UBE3C;FBXO9;THOP1;RMND5A;CHFR;USP22;VHL;FBXW7;CUL2;TRIM5;UBE2E1;FBXW2;RCHY1;ARIH2;UBE2V1;SMURF2;BLMH;RNF168;DET1;RNF213;TRIM3;CTR9;RNF14;RNF7;CDC23;PSMA7;LEO1;FBXO4
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.33595068858576344,0.8410177696343886,0.6509298998569385,0.963866019697185,1.0,14/27,25.98%,TAB3;TLR6;TLR4;IRAK1;TNIP1;RPS27A;UBC;TAB2;IRAK4;MAP3K1;TLR1;TLR5;LY96;TAB1
prerank,protein dephosphorylation (GO:0006470),0.27613677652938656,0.840869442017066,0.7417943107221007,0.9636160560263691,1.0,33/135,18.01%,PTPN14;EYA2;PPM1L;PPP2CA;DUSP10;PPM1B;PTPRU;PTPRD;PPP1R15A;DUSP12;DUSP1;UBLCP1;PTPRF;EYA1;PTPN9;PTPRA;PP2D1;PPP2R2D;PPM1A;PTPN6;MTMR3;PTPRE;PPP1CB;PTPN2;PPM1D;PGP;PPP2CB;DUSP11;PTPN13;PPP2R2C;PDP1;DUSP3;PTPN11
prerank,negative regulation of intracellular protein transport (GO:0090317),0.35296531436331147,0.8407965394366277,0.6631419939577039,0.9632386691870687,1.0,8/22,18.46%,INSIG1;DMTN;CHP1;SIAH3;ITGB1BP1;UFM1;SUFU;PARK7
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.3521694079819254,0.8406565501217532,0.6711509715994021,0.9629866833623789,1.0,5/21,12.70%,PMAIP1;BCL2L1;CREB3;EIF2AK3;OPA1
prerank,regulation of protein localization to cell surface (GO:2000008),0.3319352960639623,0.840435251360808,0.6631439894319683,0.9628729696137018,1.0,5/33,11.07%,ACTN2;TOR1A;SNX33;RAB11FIP5;ABCA2
prerank,PERK-mediated unfolded protein response (GO:0036499),0.40772218204908334,0.8404164016392919,0.6482758620689655,0.9623983420460606,1.0,2/10,12.29%,NFE2L2;EIF2AK3
prerank,response to prostaglandin E (GO:0034695),0.4155382261343873,0.8403380205224409,0.6639477977161501,0.9620390981544914,1.0,3/10,14.16%,ADCY6;SFRP1;TGFBR3
prerank,muscle tissue morphogenesis (GO:0060415),-0.30173947935958356,-0.8402768040024952,0.6529411764705882,0.9120700652440848,1.0,2/16,4.22%,MYLK;NOTCH1
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.2949046862353654,0.8402046807623418,0.7016706443914081,0.9617961000943315,1.0,14/70,15.26%,DAXX;NGF;BCL2L1;ERBB3;TGFB2;BAD;TNFRSF10B;TNFRSF1A;BAG3;DDX47;BLOC1S2;GSK3A;GSK3B;TLR3
prerank,chromatin assembly or disassembly (GO:0006333),-0.3391443604329947,-0.8396345856282047,0.6761363636363636,0.9122747552953988,1.0,4/11,24.44%,TP53;NOC2L;SUV39H2;MTA2
prerank,retinoic acid metabolic process (GO:0042573),-0.3228302193694075,-0.8394273786166976,0.6578947368421053,0.9115607573727026,1.0,2/14,5.05%,ALDH1A2;CYP26B1
prerank,acetyl-CoA metabolic process (GO:0006084),0.37479006795714886,0.8394022377529882,0.6546875,0.9628006391934364,1.0,6/15,22.88%,TDO2;PMVK;ACACA;HMGCS1;ACLY;MLYCD
prerank,respiratory chain complex IV assembly (GO:0008535),0.35673332584438644,0.8391906441337715,0.6763358778625954,0.9627013985080468,1.0,4/21,12.06%,COX19;COX16;COX20;COA8
prerank,regulation of Wnt signaling pathway (GO:0030111),0.2847960457684753,0.8391218993519997,0.7288888888888889,0.9623166933981566,1.0,19/108,14.16%,KANK1;NXN;RSPO3;PTK7;AMER3;RNF43;PPP2CA;AMER2;TSC2;WLS;GPC3;CXXC4;FOXP3;SMARCA4;HMGXB4;GNAQ;SPIN1;SFRP1;TRABD2B
prerank,cellular calcium ion homeostasis (GO:0006874),0.2753183686422002,0.8388852158315068,0.7502645502645503,0.9622396853597238,1.0,15/133,8.84%,ANK2;STIM2;CCL5;CAV1;MCU;CSRP3;ATP13A3;MCUB;TMEM165;CAV2;MICU1;AFG3L2;ATP13A4;PML;HCRTR1
prerank,cellular response to ionizing radiation (GO:0071479),0.308172189130965,0.8383582673193076,0.6590038314176245,0.9627379818914328,1.0,13/47,24.27%,CDKN1A;KDM4D;CRYAB;EEF1D;HRAS;MDM2;ATR;KDM1A;NUCKS1;SWI5;RHOB;RPL26;RAD9A
prerank,tetrahydrofolate metabolic process (GO:0046653),-0.35279945291397546,-0.8383553021974421,0.6785714285714286,0.912658234327272,1.0,6/10,30.64%,MTHFD2L;DHFR;MTHFR;TYMS;SHMT2;MTHFS
prerank,"transcription, DNA-templated (GO:0006351)",0.2672787870222345,0.838153876968527,0.7745604963805585,0.9625989192163028,1.0,55/207,24.92%,THRB;DDX5;MLLT3;GTF2F1;FOXO3;CREBL2;POLR2H;TAF1C;ELOB;NKX2-8;POLR2A;ZBTB7B;SSRP1;UBTF;POLR1C;NFE2L3;NFIC;PTMA;GTF3C3;GTF2E1;TAF5;ELL;RREB1;RPAP1;TCEA2;RNPS1;POLR3G;GTF3C2;TBPL1;E2F1;ERCC2;NELFB;POLR2C;GTF3C5;POLR3H;POLR2E;NELFA;TAF9B;TBP;MNT;SNAPC3;TWNK;GTF2E2;TAF6;GTF3C4;AFF4;TFAM;CTR9;CDK9;LEO1;GMEB2;MBD1;MNAT1;POLR2K;BAZ2A
prerank,positive regulation of transport (GO:0051050),0.28626541187776783,0.8380312866392305,0.7261219792865362,0.9623221966719003,1.0,22/85,20.93%,CHRM1;IL15;ANXA2;CBLL1;GPC3;SYNGR3;ACSL3;CHP1;KMT2A;ACTB;ZNF205;FCER1G;GSK3A;GSK3B;DYNC1H1;CDH3;NUMA1;RAB27A;GPLD1;FLOT1;ABCA7;TULP1
prerank,positive regulation of neuroinflammatory response (GO:0150078),0.38256935319945495,0.8379063167896327,0.6473429951690821,0.9620556386523694,1.0,1/12,2.39%,NUPR1
prerank,cellular response to gamma radiation (GO:0071480),0.3694270505834142,0.8378025028862751,0.6738461538461539,0.9617592295171609,1.0,5/17,16.82%,CRYAB;HRAS;MDM2;ATR;KDM1A
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),-0.28391998828911696,-0.8377365225762808,0.7387096774193549,0.9127712222844179,1.0,6/21,20.54%,SMARCD3;NES;DRD2;TOX;CX3CL1;CX3CR1
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),0.339625266574699,0.8375712695316012,0.6718528995756718,0.9616978108196337,1.0,8/26,23.75%,NINJ1;CAV1;LBP;TLR3;FLOT1;TLR1;WDFY1;TLR5
prerank,regulation of protein localization to plasma membrane (GO:1903076),0.28885685993222143,0.8375065379866674,0.7023809523809523,0.961320425132134,1.0,13/78,14.06%,SORBS1;STAC3;RHOQ;BCL2L1;PTPN9;LGALS3;ACTB;AKAP5;CNPY4;EPHA3;VTI1B;VPS4A;ATP2B4
prerank,negative regulation of lyase activity (GO:0051350),0.36995247757157823,0.837438067513917,0.6521739130434783,0.9609496571353242,1.0,4/16,11.56%,PALM;GRM2;AKAP5;GABBR2
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),0.39825856189365344,0.8373863099716932,0.6477272727272727,0.9605383226821071,1.0,4/10,23.96%,ATP1A2;VDAC1;SESTD1;CBARP
prerank,positive regulation of metabolic process (GO:0009893),0.2805799980863351,0.837015525437962,0.7347391786903441,0.9606900987504166,1.0,16/103,12.64%,PPARGC1A;OGT;PDGFC;CAV1;TRPM8;CXCR4;BEND3;ZBTB7B;ACADL;ELOVL6;KDM3A;HDAC3;ACACA;FASN;PIGA;CPT2
prerank,negative regulation of protein kinase activity (GO:0006469),0.2828128086285973,0.8361253678803194,0.7191780821917808,0.9618059596963171,1.0,23/88,19.73%,TRIB2;CDKN1A;CAV1;QARS1;DUSP10;HSPB1;TARBP2;TSC2;SRCIN1;CHP1;PYDC1;SMCR8;GNAQ;MVP;ITGB1BP1;TESK1;ABL1;DUSP3;CAMK2N1;PARK7;CDK5RAP3;SH3BP5L;RB1
prerank,glycosphingolipid metabolic process (GO:0006687),0.3156709871671075,0.8361194251496897,0.6556728232189973,0.9613166667065798,1.0,10/42,14.44%,HEXA;A4GALT;LARGE1;GLB1;SUMF1;ABCA2;HEXB;SUMF2;ESYT2;SMPD2
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.2815410593513804,0.8353179862782052,0.7087155963302753,0.9623203352054907,1.0,8/86,6.46%,ANGPT1;CD44;IL15;CD81;PTK2B;EFNA5;DMTN;HAX1
prerank,monocyte differentiation (GO:0030224),-0.34667417040161747,-0.8352973016673327,0.6823821339950372,0.9165166896688755,1.0,3/10,15.42%,IL31RA;PPARG;PIR
prerank,regulation of biomineral tissue development (GO:0070167),0.34132939021516057,0.8350858013896618,0.6731301939058172,0.9622366472773574,1.0,5/26,10.33%,ANKH;SGMS2;SOX9;FBXO5;TWIST1
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.37838135837387626,0.8341842214886028,0.6530612244897959,0.9633757401410453,1.0,6/14,21.50%,PPP2CA;DUSP1;PPP2R2D;PPP2CB;PPP2R2C;PPP1R15B
prerank,response to estradiol (GO:0032355),0.3315123035778395,0.8336555290976844,0.6937669376693767,0.9638489033523984,1.0,7/31,19.14%,NCOA3;FAM210B;LCOR;SOCS2;SFRP1;POU4F1;GPER1
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.2813879355742725,0.833551730740108,0.7058165548098434,0.9635275979146262,1.0,31/96,25.54%,SRSF2;NUP93;EIF4A3;SMG7;DDX39B;RBM8A;NDC1;WDR33;AGFG1;SRSF7;POLDIP3;THOC7;RNPS1;SRSF9;UPF3B;MAGOHB;MAGOH;AAAS;SRSF1;RAE1;SRSF5;THOC1;POM121;U2AF1;TPR;SRRM1;RANBP2;NUP42;NUP62;SEH1L;RBM15B
prerank,regulation of biosynthetic process (GO:0009889),0.3848312406497198,0.8335341163211495,0.6521035598705501,0.9630564780373998,1.0,1/11,5.07%,ALOX5
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.37451097429006935,0.8330475761144779,0.6926751592356688,0.9634635761068296,1.0,5/16,21.60%,RECQL4;MCM6;MCM7;TWNK;MCM4
prerank,regulation of ion transmembrane transport (GO:0034765),0.32799719483285894,0.8330177358851727,0.686382393397524,0.9630141108065677,1.0,6/33,14.55%,WWP2;KCNJ13;AHCYL1;ANO6;WNK1;NEDD4
prerank,negative regulation of nuclear division (GO:0051784),0.39548458653205676,0.8329727913870535,0.6655737704918033,0.9625867484215777,1.0,4/11,23.64%,BMP4;FBXO5;TOM1L2;AURKAIP1
prerank,cell cycle G1/S phase transition (GO:0044843),0.29382072666546466,0.83273637278793,0.6894865525672371,0.9625006947232955,1.0,13/61,16.70%,CDKN1A;CDK6;USP29;CDK4;PLK3;LATS1;EIF4EBP1;CCND1;CDK2;MYC;PLK2;E2F1;HINFP
prerank,inorganic ion transmembrane transport (GO:0098660),0.38352117136606356,0.8326070551730013,0.6559865092748736,0.9622423267490673,1.0,3/12,11.40%,ABCC8;TRPM4;PKD2L1
prerank,negative regulation of hydrolase activity (GO:0051346),0.30929204670389815,0.8324774379360856,0.6843434343434344,0.9619893698046793,1.0,12/49,17.04%,CPEB2;SH3RF2;SH3BP4;MAPK7;CHP1;ATP5IF1;BCAS3;ARFGEF1;HRAS;WNK1;NEIL1;FICD
prerank,positive regulation of protein modification process (GO:0031401),0.2651139191649186,0.832353212773888,0.7933884297520661,0.961722793623017,1.0,45/203,19.54%,ANGPT1;NTRK3;LIMK2;DAXX;ADTRP;MMP9;MAVS;RAMP1;EFNA5;KRAS;SOX9;WDFY2;MYDGF;BMP4;CCND2;ILK;DVL3;NNMT;FGF22;CHP1;VEGFB;CCND1;MUSK;HDAC3;DLC1;RAPGEF3;FXR1;TRABD2B;HRAS;FLCN;HSP90AA1;RB1CC1;TESK1;UBE2N;ABL1;CDH5;SPPL3;TMEM119;GPNMB;ROCK2;PTBP1;GPER1;APP;FLOT1;ADAM17
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.28728333615218954,0.8321440943533367,0.7422222222222222,0.9615839250453438,1.0,18/88,19.01%,SAMD4A;SAMD4B;EPRS1;DAPK3;DAPK1;EIF4A3;SHMT1;EIF2AK3;CPEB3;SYNCRIP;FXR1;BTG2;GAPDH;HDAC6;CAMK2N1;IGF2BP3;CDK5RAP3;IGF2BP2
prerank,regulation of macrophage chemotaxis (GO:0010758),0.34881349045366816,0.8321385050972654,0.648493543758967,0.9611000784734353,1.0,2/21,3.61%,CCL5;PTK2B
prerank,monocyte chemotaxis (GO:0002548),-0.25175290815552576,-0.8318930576275319,0.7202797202797203,0.9221403784959371,1.0,1/32,0.06%,FLT1
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.3708274770105526,0.8318268326610097,0.6452599388379205,0.9611808574746802,1.0,3/16,6.86%,ANK2;ATP1A2;GSTO1
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.30715683600455523,0.8315974913131305,0.6775032509752926,0.961101483513261,1.0,5/46,8.41%,CDH13;CCL5;BMP4;ANG;TCF7L2
prerank,ceramide biosynthetic process (GO:0046513),0.3145680725056923,0.8311944764329351,0.6814516129032258,0.9613108859976068,1.0,3/40,5.85%,SPTSSB;SGMS2;AGK
prerank,regulation of receptor-mediated endocytosis (GO:0048259),0.3184427643553252,0.8305816551015609,0.6840052015604682,0.9618860080824172,1.0,1/35,0.40%,CLU
prerank,sphingoid biosynthetic process (GO:0046520),-0.3411176944942672,-0.8304905710282561,0.6624365482233503,0.92269582032898,1.0,6/11,33.30%,ACER2;SPHK1;ASAH2;SPTLC2;ACER3;SPTLC3
prerank,sphingosine biosynthetic process (GO:0046512),-0.3411176944942672,-0.8304905710282561,0.6624365482233503,0.92269582032898,1.0,6/11,33.30%,ACER2;SPHK1;ASAH2;SPTLC2;ACER3;SPTLC3
prerank,glucose transmembrane transport (GO:1904659),-0.29625325640855027,-0.8303782877794658,0.7162921348314607,0.921806819009001,1.0,3/18,8.80%,SLC2A1;PPARD;SORT1
prerank,negative regulation of cation channel activity (GO:2001258),0.33677837912324976,0.8300800845835206,0.6530324400564175,0.962326327898217,1.0,3/26,6.86%,MMP9;EPO;GSTO1
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),0.3824082572294527,0.8300202592195989,0.6634460547504025,0.9619388234852141,1.0,2/14,9.55%,SHLD2;RIF1
prerank,nonribosomal peptide biosynthetic process (GO:0019184),0.38927478886413613,0.829832673768099,0.6677265500794912,0.9617809700062426,1.0,1/12,3.31%,HAGH
prerank,positive regulation of interleukin-1 production (GO:0032732),0.301183608676334,0.8290623371374262,0.714987714987715,0.9626646117322133,1.0,7/51,11.15%,NLRP2;IL16;HSPB1;FZD5;PYDC1;TLR6;TLR4
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),-0.28986407561690913,-0.828997330549121,0.7201166180758017,0.9233539642001453,1.0,4/18,12.76%,NRXN1;SHANK3;NLGN1;NLGN3
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),0.3728469923953185,0.8289333404424043,0.6666666666666666,0.9624135095316928,1.0,4/15,12.14%,EIF4A3;SIX1;TWIST1;TGFBR2
prerank,positive regulation of response to cytokine stimulus (GO:0060760),-0.3214558691145681,-0.8288991216517014,0.6765498652291105,0.9224288026919185,1.0,3/13,2.88%,WNT5A;GAS6;AXL
prerank,atrial cardiac muscle cell action potential (GO:0086014),0.3877550107370744,0.8287750171390856,0.6693811074918566,0.9622142697824546,1.0,1/13,0.66%,ANK2
prerank,phosphatidic acid biosynthetic process (GO:0006654),-0.23527943527472997,-0.828729968471903,0.7638888888888888,0.9216532290228605,1.0,5/46,5.36%,PLA2G4A;DGKH;GPD1L;DGKB;PLD1
prerank,actin filament network formation (GO:0051639),0.39684154525354953,0.8285906839086075,0.6550580431177446,0.9620754939979501,1.0,1/11,1.26%,COBL
prerank,negative regulation of GTPase activity (GO:0034260),0.35037417493516004,0.8285494143327065,0.6828908554572272,0.9616622601708292,1.0,7/22,17.04%,CPEB2;SH3BP4;BCAS3;ARFGEF1;HRAS;WNK1;FICD
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),0.38007616126541466,0.8284001135654051,0.6656151419558359,0.961454529891109,1.0,6/13,22.63%,RHOQ;AK3;OPA1;GNAI3;RAB23;EFL1
prerank,cellular response to hexose stimulus (GO:0071331),-0.2707783854200196,-0.8280407962142475,0.7220338983050848,0.9218677362027058,1.0,6/23,12.35%,UNC13B;ZBTB20;GAS6;PRKAA1;IGF1R;RACK1
prerank,regulation of chemotaxis (GO:0050920),0.32276455893523914,0.8280074730654847,0.7002762430939227,0.961650842694127,1.0,6/30,12.51%,EFNB2;YTHDF1;CXCR4;ADGRA2;ZSWIM8;PTPN2
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.26587947786656796,0.8278020161164492,0.7841501564129302,0.9615630931008443,1.0,24/190,10.33%,PRKAA2;PIK3IP1;MMP9;DAG1;UACA;MAGI2;ZC3H12A;CAV1;PHLDA3;TRIM59;PPM1B;DUSP1;SH3BP4;USP10;TSC2;BCL2L1;OTUD7B;MUL1;PPM1A;NDUFS3;UBE2B;NMI;PRDM15;TWIST1
prerank,cellular response to catecholamine stimulus (GO:0071870),-0.2728571425382845,-0.827637469549483,0.6978193146417445,0.9215056459512497,1.0,6/23,15.80%,TGM2;LRRK2;PDE4B;RYR2;GNB1;SIRT2
prerank,vesicle transport along actin filament (GO:0030050),-0.28308417306490613,-0.827637208564201,0.7021276595744681,0.9204137232187745,1.0,5/19,11.88%,MYO1B;FNBP1L;MYO1D;MYO5B;MYO6
prerank,cellular response to zinc ion (GO:0071294),-0.30298730340519153,-0.8275542137935454,0.7082228116710876,0.9194867050828845,1.0,10/15,36.67%,GLRA1;GLRA2;MT1A;MT1H;MT1M;MT1E;MT1G;MT1X;MT1B;MT1F
prerank,regulation of epithelial cell migration (GO:0010632),0.30515299595815415,0.8274751995492035,0.7051442910915935,0.9616924224669741,1.0,10/51,13.11%,DOCK5;EMP2;GLUL;DUSP10;SOX9;TGFB2;ARSB;PTN;DOCK1;RREB1
prerank,ATP-dependent chromatin remodeling (GO:0043044),-0.23921368785106806,-0.8274699678702808,0.7711864406779662,0.9185570773687388,1.0,12/42,17.61%,SMARCA2;MBD2;ARID1A;CHD8;ACTR6;SMARCC2;SMARCE1;NASP;ACTR5;CECR2;MBD3;HDAC2
prerank,glucose metabolic process (GO:0006006),0.29293146541807835,0.8271173250809781,0.7175283732660782,0.9618292559387698,1.0,11/58,16.09%,PPARGC1A;HECTD4;SLC25A1;ENO2;MDH2;IRS2;ALDOA;GAPDH;SLC25A12;DCXR;TPI1
prerank,receptor internalization (GO:0031623),0.3096206936967497,0.826947679682517,0.7058064516129032,0.9616530111465093,1.0,9/44,15.65%,CAV1;CD81;ACKR3;RAMP1;CD9;GRK2;FCER1G;NEDD4;ITGB2
prerank,transcription by RNA polymerase I (GO:0006360),0.3249216841307479,0.8267785156867672,0.6955380577427821,0.961471352250095,1.0,15/34,26.40%,POLR2H;TAF1C;UBTF;POLR1C;POLR1E;POLR1F;ERCC2;POLR2E;TBP;POLR1G;TCOF1;MNAT1;POLR2K;POLR1B;TTF1
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),-0.32097359845095147,-0.8265257352917272,0.6907216494845361,0.9192177939236529,1.0,3/12,7.58%,TMED10;RANBP9;ROCK1
prerank,cilium organization (GO:0044782),0.2613712432745721,0.8263750368172437,0.7863777089783281,0.9617077200524378,1.0,40/209,18.72%,RAB17;CYS1;ABLIM1;PARVA;GSN;EHD1;CNGA2;ARL3;INPP5E;CCDC28B;RAB11FIP3;AVIL;IFT46;EXOC7;CFAP54;EXOC4;PKD1;CC2D2A;IFT80;EXOC2;MARK4;CPLANE2;CNGB1;EXOC8;ARF4;OCRL;MKKS;ATP6V1D;ATP6V0D1;FLNA;TMEM138;PTPDC1;CFAP61;RAB8B;HDAC6;RILPL1;FHDC1;ODF2;WDR35;GALNT11
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.33622195020848855,0.8263730640652708,0.6898550724637681,0.9612193490513068,1.0,7/26,14.38%,LSM10;CDK10;CCND2;ADAMTS1;CCND1;ANKRD17;EIF4G1
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),-0.3139319547644814,-0.8263366283265645,0.7078651685393258,0.9184823732490617,1.0,3/14,5.34%,SULF1;FGF2;THBS1
prerank,phagosome-lysosome fusion (GO:0090385),0.3987355646455356,0.8262101635279417,0.6749174917491749,0.9610097529967132,1.0,2/10,8.69%,RAB7B;RAB7A
prerank,negative regulation of fibroblast proliferation (GO:0048147),-0.2952220180803973,-0.8261075636226509,0.7241379310344828,0.9178109142844013,1.0,5/18,16.87%,DAB2IP;NF1;TP53;CD300A;B4GALT7
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.2579549585669457,0.8255421291004559,0.8694779116465864,0.961713442376223,1.0,69/417,14.23%,FOXN3;DAXX;TMPRSS6;TBR1;KLF4;ELF3;LBH;NIBAN2;FOXP2;GLI3;TRIM33;WNT11;HDAC5;QARS1;RBFOX2;PCGF6;ZNF219;GLIS2;HDAC4;ZBTB16;WWP2;NACC1;CRYAB;PATZ1;FOXM1;SOX9;FOXD1;ZIC2;SHC1;KDM5C;KAT6B;PHF10;BMP4;COMMD7;NKAP;MAGEL2;CIC;L3MBTL3;JUN;TCF7L2;CRY2;PML;FOXP3;BRD7;SCML2;DPF2;YWHAQ;TWIST1;HDAC3;ARID4A;TLE2;BCL7A;SMARCA4;NCOR1;SFMBT2;ZNF148;FOXK1;GATA3;TSC22D4;SBNO2;CHMP1A;BEND5;CBX4;PRDM11;ING4;TLE5;SFRP1;FOXP1;SET
prerank,cellular metal ion homeostasis (GO:0006875),0.2755442450801691,0.8253503791006055,0.7329670329670329,0.9615662041537665,1.0,8/102,5.62%,ANK2;STIM2;CCL5;CAV1;ATP1A2;CSRP3;ATP13A3;TMEM165
prerank,quinone biosynthetic process (GO:1901663),0.37035051369148064,0.825218612233131,0.6661341853035144,0.9613192319268341,1.0,2/14,8.22%,UBIAD1;PDSS2
prerank,serine family amino acid biosynthetic process (GO:0009070),0.3855879425585209,0.8251509737928039,0.6644518272425249,0.9609549413200189,1.0,2/12,8.15%,SERINC5;PHGDH
prerank,B cell proliferation (GO:0042100),-0.2936185798022794,-0.8250224668361099,0.7433628318584071,0.9187032522715192,1.0,4/17,19.45%,BCL2;CTPS1;CD40;HSPD1
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.3250802995523642,0.8248264883032126,0.6903137789904502,0.9610215550858169,1.0,1/32,0.23%,FGF13
prerank,peroxisome organization (GO:0007031),0.334515784021416,0.8246282816548193,0.6768802228412256,0.9608820565470697,1.0,7/25,18.72%,ACOT8;ABCD1;PEX11G;DNM1L;PEX6;PEX3;PEX2
prerank,histone H3 acetylation (GO:0043966),-0.24094899424998362,-0.8246224975620935,0.7975708502024291,0.918363813053135,1.0,9/40,15.40%,LEF1;MBIP;KAT7;JADE1;TAF12;BRCA2;TAF5L;KAT6A;WDR5
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.36820930651659006,0.8241614259694964,0.6708268330733229,0.9612274423718897,1.0,5/15,18.47%,MRE11;HUS1B;MDC1;CHEK2;ATF2
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.280144736903628,0.824002841083833,0.7545871559633027,0.9610222352412171,1.0,11/90,10.49%,PPARGC1A;OGT;PDGFC;CAV1;TRPM8;CXCR4;ZBTB7B;ACADL;ELOVL6;KDM3A;HDAC3
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.2906696786842958,0.8236853720041845,0.6971916971916972,0.9611018218038219,1.0,13/60,16.71%,CDKN1A;CDK4;MOV10;SOX9;MED30;TCF7L2;CCND1;MED8;MED12;PPM1D;MED24;MED6;MED27
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),0.3710048863900617,0.82367673776047,0.6599690880989181,0.960630634632219,1.0,5/15,16.00%,HPN;TMC2;PDZD7;MKKS;TMEM120A
prerank,T cell homeostasis (GO:0043029),0.4038214902111016,0.8226541133863268,0.6599326599326599,0.9619146836560136,1.0,2/10,8.98%,PMAIP1;FOXP3
prerank,synaptic vesicle recycling (GO:0036465),-0.25163976491011664,-0.8224568676822067,0.7316176470588235,0.9213485543691577,1.0,8/31,14.77%,SYNJ2;SYT1;NLGN1;TBC1D24;STON2;NLGN3;AMPH;FCHO2
prerank,negative regulation of cyclase activity (GO:0031280),0.37647901323312494,0.8223550021065464,0.6744186046511628,0.9619528145006326,1.0,4/14,11.56%,PALM;GRM2;AKAP5;GABBR2
prerank,cAMP biosynthetic process (GO:0006171),-0.34915092705775524,-0.8221084583051609,0.681265206812652,0.920943681001938,1.0,4/10,7.75%,ADCY5;ADCY7;ADCY1;ADCY4
prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.3076811608237733,0.8216969929861336,0.7090909090909091,0.96264316543869,1.0,16/41,25.47%,OGT;EP300;NUP93;EIF6;NDC1;JMJD8;PRKAG1;AAAS;RAE1;ZBTB7A;POM121;TPR;RANBP2;NUP42;NUP62;SEH1L
prerank,negative regulation of adenylate cyclase activity (GO:0007194),0.3805644698324727,0.821681692949739,0.678407350689127,0.9621822363677542,1.0,4/13,11.56%,PALM;GRM2;AKAP5;GABBR2
prerank,centromere complex assembly (GO:0034508),-0.2418597500422067,-0.8216263493640765,0.7741935483870968,0.9207146373773696,1.0,18/36,33.60%,RUVBL1;ITGB3BP;CENPP;HJURP;NASP;HELLS;MIS18BP1;KNL1;CENPE;CENPU;CENPX;NPM1;CENPI;MIS18A;CENPN;CENPA;SMARCA5;CENPV
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.25627131777275214,0.821586553161227,0.8810483870967742,0.961846248321159,1.0,77/366,19.78%,BNC2;NFATC2;FOXN3;DAXX;PPARGC1A;EP300;FOXO3;DAPK3;ZNF219;PPP2CA;CREBL2;IGSF1;MLF2;ESRRB;PRRX2;PATZ1;PHF1;POLR2A;HCFC1;KAT6B;EFEMP1;ZFHX3;ATRX;SIX1;FBXO5;PML;FOXP3;MYCBP;APBB1;FADS1;NFYC;ZNF205;GON4L;MYT1;ANKRD17;RABL3;AJUBA;SP1;TAF5;TFEB;SPIN1;CHD3;RREB1;SBNO2;GPBP1;NFIA;REXO4;MEF2C;MYBL1;SRRT;PTP4A3;IRF2;CCDC88A;UTP4;NAB2;PAK6;E2F1;HINFP;SPTY2D1;ABL1;EIF2B4;MLLT6;LIN54;TRRAP;CHEK2;PRKCQ;BRDT;APBB3;SUFU;WTIP;ATF2;RPL6;NFKB2;APP;NUCKS1;RB1;CDK11B
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),0.3703241184376927,0.8214329075570562,0.6827371695178849,0.9616199008038337,1.0,4/14,14.45%,GAB1;VEGFB;MYO1C;NUS1
prerank,detection of light stimulus involved in sensory perception (GO:0050962),0.389509231389062,0.8214140902395756,0.6773648648648649,0.9606798110151821,1.0,3/10,20.93%,CACNA2D4;CNGB1;TULP1
prerank,detection of light stimulus involved in visual perception (GO:0050908),0.389509231389062,0.8214140902395756,0.6773648648648649,0.9606798110151821,1.0,3/10,20.93%,CACNA2D4;CNGB1;TULP1
prerank,oxoacid metabolic process (GO:0043436),0.33237997957814097,0.82035164092818,0.7026279391424619,0.9620808494676141,1.0,2/27,3.24%,SULT1A1;SULT2B1
prerank,regulation of trophoblast cell migration (GO:1901163),0.3677627614584347,0.8200644191513069,0.6749611197511665,0.9620966246674454,1.0,5/14,24.22%,TIMP1;ARHGDIB;YTHDF3;SMURF2;C1QBP
prerank,positive regulation of TORC1 signaling (GO:1904263),0.36729802101940057,0.8199675847302448,0.6801872074882995,0.9617747613203366,1.0,11/16,32.24%,PIH1D1;SIK3;FLCN;PIP4P1;SEH1L;GPR137;LARS1;LAMTOR5;RRAGB;TELO2;CLEC16A
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),-0.3469229286364685,-0.8199006200362243,0.6935866983372921,0.9217927934045308,1.0,3/10,7.51%,CLTA;MYLIP;AP2B1
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),-0.3469229286364685,-0.8199006200362243,0.6935866983372921,0.9217927934045308,1.0,3/10,7.51%,CLTA;MYLIP;AP2B1
prerank,negative regulation of lipid metabolic process (GO:0045833),-0.27380500817056486,-0.8191324661073263,0.7096774193548387,0.9222321789085501,1.0,2/22,5.29%,PDE3B;PRKAA1
prerank,telomere capping (GO:0016233),0.36127496591779434,0.819080782553739,0.6977099236641221,0.9628497323978151,1.0,8/16,29.48%,MRE11;DCLRE1C;NBN;RAD50;TERF2;TINF2;TERF1;TERF2IP
prerank,glial cell differentiation (GO:0010001),0.3240895834685006,0.8190420777554408,0.7014725568942436,0.9624404819556157,1.0,5/28,10.48%,GPC1;SOX9;ERBB3;NFIB;ADGRG6
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),-0.24767558009511176,-0.8190125825670329,0.7745901639344263,0.9213822270692443,1.0,11/32,24.07%,CDK14;CDK17;BRD4;ID2;DHFR;NPAT;ORC1;TYMS;BACH1;CDC45;TFDP2
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",0.3572226206522,0.818269339865335,0.6819571865443425,0.9633143740749073,1.0,6/16,23.22%,CWC15;SRSF1;WBP4;SFSWAP;DDX23;DCPS
prerank,DNA repair (GO:0006281),0.25864102855130816,0.8180004307546734,0.8408163265306122,0.9632738319216714,1.0,66/284,20.44%,FEN1;MLH1;RECQL4;DOT1L;NABP2;KDM4B;ASF1A;NSMCE4A;MRE11;EYA1;PARP3;TEX264;CENPS;INIP;RAD54L;TENT4A;POLK;WDR33;UBE2B;APBB1;MUTYH;USP3;CSNK1E;HUS1B;MDC1;TOPBP1;ABRAXAS1;ERCC5;MBD4;MLH3;PWWP3A;BTG2;RPA3;REXO4;POLH;ENDOV;APTX;POLD2;PCNA;FAN1;UBE2N;DCLRE1C;LIG3;DDB1;ATR;RPS27A;UBC;HINFP;ERCC2;ABL1;NEIL1;NBN;INTS3;TRRAP;CHEK2;RAD50;PARP2;PARK7;CDKN2D;PNKP;NUCKS1;UVRAG;ERCC4;NABP1;POLN;APEX2
prerank,positive regulation of tissue remodeling (GO:0034105),0.3934807405638793,0.8178162694221014,0.6577181208053692,0.9631160619063265,1.0,1/10,2.47%,IL15
prerank,positive regulation of p38MAPK cascade (GO:1900745),0.34561450830228846,0.8171911998925849,0.7121879588839941,0.963747361984348,1.0,8/22,20.34%,ZC3H12A;MAP3K4;RELL1;EMC10;GADD45B;PRMT1;RELL2;AGER
prerank,positive regulation of immune system process (GO:0002684),0.3608059264008331,0.8168902457027533,0.6825885978428351,0.9637982808578729,1.0,2/16,7.38%,IL15;TGFB2
prerank,homeostasis of number of cells (GO:0048872),0.37756626394180587,0.816486388974531,0.6777777777777778,0.9640212832528051,1.0,1/12,0.90%,NAPEPLD
prerank,regulation of execution phase of apoptosis (GO:1900117),0.3835370011943949,0.8164832500800624,0.6730462519936204,0.9635418646310508,1.0,3/11,10.78%,ZC3H12A;BCL2L1;DLC1
prerank,CENP-A containing nucleosome assembly (GO:0034080),-0.2503019075615777,-0.8161802866404932,0.77,0.9244231241691024,1.0,14/29,31.03%,RUVBL1;ITGB3BP;CENPP;HJURP;NASP;MIS18BP1;KNL1;CENPU;CENPX;NPM1;CENPI;MIS18A;CENPN;CENPA
prerank,CENP-A containing chromatin organization (GO:0061641),-0.2503019075615777,-0.8161802866404932,0.77,0.9244231241691024,1.0,14/29,31.03%,RUVBL1;ITGB3BP;CENPP;HJURP;NASP;MIS18BP1;KNL1;CENPU;CENPX;NPM1;CENPI;MIS18A;CENPN;CENPA
prerank,purine ribonucleotide metabolic process (GO:0009150),0.29234148205223764,0.8161321303463654,0.7209302325581395,0.9636567957646578,1.0,8/68,10.00%,SULT1A1;ACOT8;SULT2B1;RHOQ;NT5C2;BAD;ACSM3;AK3
prerank,response to progesterone (GO:0032570),-0.28930603366151364,-0.8158720001238254,0.7427745664739884,0.9239169637371544,1.0,7/18,20.30%,THBS1;NR1H3;TGFB1;UBE3A;CATSPER3;ABHD2;YAP1
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.3378929526900399,0.8147746886520828,0.6861861861861862,0.9655628115536321,1.0,2/22,6.81%,CDKN1A;BMP4
prerank,regulation of lysosomal lumen pH (GO:0035751),-0.3210208681445251,-0.8147391048515816,0.7034883720930233,0.9248475249948306,1.0,6/12,23.03%,LRRK2;CLN3;VPS33A;CLN6;CCDC115;TMEM9
prerank,T cell receptor signaling pathway (GO:0050852),-0.18832452060917293,-0.814241083376344,0.9125,0.9246139894719781,1.0,30/138,20.31%,PTPRJ;PIK3R1;PDE4D;PAK3;PAG1;INPP5D;EIF2B3;PSMC6;RFTN1;PSMA6;PIK3CB;FYB1;TNFRSF21;PDE4B;THEMIS;PIK3CD;TRAF6;RBCK1;BTRC;PSME1;PSMB10;CUL1;PSMD5;SKAP1;RC3H1;PIK3R2;ICOSLG;PSMD3;PSMA4;PSMB9
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),-0.2554176714754741,-0.8140903048127388,0.7749077490774908,0.9238212773711403,1.0,8/29,15.09%,TUT4;ADAR;HNRNPA2B1;ZC3H7B;DROSHA;SMAD3;SNIP1;AGO1
prerank,ERBB signaling pathway (GO:0038127),0.28924701994392765,0.8136521533777241,0.7416563658838071,0.9670963679459726,1.0,17/64,20.16%,REPS2;GAB1;PTK2B;SOX9;SHC1;EFEMP1;ERBB3;IQGAP1;MVP;BCAR1;AAMP;HSP90AA1;STUB1;PTPN11;PTPN18;ADAM17;HBEGF
prerank,ncRNA metabolic process (GO:0034660),0.31157271652003005,0.8134781662892916,0.712,0.9669318221077831,1.0,7/37,15.77%,DGCR8;TARBP2;MOV10L1;ZCCHC8;TUT7;DTD1;MEPCE
prerank,neuron fate commitment (GO:0048663),-0.3120805365219578,-0.8130753170460343,0.7369942196531792,0.9244985461930888,1.0,8/14,43.72%,ID2;MYT1L;DLL4;SHH;POU3F2;PAX6;ASCL1;ISL1
prerank,stress-activated MAPK cascade (GO:0051403),0.28864162357231515,0.8130700740746519,0.7209876543209877,0.9671780240242979,1.0,13/61,18.37%,MAP3K8;MAP3K5;TAB3;MAPK9;MAP3K13;IRAK1;CHUK;IKBKG;UBE2N;RPS27A;UBC;TAB2;ARHGEF6
prerank,regulation of protein kinase B signaling (GO:0051896),0.25932036020439075,0.8130204884760138,0.8229166666666666,0.9667677751511567,1.0,19/193,8.41%,FGFR1;ANGPT1;NTRK3;DAG1;MAGI2;GDF15;GAB1;PHLDA3;GCNT2;MTDH;TSC2;HAX1;GRM2;MYDGF;MUL1;ERBB3;FGF22;MAZ;TCF7L2
prerank,protein targeting to membrane (GO:0006612),0.2821731227764241,0.8129926790311284,0.7401847575057737,0.9663315231395027,1.0,24/83,24.32%,PEX26;ABCD1;ZDHHC12;VPS37B;SIL1;CHMP4A;CHMP4B;SSR1;GOLGA7;MYO1C;SLC25A17;PXMP4;RAB8B;PEX3;PEX2;VPS37A;PARD3;ARL6IP1;ZDHHC3;SGTA;SRP14;ARL6;RAB3IP;ATG3
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),0.314177569438453,0.8127713401037985,0.6901217861975643,0.9662518751420601,1.0,10/31,24.40%,SCAMP5;STXBP1;KCNB1;SYT6;SYT11;SYT12;SYT3;SYT2;CBARP;SYT13
prerank,mRNA methylation (GO:0080009),-0.3012933401233782,-0.8119627849337614,0.7251461988304093,0.9253807250472483,1.0,5/15,21.98%,METTL8;METTL16;TRMT61B;TRMT6;TRMT10C
prerank,negative regulation of blood coagulation (GO:0030195),0.3023944548171238,0.8114149795748999,0.7,0.9680607887594748,1.0,3/38,6.27%,ADTRP;THBD;KLKB1
prerank,peptidyl-amino acid modification (GO:0018193),0.3967817988235598,0.8113727410818912,0.6991596638655462,0.9676618673924238,1.0,1/10,2.90%,PDF
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),0.36791802553809516,0.8108342859512068,0.6882067851373183,0.9681178576110177,1.0,5/15,14.09%,RSPO3;GPC3;WNT5B;CSNK1E;SFRP1
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.39065946294079906,0.8106666892263579,0.6882453151618398,0.9679335736418843,1.0,4/10,23.60%,RIF1;DCLRE1C;TERF2;APEX1
prerank,RNA biosynthetic process (GO:0032774),0.3183375317754245,0.8106546553632883,0.6802721088435374,0.9674736994755034,1.0,11/31,28.25%,POLR2A;TAF5;TCEA2;PRIM2;TBPL1;TBP;TAF6;TTF1;TAF4;TERT;BRF1
prerank,cellular response to peptide (GO:1901653),0.2917631230657232,0.8106213436847047,0.74125,0.967052029561019,1.0,7/56,11.15%,VIM;EPHA4;CACNA1A;CAV1;TRIM41;TLR6;TLR4
prerank,ATP synthesis coupled proton transport (GO:0015986),0.35545618623131103,0.8105852546647827,0.6890243902439024,0.966643686945652,1.0,9/17,26.15%,ATP5PF;ATP5F1B;STOML2;VPS9D1;ATP5PD;ATP5ME;ATP5F1D;ATP5F1C;ATP5MC3
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),0.3735990686894206,0.8102414709942326,0.6772151898734177,0.9667175105392247,1.0,6/12,19.56%,SMARCA4;NCOR1;SFRP1;FOXP1;NCOR2;ZBTB7A
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),-0.24087955197965083,-0.8092723466956232,0.8127340823970037,0.9290614786777025,1.0,2/32,2.45%,CEMIP;TRPC3
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.29669593373586217,0.8091841254656896,0.7206632653061225,0.9680820868602643,1.0,9/48,17.49%,IKBKE;EP300;PHLDA3;BCL2L1;PML;USP28;E2F1;ABL1;CHEK2
prerank,DNA geometric change (GO:0032392),0.3280887012327461,0.8086553120505335,0.7027417027417028,0.9685243807506654,1.0,5/24,18.05%,RECQL4;MRE11;DHX9;NBN;RAD50
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.39736009831023533,0.8085788370432028,0.6961602671118531,0.9681720991650663,1.0,3/10,17.41%,INSIG1;UBE2G2;UBE2J1
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.35608393650002373,0.808213998039342,0.7068702290076336,0.9683044335704873,1.0,4/17,9.74%,CCND2;PSRC1;PKD1;CCND1
prerank,transcription preinitiation complex assembly (GO:0070897),-0.3141871434517701,-0.8081351810219557,0.7514970059880239,0.9300206322123334,1.0,3/12,11.00%,BDP1;TAF1B;TAF12
prerank,response to peptide (GO:1901652),0.31538743916500844,0.8079802871362414,0.7055702917771883,0.9682159054234635,1.0,4/33,7.42%,MMP9;CACNA1A;EIF2B2;STAT4
prerank,intermediate filament organization (GO:0045109),0.3510781208444784,0.8079518127848762,0.6854961832061068,0.9677782312337581,1.0,2/17,10.09%,VIM;KLHL24
prerank,regulation of secretion by cell (GO:1903530),-0.21825948320318428,-0.8079116434069011,0.8298969072164949,0.9293548590400159,1.0,15/54,21.20%,SNCAIP;RIC1;MCTP2;SYT1;STXBP5L;CAMK2A;MCTP1;KCNMB4;RAB3D;CPLX2;DISP1;FMR1;RAB3C;DNAJC1;RIMS1
prerank,BMP signaling pathway (GO:0030509),0.2904199763735958,0.8075187135982361,0.7479579929988331,0.9680410909408406,1.0,7/62,7.38%,SMAD6;DDX5;HIVEP1;GDF15;BMP5;BMP4;TGFB2
prerank,protein catabolic process (GO:0030163),0.2863486818407663,0.8074649033402678,0.7379480840543882,0.9676523677716303,1.0,14/59,19.31%,PMAIP1;ATE1;RNF5;DENND3;UBE2G2;MANBA;SOCS6;HSP90AA1;PRPF19;DDB1;SIAH1;CHEK2;RNF41;IDE
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),-0.19950332266193688,-0.807464566093268,0.88125,0.9290327714964253,1.0,36/82,36.72%,CEP250;CCP110;CEP78;ALMS1;NDE1;PRKAR2B;TP53;NEDD1;CSNK1D;SDCCAG8;KCNH5;CKAP5;CEP41;MAPRE1;HAUS4;HAUS7;CEP72;YWHAE;SSNA1;HAUS6;TPX2;TUBB4B;NPM1;CEP131;CEP135;HMMR;KIF14;PCNT;TUBA4A;ATAD5;HAUS3;NEK10;CETN2;PLK1;AURKA;CDK1
prerank,phosphatidic acid metabolic process (GO:0046473),-0.22465249044430885,-0.8073159313849878,0.8246445497630331,0.9282355263959428,1.0,5/48,5.36%,PLA2G4A;DGKH;GPD1L;DGKB;PLD1
prerank,axonal transport (GO:0098930),0.3162315088198264,0.807238392378727,0.7144736842105263,0.967550509461237,1.0,14/36,24.47%,BLOC1S6;AP3B1;KIF1B;AP3S1;PAFAH1B1;BLOC1S2;OPA1;DYNC1H1;AP3S2;AP3M1;MAPT;AP3D1;BLOC1S5;RAB21
prerank,negative regulation of protein modification process (GO:0031400),0.278917559093491,0.8070524357182861,0.7467911318553092,0.9673979029055013,1.0,14/79,14.41%,PRKAA2;NTRK3;OCLN;ZC3H12A;PPP1R15A;FBLN1;PIP5KL1;CHP1;YWHAB;FKBP8;SH3GL2;ATP2B4;GSK3B;DNAJC10
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),0.297429875514191,0.8068543445724993,0.7219387755102041,0.967230151228397,1.0,9/45,15.49%,CD44;TRIM25;IRF3;TRIM21;PML;TRIM26;JAK1;IRF2;OAS2
prerank,positive regulation of gene silencing by miRNA (GO:2000637),0.33410747492430815,0.8066377672805026,0.7241847826086957,0.9671059670160727,1.0,8/27,18.39%,DDX5;BMP4;MAP2K2;AJUBA;FXR1;EIF4G1;DHX9;WTIP
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),0.3557604554903954,0.8066321030729694,0.7086614173228346,0.9666368415232224,1.0,6/15,23.95%,NGF;ZFYVE27;BCAR1;CASP3;SOS1;FRS2
prerank,regulation of protein polymerization (GO:0032271),0.310746542330099,0.806608824304235,0.7271523178807947,0.9662002067894131,1.0,13/35,20.66%,ARHGAP18;FCHSD2;FCHSD1;HAX1;LATS1;RASA1;HSP90AA1;CAMSAP1;PFN2;ABL1;PLEKHG2;MAPT;DBN1
prerank,tyrosine metabolic process (GO:0006570),-0.3269641987555174,-0.8064532100206737,0.7208121827411168,0.9287077162236149,1.0,1/11,3.53%,GSTZ1
prerank,beta-catenin-TCF complex assembly (GO:1904837),0.3216736145685682,0.8062568540321737,0.7005420054200542,0.9663185155079557,1.0,7/29,13.47%,EP300;PYGO2;TCF7L2;TLE2;SMARCA4;TLE4;MYC
prerank,regulation of plasminogen activation (GO:0010755),0.3843164330922832,0.8057163711002077,0.7194719471947195,0.9667556637478852,1.0,2/12,6.15%,HPN;CTSZ
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.25006669812759114,0.8055714066794556,0.965,0.9665193596138278,1.0,147/834,16.87%,CDH13;KLF5;THRB;TMPRSS6;KLF4;TFAP2C;PPARGC1A;NCOA3;PBX1;GAL;ELF3;OGT;SREBF2;MICAL2;GLI3;GTF2F1;HIVEP1;ZC3H12A;GABPB1;GABPB2;MAVS;EP300;HDAC5;CD81;FOXO3;CSRP3;FOS;GDNF;FOXC2;GLIS2;HDAC4;BMP5;NFE2L2;SSBP3;DOT1L;SMARCB1;RHOQ;FOXD2;POU2F3;NFKBIA;ESRRB;RARG;IRF3;JUND;NKX2-8;CREB1;FOXM1;HOXA5;ZBTB17;RXRB;RNASEL;SOX9;HCFC1;AKNA;HAX1;NRF1;KAT6B;MYDGF;DDRGK1;PHF10;BMP4;MEF2D;MAPK7;KLF7;TGFB2;MED30;DVL3;FIZ1;ZFHX3;LARP7;ATRX;SIX1;PKD1;JUN;FZD5;TCF7L2;GRHL2;FOXP3;TNFRSF1A;KMT2A;TXK;DPF2;APBB1;PRDM15;NFIB;TWIST1;BCAS3;HDAC3;NFIC;SMARCA4;TLR4;CREB3L4;CREB3;DR1;CALCOCO1;MEF2B;MMP12;SP1;COPS5;ELL;DCAF6;MPND;MED12;TFEB;MYSM1;GATA3;SMARCD2;RREB1;ARF4;SBNO2;NFIA;CAPRIN2;MED21;MYC;MED24;MEF2C;PAX3;MYBL1;CHUK;IRF2;HRAS;SS18L2;ATMIN;FLCN;ITGB1BP1;TNIP1;RFXAP;TLR3;DHX9;MED6;ZMIZ2;TET1;IKBKG;KLF6;MEPCE;CDC5L;RNF10;RPS27A;UBC;E2F1;POU4F1;HINFP;ABL1;KDM1A;MLLT6;SLC9A1;CAMTA2
prerank,hydrogen peroxide metabolic process (GO:0042743),-0.285380525653165,-0.8054069225209732,0.7625,0.9294744133550252,1.0,5/19,18.91%,MAOB;ACOX1;GPX1;PRDX4;SOD1
prerank,retinoic acid receptor signaling pathway (GO:0048384),0.38938762247557235,0.8051920585943955,0.6996644295302014,0.9667071606489954,1.0,4/10,18.35%,RARG;RXRB;ACTN4;RARA
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.3650534770146986,0.8050796141234622,0.7189952904238619,0.9664229483691114,1.0,3/15,6.48%,HOMER2;HOMER3;GRM2
prerank,positive regulation of protein binding (GO:0032092),0.2885191952318751,0.8049813987003758,0.7287705956907478,0.9661247708465576,1.0,16/56,19.47%,MMP9;CAV1;PPP2CA;ADD1;BMP4;TRIM21;PKD1;TCF7L2;CAPRIN2;GSK3B;PPP2CB;ABL1;SPPL3;IDE;APP;FLOT1
prerank,regulation of neutrophil migration (GO:1902622),-0.34733475723398055,-0.8048512499776327,0.7131782945736435,0.9293640605465298,1.0,8/10,44.47%,NCKAP1L;RHOH;JAM3;BST1;RAC2;RHOG;OLFM4;RAC1
prerank,sulfur amino acid metabolic process (GO:0000096),-0.2582281347911754,-0.8048340006306131,0.7532051282051282,0.9283262586631108,1.0,10/24,33.81%,NOX4;MSRA;MTR;MTHFR;ADI1;CTH;SMS;AHCY;MMUT;GCLC
prerank,rRNA modification (GO:0000154),-0.2703963241768163,-0.8044455612882331,0.7709677419354839,0.9279843602351192,1.0,10/21,27.09%,NAT10;NSUN4;DKC1;THUMPD1;TFB1M;NOP10;TSR3;DIMT1;MRM2;MTERF4
prerank,cellular response to interleukin-12 (GO:0071349),0.2971833523053033,0.8043580527311628,0.7313997477931904,0.9666881048287206,1.0,9/48,11.60%,RAP1B;GSTO1;ANXA2;MSN;MTAP;STAT4;CDC42;SOD2;JAK1
prerank,primary alcohol metabolic process (GO:0034308),0.3249269457112357,0.8043394639608312,0.7051094890510949,0.966235010821,1.0,2/25,2.95%,NAPEPLD;ADH7
prerank,interleukin-7-mediated signaling pathway (GO:0038111),0.3500743840232394,0.8042981395942357,0.6840490797546013,0.9653443813064316,1.0,5/17,11.68%,IL7R;SMARCA4;SOCS2;JAK1;IRS2
prerank,cellular response to interleukin-7 (GO:0098761),0.3500743840232394,0.8042981395942357,0.6840490797546013,0.9653443813064316,1.0,5/17,11.68%,IL7R;SMARCA4;SOCS2;JAK1;IRS2
prerank,mitotic metaphase plate congression (GO:0007080),0.2938498360280828,0.8040035145428566,0.7348484848484849,0.9653630518821635,1.0,21/51,26.59%,PSRC1;CHMP4A;CHMP4B;ZW10;VPS4B;CHMP1A;PINX1;VPS4A;MAD1L1;CHMP2A;PDCD6IP;RMDN1;NUDC;CDC23;CHMP5;MIS12;NUP62;SEH1L;DCTN2;RRS1;CHMP1B
prerank,receptor metabolic process (GO:0043112),0.29089328403794107,0.8038195224351522,0.7333333333333333,0.9652019502702999,1.0,13/53,15.65%,CAV1;CD81;ACKR3;RAMP1;CD9;LMTK2;GRK2;FCER1G;PHETA2;PLEKHJ1;PHETA1;NEDD4;ITGB2
prerank,regulation of monocyte differentiation (GO:0045655),0.3627648683869607,0.8035635560565131,0.6868217054263566,0.9651844458006683,1.0,4/14,14.17%,CDK6;ACIN1;MYC;FOXP1
prerank,intracellular protein transport (GO:0006886),0.2524966893675427,0.8033607048012071,0.8674089068825911,0.9650852437443801,1.0,79/304,22.76%,RAB17;RANBP3L;GRTP1;HOMER3;KIF13A;TBC1D16;EHD1;ARL4A;COPA;AP3B1;SNX8;SIL1;TMED1;IPO7;TSC2;NUP93;WLS;DESI1;STXBP1;PKD1;TNPO2;CHP1;RAB7A;BAG3;MYO1C;GGA1;SGSM2;AP1S3;TECPR2;AP2A1;ARFIP2;RABL3;TBC1D1;MMP12;NAPA;VIPAS39;STX11;ARF4;NAPB;VPS26B;PREB;RAB5C;TNPO1;NXT2;RAB1B;STX16;RANBP6;HEATR3;USP6NL;IPO4;AP4E1;TBC1D22A;NSF;TBC1D10A;HDAC6;ARFRP1;STAM;CSE1L;STX4;SEC23IP;PPP1R10;TMED5;SEC31B;YWHAH;XPO4;TBC1D17;TBCK;HIKESHI;ARFIP1;SEC16A;RANBP3;POM121;VPS26A;RAB3GAP2;SEC31A;RABGAP1;RAB23;AP3D1;TPR
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.3406471281345722,0.803302417062357,0.6938483547925608,0.9647176400758548,1.0,5/20,15.37%,DAXX;DCUN1D5;DCUN1D1;WASHC1;HSP90AA1
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.31989298158852403,0.8031373826397901,0.7018813314037626,0.9645268651861716,1.0,4/28,9.55%,KDM4D;SHLD2;PARP3;RIF1
prerank,phagolysosome assembly (GO:0001845),0.369974387832098,0.8029730146332129,0.6883942766295708,0.9643333462566556,1.0,2/12,8.69%,RAB7B;RAB7A
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",-0.268871396035573,-0.8028952335501173,0.7824561403508772,0.9296693320636359,1.0,9/22,26.97%,CDK12;KAT7;BRD4;SUPT4H1;ALYREF;EAPP;THOC5;ERCC6;TCERG1
prerank,regulation of triglyceride biosynthetic process (GO:0010866),0.3596885392206474,0.80270332790599,0.6651017214397497,0.9643143580013996,1.0,1/15,1.18%,LDLR
prerank,acute inflammatory response (GO:0002526),0.3359110135003778,0.8023832146058835,0.7187948350071736,0.9643710453179936,1.0,5/23,14.97%,LBP;HP;HPR;ANO6;VNN1
prerank,positive regulation of interleukin-17 production (GO:0032740),-0.26802122031010167,-0.8022322972377554,0.7728706624605678,0.929777953462894,1.0,4/22,7.31%,SLC7A5;RFTN1;IL18;TGFB1
prerank,negative regulation of histone methylation (GO:0031061),-0.33716242902106297,-0.802211969111991,0.7170731707317073,0.9287490313568273,1.0,6/10,26.80%,JARID2;BCOR;MTF2;WDR5;BRCA1;AASS
prerank,import into nucleus (GO:0051170),0.27587078571527496,0.8021025879810372,0.7423529411764705,0.9643696205085104,1.0,28/73,27.61%,IPO7;SNRPB;TSC2;NUP93;TNPO2;MMP12;TNPO1;NXT2;GEMIN6;RANBP6;HEATR3;IPO4;CSE1L;PPP1R10;SNUPN;DDX20;HIKESHI;POM121;GEMIN5;TPR;IPO9;NUP62;GEMIN8;GEMIN2;NUP133;SNRPD2;SNRPD1;IPO8
prerank,negative regulation of chemotaxis (GO:0050922),0.3132149154867187,0.8019605347962769,0.7265193370165746,0.964133159223075,1.0,2/31,2.81%,SEMA3D;SEMA3B
prerank,heterochromatin assembly (GO:0031507),-0.27312850325841304,-0.8017774481055999,0.7543859649122807,0.9284463054461004,1.0,5/20,15.80%,MBD2;SMCHD1;HMGA2;HELLS;SIRT2
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.35896629696710686,0.8012162455078113,0.7136075949367089,0.9649048551950724,1.0,3/15,11.15%,IL17RA;TLR6;TLR4
prerank,calcium ion import (GO:0070509),0.32139606212783695,0.8012028850280811,0.7142857142857143,0.9644535290792597,1.0,7/28,13.02%,CACNA1A;MCU;MCUB;MICU1;AFG3L2;MCUR1;CACNB2
prerank,negative regulation of DNA metabolic process (GO:0051053),0.3344020927256779,0.8008196941212338,0.7121879588839941,0.9646400154872764,1.0,2/24,2.09%,CDKN1A;NIBAN2
prerank,long-term memory (GO:0007616),0.33377267506212965,0.8007736270722202,0.7037593984962406,0.9642515553217866,1.0,1/19,1.18%,LDLR
prerank,DNA conformation change (GO:0071103),-0.2880806038073557,-0.800660356312958,0.75,0.9293158800420569,1.0,6/17,22.80%,TOP3A;KAT6A;ERCC3;HMGB1;HHEX;TOP2A
prerank,regulation of actin polymerization or depolymerization (GO:0008064),0.32558601383902536,0.8006107244663155,0.7302452316076294,0.9640526994842853,1.0,5/28,7.60%,ARHGAP18;FCHSD2;FCHSD1;HAX1;LATS1
prerank,regulation of hippo signaling (GO:0035330),0.35107831074434676,0.8002211874075527,0.7131782945736435,0.9642668217081181,1.0,1/17,0.88%,MOB3B
prerank,tRNA modification (GO:0006400),0.2825791830503413,0.8001756125245894,0.7605804111245466,0.963873767950776,1.0,17/62,20.36%,MOCS3;LCMT2;THADA;ELP5;TRIT1;METTL6;THG1L;AARS1;ANKRD16;TYW1;THUMPD3;WDR6;DUS2;CTU1;TRMT112;CTU2;TYW5
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.3198732199242198,0.7999756923882003,0.7272727272727273,0.9637458181872849,1.0,1/27,0.58%,CD44
prerank,positive regulation of neuron apoptotic process (GO:0043525),0.332323893827008,0.7998784214661573,0.7017291066282421,0.9634514711499736,1.0,4/24,10.37%,NUPR1;FOXO3;TGFB2;SRPK2
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.36386919084449804,0.7994187579109314,0.6902927580893683,0.9637484466477729,1.0,3/13,10.02%,SOX9;BMP4;NFIB
prerank,regulation of cellular response to heat (GO:1900034),0.2769895632236154,0.7991418752850897,0.7903981264637002,0.9637643093714344,1.0,28/77,26.80%,EP300;BAG1;CRYAB;HSPB8;NUP93;CHORDC1;NDC1;BAG3;RPA3;GSK3B;HSP90AA1;HSPH1;ATR;MAPKAPK2;AAAS;RAE1;MAPT;CAMK2B;HIKESHI;PTGES3;POM121;TPR;RANBP2;NUP42;NUP62;SEH1L;RPA2;NUP133
prerank,RNA export from nucleus (GO:0006405),0.26883188488130433,0.7989972796538684,0.7700892857142857,0.9635387374753471,1.0,31/100,25.54%,SRSF2;NUP93;EIF4A3;SMG7;DDX39B;RBM8A;NDC1;WDR33;AGFG1;SRSF7;POLDIP3;THOC7;RNPS1;SRSF9;UPF3B;MAGOHB;MAGOH;AAAS;SRSF1;RAE1;SRSF5;THOC1;POM121;U2AF1;TPR;SRRM1;RANBP2;NUP42;NUP62;SEH1L;RBM15B
prerank,Golgi to lysosome transport (GO:0090160),-0.3303096953495112,-0.7987793775059773,0.7166212534059946,0.9314505188522285,1.0,6/11,24.34%,EHD3;SORT1;CLN3;RBSN;CCDC91;GAK
prerank,regulation of sister chromatid cohesion (GO:0007063),0.37821732269585595,0.7986134456288919,0.6932515337423313,0.9637271835909124,1.0,6/12,30.40%,FEN1;WAPL;RB1;HDAC8;CTNNB1;DDX11
prerank,aromatic amino acid family metabolic process (GO:0009072),0.392259217548446,0.7986040340672854,0.7120689655172414,0.9632751947167987,1.0,2/10,19.46%,THAP4;KYAT1
prerank,outflow tract septum morphogenesis (GO:0003148),0.32762679760529134,0.7985789137796538,0.6936170212765957,0.962847849416886,1.0,6/24,12.14%,PARVA;SMAD6;BMP4;TGFB2;NRP2;TGFBR2
prerank,epithelium development (GO:0060429),0.2698153805391149,0.7985503290323772,0.7955801104972375,0.9624223715262283,1.0,11/107,8.89%,UPK1B;SMO;DAG1;KANK2;ANXA4;PIH1D1;SOX9;SIX1;PKD1;LGALS3;GRHL2
prerank,cellular transition metal ion homeostasis (GO:0046916),-0.19545842873795682,-0.7985125447478842,0.9416666666666667,0.930847768031467,1.0,14/91,13.00%,BMP6;SLC30A10;SCARA5;SLC39A12;FBXL5;SLC40A1;SLC39A8;TFRC;ATOX1;SLC39A10;CYB561A3;GLRX3;SLC30A1;FXN
prerank,transferrin transport (GO:0033572),0.30870771969408767,0.798193940916296,0.7330567081604425,0.9625273314577575,1.0,13/33,27.02%,ATP6V1B1;LMTK2;ATP6V1E1;ATP6V1D;ATP6V0D1;ATP6V1B2;ATP6V0B;ATP6AP1;REP15;ATP6V0E1;HFE;ATP6V0E2;ATP6V0D2
prerank,axonal fasciculation (GO:0007413),-0.31110391820829464,-0.7976925453632063,0.7206982543640897,0.9311657776650839,1.0,6/12,17.76%,SEMA5A;NRCAM;EPHB2;MEGF8;EPHB3;ARHGAP35
prerank,nucleus organization (GO:0006997),0.28995843736561877,0.7975509374278844,0.7289603960396039,0.9631218364420315,1.0,14/47,17.81%,REEP3;NUP93;CHMP4A;CHMP4B;NDC1;TOR1A;VPS4B;CHMP1A;VPS4A;CHMP2A;REEP4;NUMA1;PDCD6IP;SUN2
prerank,'de novo' posttranslational protein folding (GO:0051084),-0.2423946072299239,-0.7974084115947175,0.775,0.9305888194628661,1.0,17/30,33.85%,DNAJB4;DNAJC18;DNAJB12;SELENOF;ST13;DNAJB5;CCT2;ENTPD5;HSPA9;DNAJB1;GAK;HSPA1B;UGGT1;HSPA2;SDF2L1;HSPA5;CHCHD4
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),0.33297087140776416,0.7973255376481777,0.7444444444444445,0.9630268224210764,1.0,4/22,10.51%,TIMP4;TIMP1;TIMP2;SNX33
prerank,nucleoside triphosphate metabolic process (GO:0009141),0.3638693213935158,0.7968883580368861,0.6955177743431221,0.9632646145662607,1.0,4/14,10.00%,CMPK1;DCTPP1;AK5;AK3
prerank,histone mRNA metabolic process (GO:0008334),0.31927819835542903,0.7965862833778359,0.7267683772538142,0.9633293837611061,1.0,2/27,5.43%,LSM10;SNRPB
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.3454250133063826,0.7965235852382798,0.7091194968553459,0.9629608722148888,1.0,10/17,29.92%,FCHSD2;ARFIP2;WASF1;ARFIP1;BRK1;NCKAP1;WASF3;WASF2;ARF1;CYFIP1
prerank,mesenchyme development (GO:0060485),0.3498067469607828,0.796266030511933,0.6956521739130435,0.9629206081880088,1.0,2/15,6.81%,WNT11;BMP4
prerank,central nervous system development (GO:0007417),0.25254505306396835,0.7961773526943243,0.8628454452405322,0.9625979560577621,1.0,28/250,10.14%,CELSR1;TBR1;PBX3;PBX1;SMO;ZIC4;PDGFC;GSN;CXCR4;QARS1;ADGRL2;GLIS2;ZBTB16;CTNS;EIF2B2;SOX9;ZIC2;LSR;ZFHX3;CIC;PHGDH;PKD1;GRHL2;CDK5RAP1;ZIC1;ADGRA2;NFIB;IER3IP1
prerank,regulation of defense response to virus (GO:0050688),0.36138325825160833,0.7960408374933599,0.7024390243902439,0.9623637720790936,1.0,5/14,24.22%,PPM1B;DHX9;ILRUN;PCBP2;C1QBP
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.33011589965242527,0.795989427149233,0.6965034965034965,0.9619882566218945,1.0,5/23,10.62%,DGAT1;ELOVL1;ELOVL6;ACSL3;ACSF3
prerank,peptide biosynthetic process (GO:0043043),0.2595506419137016,0.7958205602928536,0.8163265306122449,0.9617849136941481,1.0,60/153,28.73%,MRPS16;EEF1A1;MRPL24;MRPL37;HARS1;RPS4X;MRPS7;ABCF1;RPL31;RPSA;GSPT2;RPL22;MRPS33;CARNS1;RPL28;SRBD1;RPS26;MRPL9;COPS5;HARS2;RPL10A;MRPS15;SARS1;EIF4G1;TNIP1;MRPS18C;RPL14;RRBP1;RPS27A;HBS1L;IGF2BP3;EIF4EBP2;RPL6;FARSB;RPS28;RHD;RPL41;RPLP2;YARS2;RPLP1;RPL7;IGHMBP2;MRPL32;RPL21;RPL26;MRPS21;RPS27;MRPS12;RPS12;RPL18;MRPL35;RPS17;RPS3;MRPL18;MRPS6;RPL24;RSL24D1;EEF1A2;GGTA1;RPS6
prerank,ERBB2 signaling pathway (GO:0038128),-0.24181994059169004,-0.7953050030042094,0.7834645669291339,0.9331733238776418,1.0,9/31,17.58%,PIK3R1;ERBIN;PTPN12;ERBB4;MYOC;GRB2;CUL5;CDC37;EGF
prerank,B cell differentiation (GO:0030183),0.2969404360091386,0.7949685484086031,0.7568988173455979,0.9626876437687041,1.0,13/46,20.22%,HDAC5;HDAC4;CLCF1;NFAM1;CR2;RABL3;PTPN2;KLF6;IRF2BP2;TPD52;ADAM17;ZBTB7A;DCAF1
prerank,positive regulation of protein deacetylation (GO:0090312),-0.30070528875537283,-0.7949460604844066,0.7587209302325582,0.9327351352375876,1.0,6/14,21.92%,SAP30BP;ING2;NIPBL;DYRK1A;APLNR;BRMS1
prerank,covalent chromatin modification (GO:0016569),-0.3012118429928284,-0.7947473521866482,0.7527173913043478,0.9320050548994682,1.0,2/14,4.18%,MBD2;SETD5
prerank,positive regulation of muscle cell differentiation (GO:0051149),-0.26040744741360383,-0.7946774778228916,0.8061538461538461,0.9310777763745455,1.0,3/24,6.45%,CDH2;BOC;CTNNA2
prerank,regulation of cell-substrate adhesion (GO:0010810),0.3011758185756698,0.7937527644541837,0.7461734693877551,0.9642486670379496,1.0,7/42,12.80%,WNT1;EMP2;GCNT2;DMTN;RHOA;NPNT;PDPN
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.30703232541538983,0.7931115304541128,0.7398921832884097,0.9648167862294933,1.0,2/33,1.44%,ARAP1;MMP9
prerank,cellular protein-containing complex assembly (GO:0034622),0.25994894034355387,0.7919587847134919,0.8136125654450261,0.9662326153463032,1.0,17/159,9.90%,CLU;ANGPT1;STXBP6;CLTB;PSMD11;NUP93;POMP;PXN;PSMD4;STXBP1;HSPA4;CHMP4A;CHMP4B;CENPT;EIF4B;NDC1;COX7A2L
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.3534929347887646,0.7919488884765483,0.7200622083981337,0.9657804645683458,1.0,3/16,9.55%,SHLD2;KLHL15;RIF1
prerank,regulation of mRNA processing (GO:0050684),0.3164967158156383,0.7919054261008809,0.7101063829787234,0.9653882533812344,1.0,8/32,15.47%,AHCYL1;SON;SLTM;LARP7;SRPK2;SRPK1;DHX9;PABPN1
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.2948014547516477,0.7915910892517753,0.7547892720306514,0.9654218547498922,1.0,12/48,16.85%,ADCY9;GUCY2F;IMPDH2;NUDT2;DCAKD;GMPS;ADCY6;AK5;ADCY10;AMPD2;PPCDC;ADSS2
prerank,glycine metabolic process (GO:0006544),0.364215101507445,0.7914267337165596,0.7093206951026856,0.9652152436220146,1.0,2/12,12.04%,SHMT1;AMT
prerank,epithelial cell differentiation (GO:0030855),0.26845797245426967,0.7913307587561955,0.7734994337485843,0.9649072475235038,1.0,14/88,15.68%,UPK1B;ANXA4;PIH1D1;OVOL2;BMP4;LATS1;SIX1;LGALS3;GRHL2;PTER;GATA3;VDAC1;GSTK1;PCNA
prerank,tRNA methylation (GO:0030488),-0.23609645508271998,-0.7910757377753451,0.7837837837837838,0.935977595177252,1.0,15/34,25.50%,TARBP1;METTL1;TRMT61B;TRMT10A;THUMPD2;TRMT5;TRMO;TRMT1L;GTPBP3;TRMT44;TRMT10C;ALKBH8;TYW3;BCDIN3D;PRORP
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),0.3267502294385349,0.791022998726683,0.7272727272727273,0.9649582738568951,1.0,6/21,20.76%,CDK4;FBXO5;CCND1;VPS4B;CDC25B;RCC2
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.30575904637738976,0.790952161367635,0.7449664429530202,0.9646061781262003,1.0,1/35,0.37%,CDH13
prerank,inositol phosphate biosynthetic process (GO:0032958),0.372443289477455,0.7908596126637437,0.7016129032258065,0.9643089678321788,1.0,3/11,15.85%,IP6K1;PPIP5K2;IP6K2
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),0.35803635053923877,0.7907086775958424,0.7170418006430869,0.9641029106552796,1.0,5/14,27.19%,CD81;IKBKG;PRKD2;RELA;RPS3
prerank,cellular response to amino acid stimulus (GO:0071230),-0.2413576563639552,-0.7906361538051696,0.828,0.9356910125313993,1.0,10/33,17.72%,UBR1;GLRA1;IPO5;CPEB1;SLC38A9;LAMTOR1;KLHL22;RRAGD;GLRA2;RRAGA
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.3307334253269247,0.7905599910490414,0.733433734939759,0.9638717166299543,1.0,4/22,9.20%,CDKN1A;IPO7;LATS1;CDK5RAP1
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.3251424647978155,0.7903590286194021,0.7150837988826816,0.963756847475864,1.0,9/26,18.82%,HOMER2;HOMER3;RCAN1;CHP1;ATP2B4;GSK3B;SLC9A1;SPPL3;PTBP1
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.28239514240349345,0.7902780062042905,0.7776442307692307,0.9634219338271338,1.0,11/69,15.49%,CLU;MAVS;TNFRSF8;HSPB1;FZD5;LBP;TWIST1;TLR4;TLR3;DHX9;OAS2
prerank,organelle disassembly (GO:1903008),0.3113383648073093,0.7897909092377327,0.7374830852503383,0.9637198040498857,1.0,8/33,18.05%,DDRGK1;TEX264;PLK3;KLC1;ULK1;RB1CC1;UFM1;PELO
prerank,regulation of cellular component size (GO:0032535),0.3197259421027805,0.7891515824869857,0.75,0.9643150994294684,1.0,6/30,9.58%,PPP1R15A;RARG;MSN;PEX11G;RAB3B;EZR
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),-0.314827671009266,-0.7890175638935444,0.7299270072992701,0.9371931859463852,1.0,4/12,17.61%,AR;TGFB1;EDN1;HDAC2
prerank,response to amyloid-beta (GO:1904645),0.2956533883793104,0.7885004336834306,0.7570469798657719,0.9648959944893953,1.0,7/44,14.36%,MMP9;EPHA4;CACNA1A;TLR6;TLR4;MMP12;GSK3B
prerank,ceramide catabolic process (GO:0046514),0.3625999193295064,0.7882492064472572,0.6943573667711599,0.9648309572181418,1.0,3/14,14.65%,HEXA;HEXB;NAGA
prerank,histone H4 deacetylation (GO:0070933),0.3857673997590527,0.7881437608714589,0.7026578073089701,0.9645506426132293,1.0,2/10,10.49%,HDAC4;HDAC3
prerank,inorganic anion transport (GO:0015698),-0.21571319842743572,-0.7880905793146348,0.8810810810810811,0.937681759379131,1.0,13/53,19.18%,SLC26A7;ENPP1;SLC4A10;ANO4;GLRA1;ENPP3;XPR1;TTYH1;CLIC5;SLC5A5;SLC26A6;CLCN1;FXYD1
prerank,receptor recycling (GO:0001881),0.379380952696129,0.7870192976101733,0.7123966942148761,0.9659153464353603,1.0,4/10,13.88%,LMTK2;PHETA2;PLEKHJ1;PHETA1
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.32493438056411567,0.7870128413127715,0.7158931082981715,0.9654639118056084,1.0,5/23,15.84%,ALOX5;ELOVL6;FADS1;LTA4H;GSTM2
prerank,cilium assembly (GO:0060271),0.24566760185541833,0.7869515464721174,0.8875379939209727,0.9651123370180383,1.0,50/296,18.72%,RAB17;RP1;CYS1;ABLIM1;PARVA;GSN;DYNLRB1;EHD1;CNGA2;ARL3;INPP5E;CCDC28B;RAB11FIP3;AVIL;IFT46;EXOC7;CFAP54;EXOC4;CFAP206;PKD1;CC2D2A;CEP76;IFT80;EXOC2;PAFAH1B1;CSNK1E;MARK4;CPLANE2;CNGB1;EXOC8;ARF4;OCRL;MKKS;TNPO1;ATP6V1D;HSP90AA1;ATP6V0D1;FLNA;KIF17;TMEM138;PTPDC1;DYNC1H1;RAB8B;HDAC6;RILPL1;FHDC1;ODF2;WDR35;SFI1;GALNT11
prerank,phospholipid transport (GO:0015914),0.2882642930851376,0.786631683523739,0.7675276752767528,0.9651576686849064,1.0,5/52,6.77%,LDLR;ATP10A;PITPNC1;PRELID3B;ATP8B2
prerank,cardiac ventricle morphogenesis (GO:0003208),-0.2247085521665675,-0.7866053938609132,0.8622222222222222,0.9390601562308221,1.0,6/41,9.11%,JAG1;ENG;NOTCH1;TGFB1;HEYL;FGFR2
prerank,glycogen catabolic process (GO:0005980),0.35601038471358937,0.7865325401694165,0.724031007751938,0.9648512523912067,1.0,4/15,15.50%,PHKA2;PGM2;PHKB;RB1CC1
prerank,superoxide anion generation (GO:0042554),-0.30312126517320087,-0.7857632981249976,0.7544303797468355,0.9393877689464528,1.0,3/13,21.29%,NOX4;NCF2;CYBB
prerank,negative regulation of interleukin-17 production (GO:0032700),0.3723344917817116,0.7857407132236429,0.7237936772046589,0.9656814471536463,1.0,2/10,11.15%,FOXP3;TLR4
prerank,iron-sulfur cluster assembly (GO:0016226),0.3209976474066205,0.785725307147649,0.7347222222222223,0.9652421230670245,1.0,7/24,20.22%,CIAO1;NFS1;ISCA1;IBA57;CIAO3;CIAPIN1;ISCA2
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),0.31211826355708666,0.7855944982783317,0.7372654155495979,0.9649883107955455,1.0,13/32,26.25%,POLR2H;TAF1C;UBTF;POLR1C;POLR1E;POLR1F;ERCC2;POLR2E;TBP;POLR1G;MNAT1;POLR2K;POLR1B
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),-0.2690761543534983,-0.7854624434436284,0.7654320987654321,0.9388552025100406,1.0,7/20,20.62%,SULF1;FGF2;THBS1;SPRY4;SPRY1;FGFBP3;SMOC2
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.28198419600091384,0.7854520362251363,0.7528373266078184,0.964764151620384,1.0,4/51,3.27%,SRGAP2;PLXNB1;NBL1;NGF
prerank,cellular response to superoxide (GO:0071451),-0.32705914460324803,-0.785396029648868,0.7308707124010554,0.9379240277247285,1.0,3/10,18.91%,NOS3;SOD3;SOD1
prerank,ubiquinone metabolic process (GO:0006743),0.3479022322407007,0.7851467064103905,0.7213375796178344,0.9647810710254513,1.0,2/15,8.22%,UBIAD1;PDSS2
prerank,regulation of autophagosome assembly (GO:2000785),0.30532652598854704,0.7851208487224932,0.7208672086720868,0.9643567573049865,1.0,12/33,22.65%,NUPR1;TMEM39A;CHMP4A;CHMP4B;SMCR8;MTMR3;PIP4K2C;RAB1B;FEZ1;PHF23;RAB3GAP2;UBQLN2
prerank,regulation of transport (GO:0051049),-0.233754045310532,-0.7842648476338498,0.8125,0.9387009402538743,1.0,6/36,11.88%,LEPR;EPB41;LRRK2;DNAJA1;ICA1;MYO6
prerank,regulation of smooth muscle contraction (GO:0006940),0.3330262553585246,0.7842356808244751,0.7093184979137691,0.9652876055953908,1.0,2/20,3.76%,CAV1;DAPK3
prerank,negative regulation of Notch signaling pathway (GO:0045746),-0.24529366733081018,-0.7840110117509949,0.8233082706766918,0.9380522628688905,1.0,14/28,27.24%,NOTCH3;TSPAN15;ARRB1;GATA2;BEND6;EGFL7;LFNG;EGF;TCIM;HEY1;YTHDF2;DLL4;EGFR;HIF1AN
prerank,B cell activation involved in immune response (GO:0002312),0.3607214106096797,0.7839686194478067,0.7051282051282052,0.9652545376424214,1.0,5/13,30.44%,EXOSC3;RNF168;RNF8;MSH2;MSH6
prerank,negative regulation of DNA biosynthetic process (GO:2000279),0.31246827804302424,0.783817162431831,0.7419354838709677,0.965033624654727,1.0,2/30,2.09%,CDKN1A;NIBAN2
prerank,positive regulation of histone modification (GO:0031058),0.3149095229789012,0.7835631329917864,0.7325268817204301,0.9649713820354909,1.0,7/33,16.82%,PPARGC1A;ZBTB7B;FOXP3;BRD7;TET1;UBE2N;KDM1A
prerank,regulation of histone H3-K9 methylation (GO:0051570),0.37682666894257244,0.7831541270191794,0.7112211221122112,0.9652089478029653,1.0,3/10,16.82%,ATRX;RIF1;KDM1A
prerank,regulation of interleukin-1 beta production (GO:0032651),0.276920870978318,0.7830378363007442,0.7870588235294118,0.9649378069313211,1.0,9/66,11.15%,NLRP2;ZC3H12A;HSPB1;NLRP2B;FZD5;PYDC1;TLR6;CARD16;TLR4
prerank,negative regulation of JUN kinase activity (GO:0043508),0.38172795918919566,0.7828914817700637,0.7081339712918661,0.9647023492745146,1.0,1/10,4.06%,DUSP10
prerank,acute-phase response (GO:0006953),-0.3089643234500161,-0.7825778720235187,0.7450424929178471,0.9392968811257079,1.0,4/12,22.44%,IL6R;PLSCR1;IL22;SIGIRR
prerank,necroptotic process (GO:0070266),-0.2861978618168795,-0.7824761584738644,0.7304347826086957,0.9384212208007856,1.0,6/16,22.22%,ITPK1;PGAM5;RIPK1;IPMK;MLKL;CYLD
prerank,regulation of fibrinolysis (GO:0051917),0.3550203192416006,0.7824649581740568,0.7125193199381762,0.9649076004167662,1.0,2/13,6.27%,THBD;KLKB1
prerank,positive regulation of mRNA metabolic process (GO:1903313),0.35568598431137327,0.7821194881749576,0.731437598736177,0.9649677855915002,1.0,2/13,6.24%,ZC3H12A;MOV10
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.3362003876794174,0.7818430410473398,0.7256637168141593,0.9649698983646433,1.0,2/18,3.88%,JCAD;FOXC2
prerank,RNA transport (GO:0050658),0.2734782499600016,0.781745306784494,0.7923627684964201,0.9646834845132491,1.0,24/71,23.24%,SRSF2;EIF4A3;SIDT2;DDX39B;RBM8A;SRSF7;POLDIP3;TGFBR2;THOC7;RNPS1;SRSF9;UPF3B;MAGOHB;MAGOH;SRSF1;RAE1;SRSF5;FLOT1;THOC1;YBX1;POM121;U2AF1;TPR;SRRM1
prerank,mRNA transport (GO:0051028),0.2633675163761705,0.7815574541908391,0.7991120976692564,0.9645208023147852,1.0,31/101,25.54%,SRSF2;NUP93;EIF4A3;SMG7;DDX39B;RBM8A;NDC1;WDR33;AGFG1;SRSF7;POLDIP3;THOC7;RNPS1;SRSF9;UPF3B;MAGOHB;MAGOH;AAAS;SRSF1;RAE1;SRSF5;THOC1;POM121;U2AF1;TPR;SRRM1;RANBP2;NUP42;NUP62;SEH1L;RBM15B
prerank,sister chromatid segregation (GO:0000819),-0.23991008731211003,-0.7815471747948194,0.8296296296296296,0.9388945406757682,1.0,17/31,32.09%,KIF18A;NCAPG2;RAN;KLHL22;WRAP73;DSN1;NUSAP1;TOP2A;KNSTRN;SPAG5;KIF18B;KIFC1;NSL1;NDC80;TUBG2;CDCA8;SGO1
prerank,RNA metabolic process (GO:0016070),0.2545770236727719,0.78112749539775,0.8214676889375685,0.9647557972341725,1.0,30/127,20.32%,CELF2;GTF2F1;ZC3H12A;RBFOX2;POLR2H;POLR2A;RNASEL;SIDT2;DDX39B;XRN2;HNRNPH2;RNASE3;MTREX;TBRG4;HNRNPUL1;SYNCRIP;DHX9;PABPN1;DUSP11;CLP1;RNASE4;WTAP;POLR2C;HNRNPA3;RBMS2;POLR2E;PTBP1;PCBP2;DDX20;THOC1
prerank,histone H2B ubiquitination (GO:0033523),-0.3282347636545392,-0.7811040775917495,0.7752525252525253,0.9384780326188439,1.0,3/10,18.20%,WAC;DTX3L;PAF1
prerank,regulation of mitotic spindle assembly (GO:1901673),0.3307012188937726,0.7809195006369231,0.7474302496328928,0.9646351338973523,1.0,9/19,26.59%,CHMP4B;VPS4B;CHMP1A;CHMP2A;PDCD6IP;CEP97;TPR;CHMP5;CHMP1B
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.28278994845380556,0.7798832932206327,0.7565872020075283,0.9658278981731185,1.0,14/50,24.77%,CDKN1A;CCND2;ACTB;CCND1;PKMYT1;SERTAD1;CCNG1;CAMK2N1;CDKN2D;CDK5RAP3;CDK5R1;GTPBP4;CDC25A;MNAT1
prerank,protein export from nucleus (GO:0006611),0.3139233068258357,0.7798360112327738,0.7528735632183908,0.965449100788246,1.0,4/27,8.66%,RANBP3L;DESI1;PKD1;CHP1
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.318188798477203,0.7792172119289364,0.7411444141689373,0.9659916032254927,1.0,6/26,21.92%,OCLN;PSRC1;NUMA1;MAPT;CDK5R1;TRPV4
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),-0.29463737322111655,-0.7789634421114918,0.7669376693766937,0.9408168566339418,1.0,9/15,35.12%,DAB2;PIK3CB;NEU3;HIP1R;TNK2;WASL;BMP2K;SCYL2;DGKD
prerank,extracellular matrix assembly (GO:0085029),0.32432034981312374,0.7789268722512117,0.7275320970042796,0.9659889951923608,1.0,3/23,9.94%,TNXB;PXDN;LAMB2
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.32622315140758823,0.7789238593328466,0.7525325615050651,0.9655397392556133,1.0,5/21,13.64%,MED30;JUN;TWIST1;MED12;MED24
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.29361516290748274,0.7787657492454257,0.7713178294573644,0.9653340785790145,1.0,18/40,26.25%,NSMCE4A;FBXO5;FEM1B;FXR1;MYC;POLH;UBE2N;ABL1;PARG;MAPT;UBE2V1;SIRT7;NSMCE1;KMT5A;CDK9;ARMT1;SMYD2;RPA2
prerank,protein O-linked glycosylation via serine (GO:0018242),-0.3239224546498629,-0.7779338375514916,0.7538071065989848,0.941420661355692,1.0,5/10,20.17%,GALNT13;GALNT16;GALNT2;POGLUT3;MGAT5B
prerank,cellular response to type I interferon (GO:0071357),-0.2227463412087685,-0.7778996719344273,0.8526785714285714,0.9394007136360023,1.0,16/41,29.10%,SP100;XAF1;ADAR;IFNAR2;IFITM3;SAMHD1;TYK2;IFI35;GBP2;BST2;IFIT3;IRF8;RSAD2;IFITM1;ISG15;IRF7
prerank,type I interferon signaling pathway (GO:0060337),-0.2227463412087685,-0.7778996719344273,0.8526785714285714,0.9394007136360023,1.0,16/41,29.10%,SP100;XAF1;ADAR;IFNAR2;IFITM3;SAMHD1;TYK2;IFI35;GBP2;BST2;IFIT3;IRF8;RSAD2;IFITM1;ISG15;IRF7
prerank,regulation of exit from mitosis (GO:0007096),-0.2264080626824906,-0.7778147874426594,0.8192307692307692,0.9384891812666858,1.0,10/38,22.93%,ANAPC11;CDC14A;RGCC;UBE2S;ANAPC15;ANAPC7;SIRT2;ANLN;BUB3;MAD2L1
prerank,placenta development (GO:0001890),-0.3004942677162073,-0.7775639130906202,0.7583547557840618,0.937845645916821,1.0,2/12,9.23%,PTK2;PPARG
prerank,regulation of endopeptidase activity (GO:0052548),0.27821223751720847,0.7764552984648574,0.7724477244772447,0.9685783219403453,1.0,6/59,8.77%,CRB2;TIMP4;SERPINC1;TIMP1;TIMP2;SERPINB8
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),-0.30134484338292283,-0.776365199953633,0.7654986522911051,0.9386949999581439,1.0,5/13,24.80%,PTGIS;PTGS2;NAXE;NAXD;NAMPT
prerank,regulation of integrin activation (GO:0033623),0.35126786255615006,0.7760195183679804,0.7391304347826086,0.9688057153226421,1.0,1/15,2.26%,RAP1B
prerank,chondroitin sulfate catabolic process (GO:0030207),0.3603930247460633,0.7759414378389656,0.7265861027190332,0.9684755170541098,1.0,3/13,11.11%,HEXA;ARSB;HEXB
prerank,smoothened signaling pathway (GO:0007224),0.3065174350814188,0.7759260858547082,0.7604306864064603,0.968039267505238,1.0,4/32,11.40%,SMO;GLI3;CC2D2A;PKD2L1
prerank,DNA packaging (GO:0006323),-0.2908399961583497,-0.7757931181017186,0.7800586510263929,0.9385566985978044,1.0,5/16,24.15%,TP53;KAT6A;NOC2L;AIFM1;BANF1
prerank,negative regulation of cellular senescence (GO:2000773),0.3462749448644028,0.7756190597846936,0.7245222929936306,0.9680586520473011,1.0,7/13,21.57%,CDK6;FBXO5;TWIST1;MAP3K3;ZKSCAN3;TERF2;YBX1
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.3733478406583655,0.775170023974225,0.7364975450081833,0.9683022459206178,1.0,3/11,17.89%,MAVS;ITGB2;STX4
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),0.2627765692292884,0.7751016103932191,0.7952488687782805,0.9679457681749233,1.0,20/87,17.76%,SMAD6;GDF15;TWSG1;FOS;GCNT2;ARHGEF18;PXN;TGFB2;JUN;RHOA;TGFBR2;TGFBR3;ZMIZ2;RPS27A;UBC;PRKCZ;ZYX;SMAD5;CDH5;BMPR1A
prerank,ovarian follicle development (GO:0001541),0.357035380151404,0.7746123024040591,0.7544426494345718,0.9682340828523571,1.0,3/13,16.84%,EIF2B2;ANG;EIF2B4
prerank,liver development (GO:0001889),0.3065313087457257,0.7746005667501692,0.7537212449255751,0.9677961675823319,1.0,7/32,18.96%,COBL;NKX2-8;LSR;TGFBR3;PRKCSH;PCK2;CDK5RAP3
prerank,mitochondrial fission (GO:0000266),0.34000376780648345,0.7745817979157404,0.750373692077728,0.967369410317675,1.0,6/16,21.30%,MUL1;MTFR1L;OPA1;DNM1L;MTFR2;MIEF1
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.24897917928513055,0.77428772074264,0.8467309753483387,0.9673652370146475,1.0,36/145,24.60%,FBXL7;FHL1;CDK4;PSMD11;AVEN;PSMD4;PSMF1;RBX1;CEP76;FBXO5;CCND1;PSMD7;PAFAH1B1;CSNK1E;VPS4B;PSMB5;CDK2;PINX1;HSP90AA1;CDC25B;DYNC1H1;PSMD1;PSMC4;ODF2;SFI1;PSMD8;CENPF;RCC2;HAUS1;CEP192;PSMA7;PLK4;CDC25A;PRKACA;TUBG1;PCM1
prerank,regulation of transcription by RNA polymerase I (GO:0006356),0.3345707942664867,0.7740051995090198,0.7307692307692307,0.9673498644924878,1.0,6/18,24.82%,UBTF;WDR43;EIF2AK3;FLNA;SIRT7;POLR2K
prerank,amide biosynthetic process (GO:0043604),0.2907860269707604,0.7738355073171473,0.7757496740547588,0.9671553403097617,1.0,4/47,6.98%,SPTSSB;SGMS2;AGK;AANAT
prerank,negative regulation of interleukin-1 production (GO:0032692),0.31783166435593013,0.7737747417651923,0.7602256699576869,0.9667917101057368,1.0,4/23,10.40%,ZC3H12A;NLRP2B;PYDC1;CARD16
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),0.3707652822066568,0.7736262806631432,0.7210776545166403,0.9665719922459015,1.0,1/10,2.68%,ABCD1
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.3468378570042659,0.7734924511871666,0.719047619047619,0.9663282523406644,1.0,4/14,12.51%,NLRP2B;PYDC1;CARD16;PTPN2
prerank,iron ion homeostasis (GO:0055072),-0.20361782245395596,-0.7734881416864103,0.912568306010929,0.9409305938155627,1.0,16/58,22.76%,BMP6;SCARA5;FBXL5;SLC40A1;TFRC;B2M;CYB561A3;GLRX3;FXN;CUL1;ATP6V1A;ISCU;SOD1;SMAD4;CCDC115;ATP6V1G1
prerank,negative regulation of ATP metabolic process (GO:1903579),0.3433265244272876,0.7733938304922254,0.7253731343283583,0.9660074338655249,1.0,6/17,17.29%,NUPR1;HDAC4;TIGAR;NCOR1;FLCN;GIT1
prerank,presynaptic endocytosis (GO:0140238),-0.2531629659476743,-0.7732093815699276,0.8266666666666667,0.9403194723040863,1.0,7/24,14.77%,SYNJ2;SYT1;NLGN1;STON2;NLGN3;AMPH;FCHO2
prerank,tRNA 5'-leader removal (GO:0001682),0.3483601358712626,0.7730637215463365,0.7395498392282959,0.9660620976405516,1.0,3/13,12.36%,POP4;POP1;RPP21
prerank,adipose tissue development (GO:0060612),0.37218516324759754,0.7727669335342073,0.732463295269168,0.9660832109347077,1.0,2/11,7.90%,RORC;DYRK1B
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.36525336433010674,0.7727567419156994,0.747588424437299,0.9656439042498816,1.0,1/11,2.67%,TWSG1
prerank,regulation of aerobic respiration (GO:1903715),0.34771401331759166,0.7724784797038178,0.7386541471048513,0.9656331198124578,1.0,2/15,9.90%,ABCD1;COX7A2L
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.2555956436576887,0.7722885574370334,0.8480603448275862,0.9654550836547163,1.0,27/128,17.76%,SMAD6;DDX5;HIVEP1;GDF15;TWSG1;FOS;BMP5;GCNT2;ARHGEF18;PXN;BMP4;TGFB2;TGFB1I1;JUN;RHOA;TGFBR2;TGFBR3;ZMIZ2;RPS27A;UBC;PRKCZ;ZYX;RGMB;SMAD5;STUB1;CDH5;BMPR1A
prerank,cellular iron ion homeostasis (GO:0006879),-0.2042440005443752,-0.7721455613506352,0.9226519337016574,0.940857849740199,1.0,15/55,22.76%,BMP6;SCARA5;FBXL5;SLC40A1;TFRC;CYB561A3;GLRX3;FXN;CUL1;ATP6V1A;ISCU;SOD1;SMAD4;CCDC115;ATP6V1G1
prerank,regulation of T cell proliferation (GO:0042129),0.27274197752523804,0.7720852176715784,0.8010012515644556,0.9653357280947982,1.0,5/61,8.98%,CCL5;IL15;SDC4;LGALS3;FOXP3
prerank,G2/M transition of mitotic cell cycle (GO:0000086),-0.1789477588846028,-0.7716716347748773,0.9888888888888889,0.9405345935082753,1.0,34/128,23.68%,PLCB1;CDK14;CEP250;BRSK1;CCP110;CCDC57;CCNH;CEP78;ALMS1;TPD52L1;CCNY;TAF2;NES;NDE1;PRKAR2B;NEDD1;PPME1;BTRC;CSNK1D;SDCCAG8;BORA;CUL1;MASTL;CKAP5;CEP41;BRSK2;MAPRE1;OPTN;HAUS4;HAUS7;CEP72;YWHAE;SSNA1;BACH1
prerank,cell cycle G2/M phase transition (GO:0044839),-0.17706221773268405,-0.7715268920419823,0.9897959183673469,0.9397562235227531,1.0,23/129,16.47%,PLCB1;CDK14;CEP250;BRSK1;CCP110;CCDC57;CCNH;CEP78;ALMS1;TPD52L1;CCNY;TAF2;NES;NDE1;PRKAR2B;NEDD1;PPME1;BTRC;CSNK1D;SDCCAG8;BORA;CUL1;MASTL
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.2737306680950695,0.7711091523364293,0.8038277511961722,0.9663639426081237,1.0,11/73,15.49%,CLU;MAVS;TNFRSF8;HSPB1;FZD5;LBP;TWIST1;TLR4;TLR3;DHX9;OAS2
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.2897830588278582,0.7710071177634183,0.7599469496021221,0.9660739989252468,1.0,10/39,16.78%,TTC7A;PIK3C2B;IP6K1;PI4KA;SOCS2;PIP4K2C;EFR3A;SOCS6;IP6K2;PI4K2A
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.3540969891959351,0.7709466093885792,0.7442622950819672,0.9657254295526629,1.0,5/14,17.04%,DDRGK1;TMEM33;COPS5;BFAR;FICD
prerank,protein insertion into ER membrane (GO:0045048),0.29859192482227964,0.770833458700302,0.7792378449408672,0.9654610846753687,1.0,13/37,24.96%,OTOF;EMC9;EMC10;GET4;EMC6;EMC2;CCDC47;APP;VAMP2;SGTA;MMGT1;VAPA;CYB5A
prerank,proteasomal protein catabolic process (GO:0010498),0.24332192065618313,0.7705659846896032,0.8647242455775234,0.9654087220683494,1.0,43/201,19.57%,PMAIP1;SPSB4;ATE1;NFE2L2;WWP2;RNF5;PSMD11;NSFL1C;PSMD4;PSMF1;FEM1C;RMND5B;RBX1;PML;UBE2B;PCNP;SIAH3;COP1;PSMD7;AGAP3;FEM1B;RNF126;ZSWIM8;PSMB5;PELI1;GSK3A;SOCS6;NEDD4;MDM2;BFAR;CCDC47;PRPF19;MAEA;DDB1;ARMC8;UBE2D3;SIAH1;STUB1;PSMD1;PSMC4;RNF41;PSMD8;PCBP2
prerank,skeletal system morphogenesis (GO:0048705),0.2863131043984081,0.7704236341454057,0.7994825355756792,0.9651804297479603,1.0,2/42,2.42%,FGFR1;HOXA4
prerank,rRNA catabolic process (GO:0016075),-0.27888927894487336,-0.7701640028411947,0.7875354107648725,0.9407897654403449,1.0,3/16,13.21%,DIS3L;EXOSC7;EXOSC2
prerank,regulation of carbohydrate catabolic process (GO:0043470),0.28962461087389507,0.7696423736243592,0.774869109947644,0.9659244099500924,1.0,16/41,25.47%,OGT;EP300;NUP93;EIF6;NDC1;JMJD8;PRKAG1;AAAS;RAE1;ZBTB7A;POM121;TPR;RANBP2;NUP42;NUP62;SEH1L
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",-0.2542381212333501,-0.7694591222374857,0.7881944444444444,0.9408328298949754,1.0,6/24,14.75%,JARID2;SUZ12;EZH2;TASOR;CREBZF;MTF2
prerank,copper ion transport (GO:0006825),-0.31205930928883496,-0.7690732721185629,0.78,0.9404082046811861,1.0,2/11,6.66%,STEAP3;ATOX1
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),0.30224867424427876,0.7688712666216891,0.7496598639455783,0.9666431762297103,1.0,8/29,20.56%,MAVS;RNASEL;MUL1;PTPN6;PTPN2;PTPN11;YTHDF3;ZBP1
prerank,negative regulation of gluconeogenesis (GO:0045721),0.3715077374068635,0.768614030656883,0.7384615384615385,0.9665843493151197,1.0,2/11,14.00%,EP300;PGP
prerank,regulation of cellular amide metabolic process (GO:0034248),-0.23009243563390921,-0.7680175701106867,0.8185328185328186,0.9409849311238667,1.0,8/32,20.66%,TMED10;TSC1;GRM5;ROCK1;MTPN;ATXN2;NOLC1;NR1H4
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.33683738147930375,0.7677397355808908,0.7602427921092565,0.9674532929953947,1.0,3/18,7.43%,TSSK4;CD200;LPAR5
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.28281592638830483,-0.767684338934902,0.8012232415902141,0.9404673066045001,1.0,6/15,26.37%,SRPRB;SPCS2;RYR2;SRPRA;RAB3GAP1;EDEM1
prerank,cellular response to misfolded protein (GO:0071218),0.32562362696907377,0.7675890142372356,0.749618320610687,0.9672402898751747,1.0,5/20,17.31%,RNF5;KLHL15;TOR1A;RNF126;STUB1
prerank,zinc ion transport (GO:0006829),0.3152808494417059,0.7674269259289886,0.7439024390243902,0.9670302554856003,1.0,5/21,14.89%,SLC39A3;SLC39A6;TRPM2;SLC39A13;SLC30A6
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.2990905722477949,0.7674163219884834,0.7610966057441253,0.9666011578620453,1.0,15/35,30.06%,NEK7;MAPK15;MAP3K4;HMBOX1;TNKS2;ATR;PRKCQ;PNKP;FBXO4;CCT5;XRCC5;NAF1;CTNNB1;CCT8;CCT6A
prerank,glycogen metabolic process (GO:0005977),-0.24246152427538903,-0.7672280267302026,0.8309859154929577,0.9401711714922263,1.0,3/27,7.79%,PRKAG2;PHKA1;GAA
prerank,positive regulation of double-strand break repair (GO:2000781),0.29183418921428483,0.767167055716691,0.7723577235772358,0.9665438710812646,1.0,5/39,9.55%,KDM4D;SHLD2;FOXM1;PARP3;RIF1
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.28384907862856934,0.7669912234404117,0.7717528373266078,0.9663482870053073,1.0,9/44,18.79%,YTHDF1;ZC3H12A;CELF1;MOV10;CPEB3;BTG2;MEX3D;YTHDF3;ROCK2
prerank,negative regulation of signal transduction (GO:0009968),0.2439547068404862,0.7666355340148671,0.8925281473899693,0.9664317616425825,1.0,24/249,8.94%,PRKCB;KANK1;NXN;GPC1;CCL5;NIBAN2;GLI3;GDF15;TMEM25;RNF43;QARS1;KANK2;PALM;GLIS2;BMP5;WWP2;TSC2;GPC3;ERBB3;LGR4;NLRP2B;MAZ;CXXC4;YWHAB
prerank,regulation of activin receptor signaling pathway (GO:0032925),0.3465920834290176,0.7664929750633955,0.7492537313432835,0.9661903367094753,1.0,2/15,5.10%,MAGI2;IGSF1
prerank,membrane lipid catabolic process (GO:0046466),-0.31518695675194375,-0.7663577327086668,0.7797029702970297,0.9404370009485027,1.0,2/10,4.73%,CYP1B1;ENPP2
prerank,histone H2A ubiquitination (GO:0033522),-0.2739992409663725,-0.7662957435230746,0.8023598820058997,0.9395269537805978,1.0,8/17,30.25%,CUL4B;BCOR;DTX3L;KDM2B;RYBP;RNF2;DDB2;SKP1
prerank,negative regulation of ATPase activity (GO:0032780),-0.2821820526255311,-0.765956664132646,0.8028571428571428,0.9389933794678118,1.0,3/16,10.36%,TSC1;OXA1L;TP53
prerank,tRNA wobble uridine modification (GO:0002098),0.3444118163711495,0.7654853003099537,0.7338582677165354,0.967257954050903,1.0,5/14,23.35%,MOCS3;ELP4;CTU1;CTU2;URM1
prerank,regulation of cytoplasmic transport (GO:1903649),-0.3182664258762713,-0.7648106487956708,0.7449856733524355,0.9396249417539839,1.0,4/11,17.84%,LRRK2;CHMP3;USP7;MAP2K1
prerank,regulation of histone modification (GO:0031056),0.35901978632294296,0.7646938261208654,0.7302325581395349,0.9680037439245025,1.0,7/13,23.26%,NNMT;FLCN;UBE2N;PARG;PARK7;AKAP8;CDK9
prerank,negative regulation of DNA binding (GO:0043392),0.30457151815547845,0.764524478314112,0.7652050919377652,0.9678203595553077,1.0,8/28,19.05%,SMO;NFKBIA;JUN;SUMO3;HABP4;E2F1;KDM1A;ILRUN
prerank,positive regulation of protein autophosphorylation (GO:0031954),0.3167310765080738,0.7643916380576118,0.7496339677891655,0.9675695412514119,1.0,6/22,18.69%,PDGFC;MRE11;RAP2C;NBN;RAD50;GPNMB
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),-0.3116232689110996,-0.7643511278761417,0.7745358090185677,0.9392820008415597,1.0,3/11,12.22%,FOXO1;NOTCH1;GLRX3
prerank,regulation of innate immune response (GO:0045088),0.27417341719423094,0.7643237568783194,0.7875,0.9672196649199596,1.0,12/57,18.01%,CCL5;RNASEL;MUL1;TRIM21;POLR3B;PTPN6;NMI;POLR3C;DHX9;POLR3G;XIAP;PTPN11
prerank,regulation of ATP biosynthetic process (GO:2001169),0.33872781615208053,0.7638065223922239,0.7518463810930576,0.9675772258911544,1.0,1/16,1.13%,PPARGC1A
prerank,negative regulation of bone mineralization (GO:0030502),0.3490460409317942,0.7636750564985973,0.7611202635914333,0.9673323784557364,1.0,3/13,11.35%,PTK2B;SRGN;TRPM4
prerank,positive regulation of establishment of protein localization (GO:1904951),-0.2706589381146365,-0.7636595892602945,0.819047619047619,0.9393196590666387,1.0,10/18,34.82%,CORO2B;DKC1;CCT7;CCT2;CCT4;WRAP53;CEP135;TREM2;CCT3;CEP295
prerank,positive regulation of leukocyte degranulation (GO:0043302),0.3572428375424054,0.7635370482964112,0.7350993377483444,0.967088675180899,1.0,3/13,17.89%,LAMP1;ITGB2;STX4
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.294965722049792,0.7633359097782446,0.7910643889618922,0.9669392563977813,1.0,10/39,22.25%,MCU;GLUD1;BAD;TCF7L2;IRS2;AACS;NLGN2;GPER1;SOX4;ADCYAP1
prerank,regulation of mitotic sister chromatid separation (GO:0010965),-0.2882310547872385,-0.7629604156042546,0.7871148459383753,0.9393222436326302,1.0,5/15,26.19%,NEK6;ANAPC7;HECW2;CENPE;RIOK2
prerank,myeloid dendritic cell activation (GO:0001773),-0.3010068023982157,-0.7624716821687373,0.7983870967741935,0.9389763666501959,1.0,4/12,25.34%,CAMK4;HMGB1;DOCK2;PYCARD
prerank,JNK cascade (GO:0007254),0.2868667216569104,0.761562319413093,0.7835723598435462,0.9691756934519284,1.0,11/40,18.37%,MAP3K5;TAB3;MAPK9;MAP3K13;IRAK1;IKBKG;UBE2N;RPS27A;UBC;TAB2;ARHGEF6
prerank,regulation of interleukin-6 production (GO:0032675),0.2582365497389706,0.7613124018211391,0.8279329608938547,0.9691157558483946,1.0,18/96,18.01%,CD200;IL17RA;ZC3H12A;MAVS;IL16;RAB7B;LBP;TLR6;PTPN6;TWIST1;TLR4;CD200R1;TLR3;SYT11;DHX9;F2R;MAPKAPK2;PTPN11
prerank,regulation of multicellular organismal development (GO:2000026),-0.2537993218782317,-0.7610329177037476,0.8360128617363344,0.9400573847732405,1.0,4/25,13.56%,INSR;SOX17;TRIP12;NIPBL
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.3276483424734527,0.7604951124896759,0.7709923664122137,0.96987924602899,1.0,7/18,21.70%,CHRM1;GRK2;GNAQ;GNA11;GNA15;CDK5R1;CHRM5
prerank,positive regulation of leukocyte activation (GO:0002696),-0.2637037990155203,-0.7604177055027451,0.8108108108108109,0.9398804099351316,1.0,3/18,7.77%,WNT5A;THBS1;IL33
prerank,spliceosomal snRNP assembly (GO:0000387),0.29605673890474227,0.7600458521072393,0.782967032967033,0.9700878748862588,1.0,14/38,27.56%,SNRPB;LSM4;GEMIN6;PRPF19;PRPF6;SNUPN;DDX20;PRPF8;GEMIN5;CLNS1A;GEMIN8;GEMIN2;SNRPD2;SNRPD1
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.24492519006766653,0.7594677257330548,0.8853838065194533,0.9705663964882226,1.0,31/186,14.36%,IGFBP6;NXN;GLI3;MLLT3;WNT11;CAV1;RNF43;PTPRU;AMER2;PSMD11;TSC2;SOX9;RBMS3;PSMD4;PSMF1;LATS1;DVL3;RBX1;TCF7L2;CXXC4;PSMD7;TLE2;HMGXB4;TLE4;PSMB5;GSK3A;LMBR1L;TLE5;SFRP1;TRABD2B;GSK3B
prerank,endothelial tube morphogenesis (GO:0061154),0.36781217859985993,0.7594380684908659,0.7401032702237521,0.9701554380549147,1.0,4/10,23.74%,BMP4;RHOA;PRKD2;RHOB
prerank,positive regulation of viral life cycle (GO:1903902),0.3154979855084778,0.7591932090653057,0.7369207772795217,0.9700746068966984,1.0,7/22,18.00%,VPS37B;TRIM11;LGALS1;VPS4A;CHMP2A;DDB1;TSG101
prerank,mRNA catabolic process (GO:0006402),-0.21482497581876855,-0.7580284499862946,0.890295358649789,0.9422973898221945,1.0,19/44,29.97%,TUT4;METTL16;RNH1;AGO1;LSM6;RC3H1;ZFP36;UPF1;LSM2;CNOT10;AGO4;YTHDF2;NUDT16;MRTO4;DCP2;ERN1;EXOSC9;HSPA1B;PNPT1
prerank,protein localization to nucleus (GO:0034504),0.25171374963675147,0.7569487775183649,0.8547486033519553,0.9730086852525593,1.0,32/102,24.24%,IPO7;TSC2;NUP93;BMP4;SIX1;TNPO2;PML;BANP;TOR1A;MMP12;PINX1;TOR1AIP1;TNPO1;NXT2;RANBP6;HEATR3;LMNA;MDM2;IPO4;CSE1L;INTS13;PPP1R10;ARL2BP;TAF8;ZBTB7A;HIKESHI;ABCA7;POM121;TPR;TOR1AIP2;IPO9;SIX4
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),-0.24425343811844327,-0.7564346948150661,0.8309859154929577,0.9435432220432292,1.0,5/26,10.32%,PDE8A;STAT5B;DAB2IP;PTPN12;GAREM1
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.30255067993592044,0.7563930042993022,0.7694483734087695,0.9733867451042871,1.0,5/27,11.88%,CHST12;CHST11;CHPF;CHST13;CHPF2
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),-0.29419708630718155,-0.7553480731626343,0.7751322751322751,0.9440779944807569,1.0,5/13,20.66%,SRSF10;CD2BP2;SRSF12;USP4;LSM2
prerank,ncRNA catabolic process (GO:0034661),-0.2377023350089881,-0.7547188486574433,0.8478260869565217,0.9439712789987003,1.0,5/28,13.21%,TUT4;DIS3L;EXOSC7;PARN;EXOSC2
prerank,positive regulation of microtubule polymerization (GO:0031116),0.30475886803751157,0.7542835956828473,0.7754010695187166,0.976013801446985,1.0,6/28,21.48%,OCLN;PSRC1;GIT1;NUMA1;MAPT;CDK5R1
prerank,ubiquinone biosynthetic process (GO:0006744),0.3352904014178538,0.7541914898153077,0.7412698412698413,0.975696695900779,1.0,2/15,8.22%,UBIAD1;PDSS2
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.3015545156563749,0.7539791480712659,0.7944444444444444,0.9755514503440263,1.0,4/30,9.24%,ABCD1;ELOVL1;ELOVL6;HACD4
prerank,positive regulation of interleukin-1 beta production (GO:0032731),0.2816668514280516,0.7533645507510424,0.819693094629156,0.9760083782165153,1.0,6/45,11.15%,NLRP2;HSPB1;FZD5;PYDC1;TLR6;TLR4
prerank,pyrimidine-containing compound metabolic process (GO:0072527),0.3599779004205147,0.752446757504473,0.7301038062283737,0.9769066366643333,1.0,3/11,14.46%,NT5C3A;SLC19A2;CTPS2
prerank,monoacylglycerol metabolic process (GO:0046462),0.339668732120098,0.7520574651573037,0.7539184952978056,0.9770585907587771,1.0,2/13,4.20%,DGAT1;MOGAT3
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.3307650045882387,0.7518704875403496,0.7533632286995515,0.976892947050191,1.0,5/17,14.45%,SRD5A3;ALG1;ALG12;DOLK;NUS1
prerank,cell differentiation in hindbrain (GO:0021533),0.35907720126860215,0.7517576552470462,0.7516447368421053,0.9766068122665212,1.0,3/11,13.81%,AGTPBP1;OPHN1;CEND1
prerank,histone methylation (GO:0016571),0.30474172444968095,0.7515904841550909,0.7689133425034388,0.9764101286729273,1.0,10/26,26.58%,NTMT1;SMYD3;PRMT1;TRMT112;PRMT2;SMYD1;SIRT7;N6AMT1;SMYD2;EHMT1
prerank,renal absorption (GO:0070293),0.36983309154210126,0.7515574302533488,0.7529411764705882,0.9760103119090057,1.0,1/10,2.11%,GSN
prerank,ribosome biogenesis (GO:0042254),0.2412143655616773,0.7515296205315719,0.8911917098445595,0.975609951512977,1.0,35/187,15.88%,GLUL;PES1;UTP11;PIH1D1;EIF6;KRR1;POP4;WDR55;XRN2;RPL31;EXOSC3;RPL22;SDAD1;RRP12;MPHOSPH6;BMS1;NIP7;MTREX;WDR43;WDR36;RPL28;PWP2;DDX47;NOC4L;SENP3;RPL10A;NOL6;RRP9;RPF1;UTP14A;HEATR3;UTP4;PAK1IP1;IMP4;RPL14
prerank,lysine metabolic process (GO:0006553),0.3508388547116097,0.7513478118596549,0.7458745874587459,0.9749783879605094,1.0,5/12,22.70%,PIPOX;SLC25A21;OGDH;DLST;GCDH
prerank,lysine catabolic process (GO:0006554),0.3508388547116097,0.7513478118596549,0.7458745874587459,0.9749783879605094,1.0,5/12,22.70%,PIPOX;SLC25A21;OGDH;DLST;GCDH
prerank,branched-chain amino acid catabolic process (GO:0009083),-0.2552353533416781,-0.7507597839328235,0.8006756756756757,0.9474895085654685,1.0,6/20,17.93%,BCKDHB;ALDH6A1;DLD;BCKDK;HIBADH;BCAT1
prerank,branched-chain amino acid metabolic process (GO:0009081),-0.2552353533416781,-0.7507597839328235,0.8006756756756757,0.9474895085654685,1.0,6/20,17.93%,BCKDHB;ALDH6A1;DLD;BCKDK;HIBADH;BCAT1
prerank,chloride transport (GO:0006821),0.2595562331971916,0.7507515666999395,0.8261376896149358,0.9753885442415877,1.0,8/74,12.23%,CFTR;SLC12A8;ANO8;ANO7;CLIC1;CLCN4;SLC12A4;ANO6
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.2844995263141263,0.7500057422688954,0.7851458885941645,0.9760406559732053,1.0,7/37,10.71%,MMP9;CDKN1A;MEF2D;JUN;ADAMTS1;HTR1B;SOD2
prerank,positive regulation of cell aging (GO:0090343),0.35569452722562983,0.7495321777620285,0.7399328859060402,0.9763034424881246,1.0,3/11,14.97%,YPEL3;EEF1E1;LMNA
prerank,neural crest cell differentiation (GO:0014033),-0.2689798343213853,-0.7493716305229082,0.8024316109422492,0.9483455962625822,1.0,8/18,25.44%,CDH2;LRP6;PDCD6;SOX11;NOLC1;KBTBD8;HTR2B;KLHL12
prerank,protein methylation (GO:0006479),0.2847420181165988,0.7491327189510113,0.7947019867549668,0.9764440281447117,1.0,15/40,27.18%,EEF2KMT;NTMT1;SNRPB;EEF1AKMT3;PRMT1;TRMT112;ETF1;PRMT2;ATPSCKMT;FAM98B;N6AMT1;FAM98A;CAMKMT;EHMT1;EEF1AKMT2
prerank,establishment of protein localization to organelle (GO:0072594),0.2591457613403719,0.7489585309433404,0.8218527315914489,0.976253210549144,1.0,15/72,18.15%,LAMP5;LAMP1;IPO7;TSC2;NUP93;TNPO2;HK1;MMP12;TNPO1;NXT2;RANBP6;HEATR3;IPO4;CSE1L;PPP1R10
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.2783139552615855,0.7483727462502242,0.8033854166666666,0.9766564160577066,1.0,16/49,24.30%,EP300;MOV10;EIF6;RAB7B;KMT2A;MEF2C;MTURN;PRMT1;PITHD1;PRKCQ;H3-3A;KMT2B;RBM15;KMT2C;KMT2E;ZFPM1
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",-0.24743900106578864,-0.7479153831988616,0.8024316109422492,0.9493673699108657,1.0,6/22,20.64%,MAN1C1;SEL1L;SYVN1;UGGT2;EDEM2;TRIM13
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.27612275758301524,0.7475101196347391,0.818523153942428,0.9775061363395107,1.0,20/51,30.06%,NEK7;MAPK15;MAP3K4;PINX1;HMBOX1;TNKS2;ATR;PRKCQ;PNKP;TERF2;TINF2;FBXO4;CCT5;EXOSC10;XRCC5;TERF1;NAF1;CTNNB1;CCT8;CCT6A
prerank,acetylcholine receptor signaling pathway (GO:0095500),0.31684522698912926,0.7467483788449827,0.7779390420899854,0.9781722480897992,1.0,4/20,15.14%,CHRM1;GRK2;GNAQ;GNA11
prerank,negative regulation of T cell proliferation (GO:0042130),-0.23905446610213033,-0.7463976028188293,0.8732876712328768,0.9503178779999336,1.0,4/28,10.79%,GLMN;LGALS9;TNFRSF21;DLG5
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.24491012854255928,0.7463018472623512,0.8874734607218684,0.9783704699918969,1.0,21/151,12.85%,SPTSSB;ST3GAL4;SGMS2;PPM1L;ELOVL1;LARGE1;MOCS3;LCMT2;MGST3;GSTO1;GOLPH3;ELOVL6;HPGDS;HACD4;NFS1;TYW1;CDO1;CERS2;LPCAT2;CHPT1;LPCAT3
prerank,cellular potassium ion homeostasis (GO:0030007),-0.29920643301248484,-0.7460413154146673,0.7963446475195822,0.9497932597592438,1.0,3/13,6.35%,ATP1B1;SLC12A2;KCNJ2
prerank,Golgi organization (GO:0007030),0.2528754472210142,0.7458538933019642,0.8425110132158591,0.9786200567426268,1.0,26/112,19.44%,FBXW8;TJAP1;TMED1;ATP8B2;NSFL1C;GOLPH3;ARHGAP21;PLK3;GCC2;CDC42;BCAS3;ZW10;YWHAZ;VTI1B;GOLGB1;ARFGEF1;NPLOC4;STX16;ATL2;USP6NL;PI4K2A;SEC23IP;FHDC1;TMED5;VTI1A;MYO18A
prerank,miRNA metabolic process (GO:0010586),0.31755316470949224,0.7455637766138488,0.7795857988165681,0.978595086126657,1.0,3/20,12.98%,DGCR8;TARBP2;TUT7
prerank,positive regulation of smoothened signaling pathway (GO:0045880),0.31809379539840327,0.7451116857666024,0.7553956834532374,0.9788253709757461,1.0,4/21,14.09%,SMO;PDCL;EVC;SFRP1
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.32113016055668847,0.7449389624258765,0.7551622418879056,0.9786490658177575,1.0,4/18,10.62%,ELOVL1;ELOVL6;ACSL3;ACSF3
prerank,peptidyl-serine phosphorylation (GO:0018105),0.24220672751198427,0.7448279603965476,0.8839957035445757,0.9783722742824613,1.0,32/153,19.24%,PRKCB;IKBKE;MKNK2;SGK3;STK39;LATS1;DYRK1B;PKD1;MAPK9;LMTK2;MAP2K2;SRPK2;GRK2;CSNK1E;TGFBR2;EIF2AK3;MAP3K13;CDK2;CHUK;ULK1;GSK3B;WNK1;PLK2;TTK;ATR;PRKCZ;MAPKAPK2;PRKCQ;STK38L;ROCK2;CAB39;PRKD2
prerank,telomere maintenance via telomere trimming (GO:0090737),-0.3153401990164295,-0.7446400589267184,0.7620253164556962,0.9486453166726944,1.0,5/10,32.15%,BLM;ERCC1;SLX4;EXO1;DNA2
prerank,formation of extrachromosomal circular DNA (GO:0001325),-0.3153401990164295,-0.7446400589267184,0.7620253164556962,0.9486453166726944,1.0,5/10,32.15%,BLM;ERCC1;SLX4;EXO1;DNA2
prerank,t-circle formation (GO:0090656),-0.3153401990164295,-0.7446400589267184,0.7620253164556962,0.9486453166726944,1.0,5/10,32.15%,BLM;ERCC1;SLX4;EXO1;DNA2
prerank,iron ion transport (GO:0006826),0.2693736412096266,0.7445158877826255,0.810880829015544,0.9783858069945981,1.0,13/47,21.12%,ATP6V1B1;LMTK2;HEPH;CP;ATP6V1E1;ATP6V1D;ATP6V0D1;SLC11A2;ATP6V1B2;ATP6V0B;ATP6AP1;REP15;MELTF
prerank,nucleotide-excision repair (GO:0006289),0.252499439888871,0.744353427514978,0.8683914510686164,0.9781662018218948,1.0,25/101,19.88%,EP300;POLR2H;POLR2A;RBX1;POLK;HUS1B;COPS5;ERCC5;HMGN1;RPA3;POLD2;ISY1;PCNA;FAN1;PRPF19;LIG3;DDB1;RPS27A;UBC;ERCC2;POLR2C;RFC1;POLR2E;PNKP;ERCC4
prerank,positive regulation of cell development (GO:0010720),0.2894951471343232,0.7436935677448416,0.7967032967032966,0.9786395455266462,1.0,4/31,7.48%,NIBAN2;LMOD3;BMP4;BAD
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),0.33786401868861893,0.7436870472749227,0.7799043062200957,0.978204679983132,1.0,5/14,18.31%,NFKBIA;PKD1;CCDC22;KEAP1;SUFU
prerank,Fc-gamma receptor signaling pathway (GO:0038094),0.25929985957938406,0.7434275096626425,0.8208778173190985,0.9781421621524605,1.0,16/71,18.34%,CYFIP2;NCKIPSD;CDC42;ACTB;MYO1C;ABI1;ACTG1;FCER1G;DOCK1;WIPF2;PLA2G6;HSP90AA1;CRK;ABL1;ARPC2;YES1
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),0.34756325432377105,0.7432585483984584,0.7558139534883721,0.9779343175172688,1.0,2/12,8.48%,CHMP4A;CHMP4B
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.344191770159218,0.7431131045866813,0.7788018433179723,0.9777086649863044,1.0,5/13,22.39%,LARP7;HEXIM1;NELFB;NELFA;RNF168
prerank,peptidyl-serine modification (GO:0018209),0.24145194580198798,0.743076919575464,0.8907741251325557,0.9773163792538484,1.0,35/166,19.24%,PRKCB;IKBKE;MKNK2;GALNT1;SGK3;NTMT1;STK39;LATS1;DYRK1B;PKD1;MAPK9;LMTK2;SRPK2;GRK2;CSNK1E;TGFBR2;EIF2AK3;MAP3K13;CDK2;NAA10;CHUK;ULK1;GSK3B;WNK1;PLK2;TTK;ATR;PRKCZ;MAPKAPK2;PRKCQ;PARP2;STK38L;ROCK2;CAB39;PRKD2
prerank,positive regulation of interleukin-6 production (GO:0032755),0.2605814773850009,0.7427158948278192,0.8249118683901293,0.9773901229380776,1.0,14/68,20.34%,IL17RA;MAVS;IL16;RAB7B;LBP;TLR6;TWIST1;TLR4;TLR3;DHX9;F2R;PTPN11;APP;AGER
prerank,histone H2A acetylation (GO:0043968),0.3242752603895084,0.7425699837630971,0.7797427652733119,0.9771443548817649,1.0,4/16,17.42%,NAA40;MORF4L2;MEAF6;TRRAP
prerank,positive regulation of TOR signaling (GO:0032008),0.28043892807481935,0.7424837912750877,0.8095238095238095,0.9768471638406708,1.0,6/40,10.49%,PIH1D1;RHEB;SIK3;GOLPH3;SMCR8;HDAC3
prerank,peptidyl-lysine modification (GO:0018205),0.2514716189746779,0.7423674205467397,0.8579418344519015,0.9765646054376015,1.0,31/99,25.47%,EP300;HDAC4;NUP93;EYA1;NDC1;SUMO2;SUMO3;NDUFAB1;SAE1;TRPM4;NSMCE2;PIAS1;PIAS3;VIPAS39;EEF1AKMT3;SENP3;P3H3;HDAC6;AAAS;PARK7;RAE1;SIRT4;ATPSCKMT;POM121;SIRT7;TPR;RANBP2;NUP42;RANGAP1;NUP62;SEH1L
prerank,synaptic vesicle cycle (GO:0099504),-0.2282844246606661,-0.7423167306776838,0.8764478764478765,0.9506224498287279,1.0,9/30,21.20%,BRSK1;NLGN1;SNAPIN;SLC17A6;SNAP25;SYNDIG1;CPLX2;SYT10;RIMS1
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.24684062373088797,0.7422904789360177,0.8686210640608035,0.9762360878441287,1.0,26/112,17.76%,WNT10A;SMAD6;GDF15;TWSG1;FOS;GCNT2;OVOL2;ARHGEF18;SOX9;PXN;MAPK7;TGFB2;JUN;RHOA;TGFBR2;MEF2C;SFRP1;TGFBR3;ZMIZ2;RPS27A;UBC;PRKCZ;ZYX;SMAD5;CDH5;BMPR1A
prerank,gas transport (GO:0015669),-0.30909789714737346,-0.7414399970438871,0.7980535279805353,0.9507814525083998,1.0,3/10,15.21%,IPCEF1;CYGB;CA2
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.26635715837264806,0.7413033781330595,0.8161592505854801,0.9772846978771481,1.0,14/60,19.55%,KLF4;NEK7;MAPK15;MAP3K4;GRHL2;MYC;HSP90AA1;HMBOX1;PCNA;TNKS2;ATR;PRKCQ;PRKD2;PNKP
prerank,negative regulation of cell division (GO:0051782),0.3524877433135264,0.7405431524758288,0.7734627831715211,0.9779930166458374,1.0,3/11,13.87%,ZFYVE19;MYC;VPS4A
prerank,positive regulation of cellular component movement (GO:0051272),-0.24183072481691625,-0.740445330237979,0.8435374149659864,0.9510547780174367,1.0,3/24,9.37%,LYN;SPOCK2;CFAP20
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),0.32801806645724074,0.7402014878749927,0.768160741885626,0.9780420267200012,1.0,8/16,26.15%,ATP5PF;ATP5F1B;STOML2;ATP5PD;ATP5ME;ATP5F1D;ATP5F1C;ATP5MC3
prerank,ceramide transport (GO:0035627),-0.2915891324447202,-0.7400021567597693,0.8068783068783069,0.9506724141536965,1.0,3/12,13.62%,PLTP;PLEKHA8;SGPP1
prerank,cellular response to inorganic substance (GO:0071241),-0.25245578950006187,-0.7395161841911644,0.8273809523809523,0.9502769549849609,1.0,6/21,19.48%,GUCY1B1;FOXO1;MTR;BLM;SPIDR;FMR1
prerank,embryonic skeletal system morphogenesis (GO:0048704),0.290337570942983,0.7394928450019639,0.8024357239512855,0.978571112696476,1.0,5/31,12.14%,HOXA4;EIF4A3;SIX1;TWIST1;TGFBR2
prerank,rRNA pseudouridine synthesis (GO:0031118),-0.30307054953494184,-0.7390456623933223,0.7929292929292929,0.9499036922034114,1.0,4/10,22.04%,DKC1;RPUSD4;NOP10;TSR3
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.3030196724964232,0.7389466408513672,0.7824207492795389,0.9788893166133555,1.0,9/22,23.93%,PPP1R15A;LGALS3;CRY2;PPP1R11;GSK3B;PPP1R1B;ROCK2;TIPRL;IKBKB
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.26913223159681104,0.7389186716514088,0.8251833740831296,0.9784885972017904,1.0,2/54,0.54%,FGFR1;ANGPT1
prerank,negative regulation of gene silencing by miRNA (GO:0060965),0.3475841688326091,0.7388932915006101,0.7738853503184714,0.9780806347424422,1.0,3/12,14.55%,ZC3H12A;NCOR1;NCOR2
prerank,positive regulation of protein transport (GO:0051222),0.2615810289393006,0.7385543134218697,0.8473557692307693,0.9781594487686014,1.0,12/67,10.45%,SYTL4;GOLPH3;TGFB2;PLK3;ANG;ACSL3;CHP1;ARHGEF5;EZR;APBB1;IER3IP1;BCAS3
prerank,cellular response to pH (GO:0071467),0.32551819180144265,0.7384894676785805,0.786910197869102,0.9778087530236125,1.0,6/17,19.43%,CHP1;RAB11FIP5;PKD2L1;HVCN1;SLC9A1;GPLD1
prerank,negative regulation of small molecule metabolic process (GO:0062014),0.3143240815977485,0.7383464455891046,0.7709580838323353,0.9775686988663919,1.0,4/20,14.00%,EP300;NCOR1;GSK3A;PGP
prerank,7-methylguanosine RNA capping (GO:0009452),0.29224241799433126,0.7382542248267205,0.7936726272352133,0.9768210317380124,1.0,3/31,6.00%,GTF2F1;POLR2H;POLR2A
prerank,7-methylguanosine mRNA capping (GO:0006370),0.29224241799433126,0.7382542248267205,0.7936726272352133,0.9768210317380124,1.0,3/31,6.00%,GTF2F1;POLR2H;POLR2A
prerank,release of sequestered calcium ion into cytosol (GO:0051209),0.30058630936385466,0.7382209292653183,0.8033707865168539,0.9764318660136134,1.0,6/26,17.28%,ITPR2;ITPR3;LETM1;TRPM2;SLC8B1;F2R
prerank,negative regulation of G0 to G1 transition (GO:0070317),-0.2181482017665471,-0.7380618521623518,0.8867924528301887,0.9501245046914388,1.0,14/36,27.47%,DAB2IP;PHC3;SUZ12;EZH2;CBX3;YAF2;FOXO4;RYBP;RNF2;RAD51;TFDP2;BRCA1;CHEK1;PHC1
prerank,microvillus organization (GO:0032528),0.3383576914692509,0.737104433371471,0.776,0.9775384798096565,1.0,3/13,9.58%,RAP1B;RAP1A;EZR
prerank,endodermal cell fate commitment (GO:0001711),-0.3177777871599836,-0.7370380060737666,0.8085642317380353,0.95038749120678,1.0,2/10,18.20%,SOX17;PAF1
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.33001847272092627,0.7369662881668295,0.7803379416282642,0.9772995304585647,1.0,3/16,12.61%,RORC;PDK2;FOXK1
prerank,neuromuscular process (GO:0050905),0.32953925401544093,0.7355604717753695,0.7880597014925373,0.978861811289318,1.0,3/16,10.55%,STRA6;AGTPBP1;PAFAH1B1
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),-0.27001108170566407,-0.7355165447106118,0.8202898550724638,0.9512717862132637,1.0,5/15,17.82%,EIF4ENIF1;TNRC6A;POLR2G;CNOT7;ZFP36
prerank,positive regulation of cell growth (GO:0030307),0.24839937460715072,0.7353745566240002,0.8741573033707866,0.978686156335401,1.0,22/96,21.89%,ISLR2;ADAM10;HPN;NGF;ZFYVE27;TGFB2;CDC42;EIF4G2;CDKN2AIP;MAP3K13;SFRP1;EIF4G1;SHTN1;H3-3A;TAF9B;ADAM17;MAPT;DBN1;MMP14;SYT3;UNC13A;SYT2
prerank,tRNA 5'-end processing (GO:0099116),0.3205838810128204,0.7353570073622989,0.7869362363919129,0.9782743283468529,1.0,5/15,21.57%,POP4;POP1;RPP21;HSD17B10;RPP40
prerank,regulation of osteoblast proliferation (GO:0033688),0.32412516178143713,0.7350064738020332,0.775,0.9783286449746025,1.0,4/17,18.50%,PLXNB1;RHOA;SFRP1;TMEM119
prerank,positive regulation of phosphate metabolic process (GO:0045937),0.2967033232176719,0.7348616396584743,0.793859649122807,0.9780938785787205,1.0,3/25,7.61%,CCL5;ILK;ANG
prerank,autophagy of peroxisome (GO:0030242),0.34298113191747104,0.734831913016396,0.7777777777777778,0.9776966462067984,1.0,4/12,27.41%,MAP1LC3B;RB1CC1;PIK3R4;TRAPPC8
prerank,protein K63-linked deubiquitination (GO:0070536),-0.22296580873237334,-0.7346395282103989,0.8833333333333333,0.9513862263596014,1.0,12/31,23.81%,USP8;STAMBPL1;OTUD7A;BABAM2;BRCC3;USP7;TNFAIP3;BABAM1;OTUD5;ATXN3;CYLD;YOD1
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.31346424069020523,0.734589957848054,0.7839116719242902,0.9776280850844041,1.0,4/17,19.69%,SPRED3;DMTN;EIF4G1;PARD3
prerank,negative regulation of lipid storage (GO:0010888),0.31676680663556245,0.734582760061061,0.7764530551415797,0.9772043271525768,1.0,3/19,5.36%,TTC39B;ABHD5;NFKBIA
prerank,positive regulation of RNA splicing (GO:0033120),0.2851322915896146,0.7343983018326624,0.803030303030303,0.977018864210706,1.0,5/29,14.63%,POLR2A;RBM20;HABP4;DAZAP1;ZPR1
prerank,autophagy of nucleus (GO:0044804),0.3294938945660449,0.7331882364838694,0.7850609756097561,0.9782697468037107,1.0,9/16,31.50%,ULK1;RB1CC1;ATG3;WIPI2;ATG2B;ATG12;WDR45;WIPI1;ATG13
prerank,cellular amide metabolic process (GO:0043603),0.24792703863204665,0.7325395735384639,0.8561797752808988,0.9787726959827692,1.0,25/102,22.88%,NAPEPLD;ACOT8;PPP2CA;ORMDL3;CPE;NNMT;ACSM3;SHMT1;NIT1;ABCA2;ALDH1L2;PCCA;SMPD2;ALDH1L1;VNN1;ABCB9;GNE;SLC19A1;MCCC2;THOP1;ABHD4;AASDHPPT;SGPL1;ST6GAL1;MLYCD
prerank,negative regulation of transposition (GO:0010529),0.3267587984286462,0.7321709207761256,0.7976011994002998,0.9788837798964688,1.0,5/16,24.44%,MOV10;TUT7;MYBL1;SIRT7;TEX15
prerank,rRNA metabolic process (GO:0016072),0.23652038706282882,0.7317945306042307,0.9050632911392406,0.9789588750739128,1.0,61/160,29.38%,PES1;UTP11;PIH1D1;KRR1;POP4;WDR55;XRN2;RPL31;EXOSC3;RPL22;RRP12;MPHOSPH6;BMS1;MTREX;WDR43;WDR36;RPL28;PWP2;DDX47;NOC4L;SENP3;RPL10A;NOL6;RRP9;RPF1;UTP14A;UTP4;IMP4;RPL14;PDCD11;IMP3;RPL6;RPS28;MAPT;RPL41;RPLP2;DDX52;BYSL;RPLP1;RPL7;WDR74;RPL21;RPL26;WDR18;RPS27;RPL18;NOP53;MDN1;RPS17;EXOSC4;EXOSC10;ESF1;NOP58;TEX10;RPL24;DDX10;RPS6;POP5;LAS1L;DDX49;RPL37A
prerank,cellular response to interferon-beta (GO:0035458),-0.2713891938655709,-0.7317359501887111,0.8097826086956522,0.9540867939012938,1.0,5/14,29.97%,AIM2;IRGM;HTRA2;TRIM6;PNPT1
prerank,regulation of TOR signaling (GO:0032006),0.2600215795674316,0.7317175924590782,0.855621301775148,0.978633977533468,1.0,9/67,10.49%,PRKAA2;PIH1D1;SH3BP4;TSC2;ROS1;RHEB;GOLPH3;SMCR8;HDAC3
prerank,superoxide metabolic process (GO:0006801),-0.22633647554382116,-0.731396301206721,0.8920863309352518,0.9535155133163932,1.0,8/29,21.29%,SH3PXD2B;NOS3;NOX4;NRROS;NCF2;SOD3;SOD1;CYBB
prerank,fatty acid metabolic process (GO:0006631),0.2436147247102338,0.7307134392791323,0.8799126637554585,0.9795843123162276,1.0,16/115,13.29%,PPARGC1A;ACOT8;ALOX5;SLC27A3;CPT1B;ACSL3;MSMO1;ACSM3;NDUFAB1;ACSF3;PON3;ACACA;GPAM;FASN;CPT2;ACADM
prerank,histone lysine methylation (GO:0034968),0.2873798349325063,0.7295622695913591,0.8276333789329685,0.9807382323170809,1.0,13/33,25.44%,DOT1L;SMYD3;KMT2A;KDM6A;SETDB1;TRMT112;DYDC2;SMYD1;MEN1;KMT2B;CXXC1;N6AMT1;SMYD2
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.3067752371692864,0.729534675925424,0.8029411764705883,0.9803426519733166,1.0,6/22,17.81%,UBASH3A;LGALS3;EZR;PTPN2;SH2D1A;DUSP3
prerank,endochondral bone morphogenesis (GO:0060350),-0.2991400542673975,-0.7286471282740378,0.8143564356435643,0.9559611438271645,1.0,5/11,23.59%,COL13A1;BMPR1B;BMPR2;INPPL1;FGFR3
prerank,T-helper cell differentiation (GO:0042093),0.3257309528802564,0.7284624238526839,0.7719033232628398,0.9813944102705017,1.0,1/14,1.95%,RORC
prerank,regulation of ion transport (GO:0043269),0.25128733262177827,0.7275051062931519,0.8562945368171021,0.9822755434786618,1.0,24/76,26.11%,CHRM1;GDNF;WWP2;KCNJ13;ANK3;TOR1A;KCNA5;SYT6;WNK1;NEDD4;SYT11;SYT12;YWHAH;ATP1A1;SYT3;VAMP2;SYT2;NKAIN4;NKAIN1;SYT13;PER1;P2RX4;HFE;SNCA
prerank,cellular response to lipopolysaccharide (GO:0071222),0.24552330242594317,0.7275009154400719,0.8732876712328768,0.9818462377976722,1.0,12/101,13.83%,CCL5;VIM;ZC3H12A;MTDH;TRIM41;LBP;CARD16;TLR4;RHOA;SBNO2;IRAK1;MEF2C
prerank,DNA-dependent DNA replication (GO:0006261),0.23746962960214468,0.7272242868252993,0.9011943539630836,0.9817952451648299,1.0,30/128,22.27%,RECQL4;PSMD11;PSMD4;PSMF1;POLG;SRPK2;PSMD7;POLE4;TOPBP1;PSMB5;CDK2;RPA3;POLD2;MCM8;PRIM2;MCM6;RPS27A;UBC;MCM7;PSMD1;PSMC4;RFC1;PSMD8;PNKP;GINS3;ORC2;TWNK;MCM4;DDX23;SIRT7
prerank,negative regulation of RNA metabolic process (GO:0051253),0.3188246132177444,0.7269082945901677,0.780559646539028,0.9817879877979055,1.0,7/18,23.22%,ZC3H12A;NCOR1;RPS26;NCOR2;PTBP1;NRDE2;SHQ1
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.2529808954388087,0.7267454781566364,0.8481613285883749,0.9815597370856649,1.0,16/73,18.34%,CYFIP2;NCKIPSD;CDC42;ACTB;MYO1C;ABI1;ACTG1;FCER1G;DOCK1;WIPF2;PLA2G6;HSP90AA1;CRK;ABL1;ARPC2;YES1
prerank,DNA replication-independent nucleosome assembly (GO:0006336),0.27315599120304873,0.7264365153331567,0.8339973439575034,0.9815759594446354,1.0,9/38,18.29%,ASF1A;CENPS;ATRX;CENPT;UBN1;CENPH;IPO4;CENPO;H3-3A
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.24142524085961975,0.7260771683910158,0.8748615725359912,0.9816380029545348,1.0,9/107,8.71%,ANK2;STIM2;CCL5;CAV1;CSRP3;ATP13A3;TMEM165;ATP13A4;SLC39A6
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.2938092987151648,0.7260072819163852,0.8220338983050848,0.9813087999552504,1.0,3/26,8.29%,ATP1A2;GSTO1;THADA
prerank,integrated stress response signaling (GO:0140467),0.3270925720820892,0.7259447679102233,0.7912621359223301,0.9809613944360918,1.0,3/14,17.03%,NFE2L2;EIF2AK3;EIF2AK4
prerank,regulation of cellular amine metabolic process (GO:0033238),0.25919636194862805,0.7250860048645612,0.8265822784810126,0.9816864799181598,1.0,9/50,19.45%,PSMD11;PSMD4;PSMF1;AZIN1;PSMD7;PSMB5;PSMD1;PSMC4;PSMD8
prerank,neuron projection fasciculation (GO:0106030),0.35320732708796565,0.7241616446537922,0.7996575342465754,0.9825235499657928,1.0,1/10,1.67%,EPHA4
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),0.35284173567064875,0.7231867954113506,0.773356401384083,0.9833647168392153,1.0,3/10,13.47%,SOX9;TGFBR2;MYC
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.24094933784904848,0.7230922356052878,0.8792710706150342,0.9830477857667046,1.0,21/104,19.80%,TRIB2;CDKN1A;PPP2CA;PIH1D1;CCND2;ACTB;MAP2K2;CCND1;PKMYT1;RHOA;SERTAD1;TESK1;CCNG1;ABL1;MTCP1;TSG101;CDKN2D;CAB39;CDK5RAP3;RB1;UVRAG
prerank,defense response to symbiont (GO:0140546),0.24605893587916605,0.7229270106557647,0.8721719457013575,0.9828418542688261,1.0,8/92,6.43%,SERINC5;MAVS;PMAIP1;IRF3;BCL2L1;RNASEL;MOV10;NT5C3A
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),0.23753686322328843,0.7221706712772179,0.8934240362811792,0.9834468105468028,1.0,20/109,19.70%,NFATC2;FOS;PSMD11;SHC1;PSMD4;PSMF1;TAB3;JUN;MAPK9;PSMD7;FCER1G;PSMB5;CHUK;IKBKG;PSMD1;TAB2;PRKCQ;PSMC4;PSMD8;MAP3K1
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.2580326466913573,0.7213682393006774,0.8511166253101737,0.9840929352761697,1.0,15/58,19.88%,MRE11;RIF1;MDC1;NSMCE2;ABRAXAS1;PAXX;UBE2N;PRPF19;DCLRE1C;LIG3;NBN;RAD50;ZBTB7A;UVRAG;ERCC4
prerank,negative regulation of sequestering of calcium ion (GO:0051283),0.2962189890791121,0.7210461273360785,0.8016877637130801,0.984086460684864,1.0,1/24,0.49%,ITPR2
prerank,purine nucleotide biosynthetic process (GO:0006164),-0.2925407935652429,-0.7208625613260093,0.830423940149626,0.9641874117226177,1.0,2/12,6.48%,HPRT1;PRPSAP2
prerank,lipid transport (GO:0006869),0.2439428794251086,0.720425129588276,0.8769574944071589,0.9844848083167397,1.0,7/97,6.47%,SLCO2A1;LDLR;SLC10A5;ABCD1;PITPNC1;PRELID3B;SLC27A3
prerank,regulation of macrophage activation (GO:0043030),0.28933513977682446,0.7202898297740608,0.8231292517006803,0.9842379265265029,1.0,5/30,11.15%,CD200;ZC3H12A;LBP;TLR6;TLR4
prerank,programmed necrotic cell death (GO:0097300),-0.25704314086855223,-0.7200329064647634,0.8226299694189603,0.9640930846097864,1.0,6/18,22.22%,ITPK1;PGAM5;RIPK1;IPMK;MLKL;CYLD
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.26150145330348884,0.7192336387451619,0.8608695652173913,0.9852291806773813,1.0,5/52,8.90%,CNOT6;SAMD4A;SAMD4B;LSM4;EXOSC3
prerank,amino sugar metabolic process (GO:0006040),0.34519604911949753,0.7191548270054843,0.7684729064039408,0.9848915208022396,1.0,1/10,1.52%,B4GALNT2
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),0.2968818541499877,0.7189782644098847,0.8130311614730878,0.9846925079184161,1.0,8/25,19.73%,NIBAN2;DOT1L;TWIST1;GATA3;POU4F1;PARK7;ZBTB7A;RB1
prerank,spindle assembly (GO:0051225),0.2539163001809533,0.7188000680038914,0.861904761904762,0.9845089870118505,1.0,13/67,18.91%,MAPRE2;NEK7;KIF2A;HDAC3;NCOR1;RHOA;ABRAXAS1;FLNA;CHEK2;NUMA1;AAAS;MISP;TUBGCP5
prerank,sulfur compound catabolic process (GO:0044273),0.27583165047074076,0.7187512727968227,0.8383311603650587,0.9841384075286373,1.0,7/38,13.96%,HEXA;PRELP;GLB1;ARSB;HEXB;ADO;TXN2
prerank,"synaptic transmission, cholinergic (GO:0007271)",-0.24680577789671668,-0.7183909696239869,0.8459119496855346,0.9650528478941119,1.0,12/19,50.29%,CHRNB1;SLC5A7;CHRNA4;CHRNB2;ACHE;COLQ;CHRNA5;CHRNA3;CHRNE;CHRNB4;CHRNB3;APOE
prerank,tRNA wobble base modification (GO:0002097),0.3173159240481087,0.7183834584618914,0.7996918335901386,0.9841931489930602,1.0,5/14,23.35%,MOCS3;ELP4;CTU1;CTU2;URM1
prerank,positive regulation of cholesterol efflux (GO:0010875),0.29985379715937144,0.7182540583567867,0.8359941944847605,0.9839388511768297,1.0,2/21,5.36%,CAV1;NFKBIA
prerank,response to interleukin-1 (GO:0070555),0.25153068926469063,0.7182387786097901,0.8857479387514723,0.9835266358686534,1.0,6/73,6.28%,CCL5;ADAMTS7;ZC3H12A;HDAC4;USP10;SOX9
prerank,regulation of interleukin-8 production (GO:0032677),0.2546880826433958,0.7175967025753663,0.8854415274463007,0.9839780626211476,1.0,7/69,11.15%,KLF4;MAVS;ANXA4;OTUD7B;LBP;TLR6;TLR4
prerank,regulation of G0 to G1 transition (GO:0070316),-0.2088282752857575,-0.7174347056146846,0.9153846153846154,0.9651225470914484,1.0,14/38,27.47%,DAB2IP;PHC3;SUZ12;EZH2;CBX3;YAF2;FOXO4;RYBP;RNF2;RAD51;TFDP2;BRCA1;CHEK1;PHC1
prerank,early endosome to Golgi transport (GO:0034498),-0.29302805839581375,-0.7174303535123285,0.8211382113821138,0.9641277401399976,1.0,4/11,18.70%,EHD3;STX5;SURF4;RBSN
prerank,positive regulation of T cell activation (GO:0050870),0.25169411454762836,0.7171264960888026,0.8733087330873309,0.9842156592476967,1.0,4/62,4.97%,CCL5;IL15;CD81;FLOT2
prerank,protein lipidation (GO:0006497),0.2582302632049514,0.7168615192702504,0.838479809976247,0.9841563780528179,1.0,13/59,21.36%,GLUL;PIGU;ZDHHC12;PIGZ;PGAP2;PIGA;DPM2;PIGN;PIGP;PIGQ;GPLD1;ZDHHC3;ZDHHC13
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.30467201636920377,0.7164712067366557,0.7896341463414634,0.984258064980309,1.0,4/18,14.36%,MUL1;ZNF205;GSK3A;GSK3B
prerank,positive regulation of interleukin-4 production (GO:0032753),0.3135168387328461,0.7162931345411222,0.8035982008995503,0.9840719714754582,1.0,5/17,18.35%,FCER1G;GATA3;PRKCZ;PRKCQ;RARA
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.2494352124295698,0.7162840771623238,0.8760139049826188,0.9836503247423009,1.0,25/80,25.99%,KIF2A;ERGIC1;COPA;KIF1C;GOLPH3;ERGIC2;ZW10;ATP9A;KLC1;ERGIC3;NAPA;ARF4;RAB1B;NSF;COPG1;UVRAG;ARFGAP2;GOLPH3L;KLC2;DNAJC28;TAPBP;RACGAP1;RER1;ARF5;KIF5A
prerank,protein K48-linked deubiquitination (GO:0071108),0.2973041038131641,0.7160286850747623,0.8124098124098124,0.9835574249483747,1.0,3/23,9.93%,MINDY2;OTUD7B;USP20
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.33398280993066287,0.7159707263661967,0.7788018433179723,0.983202977184742,1.0,3/12,14.55%,ZC3H12A;NCOR1;NCOR2
prerank,regulation of endothelial cell apoptotic process (GO:2000351),0.2749897126831692,0.7152181951627085,0.849476439790576,0.9837217160787816,1.0,6/39,12.94%,ANGPT1;NFE2L2;MAPK7;KRIT1;ANO6;GATA3
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.22469372111057315,0.7146547203621108,0.9260823653643083,0.9840508011610829,1.0,26/184,18.57%,FZR1;PSMD11;PSMD4;PSMF1;PKD1;CEP76;FBXO5;PTPN6;PSMD7;PAFAH1B1;ZW10;CSNK1E;PSMB5;ANAPC4;CDK2;HSP90AA1;DDB1;RPS27A;UBC;E2F1;ERCC2;DYNC1H1;PSMD1;PSMC4;ODF2;SFI1
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),-0.24139697605913385,-0.7146370421748847,0.8705882352941177,0.9661846155302025,1.0,11/20,30.57%,NR2F2;APC;IPO5;MYOCD;HHEX;INCA1;CDKN1B;PTEN;CEBPA;HEXIM2;CDKN1C
prerank,positive regulation of cell communication (GO:0010647),-0.22801407620652192,-0.714322292734334,0.8860294117647058,0.9655044690796394,1.0,10/28,23.00%,GRIK2;LGI1;SYT1;CLSTN2;EDN1;SOX11;EDN3;KCTD13;RIMS1;RIMS3
prerank,positive regulation of endocytosis (GO:0045807),0.26559969839887515,0.7142843714960163,0.8369704749679076,0.9840844016550712,1.0,6/45,12.23%,CLU;CBLL1;GPC3;CDC42;TOR1A;ANO6
prerank,Fc receptor signaling pathway (GO:0038093),0.23460165030873242,0.7140682925834316,0.8984198645598194,0.9839306764397323,1.0,20/110,19.70%,NFATC2;FOS;PSMD11;SHC1;PSMD4;PSMF1;TAB3;JUN;MAPK9;PSMD7;FCER1G;PSMB5;CHUK;IKBKG;PSMD1;TAB2;PRKCQ;PSMC4;PSMD8;MAP3K1
prerank,regulation of B cell differentiation (GO:0045577),-0.25487400500321394,-0.7138832037989264,0.8571428571428571,0.9649382521810652,1.0,8/17,37.91%,ID2;NCKAP1L;CD27;BTK;XBP1;IL4I1;PPP2R3C;IKZF3
prerank,muscle cell migration (GO:0014812),0.35013708454445513,0.7136335878460968,0.7993079584775087,0.9840615994770721,1.0,4/10,14.84%,SIX1;DDR1;AAMP;ITGB1BP1
prerank,regulation of lymphocyte proliferation (GO:0050670),-0.26277614533634874,-0.7135318234844036,0.8609625668449198,0.9643437935894392,1.0,14/16,51.46%,TNFRSF1B;SOX11;AHR;TNFSF8;IL27;LST1;PTPN22;IKZF3;IL12A;CD22;TNFSF9;FGF10;IL12B;TNFSF18
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),0.3334427106989317,0.7126456201901591,0.8066561014263075,0.9849183617114109,1.0,2/13,10.39%,CD81;BCAP31
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.28009871951037435,0.7123624975114108,0.8454172366621067,0.9848391206134799,1.0,6/29,18.22%,CNOT6;LSM4;EXOSC3;DCP1A;PATL1;HBS1L
prerank,regulation of intracellular transport (GO:0032386),0.26867584533643923,0.7118789738108569,0.8535620052770448,0.9850332451003291,1.0,7/38,17.62%,NDEL1;LAMP1;CRYAB;ATP9A;DYNC1H1;NUMA1;AAAS
prerank,natural killer cell activation (GO:0030101),0.3008540840325592,0.7115915795417433,0.8262108262108262,0.9849835088148643,1.0,1/23,1.28%,PBX1
prerank,negative regulation of bone remodeling (GO:0046851),-0.2905606464817611,-0.7111491024827014,0.8475452196382429,0.9660089014944413,1.0,4/11,25.42%,UBASH3B;TNFAIP3;GREM1;CALCA
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.2767618265775987,0.711115194074888,0.835781041388518,0.9851535627031078,1.0,2/34,4.18%,SASH3;CLCF1
prerank,regulation of establishment of endothelial barrier (GO:1903140),0.3109962481096484,0.7108380342362891,0.812778603268945,0.9850886540465782,1.0,8/17,25.34%,ADD1;TNFRSF1A;VCL;CDH5;ROCK2;IKBKB;PPP1R12A;F11R
prerank,positive regulation of myeloid cell differentiation (GO:0045639),0.2720256782928797,0.7104210088508359,0.8498659517426274,0.9851801323003885,1.0,8/33,17.41%,FAM210B;FOXO3;HOXA5;RAB7B;BRD1;MTURN;PRMT1;PITHD1
prerank,cellular response to interleukin-1 (GO:0071347),0.22824040776119905,0.7103736812289689,0.9210526315789473,0.9848118340217417,1.0,27/143,18.10%,MAP3K8;CCL5;ADAMTS7;ZC3H12A;NFKBIA;PSMD11;USP10;SOX9;PSMD4;PSMF1;TAB3;RBX1;PSMD7;IL1R2;PSMB5;PELI1;IRAK1;SFRP1;CHUK;IKBKG;UBE2N;RPS27A;UBC;PSMD1;TAB2;MAP3K3;PSMC4
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.24373686155626645,0.7103609877776377,0.8905704307334109,0.9844014545012252,1.0,17/83,16.70%,CDKN1A;CDK6;USP29;CDK4;CDK16;PLK3;LATS1;FBXO5;EIF4EBP1;CCND1;CDK18;CDK2;MYC;PLK2;PCNA;E2F1;HINFP
prerank,NIK/NF-kappaB signaling (GO:0038061),0.2445474264274078,0.7102867552315455,0.8978622327790974,0.9840653865848668,1.0,16/72,20.84%,RELB;PSMD11;PSMD4;PSMF1;TNFRSF10B;TLR6;PSMD7;PSMB5;IRAK1;CHUK;TLR3;PSMD1;PSMC4;NFKB2;PSMD8;ZFP91
prerank,pyroptosis (GO:0070269),-0.2687551495549167,-0.7100180290937668,0.8595505617977528,0.9662207300833279,1.0,3/15,11.65%,AIM2;GSDMD;CASP4
prerank,negative regulation of translational initiation (GO:0045947),0.3275487238095295,0.7098291334138029,0.8111111111111111,0.9842323699729312,1.0,4/13,22.76%,EIF4EBP1;EIF2AK4;EIF4EBP2;TPR
prerank,cellular response to topologically incorrect protein (GO:0035967),0.277163355070673,0.7095171869322251,0.8408450704225352,0.9841844509846549,1.0,4/31,9.27%,DAXX;HSPB8;HSPA14;BAG3
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),0.343941587294454,0.7091501332801154,0.7924217462932455,0.9837852303538535,1.0,3/10,14.70%,TNFRSF1A;SMPD2;PLA2G6
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),0.343941587294454,0.7091501332801154,0.7924217462932455,0.9837852303538535,1.0,3/10,14.70%,TNFRSF1A;SMPD2;PLA2G6
prerank,peptidyl-arginine modification (GO:0018195),-0.2698331707141967,-0.708771703007109,0.8735955056179775,0.96658816128472,1.0,3/15,20.05%,ART3;PADI2;KRTCAP2
prerank,regulation of adaptive immune response (GO:0002819),0.30689466705808166,0.7086478795331643,0.8105263157894737,0.9840241133633175,1.0,1/18,2.07%,SASH3
prerank,regulation of early endosome to late endosome transport (GO:2000641),0.307501442545971,0.7081613692115899,0.8146487294469357,0.9842403585217506,1.0,5/18,12.17%,MSN;MAP2K2;EZR;VPS11;SNX12
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),0.3384572218291939,0.7077974700568213,0.7870216306156406,0.9842925714554936,1.0,1/11,2.65%,CAV1
prerank,negative regulation of receptor internalization (GO:0002091),0.33305821604705926,0.7076325808094609,0.7961165048543689,0.9840762365285192,1.0,7/12,28.30%,RIN3;NECAB2;WDR54;DLG4;UBQLN2;ANKRD13D;ANKRD13B
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.2466256447602963,0.7076090935972819,0.8588374851720048,0.9836838932715238,1.0,15/70,18.34%,CYFIP2;NCKIPSD;CDC42;ACTB;MYO1C;ABI1;ACTG1;DOCK1;WIPF2;PLA2G6;HSP90AA1;CRK;ABL1;ARPC2;YES1
prerank,positive regulation of mitochondrial translation (GO:0070131),-0.27190783312989325,-0.7075751372232547,0.8412698412698413,0.9669077573585309,1.0,7/14,32.51%,RPUSD4;FASTKD2;TRMT10C;FASTKD3;RMND1;MPV17L2;COA3
prerank,diacylglycerol metabolic process (GO:0046339),0.2958028660432829,0.7075294513281011,0.797037037037037,0.9833603568416198,1.0,5/23,11.59%,DGAT1;MOGAT1;ANG;DGKA;GPAM
prerank,protein processing (GO:0016485),0.23846384765391218,0.7066796574648225,0.8955732122587968,0.9840494567934662,1.0,24/102,21.14%,OGT;ADAM10;PRSS12;KLKB1;CPE;SRGN;AFG3L2;PITRM1;SDE2;KLK1;HP;HPR;SPCS3;CTSH;HM13;BACE1;SEC11A;PIDD1;SPPL3;SPG7;ADAM17;STOML2;APH1A;MMP14
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),0.33054261995636636,0.7066224407851368,0.8196994991652755,0.9836954953258037,1.0,6/12,28.67%,HUS1B;TOPBP1;CHEK2;STK33;SETMAR;CDC6
prerank,regulation of cellular localization (GO:0060341),0.26155883708581995,0.7066019206675618,0.8419721871049305,0.9832966846726953,1.0,12/46,17.60%,GSN;UNC13D;EFNA5;CDK16;DVL3;PARD6B;CSNK1E;HSP90AA1;MAD1L1;KDM1A;DYNC1H1;NUMA1
prerank,urogenital system development (GO:0001655),-0.2833030869507697,-0.7063791528392672,0.8377659574468085,0.9672287853301806,1.0,4/11,23.87%,EPHB2;EPHB3;PAX8;PAX2
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),0.3167119152012272,0.70539548966287,0.8155802861685215,0.9844048967908351,1.0,4/15,16.81%,PTK2B;TXK;DDR1;ABL1
prerank,lipid translocation (GO:0034204),0.29849388589128256,0.7048135967496059,0.827536231884058,0.984748610520416,1.0,3/21,10.93%,ATP10A;ATP8B2;ATP9A
prerank,positive regulation of macrophage activation (GO:0043032),-0.2593659647058918,-0.7045694472453267,0.8746355685131195,0.9681536373725852,1.0,5/17,19.45%,WNT5A;THBS1;IL33;TTBK1;HSPD1
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.32259965534674945,0.7044396804390317,0.8330683624801272,0.9848081318101483,1.0,3/13,15.91%,NIBAN2;NEDD4;CNMD
prerank,protein import into nucleus (GO:0006606),0.2469647523747226,0.7043687151745762,0.8789731051344744,0.984474355118863,1.0,15/66,18.15%,KPNA7;IPO7;TSC2;NUP93;TNPO2;KPNA4;MMP12;TNPO1;NXT2;RANBP6;HEATR3;IPO4;KPNA1;CSE1L;PPP1R10
prerank,response to growth factor (GO:0070848),0.26454560388016474,0.7039222020743594,0.8611825192802056,0.984614189437215,1.0,9/41,17.76%,KLF4;SHC1;MAPK7;TGFBR2;MYC;SFRP1;LRP2;HDAC6;BMPR1A
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.30123217662188506,0.7035854520749563,0.8163265306122449,0.9846093509712239,1.0,2/18,4.97%,PMAIP1;TMEM259
prerank,striated muscle contraction (GO:0006941),0.2584804566469935,0.7035392292279635,0.8467243510506799,0.9842417915430072,1.0,9/53,15.15%,ATP1A2;CSRP3;STAC3;LMOD3;GRK2;MYL4;ALDOA;CCDC78;TNNI3
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.2836245506017796,0.7035054201077616,0.8486111111111111,0.9838629776320663,1.0,6/26,18.35%,CDK6;TLR4;PTPN2;MYC;TLR3;RARA
prerank,neuron projection organization (GO:0106027),-0.253719767581613,-0.7031787087188558,0.8785310734463276,0.9686489822016117,1.0,4/15,15.91%,INSR;PLS1;ABCD2;MAP1A
prerank,macroautophagy (GO:0016236),0.23061238116849356,0.7025354063097505,0.9262926292629263,0.9846963875162675,1.0,31/118,20.47%,PRKAA2;VPS37B;RUBCNL;TOMM5;CHMP4A;CHMP4B;MTMR3;PLEKHM1;VPS4B;VTI1B;TOMM20;VIPAS39;VDAC1;VPS4A;VAMP7;ULK1;MAP1LC3B;CHMP2A;RB1CC1;ATG4B;PRKAG1;ZFYVE1;STAM;TSG101;ILRUN;VPS37A;UVRAG;PRKAB1;TOMM40;PRKAB2;PIK3R4
prerank,response to ionizing radiation (GO:0010212),0.24507019915473963,0.7023531575852062,0.893719806763285,0.9844859863838877,1.0,10/70,13.47%,CDKN1A;KDM4D;NABP2;EYA1;INIP;COP1;TOPBP1;ABRAXAS1;EEF1D;MYC
prerank,positive regulation of vacuole organization (GO:0044090),-0.2968621592655056,-0.7020212651304863,0.8325471698113207,0.9688588790787,1.0,5/10,22.21%,PIP4K2A;SH3GLB1;PIP4K2B;RALB;RAB3GAP1
prerank,ncRNA export from nucleus (GO:0097064),-0.20778199723081336,-0.7013604674092545,0.9504132231404959,0.9685635561672021,1.0,12/36,23.28%,TSC1;NUP85;NUP54;RAN;NUP210;NUP214;XPOT;NUP88;NUP188;NUP37;PHAX;NUP205
prerank,cardiac muscle contraction (GO:0060048),0.2774823902182909,0.7011817867261209,0.8421052631578947,0.9855666591548474,1.0,5/34,11.42%,GSN;ATP1A2;CSRP3;GRK2;MYL4
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.2801528750878414,0.701049559647192,0.8399452804377565,0.9853038692775861,1.0,4/30,7.60%,TRIM33;TWSG1;LTBP4;LATS1
prerank,response to hydroxyurea (GO:0072710),-0.2873939752787116,-0.7010294280702102,0.8224543080939948,0.967890374469963,1.0,4/11,19.48%,KAT7;BLM;SPIDR;FMR1
prerank,negative regulation of receptor binding (GO:1900121),0.3369447108926828,0.7005443041854581,0.7990033222591362,0.9855343820495127,1.0,2/10,10.44%,PTPRF;ADAM15
prerank,pattern recognition receptor signaling pathway (GO:0002221),0.25512035466576743,0.7004658352916937,0.864321608040201,0.9852072851247041,1.0,20/56,25.98%,TAB3;LBP;TLR6;CNPY3;TLR4;S100A1;IRAK1;TLR3;RPS27A;UBC;MAPKAPK2;TAB2;SFTPA1;SFTPA2;IRAK4;CTSK;TLR1;TLR5;LY96;TAB1
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.23497863175441686,0.70011410532193,0.8934707903780069,0.9852099015203477,1.0,19/88,18.46%,CLU;PIH1D1;SDC4;LGALS3;RAB7A;MTLN;VPS4B;AJUBA;HRK;VPS4A;TRABD2B;GSK3B;CHMP2A;PFN2;CDH5;PDCD6IP;STAM;TSG101;PARK7
prerank,cellular senescence (GO:0090398),0.27541176432514763,0.6999655750757126,0.8363892806770099,0.984977613107978,1.0,6/27,16.91%,CDKN1A;PML;NSMCE2;OPA1;HRAS;SMC6
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.2975296403068071,0.6996013184217654,0.8350668647845468,0.9850136250210695,1.0,4/20,9.74%,CCND2;PSRC1;PKD1;CCND1
prerank,negative regulation of peptide hormone secretion (GO:0090278),0.30578640060598233,0.699501346145149,0.8357771260997068,0.9847171841640087,1.0,9/18,32.96%,KCNB1;SFRP1;SIRT4;BMP8A;CHGA;PRKN;PSMD9;REST;MIDN
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.25214175320839377,0.6992828599396947,0.888748419721871,0.9845591985223202,1.0,11/56,14.38%,LSM10;CDK4;CCND2;FBXO5;ADAMTS1;CCND1;ANKRD17;VPS4B;NSMCE2;ANAPC4;EIF4G1
prerank,purine-containing compound salvage (GO:0043101),-0.2792283921229401,-0.6988974409317892,0.8480662983425414,0.9691785447611748,1.0,4/12,12.80%,HPRT1;AMPD3;PNP;DCK
prerank,response to interferon-gamma (GO:0034341),0.24602560995738773,0.6985906037607303,0.8852071005917159,0.9849735274956951,1.0,6/67,7.37%,CCL5;EPRS1;DAPK3;DAPK1;NUB1;TRIM21
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.2865632647995823,0.6983304123039306,0.828080229226361,0.9848739541038058,1.0,3/24,6.85%,SESN2;NFE2L2;MAPK7
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),0.27927689548741497,0.6979696037235162,0.8469945355191257,0.9848809654441725,1.0,10/29,24.31%,COPA;VTI1B;NAPA;COG8;RAB33B;NSF;COPG1;VTI1A;GOSR1;GABARAPL2
prerank,hexose metabolic process (GO:0019318),0.2647391506717319,0.69692335207928,0.8635135135135135,0.9857340655655165,1.0,8/39,15.07%,SLC35A2;HECTD4;HK1;IRS2;FUOM;ALDOA;DCXR;GALK2
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),-0.2754316884008187,-0.6968574682108899,0.8661417322834646,0.9702492955096488,1.0,6/12,29.43%,STX2;SNAP25;STX1B;SNAP29;STX19;STX1A
prerank,T cell differentiation (GO:0030217),0.264262288777065,0.6967989435797693,0.8622516556291391,0.9854814922636205,1.0,9/40,15.36%,GLI3;FCER1G;RABL3;PTPN2;GATA3;LMBR1L;GPR89B;GPR89A;MR1
prerank,rRNA methylation (GO:0031167),0.2947279678242738,0.6948713029064981,0.8404099560761347,0.9873487309001593,1.0,2/22,4.72%,NOP2;BUD23
prerank,myeloid cell activation involved in immune response (GO:0002275),0.3090917271246738,0.6937046547676485,0.8134863701578192,0.988292814733998,1.0,4/18,13.15%,LBP;NMI;FCER1G;SBNO2
prerank,organophosphate biosynthetic process (GO:0090407),0.2658651848766684,0.6934380531502509,0.8604026845637583,0.98817847487865,1.0,8/37,16.09%,MOCS3;IP6K1;PPIP5K2;NFS1;FADS1;GPAM;IP6K2;TPI1
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),0.32244930934646715,0.6929182216887861,0.8222222222222222,0.9883722891142362,1.0,5/14,20.84%,TNFRSF10B;TLR6;IRAK1;TLR3;ZFP91
prerank,nucleoside phosphate biosynthetic process (GO:1901293),0.3157691696710949,0.6929098198751372,0.8330683624801272,0.9879619804889204,1.0,3/14,10.00%,CMPK1;AK5;AK3
prerank,aromatic amino acid family catabolic process (GO:0009074),0.30502265349383934,0.6923558295005761,0.819620253164557,0.9881973268151525,1.0,4/15,24.54%,TDO2;HAAO;KYAT1;KMO
prerank,positive regulation of collagen biosynthetic process (GO:0032967),0.30645598883275427,0.6917422644030266,0.8448540706605223,0.9885317727871714,1.0,2/16,6.81%,VIM;BMP4
prerank,polyol biosynthetic process (GO:0046173),0.2988005744552623,0.6911774717028067,0.8169642857142857,0.9887717653833386,1.0,3/16,15.85%,IP6K1;PPIP5K2;IP6K2
prerank,synaptonemal complex organization (GO:0070193),0.3114369928621078,0.6909096508730305,0.8368263473053892,0.9882594012223561,1.0,1/15,6.12%,SYCP2
prerank,synaptonemal complex assembly (GO:0007130),0.3114369928621078,0.6909096508730305,0.8368263473053892,0.9882594012223561,1.0,1/15,6.12%,SYCP2
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.2643983764378355,-0.6906859846566953,0.8715083798882681,0.9753085764166587,1.0,9/15,35.14%,RPL11;DTX3L;BAG5;BAG2;MAD2L1;LIMK1;SMAD7;RPS7;MAD2L2
prerank,glycerophospholipid metabolic process (GO:0006650),0.24202728367488524,0.690498347017235,0.9036427732079906,0.9883187333004962,1.0,18/75,19.58%,PLCB3;SERINC5;AGK;PIGZ;PAFAH1B1;PIGA;PIGX;DPM2;PGP;PLA2G6;PLCD1;PIGN;ABHD6;SERINC1;PIGP;PIGQ;GPLD1;SMPD4
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),0.2812608748939844,0.690311072778531,0.8196480938416423,0.9881205526120832,1.0,11/24,25.81%,BCAP31;FCER1G;SEC23A;ABCB9;CANX;SEC24B;IDE;SEC31A;SEC24D;TAPBP;HFE
prerank,positive regulation of cytokinesis (GO:0032467),0.2694778062993764,0.6901247189162351,0.8547717842323651,0.9879238104919107,1.0,7/32,20.17%,PKP4;CDC42;AURKC;RHOA;CDC25B;KIF20B;CSPP1
prerank,lipid catabolic process (GO:0016042),0.30023193842035445,0.6900605600802004,0.8424962852897474,0.9875859213394781,1.0,2/18,7.49%,HSD17B14;ACADL
prerank,regulation of stem cell proliferation (GO:0072091),-0.24591192886507632,-0.6900288670132201,0.9073033707865169,0.9749719366996641,1.0,4/17,20.30%,ACE;HMGA2;SOX11;YAP1
prerank,NAD biosynthetic process (GO:0009435),-0.23418154183703502,-0.6896838873023677,0.8987341772151899,0.9743370310747312,1.0,6/20,24.80%,PTGIS;PTGS2;NAXE;QPRT;NAXD;NAMPT
prerank,kinetochore organization (GO:0051383),0.3218312463825341,0.6892196441395627,0.8314424635332253,0.9881757771764322,1.0,4/13,25.00%,CENPT;CENPH;CENPF;MIS12
prerank,determination of left/right symmetry (GO:0007368),-0.1993872005284333,-0.6890828605914265,0.9458333333333333,0.9739080284449049,1.0,10/36,18.26%,NOTCH1;PKD2;MEGF8;RFX3;NPHP3;ZIC3;TBX1;BBS7;DNAH11;KIF3B
prerank,positive regulation of mitochondrial fission (GO:0090141),0.3019268097098561,0.6887781383077786,0.8348214285714286,0.9882751787352738,1.0,5/18,15.12%,MCU;MUL1;MIEF2;DNM1L;DDHD1
prerank,regulation of centrosome cycle (GO:0046605),0.28796238434784094,0.6886914138676821,0.8343023255813954,0.9879494026710112,1.0,6/21,17.64%,CHMP4B;VPS4B;MARK4;CHMP1A;CHMP2A;PDCD6IP
prerank,protein modification process (GO:0036211),-0.17216698480571832,-0.6879868710248795,0.9733333333333334,0.9740105173686254,1.0,11/76,12.29%,PLOD2;ST3GAL1;ST8SIA4;MSRA;SERP1;CHRM3;UBE2S;ABL2;ARAF;MAN2B1;LOX
prerank,response to hexose (GO:0009746),0.27868481894929686,0.6874024487123619,0.8614285714285714,0.9890633685731116,1.0,6/25,21.68%,EIF2B2;TCF7L2;IRS2;EIF2B4;GPLD1;VAMP2
prerank,ether lipid biosynthetic process (GO:0008611),0.3320672344955575,0.68703161188951,0.8197278911564626,0.9891048475551254,1.0,3/10,12.14%,DHRS7B;LPCAT2;CHPT1
prerank,macrophage activation involved in immune response (GO:0002281),0.3183814058771258,0.6868264784063808,0.8226059654631083,0.9889259970290838,1.0,3/13,13.15%,LBP;NMI;SBNO2
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.2371780978245575,0.6867506653750887,0.9003516998827668,0.9885827804005821,1.0,22/78,24.77%,CDKN1A;IPO7;CCND2;LATS1;PSRC1;PKD1;CDK5RAP1;ACTB;CCND1;PKMYT1;SERTAD1;HEXIM1;CCNG1;CDKN2D;CDK5RAP3;ADAM17;CDK5R1;MEN1;LATS2;GTPBP4;CDC25A;MNAT1
prerank,negative regulation of mitotic cell cycle (GO:0045930),-0.19532393447762844,-0.6866135749427841,0.9592760180995475,0.974319054582027,1.0,14/45,22.93%,BRINP3;RGCC;TGFB1;BTG1;PTPN3;PRCC;TOM1L1;SMAD3;BRINP2;ZWILCH;GAS1;BMP7;CDKN1B;MAD2L1
prerank,regulation of gene silencing by RNA (GO:0060966),0.2524664425981761,0.686443143861344,0.8951911220715166,0.9881092260633727,1.0,22/50,28.98%,POLR2H;POLR2A;NUP93;NDC1;EIF4G1;AAAS;POLR2C;H3-3A;RAE1;POLR2E;POM121;TPR;RANBP2;NUP42;POLR2K;NUP62;SEH1L;NUP133;IPO8;TRIM71;NUP35;PUM2
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.2524664425981761,0.686443143861344,0.8951911220715166,0.9881092260633727,1.0,22/50,28.98%,POLR2H;POLR2A;NUP93;NDC1;EIF4G1;AAAS;POLR2C;H3-3A;RAE1;POLR2E;POM121;TPR;RANBP2;NUP42;POLR2K;NUP62;SEH1L;NUP133;IPO8;TRIM71;NUP35;PUM2
prerank,protein O-linked glycosylation (GO:0006493),0.23349720997481754,0.68600494060981,0.919683257918552,0.988192730603203,1.0,6/96,4.29%,ST3GAL4;OGT;B4GAT1;TMTC1;GALNT1;LARGE1
prerank,positive regulation of ATPase activity (GO:0032781),-0.19502355208979316,-0.6857314896050645,0.957983193277311,0.974131421800864,1.0,11/41,24.18%,ATP1B1;MSH3;VMP1;PLSCR1;RYR2;DNAJB2;TNNT3;DYNLL2;DNAL4;DNAJB1;AHSA1
prerank,peptidyl-lysine dimethylation (GO:0018027),0.29490332210637604,0.6853895751492065,0.8370702541106129,0.9885107315854292,1.0,7/18,28.64%,KMT2A;SETD7;KMT2B;SMYD2;EHMT1;EEF1AKMT2;SETMAR
prerank,female gamete generation (GO:0007292),0.2725023626114396,0.6846842570104487,0.8472775564409031,0.9888802398708902,1.0,4/29,15.44%,DIAPH2;TOB2;PTN;MCM8
prerank,response to metal ion (GO:0010038),0.24210829891866045,0.6844229256980535,0.8965116279069767,0.9887697581114813,1.0,13/67,17.53%,NDRG1;CAV1;PEF1;PPP2CA;AHCYL1;ITPR3;NEDD4;SLC25A12;HVCN1;SNCB;PPP2CB;HAAO;SLC11A2
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),0.3308501645675528,0.6840281594686153,0.821656050955414,0.9887998474068821,1.0,4/11,18.39%,AJUBA;FXR1;DHX9;WTIP
prerank,regulation of receptor recycling (GO:0001919),0.3023019337207828,0.6838094112706844,0.8427672955974843,0.9886604845233005,1.0,2/16,6.89%,TBC1D16;ANXA2
prerank,ganglion development (GO:0061548),0.3246148127902365,0.6835876698419834,0.8278688524590164,0.9885014883504232,1.0,2/11,17.94%,NRP2;SEMA3A
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),0.27705033074376695,0.6833993292262498,0.8623978201634878,0.9883006206714305,1.0,10/25,28.30%,UNC119;ABCA2;RIN3;APP;WDR54;DLG4;UBQLN2;PSEN1;ANKRD13D;ANKRD13B
prerank,peptidyl-threonine modification (GO:0018210),0.24010892356763097,0.6833797467629916,0.8968824940047961,0.9879025785215556,1.0,23/66,25.19%,CDK10;GALNT1;STK39;DYRK1B;OXSR1;LMTK2;TGFBR2;GSK3A;ULK1;GSK3B;WNK1;CDC42BPA;GALNT11;ROCK2;PRKD2;CDC42BPG;CDK5R1;CDC42BPB;MAP3K12;PRKCA;MAP3K10;GALNT3;PDPK1
prerank,C-terminal protein amino acid modification (GO:0018410),0.3271686361209594,0.683063352588159,0.8311688311688312,0.9878742118215421,1.0,2/11,7.95%,AGTPBP1;AGBL1
prerank,response to leucine (GO:0043201),-0.27860175787495234,-0.6827999406899405,0.8556701030927835,0.9748676971393616,1.0,3/10,15.29%,UBR1;KLHL22;RRAGD
prerank,cellular response to leucine (GO:0071233),-0.27860175787495234,-0.6827999406899405,0.8556701030927835,0.9748676971393616,1.0,3/10,15.29%,UBR1;KLHL22;RRAGD
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.27338845984245025,0.6807949507190285,0.859481582537517,0.9900840444413435,1.0,6/26,18.46%,NFE2L2;HSPB1;MAPK7;SOD2;VNN1;PARK7
prerank,interleukin-1-mediated signaling pathway (GO:0070498),0.22768732836525454,0.6807455577638033,0.9301260022909508,0.9897155275863978,1.0,23/94,19.49%,MAP3K8;NFKBIA;PSMD11;PSMD4;PSMF1;TAB3;RBX1;PSMD7;IL1R2;PSMB5;PELI1;IRAK1;CHUK;IKBKG;UBE2N;RPS27A;UBC;PSMD1;TAB2;MAP3K3;PSMC4;PSMD8;IRAK4
prerank,pre-replicative complex assembly (GO:0036388),0.2367357779655574,0.6806370248733455,0.8970588235294118,0.9894131316226846,1.0,15/64,21.60%,PSMD11;PSMD4;PSMF1;PSMD7;PSMB5;MCM8;MCM6;RPS27A;UBC;MCM7;PSMD1;PSMC4;PSMD8;ORC2;MCM4
prerank,positive regulation of collagen metabolic process (GO:0010714),0.2969506480317133,0.6804230532401366,0.8577844311377245,0.9892593152508141,1.0,2/17,6.81%,VIM;BMP4
prerank,potassium ion import across plasma membrane (GO:1990573),0.25618900240812387,0.6802927342001593,0.8909574468085106,0.9889837518684301,1.0,3/41,4.49%,SLC12A8;ATP1A2;KCNJ13
prerank,defense response to virus (GO:0051607),0.2282355481798386,0.6801208461976737,0.9296875,0.9887645187774877,1.0,8/100,6.43%,SERINC5;MAVS;PMAIP1;IRF3;BCL2L1;RNASEL;MOV10;NT5C3A
prerank,fluid transport (GO:0042044),-0.2728306527808037,-0.680075556691615,0.875,0.9763881590047847,1.0,3/12,17.69%,AQP11;AQP4;SLC26A6
prerank,negative regulation of synaptic transmission (GO:0050805),0.2821638534646928,0.6797719148899224,0.8553008595988538,0.9887275035325166,1.0,5/23,15.37%,TMEM25;STXBP1;SYT11;PLK2;PNKD
prerank,skeletal muscle contraction (GO:0003009),0.28787297296224856,0.6784777956168359,0.8492537313432836,0.9897651098391478,1.0,3/19,15.15%,STAC3;CCDC78;TNNI3
prerank,regulation of Golgi organization (GO:1903358),0.30115581992472684,0.6783357024057249,0.8462686567164179,0.9895056856665715,1.0,5/17,15.46%,MAP2K2;MYO5A;ARMH3;USP6NL;RAB33B
prerank,histone H2A monoubiquitination (GO:0035518),0.3017340815217723,0.6779905108934366,0.8466257668711656,0.9894830334419483,1.0,8/17,26.50%,PCGF6;PCGF3;PCGF2;DDB1;TRIM37;RNF168;RING1;BMI1
prerank,male gonad development (GO:0008584),0.2620636357453765,0.6776075799122939,0.8821192052980132,0.9895105319405327,1.0,5/34,12.94%,TFAP2C;SOX9;TGFB2;MAMLD1;GATA3
prerank,phospholipid translocation (GO:0045332),0.27103372842978285,0.6767499139717242,0.8651994497936726,0.9900616634539868,1.0,5/28,12.23%,ATP10A;ATP8B2;ATP9A;PLSCR3;ANO6
prerank,fibrinolysis (GO:0042730),-0.26417226442337877,-0.6763221466640322,0.8668407310704961,0.9788146434674256,1.0,13/13,73.61%,PLAU;HRG;PLG;SERPINB2;CPB2;GP1BA;F2;KRT1;FGG;SERPINF2;PLAUR;SERPINE1;PLAT
prerank,negative regulation of protein dephosphorylation (GO:0035308),0.28344995688671853,0.6762229639573653,0.8425655976676385,0.9902441736927157,1.0,6/21,15.10%,PPP1R15A;CRY2;YWHAB;PPP1R11;GSK3B;PPP1R1B
prerank,anterior/posterior axis specification (GO:0009948),0.3060654301604036,0.6757087454794922,0.8576,0.9903952378945297,1.0,2/15,8.36%,WLS;FZD5
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),0.27200395704052116,0.6745505871753903,0.8695652173913043,0.9912760358210537,1.0,4/26,11.07%,CYB5R3;DDAH2;CYB5B;ABCA2
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),0.23849209882777556,0.6739463188961115,0.921146953405018,0.9915315965363756,1.0,13/69,17.41%,RNF5;TRIM25;ERLIN2;UBE2G2;ERLIN1;USP19;RNF121;NPLOC4;RHBDD2;UBE4A;DNAJC10;STUB1;UBE2J1
prerank,response to lipid (GO:0033993),0.22519074628280195,0.6738078940190009,0.9204035874439462,0.9912760522518722,1.0,23/105,19.54%,SMAD6;SLPI;FOXO3;RARG;RXRB;SOX9;LBP;ABCA2;TLR4;SOCS2;VPS4B;PELI1;IRAK1;FOXP1;CTSH;F2R;MAPKAPK2;TAB2;TRIM16;PCK2;RARA;CDKN2D;ADAM17
prerank,regulation of cellular amino acid metabolic process (GO:0006521),0.23989454320299824,0.6736835001813511,0.8947368421052632,0.9909969793605806,1.0,9/53,19.45%,PSMD11;PSMD4;PSMF1;AZIN1;PSMD7;PSMB5;PSMD1;PSMC4;PSMD8
prerank,serine family amino acid catabolic process (GO:0009071),0.32708103663647714,0.6733917832212373,0.8283828382838284,0.9909042551390153,1.0,2/10,12.04%,SHMT1;AMT
prerank,nuclear body organization (GO:0030575),0.30833922752382315,0.6733580231528402,0.8552412645590682,0.9905227725198095,1.0,4/12,14.63%,PML;SRPK2;HABP4;ZPR1
prerank,regulation of DNA repair (GO:0006282),0.25480528612566045,0.6730999169358048,0.8983050847457628,0.9903895547270766,1.0,15/44,23.26%,EYA2;EYA1;PML;TIGAR;ABRAXAS1;UBR5;POLH;DHX9;PCNA;UBE2N;PARG;UBE2V1;SIRT7;RNF168;CDK9
prerank,regulation of erythrocyte differentiation (GO:0045646),0.2566951335588125,0.6728549210205598,0.8812415654520918,0.9902510424196778,1.0,4/35,6.12%,CDK6;FAM210B;FOXO3;HOXA5
prerank,regulation of collagen biosynthetic process (GO:0032965),0.2848426862730048,0.6726756063180591,0.8448275862068966,0.9900336689562192,1.0,2/19,6.81%,VIM;BMP4
prerank,regulation of cellular metabolic process (GO:0031323),0.2489297546626012,0.6713965741374808,0.904639175257732,0.9910438480864845,1.0,13/45,19.47%,TBC1D16;FOXM1;EIF6;ABCA2;PDK2;ACACA;MBOAT7;FASN;ARF4;NCOR2;STUB1;RNF41;FLOT1
prerank,regulation of interleukin-17 production (GO:0032660),0.26192862870927364,0.6713363419322772,0.885989010989011,0.9906959142640757,1.0,4/31,11.15%,IL15;ZBTB7B;FOXP3;TLR4
prerank,axonemal dynein complex assembly (GO:0070286),0.2682890967317416,0.6713320275817938,0.8700410396716827,0.9902884897391631,1.0,8/27,26.70%,LRRC49;ODAD3;DNAAF5;ODAD2;DNAH5;DRC1;SPAG1;DNAAF4
prerank,ERAD pathway (GO:0036503),0.23226568890302624,0.6712747000421257,0.9331026528258363,0.9899299572970613,1.0,16/83,17.41%,RNF5;TRIM25;ERLIN2;UBE2G2;ERLIN1;USP19;RNF121;GET4;TOR1A;NPLOC4;RHBDD2;UBE4A;DNAJC10;CCDC47;STUB1;UBE2J1
prerank,stem cell differentiation (GO:0048863),0.2548627539988831,0.6712069793543795,0.8793774319066148,0.9895953676742574,1.0,7/39,16.96%,MLLT3;PSMD11;TGFB2;LMBR1L;MEF2C;SFRP1;NELFB
prerank,monocarboxylic acid metabolic process (GO:0032787),0.22473606908112592,0.6710340603258617,0.9390919158361019,0.9893705189589482,1.0,17/117,11.91%,ADH7;HAGH;ME3;GAMT;LDHB;NPC1;ABAT;CPT1B;ACSL3;MSMO1;LDHAL6B;ALDH8A1;CKMT1A;ACSF3;GPAM;PCCA;FASN
prerank,positive regulation of DNA metabolic process (GO:0051054),0.24049770061758638,0.670534230949725,0.9034229828850856,0.9895234265531525,1.0,16/61,19.24%,EYA2;MRE11;EYA1;PARP3;ATRX;PML;TIGAR;ABRAXAS1;MYC;DHX9;PCNA;UBE2N;NBN;RAD50;PPP1R10;PRKD2
prerank,tRNA transport (GO:0051031),0.25934308062862294,0.6695070281369032,0.9086092715231788,0.9902628310235536,1.0,14/35,26.80%,NUP93;NDC1;TOMM20;NOL6;AAAS;RAE1;YBX1;POM121;TPR;RANBP2;NUP42;NUP62;SEH1L;NUP133
prerank,pancreas development (GO:0031016),-0.26403831615775786,-0.6695043218093114,0.8885793871866295,0.9837670319306092,1.0,5/12,29.27%,NPHP3;ZIC3;NKX6-1;CCDC39;FOXF1
prerank,positive regulation of binding (GO:0051099),0.2276563012719166,0.6692729156536441,0.9188876013904983,0.9900984453402665,1.0,9/84,8.41%,MMP9;CAV1;NGF;KDM4D;ADD1;BMP4;TRIM21;PKD1;TCF7L2
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.2822554259033414,0.6692044911888165,0.8379970544918999,0.9893492849211946,1.0,6/21,19.88%,RBX1;ERCC5;RPA3;DDB1;ERCC2;ERCC4
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.2822554259033414,0.6692044911888165,0.8379970544918999,0.9893492849211946,1.0,6/21,19.88%,RBX1;ERCC5;RPA3;DDB1;ERCC2;ERCC4
prerank,regulation of cellular ketone metabolic process (GO:0010565),0.23354395576416467,0.6691799556728862,0.9055900621118013,0.9889629711532846,1.0,12/61,19.45%,CAV1;PSMD11;PSMD4;PSMF1;AZIN1;PSMD7;PDK2;PSMB5;NCOR2;PSMD1;PSMC4;PSMD8
prerank,RNA polyadenylation (GO:0043631),0.2671991503750651,0.6690846816493827,0.8811881188118812,0.9882475089354046,1.0,9/26,23.49%,AHCYL1;WDR33;GRSF1;CLP1;APP;CSTF3;TUT1;PABPC1;LEO1
prerank,mRNA polyadenylation (GO:0006378),0.2671991503750651,0.6690846816493827,0.8811881188118812,0.9882475089354046,1.0,9/26,23.49%,AHCYL1;WDR33;GRSF1;CLP1;APP;CSTF3;TUT1;PABPC1;LEO1
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.29583850699992775,0.6689372564420459,0.8502340093603744,0.9879972108625625,1.0,4/14,18.46%,BCL2L1;CREB3;OPA1;PARK7
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.26808715227167157,0.6689361303803454,0.8529411764705882,0.9875873259238626,1.0,7/29,16.77%,RBX1;ERCC5;RPA3;DDB1;RPS27A;UBC;ERCC2
prerank,protein deneddylation (GO:0000338),0.32867161994466976,0.6684585885816826,0.8535773710482529,0.9877031928599116,1.0,2/10,12.29%,TOR1A;COPS5
prerank,retinal metabolic process (GO:0042574),0.3182897564745368,0.6679945352747885,0.8661290322580645,0.9877896716194171,1.0,2/12,9.57%,DHRS13;ALDH8A1
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),-0.19099394160672456,-0.6673964304532021,0.9684684684684685,0.9846205998110693,1.0,19/42,32.79%,SMCHD1;UBQLN4;PPP4C;SPIDR;MRNIP;FANCB;WDR48;CGAS;RMI2;ERCC6;RAD51;WRAP53;PARPBP;CHEK1;SIRT6;SHLD3;RTEL1;HELB;RAD51AP1
prerank,mRNA stabilization (GO:0048255),0.24993417287010128,0.6670720434286604,0.8996036988110965,0.9883470309508362,1.0,11/40,22.90%,GDNF;YBX3;SYNCRIP;BOLL;PAIP1;DHX9;E2F1;MAPKAPK2;IGF2BP1;YBX1;PABPC1
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.3209613988476583,0.6670057471928489,0.8464052287581699,0.9879982772953985,1.0,2/10,9.27%,JUN;BAG3
prerank,regulation of oxidoreductase activity (GO:0051341),0.31081516598282755,0.6669107935051136,0.8446909667194928,0.9876980226406552,1.0,5/13,21.95%,HP;ABL1;HDAC6;SIRT4;SZT2
prerank,regulation of lipid catabolic process (GO:0050994),0.29115074602741087,0.6660622694227022,0.872992700729927,0.9882061254315383,1.0,1/19,2.68%,ABCD1
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),0.3279619862756282,0.6657475021420447,0.8608695652173913,0.9881135349638217,1.0,1/10,2.27%,SYP
prerank,stem cell development (GO:0048864),-0.2480149708329656,-0.6654964145614657,0.868421052631579,0.9852811521083776,1.0,10/16,36.45%,CDH2;PDCD6;SOX11;NOLC1;KBTBD8;KLHL12;SNAI2;NRG1;SHH;WNT7A
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.2612362745438702,0.6643230282416003,0.8884297520661157,0.989179092180104,1.0,6/31,18.22%,CNOT6;LSM4;EXOSC3;DCP1A;PATL1;HBS1L
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),0.3083081002735505,0.6637444079639921,0.8456692913385827,0.9893782476495675,1.0,5/12,26.28%,UPP2;UMPS;UPP1;UCK2;UCKL1
prerank,N-acetylneuraminate metabolic process (GO:0006054),0.3181883236293146,0.6630278160158557,0.836038961038961,0.9896993644075354,1.0,4/10,22.88%,NAGK;GNE;GNPDA2;ST6GAL1
prerank,negative regulation of cell cycle process (GO:0010948),0.2327642249370687,0.6625821195942995,0.9227941176470589,0.9897489367149731,1.0,14/61,20.98%,PCGF6;MGA;BMP4;ZFYVE19;FBXO5;VPS4A;PCGF2;CHMP2A;E2F1;PPP1R10;WAPL;GPER1;TOM1L2;TERF2
prerank,protein deacetylation (GO:0006476),0.24733235274680576,0.6624892347701443,0.8983268983268984,0.9894373231039959,1.0,11/41,22.27%,HDAC5;HDAC4;MORF4L2;HDAC3;MIER2;FLNA;RCOR2;HDAC6;RCOR3;SIRT4;SIRT7
prerank,regulation of stress-activated MAPK cascade (GO:0032872),0.2438070796349628,0.6624344183012691,0.9069767441860465,0.9890795590426881,1.0,9/47,15.58%,QARS1;FOXM1;TGFB2;MAP2K2;ARL6IP5;COPS5;MYC;TGFBR3;IGBP1
prerank,vasodilation (GO:0042311),-0.26184794574357195,-0.662368708190837,0.8763440860215054,0.9868662480283183,1.0,3/13,18.91%,NOS3;KCNMA1;SOD1
prerank,phasic smooth muscle contraction (GO:0014821),0.31531196309485116,0.6616566963733456,0.8659127625201939,0.989472930759918,1.0,1/10,3.81%,GDNF
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.2725221934790963,0.6615541995722312,0.8602305475504323,0.9891716652835446,1.0,8/23,23.94%,MTMR12;MTMR3;INPP5B;OCRL;TPTE;PIP4P1;MTMR10;MTMR9
prerank,peptidyl-threonine phosphorylation (GO:0018107),0.23299415936170545,0.6592130507652169,0.9127272727272727,0.991184478766872,1.0,20/59,25.19%,CDK10;STK39;DYRK1B;OXSR1;LMTK2;TGFBR2;GSK3A;ULK1;GSK3B;WNK1;CDC42BPA;ROCK2;PRKD2;CDC42BPG;CDK5R1;CDC42BPB;MAP3K12;PRKCA;MAP3K10;PDPK1
prerank,cardiac left ventricle morphogenesis (GO:0003214),0.3009675403267919,0.6591660979910845,0.8451127819548873,0.9908265843552888,1.0,3/13,13.53%,CPE;TGFBR2;GSK3A
prerank,negative regulation of T cell activation (GO:0050868),0.2509596069589318,0.6588969692010821,0.8926174496644296,0.9906956280247059,1.0,4/35,8.98%,RIPOR2;SDC4;LGALS3;FOXP3
prerank,regulation of spindle assembly (GO:0090169),0.26590418896312745,0.658837991710556,0.8888888888888888,0.9903443750703388,1.0,11/25,26.59%,CHMP4B;VPS4B;CHMP1A;CHMP2A;DYNC1H1;NUMA1;PDCD6IP;CEP97;TPR;CHMP5;CHMP1B
prerank,folic acid metabolic process (GO:0046655),0.288248533664377,0.6586206623302395,0.8623298033282905,0.9901707271756124,1.0,4/18,18.64%,SHMT1;ALDH1L2;ALDH1L1;SLC19A1
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.2813877372650919,0.6580335226440546,0.8805555555555555,0.9903582570944546,1.0,3/23,13.95%,GUCY2F;CNGB1;PDE6B
prerank,glycerol metabolic process (GO:0006071),0.3241832757140557,0.6575748893027406,0.8436974789915966,0.9904163355493579,1.0,6/10,30.21%,PGP;TPI1;COQ3;ANGPTL3;GK;COQ2
prerank,regulation of spindle organization (GO:0090224),0.28815302997778575,0.6571870978172751,0.839258114374034,0.9903856132697505,1.0,5/18,18.54%,PARP3;PSRC1;DYNC1H1;NUMA1;RAE1
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.24131283342607815,0.6567771578801482,0.9138576779026217,0.9903917110999902,1.0,1/53,0.76%,CHRM1
prerank,regulation of protein dephosphorylation (GO:0035304),0.2489235219859331,0.6564565148210706,0.8949416342412452,0.9903132105580087,1.0,8/37,18.82%,PPP6R3;PPP1R15A;YWHAB;PPP1R16A;DLC1;CDH5;SPPL3;PTBP1
prerank,negative regulation of cellular metabolic process (GO:0031324),-0.19552063418488597,-0.6562024992345334,0.9620253164556962,0.9909003754490974,1.0,10/37,24.80%,AATF;MTMR2;ITGAV;EDNRB;EDN1;SIRT2;ATXN2;OPTN;PAX2;BRCA1
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),0.30281918250298445,0.655884431368944,0.8712871287128713,0.9904627151060571,1.0,2/13,15.36%,PVR;MR1
prerank,erythrocyte differentiation (GO:0030218),0.2419121942064037,0.655816049642372,0.9027237354085603,0.990124961655078,1.0,14/44,24.95%,ACIN1;EPO;DMTN;ATP5IF1;SLC25A38;PTPN2;TGFBR3;CDK5RAP3;IKZF1;FLVCR1;CASP3;KMT2E;ZFPM1;ABCB10
prerank,I-kappaB phosphorylation (GO:0007252),0.313052156411008,0.6557653483777945,0.8486842105263158,0.9897638122088018,1.0,3/10,15.26%,TLR4;CHUK;TLR3
prerank,protein acylation (GO:0043543),0.2526604477649555,0.6554040852665164,0.895778364116095,0.9897236414981978,1.0,3/38,4.61%,GLUL;EP300;ZDHHC12
prerank,positive regulation of mitotic cell cycle (GO:0045931),-0.21144216299851687,-0.6551933574583787,0.9252336448598131,0.9907530374021714,1.0,8/26,20.81%,CCDC57;HSF1;RPS6KB1;MEIS2;TAL1;ASNS;SMOC2;SPHK1
prerank,sno(s)RNA 3'-end processing (GO:0031126),0.31970495271789323,0.654846192805916,0.8560126582278481,0.9898825225662429,1.0,2/11,8.90%,LARP7;EXOSC3
prerank,mitochondrial RNA metabolic process (GO:0000959),-0.24779215325556206,-0.6538902002128576,0.8794520547945206,0.9907282581635086,1.0,7/14,29.97%,SLC25A33;MTERF2;TFB1M;MRPL12;EARS2;FASTKD5;PNPT1
prerank,positive regulation of organelle assembly (GO:1902117),0.2457873018897021,0.6533263379508432,0.9125475285171103,0.9910053851131723,1.0,16/44,25.07%,CNOT6;SDC4;MARK4;PIP4K2C;CCDC88A;FSCN1;DYNC1H1;NUMA1;PDCD6IP;CROCC;RAB3GAP2;TAPT1;PLK4;CEP120;NUP62;LRSAM1
prerank,regulation of regulated secretory pathway (GO:1903305),0.2518925377615753,0.6529515606234185,0.8983739837398373,0.9909549751631708,1.0,11/34,21.89%,UNC13D;SYN1;RIMS4;VPS18;SYT6;GSK3B;SYT11;SYT12;RAB27A;SYT3;SYT2
prerank,regulation of B cell apoptotic process (GO:0002902),0.30204177511523,0.6524946169179017,0.8648233486943164,0.9909938105247355,1.0,3/12,14.17%,ORMDL3;IRS2;FOXP1
prerank,toll-like receptor 4 signaling pathway (GO:0034142),0.2775651929524945,0.6517094055897065,0.882179675994109,0.9913713690717977,1.0,5/19,15.65%,LBP;NMI;TLR4;IRAK1;ITGB2
prerank,positive regulation of superoxide anion generation (GO:0032930),-0.253543080673559,-0.6513924638111865,0.8818897637795275,0.9916389199002859,1.0,4/13,26.34%,TGFB1;SOD1;TYROBP;ITGAM
prerank,regulation of centrosome duplication (GO:0010824),0.2557047248434809,0.6512679569808413,0.9009628610729024,0.9913815128419761,1.0,8/29,17.64%,CHMP4B;CEP76;VPS4B;CHMP1A;PLK2;CHMP2A;CENATAC;PDCD6IP
prerank,protein palmitoylation (GO:0018345),0.25406215735108933,0.6506748398225514,0.8918558077436582,0.9915673963882942,1.0,3/30,9.25%,GLUL;ZDHHC12;GOLGA7
prerank,protein prenylation (GO:0018342),-0.27189364072462474,-0.6504891939787384,0.8842975206611571,0.9913255437034112,1.0,5/10,33.85%,FNTB;CHM;PTAR1;RCE1;FNTA
prerank,response to alcohol (GO:0097305),0.2639723402335452,0.6501515919674203,0.8962655601659751,0.9916994490448144,1.0,5/27,14.16%,ADH7;PMVK;ABCA2;TGFBR2;TGFBR3
prerank,nucleotide metabolic process (GO:0009117),0.2700275079679951,0.6489597117769116,0.8879310344827587,0.9924338142900425,1.0,4/23,14.46%,FHIT;CMPK1;AK5;CTPS2
prerank,positive regulation of cell cycle phase transition (GO:1901989),-0.2417232686691485,-0.6486572787685587,0.8960674157303371,0.9916364950257732,1.0,8/15,35.52%,GLI1;EZH2;PAF1;PHB2;NPM1;PLCG2;ATAD5;FAM83D
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),0.30156772106401286,0.6477463776905575,0.8740031897926634,0.9931846449890445,1.0,2/13,11.15%,CIAO1;ISCA1
prerank,DNA strand elongation involved in DNA replication (GO:0006271),0.2874717231593492,0.647226878104171,0.875,0.9933077519854197,1.0,6/18,21.60%,POLD2;PCNA;LIG3;MCM7;GINS3;MCM4
prerank,lipid droplet formation (GO:0140042),0.3115930255401375,0.646823258287281,0.8847402597402597,0.993314644258508,1.0,3/10,17.75%,SQLE;CDS1;ZFYVE1
prerank,histone deacetylation (GO:0016575),0.24082762604929922,0.6467609264435158,0.9217731421121251,0.9929700839020682,1.0,14/43,25.08%,HDAC5;HDAC4;MORF4L2;HDAC3;MIER2;RCOR2;HDAC6;RCOR3;SFPQ;SIRT7;PER1;BAZ2A;PER2;HDAC8
prerank,membrane repolarization (GO:0086009),0.2900019286211478,0.6449499342256675,0.863568215892054,0.9942869921170264,1.0,1/15,2.79%,ATP1A2
prerank,synaptic vesicle localization (GO:0097479),-0.24974233109422883,-0.6443015712472762,0.9156976744186046,0.9936861616067294,1.0,3/13,13.07%,NLGN1;SNAPIN;SYNDIG1
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),0.2477115876281721,0.644288832696473,0.918010752688172,0.9944873041263472,1.0,7/35,15.10%,MAGI2;PPP6R3;PPP1R15A;CRY2;PPP1R11;GSK3B;PPP1R1B
prerank,negative regulation of neurogenesis (GO:0050768),0.25117795528282694,0.6441744497720863,0.903485254691689,0.9941949748927144,1.0,1/34,0.73%,RTN4R
prerank,serine family amino acid metabolic process (GO:0009069),0.2865544607208196,0.643877084329595,0.8757668711656442,0.9940702176508915,1.0,3/16,14.26%,SHMT1;CDO1;SARS1
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),-0.2546979317497473,-0.6434264883807689,0.8970189701897019,0.9933595141782768,1.0,3/12,17.33%,TASOR;APOBEC1;SETDB2
prerank,actin filament-based transport (GO:0099515),0.2751847670093519,0.6428096470079359,0.869753979739508,0.9946814496148939,1.0,7/21,17.81%,MYO1H;MYO5A;MYO1C;MYO15A;ACTN4;MYO1E;SUN2
prerank,cellular response to estrogen stimulus (GO:0071391),0.29214366397450775,0.6425120142049324,0.8746081504702194,0.9945707651688054,1.0,5/14,23.30%,BCAS3;SFRP1;SFR1;RARA;NCOA4
prerank,regulation of peptidase activity (GO:0052547),0.27564707084315915,0.642093358914126,0.8926974664679582,0.9945512219621813,1.0,1/19,2.65%,CAV1
prerank,primary miRNA processing (GO:0031053),0.3144989551516107,0.6418013679680498,0.871404399323181,0.9944018478753757,1.0,2/10,14.13%,DGCR8;SRRT
prerank,regulation of histone methylation (GO:0031060),0.29488983367902905,0.6416650943030011,0.8648233486943164,0.9941199709048617,1.0,3/13,15.42%,PIH1D1;NNMT;TET1
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),0.3066976335446615,0.6409762915404067,0.8946459412780656,0.9943504169341424,1.0,11/11,69.35%,PRKCQ;NLRP10;CLEC6A;IL12B;NFKBIZ;IL23R;IL23A;CARD9;IL12RB1;NFKBID;MALT1
prerank,regulation of DNA recombination (GO:0000018),0.2503420277100439,0.6409372552153856,0.903663500678426,0.9939803108694596,1.0,7/32,20.32%,SHLD2;MRE11;IL7R;KDM1A;KPNA1;RAD50;THOC1
prerank,regulation of cytokine production (GO:0001817),0.21097171147001306,0.6400986138223665,0.9684439608269858,0.9943798395340979,1.0,24/126,20.56%,SCAMP5;IL15;TWSG1;ALOX5;IRF3;TRIM21;NFAM1;SRGN;LGR4;FOXP3;TXK;PPP1R11;GATA3;FOXP1;GAPDH;SYT11;MAPKAPK2;IGF2BP3;GPNMB;IGF2BP2;FLOT1;HILPDA;IGF2BP1;ZBP1
prerank,regulation of microtubule polymerization (GO:0031113),0.2400270278654969,0.6398184842311678,0.9196428571428571,0.9942469857038047,1.0,10/40,22.91%,OCLN;EML2;PSRC1;CAMSAP1;ABL1;CDH5;NUMA1;MAPT;CDK5R1;TBCD
prerank,regulation of protein localization to centrosome (GO:1904779),0.3098677025887656,0.639713309115334,0.8711755233494364,0.9939463745126375,1.0,3/10,14.36%,NSFL1C;MARK4;GSK3B
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.2912214006739409,0.6384857837331692,0.882262996941896,0.9946725543708392,1.0,5/14,27.63%,PES1;DDX18;RPL7;ZNHIT6;URB1
prerank,negative regulation of osteoclast differentiation (GO:0045671),-0.22442028649404175,-0.6374502334360724,0.94,0.9965163899280219,1.0,1/18,1.34%,FBN1
prerank,interleukin-35-mediated signaling pathway (GO:0070757),0.294376187036842,0.6366947099415873,0.8653846153846154,0.9958783503287465,1.0,3/11,16.44%,STAT4;JAK1;CANX
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.2480149075540665,0.6366430420540472,0.9057377049180327,0.9955165856797334,1.0,11/33,25.27%,CDKN1A;DDRGK1;PKD1;PTPN6;ATP2B4;E2F1;FBXW7;PLK5;SUSD2;CRNN;TRIM39
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.2536697302532701,0.6362221580020273,0.9124487004103967,0.9954911061911552,1.0,3/29,8.79%,CAV1;PMAIP1;PML
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.20872600816181555,0.6347152804068029,0.9679203539823009,0.9964430122082273,1.0,26/125,21.28%,DYNC1I1;NDEL1;KIF2A;MAP4;CENPS;AURKC;CENPT;PAFAH1B1;ZW10;EFHC2;CENPH;PLK2;MAD1L1;DYNC1LI2;CENPO;TTK;DYNC1H1;ZWINT;SUN2;INTS13;TBCE;CENPF;RCC2;WDR62;RMDN1;NUDC
prerank,positive regulation of type 2 immune response (GO:0002830),0.28839709850508904,0.6346868264083578,0.8928571428571429,0.9960657592076404,1.0,5/14,26.42%,CD81;PRKCZ;RARA;IL6;DENND1B
prerank,response to glucose (GO:0009749),0.23065464859155602,0.6346527415169643,0.9337423312883436,0.9956900186884055,1.0,11/46,21.68%,PRKAA2;EIF2B2;TCF7L2;KCNB1;IRS2;EIF2B4;PCK2;GPER1;GPLD1;SOX4;VAMP2
prerank,mitochondrial transcription (GO:0006390),0.3084440854596799,0.6344612508348882,0.8795986622073578,0.995449726813198,1.0,1/10,3.62%,FOXO3
prerank,amyloid-beta metabolic process (GO:0050435),0.27862846696226345,0.6338560668768126,0.8778979907264297,0.9956148992666373,1.0,6/16,23.99%,MGAT3;BACE1;IDE;ABCA7;APH1A;PSEN1
prerank,response to gamma radiation (GO:0010332),0.26614531045433676,0.6333893095058816,0.9127218934911243,0.9956155647514232,1.0,6/24,16.82%,CRYAB;MYC;HRAS;MDM2;ATR;KDM1A
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.2664516233929877,0.6328809989301878,0.8988439306358381,0.995647966263851,1.0,5/23,16.57%,RBX1;COPS5;DDB1;RPS27A;UBC
prerank,protein auto-ADP-ribosylation (GO:0070213),0.29575490051687814,0.6328329847242204,0.8821705426356589,0.9952847986732359,1.0,7/12,28.74%,PARP3;PARP6;TNKS2;PARP2;PARP11;PARP1;TIPARP
prerank,thymus development (GO:0048538),-0.2432317607203589,-0.632578569793061,0.928374655647383,0.9987756214987976,1.0,7/13,39.28%,TBX1;EPHB3;SOD1;FOXE1;FADD;SHH;HES1
prerank,regulation of tumor necrosis factor production (GO:0032680),0.2131391170924436,0.6325734935602909,0.9633333333333334,0.9951137955740922,1.0,20/112,19.38%,CLU;ZC3H12A;MAVS;TNFRSF8;HSPB1;FZD5;LBP;PTPN6;TWIST1;TLR4;FOXP1;TLR3;SYT11;DHX9;OAS2;MAPKAPK2;PTPN11;RARA;ILRUN;APP
prerank,regulation of DNA replication (GO:0006275),-0.17391348951264798,-0.631929654464766,0.9675925925925926,0.9982043249204146,1.0,11/49,19.92%,GLI2;ACVRL1;USP37;KAT7;GLI1;ORC5;BCAR3;BLM;EGF;CTC1;STN1
prerank,regulation of gene silencing by miRNA (GO:0060964),0.2256590415927343,0.6316123962101085,0.9502369668246445,0.9955375716127577,1.0,26/62,28.98%,POLR2H;POLR2A;NUP93;NDC1;AJUBA;FXR1;EIF4G1;DHX9;AAAS;POLR2C;H3-3A;WTIP;RAE1;POLR2E;POM121;TPR;RANBP2;NUP42;POLR2K;NUP62;SEH1L;NUP133;IPO8;TRIM71;NUP35;PUM2
prerank,membrane lipid metabolic process (GO:0006643),0.26252914019879314,0.6316017519955546,0.9007407407407407,0.9951460102534264,1.0,5/22,18.79%,AGK;ST3GAL6;ST6GALNAC4;SERINC1;TEX2
prerank,modification-dependent macromolecule catabolic process (GO:0043632),0.3062888020090539,0.6315614428473426,0.8521008403361344,0.9947772161187797,1.0,4/10,21.18%,TUT7;RPS27A;UBC;CHFR
prerank,atrioventricular valve development (GO:0003171),-0.2432558723724983,-0.6315210774186296,0.9470899470899471,0.9974615007699149,1.0,4/14,14.37%,NOTCH1;HEYL;SLIT3;BMPR2
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),0.2568639467631508,0.6311254406463358,0.8958630527817404,0.9947529696652109,1.0,3/25,8.71%,BAG1;SDF2;HSPA14
prerank,protein localization to Golgi apparatus (GO:0034067),0.2583960575680635,0.6301096292140672,0.9009628610729024,0.995235095686679,1.0,7/27,17.51%,VPS13A;GOLPH3;GCC2;VPS13D;RAB33B;RIPOR1;ARFRP1
prerank,negative regulation of viral transcription (GO:0032897),0.2898025162486717,0.629157188151766,0.8888888888888888,0.9956347443263304,1.0,3/13,9.40%,TRIM21;LARP7;TRIM11
prerank,histone deubiquitination (GO:0016578),0.2742049617786919,0.628352983515853,0.8942598187311178,0.995938806180997,1.0,6/18,21.27%,ENY2;USP3;TRRAP;USP21;USP16;USP22
prerank,cellular response to acid chemical (GO:0071229),0.2557838022388889,0.6279235323934035,0.9222065063649222,0.9959109304187627,1.0,4/27,12.58%,SESN2;SH3BP4;CAPN2;CPEB3
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.29622766149079127,0.6270623774843815,0.8846761453396524,0.9962238354331565,1.0,3/11,18.46%,ABCD1;COA8;PARK7
prerank,protein targeting (GO:0006605),0.21005053264407786,0.6270157958552897,0.9683406113537117,0.9958608432100156,1.0,30/118,24.32%,TIMM10;HOMER3;TIMM44;ZDHHC12;VPS37B;TOMM5;PITRM1;GOLGA7;MYO1C;BCAP31;SPCS3;AP1S3;TOMM20;ZFAND6;TIMM17B;AP4E1;PEX6;VPS37A;PARD3;TIMM9;TOMM40;TSPO;ZDHHC3;SRP14;TIMM23;AP4M1;AIP;ARL6;RAB3IP;ATG3
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.2542385293426725,0.6270155422806607,0.9242424242424242,0.9954605775977928,1.0,11/25,27.90%,LARP7;WDR43;ELL;HEXIM1;NELFB;NELFA;RNF168;LEO1;LDB1;CDK13;RNF8
prerank,protein localization to chromatin (GO:0071168),-0.2222759098418379,-0.6267325952709311,0.9651898734177216,0.9995082833865442,1.0,5/18,18.84%,ESR1;TASOR;NIPBL;CHMP7;MRNIP
prerank,positive regulation of cellular senescence (GO:2000774),0.30413630358289456,0.6265078115925293,0.8812392426850258,0.9954932585977468,1.0,2/10,13.52%,YPEL3;EEF1E1
prerank,negative regulation of JNK cascade (GO:0046329),0.2482154746474152,0.6263786996583762,0.91268758526603,0.9951968830419086,1.0,10/31,25.57%,DUSP10;SH3RF2;HDAC3;NCOR1;DUSP3;TAOK3;MEN1;SIRPA;PER1;MAPK8IP1
prerank,cilium movement (GO:0003341),0.231954396700479,0.625877309483243,0.9390862944162437,0.9952372274796576,1.0,8/47,17.11%,CFAP91;CFAP54;CFAP206;ODAD3;SPAG17;ADCY10;DNAAF5;CFAP61
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),0.26390064291169446,0.6257531393972965,0.8912732474964234,0.9949415915147917,1.0,4/21,12.78%,RASAL3;TGFB2;MAPKAP1;SYNGAP1
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),0.28952549977469333,0.6243896098395021,0.8947368421052632,0.9957062778338064,1.0,8/13,26.55%,CHP1;UFM1;SUFU;PARK7;RAB23;TPR;RANGAP1;APOD
prerank,negative regulation of secretion (GO:0051048),-0.2701435097221735,-0.6233801109958171,0.934010152284264,1.0,1.0,3/10,17.58%,NR1H3;CD74;EGF
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.2801708544006269,0.6231410630054427,0.8791732909379968,0.996338790428364,1.0,3/14,17.33%,YBX3;BOLL;MAPKAPK2
prerank,intracellular sterol transport (GO:0032366),0.2865092534470699,0.6209161665610894,0.8906752411575563,0.9977666172857695,1.0,5/13,18.13%,NPC1;STARD4;VPS4A;RELCH;OSBPL2
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),-0.2203246034733934,-0.6207249628003236,0.9532710280373832,1.0,1.0,7/19,21.68%,HPRT1;AMPD3;PNP;DCK;TYMS;GMPR2;CDA
prerank,protein localization to kinetochore (GO:0034501),0.284420399782891,0.6206178702264703,0.8725490196078431,0.9976054819444896,1.0,5/14,25.00%,CENPT;ZW10;TTK;RCC2;MIS12
prerank,regulation of lymphocyte differentiation (GO:0045619),-0.2171874817540635,-0.620249514978575,0.9447852760736196,1.0,1.0,12/18,51.86%,NCKAP1L;PRDM1;CCR2;PRKDC;IL4I1;IKZF3;CRTAM;ZFP36L2;TBX21;SLAMF8;PRELID1;CD2
prerank,regulation of sequestering of triglyceride (GO:0010889),0.2778427181764194,0.6199958272890791,0.9047619047619048,0.9977391356864519,1.0,1/15,3.17%,ABHD5
prerank,interstrand cross-link repair (GO:0036297),-0.1682503672846245,-0.6199511519904901,0.9842931937172775,0.9996069551670961,1.0,16/53,26.17%,ERCC6L2;FANCL;FANCI;FANCC;USP1;FAAP100;FANCB;WDR48;FANCD2;DCLRE1A;NEIL3;EXO5;RAD51;ERCC1;RAD51AP2;CENPX
prerank,regulation of rRNA processing (GO:2000232),0.26861332686179473,0.6199206627736107,0.9046898638426626,0.9973934545248012,1.0,5/16,23.22%,BUD23;WDR43;TRMT112;SIRT7;SHQ1
prerank,alcohol catabolic process (GO:0046164),0.3004567999167096,0.6195198498527644,0.905448717948718,0.9972947297519908,1.0,1/10,8.38%,SRD5A3
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.2574348238652667,0.6190137143428704,0.91,0.9973066477252192,1.0,3/23,7.60%,TRIM33;LTBP4;LATS1
prerank,rhodopsin mediated signaling pathway (GO:0016056),0.30464359117525686,0.6188158154368886,0.8848080133555927,0.9970637250997781,1.0,2/10,13.95%,CNGB1;PDE6B
prerank,DNA replication initiation (GO:0006270),0.23754160234794755,0.6186922331753847,0.9303547963206308,0.9967764885879469,1.0,13/37,26.93%,POLE4;TOPBP1;CDK2;RPA3;MCM8;PRIM2;MCM6;MCM7;ORC2;MCM4;ORC3;RPA2;MCM2
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),0.2874721646170697,0.6186622270056948,0.8925750394944708,0.9964060623013056,1.0,2/12,9.54%,PCGF3;LRIF1
prerank,signal release from synapse (GO:0099643),0.23261456962561095,0.6181758682733625,0.9438775510204082,0.9964167278311095,1.0,5/43,8.85%,OTOF;SYN1;STXBP1;DNAJC5;PCLO
prerank,negative regulation of interferon-gamma production (GO:0032689),0.254331949789971,0.6177992103664486,0.9165487977369166,0.9963301400447475,1.0,3/23,11.15%,ZC3H12A;FOXP3;TLR4
prerank,regulation of leukocyte activation (GO:0002694),0.2833108504471909,0.6176022942362297,0.8876755070202809,0.9960872982508552,1.0,1/14,2.15%,CD200
prerank,neurotransmitter secretion (GO:0007269),0.231812062299956,0.6174132540047924,0.9439490445859873,0.9958264065462412,1.0,5/44,8.85%,OTOF;SYN1;STXBP1;DNAJC5;PCLO
prerank,aspartate family amino acid catabolic process (GO:0009068),0.26601186982074077,0.6172685045745567,0.9007518796992481,0.9955419363228937,1.0,4/19,17.16%,PIPOX;SLC25A21;OGDH;DLST
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),0.24516603738043757,0.6170726474212307,0.9159420289855073,0.9952957361967462,1.0,3/26,8.12%,FLOT2;LGR4;NLRP2B
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),-0.21289136952456256,-0.6162280752812491,0.9577464788732394,1.0,1.0,5/19,25.39%,NAT10;GNL3L;CTC1;STN1;DCP2
prerank,positive regulation of cholesterol transport (GO:0032376),0.2457720467566676,0.6152362833580033,0.9279891304347826,0.9963537819407382,1.0,2/27,5.36%,CAV1;NFKBIA
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),-0.20759621539700965,-0.6144150835366111,0.9545454545454546,1.0,1.0,7/22,24.74%,PSMA6;PSMB10;PSMA4;PSMB9;PSMA8;PSMB7;PSMA3
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.2808491477571972,0.6132544203066157,0.9204545454545454,0.9975202724346776,1.0,1/13,5.44%,DUSP1
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.25566697372024866,0.6131921452757574,0.9138187221396731,0.9971766049671011,1.0,5/22,16.77%,RBX1;DDB1;RPS27A;UBC;ERCC2
prerank,positive regulation of dephosphorylation (GO:0035306),-0.1921827273890255,-0.6127943970450118,0.9727891156462585,1.0,1.0,7/27,28.33%,PPP1R16B;TGFB1;CNEP1R1;PPP1R7;CDCA2;CALM3;NSMF
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),0.26754960398596883,0.6127248011076957,0.8974739970282318,0.9971137296891146,1.0,8/16,28.99%,PINX1;TNKS2;ERCC4;TERF2;TINF2;PARP1;TERF1;NAF1
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.3037984095982895,0.612161343491443,0.8829268292682927,0.9971616434815552,1.0,2/10,12.51%,PPP2CA;PTPN2
prerank,cytoplasmic translational initiation (GO:0002183),0.2730328452817096,0.6119094309746635,0.9075500770416025,0.9969513625739603,1.0,5/17,17.44%,EIF4B;EIF3M;EIF4G1;EIF4A1;EIF4A2
prerank,mitotic spindle organization (GO:0007052),0.19837038802984205,0.6118128911040126,0.9892241379310345,0.9966266459766141,1.0,43/153,25.79%,DYNC1I1;NDEL1;KIF2A;MAP4;CENPS;AURKC;CENPT;PAFAH1B1;ZW10;RHOA;EFHC2;ABRAXAS1;CENPH;PLK2;MAD1L1;FLNA;DYNC1LI2;CENPO;TTK;DYNC1H1;CHEK2;AAAS;ZWINT;SUN2;INTS13;TBCE;MISP;CENPF;RCC2;WDR62;RMDN1;NUDC;CEP192;RANBP2;SMC3;TUBG1;CEP126;RANGAP1;MIS12;KIFC2;SEH1L;RPS27;DCTN2
prerank,mesenchymal to epithelial transition (GO:0060231),0.2923872127176901,0.6114723623339762,0.8848,0.9964838989982069,1.0,2/10,12.94%,BMP4;GATA3
prerank,positive regulation of hormone secretion (GO:0046887),-0.21684199670253274,-0.6111132850778386,0.9403409090909091,1.0,1.0,12/17,50.58%,EDN1;SOX11;EDN3;GRP;RASL10B;VAMP8;NMB;C1QTNF3;PLA2G3;TFR2;CYP19A1;HCAR2
prerank,histone mRNA catabolic process (GO:0071044),-0.23261848300813892,-0.6106071193956846,0.935672514619883,1.0,1.0,4/15,25.39%,TUT4;TENT2;UPF1;DCP2
prerank,regulation of histone H3-K4 methylation (GO:0051569),-0.21991794502981504,-0.6105064836616675,0.9498525073746312,0.9990893029735245,1.0,6/16,24.80%,AUTS2;BCOR;WDR5;PAXIP1;SMAD4;BRCA1
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.2452723195268513,0.6104312794054079,0.9234104046242775,0.9968881580481352,1.0,4/26,12.95%,DUSP1;FBXO5;NSMCE2;ANAPC4
prerank,cellular response to heat (GO:0034605),0.23339037551913147,0.6096435987300953,0.9378306878306878,0.9970781624531337,1.0,9/35,24.29%,DAXX;BAG3;HSP90AA1;STUB1;MAPT;HIKESHI;TRPV4;TPR;PRKACA
prerank,action potential (GO:0001508),0.22669638550972768,0.6094172730300412,0.9388535031847134,0.9968671482321053,1.0,11/44,21.42%,SCN3A;ANK3;KCNB1;GNAQ;GNA11;SCN9A;GPER1;YWHAH;GNA15;KCNMB2;KCNMB3
prerank,cellular response to corticosteroid stimulus (GO:0071384),-0.22173489892802048,-0.6085387707131833,0.9338842975206612,0.99914065532414,1.0,3/15,21.15%,BCL2L11;ZFP36;NR3C1
prerank,activation of adenylate cyclase activity (GO:0007190),0.23587730983357658,0.6079964707532607,0.9363395225464191,0.9975373875364979,1.0,4/35,9.97%,ADCY9;ADCY6;LGR4;RAF1
prerank,negative regulation of biosynthetic process (GO:0009890),0.27391449175612437,0.6075337317064055,0.9049079754601227,0.9974757763070251,1.0,4/16,19.14%,ABCD1;COA8;PARK7;GPER1
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),-0.24924549956125758,-0.6069731814284623,0.9306930693069307,0.9989795800011176,1.0,5/10,27.75%,APC;SIRT2;ECT2;KNSTRN;SPAG5
prerank,regulation of secretion (GO:0051046),0.27970644064402483,0.6069005521011248,0.9051321928460342,0.9975509616897847,1.0,4/13,19.43%,ERBB3;ACSL3;OAS2;GPLD1
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.2734913376320629,0.6064039074959473,0.9070121951219512,0.9975216961350779,1.0,2/15,8.98%,TGFB2;FOXP3
prerank,cellular response to amyloid-beta (GO:1904646),0.23318354289250237,0.60585709687458,0.9397260273972603,0.9975393128256862,1.0,11/35,24.63%,EPHA4;CACNA1A;TLR6;TLR4;GSK3B;APP;AGER;ATP1A3;PSEN1;FYN;CACNA2D1
prerank,endoplasmic reticulum membrane organization (GO:0090158),0.28926039729236525,0.6054632414351931,0.9064124783362218,0.9974348940609995,1.0,3/11,20.20%,LPCAT3;ATL2;ARL6IP1
prerank,regulation of DNA metabolic process (GO:0051052),0.22465681705172005,0.605142965731324,0.9426751592356688,0.997257374006844,1.0,16/44,25.08%,IL7R;GRHL2;MYC;POLH;UBE2N;NBN;KPNA1;PARG;NUCKS1;THOC1;TERF2;UBE2V1;SIRT7;CDK9;WDR18;HDAC8
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),0.28994543359481606,0.6035583511794648,0.9039087947882736,0.9980475280366279,1.0,3/11,16.08%,FBXO5;DONSON;LIG3
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),-0.22471350899352702,-0.6020488759999627,0.9303621169916435,1.0,1.0,8/15,39.40%,SEL1L;SYVN1;FAF2;OS9;DERL1;UFD1;HERPUD1;VCP
prerank,hydrogen peroxide catabolic process (GO:0042744),0.2887599512474316,0.6017871173623014,0.8954983922829582,0.9989380969574968,1.0,1/11,6.76%,PXDN
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.20449390581112842,0.6016562546100417,0.9748858447488584,0.9986438665986761,1.0,11/95,13.83%,VIM;ZC3H12A;TRIM41;FZD5;LBP;CARD16;TLR4;RHOA;SBNO2;IRAK1;MEF2C
prerank,innate immune response in mucosa (GO:0002227),0.29153766481198595,0.6005241252653756,0.87893864013267,0.9990404817620268,1.0,1/10,9.98%,RNASE3
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),-0.18239707344159467,-0.6002406229251904,0.9923371647509579,1.0,1.0,2/32,4.78%,CEMIP;PKD2
prerank,autophagosome assembly (GO:0000045),0.21884444056227553,0.6000448026249741,0.9644171779141104,0.9989903007743652,1.0,23/52,29.50%,NSFL1C;RAB7A;EMC6;ULK1;RAB1B;MAP1LC3B;RB1CC1;TMEM41B;ATG16L2;RAB23;UBQLN2;GABARAPL2;ATG3;UBXN2A;PACS2;WIPI2;ATG2B;STX12;ATG12;TRAPPC8;WDR45;RAB19;WIPI1
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.21737840167209427,0.5997762575028216,0.9576059850374065,0.9987858951210915,1.0,13/59,18.79%,RELB;NFKBIA;TAB3;TNFRSF1A;TLR4;CHUK;TLR3;IKBKG;RNF31;RPS27A;UBC;TAB2;ROCK2
prerank,positive regulation of peptidase activity (GO:0010952),-0.20645127702307564,-0.5991501947970823,0.9501557632398754,0.9999702284184998,1.0,4/20,17.91%,RCN3;MAPK12;PSME1;APH1B
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.2367734466194596,0.5991421193069629,0.9273972602739726,0.9984352239997439,1.0,2/29,9.10%,ACOT8;ACSM3
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.2367734466194596,0.5991421193069629,0.9273972602739726,0.9984352239997439,1.0,2/29,9.10%,ACOT8;ACSM3
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.24992774165733594,0.5989486076894187,0.9124087591240876,0.9981709009209422,1.0,7/21,22.76%,FBXO5;ZW10;MAD1L1;TTK;ZWINT;CENPF;TPR
prerank,regulation of myotube differentiation (GO:0010830),0.24292404030368775,0.5979538620839892,0.9241773962804005,0.9984421367859948,1.0,3/24,10.49%,HDAC5;HDAC4;HDAC3
prerank,cranial nerve development (GO:0021545),-0.2394851327551163,-0.5955303697666582,0.9422572178477691,1.0,1.0,2/11,7.59%,SALL1;CHD7
prerank,fatty acid transport (GO:0015908),0.25662049718742064,0.5949808810289495,0.9054054054054054,1.0,1.0,4/17,18.32%,SLC27A3;CPT1B;SLC25A17;SLC27A4
prerank,cell junction maintenance (GO:0034331),0.2697324474983447,0.5947620337789223,0.9166666666666666,0.999796934114835,1.0,3/14,17.28%,NLGN2;PRTN3;F2R
prerank,positive regulation of phospholipid transport (GO:2001140),0.28900382982559114,0.5946205294774501,0.9029605263157895,0.9994980437433394,1.0,3/10,23.46%,TRIAP1;ABCA7;ABCB4
prerank,regulation of viral life cycle (GO:1903900),0.24924704369045617,0.594572048167762,0.9244444444444444,0.999135998971247,1.0,5/21,21.76%,TRIM25;TRIM21;VPS4A;TSG101;TRIM5
prerank,regulation of catabolic process (GO:0009894),-0.21516035483270193,-0.5933581715536378,0.9627329192546584,1.0,1.0,10/18,39.10%,FAP;HPGD;RARRES2;TMEM9;FAF1;ZDHHC2;FAM83D;ZDHHC7;SNF8;HGS
prerank,positive regulation of protein localization to cell surface (GO:2000010),-0.2355265808532822,-0.5932506538131077,0.9331395348837209,0.9998877668598009,1.0,5/13,23.34%,GPD1L;MAP1A;HSP90AB1;TYROBP;TMEM35A
prerank,lipoprotein catabolic process (GO:0042159),0.27992800044931654,0.592856912983656,0.902317880794702,0.9999007229215705,1.0,3/11,19.43%,ABHD10;LYPLAL1;ABHD17C
prerank,negative regulation of activated T cell proliferation (GO:0046007),-0.24793073531980953,-0.5924597296113512,0.9311224489795918,0.9992874886070826,1.0,2/10,17.23%,LGALS9;RC3H1
prerank,response to molecule of bacterial origin (GO:0002237),0.2079020766419571,0.5923254014777541,0.9758454106280193,0.9998523756508064,1.0,11/69,17.63%,SMAD6;SLPI;FZD5;LBP;TLR4;PELI1;IRAK1;FOXP1;F2R;MAPKAPK2;TAB2
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.2743208317373115,0.5918411284551374,0.9238249594813615,0.99978647891591,1.0,3/13,13.67%,SRD5A3;ALG1;ALG12
prerank,actin nucleation (GO:0045010),0.25359271642008663,0.5916925446228704,0.9327354260089686,0.9994975561634375,1.0,4/21,17.05%,LMOD3;MAGEL2;WASHC1;ARPC2
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.2699043357901723,0.5911670739160713,0.8992248062015504,0.9994529389456307,1.0,6/14,31.83%,ANKRD17;TLR3;TLR5;PUM2;PUM1;USP15
prerank,alpha-amino acid catabolic process (GO:1901606),0.2363680215775735,0.5898652618228569,0.9378453038674033,0.9999408247006903,1.0,8/29,24.54%,TDO2;HAAO;PRODH;KYAT1;HSD17B10;SARDH;BLMH;KMO
prerank,RNA methylation (GO:0001510),0.21176434683895423,0.5891022980934324,0.9632352941176471,1.0,1.0,8/60,12.33%,NOP2;BUD23;LCMT2;CBLL1;THADA;METTL6;THUMPD3;WDR6
prerank,vacuolar acidification (GO:0007035),-0.1999227949352697,-0.5889291824408368,0.9746835443037974,0.9999553749803871,1.0,9/21,30.41%,ATP6V1H;CLN3;CLN6;CCDC115;TMEM9;ATP6V0A4;DMXL1;SLC11A1;PPT1
prerank,negative regulation of establishment of protein localization (GO:1904950),0.2864031082873709,0.5888654228910505,0.9074380165289256,0.9998029792943256,1.0,2/10,12.17%,WWP2;SNX12
prerank,positive regulation of DNA repair (GO:0045739),0.22090807622447917,0.5882876745251864,0.9518377693282636,0.9997883356012943,1.0,8/46,15.75%,EYA2;FOXM1;EYA1;TIGAR;ABRAXAS1;DHX9;PCNA;UBE2N
prerank,regulation of RIG-I signaling pathway (GO:0039535),0.25898061120423077,0.5882711985695188,0.9112426035502958,0.9994073287262054,1.0,8/18,31.83%,ANKRD17;NPLOC4;BIRC3;C1QBP;NOP53;PUM2;PUM1;USP15
prerank,negative regulation of double-strand break repair (GO:2000780),0.22899518656887913,0.5876375159415563,0.9470013947001394,0.9994185656433566,1.0,5/30,14.22%,SHLD2;KLHL15;RIF1;TWIST1;UBR5
prerank,glial cell development (GO:0021782),0.2400495981543833,0.5863101738448655,0.9421720733427362,0.9998815614931701,1.0,2/25,6.18%,CDK6;EIF2B2
prerank,cytoplasmic translation (GO:0002181),0.20040832110845472,0.5860274114539606,0.9872979214780601,0.9996613582694888,1.0,29/91,27.54%,TMA7;RPS4X;RPL31;RPSA;GSPT2;RPL22;RPL28;RPS26;RPL10A;EIF3M;EIF4A1;RPL14;RPS27A;EIF4A2;RPL6;RPS28;ETF1;RPL41;RPLP1;RPL7;RPL21;RPL26;RPS27;RPS12;FTSJ1;RPL18;RPS17;RPS3;RPL22L1
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.23208436926827866,0.5851253413816172,0.9364864864864865,0.9998437086065682,1.0,13/28,26.05%,TAB3;IRAK1;AAMP;IKBKG;UBE2N;RPS27A;UBC;TAB2;OTULIN;UBE2V1;CASP8;TAB1;RELA
prerank,double-strand break repair via break-induced replication (GO:0000727),0.2764203713058449,0.5849228505463725,0.9245585874799358,0.9995754567634253,1.0,4/12,26.93%,MCM6;MCM7;MCM4;MCM2
prerank,methylguanosine-cap decapping (GO:0110156),-0.24823117291258945,-0.5842647338715145,0.9479166666666666,1.0,1.0,2/10,12.41%,DCP1B;EDC4
prerank,autophagosome organization (GO:1905037),0.2139746818987089,0.5834057295025027,0.9677819083023544,1.0,1.0,23/50,30.18%,NSFL1C;RAB7A;EMC6;ULK1;RAB1B;MAP1LC3B;RB1CC1;TMEM41B;ATG16L2;RAB23;UBQLN2;GABARAPL2;ATG3;UBXN2A;PACS2;WIPI2;ATG2B;STX12;ATG12;WDR45;RAB19;WIPI1;ATP13A2
prerank,rRNA 3'-end processing (GO:0031125),0.2778640238030683,0.5827113740435237,0.9259259259259259,1.0,1.0,2/10,9.41%,EXOSC3;ERI3
prerank,lipoxygenase pathway (GO:0019372),0.25930823975486894,0.5818467723095099,0.9102167182662538,1.0,1.0,2/14,11.30%,ALOX5;PON3
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.2547238767903795,0.5817925160833993,0.9352409638554217,0.9999559586452439,1.0,7/16,32.19%,DAZAP1;CELF4;RBM3;RBMXL1;TRA2B;NCL;NUP98
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),0.2682360326428123,0.5813920972281449,0.9247135842880524,0.9997976699175332,1.0,12/12,73.20%,PRKCQ;NLRP10;IL1B;CLEC6A;IL12B;IL23R;ZBTB1;IL23A;CARD9;IL12RB1;CCR2;SLC11A1
prerank,RNA modification (GO:0009451),0.2078337239381061,0.5813379012347752,0.9752168525402726,0.9994349829939111,1.0,7/54,10.26%,NOP2;LCMT2;ELP5;TRIT1;THG1L;AARS1;ANKRD16
prerank,positive regulation of protein localization to Cajal body (GO:1904871),-0.23656454592130594,-0.5812570391313333,0.9224376731301939,1.0,1.0,4/11,19.63%,DKC1;CCT7;CCT2;CCT4
prerank,regulation of protein localization to Cajal body (GO:1904869),-0.23656454592130594,-0.5812570391313333,0.9224376731301939,1.0,1.0,4/11,19.63%,DKC1;CCT7;CCT2;CCT4
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),-0.2437564376138853,-0.5793564736800861,0.9516539440203562,1.0,1.0,5/10,37.08%,THAP7;NOC2L;BRCA1;KLF15;TAF7
prerank,regulation of cholesterol transport (GO:0032374),0.24549204602702562,0.5778619318427817,0.9440459110473458,1.0,1.0,3/20,14.45%,TTC39B;ABCA2;NUS1
prerank,negative regulation of histone modification (GO:0031057),0.26652965936479367,0.5774859007416285,0.9207606973058637,1.0,1.0,3/14,14.23%,FOXP3;TWIST1;SET
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.23750716814048675,0.5770492432739777,0.9513590844062947,1.0,1.0,8/24,17.63%,TAB3;IRAK1;AAMP;IKBKG;UBE2N;RPS27A;UBC;TAB2
prerank,DNA recombination (GO:0006310),0.22187727652997893,0.5769707423972711,0.9529411764705882,1.0,1.0,3/37,8.08%,RECQL4;MRE11;RAD54L
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.22456437284090086,0.5768610090737074,0.9656538969616909,1.0,1.0,6/37,13.74%,SIDT2;XRN2;RNASE3;DNASE1L2;MTREX;DNASE1L1
prerank,cilium-dependent cell motility (GO:0060285),-0.19155286438210467,-0.5760965285407073,0.9668874172185431,1.0,1.0,10/22,35.75%,CFAP44;RFX3;DNAH3;DNAH2;CCDC39;RSPH9;CCDC65;DNAAF2;TEKT2;DNAH17
prerank,replication fork processing (GO:0031297),0.21946598029273598,0.5757318077406111,0.9624352331606217,1.0,1.0,11/38,25.25%,MRE11;CENPS;ATRX;MMS22L;PCNA;ATR;NUCKS1;THOC1;CDK9;FANCM;FBH1
prerank,ribosomal subunit export from nucleus (GO:0000054),0.26227703894516446,0.5753718008097258,0.9367469879518072,1.0,1.0,2/13,9.69%,EIF6;SDAD1
prerank,response to lipopolysaccharide (GO:0032496),0.18780969015716195,0.5741269071521949,0.9934640522875817,1.0,1.0,19/138,17.63%,VIM;SMAD6;ZC3H12A;SLPI;TRIM41;LBP;CARD16;TLR4;RHOA;SBNO2;PELI1;IRAK1;MEF2C;FOXP1;PABPN1;F2R;GIT1;MAPKAPK2;TAB2
prerank,carbohydrate transport (GO:0008643),-0.2347317761374944,-0.5725598188574283,0.9434889434889435,1.0,1.0,8/11,46.00%,AQP11;SLC26A6;SLC2A2;SLC23A1;SLC23A2;SLC50A1;SLC2A5;AQP9
prerank,folic acid-containing compound metabolic process (GO:0006760),0.24751848852242442,0.5720626879826357,0.9389880952380952,1.0,1.0,4/19,18.64%,SHMT1;ALDH1L2;ALDH1L1;SLC19A1
prerank,TOR signaling (GO:0031929),0.2281655526140694,0.5719513585473609,0.9382183908045977,1.0,1.0,11/26,28.73%,EIF4EBP1;MAPKAP1;GATA3;CCDC88A;FLCN;EIF4EBP2;TIPRL;SYAP1;AKT1;LARP1;RPS6
prerank,RNA catabolic process (GO:0006401),0.21054855464254035,0.5715963265619447,0.9831824062095731,1.0,1.0,5/46,10.46%,FEN1;SIDT2;XRN2;RNASE3;MTREX
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),0.2438765611362111,0.5713054158423438,0.9262536873156342,1.0,1.0,2/20,7.97%,TARBP2;TSNAX
prerank,cellular response to increased oxygen levels (GO:0036295),0.2732400118170057,0.5683280237791596,0.9338709677419355,1.0,1.0,1/11,2.65%,CAV1
prerank,negative regulation of neuron differentiation (GO:0045665),-0.1901333835658413,-0.5681122155825468,0.9837662337662337,1.0,1.0,5/22,22.26%,DTX1;B2M;NEPRO;BMP7;HEY1
prerank,myeloid cell differentiation (GO:0030099),0.20938618259377156,0.5666398464937884,0.966794380587484,1.0,1.0,6/47,12.51%,ACIN1;ZBTB16;EPO;ATP5IF1;SLC25A38;PTPN2
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",0.2296601842386716,0.5664710564083392,0.9517730496453901,1.0,1.0,5/25,13.40%,DDX39B;WDR43;ELL;HMGN1;TCEA2
prerank,nucleoside salvage (GO:0043174),-0.24004758403695137,-0.5661244311010322,0.9450261780104712,1.0,1.0,4/10,22.88%,HPRT1;DCK;CDA;UCK1
prerank,establishment of spindle localization (GO:0051293),0.2574426888130154,0.5656116033251838,0.944078947368421,1.0,1.0,5/14,21.85%,MAP4;LLGL2;DYNC1H1;TLE6;LLGL1
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.21887886534565404,0.565439985672534,0.9585062240663901,1.0,1.0,6/34,15.26%,LGR4;NLRP2B;RAB7B;TLR6;TLR4;TLR3
prerank,tRNA export from nucleus (GO:0006409),0.22151596576431704,0.5645832500369143,0.9650537634408602,1.0,1.0,12/32,26.80%,NUP93;NDC1;NOL6;AAAS;RAE1;POM121;TPR;RANBP2;NUP42;NUP62;SEH1L;NUP133
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.22151596576431704,0.5645832500369143,0.9650537634408602,1.0,1.0,12/32,26.80%,NUP93;NDC1;NOL6;AAAS;RAE1;POM121;TPR;RANBP2;NUP42;NUP62;SEH1L;NUP133
prerank,regulation of transposition (GO:0010528),0.2614727854855923,0.5642425574091202,0.9354330708661417,1.0,1.0,13/13,73.87%,MYBL1;SIRT7;TEX15;SMYD5;AICDA;UBR2;PIWIL1;BTBD18;SPOCD1;PIWIL4;DDX4;TDRD9;PIWIL2
prerank,sulfate transport (GO:0008272),0.2540533486089661,0.5623013859636231,0.9361370716510904,1.0,1.0,3/14,13.62%,SLC13A4;SLC25A14;SLC26A4
prerank,positive regulation of osteoclast differentiation (GO:0045672),-0.21640700805306196,-0.5621545894081851,0.957983193277311,1.0,1.0,10/14,49.69%,TRAF6;CSF1;TYROBP;CCR1;TNFSF11;OCSTAMP;IL23A;TNF;IL23R;IL12B
prerank,telomere maintenance via recombination (GO:0000722),0.27235490832066894,0.560943396169596,0.9386401326699834,1.0,1.0,4/11,19.88%,NSMCE2;SMC6;RAD50;ERCC4
prerank,ncRNA 3'-end processing (GO:0043628),0.24864766682029346,0.5603411568887182,0.9534883720930233,1.0,1.0,3/14,18.77%,INTS2;TRNT1;INTS6
prerank,apoptotic nuclear changes (GO:0030262),-0.18657069767530077,-0.5602164883166693,0.9896551724137931,1.0,1.0,9/24,25.45%,CECR2;DNASE2;HMGB1;EXOG;ACVR1C;DICER1;TOP2A;FOXL2;BLCAP
prerank,Golgi inheritance (GO:0048313),0.27032025182177943,0.560180308677199,0.9172297297297297,1.0,1.0,2/11,11.77%,PLK3;YWHAZ
prerank,V(D)J recombination (GO:0033151),-0.22834519882260093,-0.559681047171085,0.9439775910364145,1.0,1.0,2/11,16.47%,LIG1;HMGB1
prerank,inner dynein arm assembly (GO:0036159),0.2714034647250817,0.5594640172126855,0.926948051948052,1.0,1.0,10/10,72.88%,DNAAF5;DNAAF4;CFAP73;ZMYND10;DNAI3;DNAAF1;DNAH1;CCDC40;CFAP100;CCDC39
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",-0.18397923997945506,-0.5593534639885483,0.976897689768977,1.0,1.0,4/25,14.39%,SRSF4;SRSF10;TXNL4A;WDR83
prerank,acyl-CoA metabolic process (GO:0006637),0.21689585639538017,0.5586202052282991,0.964769647696477,1.0,1.0,8/35,22.88%,ACOT8;ACSM3;ACACA;OGDH;DLST;HMGCS1;SUCLA2;MLYCD
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.22658994129963664,0.5558805436242551,0.9540389972144847,1.0,1.0,8/26,17.63%,TAB3;IRAK1;AAMP;IKBKG;UBE2N;RPS27A;UBC;TAB2
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.26443635450665315,0.5556862138088725,0.9523809523809523,1.0,1.0,10/10,73.57%,FTO;MGMT;ASCC2;ALKBH5;ASCC1;MPG;ALKBH3;ASCC3;ALKBH1;ALKBH2
prerank,DNA dealkylation (GO:0035510),0.26443635450665315,0.5556862138088725,0.9523809523809523,1.0,1.0,10/10,73.57%,FTO;MGMT;ASCC2;ALKBH5;ASCC1;MPG;ALKBH3;ASCC3;ALKBH1;ALKBH2
prerank,inositol phosphate dephosphorylation (GO:0046855),-0.22845929121238595,-0.5545830856137083,0.9736147757255936,0.9997412515415972,1.0,5/11,28.78%,SYNJ2;INPP1;PTEN;IMPA2;INPP5J
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),-0.22845929121238595,-0.5545830856137083,0.9736147757255936,0.9997412515415972,1.0,5/11,28.78%,SYNJ2;INPP1;PTEN;IMPA2;INPP5J
prerank,P-body assembly (GO:0033962),-0.21420244481512396,-0.5533894829761642,0.9594594594594594,0.9991688616984625,1.0,5/12,24.76%,EIF4ENIF1;ATXN2;RC3H1;LIMD1;LSM3
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.2637946472027391,0.5531630581202897,0.9402460456942003,1.0,1.0,4/12,23.17%,NSMCE2;ANAPC4;RB1;CDC23
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.2637946472027391,0.5531630581202897,0.9402460456942003,1.0,1.0,4/12,23.17%,NSMCE2;ANAPC4;RB1;CDC23
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),0.2637946472027391,0.5531630581202897,0.9402460456942003,1.0,1.0,4/12,23.17%,NSMCE2;ANAPC4;RB1;CDC23
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.20940703834666965,0.5531191326416633,0.9752604166666666,1.0,1.0,17/40,30.86%,CENPS;ATRX;MMS22L;DONSON;PCNA;ATR;NUCKS1;THOC1;CDK9;FANCM;FBH1;POLD1;SETMAR;PRIMPOL;ZRANB3;DDX11;RFWD3
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.26615994983040137,0.5525977993838109,0.9320557491289199,1.0,1.0,1/10,5.26%,PIH1D1
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),0.26734838688422097,0.552145100307426,0.9451114922813036,1.0,1.0,3/10,26.01%,ATRX;STOML2;WIZ
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.22937120092290056,0.5513553022411753,0.9649122807017544,1.0,1.0,3/22,9.41%,PES1;EXOSC3;ERI3
prerank,regulation of T cell activation (GO:0050863),0.2027747549629175,0.5512094390334338,0.9767141009055628,1.0,1.0,6/42,18.69%,CCL5;LGALS3;ABL1;DUSP3;PRKCQ;GPNMB
prerank,positive regulation of bone resorption (GO:0045780),0.2594742181682077,0.5482670364478028,0.940983606557377,1.0,1.0,3/11,24.29%,PLEKHM1;ATP6AP1;PRKCA
prerank,pseudouridine synthesis (GO:0001522),-0.20998674544351678,-0.54641305527692,0.9752066115702479,1.0,1.0,3/13,19.85%,PUS7;DKC1;NOP10
prerank,regulation of cilium movement (GO:0003352),0.2670572465563355,0.5458411155271842,0.9370967741935484,1.0,1.0,3/10,24.02%,CFAP206;ODAD2;DRC1
prerank,snRNA processing (GO:0016180),0.23747346158048904,0.5456138207079175,0.9461077844311377,1.0,1.0,7/16,29.28%,INTS2;INTS3;INTS6;TUT1;INTS1;INTS9;INTS12
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),0.24511851021391384,0.5442626916146777,0.9586894586894587,1.0,1.0,3/17,21.68%,ANK3;KCNRG;VAMP2
prerank,glutathione metabolic process (GO:0006749),0.20756699943963564,0.5438018150525061,0.9750328515111695,1.0,1.0,6/38,18.46%,HAGH;CTNS;HPGDS;GSTK1;GSTM2;PARK7
prerank,organonitrogen compound catabolic process (GO:1901565),0.19409343433616186,0.5423909427414904,0.9775561097256857,1.0,1.0,14/57,22.81%,NAGK;GGACT;NPEPPS;ADO;LTA4H;TXN2;SMPD2;PLA2G6;SIAH1;IDE;PDXDC1;LVRN;GNPDA2;SGPL1
prerank,regulation of DNA damage checkpoint (GO:2000001),0.2666346405047268,0.5410051512525457,0.9324546952224053,1.0,1.0,2/10,10.99%,DDX39B;FEM1B
prerank,pinocytosis (GO:0006907),0.260224825389061,0.5407728132382896,0.9533011272141707,1.0,1.0,2/10,17.33%,SNX33;MAPKAPK2
prerank,positive regulation of cell division (GO:0051781),0.20481490735437982,0.5389315640614227,0.982620320855615,1.0,1.0,7/38,20.17%,PKP4;CDC42;AURKC;RHOA;CDC25B;KIF20B;CSPP1
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.2222640095812421,0.5384999158872851,0.9674220963172805,1.0,1.0,7/23,25.25%,DNASE1L2;DNASE1L1;REXO4;KPNA1;CASP3;DFFA;FBH1
prerank,glycogen biosynthetic process (GO:0005978),-0.21472025943570078,-0.5380254750901831,0.9705093833780161,1.0,1.0,6/12,29.96%,UGP2;GBE1;PGM1;GYS1;GYG1;PGM2L1
prerank,glucan biosynthetic process (GO:0009250),-0.21472025943570078,-0.5380254750901831,0.9705093833780161,1.0,1.0,6/12,29.96%,UGP2;GBE1;PGM1;GYS1;GYG1;PGM2L1
prerank,snRNA 3'-end processing (GO:0034472),-0.18460920016107488,-0.5365009469212115,0.9719626168224299,1.0,1.0,9/19,32.84%,EXOSC7;EXOSC2;INTS14;TOE1;USB1;INTS5;EXOSC9;EXOSC5;EXOSC8
prerank,global genome nucleotide-excision repair (GO:0070911),0.21662057391270245,0.5358884058211836,0.9672830725462305,1.0,1.0,6/26,19.88%,RBX1;DDB1;RPS27A;UBC;ERCC2;ERCC4
prerank,ribonucleoprotein complex biogenesis (GO:0022613),0.1937422150307178,0.5352370725528224,0.986335403726708,1.0,1.0,14/57,24.09%,GLUL;PES1;SDAD1;NIP7;HEATR3;PAK1IP1;RPL14;METTL17;RPS28;BYSL;RPL7;WDR74;SHQ1;RPL26
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",0.2408299683655702,0.5342165689307574,0.9363354037267081,1.0,1.0,6/14,28.71%,TRPT1;CLP1;TSEN2;FAM98B;CSTF2;RTCB
prerank,sensory perception of taste (GO:0050909),0.2585990459452674,0.5331540124462181,0.9464594127806563,1.0,1.0,10/10,74.16%,PKD2L1;ASIC2;TAS1R3;GNAT3;TAS1R2;TAS1R1;ASIC3;CD36;ASIC1;PKD1L3
prerank,regulation of transcription by RNA polymerase III (GO:0006359),0.22608465846677384,0.5330183457834325,0.9623188405797102,1.0,1.0,7/19,26.16%,ELL;POLR3C;POLR3G;NAB2;POLR3F;ICE1;ZC3H8
prerank,regulation of protein localization (GO:0032880),0.19123689752106587,0.532485113527759,0.9841849148418491,1.0,1.0,15/58,22.76%,TRIM25;TRIM21;DVL3;CSNK1E;SLC26A4;VPS4A;HSP90AA1;TESK1;AAK1;KDM1A;RAB9A;FBXW7;TRIM5;ADCYAP1;TPR
prerank,negative regulation of oxidoreductase activity (GO:0051354),0.25442039281606804,0.5310602488095834,0.9566666666666667,1.0,1.0,2/10,17.34%,HP;HDAC6
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.24893816265677388,0.5303312592380128,0.9564516129032258,1.0,1.0,3/13,17.41%,UBE2G2;BCAP31;UBE2J1
prerank,cellular modified amino acid catabolic process (GO:0042219),0.2408316409074849,0.5298753116311358,0.9509954058192955,1.0,1.0,1/15,3.38%,GGACT
prerank,regulation of mRNA 3'-end processing (GO:0031440),0.25134529523617954,0.5289766196255663,0.9574105621805792,1.0,1.0,1/11,4.79%,AHCYL1
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",0.25631206355217495,0.52763317226855,0.9394957983193277,1.0,1.0,5/10,26.15%,VPS9D1;ATP5PD;ATP5F1D;ATP5F1C;ATP5MC3
prerank,mitotic sister chromatid segregation (GO:0000070),0.17865177389742015,0.5271923051920363,0.9988851727982163,1.0,1.0,30/98,26.59%,PSRC1;CHMP4A;CHMP4B;TENT4A;NCAPD3;ZW10;VPS4B;CHMP1A;PINX1;VPS4A;SET;CHMP2A;NCAPH2;PDCD6IP;ZWINT;RB1;PHF13;NUDC;NCAPH;SMC4;KMT5A;CDC23;TUBG1;CHMP5;MIS12;NUP62;SEH1L;DCTN2;RRS1;CHMP1B
prerank,regulation of double-strand break repair (GO:2000779),0.1987970527473571,0.526577078026959,0.9869109947643979,1.0,1.0,6/39,16.82%,SHLD2;FOXM1;PML;TWIST1;UBR5;KDM1A
prerank,protein monoubiquitination (GO:0006513),0.20199045523009115,0.5264524354967041,0.9827127659574468,1.0,1.0,5/36,12.15%,TRIM25;TRIM21;RBX1;UBE2B;RNF126
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),-0.17270299156598,-0.5263977298068155,0.9935483870967742,1.0,1.0,5/24,19.92%,TNKS;NAT10;GNL3L;CTC1;STN1
prerank,NLS-bearing protein import into nucleus (GO:0006607),0.2396030131932087,0.5261802478704845,0.9601910828025477,1.0,1.0,3/13,17.56%,KPNA7;KPNA4;KPNA1
prerank,hexose transmembrane transport (GO:0008645),0.22236355147071069,0.522123355566064,0.9721407624633431,1.0,1.0,3/21,12.58%,SLC2A12;SLC2A8;SLC2A9
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.18677753912813191,0.522043672500576,0.9888751545117429,1.0,1.0,12/54,19.54%,NLRP2B;TNFRSF1A;PYDC1;CARD16;PTPN2;CHUK;IKBKG;RNF31;SPPL2B;OTULIN;SPPL2A;ADAM17
prerank,negative regulation of mRNA catabolic process (GO:1902373),-0.16133751097316967,-0.5211112835932838,0.9962546816479401,1.0,1.0,6/29,19.57%,TENT5A;EIF4ENIF1;AXIN2;TENT5D;FMR1;NOCT
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),0.23438926436241292,0.5207188451244665,0.9617737003058104,1.0,1.0,3/15,17.05%,MAGEL2;WASHC1;ARPC2
prerank,cotranslational protein targeting to membrane (GO:0006613),0.17688080955623506,0.5187578287908878,0.9977246871444824,1.0,1.0,29/91,28.77%,SIL1;RPS4X;SSR1;RPL31;RPSA;RPL22;RPL28;RPS26;RPL10A;RPL14;RPS27A;RPL6;RPS28;ARL6IP1;RPL41;RPLP2;RPLP1;SRP14;RPL7;RPL21;RPL26;RPS27;RPS12;RPL18;RPS17;RPS3;RPL24;RPS6;SSR2
prerank,lipid droplet organization (GO:0034389),-0.17346300693778055,-0.5146493885876293,0.9875389408099688,1.0,1.0,5/22,22.42%,CDS2;PNPLA3;PLA2G4C;RAB3GAP1;FITM2
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.18815237187394532,0.5102494714175616,0.9871134020618557,1.0,1.0,17/45,29.92%,FOXO3;GCNT2;MEX3D;EIF2B4;APP;GEMIN5;ZC3H7A;EIF2A;PER1;TCOF1;ZC3H10;RBM3;LARP1;TRIM71;PUM2;METTL18;CYFIP1
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.23287395547353634,0.509033970350315,0.9710806697108066,1.0,1.0,2/15,11.68%,PMAIP1;IRS2
prerank,positive regulation of leukocyte migration (GO:0002687),-0.16097299290279765,-0.508758299843587,0.996551724137931,1.0,1.0,7/27,25.77%,IL6R;NCKAP1L;ICAM1;EDN3;CSF1;JAM3;ADAM8
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),-0.2048352023949986,-0.5079937727624302,0.9778325123152709,1.0,1.0,1/11,2.87%,PANK2
prerank,coenzyme A biosynthetic process (GO:0015937),-0.2048352023949986,-0.5079937727624302,0.9778325123152709,1.0,1.0,1/11,2.87%,PANK2
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),-0.2048352023949986,-0.5079937727624302,0.9778325123152709,1.0,1.0,1/11,2.87%,PANK2
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.17264198747124151,0.507401785794203,0.9976218787158145,1.0,1.0,16/70,24.74%,PSMD11;PSMD4;PSMF1;PSMD7;FCER1G;PSMB5;CHUK;IKBKG;PSMD1;PSMC4;PSMD8;SNAP23;FCGR1A;PSMA7;IKBKB;TAPBP
prerank,regulation of protein localization to cell periphery (GO:1904375),0.22091715949848262,0.5064938521594061,0.9738751814223512,1.0,1.0,6/18,21.14%,ACTB;ABCA2;VTI1B;VPS4A;MISP;MMP14
prerank,DNA replication checkpoint signaling (GO:0000076),-0.18652160682814034,-0.5064232083669792,0.9878787878787879,0.9998498491675152,1.0,8/16,37.55%,HUS1;TIPIN;ORC1;CDC45;DNA2;NAE1;RAD9B;TICRR
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),-0.18558437235151565,-0.5064149921585402,0.9943342776203966,0.9989021878139165,1.0,3/18,17.40%,LYN;SPG21;SH2B2
prerank,protein localization to condensed chromosome (GO:1903083),-0.20147589401378016,-0.5050422524280465,0.9896640826873385,0.9982179540961117,1.0,4/12,22.54%,IK;ZWILCH;BUB3;KNL1
prerank,modulation by symbiont of host process (GO:0044003),-0.2153386635466008,-0.5043888446904952,0.9673659673659674,0.9973918320059013,1.0,6/10,39.10%,B2M;MRC1;UBB;UBA52;TLR2;HGS
prerank,body fluid secretion (GO:0007589),0.22189304920673086,0.5031875784440301,0.9700149925037481,1.0,1.0,1/15,6.56%,ZBTB7B
prerank,negative regulation of T cell mediated immunity (GO:0002710),0.24336384323991248,0.5024737575781136,0.9576988155668359,1.0,1.0,1/11,8.98%,FOXP3
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.19744710377893937,0.5011865181935512,0.9847222222222223,1.0,1.0,4/27,14.46%,CMPK1;AK5;AK6;CTPS2
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.2102807926216981,0.5010003553893325,0.9800285306704708,1.0,1.0,2/22,9.25%,ZDHHC12;GOLGA7
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.2102807926216981,0.5010003553893325,0.9800285306704708,1.0,1.0,2/22,9.25%,ZDHHC12;GOLGA7
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",-0.1810009990097572,-0.5009748339707939,0.9798270893371758,0.9970780245047144,1.0,7/17,31.03%,IK;BOD1;ZWILCH;BUB3;KNL1;SPDL1;CENPA
prerank,regulation of microtubule nucleation (GO:0010968),0.2409321110717373,0.500757994620866,0.9542586750788643,1.0,1.0,2/10,17.29%,EML2;GIT1
prerank,positive regulation of cilium assembly (GO:0045724),0.21524209542190265,0.5000702193598363,0.9814020028612304,1.0,1.0,6/18,23.97%,MARK4;SEPTIN9;CCDC88A;CROCC;TAPT1;CEP120
prerank,mitotic spindle assembly (GO:0090307),0.18717432051601918,0.4983011017268982,0.9897435897435898,1.0,1.0,12/42,25.12%,KIF2A;AURKC;RHOA;ABRAXAS1;FLNA;CHEK2;AAAS;MISP;CEP192;SMC3;RACGAP1;KIFC2
prerank,regulation of oxidative stress-induced cell death (GO:1903201),-0.2056976983818714,-0.4977713706845486,0.9740932642487047,0.996707261111783,1.0,1/11,6.60%,UBQLN1
prerank,endoplasmic reticulum mannose trimming (GO:1904380),0.21328495253810992,0.49776243771947304,0.963020030816641,1.0,1.0,3/18,16.57%,RNF5;RPS27A;UBC
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),0.20779393146080183,0.497106375170786,0.978386167146974,1.0,1.0,4/21,18.46%,ABCD1;COA8;HDAC6;PARK7
prerank,protein localization to chromosome (GO:0034502),0.1946334611430099,0.49709043045252954,0.9854304635761589,1.0,1.0,9/34,20.98%,PARP3;ATRX;PINX1;MCM8;TNKS2;ATR;WAPL;RB1;TERF2
prerank,female gonad development (GO:0008585),0.21479872849577863,0.49700952883020044,0.9740853658536586,1.0,1.0,2/19,7.61%,EIF2B2;ANG
prerank,male meiosis I (GO:0007141),0.21476684466721704,0.4968607256758238,0.9739263803680982,1.0,1.0,4/16,23.42%,MOV10L1;MYBL1;BRDT;FOXJ2
prerank,maintenance of protein localization in organelle (GO:0072595),0.2118391918124362,0.49684990105916493,0.9757834757834758,1.0,1.0,5/19,23.62%,PML;HK1;ARL2BP;TAF8;TAPT1
prerank,mitotic nuclear division (GO:0140014),0.17329671191486895,0.4967161543674527,0.9963942307692307,1.0,1.0,21/71,25.12%,NDEL1;KIF2A;PPP2R2D;CHMP4B;ZW10;RHOA;ABRAXAS1;CHMP2A;FLNA;CHEK2;AAAS;ZWINT;MISP;SMC4;CEP192;SMC3;KLHDC8B;TUBG1;MIS12;NUP62;KIFC2
prerank,histone exchange (GO:0043486),0.18733356483831148,0.49419891718056186,0.9892183288409704,1.0,1.0,7/37,17.91%,CENPS;CENPT;SRCAP;CENPH;CENPO;SPTY2D1;ZNHIT1
prerank,inositol phosphate catabolic process (GO:0071545),-0.198524431916847,-0.49384172907672746,0.9866666666666667,0.996469435875851,1.0,5/12,28.78%,SYNJ2;INPP1;PTEN;IMPA2;INPP5J
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.22564799953427853,0.4917570408760513,0.9755351681957186,1.0,1.0,3/15,18.75%,MUL1;PTPN2;YTHDF3
prerank,histone ubiquitination (GO:0016574),0.20667711654628756,0.4906753872402593,0.9870689655172413,1.0,1.0,6/21,23.49%,UBE2B;UBE2N;USP22;UBE2E1;CTR9;LEO1
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.16668335091357747,0.4899160713043763,0.997624703087886,1.0,1.0,15/67,24.74%,PSMD11;PSMD4;PSMF1;PSMD7;PSMB5;CHUK;IKBKG;PSMD1;PSMC4;PSMD8;SNAP23;FCGR1A;PSMA7;IKBKB;TAPBP
prerank,autophagy of mitochondrion (GO:0000422),-0.14342303822937627,-0.4817169728598491,1.0,0.9974890493563803,1.0,38/38,85.70%,ATG5;FIS1;FUNDC2;MAP1LC3A;GABARAP;PHB2;AMBRA1;ATG14;ATG7;ULK2;USP30;BECN1;MARK2;GABARAPL1;FUNDC1;ATG9B;ATG9A;SQSTM1;SPATA18;PINK1;ATG2A;WDR45B;BNIP3;ATG13;PRKN;WIPI1;WDR45;ATG12;FBXO7;CISD2;ATG2B;WIPI2;ATG3;GABARAPL2;CTSK;RB1CC1;MAP1LC3B;ULK1
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.21099706827132964,0.4815537613552267,0.974512743628186,1.0,1.0,2/16,8.48%,CHMP4A;CHMP4B
prerank,ribosomal small subunit biogenesis (GO:0042274),0.18017256002397436,0.47987664657628204,0.9933065595716198,1.0,1.0,7/39,21.35%,MRPS7;RPSA;PWP2;UTP4;METTL17;RPS28;DDX52
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.23575194576952047,0.4787571611027696,0.9626623376623377,1.0,1.0,10/10,76.44%,NPLOC4;C1QBP;SEC14L1;RNF125;GPATCH3;TSPAN6;RIOK3;UFD1;DHX58;TKFC
prerank,negative regulation of innate immune response (GO:0045824),0.18692694350212768,0.4773081851240707,0.996042216358839,1.0,1.0,4/34,12.51%,MUL1;TRIM21;NMI;PTPN2
prerank,protein targeting to ER (GO:0045047),0.1604977730759539,0.4762823254978248,1.0,1.0,1.0,26/99,26.53%,RPS4X;CHMP4A;CHMP4B;RPL31;RPSA;RPL22;SPCS3;RPL28;RPS26;RPL10A;RPL14;RPS27A;RPL6;RPS28;RPL41;RPLP2;RPLP1;SGTA;SRP14;RPL7;RPL21;RPL26;RPS27;RPS12;RPL18;RPS17
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",0.21152557598229682,0.4726159829203143,0.9734789391575663,1.0,1.0,6/15,28.71%,TRPT1;CLP1;TSEN2;FAM98B;CSTF2;RTCB
prerank,osteoclast differentiation (GO:0030316),0.19591197785880826,0.47153845868784017,0.9897959183673469,1.0,1.0,3/22,14.17%,ANXA2;SBNO2;FOXP1
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.201345973247545,0.46978300693467623,0.9863013698630136,1.0,1.0,2/17,10.22%,TGFB2;ARL6IP5
prerank,regulation of centriole replication (GO:0046599),0.20506726077609716,0.4664969836924547,0.9817905918057663,1.0,1.0,5/17,25.06%,CEP76;PLK2;TRIM37;PLK4;NUP62
prerank,piRNA metabolic process (GO:0034587),0.20091727255352337,0.46583932207644135,0.984984984984985,1.0,1.0,2/19,14.05%,MOV10L1;MYBL1
prerank,positive regulation of lipid transport (GO:0032370),-0.17991211550533584,-0.46478769803295356,0.9947780678851175,0.998803237144284,1.0,12/12,82.03%,ABCA3;LRP1;ABCA12;CYP19A1;APOE;PRELID1;PRAP1;ADIPOQ;DBI;SPP1;ABCB4;TRIAP1
prerank,regulation of chromosome organization (GO:0033044),0.19271037669898258,0.46335289167015326,0.9884892086330935,1.0,1.0,9/22,29.48%,MYC;WAPL;RB1;MAPT;TERF2;HDAC8;XRCC5;SETMAR;TERF2IP
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.2151668092491971,0.4606421500040248,0.9787234042553191,1.0,1.0,1/11,11.40%,PKD2L1
prerank,oogenesis (GO:0048477),-0.16806235042745912,-0.4586665980292585,0.9882005899705014,0.9985163331663105,1.0,5/15,32.78%,MARF1;PIWIL2;NANOS3;TRIP13;MEI4
prerank,nucleocytoplasmic transport (GO:0006913),0.17146161586805883,0.45676324339594737,0.9973579920739762,1.0,1.0,13/40,27.56%,SNRPB;NXT2;GEMIN6;RITA1;AAAS;SNUPN;DDX20;GEMIN5;GEMIN8;GEMIN2;RBM15B;SNRPD2;SNRPD1
prerank,calcium-ion regulated exocytosis (GO:0017156),0.17918338470313502,0.44226166446965753,0.9897810218978103,1.0,1.0,9/27,24.40%,SYT6;VAMP7;SYT11;SYT12;SYT3;VAMP2;SYT2;ARL8B;SYT13
prerank,establishment of skin barrier (GO:0061436),0.19258707649879353,0.4422194293684095,0.9843014128728415,1.0,1.0,1/15,7.33%,LSR
prerank,regulation of water loss via skin (GO:0033561),0.19258707649879353,0.4422194293684095,0.9843014128728415,1.0,1.0,1/15,7.33%,LSR
prerank,DNA biosynthetic process (GO:0071897),-0.16705435626565446,-0.44057710381021564,1.0,0.9991273307254548,1.0,7/16,35.02%,WRNIP1;TYMS;RFC3;POLA1;POLD4;POLL;POLD3
prerank,coenzyme A metabolic process (GO:0015936),0.20089408967975056,0.44044189441061754,0.9885245901639345,1.0,1.0,4/14,25.07%,DCAKD;PPCDC;ACLY;PANK1
prerank,protein exit from endoplasmic reticulum (GO:0032527),0.17981048459993726,0.4403452564105179,0.9957264957264957,1.0,1.0,8/23,28.45%,TECPR2;NPLOC4;PREB;SEC16A;TMEM129;HSP90B1;LMAN1;DERL2
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.210287830721207,0.4394673025511584,0.9869918699186991,1.0,1.0,2/11,15.84%,GSTO1;GSTM2
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.210287830721207,0.4394673025511584,0.9869918699186991,1.0,1.0,2/11,15.84%,GSTO1;GSTM2
prerank,positive regulation of mRNA processing (GO:0050685),0.18214936247723162,0.4393931377056102,0.9912408759124087,1.0,1.0,21/21,81.81%,DAZAP1;LEO1;CELF4;RBM3;RBMXL1;TRA2B;NCL;CDC73;NUP98;RBMX;PRDX6;SNW1;TRA2A;CIRBP;THRAP3;CELF3;NCBP2;DHX36;SF3B4;NCBP1;PAF1
prerank,mitotic DNA replication (GO:1902969),0.21672681407281597,0.43837189089422457,0.9849749582637729,1.0,1.0,4/10,26.93%,MCM6;GINS3;MCM4;MCM2
prerank,cellular response to hydroxyurea (GO:0072711),0.2131318118650209,0.4380504907765676,0.991652754590985,1.0,1.0,3/10,23.80%,ATRX;DDI2;RTF2
prerank,2-oxoglutarate metabolic process (GO:0006103),0.20288713662588057,0.4362727846362275,0.9922839506172839,1.0,1.0,5/13,26.18%,OGDH;DLST;IDH1;GPT2;IDH2
prerank,mitotic spindle checkpoint signaling (GO:0071174),0.1847440352889361,0.4359470935019253,0.9910846953937593,1.0,1.0,6/20,22.76%,ZW10;MAD1L1;TTK;ZWINT;CENPF;TPR
prerank,spindle assembly checkpoint signaling (GO:0071173),0.1847440352889361,0.4359470935019253,0.9910846953937593,1.0,1.0,6/20,22.76%,ZW10;MAD1L1;TTK;ZWINT;CENPF;TPR
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),0.1847440352889361,0.4359470935019253,0.9910846953937593,1.0,1.0,6/20,22.76%,ZW10;MAD1L1;TTK;ZWINT;CENPF;TPR
prerank,defense response to fungus (GO:0050832),0.18907378335949787,0.43330377515036284,0.9908116385911179,1.0,1.0,17/17,81.11%,GAPDH;RNASE7;FAM3A;BCL10;DEFB119;NLRP10;CLEC4E;LTF;CLEC6A;S100A8;CLEC4D;CARD9;S100A9;HRG;PLCG2;CX3CR1;RARRES2
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.2016416958268447,0.4330905819316944,0.9936204146730463,1.0,1.0,4/12,25.47%,MAD1L1;RMDN1;MIS12;SEH1L
prerank,regulation of dopamine secretion (GO:0014059),0.17450787905304793,0.4272333529394044,0.9912663755458515,1.0,1.0,8/25,26.11%,GDNF;SYT6;SYT11;SYT12;SYT3;SYT2;SYT13;SNCA
prerank,positive regulation of DNA recombination (GO:0045911),0.16959181350759467,0.42276092856346525,0.9905660377358491,1.0,1.0,2/27,9.55%,SHLD2;RIF1
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.177362267418299,0.4221882099339282,0.9985611510791367,1.0,1.0,8/18,33.21%,AQP1;PCK2;ZFP36L1;UBE2L3;FAM107A;REST;HNRNPU;ANXA1
prerank,regulation of chromosome segregation (GO:0051983),0.18623634308677606,0.420863176240905,0.9923430321592649,1.0,1.0,16/16,81.40%,SMC6;NUMA1;IHO1;CDC6;PUM2;PUM1;MKI67;HORMAD1;AURKB;KIF2C;BUB1;CSNK2A2;CSNK2A1;RMI2;RAD18;SMC5
prerank,regulation of catecholamine secretion (GO:0050433),0.16769428304759465,0.41817232158678724,0.9985855728429985,1.0,1.0,10/29,26.67%,KCNB1;GRK2;SYT6;SYT11;SYT12;SYT3;SYT2;SYT13;SNCA;CHGA
prerank,T cell activation involved in immune response (GO:0002286),0.19773183698749597,0.4159906400477033,0.9850746268656716,1.0,1.0,2/12,17.03%,FCER1G;EIF2AK4
prerank,positive regulation of heterochromatin assembly (GO:0031453),-0.16978562801858074,-0.4154208943961488,0.9973753280839895,0.9995903033821684,1.0,2/11,17.33%,TASOR;SETDB2
prerank,regulation of T cell mediated immunity (GO:0002709),0.19878230384532214,0.4138726831310996,0.9950083194675541,0.9998674505273986,1.0,2/10,20.34%,TRPM4;AGER
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),0.14178727642991776,0.4133782000854428,0.9988465974625144,0.9995280268127836,1.0,23/87,27.19%,RPS4X;RPL31;RPSA;RPL22;RPL28;RPS26;RPL10A;RPL14;RPS27A;RPL6;RPS28;RPL41;RPLP2;RPLP1;SRP14;RPL7;RPL21;RPL26;RPS27;RPS12;RPL18;RPS17;RPS3
prerank,mitochondrion disassembly (GO:0061726),0.16299859068906866,0.41161822078936033,1.0,0.9992942364980545,1.0,14/34,30.18%,ULK1;MAP1LC3B;RB1CC1;CTSK;GABARAPL2;ATG3;WIPI2;ATG2B;CISD2;FBXO7;ATG12;WDR45;WIPI1;PRKN
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.18121158185169484,0.41134987168330794,0.9923195084485407,0.9989482554490409,1.0,5/16,26.67%,GSK3A;NECAB2;GPER1;PRKCA;CHGA
prerank,cellular response to oxygen levels (GO:0071453),0.19677573628608652,0.409590736742494,0.9935379644588045,0.9987237219293137,1.0,6/10,33.23%,ATP6V0D1;ATP6AP1;TMEM199;ATP6V0A2;CPEB4;NDUFS2
prerank,meiosis I (GO:0007127),-0.1325164838005834,-0.405480200288855,0.9969512195121951,0.9990338127426188,1.0,11/23,40.39%,ING2;BCL2L11;ZSCAN21;HSF2BP;SYCP3;SGO1;TDRD9;DDX4;MEIOB;ZCWPW1;SLC25A31
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",0.16927765481938212,0.39113557961289713,1.0,0.9995564224576395,1.0,6/17,28.45%,NPLOC4;HM13;RHBDD1;TMEM129;HSP90B1;DERL2
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.17259998744270735,0.38321568893107394,0.9968944099378882,0.9991963502137101,1.0,15/15,82.76%,CPEB3;PABPC1;ZFP36L1;CNOT1;TOB1;TNRC6C;NANOS1;ZFP36L2;NANOS2;TNRC6B;AGO2;NANOS3;DHX36;ZFP36;CNOT7
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.17259998744270735,0.38321568893107394,0.9968944099378882,0.9991963502137101,1.0,15/15,82.76%,CPEB3;PABPC1;ZFP36L1;CNOT1;TOB1;TNRC6C;NANOS1;ZFP36L2;NANOS2;TNRC6B;AGO2;NANOS3;DHX36;ZFP36;CNOT7
prerank,B cell mediated immunity (GO:0019724),0.17936704293847816,0.3718479660741313,0.9966996699669967,0.9992701569706678,1.0,1/10,11.65%,FCER1G
prerank,regulation of RNA export from nucleus (GO:0046831),0.16404016456751697,0.3393375993017548,1.0,0.9996699261003262,1.0,3/11,23.06%,DHX9;TPR;NRDE2
